data_2l8o_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l8o _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 82.0 mt -55.42 132.49 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -130.31 139.11 50.74 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.4 m -136.15 156.38 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -145.24 157.48 44.06 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.038 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 p -145.81 142.78 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.9 p -97.18 117.34 31.17 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.55 126.12 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -93.64 88.73 5.96 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.09 0.471 . . . . 0.0 109.863 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.88 153.12 4.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.055 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.74 139.3 58.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.221 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.5 tp -51.07 -36.79 16.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 120.893 0.378 . . . . 0.0 111.612 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -67.66 -33.1 74.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.44 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -71.17 -51.32 25.53 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 p -65.3 -36.59 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.318 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -54.61 -43.41 72.18 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.932 0.396 . . . . 0.0 110.56 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -68.37 -45.33 73.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.622 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -65.71 -44.42 86.14 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.902 0.382 . . . . 0.0 111.497 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -66.75 -20.7 66.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.932 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -102.63 -22.56 13.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.982 0.513 . . . . 0.0 111.512 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -64.16 123.02 80.96 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.93 -39.74 3.07 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 CA-C-N 120.863 1.344 . . . . 0.0 111.889 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.11 -39.21 71.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.894 0.378 . . . . 0.0 110.759 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.9 m170 -66.33 -42.86 87.57 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.64 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 31' ' ' CYS . 97.2 mt -62.61 -43.75 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 93.5 mtp -59.31 -13.45 8.06 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.737 -0.21 . . . . 0.0 111.077 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -85.14 -38.56 18.91 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.978 -0.451 . . . . 0.0 110.759 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -122.4 23.74 9.58 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.729 0.412 . . . . 0.0 111.216 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.589 ' C ' ' H ' ' A' ' 33' ' ' ALA . 38.3 t -54.39 129.37 35.4 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.804 -0.56 . . . . 0.0 110.958 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 68.54 -30.67 0.18 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.341 0.401 . . . . 0.0 110.478 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.65 38.37 29.85 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.048 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.7 p -136.81 141.46 35.15 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.302 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.39 -16.41 21.87 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 122.008 1.805 . . . . 0.0 112.289 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -84.06 14.1 4.48 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -151.41 154.81 37.36 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.171 0.51 . . . . 0.0 110.232 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -142.5 163.01 33.99 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.234 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.58 89.57 50.72 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.97 -12.22 23.74 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.263 1.309 . . . . 0.0 111.479 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -171.91 153.05 3.13 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.02 0.438 . . . . 0.0 110.577 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -157.84 150.72 22.92 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.214 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -137.08 145.33 43.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.591 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -161.46 132.32 5.22 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.96 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -128.98 96.01 4.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.0 tp -65.8 96.65 0.3 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -167.67 142.31 3.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.964 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.55 138.19 58.41 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.23 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.27 2.44 59.12 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.9 166.49 37.29 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.8 p -129.14 164.95 22.24 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.639 0.376 . . . . 0.0 110.047 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -140.71 164.52 29.98 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.6 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 36.1 m -150.61 122.56 8.19 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.421 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 37.5 m -116.39 116.57 27.94 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.2 m -95.11 119.68 34.04 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 14.8 ptm -145.67 144.83 30.64 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.75 156.15 40.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.061 0.458 . . . . 0.0 110.535 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.81 148.05 40.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.666 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -56.58 -39.87 74.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.763 0.315 . . . . 0.0 110.721 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -76.37 -7.46 55.05 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.18 11.32 67.13 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.5 t -62.93 -41.84 99.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.45 0.167 . . . . 0.0 111.097 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.9 ttt -120.85 146.32 46.7 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -144.11 141.25 29.9 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.81 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.438 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 56.4 t80 -159.98 161.26 34.1 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.438 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 67.4 t0 -138.54 126.56 22.59 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -94.76 135.54 36.13 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.66 155.74 26.5 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.05 -171.4 41.39 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 p -128.72 139.67 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.785 0.434 . . . . 0.0 110.008 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -78.36 124.96 28.69 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -75.85 -40.01 55.55 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.926 0.393 . . . . 0.0 110.09 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -159.83 146.03 15.93 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.844 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.2 t -135.69 130.69 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -145.4 123.61 12.21 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.4 m -55.12 122.28 10.65 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.9 m120 54.79 60.54 3.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.608 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -156.12 -82.31 0.07 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.089 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.6 tp -147.76 136.8 22.15 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.554 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.7 mt -129.79 126.78 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -154.16 164.18 38.92 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -155.05 154.98 33.3 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.941 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.1 m -87.58 129.53 35.07 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.78 139.87 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.66 -43.21 59.43 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -60.72 -18.56 55.09 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.633 0.254 . . . . 0.0 110.73 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.31 0.67 65.13 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -60.71 168.64 2.17 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -125.19 118.38 25.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.789 0.436 . . . . 0.0 110.126 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -131.96 125.12 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -135.24 136.63 41.86 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.0 mt -112.48 111.52 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.9 t -97.36 128.33 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -98.61 122.15 41.45 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.268 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.1 m -144.75 149.67 35.93 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -142.14 129.16 20.78 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.7 m -63.89 -45.8 87.71 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-O 121.135 0.493 . . . . 0.0 109.968 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.09 -69.43 0.08 OUTLIER Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -102.07 10.04 39.83 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.753 0.421 . . . . 0.0 110.963 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 54.7 m -147.18 129.88 16.06 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.2 m -86.65 140.21 30.03 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -120.47 116.69 25.93 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.6 mt -96.19 124.79 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -120.34 128.35 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -142.0 125.43 16.65 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 120.858 0.361 . . . . 0.0 110.541 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.4 p -94.88 150.99 19.59 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -134.47 149.96 50.77 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 CA--C 1.549 0.907 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.123 -179.662 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 111.111 0.041 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -59.26 -47.68 84.46 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.5 t -68.94 -25.2 64.44 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.278 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.59 -51.87 48.17 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -62.01 -38.14 87.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.902 0.382 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -70.76 -37.08 73.38 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.723 0.297 . . . . 0.0 110.38 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.11 -51.62 69.24 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.795 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.0 tt -63.66 -37.68 80.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.702 0.287 . . . . 0.0 110.381 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.9 mt -63.45 -37.13 86.1 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -60.92 -30.95 70.51 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.562 0.22 . . . . 0.0 110.877 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.7 m -56.15 -35.48 67.21 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.665 0.269 . . . . 0.0 110.968 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.276 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.6 mttm . . . . . 0 C--O 1.233 0.203 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.1 mt -48.45 138.47 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 t -135.69 138.73 43.08 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.7 m -139.14 157.35 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -147.95 159.92 43.37 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.322 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 p -145.82 142.39 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.1 m -97.29 118.25 33.34 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.36 128.16 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -93.69 85.41 4.85 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.45 153.01 3.39 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.981 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.86 135.51 55.82 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.0 tt -54.52 -32.12 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.673 0.273 . . . . 0.0 111.29 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -60.35 -39.72 88.15 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.265 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -73.12 -47.61 42.66 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.38 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.64 -43.38 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.094 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.405 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 22.4 t-105 -54.76 -38.16 66.87 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.889 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.58 -53.33 56.19 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.799 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -69.67 -40.29 76.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.545 0.212 . . . . 0.0 111.398 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -59.94 -17.46 37.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.892 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.554 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.8 OUTLIER -115.72 -28.18 6.83 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.165 0.586 . . . . 0.0 112.011 -179.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -54.76 107.5 0.88 Allowed Pre-proline 0 N--CA 1.477 0.881 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.941 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.56 -42.49 64.81 Favored 'Trans proline' 0 N--CA 1.508 2.38 0 CA-C-N 121.097 1.427 . . . . 0.0 112.296 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.98 -28.45 66.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.479 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -79.8 -37.66 34.7 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.705 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.24 -44.91 99.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.641 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.5 ptp -54.46 -21.52 10.14 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 120.694 0.283 . . . . 0.0 111.66 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -73.15 -39.49 65.63 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.811 -0.555 . . . . 0.0 111.528 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -124.31 21.72 8.68 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.74 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.546 ' C ' ' H ' ' A' ' 33' ' ' ALA . 17.9 t -60.58 134.25 56.89 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.817 -0.552 . . . . 0.0 110.315 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 69.43 -33.9 0.26 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.998 0.811 . . . . 0.0 110.519 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 53.78 21.57 2.78 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 110.577 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.5 m -108.54 110.13 61.47 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.573 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -51.54 -27.97 26.96 Favored 'Trans proline' 0 N--CA 1.513 2.658 0 C-N-CA 122.112 1.875 . . . . 0.0 112.782 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -74.75 5.33 5.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.656 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -146.89 156.48 43.12 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.415 ' CE1' ' O ' ' A' ' 57' ' ' ALA . 45.8 p-80 -144.1 163.65 32.95 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.55 94.8 48.44 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 122.886 0.474 . . . . 0.0 109.915 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.32 -8.46 17.38 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.265 1.31 . . . . 0.0 111.782 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.88 154.39 6.29 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.03 150.66 6.66 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -146.39 146.17 30.53 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -164.52 135.97 4.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.47 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -125.45 101.58 7.0 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 tp -65.73 95.79 0.25 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -169.26 141.91 2.62 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.75 137.92 58.15 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.346 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.32 0.86 48.45 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.02 153.94 36.68 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 p -105.22 158.25 16.73 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 120.871 0.367 . . . . 0.0 110.058 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -145.08 154.48 42.53 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.882 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.9 m -151.73 129.88 11.92 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.2 m -123.09 121.48 36.13 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.8 m -94.74 117.35 29.98 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 68.1 mtm -130.89 140.87 50.26 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.415 ' O ' ' CE1' ' A' ' 38' ' ' HIS . . . -147.6 147.4 30.01 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.132 0.491 . . . . 0.0 110.725 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.85 148.38 51.26 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.455 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.43 -40.19 71.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.639 0.257 . . . . 0.0 110.515 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.58 -11.24 59.98 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.12 21.21 63.63 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.7 m -80.95 -12.97 59.3 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.705 0.288 . . . . 0.0 110.674 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.1 ttt -160.59 135.31 7.53 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.8 p -145.07 162.39 37.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.995 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.485 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 52.8 t80 -159.28 163.68 35.55 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.485 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 73.9 m-20 -137.88 123.65 19.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -95.29 141.22 29.13 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.04 152.71 24.26 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.95 -171.73 42.48 Favored Glycine 0 CA--C 1.517 0.174 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.76 137.54 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -70.06 120.88 16.42 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.72 -40.9 63.23 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -164.89 148.08 8.57 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.0 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.8 p -145.86 138.56 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -143.6 130.62 20.59 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.5 m -55.11 121.15 8.14 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.581 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.0 m120 51.62 72.43 0.38 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -168.74 -79.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.378 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 tp -148.53 136.72 21.09 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.498 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.3 mt -129.82 129.47 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -154.21 165.07 37.44 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -154.5 155.18 34.39 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.7 m -87.52 129.35 35.11 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.5 139.51 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.63 -40.84 56.17 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -61.3 -17.8 55.41 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.49 3.52 71.7 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -64.11 165.44 9.16 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -121.95 121.98 38.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.955 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.92 129.11 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.56 138.7 43.26 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 73.4 mt -113.36 118.32 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.7 t -105.9 122.73 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.14 125.16 44.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.0 p -132.15 150.91 52.04 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -154.63 147.43 24.4 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.8 p -105.77 -19.47 13.74 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.87 -107.88 0.28 Allowed Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -81.44 7.41 11.89 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.397 0.279 . . . . 0.0 110.69 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.6 m -128.23 124.67 37.25 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.6 m -101.89 135.25 43.77 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -119.09 119.48 34.34 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.5 mt -99.75 127.32 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.87 130.32 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -142.36 144.83 33.36 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.5 t -111.69 149.31 31.78 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -143.12 141.4 31.21 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t70 . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.229 -179.356 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 . . . . . 0 N--CA 1.463 0.178 0 N-CA-C 110.651 -0.129 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -54.66 -47.81 73.11 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.0 t -61.82 -42.34 98.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.109 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.38 -51.73 56.08 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.563 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.5 -39.37 93.29 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.863 0.331 . . . . 0.0 110.558 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -70.98 -37.06 72.74 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.67 -52.54 64.51 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.762 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.4 tt -66.87 -36.75 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.372 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.9 mt -60.06 -41.94 93.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.187 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 128' ' ' SER . 25.8 p30 -66.4 -30.61 71.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.537 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.406 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 21.9 p -61.03 -37.74 83.66 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.864 0.364 . . . . 0.0 110.654 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 53.8 t80 . . . . . 0 CA--C 1.536 0.423 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.446 -179.73 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.7 mttp . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.971 0.415 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.2 mt -50.83 143.4 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 t -133.42 139.47 46.77 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.7 m -138.88 159.68 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.81 157.15 43.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.591 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.58 144.32 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 m -101.32 119.24 38.46 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.8 t -124.71 131.33 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -93.09 89.3 6.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.82 151.55 4.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.293 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.17 130.14 43.33 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.4 tt -52.58 -33.31 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.577 0.227 . . . . 0.0 111.28 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -60.16 -41.34 92.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.622 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -72.44 -46.55 54.49 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.864 0.364 . . . . 0.0 110.033 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.28 -43.02 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.613 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -55.91 -43.88 77.74 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.787 0.327 . . . . 0.0 110.744 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 23' ' ' GLU . 88.5 tttt -67.82 -47.52 68.81 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.588 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.36 -43.09 95.63 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.697 0.284 . . . . 0.0 111.382 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -61.7 -20.71 63.78 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -106.99 -23.03 12.47 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.134 0.574 . . . . 0.0 111.293 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 19' ' ' LYS . 28.5 tp10 -62.74 122.94 77.41 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 118.703 -0.665 . . . . 0.0 109.54 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.6 -38.61 5.76 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 CA-C-N 120.923 1.365 . . . . 0.0 111.607 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.67 -38.71 78.79 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.989 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.502 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 66.9 t60 -65.64 -44.01 87.73 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.56 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.402 ' C ' ' H ' ' A' ' 29' ' ' LYS . 96.9 mt -62.69 -44.87 99.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.459 ' SD ' ' N ' ' A' ' 42' ' ' ALA . 1.2 mtm -62.99 -0.02 0.63 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 27' ' ' ILE . 83.4 tttt -99.95 -50.25 4.07 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.502 ' HE1' ' CD2' ' A' ' 26' ' ' HIS . 68.6 p-90 -102.74 -3.67 26.13 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 31' ' ' CYS . 24.8 p -67.51 72.06 0.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.437 0.637 . . . . 0.0 110.009 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 30' ' ' TRP . 23.7 pt20 -153.18 48.74 0.7 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.05 -7.44 3.96 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.692 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 t -148.6 138.04 12.41 Favored Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.13 -11.9 23.32 Favored 'Trans proline' 0 N--CA 1.506 2.23 0 C-N-CA 121.71 1.607 . . . . 0.0 112.425 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -84.74 14.99 4.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.024 0.44 . . . . 0.0 110.17 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -146.57 146.69 30.55 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.975 0.417 . . . . 0.0 110.228 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -130.52 162.68 28.7 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -114.03 95.17 37.27 Favored Pre-proline 0 N--CA 1.475 0.784 0 C-N-CA 122.69 0.396 . . . . 0.0 110.585 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.79 -19.48 14.22 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 CA-C-N 120.346 1.159 . . . . 0.0 111.29 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -178.56 160.03 1.2 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.4 0.438 . . . . 0.0 110.212 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.459 ' N ' ' SD ' ' A' ' 28' ' ' MET . . . -156.41 148.81 23.48 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.135 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -136.05 146.13 46.76 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -156.02 104.23 2.27 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.691 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -98.28 86.42 3.65 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.97 93.22 0.11 Allowed 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.328 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -169.5 143.77 2.86 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.16 137.13 58.08 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.273 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.51 1.51 37.3 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.14 159.35 43.22 Favored Glycine 0 N--CA 1.468 0.808 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.7 m -119.3 155.89 31.01 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.007 0.432 . . . . 0.0 109.919 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -135.9 163.41 30.3 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.388 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.8 m -151.12 115.37 5.06 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.656 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.1 m -115.1 119.94 38.13 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 m -94.8 125.11 39.24 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.5 mtt -130.77 106.14 8.26 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.89 144.69 46.26 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.022 0.439 . . . . 0.0 110.769 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.83 148.28 50.49 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -57.99 -40.34 80.44 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.719 0.295 . . . . 0.0 110.386 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -76.18 -9.16 58.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.039 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.99 13.88 62.52 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.2 t -65.69 -19.89 66.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.988 0.423 . . . . 0.0 110.62 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.0 ttt -148.16 145.89 28.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.878 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.8 t -143.35 139.11 29.91 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.427 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 62.9 t80 -159.84 158.82 31.68 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.427 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 29.4 p-10 -138.9 134.16 32.87 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.39 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.02 139.63 31.1 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.38 152.36 24.07 Favored Glycine 0 N--CA 1.465 0.605 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.69 -174.12 41.13 Favored Glycine 0 CA--C 1.517 0.167 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.12 136.58 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -74.52 118.8 17.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.11 -37.01 69.6 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -165.09 149.2 8.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.732 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.02 131.91 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -143.64 122.14 12.44 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.5 m -59.45 123.9 18.3 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.91 0.386 . . . . 0.0 111.964 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.9 m120 52.4 59.41 4.53 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.021 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -157.27 -76.6 0.09 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.467 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 tp -152.94 135.26 15.01 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.1 mt -131.33 130.6 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -152.2 164.88 36.44 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -157.95 157.25 32.71 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.6 m -107.96 130.73 55.02 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.8 mm -93.86 151.55 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.78 -39.6 68.28 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -63.28 -11.91 25.31 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.956 0.378 . . . . 0.0 110.648 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.86 -2.13 61.77 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -72.44 152.02 42.22 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.589 ' HZ1' ' NH2' ' A' ' 91' ' ' ARG . 88.4 tttt -136.43 152.05 50.17 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -136.41 120.58 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.289 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.589 ' NH2' ' HZ1' ' A' ' 89' ' ' LYS . 87.4 mtt-85 -101.66 130.68 48.07 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 66.9 mt -118.42 125.07 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.48 124.34 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -100.4 123.44 44.63 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.1 m -122.73 124.37 43.21 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -100.73 121.57 41.88 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.5 p -105.78 8.83 33.02 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.99 122.63 0.66 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 58.32 9.9 1.16 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.715 0.293 . . . . 0.0 110.905 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.7 m -160.17 119.63 2.8 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 67.9 m -98.01 136.8 37.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -119.26 121.55 39.9 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.7 mt -100.4 123.74 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.7 t -123.95 126.68 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -143.56 145.96 32.94 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.329 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 78.3 p -126.14 148.3 49.42 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -122.45 162.45 21.66 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.585 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 . . . . . 0 N--CA 1.467 0.378 0 N-CA-C 110.52 -0.178 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -54.12 -46.21 72.11 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.973 0.416 . . . . 0.0 109.929 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.9 t -66.77 -38.83 87.35 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.248 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.03 -52.04 54.73 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.683 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -64.47 -35.96 82.62 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.776 0.322 . . . . 0.0 110.151 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -72.81 -37.1 67.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.691 0.281 . . . . 0.0 110.432 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.11 -50.55 73.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 9.0 tt -62.27 -37.99 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 53.5 mt -63.57 -42.58 98.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -65.33 -39.29 92.21 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.3 t -58.38 -33.39 69.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 46.8 t80 . . . . . 0 CA--C 1.539 0.522 0 CA-C-O 120.883 0.373 . . . . 0.0 110.904 -179.38 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 121.014 0.435 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mt -69.98 140.57 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 t -137.28 160.07 40.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.35 166.71 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.3 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -147.36 158.66 44.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.076 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -149.45 144.99 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.75 121.67 44.5 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -128.97 137.38 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -94.82 89.7 5.77 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.98 150.86 3.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.957 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 128.54 36.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.766 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.2 tt -53.36 -36.24 26.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.632 0.254 . . . . 0.0 110.998 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -57.86 -42.27 84.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.673 0.273 . . . . 0.0 110.592 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -69.93 -47.03 64.0 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.392 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.0 t -62.33 -40.38 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.515 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.429 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 66.5 t90 -54.07 -39.76 66.57 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.741 0.305 . . . . 0.0 111.345 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -63.26 -51.03 67.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.954 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -68.89 -37.25 78.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.965 0.412 . . . . 0.0 110.684 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -61.01 -18.56 58.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.853 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 18' ' ' TRP . 81.4 m-20 -115.56 -26.44 7.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.155 0.582 . . . . 0.0 110.908 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -50.64 108.73 1.09 Allowed Pre-proline 0 CA--C 1.555 1.145 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.172 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.19 -43.4 57.54 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 CA-C-N 120.512 1.218 . . . . 0.0 112.835 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.86 -30.75 69.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.556 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -79.28 -38.98 34.1 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.186 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' A' ' 31' ' ' CYS . 98.2 mt -61.93 -45.38 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 O-C-N 121.964 -0.46 . . . . 0.0 110.657 -177.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 20.5 ptp -61.73 -17.78 57.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.252 0.549 . . . . 0.0 111.251 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -74.96 -29.46 60.93 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.162 -0.336 . . . . 0.0 111.292 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -139.34 23.26 2.54 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.601 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.619 ' C ' ' H ' ' A' ' 33' ' ' ALA . 36.8 t -55.43 125.79 22.39 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.621 -0.674 . . . . 0.0 110.239 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 67.3 -22.88 0.11 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.868 0.73 . . . . 0.0 110.459 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 51.79 37.01 19.34 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 122.761 0.424 . . . . 0.0 110.977 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.2 m -111.65 96.45 32.56 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.954 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.5 -25.59 10.9 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 122.118 1.879 . . . . 0.0 112.562 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -69.04 -26.63 65.07 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.491 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -106.22 170.26 8.02 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -147.78 152.04 37.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.996 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.0 p -116.73 96.92 49.57 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.76 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.17 -9.51 17.77 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 121.541 1.494 . . . . 0.0 111.662 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.91 155.32 6.76 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.903 0.383 . . . . 0.0 110.298 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.05 145.47 13.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.922 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -139.17 144.99 38.82 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -163.0 132.46 4.21 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.585 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -135.47 103.63 5.54 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mp -69.56 98.74 1.18 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -166.31 137.66 3.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.74 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.0 134.1 56.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.286 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.9 1.69 63.21 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.25 163.27 44.83 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.8 p -129.65 161.39 30.7 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -137.84 166.84 23.03 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.93 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.4 m -151.72 110.37 3.81 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.1 p -107.07 113.01 26.21 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.0 m -86.35 113.24 22.17 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.4 mtt -122.57 129.28 51.75 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.77 150.14 29.83 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.49 148.38 48.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.596 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.72 -31.97 66.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.958 0.409 . . . . 0.0 110.565 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -74.75 -9.53 58.65 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.125 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.24 4.67 44.8 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.7 m -62.74 -34.95 78.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.641 0.258 . . . . 0.0 110.656 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 71.4 mtp -126.26 136.44 52.79 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.149 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.8 p -145.96 129.65 17.09 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.642 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -155.13 162.42 41.0 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.8 127.04 24.54 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.673 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -94.23 144.76 25.24 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -148.59 151.58 23.75 Favored Glycine 0 N--CA 1.461 0.357 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.01 175.3 42.25 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 t -121.54 132.82 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -74.82 116.12 15.18 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -73.62 -39.56 64.46 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.225 0.536 . . . . 0.0 109.591 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.437 HE21 ' HZ3' ' A' ' 75' ' ' LYS . 57.2 tt0 -166.71 147.62 6.05 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.553 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.53 130.74 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.437 ' HZ3' HE21 ' A' ' 73' ' ' GLN . 21.7 mmtp -137.82 126.17 23.27 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.4 m -58.31 123.44 16.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.71 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 51.26 69.17 0.68 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.915 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -166.98 -81.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.806 0.336 . . . . 0.0 110.148 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 tp -150.51 131.78 14.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.422 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.0 mt -132.14 131.99 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -153.97 164.47 38.38 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -162.69 155.97 19.96 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.4 p -100.45 132.28 45.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 86' ' ' ASP . 88.9 mt -93.78 140.96 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.48 28.62 1.03 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.454 ' H ' ' C ' ' A' ' 84' ' ' ILE . 29.0 t70 -120.41 -9.53 9.45 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.009 0.523 . . . . 0.0 109.897 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.79 -14.77 57.41 Favored Glycine 0 N--CA 1.479 1.533 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -75.13 174.97 8.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -146.24 151.28 37.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.715 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.6 t -140.55 136.81 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.994 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -136.51 133.69 36.77 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 75.0 mt -116.0 128.01 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.81 122.98 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -95.37 127.35 41.34 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.3 m -137.47 141.64 41.55 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -151.19 161.18 43.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 65.4 p -127.48 -13.68 5.4 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.095 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.06 -122.4 0.94 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -73.08 5.69 3.23 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.899 -0.177 . . . . 0.0 110.76 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.4 m -122.55 127.25 49.24 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.0 m -108.73 133.24 53.07 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -110.97 126.12 54.43 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.9 mt -106.3 128.38 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.9 t -129.19 133.89 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -142.19 135.24 28.73 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 86.2 p -95.13 153.33 17.7 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -145.17 145.92 31.55 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 179.918 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.584 0.231 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -59.0 -39.17 81.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.043 0.449 . . . . 0.0 110.255 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.8 t -64.86 -36.27 83.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.56 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.12 -51.72 57.15 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -63.35 -37.54 87.66 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.008 0.432 . . . . 0.0 110.145 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -73.53 -35.07 65.51 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.429 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.46 -50.34 74.09 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.686 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 36.4 pt -63.62 -34.19 66.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.725 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.0 mt -66.87 -39.4 87.52 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.026 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -63.8 -41.19 97.96 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 22.4 m -62.24 -35.15 78.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.837 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 55.7 t80 . . . . . 0 CA--C 1.531 0.23 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.037 -179.102 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.921 0.391 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 84.3 mt -57.83 139.67 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 t -133.67 141.63 47.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.774 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.76 155.3 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -148.8 162.09 40.49 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.549 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 m -149.01 152.62 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.494 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.67 119.48 38.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.171 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.8 t -123.8 127.29 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -94.9 89.34 5.6 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.95 151.37 4.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.974 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.58 135.78 56.32 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.9 tt -52.45 -37.14 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -60.62 -36.06 77.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.461 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -72.7 -48.24 40.56 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.262 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.5 t -64.0 -41.13 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.127 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 31.0 t-105 -52.97 -39.42 62.96 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.081 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -62.31 -49.7 74.58 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.528 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -65.86 -41.38 91.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.609 0.242 . . . . 0.0 110.925 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -68.78 -16.82 63.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.409 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.538 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.8 OUTLIER -112.24 -28.7 7.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.254 0.622 . . . . 0.0 112.333 -178.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.05 135.02 96.14 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.04 -42.29 0.31 Allowed 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 121.406 1.404 . . . . 0.0 111.537 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.67 69.93 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.844 0.355 . . . . 0.0 111.016 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.511 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.2 OUTLIER -76.32 -38.92 55.32 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.787 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 31' ' ' CYS . 95.1 mt -62.95 -44.02 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 O-C-N 122.031 -0.418 . . . . 0.0 111.042 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.4 ptp -63.2 -20.87 65.81 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.858 0.361 . . . . 0.0 111.066 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -67.57 -32.11 72.64 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.116 -0.365 . . . . 0.0 110.888 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -135.39 19.95 3.38 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.448 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.495 ' C ' ' H ' ' A' ' 33' ' ' ALA . 21.9 t -58.73 133.93 56.38 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.75 -0.594 . . . . 0.0 110.429 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.2 tp60 71.33 -39.87 0.46 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.213 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 56.44 29.84 15.99 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.878 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.2 m -115.12 106.68 50.99 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.269 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.73 -23.08 19.17 Favored 'Trans proline' 0 N--CA 1.506 2.212 0 C-N-CA 121.999 1.799 . . . . 0.0 112.413 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.33 2.65 12.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.683 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -142.15 169.7 17.1 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.094 0.473 . . . . 0.0 109.848 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -146.03 163.33 35.57 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.35 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 p -123.73 91.21 49.93 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 123.364 0.666 . . . . 0.0 109.777 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.34 -11.78 20.88 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.296 1.33 . . . . 0.0 111.559 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.21 152.24 6.07 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.02 146.55 9.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.24 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -134.72 145.94 48.96 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -152.56 114.91 4.47 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -133.18 95.44 3.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.84 93.8 6.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.853 0.835 . . . . 0.0 109.457 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -149.08 137.28 20.81 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.436 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.8 123.45 12.43 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.776 0.322 . . . . 0.0 111.0 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.79 1.66 78.87 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.03 163.18 47.13 Favored Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.2 p -128.22 159.81 34.04 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.742 0.417 . . . . 0.0 110.098 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.458 ' CD1' ' CE2' ' A' ' 71' ' ' TYR . 42.5 p90 -152.94 169.83 21.9 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.344 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.1 m -161.31 141.97 11.11 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.9 m -121.87 123.01 40.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.8 m -93.22 118.06 30.8 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.1 mtm -127.91 132.94 49.26 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.72 147.68 29.15 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.065 0.459 . . . . 0.0 110.225 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.9 148.51 48.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.552 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -58.41 -34.17 70.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.739 0.304 . . . . 0.0 110.239 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -73.03 -10.22 59.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.979 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.94 15.8 58.64 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.2 m -83.7 -17.69 40.49 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 122.886 -0.185 . . . . 0.0 110.812 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 67.9 mtp -134.43 140.82 46.54 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.893 0.377 . . . . 0.0 110.247 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 96.5 p -144.38 149.6 36.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.184 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -155.29 161.49 41.09 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.786 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -136.07 99.73 4.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.711 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -94.46 134.1 37.34 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.47 172.85 41.84 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.28 -176.65 39.95 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.9 t -118.96 128.84 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.458 ' CE2' ' CD1' ' A' ' 52' ' ' PHE . 57.8 m-85 -71.9 112.23 7.82 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -73.64 -38.13 65.1 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.329 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -165.1 151.53 10.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.776 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.2 p -143.68 142.83 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -145.17 121.64 11.01 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.7 m -52.89 120.83 6.26 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.813 0.34 . . . . 0.0 111.91 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.4 m120 51.58 69.96 0.6 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.667 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -167.86 -77.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.332 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 tt -150.49 136.15 18.19 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.199 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.1 mt -129.55 131.41 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.44 162.21 41.51 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -157.31 155.52 30.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.829 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 84.9 m -98.32 131.79 44.33 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 86' ' ' ASP . 5.1 mp -94.58 139.44 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.66 26.93 0.61 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 84' ' ' ILE . 24.1 t0 -119.67 -12.79 9.21 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.76 -7.69 63.26 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.349 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -74.96 143.44 43.67 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.513 -0.404 . . . . 0.0 110.118 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -110.84 135.4 51.45 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.17 136.96 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -134.52 135.14 42.15 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.6 mt -119.61 128.34 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.2 t -118.4 129.99 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -97.23 123.15 40.93 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 67.1 p -128.58 140.56 51.72 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -154.08 148.03 25.58 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.1 p -99.56 -18.74 17.22 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.063 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.09 -102.81 0.21 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -75.72 -6.79 52.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.402 0.144 . . . . 0.0 110.805 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.9 p -107.44 165.18 11.59 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.3 m -143.14 135.48 27.26 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.14 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -124.93 124.2 41.52 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.7 mt -105.64 126.85 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.56 134.45 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -137.24 131.51 32.47 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 89.3 p -136.91 127.68 27.24 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -156.93 168.88 26.15 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.737 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.475 0.785 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.833 -179.368 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 120.635 0.255 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -50.88 -48.48 60.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.6 t -71.4 -34.83 70.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.11 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.7 -52.38 51.14 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.21 -0.519 . . . . 0.0 111.826 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -63.21 -34.88 78.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 110.125 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -74.9 -34.16 62.13 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.075 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.08 -49.45 77.29 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 10.0 tt -61.26 -41.57 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.97 -40.55 96.66 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.046 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -63.46 -39.38 94.32 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.8 m -58.51 -41.29 85.07 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.713 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 81.3 t80 . . . . . 0 N--CA 1.464 0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.271 -179.975 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 120.756 0.312 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.6 mm -52.92 140.07 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 t -137.35 134.46 36.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.86 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.6 m -138.97 158.18 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -147.16 158.01 43.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.04 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 p -149.14 140.68 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.888 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.3 p -92.69 124.71 36.89 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.42 125.62 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -93.37 88.24 5.9 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.18 151.7 3.98 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.103 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.92 132.43 52.05 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.8 tt -54.06 -33.09 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.7 0.286 . . . . 0.0 111.103 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -59.01 -40.43 84.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.656 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -73.59 -46.9 44.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.928 0.394 . . . . 0.0 110.153 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -61.77 -43.06 96.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.719 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -55.92 -40.88 73.76 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.788 0.328 . . . . 0.0 110.883 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -68.41 -48.31 65.0 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.027 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.507 ' CD2' ' ND1' ' A' ' 26' ' ' HIS . 9.9 m-85 -66.74 -42.34 86.4 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.867 0.365 . . . . 0.0 110.902 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -62.88 -15.73 55.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.184 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -112.0 -23.27 10.6 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.032 0.533 . . . . 0.0 111.358 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -69.13 122.28 84.78 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 118.809 -0.615 . . . . 0.0 109.712 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.61 -32.16 24.89 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 CA-C-N 121.104 1.43 . . . . 0.0 111.895 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.62 75.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.966 0.412 . . . . 0.0 110.764 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.507 ' ND1' ' CD2' ' A' ' 20' ' ' TYR . 45.8 m170 -80.05 -42.52 23.57 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.993 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 31' ' ' CYS . 92.3 mt -63.04 -48.11 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 122.123 -0.36 . . . . 0.0 110.842 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -64.11 -12.2 37.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.783 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -78.46 -28.11 46.52 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.871 -0.15 . . . . 0.0 111.107 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -133.37 5.89 3.79 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.994 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.53 ' C ' ' H ' ' A' ' 33' ' ' ALA . 37.0 t -50.44 138.09 17.84 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.075 -0.391 . . . . 0.0 110.623 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 71.68 -39.94 0.46 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.53 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.69 39.15 31.12 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.148 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.9 m -134.29 140.81 37.03 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 122.749 0.42 . . . . 0.0 110.286 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -75.78 -10.32 19.94 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.873 1.715 . . . . 0.0 112.559 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -88.1 15.08 7.89 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.983 0.421 . . . . 0.0 110.262 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -150.16 155.26 39.46 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.137 0.494 . . . . 0.0 109.758 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -142.56 163.46 32.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.047 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.4 t -127.72 87.08 56.79 Favored Pre-proline 0 N--CA 1.475 0.825 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.83 -20.7 44.98 Favored 'Trans proline' 0 N--CA 1.505 2.167 0 C-N-CA 122.369 2.046 . . . . 0.0 111.825 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.92 161.54 8.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.68 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.74 146.08 16.1 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.449 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -140.93 152.08 44.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -161.29 132.95 5.6 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.04 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -122.58 86.93 2.66 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.9 tp -67.21 94.9 0.39 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.939 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -169.02 144.14 3.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.03 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.5 137.7 57.93 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.317 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.89 -1.47 54.25 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.64 172.83 41.3 Favored Glycine 0 N--CA 1.47 0.929 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 t -139.02 172.92 12.14 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.396 0.278 . . . . 0.0 110.556 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -138.76 167.54 21.76 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.203 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.5 m -157.74 121.61 4.13 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.6 m -123.77 124.93 43.79 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.2 m -90.29 114.4 26.45 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.7 mtt -119.11 129.73 55.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.44 143.58 32.68 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.136 0.494 . . . . 0.0 110.223 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.68 148.53 51.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.33 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -56.35 -39.96 73.7 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.556 0.217 . . . . 0.0 110.475 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -79.21 -7.17 58.02 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.897 0.38 . . . . 0.0 110.141 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.35 18.84 67.93 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.4 p -65.63 -34.88 79.25 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.838 -0.213 . . . . 0.0 110.683 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.3 ttt -137.33 145.88 43.93 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.9 t -143.76 145.45 32.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.885 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.422 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 66.8 t80 -159.09 166.63 31.19 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.422 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 74.3 m-20 -137.78 121.05 16.93 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -93.54 140.39 29.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.847 0.356 . . . . 0.0 110.168 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -157.22 157.77 28.35 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.74 -177.67 41.55 Favored Glycine 0 N--CA 1.458 0.112 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -123.61 131.66 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -72.5 115.25 11.54 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -73.66 -47.08 42.59 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -149.79 144.11 25.81 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.6 p -133.04 128.15 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -138.13 111.21 7.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 t -56.35 131.16 47.46 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.257 0.551 . . . . 0.0 112.289 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 49.85 51.89 15.68 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.453 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -157.69 -80.81 0.06 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.688 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 tp -146.27 134.8 22.07 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.2 mt -130.33 131.27 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -152.15 162.71 40.72 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -158.16 154.67 27.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.665 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.3 m -94.78 129.8 41.59 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 88.6 mt -93.63 153.49 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.56 -41.98 65.51 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.816 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -61.49 -10.84 8.61 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.061 0.458 . . . . 0.0 110.632 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 91.53 1.79 70.98 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -77.32 142.94 39.15 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -106.42 162.38 13.75 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.142 0.496 . . . . 0.0 110.395 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.4 t -141.17 121.34 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.778 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -112.41 123.22 49.81 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 71.1 mt -117.06 119.89 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.6 t -107.91 118.22 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -93.41 122.75 36.15 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.8 m -131.72 143.65 50.42 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -152.93 147.36 25.87 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 80.7 p -102.47 -19.25 14.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.014 0.435 . . . . 0.0 109.842 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.43 -104.73 0.23 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 1.3 m-20 -77.12 -2.08 32.45 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 122.21 0.204 . . . . 0.0 111.113 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.8 m -119.91 124.24 45.53 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.2 m -105.51 133.89 49.52 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -115.48 124.57 51.44 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.0 mt -104.66 125.42 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.4 t -119.73 128.31 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -127.94 123.47 34.95 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.3 m -134.72 128.27 32.61 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.945 0.402 . . . . 0.0 110.096 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -157.13 166.8 32.24 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.567 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.4 t70 . . . . . 0 N--CA 1.477 0.903 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.392 -179.184 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -52.28 -46.64 65.95 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.5 m -66.9 -39.62 87.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.183 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.73 -52.01 51.65 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.77 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -63.83 -35.92 82.19 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.825 0.345 . . . . 0.0 110.449 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -72.01 -38.01 69.68 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.785 0.326 . . . . 0.0 110.161 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.79 72.36 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.124 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.3 tt -62.34 -37.86 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.3 mt -63.87 -40.24 96.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -63.38 -40.88 98.44 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.2 m -60.95 -38.37 85.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.619 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 CA--C 1.531 0.212 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.663 -179.794 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.8 tttp . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 121.293 0.568 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.6 mt -65.14 136.37 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 t -137.47 150.91 47.93 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.56 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.6 m -136.0 161.71 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.669 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -139.45 158.92 43.31 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.694 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.12 142.93 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 m -95.05 123.28 38.45 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.4 t -126.98 123.21 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -90.79 87.03 6.5 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.83 152.12 3.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.99 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.63 137.2 57.69 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.7 tt -52.69 -38.26 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.721 0.296 . . . . 0.0 111.35 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -60.81 -35.25 76.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.222 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -74.51 -48.06 29.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.01 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -62.71 -43.93 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.102 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.407 ' CD1' ' OD1' ' A' ' 22' ' ' ASN . 24.4 t-105 -54.27 -39.11 66.58 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.875 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -64.02 -55.76 20.0 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.506 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -69.39 -42.93 74.46 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.837 0.351 . . . . 0.0 111.492 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -59.74 -16.62 28.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.324 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.407 ' OD1' ' CD1' ' A' ' 18' ' ' TRP . 12.7 m120 -112.71 -21.72 11.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.282 0.633 . . . . 0.0 109.895 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -67.55 120.6 74.28 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.736 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.63 -36.56 18.97 Favored 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 121.512 1.474 . . . . 0.0 111.941 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.73 -31.71 69.87 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.104 0.478 . . . . 0.0 110.562 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -80.93 -45.92 15.97 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.789 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.6 mt -61.68 -47.32 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.621 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -63.61 -3.57 2.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.12 0.486 . . . . 0.0 111.072 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -90.25 -29.59 18.07 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 122.098 -0.376 . . . . 0.0 110.341 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 60.6 p-90 -135.73 21.95 3.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.128 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.605 ' C ' ' H ' ' A' ' 33' ' ' ALA . 28.5 p -55.43 131.14 45.18 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.353 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.483 ' NE2' ' CD1' ' A' ' 37' ' ' TRP . 49.9 tt0 68.57 -29.1 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.527 0.517 . . . . 0.0 110.467 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.605 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 53.48 39.72 30.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.429 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 t -128.28 136.45 29.08 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.796 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -73.21 -17.54 24.36 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 122.035 1.823 . . . . 0.0 112.372 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -81.93 13.06 3.52 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.753 0.311 . . . . 0.0 110.687 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.483 ' CD1' ' NE2' ' A' ' 32' ' ' GLN . 87.3 m95 -149.87 159.95 43.97 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.331 0.586 . . . . 0.0 109.664 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.405 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 83.6 t60 -149.13 163.43 37.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.222 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.405 ' N ' ' CG ' ' A' ' 38' ' ' HIS . 7.2 p -128.6 96.86 29.06 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.869 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.1 -9.2 19.19 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 121.927 1.752 . . . . 0.0 111.747 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.15 153.89 7.05 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.834 0.35 . . . . 0.0 110.544 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.47 145.87 13.17 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.185 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -141.04 151.96 44.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -162.41 135.28 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.922 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -133.97 99.12 4.34 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.75 95.22 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.074 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -168.15 145.25 4.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.673 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.83 137.11 58.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.056 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.97 3.57 36.86 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.13 146.14 33.03 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.6 m -107.45 154.25 21.62 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -141.52 156.81 45.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.426 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.7 m -148.25 128.0 13.4 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.1 m -123.81 121.14 34.63 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 m -92.25 124.86 36.63 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.1 mtp -135.63 135.95 40.62 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.16 147.22 30.3 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.956 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.4 148.88 50.95 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.425 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -57.51 -40.48 78.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.71 0.29 . . . . 0.0 110.397 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.24 -10.05 59.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.035 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.14 14.25 68.24 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 85.3 p -67.27 -33.49 75.42 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.668 0.271 . . . . 0.0 110.616 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.3 ttt -129.2 149.37 51.03 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.846 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.2 t -144.27 142.4 30.43 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.724 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.446 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 57.8 t80 -159.47 159.0 33.03 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.446 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 68.3 m-20 -139.12 129.85 26.09 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.867 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -94.95 134.58 37.46 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.39 149.17 20.79 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.79 -172.05 41.86 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -131.97 139.37 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -73.97 122.94 23.37 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.525 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -77.21 -32.56 56.02 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -165.41 144.91 6.6 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.722 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.6 t -135.7 130.28 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -143.09 116.86 9.28 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 65.8 p -57.33 134.2 55.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.696 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 53.76 56.02 7.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.554 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -155.01 -79.58 0.09 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -162.32 161.52 27.57 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.907 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.5 mt -136.06 141.04 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -153.43 160.27 42.56 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -159.46 165.66 32.62 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.3 m -120.94 133.76 55.29 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.7 mm -99.72 153.85 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -55.57 -41.49 81.8 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -60.59 -18.2 51.36 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.717 0.294 . . . . 0.0 110.488 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.28 -3.66 47.52 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -65.37 146.51 54.81 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -136.44 145.48 45.29 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.578 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.69 137.97 31.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -121.45 130.32 53.5 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 76.8 mt -116.97 120.19 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.72 128.37 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -95.9 123.67 39.59 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.7 m -121.14 145.0 48.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -153.44 161.8 41.91 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.3 p -132.69 -47.96 0.88 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.227 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.74 120.74 0.59 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 56.0 15.82 1.91 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 111.039 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.4 m -151.56 139.18 19.66 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 48.4 m -125.84 132.11 52.28 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -117.83 122.52 43.61 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.0 mt -96.68 128.06 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.0 t -121.73 132.49 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -136.8 134.79 37.38 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 83.9 p -138.92 130.45 27.29 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -155.93 170.12 22.86 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 . . . . . 0 N--CA 1.473 0.713 0 O-C-N 123.736 0.648 . . . . 0.0 109.856 -179.79 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.578 0.227 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -58.0 -41.88 83.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.399 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 74.1 m -58.3 -32.83 68.82 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 123.412 0.445 . . . . 0.0 110.556 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.27 -44.72 12.7 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -60.45 -39.43 87.5 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.75 0.31 . . . . 0.0 111.587 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -76.09 -34.66 59.54 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.076 0.465 . . . . 0.0 110.546 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.96 -50.92 72.23 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.5 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.7 tt -61.14 -36.62 73.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.0 mt -66.42 -36.61 83.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -62.26 -40.72 97.15 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.525 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 91.7 p -62.17 -33.89 75.38 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.983 0.421 . . . . 0.0 110.656 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 59.6 t80 . . . . . 0 N--CA 1.463 0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.541 -179.673 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.2 mt -131.04 134.91 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -135.26 139.16 44.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.49 153.82 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -148.81 162.12 40.44 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.924 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.7 p -148.34 140.8 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.703 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.5 p -89.59 119.74 30.28 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.83 124.34 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -93.21 88.54 6.08 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.31 153.33 4.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.743 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.08 134.0 55.38 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.8 tt -51.78 -36.22 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -60.03 -35.59 75.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.359 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -75.21 -44.93 43.67 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 109.958 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.6 t -63.39 -43.8 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.36 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.422 ' CE2' ' OD1' ' A' ' 22' ' ' ASN . 72.1 t90 -57.24 -46.31 83.12 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.473 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.01 -44.69 88.36 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.751 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -66.49 -44.28 83.06 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.879 0.371 . . . . 0.0 110.962 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -69.29 -18.33 63.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.483 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.423 ' N ' HD21 ' A' ' 22' ' ' ASN . 1.0 OUTLIER -98.49 -26.24 14.51 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.062 0.545 . . . . 0.0 111.14 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -64.95 119.96 62.75 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.81 -36.32 4.79 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 CA-C-N 120.863 1.344 . . . . 0.0 111.869 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.59 86.19 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.843 0.354 . . . . 0.0 111.142 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -66.84 -40.57 88.01 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.58 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.452 ' O ' ' N ' ' A' ' 31' ' ' CYS . 96.5 mt -63.31 -43.8 98.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.8 mtp -55.88 -12.27 1.31 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.599 0.238 . . . . 0.0 111.279 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -86.33 -28.73 23.5 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.154 -0.341 . . . . 0.0 110.978 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -136.36 21.66 3.18 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.481 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.6 ' C ' ' H ' ' A' ' 33' ' ' ALA . 10.4 t -57.12 131.34 49.62 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.66 -0.65 . . . . 0.0 110.479 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 66.14 -27.83 0.12 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.689 0.618 . . . . 0.0 110.864 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.6 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 47.3 29.62 1.3 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.539 0.335 . . . . 0.0 111.017 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.7 m -108.12 135.55 19.89 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.264 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.76 -17.3 20.31 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.517 1.478 . . . . 0.0 111.983 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -86.87 8.67 22.0 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.705 0.288 . . . . 0.0 110.578 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -148.4 156.31 42.33 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.314 0.578 . . . . 0.0 110.261 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -143.96 150.38 38.23 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.105 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.4 p -111.5 89.57 10.87 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.889 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.78 -11.72 20.08 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 121.334 1.356 . . . . 0.0 111.422 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -170.15 152.47 4.23 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 120.982 0.42 . . . . 0.0 110.47 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.26 151.92 18.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.248 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -139.13 150.93 46.24 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.627 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -161.23 131.45 5.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.863 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -130.27 97.53 4.45 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -71.05 94.54 1.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.926 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -167.97 140.15 3.04 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.18 137.78 58.04 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.684 0.278 . . . . 0.0 110.28 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.42 -1.58 50.17 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.97 164.88 44.91 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.4 p -126.27 157.88 37.16 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.841 0.456 . . . . 0.0 110.323 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -132.93 156.58 46.99 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.431 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.2 m -146.92 119.54 8.54 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.9 p -114.73 113.69 24.63 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.2 m -89.78 114.78 26.55 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.2 mtt -128.5 133.79 48.54 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.78 145.62 26.72 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.947 0.403 . . . . 0.0 110.176 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.58 147.58 53.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.377 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -56.33 -32.94 65.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.858 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -83.08 -7.01 59.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.08 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.82 16.34 59.13 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.8 m -60.85 -38.7 86.43 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.718 0.294 . . . . 0.0 110.763 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.4 ttp -145.31 146.42 31.62 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.047 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.4 t -143.97 155.72 44.15 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.917 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.466 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 56.4 t80 -153.8 165.18 36.84 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.466 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 30.8 t0 -138.26 119.46 14.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.186 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -93.33 136.57 33.47 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.95 154.36 25.46 Favored Glycine 0 N--CA 1.465 0.622 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.16 -173.39 40.9 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 t -123.75 132.92 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -71.3 121.35 18.32 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.54 -42.19 62.01 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -159.85 146.14 15.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.778 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.5 t -134.56 129.44 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -145.41 121.75 10.93 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.1 m -58.38 129.18 40.81 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.43 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 54.32 56.37 7.01 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.578 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -155.95 -83.95 0.06 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.005 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 tp -149.17 134.87 18.73 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.682 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.9 mt -127.29 127.97 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.11 164.18 38.51 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -156.07 154.39 30.9 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.906 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.3 m -87.97 131.76 34.5 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.7 mt -104.78 144.41 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.55 -42.49 57.9 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.411 ' CB ' ' NH1' ' A' ' 88' ' ' ARG . 44.2 m-20 -62.02 -21.35 64.81 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.766 0.317 . . . . 0.0 110.351 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.62 2.94 72.04 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.411 ' NH1' ' CB ' ' A' ' 86' ' ' ASP . 96.3 mtm-85 -65.83 140.81 58.42 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -92.11 122.03 34.22 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.245 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.9 t -135.47 122.52 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -136.49 142.76 43.56 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 77.3 mt -113.27 124.05 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.4 t -106.75 125.42 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -102.6 122.16 43.84 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.5 m -131.07 149.77 52.45 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -151.79 154.26 35.89 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.659 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.1 p -132.77 40.2 3.27 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.111 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.08 131.19 0.16 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 p30 47.35 17.33 0.07 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.087 0.555 . . . . 0.0 111.849 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.5 m -152.78 135.81 15.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.026 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.7 m -128.93 130.48 46.83 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -117.63 126.24 52.17 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.9 mt -101.18 123.82 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.01 128.52 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -142.99 140.58 31.09 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.0 m -137.01 142.65 42.52 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -153.94 155.63 35.98 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.362 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.547 0.838 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.739 -178.947 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.38 -54.49 46.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.881 0.372 . . . . 0.0 110.092 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.6 t -64.05 -42.07 97.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.917 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.05 -52.13 50.13 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.191 -0.528 . . . . 0.0 111.827 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -65.08 -41.61 94.9 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.645 0.259 . . . . 0.0 110.344 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -65.74 -37.82 87.44 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.413 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.69 68.79 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 31.3 pt -65.3 -35.47 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.905 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.3 mt -64.89 -37.11 86.54 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -62.97 -37.46 87.2 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.6 m -69.07 -33.64 73.87 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.792 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 53.3 t80 . . . . . 0 N--CA 1.469 0.507 0 CA-C-O 120.683 0.277 . . . . 0.0 111.358 -178.331 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.0 mttp . . . . . 0 N--CA 1.463 0.213 0 CA-C-O 121.115 0.483 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.59 137.36 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.2 m -122.87 133.27 54.42 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.8 m -138.74 160.05 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.21 165.9 30.47 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.231 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.02 144.25 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.2 p -92.12 125.42 36.79 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.59 130.7 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -97.25 92.82 6.19 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.06 152.53 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.966 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.33 138.06 58.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.202 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.7 tp -51.56 -37.79 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 121.067 0.461 . . . . 0.0 110.994 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -69.02 -36.74 78.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.15 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -68.64 -51.94 36.66 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 111.244 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -63.51 -36.51 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.364 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -54.92 -49.55 71.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.828 0.347 . . . . 0.0 110.587 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.7 -45.15 83.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.374 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.451 ' CD2' ' ND1' ' A' ' 26' ' ' HIS . 50.1 t80 -63.95 -43.83 94.66 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 111.186 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -71.1 -19.08 62.5 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.463 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -103.65 -23.92 13.42 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.999 0.519 . . . . 0.0 110.972 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.25 134.38 95.81 Favored Pre-proline 0 CA--C 1.553 1.064 0 CA-C-O 119.191 -0.433 . . . . 0.0 109.858 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.69 -41.49 0.55 Allowed 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.544 1.496 . . . . 0.0 111.622 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.67 -29.35 66.53 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.918 0.389 . . . . 0.0 110.695 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.451 ' ND1' ' CD2' ' A' ' 20' ' ' TYR . 33.3 m170 -79.93 -45.82 17.84 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.234 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 90.6 mt -63.52 -46.6 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 122.006 -0.434 . . . . 0.0 110.645 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -66.1 -3.37 5.4 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.71 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -90.58 -26.87 19.47 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.183 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -138.04 23.05 2.82 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.433 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.615 ' C ' ' H ' ' A' ' 33' ' ' ALA . 9.6 t -56.52 133.99 53.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.191 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 65.92 -23.99 0.1 Allowed 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.538 0.524 . . . . 0.0 110.668 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.615 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 53.3 28.19 7.0 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.507 0.194 . . . . 0.0 110.613 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.1 m -112.8 104.17 55.82 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 122.953 0.501 . . . . 0.0 110.058 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -50.09 -13.44 0.64 Allowed 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 122.266 1.977 . . . . 0.0 112.625 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -82.63 11.84 5.34 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.669 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -146.72 162.72 37.92 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -146.57 162.63 37.96 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.969 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.6 t -126.16 96.28 37.2 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.84 -10.99 23.63 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 121.76 1.64 . . . . 0.0 111.877 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.02 152.94 6.64 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.934 0.397 . . . . 0.0 110.473 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.68 150.09 9.98 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.458 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -143.65 156.25 44.5 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -157.98 104.18 1.9 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.699 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -91.99 87.62 6.26 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.2 tp -66.11 93.36 0.2 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.716 -0.394 . . . . 0.0 109.968 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -170.48 145.91 2.69 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.48 137.74 58.25 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.142 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.23 -1.58 25.2 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -77.26 163.49 51.98 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.8 m -124.14 155.41 38.5 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -135.04 158.05 45.35 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.467 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.7 m -146.17 122.37 10.84 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.6 m -119.12 119.63 34.76 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.6 m -88.86 113.4 24.37 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 93.2 mtp -119.14 124.66 47.38 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.35 140.74 33.82 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.17 150.37 47.57 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.08 -37.75 64.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.692 0.282 . . . . 0.0 110.523 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -81.17 -7.42 59.56 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.125 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.76 14.68 37.98 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.9 t -67.4 -19.14 65.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.733 0.301 . . . . 0.0 110.489 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 47.6 ttp -159.85 134.99 8.05 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.972 0.415 . . . . 0.0 110.383 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m -146.16 154.58 41.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.259 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -154.88 146.94 23.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.33 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -108.19 119.99 41.08 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.389 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -93.92 137.69 32.87 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.44 153.9 25.13 Favored Glycine 0 N--CA 1.46 0.27 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.3 178.21 43.15 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.33 134.15 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -75.68 121.05 21.92 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -75.22 -39.2 60.26 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -162.34 146.4 11.98 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.849 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.5 p -149.95 138.67 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.656 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -148.99 134.64 18.72 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.8 m -48.07 118.22 2.27 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.454 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.6 m120 54.11 79.6 0.13 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.377 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -167.9 -83.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.472 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 tt -152.78 141.49 20.96 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.774 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 63.1 mt -130.16 130.52 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -152.94 160.55 43.05 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -160.57 155.2 23.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.644 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.4 p -91.84 134.3 34.88 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.666 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.6 mt -104.71 147.37 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.05 -41.38 59.98 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.72 -17.76 50.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.777 0.323 . . . . 0.0 110.148 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.75 3.72 80.15 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -65.88 141.52 58.22 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -95.4 135.26 37.24 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.2 t -139.55 128.64 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -136.15 133.73 37.51 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.6 mt -116.59 116.18 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.5 t -101.13 116.02 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -90.89 132.52 35.87 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.5 p -132.25 156.93 45.63 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -143.85 148.69 35.85 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.2 m -150.82 87.05 1.4 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.94 -134.29 50.93 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -79.0 39.88 0.39 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.749 0.309 . . . . 0.0 110.498 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.8 m -150.09 147.62 28.0 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.2 m -134.0 146.38 50.35 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.406 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -132.68 131.08 40.91 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.5 mt -107.55 128.15 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.15 126.96 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -144.59 145.55 31.85 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 95.3 p -132.37 148.72 52.43 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -131.34 174.81 9.7 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 . . . . . 0 N--CA 1.467 0.389 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.827 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 120.605 0.241 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -53.74 -46.98 71.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.935 0.398 . . . . 0.0 110.385 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 81.5 p -64.67 -37.37 87.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.134 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.57 -52.45 46.04 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.531 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -66.41 -37.09 84.43 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.905 0.383 . . . . 0.0 110.541 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -70.55 -39.02 74.23 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.458 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.16 -52.0 67.38 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.726 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.4 tt -62.23 -37.97 79.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.7 mt -64.47 -41.99 96.17 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.28 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -67.39 -41.83 84.31 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.2 t -61.37 -32.83 72.75 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.467 0.48 . . . . 0.0 110.875 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 77.9 t80 . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 120.862 0.363 . . . . 0.0 111.031 -179.235 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.9 mt -50.17 143.01 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 t -129.91 133.96 47.18 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.4 m -139.69 158.34 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -148.65 162.88 38.83 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.335 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 p -145.3 140.59 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.3 p -93.36 119.33 32.36 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.2 t -127.48 128.7 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -98.98 88.22 3.92 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.29 154.43 4.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.041 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.25 118.84 7.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.2 tt -51.68 -34.96 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.167 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -60.31 -39.82 88.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -73.24 -45.43 55.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.238 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.88 -42.34 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.688 0.28 . . . . 0.0 110.499 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.442 ' CD1' ' ND2' ' A' ' 22' ' ' ASN . 21.0 t90 -48.92 -34.59 13.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.616 0.246 . . . . 0.0 111.123 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -61.55 -47.86 83.64 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.631 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -69.36 -42.37 75.31 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.699 0.285 . . . . 0.0 110.572 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -65.93 -15.63 63.14 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.307 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.442 ' ND2' ' CD1' ' A' ' 18' ' ' TRP . 2.1 m-80 -108.81 -26.88 10.06 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.377 0.671 . . . . 0.0 111.478 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -76.83 125.84 86.54 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.54 -31.36 13.72 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 121.427 1.418 . . . . 0.0 111.883 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.63 -37.29 78.25 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.437 0.461 . . . . 0.0 110.876 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -79.42 -41.45 27.66 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.988 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.48 -49.06 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.239 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.9 ptm -60.46 -16.35 35.59 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.495 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -72.28 -34.99 68.59 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -127.68 5.29 6.12 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.092 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.568 ' C ' ' H ' ' A' ' 33' ' ' ALA . 30.5 t -51.35 140.52 17.09 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 71.36 -36.64 0.37 Allowed 'General case' 0 CA--C 1.536 0.432 0 O-C-N 123.698 0.624 . . . . 0.0 109.573 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.568 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 56.21 34.81 24.65 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.533 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.1 m -121.93 136.03 25.84 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 122.816 0.446 . . . . 0.0 110.48 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.28 -20.34 16.42 Favored 'Trans proline' 0 N--CA 1.503 2.074 0 C-N-CA 121.832 1.688 . . . . 0.0 112.524 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -78.04 -24.06 47.94 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.543 0.211 . . . . 0.0 110.991 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -109.54 153.79 23.63 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.411 ' CD2' ' O ' ' A' ' 57' ' ' ALA . 6.1 p80 -144.77 162.87 35.68 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.3 t -120.74 95.25 48.99 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.12 -10.77 22.95 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 121.637 1.558 . . . . 0.0 111.688 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -167.49 151.99 6.81 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.893 0.378 . . . . 0.0 110.433 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -162.41 146.4 11.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.245 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -139.21 152.92 47.74 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -160.57 127.77 4.33 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.857 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -133.89 93.58 3.13 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.17 102.34 1.33 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.174 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -163.8 129.92 3.12 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.55 123.19 12.35 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.715 0.293 . . . . 0.0 110.67 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.68 4.92 90.23 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.28 173.01 52.95 Favored Glycine 0 N--CA 1.467 0.745 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.577 ' HG1' ' N ' ' A' ' 52' ' ' PHE . 2.5 t -134.08 164.21 27.84 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 117.058 0.429 . . . . 0.0 110.045 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.577 ' N ' ' HG1' ' A' ' 51' ' ' THR . 47.3 p90 -148.8 169.13 21.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.067 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.1 m -148.99 125.32 10.87 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.8 m -120.5 118.31 29.91 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.3 m -94.89 117.93 30.94 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 46.4 ttp -137.06 130.25 31.05 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' A' ' 38' ' ' HIS . . . -153.54 158.04 40.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.208 0.528 . . . . 0.0 110.157 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.84 150.72 48.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.778 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -58.03 -38.12 75.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.587 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -71.23 -11.1 60.74 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.91 6.63 60.36 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.1 m -63.78 -39.96 95.52 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.598 0.237 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.2 mtm -117.44 142.2 47.42 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.133 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.8 p -144.23 149.24 36.04 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.872 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -154.49 154.21 32.77 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -138.18 120.15 15.47 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.589 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -93.7 121.83 35.54 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -132.46 134.92 7.83 Favored Glycine 0 N--CA 1.473 1.161 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.74 -175.11 44.67 Favored Glycine 0 CA--C 1.518 0.28 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.5 m -132.38 156.81 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.894 0.378 . . . . 0.0 110.207 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -88.34 124.51 33.99 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.517 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.32 -38.49 65.8 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.46 149.6 5.84 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.664 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.7 t -134.59 132.46 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -141.46 117.42 10.53 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 m -55.88 123.69 15.13 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.964 0.412 . . . . 0.0 111.349 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.2 m120 52.14 66.22 1.27 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.011 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -167.08 -77.55 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.227 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tp -151.82 131.6 13.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.51 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.6 mt -132.94 131.69 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -153.09 165.56 35.22 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -157.28 164.79 37.28 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 54.3 m -115.36 132.57 56.58 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.8 mm -99.28 150.05 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.22 -40.49 67.62 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.424 ' CB ' ' NH1' ' A' ' 88' ' ' ARG . 63.1 m-20 -61.66 -19.41 62.28 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.59 0.233 . . . . 0.0 110.709 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.93 -3.08 48.32 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.424 ' NH1' ' CB ' ' A' ' 86' ' ' ASP . 84.5 mtt85 -64.72 144.2 57.4 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -120.97 146.42 46.7 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.567 0.542 . . . . 0.0 109.654 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.3 t -138.1 136.89 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -132.92 120.02 20.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 70.8 mt -108.72 117.6 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.0 t -108.17 114.9 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -89.87 128.43 36.19 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.4 p -132.75 152.43 51.76 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -153.93 158.65 41.01 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.3 p -135.94 36.59 2.83 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.023 0.44 . . . . 0.0 109.901 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 100' ' ' THR . . . 69.92 131.2 0.07 OUTLIER Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 57.34 8.71 0.62 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.838 0.352 . . . . 0.0 110.955 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 98' ' ' GLY . 40.7 m -150.47 139.54 21.08 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.114 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.9 m -127.76 130.36 48.62 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -120.53 123.29 42.55 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.0 mt -103.27 128.43 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.61 131.66 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -130.31 132.7 45.99 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.3 t -118.29 149.11 41.7 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -144.0 160.69 40.41 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.622 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 120.466 0.174 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -53.27 -44.98 68.65 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.01 0.433 . . . . 0.0 110.008 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.1 t -64.45 -40.72 96.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.352 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.47 -51.72 55.95 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -62.74 -36.3 82.58 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.705 0.288 . . . . 0.0 110.279 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -74.05 -37.67 64.21 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.791 0.329 . . . . 0.0 110.194 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.15 -51.08 71.56 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.805 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.3 tt -63.6 -39.57 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.5 mt -63.62 -38.61 91.76 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -62.14 -40.03 94.57 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.072 0.463 . . . . 0.0 109.763 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.5 t -72.63 -31.04 64.84 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.689 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 62.3 t80 . . . . . 0 N--CA 1.469 0.496 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -178.079 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.9 pttt . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 120.901 0.381 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.9 mt -51.53 138.97 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 m -135.64 138.73 43.16 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 m -136.17 157.05 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -147.74 161.16 41.78 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.39 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.61 142.61 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.5 m -93.48 121.27 34.7 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.7 t -126.57 124.88 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -94.74 89.9 5.88 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.98 153.47 4.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.06 134.28 55.85 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.7 tp -52.83 -34.39 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.88 0.372 . . . . 0.0 110.884 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -60.46 -40.8 92.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.473 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -72.07 -46.66 56.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.845 0.355 . . . . 0.0 110.555 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.48 -41.57 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.401 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.403 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 26.4 t-105 -56.11 -45.31 79.54 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.84 0.353 . . . . 0.0 110.868 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -65.26 -45.01 86.25 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.339 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -65.51 -43.37 90.33 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.727 0.299 . . . . 0.0 110.973 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -69.23 -20.19 63.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.492 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.626 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.7 OUTLIER -104.93 -30.86 9.55 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.129 0.571 . . . . 0.0 111.752 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -50.76 106.52 0.66 Allowed Pre-proline 0 CA--C 1.557 1.214 0 CA-C-O 119.113 -0.47 . . . . 0.0 109.819 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -53.58 -43.07 60.82 Favored 'Trans proline' 0 N--CA 1.508 2.381 0 CA-C-N 120.646 1.266 . . . . 0.0 112.244 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.06 -33.79 73.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.909 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.475 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 81.4 t60 -73.74 -38.45 64.76 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.795 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.41 -44.46 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 122.038 -0.414 . . . . 0.0 110.752 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.7 ptp -67.21 -24.9 65.89 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.283 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -62.29 -45.8 91.61 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.529 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.488 ' CE3' ' O ' ' A' ' 31' ' ' CYS . 62.7 p-90 -109.13 -10.19 15.01 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.523 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.488 ' O ' ' CE3' ' A' ' 30' ' ' TRP . 29.4 p 30.71 -130.99 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.962 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 177.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.425 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 55.2 tp60 -74.55 -4.34 36.34 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 30' ' ' TRP . . . 64.32 32.52 12.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.225 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.8 m -132.3 141.17 40.33 Favored Pre-proline 0 N--CA 1.482 1.154 0 O-C-N 123.337 0.398 . . . . 0.0 110.534 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.5 -9.94 23.32 Favored 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 121.892 1.728 . . . . 0.0 112.27 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -79.14 -24.56 43.22 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.426 0.155 . . . . 0.0 110.724 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -122.24 148.86 44.47 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.829 0.452 . . . . 0.0 110.313 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -140.09 163.25 33.2 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.179 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.21 89.23 52.94 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.61 -10.12 20.14 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 121.537 1.491 . . . . 0.0 111.141 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -167.77 150.36 5.78 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.008 0.432 . . . . 0.0 110.273 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.86 150.47 11.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.092 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -138.99 144.91 39.13 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -163.6 135.67 5.03 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -125.05 97.45 5.26 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.1 tp -65.34 94.48 0.17 Allowed 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -168.34 140.83 2.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.26 137.71 57.88 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.262 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.45 -0.05 61.24 Favored Glycine 0 N--CA 1.466 0.691 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.06 169.1 41.72 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 t -129.87 168.41 16.66 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.704 0.402 . . . . 0.0 110.066 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -140.57 166.38 24.9 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.244 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 m -154.88 118.09 4.45 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.7 m -116.96 121.46 41.47 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.1 m -93.36 116.66 29.21 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.9 mtp -121.76 125.88 47.57 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.81 138.31 42.44 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.014 0.435 . . . . 0.0 110.116 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.77 148.83 51.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.393 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.02 -39.96 75.76 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.712 0.292 . . . . 0.0 110.451 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -76.2 -9.65 58.8 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.24 22.23 62.84 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 97.0 p -81.06 -10.75 59.64 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.736 0.303 . . . . 0.0 110.617 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.1 ttt -164.49 136.48 4.59 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.087 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.9 p -144.43 161.1 39.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.874 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.466 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 61.7 t80 -159.47 168.63 25.76 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.466 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 40.8 t0 -138.55 119.53 14.39 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -93.99 140.58 29.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.71 156.21 26.97 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.36 -171.55 40.99 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 p -127.36 141.63 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 122.672 0.389 . . . . 0.0 110.107 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -81.04 123.65 28.54 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -77.0 -47.87 19.52 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.076 0.465 . . . . 0.0 110.04 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -147.38 141.31 25.87 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.559 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.3 t -136.06 125.5 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -140.54 123.13 16.16 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.8 m -53.62 121.95 8.84 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.073 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.5 m120 53.47 70.16 0.62 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.77 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -166.1 -82.39 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.536 0.208 . . . . 0.0 110.943 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.1 tp -147.02 139.55 24.85 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 58.9 mt -133.77 130.28 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -153.7 157.51 39.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -155.95 160.16 39.86 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.3 m -112.27 135.24 53.19 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.3 mm -89.19 155.89 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.8 -33.97 80.44 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -69.46 -10.26 57.27 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 122.477 -0.425 . . . . 0.0 110.352 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.7 -8.15 56.14 Favored Glycine 0 N--CA 1.475 1.29 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -71.18 161.32 31.3 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -145.4 160.79 41.03 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.428 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.4 t -144.43 113.03 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.325 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -93.92 127.41 39.67 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.7 mt -124.83 113.06 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.0 p -108.71 133.55 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -103.93 132.64 49.99 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.0 p -134.3 153.3 51.95 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -153.84 158.22 40.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.541 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 63.6 p -134.86 27.38 3.6 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.049 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.0 129.32 1.39 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 55.7 11.77 0.72 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.885 0.374 . . . . 0.0 111.03 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.2 m -153.53 141.93 20.66 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.046 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.9 m -130.37 130.85 44.9 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -117.88 122.86 44.43 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.6 mt -104.37 126.27 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.5 t -128.18 133.83 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -142.63 145.9 33.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.036 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 78.4 p -132.24 141.97 49.23 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -154.15 155.55 35.56 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 CA--C 1.547 0.831 0 CA-C-O 119.136 -0.459 . . . . 0.0 110.656 -179.165 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.496 0.188 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.53 -48.09 69.37 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.774 0.321 . . . . 0.0 110.506 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.7 t -63.34 -42.57 98.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.337 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.68 -51.78 55.21 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -64.17 -36.06 82.81 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.967 0.384 . . . . 0.0 110.291 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -73.61 -38.19 65.16 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.17 -51.23 70.89 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.9 tt -61.7 -37.76 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.4 mt -63.26 -40.92 98.77 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.2 -41.29 97.14 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 110.049 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.5 m -61.05 -33.32 73.13 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.132 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 57.6 t80 . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.986 -178.683 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.7 mttt . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.4 mt -50.14 138.15 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.4 m -133.42 134.47 43.67 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.24 156.34 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.427 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 32.8 mp0 -140.75 158.36 44.08 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.917 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 p -143.88 140.46 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -93.44 113.95 26.23 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.7 t -119.01 125.9 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -98.23 87.84 4.02 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.09 152.78 4.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.087 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.63 135.88 57.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.7 tp -53.41 -32.2 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.622 0.248 . . . . 0.0 111.441 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -59.51 -39.74 84.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.774 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -75.17 -46.4 34.43 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 110.437 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.5 t -62.53 -43.44 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.24 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -56.26 -46.05 79.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.934 0.397 . . . . 0.0 110.583 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -67.38 -45.43 76.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.606 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -65.31 -43.43 91.09 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.793 0.33 . . . . 0.0 111.136 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -70.43 -20.02 62.94 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.647 -178.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -104.68 -22.25 13.26 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.139 0.576 . . . . 0.0 111.41 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -65.8 132.09 94.76 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.02 -40.55 1.28 Allowed 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 121.262 1.308 . . . . 0.0 111.57 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.76 -35.9 69.19 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.085 0.469 . . . . 0.0 110.833 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -73.86 -45.8 48.82 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.255 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 91.8 mt -61.85 -50.29 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.816 -0.553 . . . . 0.0 111.015 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 20.0 ptm -60.8 -17.38 49.14 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -74.2 -31.73 62.76 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -133.41 14.86 4.11 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.602 0.361 . . . . 0.0 110.837 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.558 ' C ' ' H ' ' A' ' 33' ' ' ALA . 20.4 t -53.95 136.4 41.12 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 122.138 -0.351 . . . . 0.0 110.279 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 70.81 -36.25 0.35 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.539 0.524 . . . . 0.0 110.011 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 56.86 36.16 27.34 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.763 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.0 m -131.63 141.51 41.92 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 122.682 0.393 . . . . 0.0 110.436 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -75.46 -8.9 19.9 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.04 1.827 . . . . 0.0 112.03 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -86.31 7.32 25.9 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.681 0.277 . . . . 0.0 110.457 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -153.45 155.66 36.72 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.243 0.544 . . . . 0.0 110.357 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -148.55 163.18 37.98 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.303 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.6 t -127.62 91.94 44.24 Favored Pre-proline 0 N--CA 1.476 0.833 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.81 -1.94 12.09 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.768 1.645 . . . . 0.0 111.709 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.25 152.42 8.96 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.884 0.373 . . . . 0.0 110.078 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -166.07 150.47 8.03 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.36 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -136.77 150.47 48.4 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.917 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -160.88 131.4 5.25 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.09 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -129.54 95.83 4.11 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.79 93.87 0.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.08 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -168.19 140.9 3.05 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.96 137.75 58.21 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.425 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.87 1.65 48.24 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.9 148.12 34.45 Favored Glycine 0 N--CA 1.465 0.6 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.1 p -111.7 157.43 20.5 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.899 0.48 . . . . 0.0 109.846 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 69' ' ' GLY . 45.5 p90 -156.72 169.18 25.32 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.026 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.7 m -156.39 141.58 17.39 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.1 m -122.09 120.74 35.17 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.8 m -86.39 111.14 20.22 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 44.3 ttp -127.74 114.07 16.81 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -132.08 141.48 49.2 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.59 0.356 . . . . 0.0 110.275 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.35 148.07 33.75 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -58.83 -37.9 77.47 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.712 0.291 . . . . 0.0 110.263 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.51 -10.6 59.72 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.89 17.66 67.73 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.9 t -62.48 -42.22 99.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.801 0.334 . . . . 0.0 111.012 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 62.4 ttp -145.19 147.0 31.97 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.175 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.5 t -144.7 154.7 43.04 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.135 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -154.13 143.25 21.24 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -95.47 108.85 21.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.467 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -96.04 130.66 42.99 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.95 176.44 41.95 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 52' ' ' PHE . . . -174.57 -172.42 39.64 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 36.7 t -126.94 132.48 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -72.68 113.79 10.1 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.42 ' O ' ' NE2' ' A' ' 73' ' ' GLN . 23.9 t0 -74.29 -48.14 30.36 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.42 ' NE2' ' O ' ' A' ' 72' ' ' ASP . 99.2 mm-40 -139.81 137.88 35.35 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.78 125.82 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -144.19 113.15 6.77 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.3 m -47.38 116.49 1.44 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.4 m120 53.98 71.21 0.53 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.602 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -168.65 -68.86 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.634 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.0 tp -150.12 133.69 16.62 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 84.5 mt -128.49 125.21 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -153.6 152.13 30.53 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 20.2 p90 -151.2 152.25 33.03 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.9 m -82.16 128.53 34.24 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.479 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.3 mm -82.27 144.1 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.251 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.32 -41.64 87.62 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -66.21 -5.28 9.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.758 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.17 0.89 84.82 Favored Glycine 0 N--CA 1.473 1.132 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -66.84 159.3 28.47 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -113.92 132.84 55.79 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.97 0.415 . . . . 0.0 109.944 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.2 t -136.48 134.35 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -135.43 127.34 29.48 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.82 117.46 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.56 128.58 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -92.46 126.32 37.49 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.9 m -146.21 141.25 27.23 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.433 ' N ' ' ND1' ' A' ' 96' ' ' HIS . 2.3 p-80 -153.69 148.84 26.87 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.2 p -98.05 -13.63 20.94 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.011 0.434 . . . . 0.0 109.957 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.43 -101.29 0.2 Allowed Glycine 0 N--CA 1.465 0.622 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 18.0 p-10 -78.0 -2.06 35.2 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.343 0.257 . . . . 0.0 110.892 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.0 p -118.54 128.18 54.32 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.03 0.532 . . . . 0.0 109.709 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.9 m -103.72 135.07 45.97 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.666 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -119.23 115.37 24.05 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.8 mt -101.51 125.79 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.3 t -121.35 127.57 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -142.43 144.47 33.1 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 94.7 p -130.51 148.9 52.37 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.117 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -137.22 150.57 47.96 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.153 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 CA--C 1.551 0.982 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.992 179.929 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 . . . . . 0 N--CA 1.468 0.448 0 CA-C-O 120.349 0.119 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.503 ' NE2' ' NE2' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -55.52 -38.81 69.71 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.188 0.518 . . . . 0.0 110.633 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.412 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 40.7 t -59.0 -40.83 86.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.954 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.4 -48.23 64.96 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.717 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -59.04 -39.71 82.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.802 0.334 . . . . 0.0 110.563 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.503 ' NE2' ' NE2' ' A' ' 119' ' ' GLN . 78.3 mt-30 -74.85 -34.65 62.32 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.75 -51.0 71.63 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.7 tt -63.19 -39.11 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.7 mt -63.56 -40.04 95.96 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -62.71 -39.66 94.73 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.5 t -60.02 -37.07 78.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.811 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 48.5 t80 . . . . . 0 CA--C 1.534 0.352 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.681 -179.049 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.9 mt -46.38 138.16 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.0 m -136.29 136.95 40.21 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.77 156.33 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.438 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 31.6 mp0 -141.06 158.91 43.28 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.851 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 p -151.26 142.59 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.186 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.5 p -97.32 124.11 41.35 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.7 t -128.46 129.48 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -93.83 88.2 5.68 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.48 151.73 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.19 133.74 54.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.143 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.6 tt -53.44 -36.48 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.701 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.407 ' OE2' ' N ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -63.31 -34.98 78.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.984 0.421 . . . . 0.0 110.011 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.407 ' N ' ' OE2' ' A' ' 15' ' ' GLU . 63.9 tttm -73.38 -50.21 23.11 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.9 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.35 -42.64 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.154 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.476 ' NE1' ' ND2' ' A' ' 22' ' ' ASN . 25.9 t-105 -54.13 -40.15 67.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.763 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -65.46 -54.31 30.23 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.538 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -69.53 -41.63 75.71 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.838 0.351 . . . . 0.0 111.396 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -61.82 -20.69 63.91 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.708 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.476 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 91.8 m-20 -106.22 -19.58 13.66 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.809 0.444 . . . . 0.0 110.282 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -68.27 122.92 86.1 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.7 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.93 -35.1 12.74 Favored 'Trans proline' 0 N--CA 1.504 2.125 0 C-N-CA 121.324 1.35 . . . . 0.0 112.217 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.73 -39.57 94.48 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.84 0.352 . . . . 0.0 110.48 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.504 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 84.4 t60 -65.36 -45.39 84.33 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.37 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 31' ' ' CYS . 96.7 mt -62.48 -43.84 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 36.3 ttp -54.85 -15.96 2.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.497 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -84.49 -25.98 28.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.641 0.258 . . . . 0.0 111.355 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.504 ' HE1' ' CD2' ' A' ' 26' ' ' HIS . 56.7 p-90 -140.75 26.21 2.1 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.878 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.614 ' C ' ' H ' ' A' ' 33' ' ' ALA . 16.1 t -59.73 130.24 45.82 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.937 -0.477 . . . . 0.0 110.12 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 66.08 -27.46 0.11 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.754 0.658 . . . . 0.0 110.55 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.614 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 51.96 30.26 7.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.0 t -118.86 136.71 24.39 Favored Pre-proline 0 N--CA 1.48 1.068 0 O-C-N 123.476 0.485 . . . . 0.0 111.168 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.95 -13.02 24.01 Favored 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 121.931 1.754 . . . . 0.0 111.939 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -85.05 9.78 13.78 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.921 0.391 . . . . 0.0 110.911 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -149.31 162.17 40.59 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.232 0.539 . . . . 0.0 109.747 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -148.74 162.89 38.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.911 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.79 91.2 13.77 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.8 -3.07 13.36 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 122.312 2.008 . . . . 0.0 112.049 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.29 153.06 11.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.737 0.303 . . . . 0.0 110.228 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -165.03 148.21 8.4 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -150.72 152.99 34.73 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -163.16 103.65 0.98 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.095 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -85.68 90.99 8.16 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.6 tp -65.41 95.66 0.21 Allowed 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -169.51 140.69 2.28 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.08 138.05 57.96 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.192 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.87 -2.29 60.32 Favored Glycine 0 N--CA 1.467 0.732 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.18 174.22 43.54 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 t -135.21 168.06 19.86 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -135.89 167.19 21.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.975 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.9 m -160.66 125.93 3.83 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.7 m -123.99 125.63 44.91 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 m -86.73 112.17 21.41 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 72.4 mtp -119.72 118.62 31.39 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.49 139.72 40.74 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.53 147.59 52.48 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -55.18 -34.89 64.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 110.668 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -82.71 -9.21 59.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.345 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.83 15.34 64.46 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.6 t -62.5 -40.97 98.43 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.72 0.295 . . . . 0.0 110.664 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 44.6 ttp -143.58 143.32 31.45 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.09 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.6 p -145.83 157.56 43.91 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.878 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.448 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 63.5 t80 -159.81 166.69 29.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.517 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.448 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 24.1 p-10 -138.2 121.92 17.53 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.045 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -94.38 143.62 26.24 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.92 157.44 28.01 Favored Glycine 0 C--N 1.331 0.268 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.51 -173.06 40.92 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.4 t -128.31 135.85 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -76.06 120.0 20.77 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -74.05 -45.08 51.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.893 0.377 . . . . 0.0 110.23 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -148.77 139.42 22.73 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -137.34 127.67 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -144.16 129.01 18.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.0 m -60.55 135.01 57.62 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.793 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 54.81 57.8 5.37 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.915 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -154.37 -82.76 0.08 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.934 0.397 . . . . 0.0 110.273 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -163.07 160.56 24.58 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.26 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.2 mt -134.38 135.96 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.404 ' OE1' ' NH1' ' A' ' 91' ' ' ARG . 14.2 pt-20 -149.92 154.92 39.09 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -158.91 155.2 27.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.9 m -95.57 134.41 38.48 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.7 mt -101.32 152.74 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -51.88 -42.19 53.05 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -60.83 -17.46 49.97 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.984 0.421 . . . . 0.0 110.095 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.42 7.55 72.34 Favored Glycine 0 N--CA 1.471 0.99 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -70.58 139.35 51.45 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -93.7 136.47 33.94 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.0 t -137.83 132.12 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.404 ' NH1' ' OE1' ' A' ' 81' ' ' GLU . 70.2 mtp85 -135.61 135.53 40.31 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.9 mt -124.18 114.07 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.88 129.11 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -95.8 132.8 40.67 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.5 p -136.11 155.47 50.13 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -152.43 143.64 23.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.738 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.4 p -91.1 -41.46 11.04 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.003 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.45 -68.06 0.11 Allowed Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -107.28 17.4 22.92 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.157 0.583 . . . . 0.0 110.73 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.5 m -155.77 119.79 4.52 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.105 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 43.0 m -83.99 146.44 27.99 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -128.49 122.61 31.59 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.6 mt -100.27 126.67 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.37 126.73 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -144.71 146.49 32.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.523 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 96.5 p -134.52 147.5 50.33 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -122.27 170.95 9.41 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.411 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.642 0.258 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -54.02 -41.35 67.9 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.508 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.2 t -60.91 -41.85 96.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.396 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.51 -50.9 61.68 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -61.36 -36.33 79.93 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.015 0.436 . . . . 0.0 110.18 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -75.86 -36.45 59.56 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.138 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.35 -51.41 70.06 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.003 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.8 tt -61.1 -37.33 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.8 mt -63.74 -40.67 97.3 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.334 -0.393 . . . . 0.0 109.962 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -63.9 -39.23 93.7 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.2 m -57.6 -35.52 70.53 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 110.665 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 59.3 t80 . . . . . 0 CA--C 1.534 0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.465 179.819 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.1 mttp . . . . . 0 C--O 1.234 0.243 0 CA-C-O 121.04 0.448 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.9 mt -53.26 134.63 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.5 m -131.19 130.99 43.68 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.8 m -137.32 159.01 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -148.47 162.41 39.68 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.417 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 p -144.14 142.54 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 m -95.46 117.65 30.76 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -123.43 129.38 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -97.61 87.55 4.11 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.82 152.54 4.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.984 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.86 133.04 52.62 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.041 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.8 tt -53.36 -36.69 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.736 0.303 . . . . 0.0 111.629 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.35 -35.29 75.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.424 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -74.92 -47.17 31.16 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.165 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.3 -43.03 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.31 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 26.6 t-105 -53.98 -43.54 70.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.139 0.495 . . . . 0.0 110.864 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.69 -45.78 74.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.614 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -66.63 -42.72 86.32 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.886 0.374 . . . . 0.0 111.332 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -68.73 -18.09 64.17 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.571 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -109.66 -29.54 8.31 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.938 0.495 . . . . 0.0 111.981 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -51.42 106.21 0.62 Allowed Pre-proline 0 CA--C 1.561 1.383 0 CA-C-O 118.734 -0.651 . . . . 0.0 109.519 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.53 -43.33 55.61 Favored 'Trans proline' 0 N--CA 1.506 2.254 0 CA-C-N 121.006 1.395 . . . . 0.0 112.331 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.46 84.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.257 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -69.04 -36.93 78.27 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.371 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 98.7 mt -62.0 -52.41 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 121.856 -0.528 . . . . 0.0 111.218 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.8 ptp -61.59 -16.55 49.14 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -70.15 -26.92 64.16 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 32' ' ' GLN . 68.8 p-90 -134.17 6.79 3.63 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 119.525 -0.274 . . . . 0.0 111.096 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.4 t -67.93 72.52 0.17 Allowed 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 121.416 0.627 . . . . 0.0 109.706 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 30' ' ' TRP . 55.6 tt0 -161.74 63.17 0.25 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.77 -5.02 22.51 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.09 -1.413 . . . . 0.0 110.716 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 79.4 p -146.2 140.67 15.67 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.33 -13.92 22.95 Favored 'Trans proline' 0 N--CA 1.509 2.44 0 C-N-CA 122.071 1.847 . . . . 0.0 112.372 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -83.97 14.07 4.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.676 0.274 . . . . 0.0 110.598 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -147.71 143.99 27.99 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -130.95 163.01 28.46 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 t -127.93 87.35 55.92 Favored Pre-proline 0 N--CA 1.477 0.914 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.89 -7.83 14.42 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.816 1.678 . . . . 0.0 111.496 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.79 151.37 4.19 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.0 156.05 5.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.432 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -148.11 154.05 39.68 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.86 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -163.58 135.27 4.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.591 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -129.0 101.15 5.93 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tp -69.27 99.39 1.16 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -166.91 138.18 3.28 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.85 137.1 58.15 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.694 0.283 . . . . 0.0 110.436 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.96 2.14 60.99 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.2 169.57 38.21 Favored Glycine 0 N--CA 1.47 0.902 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 t -130.2 165.39 22.47 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.095 0.474 . . . . 0.0 110.203 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -140.5 162.15 36.03 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.53 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.3 m -150.45 134.91 17.25 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.8 p -131.39 119.17 21.28 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 m -88.98 118.19 28.53 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.4 mtp -134.4 125.91 28.49 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.87 146.74 33.24 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.279 0.561 . . . . 0.0 110.398 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.18 148.94 43.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.604 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -56.52 -39.67 73.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.817 0.341 . . . . 0.0 110.451 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -75.14 -10.49 59.52 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.876 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.29 10.82 70.41 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.2 t -62.72 -41.97 99.42 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.008 -0.113 . . . . 0.0 111.057 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.1 tpt -120.2 143.18 48.39 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.6 t -143.53 139.41 29.76 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.454 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 58.5 t80 -160.0 160.54 33.43 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.454 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 73.8 m-20 -138.03 128.34 26.14 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.5 134.08 38.76 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.38 156.13 26.75 Favored Glycine 0 N--CA 1.465 0.614 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.6 -172.14 40.98 Favored Glycine 0 CA--C 1.517 0.177 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.03 140.8 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 122.593 0.357 . . . . 0.0 110.301 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -79.24 121.69 25.38 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.06 -39.09 63.73 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.226 0.536 . . . . 0.0 109.757 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -166.16 147.75 6.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.218 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.7 t -137.39 135.26 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -140.74 119.63 12.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.7 m -50.99 118.61 3.29 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.7 m120 52.89 72.17 0.44 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.915 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -168.15 -77.02 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.256 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.0 tp -150.99 140.6 21.65 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.349 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.7 mt -132.09 132.09 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.14 155.15 36.2 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -155.81 155.1 32.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.4 m -98.64 128.69 45.02 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 88.3 mt -92.06 150.48 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.95 -41.44 68.05 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -60.71 -12.14 9.57 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.727 0.298 . . . . 0.0 110.477 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.49 -3.56 81.81 Favored Glycine 0 N--CA 1.468 0.822 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -65.88 138.42 57.85 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -98.37 142.69 29.69 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.2 t -143.46 136.66 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -136.24 138.77 42.16 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.1 mt -129.94 114.68 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.0 p -107.91 132.58 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -103.83 117.52 34.53 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.5 m -109.17 152.08 25.61 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -145.85 143.08 29.39 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 65.2 p -144.03 105.09 4.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.842 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.96 -93.92 0.2 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 21.3 p-10 -132.06 32.7 3.99 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.607 0.363 . . . . 0.0 110.984 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.3 m -134.72 126.64 29.43 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.6 m -108.26 124.97 51.12 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -117.18 121.24 40.68 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.8 mt -98.03 124.48 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.88 130.66 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -142.5 144.22 32.89 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 56.4 m -123.33 148.62 45.82 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -128.61 153.38 47.32 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 . . . . . 0 CA--C 1.539 0.552 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.429 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 . . . . . 0 CA--C 1.521 -0.169 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -55.04 -41.79 71.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.997 0.427 . . . . 0.0 110.358 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.1 t -61.24 -43.36 99.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.352 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.79 -51.7 57.03 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -65.23 -42.96 92.89 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.169 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.85 -38.9 92.79 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.56 -54.16 49.16 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.9 tt -67.39 -37.54 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.312 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.2 mt -61.52 -41.62 97.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.766 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 128' ' ' SER . 25.2 p30 -67.48 -31.68 71.99 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.16 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.415 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 96.2 p -76.79 -29.16 55.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.936 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 56.6 t80 . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.936 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.755 0.312 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.3 mm -51.77 136.18 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.5 m -135.73 128.9 31.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.988 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.96 149.83 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -148.91 158.29 44.06 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.664 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.43 158.9 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.503 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -122.45 124.71 44.25 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.3 p -128.42 141.8 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 122.542 0.337 . . . . 0.0 110.769 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -87.7 87.1 7.28 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.152 0.501 . . . . 0.0 110.078 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.41 147.05 4.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.403 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.16 137.67 58.07 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.242 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.6 tt -52.8 -32.24 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.248 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -59.43 -42.73 92.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.73 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -71.03 -44.47 65.75 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.076 0.465 . . . . 0.0 110.487 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.57 -43.11 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.409 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -58.72 -49.93 75.77 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.8 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -67.65 -45.82 74.22 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.575 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -63.18 -44.66 94.81 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.096 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -67.35 -21.32 65.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.649 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -101.44 -23.96 14.25 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.95 0.5 . . . . 0.0 111.797 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -62.5 117.98 36.41 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 118.743 -0.646 . . . . 0.0 109.284 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.5 -37.16 7.73 Favored 'Trans proline' 0 N--CA 1.504 2.141 0 CA-C-N 121.081 1.422 . . . . 0.0 112.214 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.13 -30.71 66.53 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.927 0.394 . . . . 0.0 111.111 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -79.96 -36.51 36.04 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.384 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 31' ' ' CYS . 96.8 mt -63.39 -42.98 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 122.087 -0.383 . . . . 0.0 110.598 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 17.2 ptp -60.09 -14.87 18.91 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.262 -0.274 . . . . 0.0 111.163 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -79.47 -30.57 42.17 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 122.133 -0.354 . . . . 0.0 110.779 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -133.89 20.57 3.82 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.538 ' C ' ' H ' ' A' ' 33' ' ' ALA . 42.9 t -57.35 134.22 55.82 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.64 -0.663 . . . . 0.0 111.219 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 70.59 -35.56 0.33 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.665 0.603 . . . . 0.0 110.283 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.538 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 55.64 33.42 21.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.189 0.518 . . . . 0.0 110.64 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.9 t -124.5 114.12 27.3 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.24 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.79 -22.1 28.23 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 121.573 1.515 . . . . 0.0 112.184 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -79.91 13.37 2.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.879 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -150.11 159.0 44.75 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.027 0.441 . . . . 0.0 110.254 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -140.0 163.3 33.05 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.387 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.1 p -126.78 92.52 44.54 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 123.559 0.744 . . . . 0.0 109.464 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.2 -12.65 23.34 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 121.302 1.335 . . . . 0.0 111.976 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.57 154.72 5.7 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.983 0.42 . . . . 0.0 110.073 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.81 144.61 13.52 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.904 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -139.86 153.59 47.07 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -159.03 103.37 1.67 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.897 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -93.49 85.83 5.05 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 tp -65.53 92.74 0.14 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -170.21 147.3 3.1 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.916 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.52 136.55 58.06 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.34 -1.77 18.16 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -73.59 155.54 50.02 Favored Glycine 0 N--CA 1.467 0.716 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.9 m -115.69 152.8 32.51 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.92 0.488 . . . . 0.0 109.966 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -136.68 160.55 38.5 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.29 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.0 m -150.99 115.98 5.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 43.5 m -109.02 113.09 25.66 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 m -94.3 122.07 36.46 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 13.4 ptp -141.82 141.91 33.15 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.81 149.83 33.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.98 0.419 . . . . 0.0 110.369 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.8 148.45 51.23 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -54.88 -38.45 67.55 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.815 0.341 . . . . 0.0 110.972 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -79.45 -7.78 58.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.915 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.87 22.09 61.85 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.9 p -82.26 -10.47 59.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.459 0.171 . . . . 0.0 111.059 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 49.3 ttp -165.78 130.93 2.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.463 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.4 p -145.38 164.12 32.47 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.318 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -155.91 143.02 19.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -108.11 114.7 28.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.178 0.591 . . . . 0.0 110.26 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -94.54 137.56 33.51 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.26 157.9 28.73 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.05 -171.59 41.58 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.8 t -131.58 138.52 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -77.55 121.66 24.2 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -72.64 -38.65 67.64 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -163.58 147.71 10.54 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.772 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.5 p -149.22 137.53 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.155 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -145.17 137.44 25.87 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.2 m -56.45 127.66 32.19 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.849 0.357 . . . . 0.0 111.497 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.6 m120 56.36 63.74 1.9 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.211 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -155.22 -84.1 0.06 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.729 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -164.22 159.28 19.92 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.893 0.377 . . . . 0.0 110.771 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.72 130.77 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -145.42 155.11 42.94 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -158.86 156.11 29.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.986 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.7 m -97.98 133.02 43.02 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.8 mt -97.87 151.3 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.2 -40.45 67.41 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -60.98 -15.71 34.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.913 0.387 . . . . 0.0 110.118 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.27 -0.2 65.96 Favored Glycine 0 N--CA 1.469 0.874 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.65 136.52 45.68 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -99.64 152.37 20.14 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.9 t -140.59 137.11 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -132.79 129.01 38.02 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.5 mt -124.44 112.51 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.9 t -109.98 128.72 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -100.4 127.01 46.83 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.1 p -132.97 153.21 51.66 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -154.0 166.01 34.35 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.847 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 t -136.96 -11.2 1.74 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.883 0.373 . . . . 0.0 110.192 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.21 -127.51 1.29 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.2 p-10 -75.03 6.88 3.69 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 122.988 -0.124 . . . . 0.0 110.749 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 53.1 m -124.59 129.73 51.12 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.0 m -106.91 135.86 47.76 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -110.83 111.15 22.11 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.7 mt -92.35 122.65 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.28 126.84 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -143.01 143.49 31.92 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.236 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.2 m -129.15 146.21 51.14 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -117.51 166.09 12.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.127 0.571 . . . . 0.0 109.606 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 . . . . . 0 N--CA 1.471 0.619 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.796 179.551 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 111.452 0.168 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -54.68 -45.4 73.92 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.897 0.38 . . . . 0.0 110.36 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.5 t -68.17 -33.03 73.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.651 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.3 -51.19 60.32 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -62.44 -38.4 89.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.905 0.383 . . . . 0.0 110.508 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -70.51 -38.29 74.26 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.97 -52.46 65.42 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.096 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.0 tt -60.92 -37.85 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.02 -46.91 79.38 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.427 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -77.87 -32.08 51.74 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 122.193 -0.317 . . . . 0.0 111.095 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.9 m -60.12 -40.73 90.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.732 0.301 . . . . 0.0 110.455 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.1 t80 . . . . . 0 N--CA 1.467 0.394 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.511 -179.638 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.2 pttm . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 120.99 0.424 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.6 mt -50.37 140.23 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.8 m -134.12 135.26 43.06 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.5 m -132.49 160.72 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -138.44 158.72 43.72 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.957 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 t -133.48 126.43 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.9 p -88.76 109.05 19.84 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.0 t -126.36 127.02 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -97.47 89.13 4.59 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.09 154.75 5.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.032 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.62 132.23 50.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.18 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.4 tt -54.08 -34.74 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.611 0.244 . . . . 0.0 110.929 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.93 -40.31 92.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.083 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -70.18 -48.09 58.78 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.803 0.335 . . . . 0.0 110.786 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.0 -41.7 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.356 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 42.9 t-105 -50.66 -39.87 51.93 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.551 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -65.68 -48.35 72.36 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.311 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -68.59 -43.0 77.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.662 0.268 . . . . 0.0 110.971 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -65.57 -19.39 65.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.612 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.566 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.8 OUTLIER -102.57 -22.82 13.94 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.282 0.633 . . . . 0.0 110.583 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -63.19 120.63 63.36 Favored Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.94 -40.98 4.44 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 CA-C-N 120.997 1.392 . . . . 0.0 112.086 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.96 -30.31 63.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.697 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.519 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 81.1 t60 -78.07 -45.17 24.27 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.378 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 31' ' ' CYS . 95.7 mt -59.73 -50.86 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 121.946 -0.471 . . . . 0.0 111.064 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.6 ptm -57.64 -15.49 7.78 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -79.03 -33.27 44.98 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.519 ' HE1' ' CD2' ' A' ' 26' ' ' HIS . 58.1 p-90 -133.69 20.8 3.89 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.661 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.594 ' C ' ' H ' ' A' ' 33' ' ' ALA . 44.1 t -55.12 129.32 37.64 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.764 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 68.63 -19.33 0.16 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.116 0.484 . . . . 0.0 110.496 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.594 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.64 35.55 23.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.482 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -111.25 97.78 36.89 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.064 0.546 . . . . 0.0 110.087 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.33 -23.21 22.97 Favored 'Trans proline' 0 N--CA 1.505 2.175 0 C-N-CA 122.378 2.052 . . . . 0.0 112.576 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -68.76 -24.67 64.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.536 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -104.76 163.96 12.12 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -141.22 162.33 35.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.21 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -129.81 89.86 44.9 Favored Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -73.95 -9.04 21.94 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 121.694 1.596 . . . . 0.0 111.873 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.1 152.58 6.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.003 0.43 . . . . 0.0 110.105 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.14 145.89 13.75 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.084 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -133.72 150.3 51.5 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -159.86 125.58 4.17 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.698 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -133.25 94.78 3.4 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.7 mt -66.83 97.37 0.47 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.139 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -162.56 135.96 6.05 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.69 133.92 56.54 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.673 0.273 . . . . 0.0 110.307 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.06 5.05 69.58 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.21 165.73 39.69 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.8 p -131.09 161.56 31.8 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.442 ' CD1' ' CE2' ' A' ' 71' ' ' TYR . 30.6 p90 -154.75 170.02 22.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.068 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.8 m -153.69 139.34 17.89 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.5 m -121.33 120.64 35.67 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.3 m -92.87 123.55 36.22 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.0 ptm -142.76 138.6 30.58 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.18 145.33 26.21 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.044 0.45 . . . . 0.0 110.326 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.48 149.8 28.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.765 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -51.46 -39.93 58.45 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.866 0.365 . . . . 0.0 110.775 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -80.21 -9.32 59.72 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.139 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.3 18.21 67.09 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.0 t -62.19 -40.51 96.29 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.659 0.266 . . . . 0.0 110.922 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 44.3 ttp -142.31 136.78 30.05 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.226 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.8 p -145.74 158.86 43.82 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -159.13 139.11 11.94 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -88.56 111.01 21.37 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -94.53 131.01 40.71 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.69 175.11 42.09 Favored Glycine 0 C--O 1.227 -0.335 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.45 -174.01 40.88 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.12 129.39 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.442 ' CE2' ' CD1' ' A' ' 52' ' ' PHE . 74.6 m-85 -72.45 113.48 9.53 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -73.4 -39.05 65.38 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.219 0.533 . . . . 0.0 109.767 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -166.89 146.21 5.4 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.524 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.6 131.03 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -140.03 128.32 22.57 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.5 p -61.51 134.88 57.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.249 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.2 m120 55.98 55.36 6.99 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.673 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -155.1 -82.52 0.07 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.645 0.259 . . . . 0.0 110.35 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -163.63 160.12 22.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.355 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.7 mt -133.7 134.99 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.06 156.69 42.92 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -161.16 156.26 24.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.5 p -103.5 133.06 49.17 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 2.6 mp -93.44 160.37 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.25 -44.95 64.93 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -62.8 -12.8 26.84 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.831 0.315 . . . . 0.0 110.36 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.34 9.56 66.93 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -58.94 155.08 13.98 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -114.57 127.73 55.94 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.7 t -136.93 132.02 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -134.98 133.79 39.85 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 77.1 mt -123.72 114.17 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 43.2 t -111.78 129.54 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -98.92 119.58 37.94 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 39.7 m -120.44 148.77 43.37 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -154.07 158.23 40.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.0 p -135.86 23.33 3.34 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.249 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 100' ' ' THR . . . 88.34 128.31 2.97 Favored Glycine 0 N--CA 1.47 0.96 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 58.07 6.06 0.46 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.824 0.345 . . . . 0.0 111.061 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.442 ' H ' ' C ' ' A' ' 98' ' ' GLY . 28.2 m -148.23 137.56 22.08 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.2 m -130.99 125.24 32.8 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -110.32 119.35 38.95 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.4 mt -95.58 120.55 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 36.6 t -105.15 132.07 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -134.0 114.37 13.15 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.7 t -94.52 149.63 21.05 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -144.36 140.9 29.36 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 108' ' ' ASP . 16.4 p-10 . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 . . . . . 0 CA--C 1.52 -0.21 0 CA-C-O 120.528 0.204 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.54 -50.64 59.63 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.871 0.367 . . . . 0.0 110.363 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.5 m -62.33 -38.55 89.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.601 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.44 -52.33 49.9 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.943 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -62.45 -39.44 93.37 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.772 0.286 . . . . 0.0 110.483 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.6 ' NE2' HD22 ' A' ' 127' ' ' ASN . 0.0 OUTLIER -74.07 -35.08 64.23 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.625 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.14 -50.54 73.64 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.45 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.4 pt -63.64 -34.53 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.818 0.342 . . . . 0.0 110.798 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.0 mt -64.67 -37.07 86.34 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.029 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.6 HD22 ' NE2' ' A' ' 123' ' ' GLN . 80.0 m-20 -61.24 -40.63 94.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.751 0.31 . . . . 0.0 110.461 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.7 t -62.69 -40.3 96.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.549 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 75.9 t80 . . . . . 0 N--CA 1.464 0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.443 -179.563 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.1 mttt . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 81.3 mt -142.28 133.01 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.8 m -137.77 133.43 34.05 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 m -138.7 153.35 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.11 163.94 36.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.049 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.9 m -145.83 157.52 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -102.73 126.73 49.95 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.19 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.06 129.5 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -98.59 89.2 4.31 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.14 155.25 6.43 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.8 135.91 57.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.209 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.6 tp -52.88 -36.49 23.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 121.1 0.476 . . . . 0.0 111.417 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -68.87 -33.62 74.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.167 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -71.42 -51.73 22.36 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.603 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 p -62.51 -36.3 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.676 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.473 ' CE2' ' ND2' ' A' ' 22' ' ' ASN . 68.4 t90 -54.47 -44.0 72.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.979 0.418 . . . . 0.0 110.906 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -69.39 -45.94 68.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.712 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -65.32 -40.56 93.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.982 0.42 . . . . 0.0 110.96 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -73.54 -17.22 61.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.707 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.473 ' ND2' ' CE2' ' A' ' 18' ' ' TRP . 90.4 m-20 -109.41 -20.39 12.93 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.182 0.593 . . . . 0.0 110.72 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -64.41 138.71 97.52 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.8 -43.48 0.43 Allowed 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 121.763 1.642 . . . . 0.0 112.43 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.25 -40.56 96.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 110.909 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -66.69 -46.26 76.17 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.641 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 31' ' ' CYS . 89.2 mt -62.8 -48.51 87.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.431 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 43.2 ttp -60.38 -23.27 64.18 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -65.58 -31.78 73.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.437 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -135.67 14.17 3.42 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.444 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.466 ' C ' ' H ' ' A' ' 33' ' ' ALA . 12.0 t -55.73 141.05 39.68 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 122.1 -0.375 . . . . 0.0 110.0 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 72.07 -46.79 0.65 Allowed 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.233 0.958 . . . . 0.0 109.227 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.466 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.38 40.58 31.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.307 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.5 m -124.32 139.12 32.17 Favored Pre-proline 0 N--CA 1.481 1.121 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.973 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.422 ' O ' ' NZ ' ' A' ' 59' ' ' LYS . 93.6 Cg_endo -74.42 -30.05 8.65 Favored 'Trans proline' 0 N--CA 1.506 2.253 0 C-N-CA 121.941 1.761 . . . . 0.0 112.51 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.94 6.47 7.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.725 0.298 . . . . 0.0 110.692 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -147.32 158.39 43.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.182 0.515 . . . . 0.0 109.717 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.4 ' CE1' ' O ' ' A' ' 57' ' ' ALA . 14.3 p-80 -146.59 155.21 42.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.229 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.85 89.63 34.25 Favored Pre-proline 0 N--CA 1.476 0.828 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.63 -1.78 11.89 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.167 1.912 . . . . 0.0 111.587 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.71 147.91 6.13 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.025 0.441 . . . . 0.0 110.031 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.68 141.82 18.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.755 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -134.95 137.96 43.6 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -163.17 136.43 5.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.62 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -130.46 99.33 4.96 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 tp -65.43 95.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.877 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -169.54 141.41 2.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.17 135.93 57.79 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.289 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.08 1.7 60.37 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.77 158.43 36.96 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.408 ' HG1' ' N ' ' A' ' 52' ' ' PHE . 2.2 t -118.27 165.26 14.05 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.142 0.577 . . . . 0.0 109.851 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.408 ' N ' ' HG1' ' A' ' 51' ' ' THR . 54.8 p90 -144.8 159.77 42.33 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.157 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.2 m -149.36 123.96 9.77 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.8 p -120.89 123.33 42.25 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.7 m -90.36 117.4 29.05 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 60.7 mtt -129.87 104.55 7.44 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.4 ' O ' ' CE1' ' A' ' 38' ' ' HIS . . . -126.82 156.42 41.32 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.02 148.83 37.76 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.422 ' NZ ' ' O ' ' A' ' 35' ' ' PRO . 28.2 mtmm -58.73 -39.54 81.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.77 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -70.7 -9.58 57.51 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.72 9.84 63.0 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.2 t -62.99 -39.36 94.5 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 110.887 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 69.5 mmm -122.63 148.97 44.63 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.882 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.3 p -146.81 128.13 14.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.168 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -159.9 155.37 25.47 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -139.71 142.88 36.84 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.274 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.43 143.2 28.4 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.45 152.02 23.7 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.91 -172.44 41.52 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.48 142.15 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 122.974 0.51 . . . . 0.0 110.175 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -79.01 120.53 23.72 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.51 -42.77 58.33 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -168.57 148.31 4.46 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.838 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.57 136.56 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -136.03 124.11 22.95 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 m -59.2 130.65 48.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.162 -178.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.2 p30 40.98 57.67 2.7 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -157.77 -77.47 0.08 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 110.449 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.2 tp -149.68 133.88 17.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.738 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.5 mt -133.02 133.14 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -153.93 160.38 42.09 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -160.2 156.78 27.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.9 m -101.92 127.65 48.66 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.7 mt -90.54 153.81 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.74 -41.96 67.23 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -60.26 -10.58 4.78 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.788 0.328 . . . . 0.0 110.17 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.0 8.81 86.12 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -68.82 150.71 47.51 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -101.89 129.29 48.1 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.8 t -139.77 131.03 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -138.94 141.75 38.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.2 mt -118.97 126.93 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.97 126.82 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -99.12 125.84 44.75 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.8 p -133.64 143.5 48.64 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -154.89 156.14 35.6 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.6 t -115.59 -24.11 8.45 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.973 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.1 -112.14 0.37 Allowed Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -76.77 10.78 2.01 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.613 0.244 . . . . 0.0 110.67 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.3 p -126.72 144.92 50.78 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.7 m -125.55 131.3 52.79 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.296 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -116.33 121.83 43.11 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.9 mt -102.51 128.98 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.9 t -119.26 133.56 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -137.94 146.08 42.8 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.0 p -133.33 148.84 51.9 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -143.31 143.14 31.57 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 . . . . . 0 CA--C 1.518 -0.254 0 CA-C-O 120.529 0.204 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -53.39 -44.42 68.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.876 0.37 . . . . 0.0 110.145 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.2 m -61.58 -40.94 96.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.255 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.97 -51.96 48.94 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -62.39 -37.72 86.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.015 0.436 . . . . 0.0 110.299 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -72.29 -35.77 68.78 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.256 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.91 -51.14 70.96 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.56 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.6 tt -63.06 -40.13 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 120.791 0.329 . . . . 0.0 110.136 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.2 mt -63.85 -38.86 92.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.4 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -61.99 -38.17 87.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.2 t -57.92 -32.79 68.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.762 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 52.7 t80 . . . . . 0 CA--C 1.534 0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.375 -179.88 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttp . . . . . 0 N--CA 1.466 0.354 0 CA-C-O 120.919 0.39 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 82.7 mt -58.94 131.19 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.44 ' HG1' ' N ' ' A' ' 6' ' ' VAL . 3.1 t -137.0 149.73 47.67 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.44 ' N ' ' HG1' ' A' ' 5' ' ' THR . 28.9 m -136.85 158.39 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 161.7 40.31 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.587 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -148.96 143.04 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.886 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.7 m -94.26 119.41 33.01 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.5 t -124.87 128.03 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -95.65 92.47 6.62 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.91 154.52 5.26 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.23 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.89 135.76 57.49 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.339 -0.391 . . . . 0.0 109.956 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.8 tp -50.72 -40.79 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.141 0.496 . . . . 0.0 111.66 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -64.25 -35.27 80.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.551 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -70.54 -46.5 63.48 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.782 0.325 . . . . 0.0 110.424 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.26 -40.39 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.308 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.439 ' NE1' ' OD1' ' A' ' 22' ' ' ASN . 31.8 t-105 -54.53 -40.49 68.71 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.805 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -67.2 -52.8 36.74 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.278 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -64.84 -42.67 94.74 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.845 0.355 . . . . 0.0 110.885 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -64.13 -18.81 64.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.326 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.439 ' OD1' ' NE1' ' A' ' 18' ' ' TRP . 4.1 m120 -110.2 -25.49 10.14 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 122.845 0.458 . . . . 0.0 112.177 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -53.09 110.21 1.88 Allowed Pre-proline 0 CA--C 1.556 1.196 0 CA-C-O 118.837 -0.602 . . . . 0.0 109.765 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.61 -43.05 58.13 Favored 'Trans proline' 0 N--CA 1.506 2.208 0 CA-C-N 120.869 1.346 . . . . 0.0 111.837 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.57 73.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.949 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.502 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 80.6 t60 -74.15 -42.74 59.46 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.417 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.18 -44.74 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.872 -0.517 . . . . 0.0 110.498 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.8 ptm -70.95 -6.42 38.48 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -84.95 -29.59 24.99 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.502 ' HE1' ' CD2' ' A' ' 26' ' ' HIS . 63.3 p-90 -133.78 17.9 3.88 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.593 0.357 . . . . 0.0 110.954 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.621 ' C ' ' H ' ' A' ' 33' ' ' ALA . 32.1 p -45.85 128.95 9.26 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.063 0.392 . . . . 0.0 111.457 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 61.54 -11.02 0.06 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 120.982 0.42 . . . . 0.0 110.523 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.621 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 52.58 32.81 12.3 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.673 0.389 . . . . 0.0 111.24 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.5 t -122.8 135.74 26.07 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.011 0.524 . . . . 0.0 110.568 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.87 -9.96 16.86 Favored 'Trans proline' 0 N--CA 1.506 2.249 0 C-N-CA 122.097 1.865 . . . . 0.0 112.418 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -73.91 -24.74 59.73 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.728 0.299 . . . . 0.0 110.737 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -103.66 155.21 18.74 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.663 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -139.02 164.15 30.51 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.1 t -132.36 94.33 23.32 Favored Pre-proline 0 N--CA 1.477 0.925 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.29 -12.01 25.12 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.343 1.362 . . . . 0.0 111.211 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.8 150.8 4.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.418 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.59 141.74 20.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.227 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -138.0 142.07 40.42 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -163.13 135.55 5.35 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -129.86 104.0 7.13 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.64 93.71 1.27 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.914 0.388 . . . . 0.0 110.111 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -171.41 151.06 2.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.662 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.09 137.95 58.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.661 0.267 . . . . 0.0 110.453 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.31 0.74 47.65 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.85 149.44 44.68 Favored Glycine 0 N--CA 1.464 0.533 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.9 p -110.75 144.01 40.38 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -127.16 152.84 46.81 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.3 m -149.94 116.83 5.92 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.7 m -116.52 115.86 26.55 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.1 m -91.84 116.27 28.76 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 71.3 mtp -117.79 129.43 55.67 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.09 135.12 37.17 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.071 0.462 . . . . 0.0 110.57 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.7 149.92 49.38 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.309 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -55.93 -39.7 72.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.626 0.25 . . . . 0.0 110.463 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -76.38 -10.21 59.22 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.62 17.62 62.66 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.6 p -83.93 -9.97 58.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.617 0.246 . . . . 0.0 110.774 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.7 ttt -152.92 120.86 6.12 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.452 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.2 m -144.25 148.68 35.2 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -158.9 164.55 35.56 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 22.4 p-10 -137.08 123.33 20.56 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.804 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -94.11 145.92 24.34 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.05 153.68 25.12 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.27 -171.68 41.05 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -128.63 135.69 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -71.94 121.85 19.81 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -73.56 -38.44 65.2 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -163.05 145.42 10.29 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.508 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.1 t -137.97 130.5 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -146.88 123.8 11.33 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.6 p -51.71 121.92 7.31 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.211 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 54.28 62.02 2.77 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.28 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -156.04 -84.58 0.06 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.753 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 tp -148.42 136.24 20.81 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.771 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.2 mt -130.32 127.82 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -153.49 165.29 36.3 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -160.8 154.42 22.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.836 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.1 m -89.35 131.09 35.59 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 80.0 mt -102.27 148.82 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.88 -44.05 71.21 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.0 p30 -61.93 -18.69 61.18 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.367 0.584 . . . . 0.0 110.394 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.07 5.19 77.19 Favored Glycine 0 N--CA 1.47 0.954 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 65.6 mmt-85 -63.04 139.38 58.77 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -89.96 128.53 36.26 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.5 t -141.34 125.96 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -136.84 142.92 42.87 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 75.5 mt -119.86 118.94 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.8 t -104.2 124.29 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -96.15 122.43 38.99 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 36.4 m -140.36 146.62 38.65 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -150.74 164.63 35.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.2 t -137.85 23.51 2.85 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.292 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.12 129.65 2.82 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 55.49 12.02 0.7 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.816 0.341 . . . . 0.0 111.037 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.9 m -153.78 140.75 19.27 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.4 m -125.43 130.68 52.33 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.756 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -110.45 117.03 32.49 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.9 mt -106.85 122.21 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.04 139.56 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -144.98 142.76 30.08 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.048 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.4 p -94.23 152.7 18.5 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -151.49 139.74 20.31 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 N--CA 1.477 0.884 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.34 -179.156 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.473 HE21 ' C ' ' A' ' 118' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 119.978 -0.058 . . . . 0.0 110.888 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -57.42 -47.32 82.07 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.84 0.352 . . . . 0.0 110.06 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.0 m -64.04 -33.04 74.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.588 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.61 -50.46 67.53 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -62.45 -39.52 93.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.985 0.422 . . . . 0.0 110.429 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -71.91 -37.57 70.06 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.348 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.35 -50.69 72.75 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.836 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 42.0 pt -65.4 -32.75 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 110.734 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.2 -37.01 82.92 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -62.55 -41.56 98.98 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.08 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.9 p -62.52 -32.4 73.33 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.616 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.5 t80 . . . . . 0 N--CA 1.467 0.377 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.579 -179.547 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 pttm . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 121.194 0.521 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.3 mt -54.65 139.99 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 t -129.27 137.43 51.05 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.682 0.614 . . . . 0.0 109.718 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.61 158.08 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.41 158.0 43.8 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.558 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.9 p -146.14 144.78 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.673 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.9 m -97.58 120.79 38.6 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.94 127.5 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -91.7 93.96 9.15 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.8 151.52 3.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.09 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.43 140.44 58.87 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.664 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.7 tp -51.6 -37.22 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.169 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -68.94 -34.32 75.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.435 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -69.3 -50.58 45.44 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.903 0.382 . . . . 0.0 111.218 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -64.3 -36.19 76.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.62 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -58.29 -49.84 75.71 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.614 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -67.64 -45.83 74.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.641 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.45 ' CD2' ' ND1' ' A' ' 26' ' ' HIS . 56.2 t80 -63.88 -44.23 93.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.049 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -70.82 -19.65 62.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.593 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.7 OUTLIER -103.05 -23.82 13.66 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.845 0.458 . . . . 0.0 111.437 -179.24 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -62.94 135.17 95.99 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.1 -40.67 0.81 Allowed 'Trans proline' 0 N--CA 1.504 2.142 0 C-N-CA 121.681 1.588 . . . . 0.0 111.745 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.83 -33.0 68.16 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.051 0.453 . . . . 0.0 110.78 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.45 ' ND1' ' CD2' ' A' ' 20' ' ' TYR . 35.5 m170 -76.4 -42.36 44.59 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.573 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.13 -44.93 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 122.161 -0.337 . . . . 0.0 110.804 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.6 ptm -68.14 -10.64 55.66 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -79.7 -28.6 40.63 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.333 -0.23 . . . . 0.0 110.395 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -137.48 21.61 2.93 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.204 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.567 ' C ' ' H ' ' A' ' 33' ' ' ALA . 29.3 t -55.97 133.17 51.44 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.639 -0.663 . . . . 0.0 110.189 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 69.35 -32.08 0.22 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.108 0.563 . . . . 0.0 110.423 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.567 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 55.66 34.61 23.6 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.327 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.8 p -128.51 138.66 33.54 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.087 0.555 . . . . 0.0 110.033 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.48 -12.53 18.66 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.746 1.63 . . . . 0.0 112.239 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -76.25 -24.61 54.52 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -115.41 140.2 49.34 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.929 0.492 . . . . 0.0 110.545 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -117.33 163.79 15.81 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.251 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.84 87.62 44.47 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.079 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.75 -8.2 14.59 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.053 1.835 . . . . 0.0 111.559 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.44 153.23 5.11 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.894 0.378 . . . . 0.0 110.055 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.99 152.88 5.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.961 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -141.28 155.52 45.98 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -159.25 103.05 1.61 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.019 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -95.59 86.98 4.58 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 tp -66.4 93.25 0.22 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.357 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -169.93 145.19 2.89 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.61 135.93 56.74 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.425 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.16 -1.05 35.76 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.96 162.28 52.69 Favored Glycine 0 N--CA 1.468 0.81 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.4 p -125.24 157.22 37.1 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.672 0.389 . . . . 0.0 110.262 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -138.16 157.03 47.11 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.318 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.0 m -146.93 116.01 6.92 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.9 m -106.99 112.62 25.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 m -92.88 120.08 32.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.7 ptm -143.14 142.12 31.39 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.79 152.73 40.78 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.028 0.442 . . . . 0.0 110.748 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.08 148.71 50.58 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.636 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -57.89 -39.32 77.58 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.591 0.234 . . . . 0.0 110.523 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -78.05 -6.06 53.41 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.78 17.51 54.57 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.1 p -66.37 -25.52 66.83 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.769 0.319 . . . . 0.0 110.389 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.2 ttt -149.09 145.34 27.18 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.916 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.7 t -142.7 144.85 32.89 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.737 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.408 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 71.1 t80 -159.35 162.53 35.91 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.408 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 30.3 p-10 -138.04 130.69 29.55 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.098 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -94.54 137.61 33.44 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.27 154.96 25.85 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.71 -176.03 40.41 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.4 t -126.24 133.26 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -75.44 115.49 15.15 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -73.85 -44.84 54.31 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.184 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -153.23 145.87 24.23 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 p -148.1 137.3 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -143.06 132.37 23.34 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.9 m -56.77 128.62 37.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.732 0.301 . . . . 0.0 111.453 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 54.88 69.38 0.74 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.767 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -165.84 -80.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -160.35 159.99 31.85 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.976 0.417 . . . . 0.0 110.795 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.9 mt -134.74 135.63 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.86 155.55 41.06 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -159.09 159.65 34.82 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 49.6 m -102.25 129.89 48.79 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.5 tt -94.57 167.1 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.91 -38.11 94.86 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -63.28 -16.77 61.34 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 117.184 0.492 . . . . 0.0 109.962 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.21 11.6 78.05 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -77.86 148.36 34.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -83.92 153.96 23.66 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.0 t -144.99 130.5 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -137.21 122.01 18.74 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.9 mt -122.46 113.93 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.4 p -118.82 131.75 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-O 121.279 0.561 . . . . 0.0 110.034 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -97.13 109.21 22.01 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 61.3 m -98.22 122.95 42.01 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -101.8 146.73 27.38 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.3 m -146.62 99.32 3.19 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.411 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.89 -95.43 0.04 OUTLIER Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -128.56 48.4 2.32 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.006 0.431 . . . . 0.0 110.587 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.6 m -161.35 119.22 2.33 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.0 m -95.27 141.09 29.26 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -127.45 129.48 47.57 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.2 mt -103.07 125.53 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.7 t -122.68 127.83 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -142.92 144.62 32.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.23 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.8 t -136.11 143.11 44.38 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.079 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -127.57 169.19 13.99 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.671 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.473 0.681 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.722 179.143 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 . . . . . 0 CA--C 1.52 -0.193 0 CA-C-O 120.648 0.261 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -54.13 -44.43 71.35 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.805 0.336 . . . . 0.0 110.299 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 78.8 p -68.28 -35.9 78.56 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.83 -51.99 51.6 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -64.22 -37.08 86.21 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.816 0.341 . . . . 0.0 110.421 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -72.4 -37.43 68.7 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.461 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.99 67.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.909 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.5 tt -60.89 -36.96 75.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.8 mt -66.19 -49.1 68.46 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.467 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -75.78 -33.71 60.19 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.664 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.0 m -60.54 -40.34 91.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.32 . . . . 0.0 110.399 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.2 t80 . . . . . 0 N--CA 1.467 0.391 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.512 -179.482 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.41 ' CG ' ' HG ' ' A' ' 106' ' ' SER . 81.8 tttt . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 79.5 mt -46.14 121.28 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 m -112.89 130.7 56.01 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 m -134.48 156.59 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.406 ' CD ' ' N ' ' A' ' 7' ' ' GLU . 1.3 pm0 -148.3 161.29 41.82 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.14 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -145.05 143.84 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.1 m -91.17 117.29 29.5 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.8 t -124.65 128.36 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -100.16 88.57 3.75 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.74 153.59 5.01 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.048 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.12 133.28 52.67 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 20.1 tt -52.25 -37.53 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.776 0.322 . . . . 0.0 111.733 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -58.96 -35.58 73.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.356 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -74.92 -46.07 38.29 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.022 0.439 . . . . 0.0 110.442 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.09 -43.28 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.189 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -54.86 -46.09 74.65 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.84 0.352 . . . . 0.0 110.943 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.78 -45.85 77.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.335 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -65.19 -43.75 90.61 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.894 0.378 . . . . 0.0 111.166 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -69.5 -15.96 63.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.561 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -109.52 -24.64 10.89 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.274 0.63 . . . . 0.0 111.298 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -65.09 117.23 37.43 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.499 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.97 -34.59 10.33 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 CA-C-N 121.033 1.405 . . . . 0.0 112.005 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -34.22 70.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.002 0.429 . . . . 0.0 110.575 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -81.17 -40.89 23.21 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.405 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.9 -45.4 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 122.069 -0.394 . . . . 0.0 111.088 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.7 ptm -59.32 -12.85 6.35 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.335 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -81.32 -39.71 24.72 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -120.22 20.76 11.95 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.654 0.381 . . . . 0.0 111.183 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.625 ' C ' ' H ' ' A' ' 33' ' ' ALA . 12.9 t -57.54 135.82 56.68 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.829 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 67.83 -26.29 0.13 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.612 0.57 . . . . 0.0 110.327 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.625 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 55.5 27.33 10.09 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.565 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.1 t -124.06 139.92 33.64 Favored Pre-proline 0 N--CA 1.478 0.93 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.253 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.54 -8.9 19.8 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 121.95 1.767 . . . . 0.0 111.668 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -83.16 9.26 10.92 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.622 0.249 . . . . 0.0 110.668 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -151.72 157.72 42.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.242 0.544 . . . . 0.0 110.072 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -147.58 163.5 36.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.105 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.57 93.14 48.69 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 123.023 0.529 . . . . 0.0 109.853 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.46 -8.79 19.81 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.488 1.459 . . . . 0.0 111.597 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.72 151.99 9.56 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.844 0.354 . . . . 0.0 110.228 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.02 144.94 14.96 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.247 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -137.59 145.11 42.41 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -162.03 134.02 5.57 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.853 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -132.99 99.42 4.57 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.5 96.58 0.53 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -166.62 147.77 6.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.09 137.55 58.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.1 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.78 5.19 44.41 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.89 151.54 33.87 Favored Glycine 0 N--CA 1.466 0.655 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.1 p -113.42 161.46 17.28 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -143.51 166.03 25.93 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.215 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.3 m -160.49 128.61 4.6 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.1 m -122.78 123.4 40.96 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -92.35 115.65 28.28 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.3 mtt -120.68 132.43 55.09 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.43 136.15 23.21 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.794 0.331 . . . . 0.0 110.699 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.66 148.77 45.39 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -58.58 -39.54 80.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.723 0.297 . . . . 0.0 110.32 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -74.16 -11.38 60.28 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.25 17.12 67.85 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.4 m -61.89 -40.46 95.5 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.847 0.356 . . . . 0.0 110.725 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 44.4 ttp -147.1 149.55 33.25 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.187 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.1 t -145.04 152.35 39.98 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.329 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -156.5 155.5 32.09 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -138.24 131.11 29.71 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.872 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -95.81 145.36 25.4 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.97 153.31 24.91 Favored Glycine 0 N--CA 1.466 0.65 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -179.09 -171.14 41.93 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.46 145.89 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -82.87 126.12 32.11 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -81.74 -26.9 34.16 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 110.035 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -167.59 140.27 3.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.839 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.5 t -137.24 126.92 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -145.66 124.72 12.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.0 m -50.07 119.57 3.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 53.67 75.8 0.25 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.443 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -168.16 -81.31 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.365 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 tp -149.94 135.03 17.95 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.902 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.0 mt -128.69 130.02 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -153.09 165.35 35.89 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -158.77 164.54 35.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.511 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.6 m -116.26 129.77 56.45 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.7 mm -98.37 149.16 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.961 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.72 -40.39 71.04 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -60.96 -15.8 35.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.656 0.265 . . . . 0.0 110.503 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.4 -2.85 59.35 Favored Glycine 0 N--CA 1.473 1.138 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -64.96 143.77 57.73 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -123.66 139.88 53.55 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.6 t -133.57 134.67 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -127.51 122.72 34.11 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 68.7 mt -110.78 124.1 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.8 123.21 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -94.98 123.29 38.37 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.9 p -134.06 150.69 51.21 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -154.38 164.4 38.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.902 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 m -149.5 118.53 6.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.753 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.09 -94.47 0.07 OUTLIER Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -130.99 31.77 4.41 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.666 0.386 . . . . 0.0 111.015 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 46.4 m -132.16 124.85 29.89 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.8 m -100.86 133.46 45.3 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -122.37 117.53 26.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.9 mt -98.01 129.04 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.48 130.84 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -132.63 120.07 21.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.41 ' HG ' ' CG ' ' A' ' 3' ' ' LYS . 15.0 t -99.22 148.2 24.36 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -136.01 149.92 49.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.445 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 120.531 0.205 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -55.23 -43.48 74.56 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.084 0.469 . . . . 0.0 109.771 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.4 m -62.23 -40.73 97.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.165 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.15 -51.99 48.23 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -63.35 -37.25 86.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.78 0.324 . . . . 0.0 110.277 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -72.1 -36.24 69.41 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.683 0.278 . . . . 0.0 110.338 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.25 70.69 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.789 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.6 tt -62.62 -39.23 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 25.5 mt -63.87 -39.14 93.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -63.89 -40.95 97.7 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m -58.37 -30.65 66.95 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.344 0.403 . . . . 0.0 111.232 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 63.9 t80 . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 120.933 0.397 . . . . 0.0 110.898 -178.589 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -64.34 -25.98 68.28 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 121.012 0.434 . . . . 0.0 110.269 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -71.81 55.45 0.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.95 0.405 . . . . 0.0 110.082 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 82.0 mt -55.42 132.49 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -130.31 139.11 50.74 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.4 m -136.15 156.38 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -145.24 157.48 44.06 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.038 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 p -145.81 142.78 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.9 p -97.18 117.34 31.17 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.55 126.12 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -93.64 88.73 5.96 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.09 0.471 . . . . 0.0 109.863 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.88 153.12 4.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.055 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.74 139.3 58.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.221 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.5 tp -51.07 -36.79 16.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 120.893 0.378 . . . . 0.0 111.612 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -67.66 -33.1 74.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.44 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -71.17 -51.32 25.53 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 p -65.3 -36.59 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.318 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 29.1 t-105 -54.61 -43.41 72.18 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.932 0.396 . . . . 0.0 110.56 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -68.37 -45.33 73.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.622 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -65.71 -44.42 86.14 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.902 0.382 . . . . 0.0 111.497 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -66.75 -20.7 66.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.932 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -102.63 -22.56 13.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.982 0.513 . . . . 0.0 111.512 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -64.16 123.02 80.96 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.93 -39.74 3.07 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 CA-C-N 120.863 1.344 . . . . 0.0 111.889 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.11 -39.21 71.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.894 0.378 . . . . 0.0 110.759 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.9 m170 -66.33 -42.86 87.57 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.64 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 31' ' ' CYS . 97.2 mt -62.61 -43.75 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 93.5 mtp -59.31 -13.45 8.06 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.737 -0.21 . . . . 0.0 111.077 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -85.14 -38.56 18.91 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.978 -0.451 . . . . 0.0 110.759 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -122.4 23.74 9.58 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.729 0.412 . . . . 0.0 111.216 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.589 ' C ' ' H ' ' A' ' 33' ' ' ALA . 38.3 t -54.39 129.37 35.4 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.804 -0.56 . . . . 0.0 110.958 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 68.54 -30.67 0.18 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.341 0.401 . . . . 0.0 110.478 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.589 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.65 38.37 29.85 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.048 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.7 p -136.81 141.46 35.15 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.302 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.39 -16.41 21.87 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 122.008 1.805 . . . . 0.0 112.289 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -84.06 14.1 4.48 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -151.41 154.81 37.36 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.171 0.51 . . . . 0.0 110.232 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -142.5 163.01 33.99 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.234 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.58 89.57 50.72 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.97 -12.22 23.74 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.263 1.309 . . . . 0.0 111.479 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -171.91 153.05 3.13 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.02 0.438 . . . . 0.0 110.577 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -157.84 150.72 22.92 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.214 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -137.08 145.33 43.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.591 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -161.46 132.32 5.22 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.96 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -128.98 96.01 4.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.0 tp -65.8 96.65 0.3 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -167.67 142.31 3.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.964 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.55 138.19 58.41 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.23 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.27 2.44 59.12 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.9 166.49 37.29 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.8 p -129.14 164.95 22.24 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.639 0.376 . . . . 0.0 110.047 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -140.71 164.52 29.98 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.6 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 36.1 m -150.61 122.56 8.19 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.421 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 37.5 m -116.39 116.57 27.94 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.2 m -95.11 119.68 34.04 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 14.8 ptm -145.67 144.83 30.64 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.75 156.15 40.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.061 0.458 . . . . 0.0 110.535 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.81 148.05 40.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.666 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -56.58 -39.87 74.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.763 0.315 . . . . 0.0 110.721 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -76.37 -7.46 55.05 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.18 11.32 67.13 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.5 t -62.93 -41.84 99.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.45 0.167 . . . . 0.0 111.097 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.9 ttt -120.85 146.32 46.7 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -144.11 141.25 29.9 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.81 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.438 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 56.4 t80 -159.98 161.26 34.1 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.438 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 67.4 t0 -138.54 126.56 22.59 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -94.76 135.54 36.13 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.66 155.74 26.5 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.05 -171.4 41.39 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 p -128.72 139.67 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.785 0.434 . . . . 0.0 110.008 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -78.36 124.96 28.69 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -75.85 -40.01 55.55 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.926 0.393 . . . . 0.0 110.09 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -159.83 146.03 15.93 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.844 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.2 t -135.69 130.69 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -145.4 123.61 12.21 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.4 m -55.12 122.28 10.65 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.9 m120 54.79 60.54 3.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.608 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -156.12 -82.31 0.07 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.089 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.6 tp -147.76 136.8 22.15 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.554 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.7 mt -129.79 126.78 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -154.16 164.18 38.92 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -155.05 154.98 33.3 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.941 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.1 m -87.58 129.53 35.07 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.78 139.87 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.66 -43.21 59.43 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -60.72 -18.56 55.09 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.633 0.254 . . . . 0.0 110.73 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.31 0.67 65.13 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -60.71 168.64 2.17 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -125.19 118.38 25.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.789 0.436 . . . . 0.0 110.126 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -131.96 125.12 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -135.24 136.63 41.86 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.0 mt -112.48 111.52 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.9 t -97.36 128.33 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -98.61 122.15 41.45 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.268 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.1 m -144.75 149.67 35.93 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -142.14 129.16 20.78 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.7 m -63.89 -45.8 87.71 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-O 121.135 0.493 . . . . 0.0 109.968 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.09 -69.43 0.08 OUTLIER Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -102.07 10.04 39.83 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.753 0.421 . . . . 0.0 110.963 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 54.7 m -147.18 129.88 16.06 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.2 m -86.65 140.21 30.03 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -120.47 116.69 25.93 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.6 mt -96.19 124.79 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -120.34 128.35 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -142.0 125.43 16.65 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 120.858 0.361 . . . . 0.0 110.541 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.4 p -94.88 150.99 19.59 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -134.47 149.96 50.77 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -102.36 96.95 7.86 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.123 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.51 155.84 36.2 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.898 1.732 . . . . 0.0 112.293 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -82.06 157.03 24.29 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.951 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -79.17 -35.12 42.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.526 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.57 ' HG1' ' N ' ' A' ' 113' ' ' ASN . 62.0 p -64.91 -44.72 88.64 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.9 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.57 ' N ' ' HG1' ' A' ' 112' ' ' THR . 3.0 m120 -87.44 142.87 33.45 Favored Pre-proline 0 N--CA 1.474 0.77 0 CA-C-O 119.457 -0.306 . . . . 0.0 110.551 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -69.93 137.87 35.96 Favored 'Trans proline' 0 N--CA 1.506 2.261 0 C-N-CA 121.573 1.515 . . . . 0.0 111.95 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -64.66 -39.92 94.53 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.689 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -50.96 -46.31 61.1 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.415 ' N ' ' CD2' ' A' ' 117' ' ' LEU . 3.6 mm? -62.97 -50.81 69.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -72.14 -33.2 67.6 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.111 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -59.26 -47.68 84.46 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.5 t -68.94 -25.2 64.44 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.278 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.59 -51.87 48.17 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -62.01 -38.14 87.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.902 0.382 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -70.76 -37.08 73.38 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.723 0.297 . . . . 0.0 110.38 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.11 -51.62 69.24 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.795 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.0 tt -63.66 -37.68 80.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.702 0.287 . . . . 0.0 110.381 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.9 mt -63.45 -37.13 86.1 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -60.92 -30.95 70.51 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.562 0.22 . . . . 0.0 110.877 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.7 m -56.15 -35.48 67.21 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.665 0.269 . . . . 0.0 110.968 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -61.67 -43.79 98.19 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -62.57 -44.72 95.62 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 48.7 m -61.05 -37.5 82.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.558 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.405 ' O ' ' ND2' ' A' ' 135' ' ' ASN . 68.3 t80 -61.52 -47.68 84.52 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.444 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 70.4 p -63.48 -32.52 73.99 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.919 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.422 ' C ' ' H ' ' A' ' 136' ' ' ASN . 77.1 tt0 -58.15 -14.01 6.05 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.283 0.563 . . . . 0.0 110.246 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.526 ' N ' HD21 ' A' ' 135' ' ' ASN . 0.1 OUTLIER -59.4 -4.93 0.66 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.149 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 138' ' ' GLU . 12.7 m120 -62.58 -16.09 54.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.629 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 67.5 tp 57.6 -78.66 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.785 0.678 . . . . 0.0 110.34 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 136' ' ' ASN . 92.1 mt-10 -58.85 -40.85 85.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.168 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.413 ' O ' ' CG ' ' A' ' 139' ' ' HIS . 56.0 t-80 53.8 17.84 1.4 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.653 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -60.89 145.28 50.8 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.341 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -155.47 146.84 22.81 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.085 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -82.48 118.69 23.42 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 77.9 m80 53.06 -88.45 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.017 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 67.6 m80 . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.541 -179.865 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.494 2.532 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 56.23 -81.52 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 110.782 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 1' ' ' GLY . 67.6 mttm -73.92 53.77 0.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.1 mt -48.45 138.47 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 t -135.69 138.73 43.08 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.7 m -139.14 157.35 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -147.95 159.92 43.37 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.322 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 p -145.82 142.39 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.1 m -97.29 118.25 33.34 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.36 128.16 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -93.69 85.41 4.85 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.45 153.01 3.39 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.981 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.86 135.51 55.82 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.0 tt -54.52 -32.12 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.673 0.273 . . . . 0.0 111.29 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -60.35 -39.72 88.15 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.265 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -73.12 -47.61 42.66 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.38 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.64 -43.38 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.094 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.405 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 22.4 t-105 -54.76 -38.16 66.87 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.889 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.58 -53.33 56.19 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.799 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -69.67 -40.29 76.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.545 0.212 . . . . 0.0 111.398 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -59.94 -17.46 37.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.892 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.554 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.8 OUTLIER -115.72 -28.18 6.83 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.165 0.586 . . . . 0.0 112.011 -179.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -54.76 107.5 0.88 Allowed Pre-proline 0 N--CA 1.477 0.881 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.941 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.56 -42.49 64.81 Favored 'Trans proline' 0 N--CA 1.508 2.38 0 CA-C-N 121.097 1.427 . . . . 0.0 112.296 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.98 -28.45 66.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.479 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -79.8 -37.66 34.7 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.705 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.24 -44.91 99.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.641 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.5 ptp -54.46 -21.52 10.14 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 120.694 0.283 . . . . 0.0 111.66 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -73.15 -39.49 65.63 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.811 -0.555 . . . . 0.0 111.528 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -124.31 21.72 8.68 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.74 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.546 ' C ' ' H ' ' A' ' 33' ' ' ALA . 17.9 t -60.58 134.25 56.89 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.817 -0.552 . . . . 0.0 110.315 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 69.43 -33.9 0.26 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.998 0.811 . . . . 0.0 110.519 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 53.78 21.57 2.78 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 110.577 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.5 m -108.54 110.13 61.47 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.573 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -51.54 -27.97 26.96 Favored 'Trans proline' 0 N--CA 1.513 2.658 0 C-N-CA 122.112 1.875 . . . . 0.0 112.782 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -74.75 5.33 5.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.656 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -146.89 156.48 43.12 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.415 ' CE1' ' O ' ' A' ' 57' ' ' ALA . 45.8 p-80 -144.1 163.65 32.95 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.55 94.8 48.44 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 122.886 0.474 . . . . 0.0 109.915 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.32 -8.46 17.38 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.265 1.31 . . . . 0.0 111.782 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.88 154.39 6.29 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.03 150.66 6.66 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -146.39 146.17 30.53 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -164.52 135.97 4.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.47 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -125.45 101.58 7.0 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 tp -65.73 95.79 0.25 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -169.26 141.91 2.62 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.75 137.92 58.15 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.346 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.32 0.86 48.45 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.02 153.94 36.68 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 p -105.22 158.25 16.73 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 120.871 0.367 . . . . 0.0 110.058 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -145.08 154.48 42.53 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.882 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.9 m -151.73 129.88 11.92 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.2 m -123.09 121.48 36.13 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.8 m -94.74 117.35 29.98 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 68.1 mtm -130.89 140.87 50.26 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.415 ' O ' ' CE1' ' A' ' 38' ' ' HIS . . . -147.6 147.4 30.01 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.132 0.491 . . . . 0.0 110.725 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.85 148.38 51.26 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.455 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.43 -40.19 71.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.639 0.257 . . . . 0.0 110.515 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.58 -11.24 59.98 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.12 21.21 63.63 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.7 m -80.95 -12.97 59.3 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.705 0.288 . . . . 0.0 110.674 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.1 ttt -160.59 135.31 7.53 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.8 p -145.07 162.39 37.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.995 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.485 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 52.8 t80 -159.28 163.68 35.55 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.485 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 73.9 m-20 -137.88 123.65 19.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -95.29 141.22 29.13 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.04 152.71 24.26 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.95 -171.73 42.48 Favored Glycine 0 CA--C 1.517 0.174 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.76 137.54 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -70.06 120.88 16.42 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.72 -40.9 63.23 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -164.89 148.08 8.57 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.0 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.8 p -145.86 138.56 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -143.6 130.62 20.59 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.5 m -55.11 121.15 8.14 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.581 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.0 m120 51.62 72.43 0.38 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -168.74 -79.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.378 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 tp -148.53 136.72 21.09 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.498 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.3 mt -129.82 129.47 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -154.21 165.07 37.44 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -154.5 155.18 34.39 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.7 m -87.52 129.35 35.11 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.5 139.51 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.63 -40.84 56.17 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -61.3 -17.8 55.41 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.49 3.52 71.7 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -64.11 165.44 9.16 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -121.95 121.98 38.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.955 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.92 129.11 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.56 138.7 43.26 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 73.4 mt -113.36 118.32 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.7 t -105.9 122.73 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.14 125.16 44.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.0 p -132.15 150.91 52.04 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -154.63 147.43 24.4 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.8 p -105.77 -19.47 13.74 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.87 -107.88 0.28 Allowed Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -81.44 7.41 11.89 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.397 0.279 . . . . 0.0 110.69 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.6 m -128.23 124.67 37.25 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.6 m -101.89 135.25 43.77 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -119.09 119.48 34.34 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.5 mt -99.75 127.32 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.87 130.32 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -142.36 144.83 33.36 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.5 t -111.69 149.31 31.78 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -143.12 141.4 31.21 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -97.53 120.41 60.75 Favored Pre-proline 0 N--CA 1.481 1.087 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.229 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.89 151.42 35.62 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 CA-C-N 121.216 1.47 . . . . 0.0 111.472 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -79.97 167.18 20.81 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -71.54 -50.01 35.31 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.606 0.241 . . . . 0.0 110.465 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.9 m -63.01 -45.95 89.97 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.504 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.99 131.91 58.43 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.313 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.73 146.47 48.61 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 121.25 1.3 . . . . 0.0 111.701 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -61.89 -38.75 89.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.4 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -51.1 -46.68 61.92 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.448 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.38 -43.66 96.94 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.755 0.312 . . . . 0.0 110.188 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -61.5 -53.86 50.81 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.651 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -54.66 -47.81 73.11 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.0 t -61.82 -42.34 98.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.109 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.38 -51.73 56.08 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.563 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.5 -39.37 93.29 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.863 0.331 . . . . 0.0 110.558 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -70.98 -37.06 72.74 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.67 -52.54 64.51 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.762 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.4 tt -66.87 -36.75 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.372 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.9 mt -60.06 -41.94 93.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.187 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 128' ' ' SER . 25.8 p30 -66.4 -30.61 71.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.537 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.406 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 21.9 p -61.03 -37.74 83.66 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.864 0.364 . . . . 0.0 110.654 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -59.52 -41.76 90.71 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.446 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -60.33 -43.49 96.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 97.7 p -61.33 -38.84 88.36 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.794 0.331 . . . . 0.0 110.324 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -62.21 -45.36 93.73 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.393 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 99.2 m -59.08 -49.42 77.96 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.715 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.54 -36.79 84.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.821 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -64.47 -36.83 85.45 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.266 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -62.34 -35.69 79.9 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.206 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 38.7 mt 57.56 -171.81 0.09 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.975 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 54.07 14.95 0.78 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.948 0.404 . . . . 0.0 110.517 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -67.91 139.59 56.46 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.445 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -67.75 142.69 56.19 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -164.25 138.2 5.42 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -162.49 154.33 18.48 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 52.29 84.33 0.05 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.141 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.72 179.929 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.588 ' H1 ' ' NH2' ' A' ' 115' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -63.24 -40.43 97.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.841 0.353 . . . . 0.0 110.324 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -72.53 52.89 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.1 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.2 mt -50.83 143.4 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 t -133.42 139.47 46.77 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.7 m -138.88 159.68 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.81 157.15 43.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.591 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.58 144.32 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 m -101.32 119.24 38.46 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.8 t -124.71 131.33 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -93.09 89.3 6.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.82 151.55 4.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.293 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.17 130.14 43.33 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.4 tt -52.58 -33.31 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.577 0.227 . . . . 0.0 111.28 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -60.16 -41.34 92.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.622 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -72.44 -46.55 54.49 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.864 0.364 . . . . 0.0 110.033 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.28 -43.02 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.613 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -55.91 -43.88 77.74 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.787 0.327 . . . . 0.0 110.744 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 23' ' ' GLU . 88.5 tttt -67.82 -47.52 68.81 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.588 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.36 -43.09 95.63 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.697 0.284 . . . . 0.0 111.382 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -61.7 -20.71 63.78 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -106.99 -23.03 12.47 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.134 0.574 . . . . 0.0 111.293 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 19' ' ' LYS . 28.5 tp10 -62.74 122.94 77.41 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 118.703 -0.665 . . . . 0.0 109.54 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.6 -38.61 5.76 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 CA-C-N 120.923 1.365 . . . . 0.0 111.607 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.67 -38.71 78.79 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.989 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.502 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 66.9 t60 -65.64 -44.01 87.73 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.56 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.402 ' C ' ' H ' ' A' ' 29' ' ' LYS . 96.9 mt -62.69 -44.87 99.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.459 ' SD ' ' N ' ' A' ' 42' ' ' ALA . 1.2 mtm -62.99 -0.02 0.63 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 27' ' ' ILE . 83.4 tttt -99.95 -50.25 4.07 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.502 ' HE1' ' CD2' ' A' ' 26' ' ' HIS . 68.6 p-90 -102.74 -3.67 26.13 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 31' ' ' CYS . 24.8 p -67.51 72.06 0.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.437 0.637 . . . . 0.0 110.009 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 30' ' ' TRP . 23.7 pt20 -153.18 48.74 0.7 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.05 -7.44 3.96 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.692 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 t -148.6 138.04 12.41 Favored Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.13 -11.9 23.32 Favored 'Trans proline' 0 N--CA 1.506 2.23 0 C-N-CA 121.71 1.607 . . . . 0.0 112.425 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -84.74 14.99 4.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.024 0.44 . . . . 0.0 110.17 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -146.57 146.69 30.55 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.975 0.417 . . . . 0.0 110.228 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -130.52 162.68 28.7 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -114.03 95.17 37.27 Favored Pre-proline 0 N--CA 1.475 0.784 0 C-N-CA 122.69 0.396 . . . . 0.0 110.585 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.79 -19.48 14.22 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 CA-C-N 120.346 1.159 . . . . 0.0 111.29 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -178.56 160.03 1.2 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.4 0.438 . . . . 0.0 110.212 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.459 ' N ' ' SD ' ' A' ' 28' ' ' MET . . . -156.41 148.81 23.48 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.135 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -136.05 146.13 46.76 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -156.02 104.23 2.27 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.691 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -98.28 86.42 3.65 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.97 93.22 0.11 Allowed 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.328 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -169.5 143.77 2.86 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.16 137.13 58.08 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.273 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.51 1.51 37.3 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.14 159.35 43.22 Favored Glycine 0 N--CA 1.468 0.808 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.7 m -119.3 155.89 31.01 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.007 0.432 . . . . 0.0 109.919 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -135.9 163.41 30.3 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.388 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.8 m -151.12 115.37 5.06 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.656 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.1 m -115.1 119.94 38.13 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 m -94.8 125.11 39.24 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.5 mtt -130.77 106.14 8.26 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.89 144.69 46.26 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.022 0.439 . . . . 0.0 110.769 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.83 148.28 50.49 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -57.99 -40.34 80.44 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.719 0.295 . . . . 0.0 110.386 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -76.18 -9.16 58.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.039 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.99 13.88 62.52 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.2 t -65.69 -19.89 66.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.988 0.423 . . . . 0.0 110.62 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.0 ttt -148.16 145.89 28.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.878 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.8 t -143.35 139.11 29.91 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.427 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 62.9 t80 -159.84 158.82 31.68 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.427 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 29.4 p-10 -138.9 134.16 32.87 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.39 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.02 139.63 31.1 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.38 152.36 24.07 Favored Glycine 0 N--CA 1.465 0.605 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.69 -174.12 41.13 Favored Glycine 0 CA--C 1.517 0.167 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.12 136.58 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -74.52 118.8 17.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.11 -37.01 69.6 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -165.09 149.2 8.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.732 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.02 131.91 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -143.64 122.14 12.44 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.5 m -59.45 123.9 18.3 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.91 0.386 . . . . 0.0 111.964 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.9 m120 52.4 59.41 4.53 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.021 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -157.27 -76.6 0.09 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.467 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 tp -152.94 135.26 15.01 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.1 mt -131.33 130.6 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -152.2 164.88 36.44 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -157.95 157.25 32.71 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.6 m -107.96 130.73 55.02 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.8 mm -93.86 151.55 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.78 -39.6 68.28 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -63.28 -11.91 25.31 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.956 0.378 . . . . 0.0 110.648 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.86 -2.13 61.77 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -72.44 152.02 42.22 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.589 ' HZ1' ' NH2' ' A' ' 91' ' ' ARG . 88.4 tttt -136.43 152.05 50.17 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -136.41 120.58 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.289 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.589 ' NH2' ' HZ1' ' A' ' 89' ' ' LYS . 87.4 mtt-85 -101.66 130.68 48.07 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 66.9 mt -118.42 125.07 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.48 124.34 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -100.4 123.44 44.63 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.1 m -122.73 124.37 43.21 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -100.73 121.57 41.88 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.5 p -105.78 8.83 33.02 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.99 122.63 0.66 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 58.32 9.9 1.16 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.715 0.293 . . . . 0.0 110.905 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.7 m -160.17 119.63 2.8 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 67.9 m -98.01 136.8 37.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -119.26 121.55 39.9 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.7 mt -100.4 123.74 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.7 t -123.95 126.68 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -143.56 145.96 32.94 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.329 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 78.3 p -126.14 148.3 49.42 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -122.45 162.45 21.66 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -129.43 77.97 76.48 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.72 170.21 20.3 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.976 1.784 . . . . 0.0 111.512 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -62.15 151.28 36.27 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.19 0.519 . . . . 0.0 110.635 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -70.02 -42.76 72.54 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.604 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 t -63.86 -34.45 77.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.579 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -65.73 148.69 98.06 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.3 108.74 2.57 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 121.961 1.774 . . . . 0.0 111.443 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.588 ' NH2' ' H1 ' ' A' ' 1' ' ' GLY . 8.8 ptm180 -68.28 -25.22 65.05 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.065 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -58.95 -50.75 72.87 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.681 0.277 . . . . 0.0 111.147 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.1 mt -64.87 -38.58 91.43 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.844 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -60.9 -45.05 96.14 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.52 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -54.12 -46.21 72.11 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.973 0.416 . . . . 0.0 109.929 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.9 t -66.77 -38.83 87.35 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.248 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.03 -52.04 54.73 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.683 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -64.47 -35.96 82.62 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.776 0.322 . . . . 0.0 110.151 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -72.81 -37.1 67.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.691 0.281 . . . . 0.0 110.432 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.11 -50.55 73.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 9.0 tt -62.27 -37.99 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 53.5 mt -63.57 -42.58 98.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -65.33 -39.29 92.21 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.3 t -58.38 -33.39 69.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -53.03 -25.28 11.87 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.883 0.373 . . . . 0.0 110.904 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -64.12 -38.91 92.77 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.632 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.9 t -58.14 -45.44 87.38 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.708 0.289 . . . . 0.0 110.395 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -64.18 -45.11 89.81 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.971 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.414 ' C ' ' H ' ' A' ' 135' ' ' ASN . 24.4 m -62.53 -40.59 97.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.842 0.353 . . . . 0.0 110.703 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -69.54 6.68 1.02 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.02 0.438 . . . . 0.0 110.713 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.414 ' H ' ' C ' ' A' ' 133' ' ' THR . 26.3 p-10 -59.81 -9.68 3.11 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.695 0.283 . . . . 0.0 110.499 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -83.36 8.16 14.48 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.423 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.94 -44.34 96.96 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.984 0.421 . . . . 0.0 110.069 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -164.85 142.45 6.28 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.052 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -163.87 150.45 11.68 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.708 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -170.16 61.44 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 52.18 -169.22 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.724 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.438 ' O ' ' N ' ' A' ' 144' ' ' HIS . 37.1 p-80 -170.35 93.92 0.22 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 55.46 -83.66 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.922 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 142' ' ' HIS . 95.4 m-70 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -72.25 -7.4 49.13 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.143 0.497 . . . . 0.0 110.438 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -77.88 51.06 0.91 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.517 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mt -69.98 140.57 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 t -137.28 160.07 40.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.35 166.71 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.3 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -147.36 158.66 44.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.076 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -149.45 144.99 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.75 121.67 44.5 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -128.97 137.38 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -94.82 89.7 5.77 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.98 150.86 3.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.957 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 128.54 36.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.766 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.2 tt -53.36 -36.24 26.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.632 0.254 . . . . 0.0 110.998 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -57.86 -42.27 84.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.673 0.273 . . . . 0.0 110.592 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -69.93 -47.03 64.0 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.392 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.0 t -62.33 -40.38 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.515 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.429 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 66.5 t90 -54.07 -39.76 66.57 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.741 0.305 . . . . 0.0 111.345 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -63.26 -51.03 67.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.954 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -68.89 -37.25 78.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.965 0.412 . . . . 0.0 110.684 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -61.01 -18.56 58.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.853 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 18' ' ' TRP . 81.4 m-20 -115.56 -26.44 7.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.155 0.582 . . . . 0.0 110.908 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -50.64 108.73 1.09 Allowed Pre-proline 0 CA--C 1.555 1.145 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.172 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.19 -43.4 57.54 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 CA-C-N 120.512 1.218 . . . . 0.0 112.835 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.86 -30.75 69.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.556 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -79.28 -38.98 34.1 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.186 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' A' ' 31' ' ' CYS . 98.2 mt -61.93 -45.38 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 O-C-N 121.964 -0.46 . . . . 0.0 110.657 -177.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 20.5 ptp -61.73 -17.78 57.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.252 0.549 . . . . 0.0 111.251 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -74.96 -29.46 60.93 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.162 -0.336 . . . . 0.0 111.292 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -139.34 23.26 2.54 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.601 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.619 ' C ' ' H ' ' A' ' 33' ' ' ALA . 36.8 t -55.43 125.79 22.39 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.621 -0.674 . . . . 0.0 110.239 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 67.3 -22.88 0.11 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.868 0.73 . . . . 0.0 110.459 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 51.79 37.01 19.34 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 122.761 0.424 . . . . 0.0 110.977 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.2 m -111.65 96.45 32.56 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.954 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.5 -25.59 10.9 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 122.118 1.879 . . . . 0.0 112.562 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -69.04 -26.63 65.07 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.491 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -106.22 170.26 8.02 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -147.78 152.04 37.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.996 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.0 p -116.73 96.92 49.57 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.76 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.17 -9.51 17.77 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 121.541 1.494 . . . . 0.0 111.662 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.91 155.32 6.76 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.903 0.383 . . . . 0.0 110.298 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.05 145.47 13.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.922 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -139.17 144.99 38.82 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -163.0 132.46 4.21 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.585 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -135.47 103.63 5.54 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mp -69.56 98.74 1.18 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -166.31 137.66 3.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.74 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.0 134.1 56.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.286 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.9 1.69 63.21 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.25 163.27 44.83 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.8 p -129.65 161.39 30.7 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -137.84 166.84 23.03 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.93 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.4 m -151.72 110.37 3.81 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.1 p -107.07 113.01 26.21 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.0 m -86.35 113.24 22.17 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.4 mtt -122.57 129.28 51.75 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.77 150.14 29.83 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.49 148.38 48.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.596 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.72 -31.97 66.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.958 0.409 . . . . 0.0 110.565 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -74.75 -9.53 58.65 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.125 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.24 4.67 44.8 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.7 m -62.74 -34.95 78.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.641 0.258 . . . . 0.0 110.656 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 71.4 mtp -126.26 136.44 52.79 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.149 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.8 p -145.96 129.65 17.09 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.642 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -155.13 162.42 41.0 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.8 127.04 24.54 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.673 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -94.23 144.76 25.24 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -148.59 151.58 23.75 Favored Glycine 0 N--CA 1.461 0.357 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.01 175.3 42.25 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 t -121.54 132.82 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -74.82 116.12 15.18 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -73.62 -39.56 64.46 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.225 0.536 . . . . 0.0 109.591 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.437 HE21 ' HZ3' ' A' ' 75' ' ' LYS . 57.2 tt0 -166.71 147.62 6.05 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.553 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.53 130.74 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.437 ' HZ3' HE21 ' A' ' 73' ' ' GLN . 21.7 mmtp -137.82 126.17 23.27 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.4 m -58.31 123.44 16.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.71 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 51.26 69.17 0.68 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.915 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -166.98 -81.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.806 0.336 . . . . 0.0 110.148 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 tp -150.51 131.78 14.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.422 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.0 mt -132.14 131.99 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -153.97 164.47 38.38 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -162.69 155.97 19.96 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.4 p -100.45 132.28 45.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 86' ' ' ASP . 88.9 mt -93.78 140.96 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.48 28.62 1.03 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.454 ' H ' ' C ' ' A' ' 84' ' ' ILE . 29.0 t70 -120.41 -9.53 9.45 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.009 0.523 . . . . 0.0 109.897 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.79 -14.77 57.41 Favored Glycine 0 N--CA 1.479 1.533 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -75.13 174.97 8.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -146.24 151.28 37.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.715 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.6 t -140.55 136.81 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.994 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -136.51 133.69 36.77 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 75.0 mt -116.0 128.01 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.81 122.98 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -95.37 127.35 41.34 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.3 m -137.47 141.64 41.55 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -151.19 161.18 43.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 65.4 p -127.48 -13.68 5.4 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.095 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.06 -122.4 0.94 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -73.08 5.69 3.23 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.899 -0.177 . . . . 0.0 110.76 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.4 m -122.55 127.25 49.24 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.0 m -108.73 133.24 53.07 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -110.97 126.12 54.43 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.9 mt -106.3 128.38 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.9 t -129.19 133.89 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -142.19 135.24 28.73 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 86.2 p -95.13 153.33 17.7 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -145.17 145.92 31.55 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -117.33 87.22 23.7 Favored Pre-proline 0 N--CA 1.478 0.946 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -77.75 160.69 30.99 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.14 1.893 . . . . 0.0 111.468 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -58.01 155.02 11.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.034 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -65.15 -38.95 92.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.823 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.504 ' HG1' ' N ' ' A' ' 113' ' ' ASN . 59.2 p -63.21 -43.0 99.35 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.712 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.504 ' N ' ' HG1' ' A' ' 112' ' ' THR . 2.5 m-20 -60.96 118.99 41.01 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.253 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.54 134.27 39.29 Favored 'Trans proline' 0 N--CA 1.506 2.254 0 C-N-CA 121.242 1.295 . . . . 0.0 112.123 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -69.64 -39.33 77.2 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.129 0.49 . . . . 0.0 110.852 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 116' ' ' GLU . 27.3 mp0 -67.78 -46.48 71.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.026 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.6 tt -70.17 -52.61 22.11 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.02 0.438 . . . . 0.0 111.123 -177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -54.71 -37.44 65.84 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.945 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -59.0 -39.17 81.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.043 0.449 . . . . 0.0 110.255 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.8 t -64.86 -36.27 83.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.56 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.12 -51.72 57.15 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -63.35 -37.54 87.66 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.008 0.432 . . . . 0.0 110.145 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -73.53 -35.07 65.51 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.429 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.46 -50.34 74.09 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.686 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 36.4 pt -63.62 -34.19 66.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.725 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.0 mt -66.87 -39.4 87.52 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.026 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -63.8 -41.19 97.96 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 22.4 m -62.24 -35.15 78.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.837 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -57.78 -28.43 63.97 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.037 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.45 -41.05 98.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.313 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 97.0 p -58.54 -34.87 71.48 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 110.909 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -61.59 -46.48 89.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.474 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.6 p -64.71 -35.02 79.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.709 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 136' ' ' ASN . 96.9 mt-10 -68.52 -29.58 68.2 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.734 0.302 . . . . 0.0 110.408 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -65.14 -1.92 2.53 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.489 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 134' ' ' GLU . 21.8 p-10 -61.36 -41.36 96.94 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.543 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 76.1 mt -88.86 76.36 7.96 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.046 0.451 . . . . 0.0 110.039 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -166.79 -60.63 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.923 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.452 ' ND1' ' N ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -164.78 149.77 9.6 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.427 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -63.85 -52.06 61.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 0.0 110.339 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 47.65 75.9 0.12 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.766 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 70.1 m80 52.7 90.34 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.683 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -60.58 -45.4 94.1 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.797 0.332 . . . . 0.0 110.457 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 69.6 m80 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.618 179.869 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -63.07 -40.14 96.79 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.696 0.284 . . . . 0.0 110.509 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -71.42 55.43 0.23 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 84.3 mt -57.83 139.67 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 t -133.67 141.63 47.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.774 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.76 155.3 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -148.8 162.09 40.49 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.549 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 m -149.01 152.62 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.494 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.67 119.48 38.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.171 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.8 t -123.8 127.29 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -94.9 89.34 5.6 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.95 151.37 4.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.974 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.58 135.78 56.32 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.9 tt -52.45 -37.14 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -60.62 -36.06 77.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.461 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -72.7 -48.24 40.56 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.262 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.5 t -64.0 -41.13 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.127 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 31.0 t-105 -52.97 -39.42 62.96 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.081 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -62.31 -49.7 74.58 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.528 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -65.86 -41.38 91.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.609 0.242 . . . . 0.0 110.925 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -68.78 -16.82 63.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.409 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.538 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.8 OUTLIER -112.24 -28.7 7.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.254 0.622 . . . . 0.0 112.333 -178.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.05 135.02 96.14 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.04 -42.29 0.31 Allowed 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 121.406 1.404 . . . . 0.0 111.537 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.67 69.93 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.844 0.355 . . . . 0.0 111.016 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.511 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.2 OUTLIER -76.32 -38.92 55.32 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.787 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 31' ' ' CYS . 95.1 mt -62.95 -44.02 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 O-C-N 122.031 -0.418 . . . . 0.0 111.042 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.4 ptp -63.2 -20.87 65.81 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.858 0.361 . . . . 0.0 111.066 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -67.57 -32.11 72.64 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.116 -0.365 . . . . 0.0 110.888 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -135.39 19.95 3.38 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.448 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.495 ' C ' ' H ' ' A' ' 33' ' ' ALA . 21.9 t -58.73 133.93 56.38 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.75 -0.594 . . . . 0.0 110.429 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.2 tp60 71.33 -39.87 0.46 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.213 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 56.44 29.84 15.99 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.878 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.2 m -115.12 106.68 50.99 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.269 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.73 -23.08 19.17 Favored 'Trans proline' 0 N--CA 1.506 2.212 0 C-N-CA 121.999 1.799 . . . . 0.0 112.413 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.33 2.65 12.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.683 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -142.15 169.7 17.1 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.094 0.473 . . . . 0.0 109.848 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -146.03 163.33 35.57 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.35 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 p -123.73 91.21 49.93 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 123.364 0.666 . . . . 0.0 109.777 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.34 -11.78 20.88 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.296 1.33 . . . . 0.0 111.559 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.21 152.24 6.07 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.02 146.55 9.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.24 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -134.72 145.94 48.96 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -152.56 114.91 4.47 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -133.18 95.44 3.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.84 93.8 6.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.853 0.835 . . . . 0.0 109.457 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -149.08 137.28 20.81 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.436 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.8 123.45 12.43 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.776 0.322 . . . . 0.0 111.0 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.79 1.66 78.87 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.03 163.18 47.13 Favored Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.2 p -128.22 159.81 34.04 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.742 0.417 . . . . 0.0 110.098 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.458 ' CD1' ' CE2' ' A' ' 71' ' ' TYR . 42.5 p90 -152.94 169.83 21.9 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.344 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.1 m -161.31 141.97 11.11 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.9 m -121.87 123.01 40.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.8 m -93.22 118.06 30.8 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.1 mtm -127.91 132.94 49.26 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.72 147.68 29.15 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.065 0.459 . . . . 0.0 110.225 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.9 148.51 48.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.552 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -58.41 -34.17 70.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.739 0.304 . . . . 0.0 110.239 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -73.03 -10.22 59.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.979 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.94 15.8 58.64 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.2 m -83.7 -17.69 40.49 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 122.886 -0.185 . . . . 0.0 110.812 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 67.9 mtp -134.43 140.82 46.54 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.893 0.377 . . . . 0.0 110.247 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 96.5 p -144.38 149.6 36.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.184 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -155.29 161.49 41.09 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.786 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -136.07 99.73 4.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.711 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -94.46 134.1 37.34 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.47 172.85 41.84 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.28 -176.65 39.95 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.9 t -118.96 128.84 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.458 ' CE2' ' CD1' ' A' ' 52' ' ' PHE . 57.8 m-85 -71.9 112.23 7.82 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -73.64 -38.13 65.1 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.329 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -165.1 151.53 10.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.776 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.2 p -143.68 142.83 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -145.17 121.64 11.01 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.7 m -52.89 120.83 6.26 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.813 0.34 . . . . 0.0 111.91 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.4 m120 51.58 69.96 0.6 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.667 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -167.86 -77.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.332 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 tt -150.49 136.15 18.19 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.199 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.1 mt -129.55 131.41 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.44 162.21 41.51 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -157.31 155.52 30.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.829 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 84.9 m -98.32 131.79 44.33 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.493 ' C ' ' H ' ' A' ' 86' ' ' ASP . 5.1 mp -94.58 139.44 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.66 26.93 0.61 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 84' ' ' ILE . 24.1 t0 -119.67 -12.79 9.21 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.76 -7.69 63.26 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.349 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.407 HH21 ' CD ' ' A' ' 110' ' ' GLU . 35.8 mmt180 -74.96 143.44 43.67 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.513 -0.404 . . . . 0.0 110.118 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -110.84 135.4 51.45 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.17 136.96 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -134.52 135.14 42.15 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.6 mt -119.61 128.34 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.2 t -118.4 129.99 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -97.23 123.15 40.93 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 67.1 p -128.58 140.56 51.72 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -154.08 148.03 25.58 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.1 p -99.56 -18.74 17.22 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.063 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.09 -102.81 0.21 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -75.72 -6.79 52.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.402 0.144 . . . . 0.0 110.805 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.9 p -107.44 165.18 11.59 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.3 m -143.14 135.48 27.26 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.14 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -124.93 124.2 41.52 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.7 mt -105.64 126.85 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.56 134.45 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -137.24 131.51 32.47 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 89.3 p -136.91 127.68 27.24 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -156.93 168.88 26.15 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.737 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.54 102.3 54.08 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.833 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.65 -169.8 0.78 Allowed 'Trans proline' 0 N--CA 1.501 1.971 0 C-N-CA 121.219 1.28 . . . . 0.0 111.22 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.407 ' CD ' HH21 ' A' ' 88' ' ' ARG . 81.0 mm-40 -56.47 137.15 53.62 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.619 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -83.49 -36.82 23.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.795 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.5 t -63.64 -34.22 77.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.974 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -73.89 150.28 88.19 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.242 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -64.66 102.54 0.42 Allowed 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 121.571 1.514 . . . . 0.0 110.7 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 78.9 mtm-85 -60.65 -25.6 66.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.055 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -59.59 -51.2 70.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.664 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.0 mt -65.46 -38.0 88.53 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.296 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -57.42 -39.63 76.62 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.635 0.255 . . . . 0.0 110.837 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -50.88 -48.48 60.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.6 t -71.4 -34.83 70.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.11 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.7 -52.38 51.14 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.21 -0.519 . . . . 0.0 111.826 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -63.21 -34.88 78.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 110.125 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -74.9 -34.16 62.13 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.075 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.08 -49.45 77.29 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 10.0 tt -61.26 -41.57 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.97 -40.55 96.66 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.046 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -63.46 -39.38 94.32 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.8 m -58.51 -41.29 85.07 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.713 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -59.19 -47.73 84.23 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.271 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -63.98 -43.09 96.77 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.007 0.432 . . . . 0.0 110.208 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 38.8 t -60.12 -39.36 85.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.797 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.471 ' CZ ' ' ND2' ' A' ' 136' ' ' ASN . 61.8 t80 -60.13 -48.26 82.47 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.47 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 76.0 p -62.88 -45.5 92.26 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.737 0.303 . . . . 0.0 110.631 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -66.48 -38.11 86.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.271 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.01 -40.9 99.14 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.395 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.471 ' ND2' ' CZ ' ' A' ' 132' ' ' TYR . 84.9 m-20 -91.62 -4.73 54.94 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.05 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.0 mt 53.03 -178.15 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.534 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -70.44 73.58 0.52 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.984 0.421 . . . . 0.0 109.946 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -168.89 147.39 3.99 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.53 127.99 34.49 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -72.55 101.98 3.13 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -66.01 145.89 55.34 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.139 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 52.24 89.34 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.002 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.608 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -69.08 -15.93 63.56 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.101 0.477 . . . . 0.0 110.565 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -73.13 55.73 0.43 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.701 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.6 mm -52.92 140.07 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 t -137.35 134.46 36.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.86 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.6 m -138.97 158.18 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -147.16 158.01 43.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.04 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 p -149.14 140.68 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.888 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.3 p -92.69 124.71 36.89 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.42 125.62 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -93.37 88.24 5.9 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.18 151.7 3.98 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.103 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.92 132.43 52.05 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.8 tt -54.06 -33.09 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.7 0.286 . . . . 0.0 111.103 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -59.01 -40.43 84.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.656 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -73.59 -46.9 44.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.928 0.394 . . . . 0.0 110.153 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -61.77 -43.06 96.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.719 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -55.92 -40.88 73.76 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.788 0.328 . . . . 0.0 110.883 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -68.41 -48.31 65.0 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.027 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.507 ' CD2' ' ND1' ' A' ' 26' ' ' HIS . 9.9 m-85 -66.74 -42.34 86.4 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.867 0.365 . . . . 0.0 110.902 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -62.88 -15.73 55.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.184 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -112.0 -23.27 10.6 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.032 0.533 . . . . 0.0 111.358 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -69.13 122.28 84.78 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 118.809 -0.615 . . . . 0.0 109.712 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.61 -32.16 24.89 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 CA-C-N 121.104 1.43 . . . . 0.0 111.895 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.62 75.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.966 0.412 . . . . 0.0 110.764 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.507 ' ND1' ' CD2' ' A' ' 20' ' ' TYR . 45.8 m170 -80.05 -42.52 23.57 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.993 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 31' ' ' CYS . 92.3 mt -63.04 -48.11 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 122.123 -0.36 . . . . 0.0 110.842 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -64.11 -12.2 37.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.783 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -78.46 -28.11 46.52 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.871 -0.15 . . . . 0.0 111.107 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -133.37 5.89 3.79 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.994 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.53 ' C ' ' H ' ' A' ' 33' ' ' ALA . 37.0 t -50.44 138.09 17.84 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.075 -0.391 . . . . 0.0 110.623 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 71.68 -39.94 0.46 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.53 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.69 39.15 31.12 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.148 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.9 m -134.29 140.81 37.03 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 122.749 0.42 . . . . 0.0 110.286 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -75.78 -10.32 19.94 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.873 1.715 . . . . 0.0 112.559 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -88.1 15.08 7.89 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.983 0.421 . . . . 0.0 110.262 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -150.16 155.26 39.46 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.137 0.494 . . . . 0.0 109.758 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -142.56 163.46 32.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.047 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.4 t -127.72 87.08 56.79 Favored Pre-proline 0 N--CA 1.475 0.825 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.83 -20.7 44.98 Favored 'Trans proline' 0 N--CA 1.505 2.167 0 C-N-CA 122.369 2.046 . . . . 0.0 111.825 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.92 161.54 8.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.68 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.74 146.08 16.1 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.449 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -140.93 152.08 44.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -161.29 132.95 5.6 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.04 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -122.58 86.93 2.66 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.9 tp -67.21 94.9 0.39 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.939 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -169.02 144.14 3.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.03 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.5 137.7 57.93 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.317 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.89 -1.47 54.25 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.64 172.83 41.3 Favored Glycine 0 N--CA 1.47 0.929 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 t -139.02 172.92 12.14 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.396 0.278 . . . . 0.0 110.556 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -138.76 167.54 21.76 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.203 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.5 m -157.74 121.61 4.13 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.6 m -123.77 124.93 43.79 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.2 m -90.29 114.4 26.45 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.7 mtt -119.11 129.73 55.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.44 143.58 32.68 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.136 0.494 . . . . 0.0 110.223 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.68 148.53 51.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.33 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -56.35 -39.96 73.7 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.556 0.217 . . . . 0.0 110.475 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -79.21 -7.17 58.02 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.897 0.38 . . . . 0.0 110.141 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.35 18.84 67.93 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.4 p -65.63 -34.88 79.25 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.838 -0.213 . . . . 0.0 110.683 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.3 ttt -137.33 145.88 43.93 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.9 t -143.76 145.45 32.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.885 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.422 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 66.8 t80 -159.09 166.63 31.19 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.422 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 74.3 m-20 -137.78 121.05 16.93 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -93.54 140.39 29.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.847 0.356 . . . . 0.0 110.168 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -157.22 157.77 28.35 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.74 -177.67 41.55 Favored Glycine 0 N--CA 1.458 0.112 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -123.61 131.66 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -72.5 115.25 11.54 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -73.66 -47.08 42.59 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -149.79 144.11 25.81 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.6 p -133.04 128.15 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -138.13 111.21 7.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 t -56.35 131.16 47.46 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.257 0.551 . . . . 0.0 112.289 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 49.85 51.89 15.68 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.453 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -157.69 -80.81 0.06 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.688 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 tp -146.27 134.8 22.07 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.2 mt -130.33 131.27 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -152.15 162.71 40.72 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -158.16 154.67 27.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.665 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.3 m -94.78 129.8 41.59 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 88.6 mt -93.63 153.49 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.56 -41.98 65.51 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.816 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -61.49 -10.84 8.61 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.061 0.458 . . . . 0.0 110.632 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 91.53 1.79 70.98 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -77.32 142.94 39.15 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -106.42 162.38 13.75 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.142 0.496 . . . . 0.0 110.395 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.4 t -141.17 121.34 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.778 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -112.41 123.22 49.81 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 71.1 mt -117.06 119.89 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.6 t -107.91 118.22 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -93.41 122.75 36.15 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.8 m -131.72 143.65 50.42 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -152.93 147.36 25.87 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 80.7 p -102.47 -19.25 14.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.014 0.435 . . . . 0.0 109.842 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.43 -104.73 0.23 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 1.3 m-20 -77.12 -2.08 32.45 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 122.21 0.204 . . . . 0.0 111.113 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.8 m -119.91 124.24 45.53 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.2 m -105.51 133.89 49.52 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -115.48 124.57 51.44 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.0 mt -104.66 125.42 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.4 t -119.73 128.31 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -127.94 123.47 34.95 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.3 m -134.72 128.27 32.61 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.945 0.402 . . . . 0.0 110.096 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -157.13 166.8 32.24 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.567 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -97.33 116.02 65.84 Favored Pre-proline 0 N--CA 1.477 0.903 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.392 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.47 168.47 22.71 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 121.741 1.627 . . . . 0.0 110.989 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -58.13 145.68 36.02 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.747 0.308 . . . . 0.0 110.377 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -70.33 -39.72 74.58 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.18 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 46.9 p -63.77 -44.43 93.46 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.511 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -73.59 135.92 78.1 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.118 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.08 133.07 47.9 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 CA-C-N 120.444 1.194 . . . . 0.0 111.12 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -68.68 -37.39 79.54 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.225 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -58.58 -42.41 87.94 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.33 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.2 tp -63.44 -44.29 94.94 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.722 0.296 . . . . 0.0 110.718 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.65 -46.13 89.62 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.529 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -52.28 -46.64 65.95 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.5 m -66.9 -39.62 87.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.183 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.73 -52.01 51.65 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.77 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -63.83 -35.92 82.19 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.825 0.345 . . . . 0.0 110.449 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -72.01 -38.01 69.68 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.785 0.326 . . . . 0.0 110.161 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.79 72.36 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.124 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.3 tt -62.34 -37.86 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.3 mt -63.87 -40.24 96.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -63.38 -40.88 98.44 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.2 m -60.95 -38.37 85.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.619 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -59.36 -43.11 92.89 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.663 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -60.32 -48.07 83.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.818 0.342 . . . . 0.0 110.447 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 78.1 p -64.74 -44.32 90.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.386 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -62.06 -47.25 85.51 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.412 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.0 m -61.06 -46.06 92.22 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.705 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -67.88 -34.0 75.83 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.457 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -62.82 -4.39 2.09 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.613 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -58.77 -22.44 58.14 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.903 0.382 . . . . 0.0 110.636 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.2 pp -168.64 153.03 5.87 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.134 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -170.09 28.14 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.315 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 53.4 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.989 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -160.06 148.45 17.05 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.471 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -69.96 149.48 47.72 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.07 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -66.16 140.49 58.2 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -62.83 -45.74 91.17 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.897 0.379 . . . . 0.0 110.327 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.483 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.4 m120 55.47 34.11 22.37 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.614 0.245 . . . . 0.0 110.782 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -72.62 55.22 0.36 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.293 0.568 . . . . 0.0 110.117 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.6 mt -65.14 136.37 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 t -137.47 150.91 47.93 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.56 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.6 m -136.0 161.71 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.669 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -139.45 158.92 43.31 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.694 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.12 142.93 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 m -95.05 123.28 38.45 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.4 t -126.98 123.21 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -90.79 87.03 6.5 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.83 152.12 3.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.99 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.63 137.2 57.69 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.7 tt -52.69 -38.26 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.721 0.296 . . . . 0.0 111.35 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -60.81 -35.25 76.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.222 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -74.51 -48.06 29.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.01 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -62.71 -43.93 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.102 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.407 ' CD1' ' OD1' ' A' ' 22' ' ' ASN . 24.4 t-105 -54.27 -39.11 66.58 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.875 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -64.02 -55.76 20.0 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.506 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -69.39 -42.93 74.46 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.837 0.351 . . . . 0.0 111.492 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -59.74 -16.62 28.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.324 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.407 ' OD1' ' CD1' ' A' ' 18' ' ' TRP . 12.7 m120 -112.71 -21.72 11.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.282 0.633 . . . . 0.0 109.895 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -67.55 120.6 74.28 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.736 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.63 -36.56 18.97 Favored 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 121.512 1.474 . . . . 0.0 111.941 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.73 -31.71 69.87 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.104 0.478 . . . . 0.0 110.562 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -80.93 -45.92 15.97 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.789 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.6 mt -61.68 -47.32 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.621 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -63.61 -3.57 2.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.12 0.486 . . . . 0.0 111.072 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -90.25 -29.59 18.07 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 122.098 -0.376 . . . . 0.0 110.341 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 60.6 p-90 -135.73 21.95 3.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.128 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.605 ' C ' ' H ' ' A' ' 33' ' ' ALA . 28.5 p -55.43 131.14 45.18 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.353 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.483 ' NE2' ' CD1' ' A' ' 37' ' ' TRP . 49.9 tt0 68.57 -29.1 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.527 0.517 . . . . 0.0 110.467 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.605 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 53.48 39.72 30.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.429 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 t -128.28 136.45 29.08 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.796 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -73.21 -17.54 24.36 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 122.035 1.823 . . . . 0.0 112.372 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -81.93 13.06 3.52 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.753 0.311 . . . . 0.0 110.687 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.483 ' CD1' ' NE2' ' A' ' 32' ' ' GLN . 87.3 m95 -149.87 159.95 43.97 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.331 0.586 . . . . 0.0 109.664 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.405 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 83.6 t60 -149.13 163.43 37.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.222 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.405 ' N ' ' CG ' ' A' ' 38' ' ' HIS . 7.2 p -128.6 96.86 29.06 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.869 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.1 -9.2 19.19 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 121.927 1.752 . . . . 0.0 111.747 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.15 153.89 7.05 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.834 0.35 . . . . 0.0 110.544 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.47 145.87 13.17 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.185 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -141.04 151.96 44.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -162.41 135.28 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.922 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -133.97 99.12 4.34 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.75 95.22 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.074 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -168.15 145.25 4.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.673 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.83 137.11 58.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.056 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.97 3.57 36.86 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.13 146.14 33.03 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.6 m -107.45 154.25 21.62 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -141.52 156.81 45.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.426 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.7 m -148.25 128.0 13.4 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.1 m -123.81 121.14 34.63 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 m -92.25 124.86 36.63 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.1 mtp -135.63 135.95 40.62 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.16 147.22 30.3 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.956 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.4 148.88 50.95 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.425 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -57.51 -40.48 78.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.71 0.29 . . . . 0.0 110.397 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.24 -10.05 59.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.035 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.14 14.25 68.24 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 85.3 p -67.27 -33.49 75.42 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.668 0.271 . . . . 0.0 110.616 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.3 ttt -129.2 149.37 51.03 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.846 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.2 t -144.27 142.4 30.43 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.724 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.446 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 57.8 t80 -159.47 159.0 33.03 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.446 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 68.3 m-20 -139.12 129.85 26.09 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.867 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -94.95 134.58 37.46 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.39 149.17 20.79 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.79 -172.05 41.86 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -131.97 139.37 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -73.97 122.94 23.37 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.525 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -77.21 -32.56 56.02 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -165.41 144.91 6.6 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.722 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.6 t -135.7 130.28 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -143.09 116.86 9.28 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 65.8 p -57.33 134.2 55.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.696 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 53.76 56.02 7.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.554 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -155.01 -79.58 0.09 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -162.32 161.52 27.57 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.907 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.5 mt -136.06 141.04 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -153.43 160.27 42.56 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -159.46 165.66 32.62 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.3 m -120.94 133.76 55.29 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.7 mm -99.72 153.85 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -55.57 -41.49 81.8 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -60.59 -18.2 51.36 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.717 0.294 . . . . 0.0 110.488 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.28 -3.66 47.52 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -65.37 146.51 54.81 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -136.44 145.48 45.29 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.578 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.69 137.97 31.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -121.45 130.32 53.5 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 76.8 mt -116.97 120.19 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.72 128.37 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -95.9 123.67 39.59 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.7 m -121.14 145.0 48.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -153.44 161.8 41.91 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.3 p -132.69 -47.96 0.88 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.227 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.74 120.74 0.59 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 56.0 15.82 1.91 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 111.039 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.4 m -151.56 139.18 19.66 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 48.4 m -125.84 132.11 52.28 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -117.83 122.52 43.61 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.0 mt -96.68 128.06 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.0 t -121.73 132.49 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -136.8 134.79 37.38 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 83.9 p -138.92 130.45 27.29 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -155.93 170.12 22.86 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -112.29 93.37 22.04 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 123.736 0.648 . . . . 0.0 109.856 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.53 -166.98 0.43 Allowed 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 122.04 1.827 . . . . 0.0 111.382 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -54.44 116.5 2.68 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.283 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -69.09 -32.07 71.23 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.302 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 80.7 p -62.57 -43.43 98.83 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.303 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.572 ' N ' HD21 ' A' ' 113' ' ' ASN . 1.0 OUTLIER -68.66 148.4 98.05 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.721 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.01 138.98 88.76 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 121.387 1.391 . . . . 0.0 112.048 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -66.47 -40.3 89.26 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -63.3 -43.01 99.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.735 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.54 -51.37 65.76 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 120.896 0.379 . . . . 0.0 110.182 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -61.1 -50.84 71.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.582 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -58.0 -41.88 83.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.399 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 74.1 m -58.3 -32.83 68.82 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 123.412 0.445 . . . . 0.0 110.556 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.27 -44.72 12.7 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -60.45 -39.43 87.5 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.75 0.31 . . . . 0.0 111.587 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -76.09 -34.66 59.54 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.076 0.465 . . . . 0.0 110.546 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.96 -50.92 72.23 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.5 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.7 tt -61.14 -36.62 73.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.0 mt -66.42 -36.61 83.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -62.26 -40.72 97.15 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.525 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 91.7 p -62.17 -33.89 75.38 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.983 0.421 . . . . 0.0 110.656 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -59.68 -41.15 90.02 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.541 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -59.24 -41.02 87.74 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.37 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.8 m -60.41 -40.79 92.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.496 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -61.31 -47.55 85.42 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.64 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 75.8 p -62.27 -33.8 75.33 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.489 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -66.83 -33.84 76.5 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.848 0.356 . . . . 0.0 110.085 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -76.43 -18.79 58.63 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.991 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -70.03 -18.04 63.29 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.937 0.399 . . . . 0.0 111.029 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 139' ' ' HIS . 4.3 mm? -62.56 -41.88 99.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.336 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -62.81 83.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.513 ' CD2' ' H ' ' A' ' 141' ' ' HIS . 80.7 t60 -169.25 -87.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.811 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 82.1 t60 55.98 7.88 0.33 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.048 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.513 ' H ' ' CD2' ' A' ' 139' ' ' HIS . 44.8 m-70 -103.51 62.74 0.78 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.275 0.56 . . . . 0.0 110.213 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -64.16 -41.25 97.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.682 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 52.15 87.32 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.711 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 . . . . . 0 C--O 1.218 -0.572 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.132 -179.678 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.44 ' H1 ' ' H ' ' A' ' 2' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.44 ' H ' ' H1 ' ' A' ' 1' ' ' GLY . 50.1 t-20 55.18 81.83 0.11 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.693 0.282 . . . . 0.0 110.573 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -71.87 -67.38 0.54 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.388 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.2 mt -131.04 134.91 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -135.26 139.16 44.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.49 153.82 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -148.81 162.12 40.44 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.924 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.7 p -148.34 140.8 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.703 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.5 p -89.59 119.74 30.28 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.83 124.34 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -93.21 88.54 6.08 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.31 153.33 4.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.743 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.08 134.0 55.38 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.8 tt -51.78 -36.22 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -60.03 -35.59 75.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.359 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -75.21 -44.93 43.67 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 109.958 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.6 t -63.39 -43.8 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.36 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.422 ' CE2' ' OD1' ' A' ' 22' ' ' ASN . 72.1 t90 -57.24 -46.31 83.12 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.473 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.01 -44.69 88.36 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.751 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -66.49 -44.28 83.06 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.879 0.371 . . . . 0.0 110.962 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -69.29 -18.33 63.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.483 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.423 ' N ' HD21 ' A' ' 22' ' ' ASN . 1.0 OUTLIER -98.49 -26.24 14.51 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.062 0.545 . . . . 0.0 111.14 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -64.95 119.96 62.75 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.81 -36.32 4.79 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 CA-C-N 120.863 1.344 . . . . 0.0 111.869 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.59 86.19 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.843 0.354 . . . . 0.0 111.142 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -66.84 -40.57 88.01 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.58 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.452 ' O ' ' N ' ' A' ' 31' ' ' CYS . 96.5 mt -63.31 -43.8 98.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.8 mtp -55.88 -12.27 1.31 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.599 0.238 . . . . 0.0 111.279 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -86.33 -28.73 23.5 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.154 -0.341 . . . . 0.0 110.978 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -136.36 21.66 3.18 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.481 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.6 ' C ' ' H ' ' A' ' 33' ' ' ALA . 10.4 t -57.12 131.34 49.62 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.66 -0.65 . . . . 0.0 110.479 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 66.14 -27.83 0.12 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.689 0.618 . . . . 0.0 110.864 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.6 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 47.3 29.62 1.3 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.539 0.335 . . . . 0.0 111.017 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.7 m -108.12 135.55 19.89 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.264 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.76 -17.3 20.31 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.517 1.478 . . . . 0.0 111.983 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -86.87 8.67 22.0 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.705 0.288 . . . . 0.0 110.578 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -148.4 156.31 42.33 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.314 0.578 . . . . 0.0 110.261 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -143.96 150.38 38.23 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.105 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.4 p -111.5 89.57 10.87 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.889 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.78 -11.72 20.08 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 121.334 1.356 . . . . 0.0 111.422 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -170.15 152.47 4.23 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 120.982 0.42 . . . . 0.0 110.47 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.26 151.92 18.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.248 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -139.13 150.93 46.24 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.627 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -161.23 131.45 5.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.863 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -130.27 97.53 4.45 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -71.05 94.54 1.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.926 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -167.97 140.15 3.04 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.18 137.78 58.04 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.684 0.278 . . . . 0.0 110.28 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.42 -1.58 50.17 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.97 164.88 44.91 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.4 p -126.27 157.88 37.16 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.841 0.456 . . . . 0.0 110.323 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -132.93 156.58 46.99 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.431 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.2 m -146.92 119.54 8.54 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.9 p -114.73 113.69 24.63 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.2 m -89.78 114.78 26.55 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.2 mtt -128.5 133.79 48.54 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.78 145.62 26.72 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.947 0.403 . . . . 0.0 110.176 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.58 147.58 53.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.377 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -56.33 -32.94 65.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.858 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -83.08 -7.01 59.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.08 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.82 16.34 59.13 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.8 m -60.85 -38.7 86.43 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.718 0.294 . . . . 0.0 110.763 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.4 ttp -145.31 146.42 31.62 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.047 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.4 t -143.97 155.72 44.15 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.917 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.466 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 56.4 t80 -153.8 165.18 36.84 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.466 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 30.8 t0 -138.26 119.46 14.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.186 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -93.33 136.57 33.47 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.95 154.36 25.46 Favored Glycine 0 N--CA 1.465 0.622 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.16 -173.39 40.9 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 t -123.75 132.92 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -71.3 121.35 18.32 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.54 -42.19 62.01 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -159.85 146.14 15.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.778 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.5 t -134.56 129.44 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -145.41 121.75 10.93 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.1 m -58.38 129.18 40.81 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.43 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 54.32 56.37 7.01 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.578 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -155.95 -83.95 0.06 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.005 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 tp -149.17 134.87 18.73 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.682 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.9 mt -127.29 127.97 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.11 164.18 38.51 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -156.07 154.39 30.9 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.906 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.3 m -87.97 131.76 34.5 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.7 mt -104.78 144.41 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.55 -42.49 57.9 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.411 ' CB ' ' NH1' ' A' ' 88' ' ' ARG . 44.2 m-20 -62.02 -21.35 64.81 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.766 0.317 . . . . 0.0 110.351 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.62 2.94 72.04 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.411 ' NH1' ' CB ' ' A' ' 86' ' ' ASP . 96.3 mtm-85 -65.83 140.81 58.42 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -92.11 122.03 34.22 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.245 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.9 t -135.47 122.52 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -136.49 142.76 43.56 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 77.3 mt -113.27 124.05 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.4 t -106.75 125.42 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -102.6 122.16 43.84 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.5 m -131.07 149.77 52.45 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -151.79 154.26 35.89 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.659 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.1 p -132.77 40.2 3.27 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.111 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.08 131.19 0.16 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 p30 47.35 17.33 0.07 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.087 0.555 . . . . 0.0 111.849 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.5 m -152.78 135.81 15.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.026 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.7 m -128.93 130.48 46.83 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -117.63 126.24 52.17 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.9 mt -101.18 123.82 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.01 128.52 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -142.99 140.58 31.09 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.0 m -137.01 142.65 42.52 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -153.94 155.63 35.98 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.362 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.54 139.23 74.45 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.739 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.75 -170.3 0.88 Allowed 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 121.964 1.776 . . . . 0.0 111.158 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 78.91 27.85 0.42 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.145 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -85.32 -71.39 0.53 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.631 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.6 m -123.63 -29.88 3.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.793 0.437 . . . . 0.0 111.37 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.405 ' OD1' ' NE2' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -139.04 163.92 42.87 Favored Pre-proline 0 N--CA 1.484 1.268 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.881 -176.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.89 171.31 7.49 Favored 'Trans proline' 0 N--CA 1.508 2.358 0 C-N-CA 122.607 2.204 . . . . 0.0 112.303 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -59.98 -51.6 68.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.167 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -50.94 -50.92 56.88 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 tp -65.86 -40.14 91.39 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.075 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.405 ' NE2' ' OD1' ' A' ' 113' ' ' ASN . 26.5 mm-40 -64.76 -52.59 56.13 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.769 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.38 -54.49 46.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.881 0.372 . . . . 0.0 110.092 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.6 t -64.05 -42.07 97.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.917 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.05 -52.13 50.13 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.191 -0.528 . . . . 0.0 111.827 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -65.08 -41.61 94.9 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.645 0.259 . . . . 0.0 110.344 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -65.74 -37.82 87.44 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.413 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.69 68.79 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 31.3 pt -65.3 -35.47 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.905 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.3 mt -64.89 -37.11 86.54 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -62.97 -37.46 87.2 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.6 m -69.07 -33.64 73.87 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.792 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -58.32 -50.63 72.94 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.683 0.277 . . . . 0.0 111.358 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -66.21 -36.0 81.92 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.255 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 36.3 t -60.83 -34.88 75.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.718 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -60.35 -43.57 96.38 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.75 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.423 ' HG1' ' N ' ' A' ' 134' ' ' GLU . 73.2 p -62.57 -34.58 77.24 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.651 0.262 . . . . 0.0 110.661 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.423 ' N ' ' HG1' ' A' ' 133' ' ' THR . 80.7 mm-40 -68.28 -40.43 81.84 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.018 0.437 . . . . 0.0 109.83 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -66.93 -28.37 68.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.935 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -66.95 -14.68 63.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.659 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.6 tp -62.12 150.04 39.63 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.121 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 54.7 33.76 20.12 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.562 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -161.5 -8.78 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.384 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -63.38 -41.45 98.79 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -168.16 57.33 0.06 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.242 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -65.04 -42.67 94.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.9 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -64.76 146.74 54.37 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.419 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 11.2 p80 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.689 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.584 ' N ' ' HE ' ' A' ' 115' ' ' ARG . 26.3 p30 -64.55 -10.83 28.64 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.329 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -73.08 51.88 0.32 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.909 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.59 137.36 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.2 m -122.87 133.27 54.42 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.8 m -138.74 160.05 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.21 165.9 30.47 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.231 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.02 144.25 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.2 p -92.12 125.42 36.79 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.59 130.7 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -97.25 92.82 6.19 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.06 152.53 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.966 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.33 138.06 58.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.202 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.7 tp -51.56 -37.79 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 121.067 0.461 . . . . 0.0 110.994 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -69.02 -36.74 78.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.15 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -68.64 -51.94 36.66 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 111.244 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -63.51 -36.51 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.364 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -54.92 -49.55 71.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.828 0.347 . . . . 0.0 110.587 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.7 -45.15 83.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.374 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.451 ' CD2' ' ND1' ' A' ' 26' ' ' HIS . 50.1 t80 -63.95 -43.83 94.66 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 111.186 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -71.1 -19.08 62.5 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.463 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -103.65 -23.92 13.42 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.999 0.519 . . . . 0.0 110.972 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.25 134.38 95.81 Favored Pre-proline 0 CA--C 1.553 1.064 0 CA-C-O 119.191 -0.433 . . . . 0.0 109.858 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.69 -41.49 0.55 Allowed 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.544 1.496 . . . . 0.0 111.622 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.67 -29.35 66.53 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.918 0.389 . . . . 0.0 110.695 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.451 ' ND1' ' CD2' ' A' ' 20' ' ' TYR . 33.3 m170 -79.93 -45.82 17.84 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.234 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 90.6 mt -63.52 -46.6 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 122.006 -0.434 . . . . 0.0 110.645 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -66.1 -3.37 5.4 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.71 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -90.58 -26.87 19.47 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.183 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -138.04 23.05 2.82 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.433 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.615 ' C ' ' H ' ' A' ' 33' ' ' ALA . 9.6 t -56.52 133.99 53.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.191 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 65.92 -23.99 0.1 Allowed 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.538 0.524 . . . . 0.0 110.668 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.615 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 53.3 28.19 7.0 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.507 0.194 . . . . 0.0 110.613 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.1 m -112.8 104.17 55.82 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 122.953 0.501 . . . . 0.0 110.058 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -50.09 -13.44 0.64 Allowed 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 122.266 1.977 . . . . 0.0 112.625 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -82.63 11.84 5.34 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.669 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -146.72 162.72 37.92 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -146.57 162.63 37.96 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.969 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.6 t -126.16 96.28 37.2 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.84 -10.99 23.63 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 121.76 1.64 . . . . 0.0 111.877 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.02 152.94 6.64 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.934 0.397 . . . . 0.0 110.473 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.68 150.09 9.98 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.458 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -143.65 156.25 44.5 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -157.98 104.18 1.9 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.699 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -91.99 87.62 6.26 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.2 tp -66.11 93.36 0.2 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.716 -0.394 . . . . 0.0 109.968 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -170.48 145.91 2.69 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.48 137.74 58.25 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.142 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.23 -1.58 25.2 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -77.26 163.49 51.98 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.8 m -124.14 155.41 38.5 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -135.04 158.05 45.35 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.467 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.7 m -146.17 122.37 10.84 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.6 m -119.12 119.63 34.76 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.6 m -88.86 113.4 24.37 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 93.2 mtp -119.14 124.66 47.38 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.35 140.74 33.82 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.17 150.37 47.57 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.08 -37.75 64.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.692 0.282 . . . . 0.0 110.523 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -81.17 -7.42 59.56 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.125 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.76 14.68 37.98 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.9 t -67.4 -19.14 65.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.733 0.301 . . . . 0.0 110.489 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 47.6 ttp -159.85 134.99 8.05 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.972 0.415 . . . . 0.0 110.383 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m -146.16 154.58 41.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.259 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -154.88 146.94 23.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.33 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -108.19 119.99 41.08 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.389 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -93.92 137.69 32.87 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.44 153.9 25.13 Favored Glycine 0 N--CA 1.46 0.27 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.3 178.21 43.15 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.33 134.15 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -75.68 121.05 21.92 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -75.22 -39.2 60.26 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -162.34 146.4 11.98 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.849 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.5 p -149.95 138.67 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.656 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -148.99 134.64 18.72 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.8 m -48.07 118.22 2.27 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.454 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.6 m120 54.11 79.6 0.13 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.377 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -167.9 -83.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.472 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 tt -152.78 141.49 20.96 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.774 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 63.1 mt -130.16 130.52 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -152.94 160.55 43.05 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -160.57 155.2 23.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.644 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.4 p -91.84 134.3 34.88 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.666 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.6 mt -104.71 147.37 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.05 -41.38 59.98 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.72 -17.76 50.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.777 0.323 . . . . 0.0 110.148 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.75 3.72 80.15 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -65.88 141.52 58.22 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -95.4 135.26 37.24 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.2 t -139.55 128.64 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -136.15 133.73 37.51 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.6 mt -116.59 116.18 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.5 t -101.13 116.02 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -90.89 132.52 35.87 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.5 p -132.25 156.93 45.63 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -143.85 148.69 35.85 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.2 m -150.82 87.05 1.4 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.94 -134.29 50.93 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -79.0 39.88 0.39 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.749 0.309 . . . . 0.0 110.498 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.8 m -150.09 147.62 28.0 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.2 m -134.0 146.38 50.35 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.406 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -132.68 131.08 40.91 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.5 mt -107.55 128.15 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.15 126.96 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -144.59 145.55 31.85 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 95.3 p -132.37 148.72 52.43 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -131.34 174.81 9.7 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -135.73 78.14 49.76 Favored Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.07 167.84 5.27 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.999 1.799 . . . . 0.0 111.701 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -58.8 148.67 29.0 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.177 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -68.64 -33.16 73.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.332 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.2 m -62.64 -45.48 92.63 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.992 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -73.27 143.31 83.0 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.717 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -71.23 141.34 39.15 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 121.521 1.48 . . . . 0.0 111.6 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.584 ' HE ' ' N ' ' A' ' 2' ' ' ASN . 79.9 mtt85 -65.92 -36.67 84.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.173 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 116' ' ' GLU . 22.3 mp0 -53.37 -48.43 68.59 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.239 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.4 tp -63.08 -44.86 94.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.864 0.364 . . . . 0.0 110.312 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -63.97 -46.62 83.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.651 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -53.74 -46.98 71.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.935 0.398 . . . . 0.0 110.385 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 81.5 p -64.67 -37.37 87.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.134 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.57 -52.45 46.04 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.531 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -66.41 -37.09 84.43 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.905 0.383 . . . . 0.0 110.541 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -70.55 -39.02 74.23 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.458 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.16 -52.0 67.38 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.726 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.4 tt -62.23 -37.97 79.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.7 mt -64.47 -41.99 96.17 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.28 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -67.39 -41.83 84.31 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.2 t -61.37 -32.83 72.75 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.467 0.48 . . . . 0.0 110.875 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -52.58 -14.08 0.46 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.862 0.363 . . . . 0.0 111.031 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -60.68 -38.2 84.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.645 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.6 m -58.28 -45.67 87.47 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.775 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -66.0 -44.69 84.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.045 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 95.1 m -61.87 -47.47 84.88 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.887 0.375 . . . . 0.0 110.745 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -78.43 8.39 5.2 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.813 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -62.12 -6.65 3.17 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.939 0.4 . . . . 0.0 110.31 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -63.01 -39.71 95.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.137 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.14 175.7 13.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.934 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -82.83 165.69 19.61 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.61 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -64.71 133.17 51.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.275 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -155.0 162.46 41.08 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.867 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -168.67 82.94 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.744 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.457 ' HE2' ' CD2' ' A' ' 144' ' ' HIS . 79.0 t60 -71.03 130.17 40.88 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -61.14 -87.12 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.692 0.282 . . . . 0.0 110.449 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.457 ' CD2' ' HE2' ' A' ' 142' ' ' HIS . 35.8 p-80 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.472 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.441 ' C ' ' HE ' ' A' ' 115' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -62.69 -40.72 98.01 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.695 0.283 . . . . 0.0 110.378 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -72.68 51.5 0.27 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.374 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.9 mt -50.17 143.01 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 t -129.91 133.96 47.18 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.4 m -139.69 158.34 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -148.65 162.88 38.83 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.335 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 p -145.3 140.59 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.3 p -93.36 119.33 32.36 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.2 t -127.48 128.7 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -98.98 88.22 3.92 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.29 154.43 4.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.041 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.25 118.84 7.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.2 tt -51.68 -34.96 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.167 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -60.31 -39.82 88.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -73.24 -45.43 55.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.238 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.88 -42.34 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.688 0.28 . . . . 0.0 110.499 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.442 ' CD1' ' ND2' ' A' ' 22' ' ' ASN . 21.0 t90 -48.92 -34.59 13.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.616 0.246 . . . . 0.0 111.123 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -61.55 -47.86 83.64 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.631 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -69.36 -42.37 75.31 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.699 0.285 . . . . 0.0 110.572 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -65.93 -15.63 63.14 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.307 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.442 ' ND2' ' CD1' ' A' ' 18' ' ' TRP . 2.1 m-80 -108.81 -26.88 10.06 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.377 0.671 . . . . 0.0 111.478 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -76.83 125.84 86.54 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.54 -31.36 13.72 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 121.427 1.418 . . . . 0.0 111.883 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.63 -37.29 78.25 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.437 0.461 . . . . 0.0 110.876 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -79.42 -41.45 27.66 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.988 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.48 -49.06 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.239 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.9 ptm -60.46 -16.35 35.59 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.495 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -72.28 -34.99 68.59 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -127.68 5.29 6.12 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.092 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.568 ' C ' ' H ' ' A' ' 33' ' ' ALA . 30.5 t -51.35 140.52 17.09 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 71.36 -36.64 0.37 Allowed 'General case' 0 CA--C 1.536 0.432 0 O-C-N 123.698 0.624 . . . . 0.0 109.573 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.568 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 56.21 34.81 24.65 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.533 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.1 m -121.93 136.03 25.84 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 122.816 0.446 . . . . 0.0 110.48 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.28 -20.34 16.42 Favored 'Trans proline' 0 N--CA 1.503 2.074 0 C-N-CA 121.832 1.688 . . . . 0.0 112.524 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -78.04 -24.06 47.94 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.543 0.211 . . . . 0.0 110.991 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -109.54 153.79 23.63 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.411 ' CD2' ' O ' ' A' ' 57' ' ' ALA . 6.1 p80 -144.77 162.87 35.68 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.3 t -120.74 95.25 48.99 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.12 -10.77 22.95 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 121.637 1.558 . . . . 0.0 111.688 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -167.49 151.99 6.81 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.893 0.378 . . . . 0.0 110.433 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -162.41 146.4 11.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.245 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -139.21 152.92 47.74 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -160.57 127.77 4.33 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.857 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -133.89 93.58 3.13 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.17 102.34 1.33 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.174 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -163.8 129.92 3.12 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.55 123.19 12.35 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.715 0.293 . . . . 0.0 110.67 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.68 4.92 90.23 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.28 173.01 52.95 Favored Glycine 0 N--CA 1.467 0.745 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.577 ' HG1' ' N ' ' A' ' 52' ' ' PHE . 2.5 t -134.08 164.21 27.84 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 117.058 0.429 . . . . 0.0 110.045 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.577 ' N ' ' HG1' ' A' ' 51' ' ' THR . 47.3 p90 -148.8 169.13 21.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.067 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.1 m -148.99 125.32 10.87 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.8 m -120.5 118.31 29.91 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.3 m -94.89 117.93 30.94 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 46.4 ttp -137.06 130.25 31.05 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' A' ' 38' ' ' HIS . . . -153.54 158.04 40.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.208 0.528 . . . . 0.0 110.157 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.84 150.72 48.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.778 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -58.03 -38.12 75.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.587 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -71.23 -11.1 60.74 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.91 6.63 60.36 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.1 m -63.78 -39.96 95.52 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.598 0.237 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.2 mtm -117.44 142.2 47.42 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.133 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.8 p -144.23 149.24 36.04 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.872 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -154.49 154.21 32.77 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -138.18 120.15 15.47 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.589 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -93.7 121.83 35.54 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -132.46 134.92 7.83 Favored Glycine 0 N--CA 1.473 1.161 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.74 -175.11 44.67 Favored Glycine 0 CA--C 1.518 0.28 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.5 m -132.38 156.81 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.894 0.378 . . . . 0.0 110.207 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -88.34 124.51 33.99 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.517 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.32 -38.49 65.8 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.46 149.6 5.84 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.664 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.7 t -134.59 132.46 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -141.46 117.42 10.53 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 m -55.88 123.69 15.13 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.964 0.412 . . . . 0.0 111.349 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.2 m120 52.14 66.22 1.27 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.011 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -167.08 -77.55 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.227 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tp -151.82 131.6 13.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.51 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.6 mt -132.94 131.69 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -153.09 165.56 35.22 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -157.28 164.79 37.28 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 54.3 m -115.36 132.57 56.58 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.8 mm -99.28 150.05 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.22 -40.49 67.62 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.424 ' CB ' ' NH1' ' A' ' 88' ' ' ARG . 63.1 m-20 -61.66 -19.41 62.28 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.59 0.233 . . . . 0.0 110.709 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.93 -3.08 48.32 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.424 ' NH1' ' CB ' ' A' ' 86' ' ' ASP . 84.5 mtt85 -64.72 144.2 57.4 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -120.97 146.42 46.7 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.567 0.542 . . . . 0.0 109.654 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.3 t -138.1 136.89 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -132.92 120.02 20.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 70.8 mt -108.72 117.6 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.0 t -108.17 114.9 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -89.87 128.43 36.19 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.4 p -132.75 152.43 51.76 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -153.93 158.65 41.01 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.3 p -135.94 36.59 2.83 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.023 0.44 . . . . 0.0 109.901 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 100' ' ' THR . . . 69.92 131.2 0.07 OUTLIER Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 57.34 8.71 0.62 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.838 0.352 . . . . 0.0 110.955 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 98' ' ' GLY . 40.7 m -150.47 139.54 21.08 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.114 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.9 m -127.76 130.36 48.62 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -120.53 123.29 42.55 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.0 mt -103.27 128.43 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.61 131.66 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -130.31 132.7 45.99 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.3 t -118.29 149.11 41.7 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -144.0 160.69 40.41 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -134.16 78.24 59.16 Favored Pre-proline 0 N--CA 1.474 0.751 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.96 164.46 6.2 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.949 1.766 . . . . 0.0 111.718 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -63.35 151.46 40.79 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.43 -43.49 90.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.412 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.446 ' HG1' HD21 ' A' ' 113' ' ' ASN . 82.0 p -64.0 -42.94 97.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.945 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.569 ' N ' HD21 ' A' ' 113' ' ' ASN . 0.8 OUTLIER -63.11 146.79 95.53 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.639 -178.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.17 110.64 3.1 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 121.944 1.763 . . . . 0.0 111.407 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.441 ' HE ' ' C ' ' A' ' 1' ' ' GLY . 9.0 ptm180 -66.37 -26.31 67.21 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.018 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 116' ' ' GLU . 30.1 mp0 -56.97 -50.98 71.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.257 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.6 mt -66.71 -37.26 84.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.59 0.233 . . . . 0.0 110.717 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -60.3 -47.21 86.97 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.61 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -53.27 -44.98 68.65 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.01 0.433 . . . . 0.0 110.008 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.1 t -64.45 -40.72 96.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.352 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.47 -51.72 55.95 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -62.74 -36.3 82.58 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.705 0.288 . . . . 0.0 110.279 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -74.05 -37.67 64.21 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.791 0.329 . . . . 0.0 110.194 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.15 -51.08 71.56 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.805 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.3 tt -63.6 -39.57 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.5 mt -63.62 -38.61 91.76 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -62.14 -40.03 94.57 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.072 0.463 . . . . 0.0 109.763 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.5 t -72.63 -31.04 64.84 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.689 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -55.35 -52.24 64.15 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -70.51 -36.09 73.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.972 0.415 . . . . 0.0 110.768 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.497 ' HG ' ' N ' ' A' ' 132' ' ' TYR . 52.6 p -54.66 -36.23 64.37 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 -178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.497 ' N ' ' HG ' ' A' ' 131' ' ' SER . 85.3 t80 -62.51 -48.17 80.72 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.046 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.1 p -64.27 -43.84 93.59 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.612 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.83 -36.46 83.54 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.034 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -62.03 -43.88 97.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.679 0.276 . . . . 0.0 110.465 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -66.71 -42.82 85.79 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.777 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.0 tp -63.77 -44.16 94.22 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.923 0.392 . . . . 0.0 110.357 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -168.56 -167.87 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.431 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 54.1 73.51 0.38 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.923 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -68.36 -163.61 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.704 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -153.67 -51.34 0.1 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 53.12 83.49 0.06 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.652 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.494 ' ND1' ' ND1' ' A' ' 144' ' ' HIS . 62.4 t-80 -62.53 -42.69 99.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.545 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.494 ' ND1' ' ND1' ' A' ' 143' ' ' HIS . 43.8 p-80 . . . . . 0 C--O 1.218 -0.561 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.203 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.482 ' ND2' ' NH2' ' A' ' 115' ' ' ARG . 54.3 t30 -65.58 169.58 6.03 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -106.47 52.61 0.72 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.279 0.632 . . . . 0.0 110.265 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.9 mt -51.53 138.97 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 m -135.64 138.73 43.16 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 m -136.17 157.05 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -147.74 161.16 41.78 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.39 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.61 142.61 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.5 m -93.48 121.27 34.7 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.7 t -126.57 124.88 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -94.74 89.9 5.88 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.98 153.47 4.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.06 134.28 55.85 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.7 tp -52.83 -34.39 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.88 0.372 . . . . 0.0 110.884 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -60.46 -40.8 92.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.473 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -72.07 -46.66 56.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.845 0.355 . . . . 0.0 110.555 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.48 -41.57 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.401 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.403 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 26.4 t-105 -56.11 -45.31 79.54 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.84 0.353 . . . . 0.0 110.868 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -65.26 -45.01 86.25 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.339 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -65.51 -43.37 90.33 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.727 0.299 . . . . 0.0 110.973 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -69.23 -20.19 63.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.492 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.626 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.7 OUTLIER -104.93 -30.86 9.55 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.129 0.571 . . . . 0.0 111.752 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -50.76 106.52 0.66 Allowed Pre-proline 0 CA--C 1.557 1.214 0 CA-C-O 119.113 -0.47 . . . . 0.0 109.819 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -53.58 -43.07 60.82 Favored 'Trans proline' 0 N--CA 1.508 2.381 0 CA-C-N 120.646 1.266 . . . . 0.0 112.244 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.06 -33.79 73.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.909 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.475 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 81.4 t60 -73.74 -38.45 64.76 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.795 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.41 -44.46 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 122.038 -0.414 . . . . 0.0 110.752 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.7 ptp -67.21 -24.9 65.89 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.283 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -62.29 -45.8 91.61 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.529 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.488 ' CE3' ' O ' ' A' ' 31' ' ' CYS . 62.7 p-90 -109.13 -10.19 15.01 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.523 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.488 ' O ' ' CE3' ' A' ' 30' ' ' TRP . 29.4 p 30.71 -130.99 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.962 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 177.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.425 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 55.2 tp60 -74.55 -4.34 36.34 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 30' ' ' TRP . . . 64.32 32.52 12.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.225 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.8 m -132.3 141.17 40.33 Favored Pre-proline 0 N--CA 1.482 1.154 0 O-C-N 123.337 0.398 . . . . 0.0 110.534 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.5 -9.94 23.32 Favored 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 121.892 1.728 . . . . 0.0 112.27 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -79.14 -24.56 43.22 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.426 0.155 . . . . 0.0 110.724 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -122.24 148.86 44.47 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.829 0.452 . . . . 0.0 110.313 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -140.09 163.25 33.2 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.179 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.21 89.23 52.94 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.61 -10.12 20.14 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 121.537 1.491 . . . . 0.0 111.141 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -167.77 150.36 5.78 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.008 0.432 . . . . 0.0 110.273 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.86 150.47 11.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.092 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -138.99 144.91 39.13 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -163.6 135.67 5.03 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -125.05 97.45 5.26 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.1 tp -65.34 94.48 0.17 Allowed 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -168.34 140.83 2.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.26 137.71 57.88 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.262 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.45 -0.05 61.24 Favored Glycine 0 N--CA 1.466 0.691 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.06 169.1 41.72 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 t -129.87 168.41 16.66 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.704 0.402 . . . . 0.0 110.066 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -140.57 166.38 24.9 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.244 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 m -154.88 118.09 4.45 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.7 m -116.96 121.46 41.47 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.1 m -93.36 116.66 29.21 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.9 mtp -121.76 125.88 47.57 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.81 138.31 42.44 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.014 0.435 . . . . 0.0 110.116 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.77 148.83 51.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.393 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.02 -39.96 75.76 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.712 0.292 . . . . 0.0 110.451 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -76.2 -9.65 58.8 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.24 22.23 62.84 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 97.0 p -81.06 -10.75 59.64 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.736 0.303 . . . . 0.0 110.617 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.1 ttt -164.49 136.48 4.59 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.087 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.9 p -144.43 161.1 39.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.874 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.466 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 61.7 t80 -159.47 168.63 25.76 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.466 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 40.8 t0 -138.55 119.53 14.39 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -93.99 140.58 29.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.71 156.21 26.97 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.36 -171.55 40.99 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 p -127.36 141.63 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 122.672 0.389 . . . . 0.0 110.107 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -81.04 123.65 28.54 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -77.0 -47.87 19.52 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.076 0.465 . . . . 0.0 110.04 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -147.38 141.31 25.87 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.559 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.3 t -136.06 125.5 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -140.54 123.13 16.16 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.8 m -53.62 121.95 8.84 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.073 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.5 m120 53.47 70.16 0.62 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.77 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -166.1 -82.39 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.536 0.208 . . . . 0.0 110.943 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.1 tp -147.02 139.55 24.85 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 58.9 mt -133.77 130.28 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -153.7 157.51 39.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -155.95 160.16 39.86 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.3 m -112.27 135.24 53.19 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.3 mm -89.19 155.89 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.8 -33.97 80.44 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -69.46 -10.26 57.27 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 122.477 -0.425 . . . . 0.0 110.352 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.7 -8.15 56.14 Favored Glycine 0 N--CA 1.475 1.29 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -71.18 161.32 31.3 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -145.4 160.79 41.03 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.428 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.4 t -144.43 113.03 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.325 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -93.92 127.41 39.67 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.7 mt -124.83 113.06 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.0 p -108.71 133.55 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -103.93 132.64 49.99 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.0 p -134.3 153.3 51.95 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -153.84 158.22 40.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.541 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 63.6 p -134.86 27.38 3.6 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.049 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.0 129.32 1.39 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 55.7 11.77 0.72 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.885 0.374 . . . . 0.0 111.03 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.2 m -153.53 141.93 20.66 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.046 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.9 m -130.37 130.85 44.9 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -117.88 122.86 44.43 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.6 mt -104.37 126.27 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.5 t -128.18 133.83 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -142.63 145.9 33.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.036 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 78.4 p -132.24 141.97 49.23 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -154.15 155.55 35.56 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.64 137.07 34.15 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-O 119.136 -0.459 . . . . 0.0 110.656 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.87 158.63 38.7 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 121.423 1.415 . . . . 0.0 111.519 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.69 ' H ' HE22 ' A' ' 118' ' ' GLN . 93.3 mt-10 -74.06 154.04 39.38 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -84.38 -42.23 15.9 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.75 0.31 . . . . 0.0 110.782 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 71.1 p -63.09 -44.93 94.36 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.536 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -93.43 147.95 34.63 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-O 119.592 -0.242 . . . . 0.0 110.76 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -62.32 137.22 64.21 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 121.424 1.416 . . . . 0.0 111.864 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.482 ' NH2' ' ND2' ' A' ' 2' ' ' ASN . 17.2 ptm180 -69.11 -37.55 78.43 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.988 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -56.67 -41.33 77.09 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.936 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.6 tp -63.86 -42.98 97.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.715 0.293 . . . . 0.0 110.427 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.69 HE22 ' H ' ' A' ' 110' ' ' GLU . 76.8 mt-30 -60.97 -46.91 88.85 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.549 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.53 -48.09 69.37 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.774 0.321 . . . . 0.0 110.506 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.7 t -63.34 -42.57 98.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.337 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.68 -51.78 55.21 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -64.17 -36.06 82.81 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.967 0.384 . . . . 0.0 110.291 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -73.61 -38.19 65.16 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.17 -51.23 70.89 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.9 tt -61.7 -37.76 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.4 mt -63.26 -40.92 98.77 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.2 -41.29 97.14 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 110.049 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.5 m -61.05 -33.32 73.13 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.132 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -55.76 -46.29 77.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.986 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -63.39 -44.71 93.93 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.174 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.2 m -61.41 -43.77 98.29 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.498 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -62.22 -44.3 96.88 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.208 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.3 m -58.48 -47.92 82.48 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.832 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.9 -43.96 82.05 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.974 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -64.47 -35.46 81.0 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.304 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -60.99 -42.89 99.28 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 139' ' ' HIS . 50.7 tp -152.44 122.39 7.03 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -79.15 35.28 0.26 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.128 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.419 ' H ' ' C ' ' A' ' 137' ' ' LEU . 94.6 m-70 54.19 79.55 0.13 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.79 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -67.53 141.07 57.0 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.903 0.382 . . . . 0.0 110.094 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -67.4 139.06 57.12 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.939 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -162.48 155.58 20.01 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.054 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -169.0 89.63 0.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 64.8 m80 . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.415 179.614 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -79.31 8.85 5.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.768 0.318 . . . . 0.0 110.442 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -125.15 52.86 1.56 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.991 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.4 mt -50.14 138.15 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.4 m -133.42 134.47 43.67 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.24 156.34 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.427 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 32.8 mp0 -140.75 158.36 44.08 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.917 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 p -143.88 140.46 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -93.44 113.95 26.23 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.7 t -119.01 125.9 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -98.23 87.84 4.02 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.09 152.78 4.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.087 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.63 135.88 57.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.7 tp -53.41 -32.2 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.622 0.248 . . . . 0.0 111.441 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -59.51 -39.74 84.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.774 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -75.17 -46.4 34.43 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 110.437 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.5 t -62.53 -43.44 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.24 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -56.26 -46.05 79.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.934 0.397 . . . . 0.0 110.583 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -67.38 -45.43 76.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.606 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -65.31 -43.43 91.09 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.793 0.33 . . . . 0.0 111.136 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -70.43 -20.02 62.94 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.647 -178.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -104.68 -22.25 13.26 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.139 0.576 . . . . 0.0 111.41 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -65.8 132.09 94.76 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.02 -40.55 1.28 Allowed 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 121.262 1.308 . . . . 0.0 111.57 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.76 -35.9 69.19 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.085 0.469 . . . . 0.0 110.833 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -73.86 -45.8 48.82 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.255 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 91.8 mt -61.85 -50.29 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.816 -0.553 . . . . 0.0 111.015 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 20.0 ptm -60.8 -17.38 49.14 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -74.2 -31.73 62.76 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -133.41 14.86 4.11 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.602 0.361 . . . . 0.0 110.837 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.558 ' C ' ' H ' ' A' ' 33' ' ' ALA . 20.4 t -53.95 136.4 41.12 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 122.138 -0.351 . . . . 0.0 110.279 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 70.81 -36.25 0.35 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.539 0.524 . . . . 0.0 110.011 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 56.86 36.16 27.34 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.763 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.0 m -131.63 141.51 41.92 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 122.682 0.393 . . . . 0.0 110.436 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -75.46 -8.9 19.9 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.04 1.827 . . . . 0.0 112.03 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -86.31 7.32 25.9 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.681 0.277 . . . . 0.0 110.457 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -153.45 155.66 36.72 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.243 0.544 . . . . 0.0 110.357 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -148.55 163.18 37.98 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.303 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.6 t -127.62 91.94 44.24 Favored Pre-proline 0 N--CA 1.476 0.833 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.81 -1.94 12.09 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.768 1.645 . . . . 0.0 111.709 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.25 152.42 8.96 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.884 0.373 . . . . 0.0 110.078 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -166.07 150.47 8.03 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.36 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -136.77 150.47 48.4 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.917 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -160.88 131.4 5.25 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.09 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -129.54 95.83 4.11 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.79 93.87 0.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.08 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -168.19 140.9 3.05 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.96 137.75 58.21 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.425 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.87 1.65 48.24 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.9 148.12 34.45 Favored Glycine 0 N--CA 1.465 0.6 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.1 p -111.7 157.43 20.5 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.899 0.48 . . . . 0.0 109.846 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 69' ' ' GLY . 45.5 p90 -156.72 169.18 25.32 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.026 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.7 m -156.39 141.58 17.39 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.1 m -122.09 120.74 35.17 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.8 m -86.39 111.14 20.22 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 44.3 ttp -127.74 114.07 16.81 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -132.08 141.48 49.2 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.59 0.356 . . . . 0.0 110.275 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.35 148.07 33.75 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -58.83 -37.9 77.47 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.712 0.291 . . . . 0.0 110.263 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.51 -10.6 59.72 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.89 17.66 67.73 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.9 t -62.48 -42.22 99.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.801 0.334 . . . . 0.0 111.012 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 62.4 ttp -145.19 147.0 31.97 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.175 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.5 t -144.7 154.7 43.04 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.135 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -154.13 143.25 21.24 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -95.47 108.85 21.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.467 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -96.04 130.66 42.99 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.95 176.44 41.95 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 52' ' ' PHE . . . -174.57 -172.42 39.64 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 36.7 t -126.94 132.48 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -72.68 113.79 10.1 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.42 ' O ' ' NE2' ' A' ' 73' ' ' GLN . 23.9 t0 -74.29 -48.14 30.36 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.42 ' NE2' ' O ' ' A' ' 72' ' ' ASP . 99.2 mm-40 -139.81 137.88 35.35 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.78 125.82 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -144.19 113.15 6.77 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.3 m -47.38 116.49 1.44 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.4 m120 53.98 71.21 0.53 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.602 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -168.65 -68.86 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.634 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.0 tp -150.12 133.69 16.62 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 84.5 mt -128.49 125.21 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -153.6 152.13 30.53 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 20.2 p90 -151.2 152.25 33.03 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.9 m -82.16 128.53 34.24 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.479 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.3 mm -82.27 144.1 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.251 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.32 -41.64 87.62 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -66.21 -5.28 9.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.758 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.17 0.89 84.82 Favored Glycine 0 N--CA 1.473 1.132 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -66.84 159.3 28.47 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -113.92 132.84 55.79 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.97 0.415 . . . . 0.0 109.944 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.2 t -136.48 134.35 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -135.43 127.34 29.48 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.82 117.46 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.56 128.58 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -92.46 126.32 37.49 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.9 m -146.21 141.25 27.23 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.433 ' N ' ' ND1' ' A' ' 96' ' ' HIS . 2.3 p-80 -153.69 148.84 26.87 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.2 p -98.05 -13.63 20.94 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.011 0.434 . . . . 0.0 109.957 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.43 -101.29 0.2 Allowed Glycine 0 N--CA 1.465 0.622 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 18.0 p-10 -78.0 -2.06 35.2 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.343 0.257 . . . . 0.0 110.892 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.0 p -118.54 128.18 54.32 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.03 0.532 . . . . 0.0 109.709 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.9 m -103.72 135.07 45.97 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.666 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -119.23 115.37 24.05 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.8 mt -101.51 125.79 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.3 t -121.35 127.57 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -142.43 144.47 33.1 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 94.7 p -130.51 148.9 52.37 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.117 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -137.22 150.57 47.96 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.153 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -89.81 110.95 43.33 Favored Pre-proline 0 CA--C 1.551 0.982 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.992 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.82 159.28 27.81 Favored 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 122.002 1.801 . . . . 0.0 112.145 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.8 151.94 31.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.839 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -78.23 -39.97 38.73 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.66 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.575 ' HG1' ' N ' ' A' ' 113' ' ' ASN . 76.1 p -63.46 -44.61 93.98 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.472 -179.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.575 ' N ' ' HG1' ' A' ' 112' ' ' THR . 31.5 m120 -87.53 144.65 35.84 Favored Pre-proline 0 N--CA 1.474 0.744 0 CA-C-O 119.553 -0.26 . . . . 0.0 110.53 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -70.02 134.22 26.93 Favored 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 121.652 1.568 . . . . 0.0 111.819 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -65.25 -34.24 77.88 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.891 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -49.91 -39.36 39.63 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.942 0.401 . . . . 0.0 111.526 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -75.83 -39.53 56.55 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -65.27 -54.61 26.61 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.069 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.503 ' NE2' ' NE2' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -55.52 -38.81 69.71 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.188 0.518 . . . . 0.0 110.633 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.412 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 40.7 t -59.0 -40.83 86.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.954 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.4 -48.23 64.96 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.717 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -59.04 -39.71 82.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.802 0.334 . . . . 0.0 110.563 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.503 ' NE2' ' NE2' ' A' ' 119' ' ' GLN . 78.3 mt-30 -74.85 -34.65 62.32 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.75 -51.0 71.63 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.7 tt -63.19 -39.11 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.7 mt -63.56 -40.04 95.96 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -62.71 -39.66 94.73 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.5 t -60.02 -37.07 78.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.811 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -57.23 -47.47 81.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.681 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -64.36 -41.99 96.45 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 41.9 t -60.5 -43.91 96.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.576 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -61.99 -47.3 85.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.243 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.0 m -61.44 -46.19 91.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.587 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -65.77 -35.53 80.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.025 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -62.96 -34.82 78.32 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.361 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -61.57 -36.4 80.54 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.423 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.6 mt 56.14 -111.36 0.61 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.515 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -62.5 175.41 0.78 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -167.25 133.77 2.25 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -169.91 23.02 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.968 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -60.37 -43.72 96.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.267 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 83.4 t60 50.94 86.81 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.743 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 53.1 80.48 0.1 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.909 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.925 -1.036 . . . . 0.0 111.205 -179.8 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -158.21 115.98 2.97 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -126.39 55.6 1.5 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.132 0.573 . . . . 0.0 110.291 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.9 mt -46.38 138.16 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.0 m -136.29 136.95 40.21 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.77 156.33 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.438 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 31.6 mp0 -141.06 158.91 43.28 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.851 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 p -151.26 142.59 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.186 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.5 p -97.32 124.11 41.35 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.7 t -128.46 129.48 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -93.83 88.2 5.68 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.48 151.73 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.19 133.74 54.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.143 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.6 tt -53.44 -36.48 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.701 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.407 ' OE2' ' N ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -63.31 -34.98 78.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.984 0.421 . . . . 0.0 110.011 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.407 ' N ' ' OE2' ' A' ' 15' ' ' GLU . 63.9 tttm -73.38 -50.21 23.11 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.9 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.35 -42.64 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.154 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.476 ' NE1' ' ND2' ' A' ' 22' ' ' ASN . 25.9 t-105 -54.13 -40.15 67.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.763 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -65.46 -54.31 30.23 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.538 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -69.53 -41.63 75.71 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.838 0.351 . . . . 0.0 111.396 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -61.82 -20.69 63.91 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.708 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.476 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 91.8 m-20 -106.22 -19.58 13.66 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.809 0.444 . . . . 0.0 110.282 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -68.27 122.92 86.1 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.7 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.93 -35.1 12.74 Favored 'Trans proline' 0 N--CA 1.504 2.125 0 C-N-CA 121.324 1.35 . . . . 0.0 112.217 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.73 -39.57 94.48 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.84 0.352 . . . . 0.0 110.48 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.504 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 84.4 t60 -65.36 -45.39 84.33 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.37 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 31' ' ' CYS . 96.7 mt -62.48 -43.84 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 36.3 ttp -54.85 -15.96 2.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.497 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -84.49 -25.98 28.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.641 0.258 . . . . 0.0 111.355 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.504 ' HE1' ' CD2' ' A' ' 26' ' ' HIS . 56.7 p-90 -140.75 26.21 2.1 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.878 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.614 ' C ' ' H ' ' A' ' 33' ' ' ALA . 16.1 t -59.73 130.24 45.82 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.937 -0.477 . . . . 0.0 110.12 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 66.08 -27.46 0.11 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.754 0.658 . . . . 0.0 110.55 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.614 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 51.96 30.26 7.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.0 t -118.86 136.71 24.39 Favored Pre-proline 0 N--CA 1.48 1.068 0 O-C-N 123.476 0.485 . . . . 0.0 111.168 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.95 -13.02 24.01 Favored 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 121.931 1.754 . . . . 0.0 111.939 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -85.05 9.78 13.78 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.921 0.391 . . . . 0.0 110.911 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -149.31 162.17 40.59 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.232 0.539 . . . . 0.0 109.747 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -148.74 162.89 38.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.911 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.79 91.2 13.77 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.8 -3.07 13.36 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 122.312 2.008 . . . . 0.0 112.049 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.29 153.06 11.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.737 0.303 . . . . 0.0 110.228 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -165.03 148.21 8.4 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -150.72 152.99 34.73 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -163.16 103.65 0.98 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.095 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -85.68 90.99 8.16 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.6 tp -65.41 95.66 0.21 Allowed 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -169.51 140.69 2.28 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.08 138.05 57.96 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.192 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.87 -2.29 60.32 Favored Glycine 0 N--CA 1.467 0.732 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.18 174.22 43.54 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 t -135.21 168.06 19.86 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -135.89 167.19 21.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.975 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.9 m -160.66 125.93 3.83 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.7 m -123.99 125.63 44.91 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 m -86.73 112.17 21.41 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 72.4 mtp -119.72 118.62 31.39 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.49 139.72 40.74 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.53 147.59 52.48 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -55.18 -34.89 64.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 110.668 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -82.71 -9.21 59.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.345 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.83 15.34 64.46 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.6 t -62.5 -40.97 98.43 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.72 0.295 . . . . 0.0 110.664 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 44.6 ttp -143.58 143.32 31.45 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.09 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.6 p -145.83 157.56 43.91 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.878 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.448 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 63.5 t80 -159.81 166.69 29.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.517 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.448 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 24.1 p-10 -138.2 121.92 17.53 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.045 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -94.38 143.62 26.24 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.92 157.44 28.01 Favored Glycine 0 C--N 1.331 0.268 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.51 -173.06 40.92 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.4 t -128.31 135.85 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -76.06 120.0 20.77 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -74.05 -45.08 51.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.893 0.377 . . . . 0.0 110.23 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -148.77 139.42 22.73 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -137.34 127.67 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -144.16 129.01 18.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.0 m -60.55 135.01 57.62 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.793 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 54.81 57.8 5.37 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.915 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -154.37 -82.76 0.08 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.934 0.397 . . . . 0.0 110.273 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -163.07 160.56 24.58 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.26 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.2 mt -134.38 135.96 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.404 ' OE1' ' NH1' ' A' ' 91' ' ' ARG . 14.2 pt-20 -149.92 154.92 39.09 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -158.91 155.2 27.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.9 m -95.57 134.41 38.48 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.7 mt -101.32 152.74 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -51.88 -42.19 53.05 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -60.83 -17.46 49.97 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.984 0.421 . . . . 0.0 110.095 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.42 7.55 72.34 Favored Glycine 0 N--CA 1.471 0.99 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -70.58 139.35 51.45 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -93.7 136.47 33.94 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.0 t -137.83 132.12 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.404 ' NH1' ' OE1' ' A' ' 81' ' ' GLU . 70.2 mtp85 -135.61 135.53 40.31 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.9 mt -124.18 114.07 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.88 129.11 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -95.8 132.8 40.67 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.5 p -136.11 155.47 50.13 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -152.43 143.64 23.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.738 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.4 p -91.1 -41.46 11.04 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.003 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.45 -68.06 0.11 Allowed Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -107.28 17.4 22.92 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.157 0.583 . . . . 0.0 110.73 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.5 m -155.77 119.79 4.52 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.105 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 43.0 m -83.99 146.44 27.99 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -128.49 122.61 31.59 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.6 mt -100.27 126.67 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.37 126.73 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -144.71 146.49 32.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.523 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 96.5 p -134.52 147.5 50.33 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -122.27 170.95 9.41 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -137.17 78.29 40.27 Favored Pre-proline 0 N--CA 1.469 0.491 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.58 -172.5 1.55 Allowed 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.161 1.907 . . . . 0.0 111.494 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -61.28 138.12 58.24 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.136 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -67.83 -40.03 83.8 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.527 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.8 p -62.59 -40.77 97.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.976 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -61.25 147.37 87.15 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.703 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.87 112.75 3.35 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.712 1.608 . . . . 0.0 111.586 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -62.82 -31.94 73.04 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.25 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -59.52 -45.68 91.03 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.613 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.4 tt -64.62 -47.0 80.19 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.104 0.478 . . . . 0.0 109.768 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -62.35 -41.29 98.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.474 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -54.02 -41.35 67.9 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.508 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.2 t -60.91 -41.85 96.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.396 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.51 -50.9 61.68 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -61.36 -36.33 79.93 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.015 0.436 . . . . 0.0 110.18 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -75.86 -36.45 59.56 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.138 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.35 -51.41 70.06 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.003 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.8 tt -61.1 -37.33 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.8 mt -63.74 -40.67 97.3 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.334 -0.393 . . . . 0.0 109.962 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -63.9 -39.23 93.7 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.2 m -57.6 -35.52 70.53 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 110.665 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -58.34 -43.58 88.37 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.465 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -61.49 -45.05 95.88 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.682 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 89.7 p -63.0 -40.49 97.95 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.24 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -60.57 -45.02 95.5 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.379 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 28.5 m -59.07 -46.82 87.3 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.563 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -67.58 -44.29 78.52 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.213 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -63.85 -38.36 90.81 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.427 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -63.03 -14.84 53.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.16 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.2 tp 55.51 84.86 0.07 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.194 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -73.44 86.8 1.54 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 139' ' ' HIS . 81.1 t60 52.45 19.0 1.04 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.896 0.379 . . . . 0.0 111.061 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.567 ' CG ' ' H ' ' A' ' 141' ' ' HIS . 79.7 t60 57.52 175.72 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.158 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.567 ' H ' ' CG ' ' A' ' 140' ' ' HIS . 61.1 t-80 -160.32 142.64 13.03 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -164.7 -28.82 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.169 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.434 ' CE1' ' NE2' ' A' ' 141' ' ' HIS . 29.6 p80 -62.01 138.75 58.41 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.349 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.19 -179.866 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.66 HD22 HH21 ' A' ' 115' ' ' ARG . 9.6 m120 -61.98 -40.54 95.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.933 0.397 . . . . 0.0 110.443 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -73.09 52.65 0.34 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.04 0.448 . . . . 0.0 110.024 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.9 mt -53.26 134.63 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.5 m -131.19 130.99 43.68 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.8 m -137.32 159.01 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -148.47 162.41 39.68 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.417 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 p -144.14 142.54 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 m -95.46 117.65 30.76 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -123.43 129.38 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -97.61 87.55 4.11 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.82 152.54 4.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.984 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.86 133.04 52.62 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.041 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.8 tt -53.36 -36.69 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.736 0.303 . . . . 0.0 111.629 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.35 -35.29 75.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.424 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -74.92 -47.17 31.16 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.165 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.3 -43.03 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.31 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 26.6 t-105 -53.98 -43.54 70.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.139 0.495 . . . . 0.0 110.864 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.69 -45.78 74.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.614 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -66.63 -42.72 86.32 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.886 0.374 . . . . 0.0 111.332 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -68.73 -18.09 64.17 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.571 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -109.66 -29.54 8.31 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.938 0.495 . . . . 0.0 111.981 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -51.42 106.21 0.62 Allowed Pre-proline 0 CA--C 1.561 1.383 0 CA-C-O 118.734 -0.651 . . . . 0.0 109.519 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.53 -43.33 55.61 Favored 'Trans proline' 0 N--CA 1.506 2.254 0 CA-C-N 121.006 1.395 . . . . 0.0 112.331 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.46 84.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.257 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -69.04 -36.93 78.27 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.371 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 98.7 mt -62.0 -52.41 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 121.856 -0.528 . . . . 0.0 111.218 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.8 ptp -61.59 -16.55 49.14 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -70.15 -26.92 64.16 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 32' ' ' GLN . 68.8 p-90 -134.17 6.79 3.63 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 119.525 -0.274 . . . . 0.0 111.096 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.4 t -67.93 72.52 0.17 Allowed 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 121.416 0.627 . . . . 0.0 109.706 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 30' ' ' TRP . 55.6 tt0 -161.74 63.17 0.25 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.77 -5.02 22.51 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.09 -1.413 . . . . 0.0 110.716 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 79.4 p -146.2 140.67 15.67 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.33 -13.92 22.95 Favored 'Trans proline' 0 N--CA 1.509 2.44 0 C-N-CA 122.071 1.847 . . . . 0.0 112.372 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -83.97 14.07 4.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.676 0.274 . . . . 0.0 110.598 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -147.71 143.99 27.99 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -130.95 163.01 28.46 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 t -127.93 87.35 55.92 Favored Pre-proline 0 N--CA 1.477 0.914 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.89 -7.83 14.42 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.816 1.678 . . . . 0.0 111.496 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.79 151.37 4.19 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.0 156.05 5.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.432 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -148.11 154.05 39.68 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.86 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -163.58 135.27 4.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.591 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -129.0 101.15 5.93 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tp -69.27 99.39 1.16 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -166.91 138.18 3.28 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.85 137.1 58.15 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.694 0.283 . . . . 0.0 110.436 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.96 2.14 60.99 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.2 169.57 38.21 Favored Glycine 0 N--CA 1.47 0.902 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 t -130.2 165.39 22.47 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.095 0.474 . . . . 0.0 110.203 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -140.5 162.15 36.03 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.53 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.3 m -150.45 134.91 17.25 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.8 p -131.39 119.17 21.28 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 m -88.98 118.19 28.53 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.4 mtp -134.4 125.91 28.49 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.87 146.74 33.24 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.279 0.561 . . . . 0.0 110.398 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.18 148.94 43.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.604 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -56.52 -39.67 73.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.817 0.341 . . . . 0.0 110.451 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -75.14 -10.49 59.52 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.876 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.29 10.82 70.41 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.2 t -62.72 -41.97 99.42 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.008 -0.113 . . . . 0.0 111.057 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.1 tpt -120.2 143.18 48.39 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.6 t -143.53 139.41 29.76 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.454 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 58.5 t80 -160.0 160.54 33.43 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.454 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 73.8 m-20 -138.03 128.34 26.14 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.5 134.08 38.76 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.38 156.13 26.75 Favored Glycine 0 N--CA 1.465 0.614 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.6 -172.14 40.98 Favored Glycine 0 CA--C 1.517 0.177 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.03 140.8 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 122.593 0.357 . . . . 0.0 110.301 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -79.24 121.69 25.38 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.06 -39.09 63.73 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.226 0.536 . . . . 0.0 109.757 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -166.16 147.75 6.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.218 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.7 t -137.39 135.26 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -140.74 119.63 12.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.7 m -50.99 118.61 3.29 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.7 m120 52.89 72.17 0.44 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.915 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -168.15 -77.02 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.256 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.0 tp -150.99 140.6 21.65 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.349 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.7 mt -132.09 132.09 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.14 155.15 36.2 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -155.81 155.1 32.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.4 m -98.64 128.69 45.02 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 88.3 mt -92.06 150.48 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.95 -41.44 68.05 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -60.71 -12.14 9.57 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.727 0.298 . . . . 0.0 110.477 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.49 -3.56 81.81 Favored Glycine 0 N--CA 1.468 0.822 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -65.88 138.42 57.85 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -98.37 142.69 29.69 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.2 t -143.46 136.66 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -136.24 138.77 42.16 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.1 mt -129.94 114.68 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.0 p -107.91 132.58 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -103.83 117.52 34.53 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.5 m -109.17 152.08 25.61 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -145.85 143.08 29.39 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 65.2 p -144.03 105.09 4.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.842 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.96 -93.92 0.2 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 21.3 p-10 -132.06 32.7 3.99 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.607 0.363 . . . . 0.0 110.984 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.3 m -134.72 126.64 29.43 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.6 m -108.26 124.97 51.12 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -117.18 121.24 40.68 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.8 mt -98.03 124.48 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.88 130.66 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -142.5 144.22 32.89 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 56.4 m -123.33 148.62 45.82 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -128.61 153.38 47.32 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -124.3 78.4 60.81 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.66 177.02 9.22 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 121.977 1.784 . . . . 0.0 111.775 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -72.07 152.73 42.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.46 0.647 . . . . 0.0 110.465 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -66.83 -42.73 85.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.339 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 58.3 p -64.43 -40.59 96.04 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.565 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -61.32 144.91 91.25 Favored Pre-proline 0 CA--C 1.551 0.996 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.795 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.57 114.44 4.01 Favored 'Trans proline' 0 N--CA 1.505 2.198 0 C-N-CA 122.098 1.866 . . . . 0.0 111.786 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.66 HH21 HD22 ' A' ' 2' ' ' ASN . 79.0 mtt85 -64.37 -42.16 96.34 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.493 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -53.05 -44.56 67.52 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.47 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.4 tp -63.29 -45.44 91.43 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.955 0.407 . . . . 0.0 110.72 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -63.9 -53.25 53.33 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.227 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -55.04 -41.79 71.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.997 0.427 . . . . 0.0 110.358 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.1 t -61.24 -43.36 99.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.352 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.79 -51.7 57.03 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -65.23 -42.96 92.89 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.169 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.85 -38.9 92.79 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.56 -54.16 49.16 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.9 tt -67.39 -37.54 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.312 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.2 mt -61.52 -41.62 97.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.766 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 128' ' ' SER . 25.2 p30 -67.48 -31.68 71.99 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.16 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.415 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 96.2 p -76.79 -29.16 55.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.936 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -54.43 -50.72 66.97 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -66.98 -36.07 81.38 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.841 0.353 . . . . 0.0 110.594 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.3 t -60.17 -41.25 92.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.766 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -60.56 -49.19 78.55 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.039 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.9 p -65.84 -37.7 86.9 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.373 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -66.64 -32.68 74.16 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.425 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -60.46 -35.09 75.03 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.474 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -62.41 -41.68 98.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.672 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.9 mp -76.75 142.65 40.34 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -64.52 142.78 58.3 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.33 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -64.5 -38.39 90.84 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.426 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -64.22 141.43 58.77 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.346 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.5 ' ND1' ' ND1' ' A' ' 144' ' ' HIS . 17.1 p80 -60.99 100.63 0.12 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.46 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -73.26 -3.76 28.88 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.401 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -59.16 -47.68 84.39 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.652 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.5 ' ND1' ' ND1' ' A' ' 141' ' ' HIS . 76.0 m80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.007 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.572 ' H1 ' HH12 ' A' ' 115' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -82.42 25.92 0.59 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 1' ' ' GLY . 16.6 ptpt -125.83 52.89 1.63 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.111 0.564 . . . . 0.0 110.269 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.3 mm -51.77 136.18 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.5 m -135.73 128.9 31.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.988 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.96 149.83 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -148.91 158.29 44.06 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.664 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.43 158.9 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.503 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -122.45 124.71 44.25 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.3 p -128.42 141.8 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 122.542 0.337 . . . . 0.0 110.769 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -87.7 87.1 7.28 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.152 0.501 . . . . 0.0 110.078 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.41 147.05 4.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.403 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.16 137.67 58.07 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.242 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.6 tt -52.8 -32.24 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.248 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -59.43 -42.73 92.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.73 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -71.03 -44.47 65.75 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.076 0.465 . . . . 0.0 110.487 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.57 -43.11 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.409 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -58.72 -49.93 75.77 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.8 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -67.65 -45.82 74.22 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.575 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -63.18 -44.66 94.81 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.096 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -67.35 -21.32 65.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.649 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -101.44 -23.96 14.25 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.95 0.5 . . . . 0.0 111.797 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -62.5 117.98 36.41 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 118.743 -0.646 . . . . 0.0 109.284 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.5 -37.16 7.73 Favored 'Trans proline' 0 N--CA 1.504 2.141 0 CA-C-N 121.081 1.422 . . . . 0.0 112.214 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.13 -30.71 66.53 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.927 0.394 . . . . 0.0 111.111 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -79.96 -36.51 36.04 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.384 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 31' ' ' CYS . 96.8 mt -63.39 -42.98 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 122.087 -0.383 . . . . 0.0 110.598 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 17.2 ptp -60.09 -14.87 18.91 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.262 -0.274 . . . . 0.0 111.163 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -79.47 -30.57 42.17 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 122.133 -0.354 . . . . 0.0 110.779 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -133.89 20.57 3.82 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.538 ' C ' ' H ' ' A' ' 33' ' ' ALA . 42.9 t -57.35 134.22 55.82 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.64 -0.663 . . . . 0.0 111.219 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 70.59 -35.56 0.33 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.665 0.603 . . . . 0.0 110.283 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.538 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 55.64 33.42 21.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.189 0.518 . . . . 0.0 110.64 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.9 t -124.5 114.12 27.3 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.24 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.79 -22.1 28.23 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 121.573 1.515 . . . . 0.0 112.184 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -79.91 13.37 2.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.879 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -150.11 159.0 44.75 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.027 0.441 . . . . 0.0 110.254 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -140.0 163.3 33.05 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.387 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.1 p -126.78 92.52 44.54 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 123.559 0.744 . . . . 0.0 109.464 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.2 -12.65 23.34 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 121.302 1.335 . . . . 0.0 111.976 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.57 154.72 5.7 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.983 0.42 . . . . 0.0 110.073 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.81 144.61 13.52 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.904 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -139.86 153.59 47.07 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -159.03 103.37 1.67 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.897 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -93.49 85.83 5.05 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 tp -65.53 92.74 0.14 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -170.21 147.3 3.1 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.916 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.52 136.55 58.06 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.34 -1.77 18.16 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -73.59 155.54 50.02 Favored Glycine 0 N--CA 1.467 0.716 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.9 m -115.69 152.8 32.51 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.92 0.488 . . . . 0.0 109.966 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -136.68 160.55 38.5 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.29 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.0 m -150.99 115.98 5.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 43.5 m -109.02 113.09 25.66 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 m -94.3 122.07 36.46 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 13.4 ptp -141.82 141.91 33.15 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.81 149.83 33.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.98 0.419 . . . . 0.0 110.369 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.8 148.45 51.23 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -54.88 -38.45 67.55 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.815 0.341 . . . . 0.0 110.972 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -79.45 -7.78 58.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.915 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.87 22.09 61.85 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.9 p -82.26 -10.47 59.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.459 0.171 . . . . 0.0 111.059 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 49.3 ttp -165.78 130.93 2.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.463 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.4 p -145.38 164.12 32.47 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.318 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -155.91 143.02 19.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -108.11 114.7 28.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.178 0.591 . . . . 0.0 110.26 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -94.54 137.56 33.51 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.26 157.9 28.73 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.05 -171.59 41.58 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.8 t -131.58 138.52 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -77.55 121.66 24.2 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -72.64 -38.65 67.64 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -163.58 147.71 10.54 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.772 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.5 p -149.22 137.53 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.155 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -145.17 137.44 25.87 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.2 m -56.45 127.66 32.19 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.849 0.357 . . . . 0.0 111.497 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.6 m120 56.36 63.74 1.9 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.211 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -155.22 -84.1 0.06 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.729 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -164.22 159.28 19.92 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.893 0.377 . . . . 0.0 110.771 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.72 130.77 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -145.42 155.11 42.94 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -158.86 156.11 29.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.986 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.7 m -97.98 133.02 43.02 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.8 mt -97.87 151.3 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.2 -40.45 67.41 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -60.98 -15.71 34.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.913 0.387 . . . . 0.0 110.118 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.27 -0.2 65.96 Favored Glycine 0 N--CA 1.469 0.874 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.65 136.52 45.68 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -99.64 152.37 20.14 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.9 t -140.59 137.11 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -132.79 129.01 38.02 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.5 mt -124.44 112.51 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.9 t -109.98 128.72 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -100.4 127.01 46.83 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.1 p -132.97 153.21 51.66 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -154.0 166.01 34.35 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.847 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 t -136.96 -11.2 1.74 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.883 0.373 . . . . 0.0 110.192 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.21 -127.51 1.29 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.2 p-10 -75.03 6.88 3.69 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 122.988 -0.124 . . . . 0.0 110.749 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 53.1 m -124.59 129.73 51.12 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.0 m -106.91 135.86 47.76 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -110.83 111.15 22.11 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.7 mt -92.35 122.65 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.28 126.84 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -143.01 143.49 31.92 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.236 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.2 m -129.15 146.21 51.14 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -117.51 166.09 12.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.127 0.571 . . . . 0.0 109.606 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -128.28 78.57 75.38 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.796 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.42 163.97 33.44 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 121.708 1.605 . . . . 0.0 112.121 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -69.17 174.13 4.95 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.847 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -84.37 -50.79 7.49 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.65 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.3 p -63.28 -41.85 99.04 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.724 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.63 HD21 ' H ' ' A' ' 113' ' ' ASN . 0.7 OUTLIER -59.2 146.72 77.41 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 119.552 -0.261 . . . . 0.0 110.371 -179.069 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.05 105.39 1.82 Allowed 'Trans proline' 0 N--CA 1.504 2.104 0 C-N-CA 121.799 1.666 . . . . 0.0 111.299 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.572 HH12 ' H1 ' ' A' ' 1' ' ' GLY . 88.4 mtm180 -65.03 -41.97 94.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.177 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.9 -38.06 84.39 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.274 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.87 -50.93 71.44 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.649 0.262 . . . . 0.0 110.916 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -72.74 -27.97 62.35 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.452 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -54.68 -45.4 73.92 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.897 0.38 . . . . 0.0 110.36 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.5 t -68.17 -33.03 73.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.651 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.3 -51.19 60.32 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -62.44 -38.4 89.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.905 0.383 . . . . 0.0 110.508 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -70.51 -38.29 74.26 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.97 -52.46 65.42 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.096 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.0 tt -60.92 -37.85 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.02 -46.91 79.38 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.427 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -77.87 -32.08 51.74 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 122.193 -0.317 . . . . 0.0 111.095 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.9 m -60.12 -40.73 90.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.732 0.301 . . . . 0.0 110.455 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -58.28 -44.38 88.43 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.511 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.5 -44.7 96.6 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.284 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 48.8 m -61.0 -49.67 76.48 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.516 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -62.87 -47.72 82.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.818 0.342 . . . . 0.0 110.477 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.408 ' O ' ' ND2' ' A' ' 136' ' ' ASN . 27.4 m -61.62 -45.05 95.75 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.068 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -70.67 -37.57 73.67 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -85.5 8.9 17.42 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.707 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.586 ' N ' HD21 ' A' ' 136' ' ' ASN . 0.1 OUTLIER -58.97 -36.5 74.95 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.276 -179.005 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.507 ' H ' ' ND2' ' A' ' 136' ' ' ASN . 59.8 tp -61.3 -47.93 83.71 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.78 0.324 . . . . 0.0 110.131 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -85.32 162.17 19.2 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.898 0.38 . . . . 0.0 110.04 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -159.12 153.8 24.51 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.766 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.407 ' ND1' ' O ' ' A' ' 144' ' ' HIS . 71.7 m80 -152.88 160.7 43.08 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -64.5 -42.48 95.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.485 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -169.8 -7.5 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.38 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -64.11 -38.58 91.58 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.061 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.407 ' O ' ' ND1' ' A' ' 140' ' ' HIS . 60.5 t-80 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.905 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.582 ' H3 ' ' NH1' ' A' ' 115' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -63.03 -42.76 99.84 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.949 0.404 . . . . 0.0 110.183 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -72.61 51.68 0.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.294 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.6 mt -50.37 140.23 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.8 m -134.12 135.26 43.06 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.5 m -132.49 160.72 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -138.44 158.72 43.72 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.957 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 t -133.48 126.43 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.9 p -88.76 109.05 19.84 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.0 t -126.36 127.02 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -97.47 89.13 4.59 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.09 154.75 5.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.032 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.62 132.23 50.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.18 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.4 tt -54.08 -34.74 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.611 0.244 . . . . 0.0 110.929 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.93 -40.31 92.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.083 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -70.18 -48.09 58.78 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.803 0.335 . . . . 0.0 110.786 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.0 -41.7 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.356 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 42.9 t-105 -50.66 -39.87 51.93 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.551 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -65.68 -48.35 72.36 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.311 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -68.59 -43.0 77.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.662 0.268 . . . . 0.0 110.971 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -65.57 -19.39 65.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.612 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.566 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.8 OUTLIER -102.57 -22.82 13.94 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.282 0.633 . . . . 0.0 110.583 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -63.19 120.63 63.36 Favored Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.94 -40.98 4.44 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 CA-C-N 120.997 1.392 . . . . 0.0 112.086 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.96 -30.31 63.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.697 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.519 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 81.1 t60 -78.07 -45.17 24.27 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.378 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 31' ' ' CYS . 95.7 mt -59.73 -50.86 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 121.946 -0.471 . . . . 0.0 111.064 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.6 ptm -57.64 -15.49 7.78 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -79.03 -33.27 44.98 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.519 ' HE1' ' CD2' ' A' ' 26' ' ' HIS . 58.1 p-90 -133.69 20.8 3.89 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.661 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.594 ' C ' ' H ' ' A' ' 33' ' ' ALA . 44.1 t -55.12 129.32 37.64 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.764 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 68.63 -19.33 0.16 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.116 0.484 . . . . 0.0 110.496 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.594 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.64 35.55 23.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.482 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -111.25 97.78 36.89 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.064 0.546 . . . . 0.0 110.087 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.33 -23.21 22.97 Favored 'Trans proline' 0 N--CA 1.505 2.175 0 C-N-CA 122.378 2.052 . . . . 0.0 112.576 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -68.76 -24.67 64.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.536 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -104.76 163.96 12.12 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -141.22 162.33 35.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.21 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -129.81 89.86 44.9 Favored Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -73.95 -9.04 21.94 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 121.694 1.596 . . . . 0.0 111.873 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.1 152.58 6.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.003 0.43 . . . . 0.0 110.105 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.14 145.89 13.75 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.084 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -133.72 150.3 51.5 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -159.86 125.58 4.17 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.698 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -133.25 94.78 3.4 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.7 mt -66.83 97.37 0.47 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.139 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -162.56 135.96 6.05 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.69 133.92 56.54 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.673 0.273 . . . . 0.0 110.307 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.06 5.05 69.58 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.21 165.73 39.69 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.8 p -131.09 161.56 31.8 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.442 ' CD1' ' CE2' ' A' ' 71' ' ' TYR . 30.6 p90 -154.75 170.02 22.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.068 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.8 m -153.69 139.34 17.89 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.5 m -121.33 120.64 35.67 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.3 m -92.87 123.55 36.22 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.0 ptm -142.76 138.6 30.58 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.18 145.33 26.21 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.044 0.45 . . . . 0.0 110.326 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.48 149.8 28.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.765 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -51.46 -39.93 58.45 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.866 0.365 . . . . 0.0 110.775 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -80.21 -9.32 59.72 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.139 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.3 18.21 67.09 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.0 t -62.19 -40.51 96.29 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.659 0.266 . . . . 0.0 110.922 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 44.3 ttp -142.31 136.78 30.05 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.226 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.8 p -145.74 158.86 43.82 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -159.13 139.11 11.94 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -88.56 111.01 21.37 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -94.53 131.01 40.71 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.69 175.11 42.09 Favored Glycine 0 C--O 1.227 -0.335 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.45 -174.01 40.88 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.12 129.39 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.442 ' CE2' ' CD1' ' A' ' 52' ' ' PHE . 74.6 m-85 -72.45 113.48 9.53 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -73.4 -39.05 65.38 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.219 0.533 . . . . 0.0 109.767 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -166.89 146.21 5.4 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.524 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.6 131.03 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -140.03 128.32 22.57 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.5 p -61.51 134.88 57.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.249 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.2 m120 55.98 55.36 6.99 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.673 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -155.1 -82.52 0.07 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.645 0.259 . . . . 0.0 110.35 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -163.63 160.12 22.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.355 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.7 mt -133.7 134.99 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.06 156.69 42.92 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -161.16 156.26 24.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.5 p -103.5 133.06 49.17 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 2.6 mp -93.44 160.37 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.25 -44.95 64.93 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -62.8 -12.8 26.84 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.831 0.315 . . . . 0.0 110.36 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.34 9.56 66.93 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -58.94 155.08 13.98 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -114.57 127.73 55.94 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.7 t -136.93 132.02 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -134.98 133.79 39.85 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 77.1 mt -123.72 114.17 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 43.2 t -111.78 129.54 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -98.92 119.58 37.94 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 39.7 m -120.44 148.77 43.37 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -154.07 158.23 40.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.0 p -135.86 23.33 3.34 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.249 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 100' ' ' THR . . . 88.34 128.31 2.97 Favored Glycine 0 N--CA 1.47 0.96 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 58.07 6.06 0.46 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.824 0.345 . . . . 0.0 111.061 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.442 ' H ' ' C ' ' A' ' 98' ' ' GLY . 28.2 m -148.23 137.56 22.08 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.2 m -130.99 125.24 32.8 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -110.32 119.35 38.95 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.4 mt -95.58 120.55 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 36.6 t -105.15 132.07 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -134.0 114.37 13.15 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.7 t -94.52 149.63 21.05 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -144.36 140.9 29.36 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 108' ' ' ASP . 16.4 p-10 -114.72 90.37 21.85 Favored Pre-proline 0 N--CA 1.478 0.968 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.76 163.85 32.98 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 121.56 1.507 . . . . 0.0 111.638 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -71.27 165.67 23.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.167 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -83.05 -28.54 29.51 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.966 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.9 p -62.74 -44.67 95.6 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.063 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -86.48 145.22 39.18 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -70.22 138.73 37.02 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.534 1.489 . . . . 0.0 111.813 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.582 ' NH1' ' H3 ' ' A' ' 1' ' ' GLY . 87.6 mtm180 -66.19 -38.94 89.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.128 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -50.07 -45.38 52.4 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.389 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.34 -45.94 85.62 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.899 0.38 . . . . 0.0 110.536 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -64.34 -50.38 67.98 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.725 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.54 -50.64 59.63 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.871 0.367 . . . . 0.0 110.363 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.5 m -62.33 -38.55 89.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.601 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.44 -52.33 49.9 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.943 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -62.45 -39.44 93.37 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.772 0.286 . . . . 0.0 110.483 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.6 ' NE2' HD22 ' A' ' 127' ' ' ASN . 0.0 OUTLIER -74.07 -35.08 64.23 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.625 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.14 -50.54 73.64 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.45 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.4 pt -63.64 -34.53 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.818 0.342 . . . . 0.0 110.798 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 36.0 mt -64.67 -37.07 86.34 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.029 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.6 HD22 ' NE2' ' A' ' 123' ' ' GLN . 80.0 m-20 -61.24 -40.63 94.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.751 0.31 . . . . 0.0 110.461 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.7 t -62.69 -40.3 96.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.549 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -58.17 -44.63 88.08 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.443 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -62.11 -40.69 96.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.084 0.468 . . . . 0.0 110.392 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 42.1 m -69.04 -34.93 75.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.529 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -60.06 -52.28 66.06 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.019 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.2 t -64.57 -33.72 76.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.445 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -69.85 -46.73 64.92 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.772 0.32 . . . . 0.0 110.387 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -65.84 -26.45 67.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.935 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -62.84 -43.08 99.76 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.442 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.6 mt -75.83 139.22 41.62 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.983 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -71.5 153.39 42.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.053 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -60.58 -87.35 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.617 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 73.4 m80 48.17 -106.35 0.17 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.524 0.202 . . . . 0.0 110.765 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 48.3 m170 49.74 -97.29 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.534 0.206 . . . . 0.0 110.983 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -70.34 136.97 50.21 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -70.04 137.98 51.75 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.585 -179.795 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 42.19 -160.1 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.791 0.436 . . . . 0.0 111.199 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -75.47 -69.68 0.47 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 109.973 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 81.3 mt -142.28 133.01 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.8 m -137.77 133.43 34.05 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 m -138.7 153.35 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.11 163.94 36.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.049 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.9 m -145.83 157.52 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -102.73 126.73 49.95 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.19 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.06 129.5 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -98.59 89.2 4.31 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.14 155.25 6.43 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.8 135.91 57.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.209 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.6 tp -52.88 -36.49 23.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 121.1 0.476 . . . . 0.0 111.417 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -68.87 -33.62 74.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.167 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -71.42 -51.73 22.36 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.603 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 p -62.51 -36.3 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.676 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.473 ' CE2' ' ND2' ' A' ' 22' ' ' ASN . 68.4 t90 -54.47 -44.0 72.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.979 0.418 . . . . 0.0 110.906 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -69.39 -45.94 68.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.712 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -65.32 -40.56 93.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.982 0.42 . . . . 0.0 110.96 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -73.54 -17.22 61.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.707 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.473 ' ND2' ' CE2' ' A' ' 18' ' ' TRP . 90.4 m-20 -109.41 -20.39 12.93 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.182 0.593 . . . . 0.0 110.72 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -64.41 138.71 97.52 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.8 -43.48 0.43 Allowed 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 121.763 1.642 . . . . 0.0 112.43 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.25 -40.56 96.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 110.909 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -66.69 -46.26 76.17 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.641 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 31' ' ' CYS . 89.2 mt -62.8 -48.51 87.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.431 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 43.2 ttp -60.38 -23.27 64.18 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -65.58 -31.78 73.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.437 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -135.67 14.17 3.42 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.444 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.466 ' C ' ' H ' ' A' ' 33' ' ' ALA . 12.0 t -55.73 141.05 39.68 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 122.1 -0.375 . . . . 0.0 110.0 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 72.07 -46.79 0.65 Allowed 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.233 0.958 . . . . 0.0 109.227 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.466 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.38 40.58 31.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.307 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.5 m -124.32 139.12 32.17 Favored Pre-proline 0 N--CA 1.481 1.121 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.973 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.422 ' O ' ' NZ ' ' A' ' 59' ' ' LYS . 93.6 Cg_endo -74.42 -30.05 8.65 Favored 'Trans proline' 0 N--CA 1.506 2.253 0 C-N-CA 121.941 1.761 . . . . 0.0 112.51 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.94 6.47 7.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.725 0.298 . . . . 0.0 110.692 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -147.32 158.39 43.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.182 0.515 . . . . 0.0 109.717 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.4 ' CE1' ' O ' ' A' ' 57' ' ' ALA . 14.3 p-80 -146.59 155.21 42.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.229 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.85 89.63 34.25 Favored Pre-proline 0 N--CA 1.476 0.828 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.63 -1.78 11.89 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.167 1.912 . . . . 0.0 111.587 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.71 147.91 6.13 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.025 0.441 . . . . 0.0 110.031 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.68 141.82 18.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.755 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -134.95 137.96 43.6 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -163.17 136.43 5.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.62 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -130.46 99.33 4.96 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 tp -65.43 95.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.877 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -169.54 141.41 2.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.17 135.93 57.79 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.289 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.08 1.7 60.37 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.77 158.43 36.96 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.408 ' HG1' ' N ' ' A' ' 52' ' ' PHE . 2.2 t -118.27 165.26 14.05 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.142 0.577 . . . . 0.0 109.851 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.408 ' N ' ' HG1' ' A' ' 51' ' ' THR . 54.8 p90 -144.8 159.77 42.33 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.157 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.2 m -149.36 123.96 9.77 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.8 p -120.89 123.33 42.25 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.7 m -90.36 117.4 29.05 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 60.7 mtt -129.87 104.55 7.44 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.4 ' O ' ' CE1' ' A' ' 38' ' ' HIS . . . -126.82 156.42 41.32 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.02 148.83 37.76 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.422 ' NZ ' ' O ' ' A' ' 35' ' ' PRO . 28.2 mtmm -58.73 -39.54 81.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.77 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -70.7 -9.58 57.51 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.72 9.84 63.0 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.2 t -62.99 -39.36 94.5 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 110.887 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 69.5 mmm -122.63 148.97 44.63 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.882 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.3 p -146.81 128.13 14.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.168 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -159.9 155.37 25.47 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -139.71 142.88 36.84 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.274 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.43 143.2 28.4 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.45 152.02 23.7 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.91 -172.44 41.52 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.48 142.15 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 122.974 0.51 . . . . 0.0 110.175 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -79.01 120.53 23.72 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.51 -42.77 58.33 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -168.57 148.31 4.46 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.838 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.57 136.56 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -136.03 124.11 22.95 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 m -59.2 130.65 48.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.162 -178.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.2 p30 40.98 57.67 2.7 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -157.77 -77.47 0.08 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 110.449 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.2 tp -149.68 133.88 17.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.738 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.5 mt -133.02 133.14 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -153.93 160.38 42.09 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -160.2 156.78 27.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.9 m -101.92 127.65 48.66 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.7 mt -90.54 153.81 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.74 -41.96 67.23 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -60.26 -10.58 4.78 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.788 0.328 . . . . 0.0 110.17 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.0 8.81 86.12 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.409 ' NH2' ' OE2' ' A' ' 110' ' ' GLU . 89.6 mtt-85 -68.82 150.71 47.51 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -101.89 129.29 48.1 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.8 t -139.77 131.03 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -138.94 141.75 38.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.2 mt -118.97 126.93 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.97 126.82 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -99.12 125.84 44.75 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.8 p -133.64 143.5 48.64 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -154.89 156.14 35.6 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.6 t -115.59 -24.11 8.45 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.973 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.1 -112.14 0.37 Allowed Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -76.77 10.78 2.01 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.613 0.244 . . . . 0.0 110.67 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.3 p -126.72 144.92 50.78 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.7 m -125.55 131.3 52.79 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.296 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -116.33 121.83 43.11 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.9 mt -102.51 128.98 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.9 t -119.26 133.56 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -137.94 146.08 42.8 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.0 p -133.33 148.84 51.9 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -143.31 143.14 31.57 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.2 115.83 64.71 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.19 157.42 33.71 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 121.693 1.596 . . . . 0.0 111.399 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.409 ' OE2' ' NH2' ' A' ' 88' ' ' ARG . 70.7 mt-10 -77.6 156.71 30.66 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -80.77 -41.24 23.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.309 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 72.9 p -63.06 -44.75 94.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -85.18 147.7 48.28 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 119.664 -0.208 . . . . 0.0 110.972 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.72 136.73 64.05 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 121.523 1.482 . . . . 0.0 111.859 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -68.35 -42.0 79.9 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.596 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -52.27 -37.11 54.51 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.76 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.3 tp -66.6 -43.29 85.23 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.883 0.373 . . . . 0.0 110.489 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -60.32 -51.76 68.15 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.832 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -53.39 -44.42 68.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.876 0.37 . . . . 0.0 110.145 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.2 m -61.58 -40.94 96.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.255 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.97 -51.96 48.94 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -62.39 -37.72 86.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.015 0.436 . . . . 0.0 110.299 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -72.29 -35.77 68.78 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.256 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.91 -51.14 70.96 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.56 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.6 tt -63.06 -40.13 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 120.791 0.329 . . . . 0.0 110.136 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.2 mt -63.85 -38.86 92.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.4 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -61.99 -38.17 87.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.2 t -57.92 -32.79 68.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.762 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -57.61 -42.36 83.13 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.375 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -61.11 -42.68 98.97 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.369 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 36.5 m -60.98 -39.7 90.6 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.504 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -60.27 -49.08 79.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.61 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.2 p -60.81 -39.53 89.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.818 0.342 . . . . 0.0 110.31 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -66.49 -43.73 84.56 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -63.89 -36.65 84.62 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.494 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -62.97 -38.12 89.85 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.196 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.9 tp -61.06 -42.91 99.37 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.156 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -60.92 -45.04 96.26 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.38 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -74.37 132.43 42.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.815 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -69.02 109.78 4.14 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.021 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.479 ' NE2' ' CE1' ' A' ' 142' ' ' HIS . 22.1 p-80 -72.46 -17.78 61.74 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.822 0.344 . . . . 0.0 110.187 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.479 ' CE1' ' NE2' ' A' ' 141' ' ' HIS . 69.2 m80 -63.69 120.18 11.33 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.132 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -74.91 137.66 41.86 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.08 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.4 p80 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.383 179.863 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -63.68 -38.23 90.35 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.047 0.451 . . . . 0.0 110.702 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -72.12 55.36 0.31 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.919 0.39 . . . . 0.0 110.423 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 82.7 mt -58.94 131.19 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.44 ' HG1' ' N ' ' A' ' 6' ' ' VAL . 3.1 t -137.0 149.73 47.67 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.44 ' N ' ' HG1' ' A' ' 5' ' ' THR . 28.9 m -136.85 158.39 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 161.7 40.31 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.587 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -148.96 143.04 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.886 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.7 m -94.26 119.41 33.01 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.5 t -124.87 128.03 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -95.65 92.47 6.62 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.91 154.52 5.26 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.23 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.89 135.76 57.49 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.339 -0.391 . . . . 0.0 109.956 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.8 tp -50.72 -40.79 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.141 0.496 . . . . 0.0 111.66 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -64.25 -35.27 80.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.551 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -70.54 -46.5 63.48 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.782 0.325 . . . . 0.0 110.424 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.26 -40.39 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.308 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.439 ' NE1' ' OD1' ' A' ' 22' ' ' ASN . 31.8 t-105 -54.53 -40.49 68.71 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.805 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -67.2 -52.8 36.74 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.278 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -64.84 -42.67 94.74 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.845 0.355 . . . . 0.0 110.885 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -64.13 -18.81 64.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.326 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.439 ' OD1' ' NE1' ' A' ' 18' ' ' TRP . 4.1 m120 -110.2 -25.49 10.14 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 122.845 0.458 . . . . 0.0 112.177 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -53.09 110.21 1.88 Allowed Pre-proline 0 CA--C 1.556 1.196 0 CA-C-O 118.837 -0.602 . . . . 0.0 109.765 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.61 -43.05 58.13 Favored 'Trans proline' 0 N--CA 1.506 2.208 0 CA-C-N 120.869 1.346 . . . . 0.0 111.837 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.57 73.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.949 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.502 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 80.6 t60 -74.15 -42.74 59.46 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.417 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.18 -44.74 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.872 -0.517 . . . . 0.0 110.498 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.8 ptm -70.95 -6.42 38.48 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -84.95 -29.59 24.99 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.502 ' HE1' ' CD2' ' A' ' 26' ' ' HIS . 63.3 p-90 -133.78 17.9 3.88 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.593 0.357 . . . . 0.0 110.954 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.621 ' C ' ' H ' ' A' ' 33' ' ' ALA . 32.1 p -45.85 128.95 9.26 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.063 0.392 . . . . 0.0 111.457 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 61.54 -11.02 0.06 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 120.982 0.42 . . . . 0.0 110.523 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.621 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 52.58 32.81 12.3 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.673 0.389 . . . . 0.0 111.24 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.5 t -122.8 135.74 26.07 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.011 0.524 . . . . 0.0 110.568 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.87 -9.96 16.86 Favored 'Trans proline' 0 N--CA 1.506 2.249 0 C-N-CA 122.097 1.865 . . . . 0.0 112.418 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -73.91 -24.74 59.73 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.728 0.299 . . . . 0.0 110.737 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -103.66 155.21 18.74 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.663 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -139.02 164.15 30.51 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.1 t -132.36 94.33 23.32 Favored Pre-proline 0 N--CA 1.477 0.925 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.29 -12.01 25.12 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.343 1.362 . . . . 0.0 111.211 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.8 150.8 4.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.418 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.59 141.74 20.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.227 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -138.0 142.07 40.42 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -163.13 135.55 5.35 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -129.86 104.0 7.13 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.64 93.71 1.27 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.914 0.388 . . . . 0.0 110.111 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -171.41 151.06 2.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.662 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.09 137.95 58.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.661 0.267 . . . . 0.0 110.453 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.31 0.74 47.65 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.85 149.44 44.68 Favored Glycine 0 N--CA 1.464 0.533 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.9 p -110.75 144.01 40.38 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -127.16 152.84 46.81 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.3 m -149.94 116.83 5.92 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.7 m -116.52 115.86 26.55 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.1 m -91.84 116.27 28.76 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 71.3 mtp -117.79 129.43 55.67 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.09 135.12 37.17 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.071 0.462 . . . . 0.0 110.57 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.7 149.92 49.38 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.309 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -55.93 -39.7 72.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.626 0.25 . . . . 0.0 110.463 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -76.38 -10.21 59.22 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.62 17.62 62.66 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.6 p -83.93 -9.97 58.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.617 0.246 . . . . 0.0 110.774 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.7 ttt -152.92 120.86 6.12 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.452 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.2 m -144.25 148.68 35.2 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -158.9 164.55 35.56 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 22.4 p-10 -137.08 123.33 20.56 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.804 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -94.11 145.92 24.34 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.05 153.68 25.12 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.27 -171.68 41.05 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -128.63 135.69 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -71.94 121.85 19.81 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -73.56 -38.44 65.2 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -163.05 145.42 10.29 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.508 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.1 t -137.97 130.5 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -146.88 123.8 11.33 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.6 p -51.71 121.92 7.31 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.211 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 54.28 62.02 2.77 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.28 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -156.04 -84.58 0.06 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.753 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 tp -148.42 136.24 20.81 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.771 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.2 mt -130.32 127.82 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -153.49 165.29 36.3 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -160.8 154.42 22.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.836 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.1 m -89.35 131.09 35.59 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 80.0 mt -102.27 148.82 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.88 -44.05 71.21 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.0 p30 -61.93 -18.69 61.18 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.367 0.584 . . . . 0.0 110.394 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.07 5.19 77.19 Favored Glycine 0 N--CA 1.47 0.954 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 65.6 mmt-85 -63.04 139.38 58.77 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -89.96 128.53 36.26 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.5 t -141.34 125.96 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -136.84 142.92 42.87 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 75.5 mt -119.86 118.94 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.8 t -104.2 124.29 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -96.15 122.43 38.99 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 36.4 m -140.36 146.62 38.65 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -150.74 164.63 35.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.2 t -137.85 23.51 2.85 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.292 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.12 129.65 2.82 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 55.49 12.02 0.7 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.816 0.341 . . . . 0.0 111.037 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.9 m -153.78 140.75 19.27 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.4 m -125.43 130.68 52.33 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.756 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -110.45 117.03 32.49 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.9 mt -106.85 122.21 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.04 139.56 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -144.98 142.76 30.08 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.048 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.4 p -94.23 152.7 18.5 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -151.49 139.74 20.31 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -92.15 138.92 24.21 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.34 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.49 146.3 34.73 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.637 1.558 . . . . 0.0 111.93 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -87.0 153.76 21.3 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -74.01 -39.29 63.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.474 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.0 m -68.51 -46.32 69.91 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.407 ' C ' HD21 ' A' ' 113' ' ' ASN . 0.4 OUTLIER -92.29 133.39 30.06 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-O 118.673 -0.679 . . . . 0.0 110.329 -179.312 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.85 147.45 41.54 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 CA-C-N 120.862 1.344 . . . . 0.0 111.755 178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -68.62 -35.18 76.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.144 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -66.45 -47.21 73.86 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.947 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.23 -52.4 41.47 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -177.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.473 HE21 ' C ' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -58.56 -35.32 72.17 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.888 -179.508 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -57.42 -47.32 82.07 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.84 0.352 . . . . 0.0 110.06 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.0 m -64.04 -33.04 74.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.588 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.61 -50.46 67.53 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -62.45 -39.52 93.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.985 0.422 . . . . 0.0 110.429 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -71.91 -37.57 70.06 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.348 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.35 -50.69 72.75 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.836 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 42.0 pt -65.4 -32.75 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 110.734 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.2 -37.01 82.92 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -62.55 -41.56 98.98 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.08 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.9 p -62.52 -32.4 73.33 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.616 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -59.24 -38.62 80.47 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.579 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.69 -45.54 91.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.436 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 78.6 p -65.12 -39.52 93.18 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 109.961 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -61.57 -44.9 96.18 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.154 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 27.3 m -58.9 -47.03 86.42 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.928 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -66.55 -42.84 86.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -64.58 -34.93 79.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.468 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -62.93 -47.96 80.99 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.733 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.85 142.88 33.2 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 139' ' ' HIS . 93.0 mt-10 53.79 -126.91 2.38 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.726 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.405 ' CG ' ' O ' ' A' ' 138' ' ' GLU . 73.0 m80 -155.4 162.55 40.76 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -60.5 -43.13 97.38 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.359 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -65.39 136.29 56.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.237 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -70.42 143.06 51.94 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.259 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -63.46 142.32 58.44 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.336 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 70.5 m80 . . . . . 0 C--O 1.222 -0.345 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.48 -179.945 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -62.45 -38.63 90.5 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.009 0.433 . . . . 0.0 110.372 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -72.49 51.13 0.25 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.057 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.3 mt -54.65 139.99 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 t -129.27 137.43 51.05 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.682 0.614 . . . . 0.0 109.718 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.61 158.08 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.41 158.0 43.8 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.558 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.9 p -146.14 144.78 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.673 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.9 m -97.58 120.79 38.6 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.94 127.5 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -91.7 93.96 9.15 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.8 151.52 3.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.09 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.43 140.44 58.87 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.664 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.7 tp -51.6 -37.22 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.169 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -68.94 -34.32 75.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.435 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -69.3 -50.58 45.44 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.903 0.382 . . . . 0.0 111.218 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -64.3 -36.19 76.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.62 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -58.29 -49.84 75.71 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.614 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -67.64 -45.83 74.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.641 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.45 ' CD2' ' ND1' ' A' ' 26' ' ' HIS . 56.2 t80 -63.88 -44.23 93.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.049 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -70.82 -19.65 62.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.593 ' N ' HD21 ' A' ' 22' ' ' ASN . 0.7 OUTLIER -103.05 -23.82 13.66 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.845 0.458 . . . . 0.0 111.437 -179.24 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -62.94 135.17 95.99 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.1 -40.67 0.81 Allowed 'Trans proline' 0 N--CA 1.504 2.142 0 C-N-CA 121.681 1.588 . . . . 0.0 111.745 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.83 -33.0 68.16 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.051 0.453 . . . . 0.0 110.78 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.45 ' ND1' ' CD2' ' A' ' 20' ' ' TYR . 35.5 m170 -76.4 -42.36 44.59 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.573 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.13 -44.93 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 122.161 -0.337 . . . . 0.0 110.804 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.6 ptm -68.14 -10.64 55.66 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -79.7 -28.6 40.63 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.333 -0.23 . . . . 0.0 110.395 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -137.48 21.61 2.93 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.204 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.567 ' C ' ' H ' ' A' ' 33' ' ' ALA . 29.3 t -55.97 133.17 51.44 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.639 -0.663 . . . . 0.0 110.189 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 69.35 -32.08 0.22 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.108 0.563 . . . . 0.0 110.423 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.567 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 55.66 34.61 23.6 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.327 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.8 p -128.51 138.66 33.54 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.087 0.555 . . . . 0.0 110.033 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.48 -12.53 18.66 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.746 1.63 . . . . 0.0 112.239 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -76.25 -24.61 54.52 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -115.41 140.2 49.34 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.929 0.492 . . . . 0.0 110.545 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -117.33 163.79 15.81 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.251 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -131.84 87.62 44.47 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.079 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.75 -8.2 14.59 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.053 1.835 . . . . 0.0 111.559 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.44 153.23 5.11 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.894 0.378 . . . . 0.0 110.055 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.99 152.88 5.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.961 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -141.28 155.52 45.98 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -159.25 103.05 1.61 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.019 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -95.59 86.98 4.58 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 tp -66.4 93.25 0.22 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.357 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -169.93 145.19 2.89 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.61 135.93 56.74 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.425 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.16 -1.05 35.76 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.96 162.28 52.69 Favored Glycine 0 N--CA 1.468 0.81 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.4 p -125.24 157.22 37.1 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.672 0.389 . . . . 0.0 110.262 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -138.16 157.03 47.11 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.318 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.0 m -146.93 116.01 6.92 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.9 m -106.99 112.62 25.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 m -92.88 120.08 32.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.7 ptm -143.14 142.12 31.39 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.79 152.73 40.78 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.028 0.442 . . . . 0.0 110.748 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.08 148.71 50.58 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.636 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -57.89 -39.32 77.58 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.591 0.234 . . . . 0.0 110.523 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -78.05 -6.06 53.41 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.78 17.51 54.57 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.1 p -66.37 -25.52 66.83 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.769 0.319 . . . . 0.0 110.389 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.2 ttt -149.09 145.34 27.18 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.916 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.7 t -142.7 144.85 32.89 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.737 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.408 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 71.1 t80 -159.35 162.53 35.91 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.408 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 30.3 p-10 -138.04 130.69 29.55 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.098 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -94.54 137.61 33.44 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.27 154.96 25.85 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.71 -176.03 40.41 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.4 t -126.24 133.26 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -75.44 115.49 15.15 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -73.85 -44.84 54.31 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.184 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -153.23 145.87 24.23 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 p -148.1 137.3 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -143.06 132.37 23.34 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.9 m -56.77 128.62 37.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.732 0.301 . . . . 0.0 111.453 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 54.88 69.38 0.74 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.767 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -165.84 -80.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -160.35 159.99 31.85 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.976 0.417 . . . . 0.0 110.795 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.9 mt -134.74 135.63 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.86 155.55 41.06 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -159.09 159.65 34.82 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 49.6 m -102.25 129.89 48.79 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.5 tt -94.57 167.1 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.91 -38.11 94.86 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -63.28 -16.77 61.34 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 117.184 0.492 . . . . 0.0 109.962 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.21 11.6 78.05 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -77.86 148.36 34.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -83.92 153.96 23.66 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.0 t -144.99 130.5 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -137.21 122.01 18.74 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.9 mt -122.46 113.93 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.4 p -118.82 131.75 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-O 121.279 0.561 . . . . 0.0 110.034 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -97.13 109.21 22.01 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 61.3 m -98.22 122.95 42.01 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -101.8 146.73 27.38 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.3 m -146.62 99.32 3.19 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.411 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.89 -95.43 0.04 OUTLIER Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -128.56 48.4 2.32 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.006 0.431 . . . . 0.0 110.587 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.6 m -161.35 119.22 2.33 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.0 m -95.27 141.09 29.26 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -127.45 129.48 47.57 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.2 mt -103.07 125.53 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.7 t -122.68 127.83 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -142.92 144.62 32.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.23 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.8 t -136.11 143.11 44.38 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.079 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -127.57 169.19 13.99 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.671 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -132.07 79.39 67.0 Favored Pre-proline 0 N--CA 1.473 0.681 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.722 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -59.03 168.23 4.77 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.141 1.894 . . . . 0.0 111.697 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.95 168.9 2.17 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.113 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -81.78 -44.7 16.63 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.781 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.7 t -65.32 -36.15 83.18 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.251 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -67.31 146.01 98.71 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 119.573 -0.251 . . . . 0.0 110.604 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.23 120.81 7.02 Favored 'Trans proline' 0 N--CA 1.504 2.092 0 C-N-CA 121.758 1.639 . . . . 0.0 111.767 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 81.7 mtm-85 -65.4 -39.67 92.48 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.763 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.84 -44.24 73.73 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.607 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.5 tp -60.74 -43.52 97.83 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.147 0.499 . . . . 0.0 110.655 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -64.37 -43.05 95.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.425 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -54.13 -44.43 71.35 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.805 0.336 . . . . 0.0 110.299 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 78.8 p -68.28 -35.9 78.56 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.83 -51.99 51.6 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -64.22 -37.08 86.21 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.816 0.341 . . . . 0.0 110.421 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -72.4 -37.43 68.7 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.461 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.99 67.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.909 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.5 tt -60.89 -36.96 75.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.8 mt -66.19 -49.1 68.46 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.467 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -75.78 -33.71 60.19 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.664 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.0 m -60.54 -40.34 91.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.32 . . . . 0.0 110.399 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -56.84 -42.65 80.03 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.512 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -60.68 -39.0 86.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.671 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 29.0 m -58.34 -46.65 85.81 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.988 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -65.45 -37.88 88.18 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.374 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 97.8 m -60.46 -48.19 82.83 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.8 0.333 . . . . 0.0 110.852 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -70.56 -41.68 72.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.385 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -66.41 -24.99 66.55 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.995 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -61.04 -41.14 96.03 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.422 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.2 mt 52.06 101.4 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.773 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -160.58 129.28 4.74 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -69.62 144.28 53.02 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -64.87 142.45 58.43 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.289 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -166.82 104.0 0.57 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.048 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -157.71 165.7 34.73 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . 0.404 ' O ' ' CG ' ' A' ' 144' ' ' HIS . 96.5 m-70 -152.58 -36.01 0.12 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.185 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.404 ' CG ' ' O ' ' A' ' 143' ' ' HIS . 33.5 p80 . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.386 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.535 ' H ' ' NH1' ' A' ' 115' ' ' ARG . 72.6 m-20 54.74 35.2 23.43 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.368 0.128 . . . . 0.0 110.918 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.41 ' CG ' ' HG ' ' A' ' 106' ' ' SER . 81.8 tttt -126.28 55.92 1.47 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.811 0.445 . . . . 0.0 110.173 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 79.5 mt -46.14 121.28 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 m -112.89 130.7 56.01 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 m -134.48 156.59 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.406 ' CD ' ' N ' ' A' ' 7' ' ' GLU . 1.3 pm0 -148.3 161.29 41.82 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.14 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -145.05 143.84 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.1 m -91.17 117.29 29.5 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.8 t -124.65 128.36 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -100.16 88.57 3.75 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.74 153.59 5.01 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.048 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.12 133.28 52.67 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 20.1 tt -52.25 -37.53 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.776 0.322 . . . . 0.0 111.733 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -58.96 -35.58 73.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.356 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -74.92 -46.07 38.29 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.022 0.439 . . . . 0.0 110.442 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.09 -43.28 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.189 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 28.0 t-105 -54.86 -46.09 74.65 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.84 0.352 . . . . 0.0 110.943 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.78 -45.85 77.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.335 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -65.19 -43.75 90.61 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.894 0.378 . . . . 0.0 111.166 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -69.5 -15.96 63.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.561 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -109.52 -24.64 10.89 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.274 0.63 . . . . 0.0 111.298 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -65.09 117.23 37.43 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.499 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.97 -34.59 10.33 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 CA-C-N 121.033 1.405 . . . . 0.0 112.005 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -34.22 70.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.002 0.429 . . . . 0.0 110.575 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -81.17 -40.89 23.21 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.405 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.9 -45.4 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 122.069 -0.394 . . . . 0.0 111.088 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.7 ptm -59.32 -12.85 6.35 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.335 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -81.32 -39.71 24.72 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -120.22 20.76 11.95 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.654 0.381 . . . . 0.0 111.183 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.625 ' C ' ' H ' ' A' ' 33' ' ' ALA . 12.9 t -57.54 135.82 56.68 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.829 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 67.83 -26.29 0.13 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.612 0.57 . . . . 0.0 110.327 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.625 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 55.5 27.33 10.09 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.565 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.1 t -124.06 139.92 33.64 Favored Pre-proline 0 N--CA 1.478 0.93 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.253 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.54 -8.9 19.8 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 121.95 1.767 . . . . 0.0 111.668 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -83.16 9.26 10.92 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.622 0.249 . . . . 0.0 110.668 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -151.72 157.72 42.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.242 0.544 . . . . 0.0 110.072 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -147.58 163.5 36.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.105 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.57 93.14 48.69 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 123.023 0.529 . . . . 0.0 109.853 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.46 -8.79 19.81 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.488 1.459 . . . . 0.0 111.597 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.72 151.99 9.56 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.844 0.354 . . . . 0.0 110.228 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.02 144.94 14.96 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.247 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -137.59 145.11 42.41 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -162.03 134.02 5.57 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.853 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -132.99 99.42 4.57 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.5 96.58 0.53 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -166.62 147.77 6.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.09 137.55 58.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.1 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.78 5.19 44.41 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.89 151.54 33.87 Favored Glycine 0 N--CA 1.466 0.655 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.1 p -113.42 161.46 17.28 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -143.51 166.03 25.93 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.215 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.3 m -160.49 128.61 4.6 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.1 m -122.78 123.4 40.96 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -92.35 115.65 28.28 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.3 mtt -120.68 132.43 55.09 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.43 136.15 23.21 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.794 0.331 . . . . 0.0 110.699 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.66 148.77 45.39 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -58.58 -39.54 80.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.723 0.297 . . . . 0.0 110.32 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -74.16 -11.38 60.28 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.25 17.12 67.85 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.4 m -61.89 -40.46 95.5 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.847 0.356 . . . . 0.0 110.725 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 44.4 ttp -147.1 149.55 33.25 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.187 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.1 t -145.04 152.35 39.98 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.329 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -156.5 155.5 32.09 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -138.24 131.11 29.71 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.872 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -95.81 145.36 25.4 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.97 153.31 24.91 Favored Glycine 0 N--CA 1.466 0.65 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -179.09 -171.14 41.93 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.46 145.89 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -82.87 126.12 32.11 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -81.74 -26.9 34.16 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 110.035 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -167.59 140.27 3.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.839 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.5 t -137.24 126.92 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -145.66 124.72 12.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.0 m -50.07 119.57 3.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 53.67 75.8 0.25 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.443 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -168.16 -81.31 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.365 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 tp -149.94 135.03 17.95 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.902 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.0 mt -128.69 130.02 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -153.09 165.35 35.89 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -158.77 164.54 35.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.511 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.6 m -116.26 129.77 56.45 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.7 mm -98.37 149.16 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.961 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.72 -40.39 71.04 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -60.96 -15.8 35.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.656 0.265 . . . . 0.0 110.503 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.4 -2.85 59.35 Favored Glycine 0 N--CA 1.473 1.138 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -64.96 143.77 57.73 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -123.66 139.88 53.55 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.6 t -133.57 134.67 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -127.51 122.72 34.11 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 68.7 mt -110.78 124.1 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.8 123.21 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -94.98 123.29 38.37 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.9 p -134.06 150.69 51.21 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -154.38 164.4 38.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.902 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 m -149.5 118.53 6.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.753 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.09 -94.47 0.07 OUTLIER Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -130.99 31.77 4.41 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.666 0.386 . . . . 0.0 111.015 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 46.4 m -132.16 124.85 29.89 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.8 m -100.86 133.46 45.3 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -122.37 117.53 26.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.9 mt -98.01 129.04 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.48 130.84 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -132.63 120.07 21.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.41 ' HG ' ' CG ' ' A' ' 3' ' ' LYS . 15.0 t -99.22 148.2 24.36 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -136.01 149.92 49.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -131.68 78.21 71.19 Favored Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -84.17 -169.85 0.74 Allowed 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.106 1.871 . . . . 0.0 111.141 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -65.43 129.28 39.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.074 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -64.05 -34.55 78.28 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.216 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 78.9 p -65.22 -38.64 91.04 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.95 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -64.7 149.16 96.26 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.36 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.33 106.53 1.95 Allowed 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 121.866 1.711 . . . . 0.0 111.398 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.535 ' NH1' ' H ' ' A' ' 2' ' ' ASN . 89.8 mtm180 -62.49 -32.8 73.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.332 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -48.92 -49.82 38.24 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.622 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.6 mt -68.34 -39.51 81.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.717 0.294 . . . . 0.0 110.928 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -61.43 -45.85 92.58 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.644 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -55.23 -43.48 74.56 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.084 0.469 . . . . 0.0 109.771 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.4 m -62.23 -40.73 97.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.165 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.15 -51.99 48.23 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -63.35 -37.25 86.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.78 0.324 . . . . 0.0 110.277 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -72.1 -36.24 69.41 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.683 0.278 . . . . 0.0 110.338 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.25 70.69 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.789 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.6 tt -62.62 -39.23 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 25.5 mt -63.87 -39.14 93.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -63.89 -40.95 97.7 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m -58.37 -30.65 66.95 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.344 0.403 . . . . 0.0 111.232 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -51.14 -20.2 1.42 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.933 0.397 . . . . 0.0 110.898 -178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -70.12 -38.99 75.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.715 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.0 m -58.25 -44.14 88.17 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.196 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -61.68 -50.5 72.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.522 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 74.5 p -65.29 -39.97 93.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.787 0.327 . . . . 0.0 110.372 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -67.74 -35.55 78.95 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -61.97 -41.69 98.29 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.377 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -63.41 -43.32 97.84 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.385 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.0 tp -97.13 108.55 21.3 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -169.7 95.9 0.29 Allowed 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -66.3 82.13 0.09 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 80.5 t60 58.0 160.45 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.593 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -167.11 159.39 12.98 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.182 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -65.64 133.97 52.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.938 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -68.16 133.94 49.71 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 86.1 t60 . . . . . 0 C--O 1.219 -0.535 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.181 179.835 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 82.0 mt -55.42 132.49 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -130.31 139.11 50.74 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.4 m -136.15 156.38 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -145.24 157.48 44.06 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.038 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 p -145.81 142.78 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.9 p -97.18 117.34 31.17 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.55 126.12 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -93.64 88.73 5.96 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.09 0.471 . . . . 0.0 109.863 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.88 153.12 4.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.055 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.74 139.3 58.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.221 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.5 tp -51.07 -36.79 16.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 120.893 0.378 . . . . 0.0 111.612 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -67.66 -33.1 74.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.44 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -71.17 -51.32 25.53 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 p -65.3 -36.59 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.318 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.758 ' CH2' HD11 ' A' ' 80' ' ' ILE . 29.1 t-105 -54.61 -43.41 72.18 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.932 0.396 . . . . 0.0 110.56 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -68.37 -45.33 73.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.622 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -65.71 -44.42 86.14 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.902 0.382 . . . . 0.0 111.497 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -66.75 -20.7 66.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.932 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -102.63 -22.56 13.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.982 0.513 . . . . 0.0 111.512 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -64.16 123.02 80.96 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.93 -39.74 3.07 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 CA-C-N 120.863 1.344 . . . . 0.0 111.889 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.11 -39.21 71.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.894 0.378 . . . . 0.0 110.759 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.9 m170 -66.33 -42.86 87.57 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.64 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 31' ' ' CYS . 97.2 mt -62.61 -43.75 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 93.5 mtp -59.31 -13.45 8.06 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.737 -0.21 . . . . 0.0 111.077 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -85.14 -38.56 18.91 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.978 -0.451 . . . . 0.0 110.759 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -122.4 23.74 9.58 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.729 0.412 . . . . 0.0 111.216 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.552 ' C ' ' H ' ' A' ' 33' ' ' ALA . 38.3 t -54.39 129.37 35.4 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.804 -0.56 . . . . 0.0 110.958 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 68.54 -30.67 0.18 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.341 0.401 . . . . 0.0 110.478 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.65 38.37 29.85 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.048 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.7 p -136.81 141.46 35.15 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.302 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.39 -16.41 21.87 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 122.008 1.805 . . . . 0.0 112.289 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -84.06 14.1 4.48 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -151.41 154.81 37.36 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.171 0.51 . . . . 0.0 110.232 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -142.5 163.01 33.99 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.234 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 39' ' ' VAL . 7.1 p -127.58 89.57 50.72 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.97 -12.22 23.74 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.263 1.309 . . . . 0.0 111.479 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -171.91 153.05 3.13 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.02 0.438 . . . . 0.0 110.577 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -157.84 150.72 22.92 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.214 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -137.08 145.33 43.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.591 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -161.46 132.32 5.22 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.96 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -128.98 96.01 4.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.0 tp -65.8 96.65 0.3 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -167.67 142.31 3.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.964 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.55 138.19 58.41 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.23 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.27 2.44 59.12 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.9 166.49 37.29 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.8 p -129.14 164.95 22.24 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.639 0.376 . . . . 0.0 110.047 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -140.71 164.52 29.98 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.6 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 36.1 m -150.61 122.56 8.19 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.421 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 37.5 m -116.39 116.57 27.94 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.2 m -95.11 119.68 34.04 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 14.8 ptm -145.67 144.83 30.64 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.75 156.15 40.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.061 0.458 . . . . 0.0 110.535 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.81 148.05 40.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.666 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -56.58 -39.87 74.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.763 0.315 . . . . 0.0 110.721 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -76.37 -7.46 55.05 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.18 11.32 67.13 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.5 t -62.93 -41.84 99.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.45 0.167 . . . . 0.0 111.097 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.9 ttt -120.85 146.32 46.7 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -144.11 141.25 29.9 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.81 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.438 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 56.4 t80 -159.98 161.26 34.1 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.438 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 67.4 t0 -138.54 126.56 22.59 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -94.76 135.54 36.13 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.66 155.74 26.5 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.05 -171.4 41.39 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 p -128.72 139.67 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.785 0.434 . . . . 0.0 110.008 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -78.36 124.96 28.69 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -75.85 -40.01 55.55 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.926 0.393 . . . . 0.0 110.09 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -159.83 146.03 15.93 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.844 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.2 t -135.69 130.69 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -145.4 123.61 12.21 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.4 m -55.12 122.28 10.65 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 54.79 60.54 3.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.608 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -156.12 -82.31 0.07 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.089 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.6 tp -147.76 136.8 22.15 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.554 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.758 HD11 ' CH2' ' A' ' 18' ' ' TRP . 69.7 mt -129.79 126.78 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -154.16 164.18 38.92 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -155.05 154.98 33.3 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.941 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.1 m -87.58 129.53 35.07 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.78 139.87 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.66 -43.21 59.43 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -60.72 -18.56 55.09 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.633 0.254 . . . . 0.0 110.73 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.31 0.67 65.13 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -60.71 168.64 2.17 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -125.19 118.38 25.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.789 0.436 . . . . 0.0 110.126 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -131.96 125.12 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -135.24 136.63 41.86 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.0 mt -112.48 111.52 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.9 t -97.36 128.33 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -98.61 122.15 41.45 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.268 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.1 m -144.75 149.67 35.93 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -142.14 129.16 20.78 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.7 m -63.89 -45.8 87.71 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-O 121.135 0.493 . . . . 0.0 109.968 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.09 -69.43 0.08 OUTLIER Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -102.07 10.04 39.83 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.753 0.421 . . . . 0.0 110.963 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 54.7 m -147.18 129.88 16.06 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.2 m -86.65 140.21 30.03 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -120.47 116.69 25.93 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.6 mt -96.19 124.79 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -120.34 128.35 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -142.0 125.43 16.65 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 120.858 0.361 . . . . 0.0 110.541 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.4 p -94.88 150.99 19.59 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -134.47 149.96 50.77 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 CA--C 1.549 0.907 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.123 -179.662 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 111.111 0.041 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -59.26 -47.68 84.46 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.5 t -68.94 -25.2 64.44 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.278 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.59 -51.87 48.17 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -62.01 -38.14 87.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.902 0.382 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -70.76 -37.08 73.38 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.723 0.297 . . . . 0.0 110.38 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.11 -51.62 69.24 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.795 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.0 tt -63.66 -37.68 80.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.702 0.287 . . . . 0.0 110.381 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.9 mt -63.45 -37.13 86.1 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -60.92 -30.95 70.51 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.562 0.22 . . . . 0.0 110.877 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.7 m -56.15 -35.48 67.21 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.665 0.269 . . . . 0.0 110.968 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.276 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.6 mttm . . . . . 0 C--O 1.233 0.203 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.1 mt -48.45 138.47 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 t -135.69 138.73 43.08 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.7 m -139.14 157.35 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -147.95 159.92 43.37 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.322 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 p -145.82 142.39 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.1 m -97.29 118.25 33.34 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.36 128.16 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -93.69 85.41 4.85 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.45 153.01 3.39 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.981 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.86 135.51 55.82 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.0 tt -54.52 -32.12 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.673 0.273 . . . . 0.0 111.29 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -60.35 -39.72 88.15 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.265 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -73.12 -47.61 42.66 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.38 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.64 -43.38 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.094 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.791 ' CH2' HD11 ' A' ' 80' ' ' ILE . 22.4 t-105 -54.76 -38.16 66.87 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.889 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.58 -53.33 56.19 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.799 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -69.67 -40.29 76.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.545 0.212 . . . . 0.0 111.398 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -59.94 -17.46 37.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.892 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -115.72 -28.18 6.83 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.165 0.586 . . . . 0.0 112.011 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -54.76 107.5 0.88 Allowed Pre-proline 0 N--CA 1.477 0.881 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.941 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.56 -42.49 64.81 Favored 'Trans proline' 0 N--CA 1.508 2.38 0 CA-C-N 121.097 1.427 . . . . 0.0 112.296 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.98 -28.45 66.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.479 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -79.8 -37.66 34.7 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.705 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.24 -44.91 99.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.641 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.5 ptp -54.46 -21.52 10.14 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 120.694 0.283 . . . . 0.0 111.66 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -73.15 -39.49 65.63 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.811 -0.555 . . . . 0.0 111.528 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -124.31 21.72 8.68 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.74 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.522 ' C ' ' H ' ' A' ' 33' ' ' ALA . 17.9 t -60.58 134.25 56.89 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.817 -0.552 . . . . 0.0 110.315 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 69.43 -33.9 0.26 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.998 0.811 . . . . 0.0 110.519 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 53.78 21.57 2.78 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 110.577 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.5 m -108.54 110.13 61.47 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.573 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -51.54 -27.97 26.96 Favored 'Trans proline' 0 N--CA 1.513 2.658 0 C-N-CA 122.112 1.875 . . . . 0.0 112.782 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -74.75 5.33 5.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.656 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -146.89 156.48 43.12 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.415 ' CE1' ' O ' ' A' ' 57' ' ' ALA . 45.8 p-80 -144.1 163.65 32.95 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 39' ' ' VAL . 7.3 p -121.55 94.8 48.44 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 122.886 0.474 . . . . 0.0 109.915 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.32 -8.46 17.38 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.265 1.31 . . . . 0.0 111.782 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.88 154.39 6.29 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.03 150.66 6.66 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -146.39 146.17 30.53 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -164.52 135.97 4.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.47 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -125.45 101.58 7.0 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 tp -65.73 95.79 0.25 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -169.26 141.91 2.62 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.75 137.92 58.15 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.346 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.32 0.86 48.45 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.02 153.94 36.68 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 p -105.22 158.25 16.73 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 120.871 0.367 . . . . 0.0 110.058 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -145.08 154.48 42.53 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.882 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.9 m -151.73 129.88 11.92 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.2 m -123.09 121.48 36.13 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.8 m -94.74 117.35 29.98 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 68.1 mtm -130.89 140.87 50.26 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.415 ' O ' ' CE1' ' A' ' 38' ' ' HIS . . . -147.6 147.4 30.01 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.132 0.491 . . . . 0.0 110.725 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.85 148.38 51.26 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.455 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.43 -40.19 71.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.639 0.257 . . . . 0.0 110.515 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.58 -11.24 59.98 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.12 21.21 63.63 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.7 m -80.95 -12.97 59.3 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.705 0.288 . . . . 0.0 110.674 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.1 ttt -160.59 135.31 7.53 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.8 p -145.07 162.39 37.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.995 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.485 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 52.8 t80 -159.28 163.68 35.55 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.485 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 73.9 m-20 -137.88 123.65 19.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -95.29 141.22 29.13 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.04 152.71 24.26 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.95 -171.73 42.48 Favored Glycine 0 CA--C 1.517 0.174 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.76 137.54 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -70.06 120.88 16.42 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.72 -40.9 63.23 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -164.89 148.08 8.57 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.0 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.8 p -145.86 138.56 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -143.6 130.62 20.59 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.5 m -55.11 121.15 8.14 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.581 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.0 m120 51.62 72.43 0.38 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -168.74 -79.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.378 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 tp -148.53 136.72 21.09 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.498 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.791 HD11 ' CH2' ' A' ' 18' ' ' TRP . 75.3 mt -129.82 129.47 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -154.21 165.07 37.44 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -154.5 155.18 34.39 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.7 m -87.52 129.35 35.11 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.5 139.51 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.63 -40.84 56.17 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -61.3 -17.8 55.41 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.49 3.52 71.7 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -64.11 165.44 9.16 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -121.95 121.98 38.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.955 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.92 129.11 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.56 138.7 43.26 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 73.4 mt -113.36 118.32 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.7 t -105.9 122.73 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.14 125.16 44.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.0 p -132.15 150.91 52.04 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -154.63 147.43 24.4 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.8 p -105.77 -19.47 13.74 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.87 -107.88 0.28 Allowed Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -81.44 7.41 11.89 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.397 0.279 . . . . 0.0 110.69 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.6 m -128.23 124.67 37.25 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.6 m -101.89 135.25 43.77 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -119.09 119.48 34.34 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.5 mt -99.75 127.32 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.87 130.32 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -142.36 144.83 33.36 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.5 t -111.69 149.31 31.78 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -143.12 141.4 31.21 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t70 . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.229 -179.356 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 . . . . . 0 N--CA 1.463 0.178 0 N-CA-C 110.651 -0.129 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -54.66 -47.81 73.11 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.0 t -61.82 -42.34 98.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.109 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.38 -51.73 56.08 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.563 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.5 -39.37 93.29 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.863 0.331 . . . . 0.0 110.558 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -70.98 -37.06 72.74 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.67 -52.54 64.51 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.762 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.4 tt -66.87 -36.75 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.372 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.9 mt -60.06 -41.94 93.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.187 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 128' ' ' SER . 25.8 p30 -66.4 -30.61 71.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.537 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.406 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 21.9 p -61.03 -37.74 83.66 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.864 0.364 . . . . 0.0 110.654 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 53.8 t80 . . . . . 0 CA--C 1.536 0.423 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.446 -179.73 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.7 mttp . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.971 0.415 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.2 mt -50.83 143.4 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 t -133.42 139.47 46.77 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.7 m -138.88 159.68 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.81 157.15 43.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.591 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.58 144.32 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 m -101.32 119.24 38.46 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.8 t -124.71 131.33 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -93.09 89.3 6.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.82 151.55 4.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.293 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.17 130.14 43.33 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.4 tt -52.58 -33.31 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.577 0.227 . . . . 0.0 111.28 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -60.16 -41.34 92.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.622 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -72.44 -46.55 54.49 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.864 0.364 . . . . 0.0 110.033 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.28 -43.02 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.613 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -55.91 -43.88 77.74 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.787 0.327 . . . . 0.0 110.744 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 23' ' ' GLU . 88.5 tttt -67.82 -47.52 68.81 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.588 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.36 -43.09 95.63 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.697 0.284 . . . . 0.0 111.382 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -61.7 -20.71 63.78 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -106.99 -23.03 12.47 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.134 0.574 . . . . 0.0 111.293 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 19' ' ' LYS . 28.5 tp10 -62.74 122.94 77.41 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 118.703 -0.665 . . . . 0.0 109.54 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.6 -38.61 5.76 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 CA-C-N 120.923 1.365 . . . . 0.0 111.607 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.67 -38.71 78.79 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.989 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -65.64 -44.01 87.73 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.56 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.69 -44.87 99.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 42' ' ' ALA . 1.2 mtm -62.99 -0.02 0.63 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -99.95 -50.25 4.07 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.441 ' O ' ' N ' ' A' ' 32' ' ' GLN . 68.6 p-90 -102.74 -3.67 26.13 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 31' ' ' CYS . 24.8 p -67.51 72.06 0.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.437 0.637 . . . . 0.0 110.009 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 30' ' ' TRP . 23.7 pt20 -153.18 48.74 0.7 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.05 -7.44 3.96 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.692 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 t -148.6 138.04 12.41 Favored Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.13 -11.9 23.32 Favored 'Trans proline' 0 N--CA 1.506 2.23 0 C-N-CA 121.71 1.607 . . . . 0.0 112.425 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -84.74 14.99 4.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.024 0.44 . . . . 0.0 110.17 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -146.57 146.69 30.55 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.975 0.417 . . . . 0.0 110.228 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -130.52 162.68 28.7 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 39' ' ' VAL . 8.2 p -114.03 95.17 37.27 Favored Pre-proline 0 N--CA 1.475 0.784 0 C-N-CA 122.69 0.396 . . . . 0.0 110.585 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.79 -19.48 14.22 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 CA-C-N 120.346 1.159 . . . . 0.0 111.29 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -178.56 160.03 1.2 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.4 0.438 . . . . 0.0 110.212 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.519 ' HB3' ' SD ' ' A' ' 28' ' ' MET . . . -156.41 148.81 23.48 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.135 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -136.05 146.13 46.76 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -156.02 104.23 2.27 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.691 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -98.28 86.42 3.65 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.97 93.22 0.11 Allowed 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.328 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -169.5 143.77 2.86 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.16 137.13 58.08 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.273 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.51 1.51 37.3 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.14 159.35 43.22 Favored Glycine 0 N--CA 1.468 0.808 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.7 m -119.3 155.89 31.01 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.007 0.432 . . . . 0.0 109.919 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -135.9 163.41 30.3 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.388 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.8 m -151.12 115.37 5.06 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.656 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.1 m -115.1 119.94 38.13 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 m -94.8 125.11 39.24 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.5 mtt -130.77 106.14 8.26 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.89 144.69 46.26 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.022 0.439 . . . . 0.0 110.769 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.83 148.28 50.49 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -57.99 -40.34 80.44 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.719 0.295 . . . . 0.0 110.386 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -76.18 -9.16 58.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.039 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.99 13.88 62.52 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.2 t -65.69 -19.89 66.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.988 0.423 . . . . 0.0 110.62 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.0 ttt -148.16 145.89 28.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.878 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.8 t -143.35 139.11 29.91 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.427 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 62.9 t80 -159.84 158.82 31.68 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.427 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 29.4 p-10 -138.9 134.16 32.87 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.39 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.02 139.63 31.1 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.38 152.36 24.07 Favored Glycine 0 N--CA 1.465 0.605 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.69 -174.12 41.13 Favored Glycine 0 CA--C 1.517 0.167 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.12 136.58 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -74.52 118.8 17.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.11 -37.01 69.6 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -165.09 149.2 8.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.732 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.02 131.91 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -143.64 122.14 12.44 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.5 m -59.45 123.9 18.3 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.91 0.386 . . . . 0.0 111.964 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 52.4 59.41 4.53 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.021 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -157.27 -76.6 0.09 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.467 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 tp -152.94 135.26 15.01 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.1 mt -131.33 130.6 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -152.2 164.88 36.44 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -157.95 157.25 32.71 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.6 m -107.96 130.73 55.02 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.8 mm -93.86 151.55 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.78 -39.6 68.28 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -63.28 -11.91 25.31 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.956 0.378 . . . . 0.0 110.648 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.86 -2.13 61.77 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -72.44 152.02 42.22 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.493 ' NZ ' ' NH2' ' A' ' 91' ' ' ARG . 88.4 tttt -136.43 152.05 50.17 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -136.41 120.58 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.289 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.493 ' NH2' ' NZ ' ' A' ' 89' ' ' LYS . 87.4 mtt-85 -101.66 130.68 48.07 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 66.9 mt -118.42 125.07 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.48 124.34 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -100.4 123.44 44.63 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.1 m -122.73 124.37 43.21 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -100.73 121.57 41.88 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.5 p -105.78 8.83 33.02 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.99 122.63 0.66 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 58.32 9.9 1.16 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.715 0.293 . . . . 0.0 110.905 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.7 m -160.17 119.63 2.8 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 67.9 m -98.01 136.8 37.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -119.26 121.55 39.9 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.7 mt -100.4 123.74 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.7 t -123.95 126.68 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -143.56 145.96 32.94 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.329 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 78.3 p -126.14 148.3 49.42 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -122.45 162.45 21.66 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.585 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 . . . . . 0 N--CA 1.467 0.378 0 N-CA-C 110.52 -0.178 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -54.12 -46.21 72.11 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.973 0.416 . . . . 0.0 109.929 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.9 t -66.77 -38.83 87.35 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.248 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.03 -52.04 54.73 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.683 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -64.47 -35.96 82.62 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.776 0.322 . . . . 0.0 110.151 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -72.81 -37.1 67.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.691 0.281 . . . . 0.0 110.432 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.11 -50.55 73.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 9.0 tt -62.27 -37.99 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 53.5 mt -63.57 -42.58 98.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -65.33 -39.29 92.21 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.3 t -58.38 -33.39 69.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 46.8 t80 . . . . . 0 CA--C 1.539 0.522 0 CA-C-O 120.883 0.373 . . . . 0.0 110.904 -179.38 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 121.014 0.435 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mt -69.98 140.57 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 t -137.28 160.07 40.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.35 166.71 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.3 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -147.36 158.66 44.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.076 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -149.45 144.99 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.75 121.67 44.5 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -128.97 137.38 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -94.82 89.7 5.77 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.98 150.86 3.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.957 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 128.54 36.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.766 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.2 tt -53.36 -36.24 26.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.632 0.254 . . . . 0.0 110.998 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -57.86 -42.27 84.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.673 0.273 . . . . 0.0 110.592 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -69.93 -47.03 64.0 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.392 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.0 t -62.33 -40.38 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.515 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 66.5 t90 -54.07 -39.76 66.57 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.741 0.305 . . . . 0.0 111.345 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -63.26 -51.03 67.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.954 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -68.89 -37.25 78.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.965 0.412 . . . . 0.0 110.684 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -61.01 -18.56 58.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.853 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -115.56 -26.44 7.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.155 0.582 . . . . 0.0 110.908 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -50.64 108.73 1.09 Allowed Pre-proline 0 CA--C 1.555 1.145 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.172 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.19 -43.4 57.54 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 CA-C-N 120.512 1.218 . . . . 0.0 112.835 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.86 -30.75 69.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.556 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -79.28 -38.98 34.1 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.186 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' A' ' 31' ' ' CYS . 98.2 mt -61.93 -45.38 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 O-C-N 121.964 -0.46 . . . . 0.0 110.657 -177.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 20.5 ptp -61.73 -17.78 57.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.252 0.549 . . . . 0.0 111.251 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -74.96 -29.46 60.93 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.162 -0.336 . . . . 0.0 111.292 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -139.34 23.26 2.54 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.601 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.583 ' C ' ' H ' ' A' ' 33' ' ' ALA . 36.8 t -55.43 125.79 22.39 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.621 -0.674 . . . . 0.0 110.239 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 67.3 -22.88 0.11 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.868 0.73 . . . . 0.0 110.459 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.583 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 51.79 37.01 19.34 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 122.761 0.424 . . . . 0.0 110.977 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.2 m -111.65 96.45 32.56 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.954 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.5 -25.59 10.9 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 122.118 1.879 . . . . 0.0 112.562 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -69.04 -26.63 65.07 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.491 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -106.22 170.26 8.02 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -147.78 152.04 37.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.996 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 39' ' ' VAL . 6.0 p -116.73 96.92 49.57 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.76 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.17 -9.51 17.77 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 121.541 1.494 . . . . 0.0 111.662 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.91 155.32 6.76 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.903 0.383 . . . . 0.0 110.298 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.05 145.47 13.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.922 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -139.17 144.99 38.82 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -163.0 132.46 4.21 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.585 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -135.47 103.63 5.54 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mp -69.56 98.74 1.18 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -166.31 137.66 3.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.74 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.0 134.1 56.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.286 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.9 1.69 63.21 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.25 163.27 44.83 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.8 p -129.65 161.39 30.7 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -137.84 166.84 23.03 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.93 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.4 m -151.72 110.37 3.81 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.1 p -107.07 113.01 26.21 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.0 m -86.35 113.24 22.17 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.4 mtt -122.57 129.28 51.75 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.77 150.14 29.83 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.49 148.38 48.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.596 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.72 -31.97 66.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.958 0.409 . . . . 0.0 110.565 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -74.75 -9.53 58.65 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.125 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.24 4.67 44.8 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.7 m -62.74 -34.95 78.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.641 0.258 . . . . 0.0 110.656 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 71.4 mtp -126.26 136.44 52.79 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.149 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.8 p -145.96 129.65 17.09 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.642 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -155.13 162.42 41.0 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.8 127.04 24.54 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.673 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -94.23 144.76 25.24 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -148.59 151.58 23.75 Favored Glycine 0 N--CA 1.461 0.357 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.01 175.3 42.25 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 t -121.54 132.82 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -74.82 116.12 15.18 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -73.62 -39.56 64.46 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.225 0.536 . . . . 0.0 109.591 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -166.71 147.62 6.05 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.553 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.53 130.74 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -137.82 126.17 23.27 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.4 m -58.31 123.44 16.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.71 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 51.26 69.17 0.68 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.915 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -166.98 -81.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.806 0.336 . . . . 0.0 110.148 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 tp -150.51 131.78 14.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.422 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.0 mt -132.14 131.99 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -153.97 164.47 38.38 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -162.69 155.97 19.96 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.4 p -100.45 132.28 45.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 86' ' ' ASP . 88.9 mt -93.78 140.96 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.48 28.62 1.03 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 84' ' ' ILE . 29.0 t70 -120.41 -9.53 9.45 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.009 0.523 . . . . 0.0 109.897 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.79 -14.77 57.41 Favored Glycine 0 N--CA 1.479 1.533 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -75.13 174.97 8.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -146.24 151.28 37.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.715 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.6 t -140.55 136.81 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.994 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -136.51 133.69 36.77 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 75.0 mt -116.0 128.01 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.81 122.98 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -95.37 127.35 41.34 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.3 m -137.47 141.64 41.55 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -151.19 161.18 43.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 65.4 p -127.48 -13.68 5.4 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.095 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.06 -122.4 0.94 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -73.08 5.69 3.23 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.899 -0.177 . . . . 0.0 110.76 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.4 m -122.55 127.25 49.24 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.0 m -108.73 133.24 53.07 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -110.97 126.12 54.43 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.9 mt -106.3 128.38 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.9 t -129.19 133.89 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -142.19 135.24 28.73 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 86.2 p -95.13 153.33 17.7 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -145.17 145.92 31.55 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 179.918 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.584 0.231 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -59.0 -39.17 81.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.043 0.449 . . . . 0.0 110.255 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.8 t -64.86 -36.27 83.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.56 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.12 -51.72 57.15 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -63.35 -37.54 87.66 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.008 0.432 . . . . 0.0 110.145 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -73.53 -35.07 65.51 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.429 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.46 -50.34 74.09 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.686 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 36.4 pt -63.62 -34.19 66.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.725 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.0 mt -66.87 -39.4 87.52 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.026 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -63.8 -41.19 97.96 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 22.4 m -62.24 -35.15 78.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.837 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 55.7 t80 . . . . . 0 CA--C 1.531 0.23 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.037 -179.102 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.921 0.391 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 84.3 mt -57.83 139.67 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 t -133.67 141.63 47.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.774 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.76 155.3 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -148.8 162.09 40.49 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.549 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 m -149.01 152.62 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.494 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.67 119.48 38.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.171 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.8 t -123.8 127.29 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -94.9 89.34 5.6 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.95 151.37 4.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.974 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.58 135.78 56.32 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.9 tt -52.45 -37.14 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -60.62 -36.06 77.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.461 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -72.7 -48.24 40.56 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.262 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.5 t -64.0 -41.13 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.127 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.79 ' CH2' HD11 ' A' ' 80' ' ' ILE . 31.0 t-105 -52.97 -39.42 62.96 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.081 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -62.31 -49.7 74.58 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.528 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -65.86 -41.38 91.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.609 0.242 . . . . 0.0 110.925 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -68.78 -16.82 63.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.409 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.535 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 2.4 m120 -112.24 -28.7 7.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.254 0.622 . . . . 0.0 112.333 -178.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.05 135.02 96.14 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.04 -42.29 0.31 Allowed 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 121.406 1.404 . . . . 0.0 111.537 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.67 69.93 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.844 0.355 . . . . 0.0 111.016 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.511 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.2 OUTLIER -76.32 -38.92 55.32 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.787 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 31' ' ' CYS . 95.1 mt -62.95 -44.02 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 O-C-N 122.031 -0.418 . . . . 0.0 111.042 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.4 ptp -63.2 -20.87 65.81 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.858 0.361 . . . . 0.0 111.066 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -67.57 -32.11 72.64 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.116 -0.365 . . . . 0.0 110.888 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -135.39 19.95 3.38 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.448 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.471 ' C ' ' H ' ' A' ' 33' ' ' ALA . 21.9 t -58.73 133.93 56.38 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.75 -0.594 . . . . 0.0 110.429 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.2 tp60 71.33 -39.87 0.46 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.213 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 56.44 29.84 15.99 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.878 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.2 m -115.12 106.68 50.99 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.269 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.73 -23.08 19.17 Favored 'Trans proline' 0 N--CA 1.506 2.212 0 C-N-CA 121.999 1.799 . . . . 0.0 112.413 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.33 2.65 12.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.683 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -142.15 169.7 17.1 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.094 0.473 . . . . 0.0 109.848 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -146.03 163.33 35.57 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.35 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 39' ' ' VAL . 6.7 p -123.73 91.21 49.93 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 123.364 0.666 . . . . 0.0 109.777 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.34 -11.78 20.88 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.296 1.33 . . . . 0.0 111.559 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.21 152.24 6.07 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.02 146.55 9.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.24 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -134.72 145.94 48.96 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -152.56 114.91 4.47 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -133.18 95.44 3.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.84 93.8 6.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.853 0.835 . . . . 0.0 109.457 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -149.08 137.28 20.81 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.436 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.8 123.45 12.43 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.776 0.322 . . . . 0.0 111.0 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.79 1.66 78.87 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.03 163.18 47.13 Favored Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.2 p -128.22 159.81 34.04 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.742 0.417 . . . . 0.0 110.098 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.458 ' CD1' ' CE2' ' A' ' 71' ' ' TYR . 42.5 p90 -152.94 169.83 21.9 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.344 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.1 m -161.31 141.97 11.11 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.9 m -121.87 123.01 40.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.8 m -93.22 118.06 30.8 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.1 mtm -127.91 132.94 49.26 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.72 147.68 29.15 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.065 0.459 . . . . 0.0 110.225 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.9 148.51 48.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.552 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -58.41 -34.17 70.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.739 0.304 . . . . 0.0 110.239 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -73.03 -10.22 59.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.979 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.94 15.8 58.64 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.2 m -83.7 -17.69 40.49 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 122.886 -0.185 . . . . 0.0 110.812 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 67.9 mtp -134.43 140.82 46.54 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.893 0.377 . . . . 0.0 110.247 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 96.5 p -144.38 149.6 36.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.184 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -155.29 161.49 41.09 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.786 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -136.07 99.73 4.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.711 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -94.46 134.1 37.34 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.47 172.85 41.84 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.28 -176.65 39.95 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.9 t -118.96 128.84 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.458 ' CE2' ' CD1' ' A' ' 52' ' ' PHE . 57.8 m-85 -71.9 112.23 7.82 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -73.64 -38.13 65.1 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.329 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -165.1 151.53 10.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.776 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.2 p -143.68 142.83 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -145.17 121.64 11.01 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.7 m -52.89 120.83 6.26 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.813 0.34 . . . . 0.0 111.91 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.4 m120 51.58 69.96 0.6 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.667 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -167.86 -77.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.332 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 tt -150.49 136.15 18.19 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.199 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.79 HD11 ' CH2' ' A' ' 18' ' ' TRP . 83.1 mt -129.55 131.41 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.44 162.21 41.51 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -157.31 155.52 30.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.829 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 84.9 m -98.32 131.79 44.33 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 86' ' ' ASP . 5.1 mp -94.58 139.44 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.66 26.93 0.61 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 84' ' ' ILE . 24.1 t0 -119.67 -12.79 9.21 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.76 -7.69 63.26 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.349 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -74.96 143.44 43.67 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.513 -0.404 . . . . 0.0 110.118 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -110.84 135.4 51.45 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.17 136.96 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -134.52 135.14 42.15 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.6 mt -119.61 128.34 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.2 t -118.4 129.99 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -97.23 123.15 40.93 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 67.1 p -128.58 140.56 51.72 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -154.08 148.03 25.58 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.1 p -99.56 -18.74 17.22 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.063 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.09 -102.81 0.21 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -75.72 -6.79 52.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.402 0.144 . . . . 0.0 110.805 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.9 p -107.44 165.18 11.59 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.3 m -143.14 135.48 27.26 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.14 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -124.93 124.2 41.52 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.7 mt -105.64 126.85 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.56 134.45 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -137.24 131.51 32.47 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 89.3 p -136.91 127.68 27.24 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -156.93 168.88 26.15 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.737 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.475 0.785 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.833 -179.368 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 120.635 0.255 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -50.88 -48.48 60.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.6 t -71.4 -34.83 70.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.11 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.7 -52.38 51.14 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.21 -0.519 . . . . 0.0 111.826 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -63.21 -34.88 78.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 110.125 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -74.9 -34.16 62.13 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.075 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.08 -49.45 77.29 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 10.0 tt -61.26 -41.57 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.97 -40.55 96.66 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.046 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -63.46 -39.38 94.32 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.8 m -58.51 -41.29 85.07 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.713 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 81.3 t80 . . . . . 0 N--CA 1.464 0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.271 -179.975 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 120.756 0.312 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.6 mm -52.92 140.07 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 t -137.35 134.46 36.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.86 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.6 m -138.97 158.18 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -147.16 158.01 43.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.04 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 p -149.14 140.68 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.888 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.3 p -92.69 124.71 36.89 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.42 125.62 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -93.37 88.24 5.9 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.18 151.7 3.98 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.103 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.92 132.43 52.05 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.8 tt -54.06 -33.09 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.7 0.286 . . . . 0.0 111.103 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -59.01 -40.43 84.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.656 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -73.59 -46.9 44.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.928 0.394 . . . . 0.0 110.153 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -61.77 -43.06 96.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.719 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -55.92 -40.88 73.76 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.788 0.328 . . . . 0.0 110.883 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -68.41 -48.31 65.0 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.027 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.507 ' CD2' ' ND1' ' A' ' 26' ' ' HIS . 9.9 m-85 -66.74 -42.34 86.4 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.867 0.365 . . . . 0.0 110.902 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -62.88 -15.73 55.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.184 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -112.0 -23.27 10.6 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.032 0.533 . . . . 0.0 111.358 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -69.13 122.28 84.78 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 118.809 -0.615 . . . . 0.0 109.712 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.61 -32.16 24.89 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 CA-C-N 121.104 1.43 . . . . 0.0 111.895 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.62 75.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.966 0.412 . . . . 0.0 110.764 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.507 ' ND1' ' CD2' ' A' ' 20' ' ' TYR . 45.8 m170 -80.05 -42.52 23.57 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.993 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 31' ' ' CYS . 92.3 mt -63.04 -48.11 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 122.123 -0.36 . . . . 0.0 110.842 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -64.11 -12.2 37.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.783 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -78.46 -28.11 46.52 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.871 -0.15 . . . . 0.0 111.107 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -133.37 5.89 3.79 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.994 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.499 ' C ' ' H ' ' A' ' 33' ' ' ALA . 37.0 t -50.44 138.09 17.84 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.075 -0.391 . . . . 0.0 110.623 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 71.68 -39.94 0.46 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.69 39.15 31.12 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.148 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.9 m -134.29 140.81 37.03 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 122.749 0.42 . . . . 0.0 110.286 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -75.78 -10.32 19.94 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.873 1.715 . . . . 0.0 112.559 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -88.1 15.08 7.89 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.983 0.421 . . . . 0.0 110.262 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -150.16 155.26 39.46 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.137 0.494 . . . . 0.0 109.758 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -142.56 163.46 32.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.047 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.4 t -127.72 87.08 56.79 Favored Pre-proline 0 N--CA 1.475 0.825 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.83 -20.7 44.98 Favored 'Trans proline' 0 N--CA 1.505 2.167 0 C-N-CA 122.369 2.046 . . . . 0.0 111.825 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.92 161.54 8.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.68 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.74 146.08 16.1 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.449 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -140.93 152.08 44.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -161.29 132.95 5.6 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.04 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -122.58 86.93 2.66 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.9 tp -67.21 94.9 0.39 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.939 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -169.02 144.14 3.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.03 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.5 137.7 57.93 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.317 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.89 -1.47 54.25 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.64 172.83 41.3 Favored Glycine 0 N--CA 1.47 0.929 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 t -139.02 172.92 12.14 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.396 0.278 . . . . 0.0 110.556 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -138.76 167.54 21.76 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.203 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.5 m -157.74 121.61 4.13 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.6 m -123.77 124.93 43.79 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.2 m -90.29 114.4 26.45 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.7 mtt -119.11 129.73 55.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.44 143.58 32.68 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.136 0.494 . . . . 0.0 110.223 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.68 148.53 51.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.33 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -56.35 -39.96 73.7 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.556 0.217 . . . . 0.0 110.475 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -79.21 -7.17 58.02 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.897 0.38 . . . . 0.0 110.141 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.35 18.84 67.93 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.4 p -65.63 -34.88 79.25 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.838 -0.213 . . . . 0.0 110.683 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.3 ttt -137.33 145.88 43.93 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.9 t -143.76 145.45 32.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.885 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.422 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 66.8 t80 -159.09 166.63 31.19 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.422 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 74.3 m-20 -137.78 121.05 16.93 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -93.54 140.39 29.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.847 0.356 . . . . 0.0 110.168 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -157.22 157.77 28.35 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.74 -177.67 41.55 Favored Glycine 0 N--CA 1.458 0.112 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -123.61 131.66 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -72.5 115.25 11.54 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -73.66 -47.08 42.59 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -149.79 144.11 25.81 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 74' ' ' VAL . 9.6 p -133.04 128.15 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -138.13 111.21 7.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 t -56.35 131.16 47.46 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.257 0.551 . . . . 0.0 112.289 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 49.85 51.89 15.68 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.453 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -157.69 -80.81 0.06 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.688 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 tp -146.27 134.8 22.07 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.2 mt -130.33 131.27 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -152.15 162.71 40.72 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -158.16 154.67 27.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.665 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.3 m -94.78 129.8 41.59 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 88.6 mt -93.63 153.49 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.56 -41.98 65.51 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.816 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -61.49 -10.84 8.61 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.061 0.458 . . . . 0.0 110.632 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 91.53 1.79 70.98 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -77.32 142.94 39.15 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -106.42 162.38 13.75 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.142 0.496 . . . . 0.0 110.395 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.4 t -141.17 121.34 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.778 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -112.41 123.22 49.81 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 71.1 mt -117.06 119.89 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.6 t -107.91 118.22 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -93.41 122.75 36.15 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.8 m -131.72 143.65 50.42 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -152.93 147.36 25.87 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 80.7 p -102.47 -19.25 14.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.014 0.435 . . . . 0.0 109.842 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.43 -104.73 0.23 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 1.3 m-20 -77.12 -2.08 32.45 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 122.21 0.204 . . . . 0.0 111.113 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.8 m -119.91 124.24 45.53 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.2 m -105.51 133.89 49.52 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -115.48 124.57 51.44 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.0 mt -104.66 125.42 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.4 t -119.73 128.31 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -127.94 123.47 34.95 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.3 m -134.72 128.27 32.61 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.945 0.402 . . . . 0.0 110.096 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -157.13 166.8 32.24 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.567 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.4 t70 . . . . . 0 N--CA 1.477 0.903 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.392 -179.184 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -52.28 -46.64 65.95 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.5 m -66.9 -39.62 87.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.183 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.73 -52.01 51.65 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.77 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -63.83 -35.92 82.19 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.825 0.345 . . . . 0.0 110.449 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -72.01 -38.01 69.68 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.785 0.326 . . . . 0.0 110.161 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.79 72.36 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.124 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.3 tt -62.34 -37.86 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.3 mt -63.87 -40.24 96.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -63.38 -40.88 98.44 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.2 m -60.95 -38.37 85.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.619 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 CA--C 1.531 0.212 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.663 -179.794 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.8 tttp . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 121.293 0.568 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.6 mt -65.14 136.37 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 t -137.47 150.91 47.93 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.56 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.6 m -136.0 161.71 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.669 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -139.45 158.92 43.31 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.694 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.12 142.93 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 m -95.05 123.28 38.45 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.4 t -126.98 123.21 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -90.79 87.03 6.5 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.83 152.12 3.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.99 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.63 137.2 57.69 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.7 tt -52.69 -38.26 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.721 0.296 . . . . 0.0 111.35 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -60.81 -35.25 76.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.222 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -74.51 -48.06 29.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.01 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -62.71 -43.93 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.102 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.557 ' NE1' ' ND2' ' A' ' 22' ' ' ASN . 24.4 t-105 -54.27 -39.11 66.58 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.875 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -64.02 -55.76 20.0 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.506 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -69.39 -42.93 74.46 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.837 0.351 . . . . 0.0 111.492 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -59.74 -16.62 28.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.324 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.557 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 83.0 m-20 -112.71 -21.72 11.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.282 0.633 . . . . 0.0 109.895 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -67.55 120.6 74.28 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.736 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.63 -36.56 18.97 Favored 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 121.512 1.474 . . . . 0.0 111.941 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.73 -31.71 69.87 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.104 0.478 . . . . 0.0 110.562 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -80.93 -45.92 15.97 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.789 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.6 mt -61.68 -47.32 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.621 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -63.61 -3.57 2.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.12 0.486 . . . . 0.0 111.072 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -90.25 -29.59 18.07 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 122.098 -0.376 . . . . 0.0 110.341 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 60.6 p-90 -135.73 21.95 3.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.128 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.571 ' C ' ' H ' ' A' ' 33' ' ' ALA . 28.5 p -55.43 131.14 45.18 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.353 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.483 ' NE2' ' CD1' ' A' ' 37' ' ' TRP . 49.9 tt0 68.57 -29.1 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.527 0.517 . . . . 0.0 110.467 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.571 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 53.48 39.72 30.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.429 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 t -128.28 136.45 29.08 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.796 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -73.21 -17.54 24.36 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 122.035 1.823 . . . . 0.0 112.372 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -81.93 13.06 3.52 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.753 0.311 . . . . 0.0 110.687 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.483 ' CD1' ' NE2' ' A' ' 32' ' ' GLN . 87.3 m95 -149.87 159.95 43.97 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.331 0.586 . . . . 0.0 109.664 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.405 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 83.6 t60 -149.13 163.43 37.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.222 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 39' ' ' VAL . 7.2 p -128.6 96.86 29.06 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.869 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.1 -9.2 19.19 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 121.927 1.752 . . . . 0.0 111.747 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.15 153.89 7.05 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.834 0.35 . . . . 0.0 110.544 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.47 145.87 13.17 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.185 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -141.04 151.96 44.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -162.41 135.28 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.922 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -133.97 99.12 4.34 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.427 HD22 ' N ' ' A' ' 46' ' ' LEU . 4.4 mm? -67.75 95.22 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.074 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -168.15 145.25 4.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.673 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.83 137.11 58.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.056 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.97 3.57 36.86 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.13 146.14 33.03 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.6 m -107.45 154.25 21.62 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -141.52 156.81 45.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.426 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.7 m -148.25 128.0 13.4 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.1 m -123.81 121.14 34.63 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 m -92.25 124.86 36.63 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.1 mtp -135.63 135.95 40.62 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.16 147.22 30.3 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.956 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.4 148.88 50.95 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.425 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -57.51 -40.48 78.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.71 0.29 . . . . 0.0 110.397 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.24 -10.05 59.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.035 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.14 14.25 68.24 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 85.3 p -67.27 -33.49 75.42 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.668 0.271 . . . . 0.0 110.616 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.3 ttt -129.2 149.37 51.03 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.846 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.2 t -144.27 142.4 30.43 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.724 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.446 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 57.8 t80 -159.47 159.0 33.03 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.446 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 68.3 m-20 -139.12 129.85 26.09 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.867 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -94.95 134.58 37.46 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.39 149.17 20.79 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.79 -172.05 41.86 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -131.97 139.37 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -73.97 122.94 23.37 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.525 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -77.21 -32.56 56.02 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -165.41 144.91 6.6 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.722 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.6 t -135.7 130.28 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -143.09 116.86 9.28 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 65.8 p -57.33 134.2 55.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.696 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 53.76 56.02 7.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.554 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -155.01 -79.58 0.09 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -162.32 161.52 27.57 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.907 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.5 mt -136.06 141.04 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -153.43 160.27 42.56 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -159.46 165.66 32.62 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.3 m -120.94 133.76 55.29 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.7 mm -99.72 153.85 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -55.57 -41.49 81.8 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -60.59 -18.2 51.36 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.717 0.294 . . . . 0.0 110.488 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.28 -3.66 47.52 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -65.37 146.51 54.81 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -136.44 145.48 45.29 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.578 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.69 137.97 31.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -121.45 130.32 53.5 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 76.8 mt -116.97 120.19 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.72 128.37 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -95.9 123.67 39.59 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.7 m -121.14 145.0 48.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -153.44 161.8 41.91 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.3 p -132.69 -47.96 0.88 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.227 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.74 120.74 0.59 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 56.0 15.82 1.91 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 111.039 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.4 m -151.56 139.18 19.66 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 48.4 m -125.84 132.11 52.28 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -117.83 122.52 43.61 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.0 mt -96.68 128.06 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.0 t -121.73 132.49 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -136.8 134.79 37.38 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 83.9 p -138.92 130.45 27.29 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -155.93 170.12 22.86 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 . . . . . 0 N--CA 1.473 0.713 0 O-C-N 123.736 0.648 . . . . 0.0 109.856 -179.79 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.578 0.227 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -58.0 -41.88 83.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.399 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 74.1 m -58.3 -32.83 68.82 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 123.412 0.445 . . . . 0.0 110.556 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.27 -44.72 12.7 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -60.45 -39.43 87.5 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.75 0.31 . . . . 0.0 111.587 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -76.09 -34.66 59.54 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.076 0.465 . . . . 0.0 110.546 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.96 -50.92 72.23 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.5 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.7 tt -61.14 -36.62 73.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.0 mt -66.42 -36.61 83.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 -62.26 -40.72 97.15 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.525 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 91.7 p -62.17 -33.89 75.38 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.983 0.421 . . . . 0.0 110.656 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 59.6 t80 . . . . . 0 N--CA 1.463 0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.541 -179.673 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.2 mt -131.04 134.91 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -135.26 139.16 44.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.49 153.82 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -148.81 162.12 40.44 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.924 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.7 p -148.34 140.8 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.703 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.5 p -89.59 119.74 30.28 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.83 124.34 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -93.21 88.54 6.08 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.31 153.33 4.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.743 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.08 134.0 55.38 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.8 tt -51.78 -36.22 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -60.03 -35.59 75.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.359 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -75.21 -44.93 43.67 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 109.958 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.6 t -63.39 -43.8 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.36 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.571 ' CE2' ' ND2' ' A' ' 22' ' ' ASN . 72.1 t90 -57.24 -46.31 83.12 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.473 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.01 -44.69 88.36 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.751 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -66.49 -44.28 83.06 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.879 0.371 . . . . 0.0 110.962 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -69.29 -18.33 63.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.483 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.571 ' ND2' ' CE2' ' A' ' 18' ' ' TRP . 8.6 m-20 -98.49 -26.24 14.51 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.062 0.545 . . . . 0.0 111.14 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -64.95 119.96 62.75 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.81 -36.32 4.79 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 CA-C-N 120.863 1.344 . . . . 0.0 111.869 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.59 86.19 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.843 0.354 . . . . 0.0 111.142 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -66.84 -40.57 88.01 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.58 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.452 ' O ' ' N ' ' A' ' 31' ' ' CYS . 96.5 mt -63.31 -43.8 98.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.8 mtp -55.88 -12.27 1.31 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.599 0.238 . . . . 0.0 111.279 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -86.33 -28.73 23.5 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.154 -0.341 . . . . 0.0 110.978 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -136.36 21.66 3.18 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.481 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.586 ' C ' ' H ' ' A' ' 33' ' ' ALA . 10.4 t -57.12 131.34 49.62 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.66 -0.65 . . . . 0.0 110.479 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 66.14 -27.83 0.12 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.689 0.618 . . . . 0.0 110.864 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 47.3 29.62 1.3 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.539 0.335 . . . . 0.0 111.017 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.7 m -108.12 135.55 19.89 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.264 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.76 -17.3 20.31 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.517 1.478 . . . . 0.0 111.983 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -86.87 8.67 22.0 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.705 0.288 . . . . 0.0 110.578 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -148.4 156.31 42.33 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.314 0.578 . . . . 0.0 110.261 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -143.96 150.38 38.23 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.105 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 39' ' ' VAL . 8.4 p -111.5 89.57 10.87 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.889 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.78 -11.72 20.08 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 121.334 1.356 . . . . 0.0 111.422 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -170.15 152.47 4.23 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 120.982 0.42 . . . . 0.0 110.47 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.26 151.92 18.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.248 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -139.13 150.93 46.24 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.627 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -161.23 131.45 5.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.863 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -130.27 97.53 4.45 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -71.05 94.54 1.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.926 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -167.97 140.15 3.04 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.18 137.78 58.04 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.684 0.278 . . . . 0.0 110.28 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.42 -1.58 50.17 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.97 164.88 44.91 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.4 p -126.27 157.88 37.16 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.841 0.456 . . . . 0.0 110.323 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -132.93 156.58 46.99 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.431 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.2 m -146.92 119.54 8.54 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.9 p -114.73 113.69 24.63 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.2 m -89.78 114.78 26.55 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.2 mtt -128.5 133.79 48.54 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.78 145.62 26.72 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.947 0.403 . . . . 0.0 110.176 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.58 147.58 53.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.377 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -56.33 -32.94 65.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.858 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -83.08 -7.01 59.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.08 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.82 16.34 59.13 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.8 m -60.85 -38.7 86.43 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.718 0.294 . . . . 0.0 110.763 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.4 ttp -145.31 146.42 31.62 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.047 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.4 t -143.97 155.72 44.15 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.917 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.466 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 56.4 t80 -153.8 165.18 36.84 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.466 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 30.8 t0 -138.26 119.46 14.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.186 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -93.33 136.57 33.47 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.95 154.36 25.46 Favored Glycine 0 N--CA 1.465 0.622 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.16 -173.39 40.9 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 t -123.75 132.92 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -71.3 121.35 18.32 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.54 -42.19 62.01 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -159.85 146.14 15.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.778 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.5 t -134.56 129.44 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -145.41 121.75 10.93 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.1 m -58.38 129.18 40.81 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.43 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 54.32 56.37 7.01 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.578 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -155.95 -83.95 0.06 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.005 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 tp -149.17 134.87 18.73 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.682 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.9 mt -127.29 127.97 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.11 164.18 38.51 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -156.07 154.39 30.9 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.906 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.3 m -87.97 131.76 34.5 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.7 mt -104.78 144.41 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.55 -42.49 57.9 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.419 ' CG ' HH12 ' A' ' 88' ' ' ARG . 44.2 m-20 -62.02 -21.35 64.81 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.766 0.317 . . . . 0.0 110.351 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.62 2.94 72.04 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.419 HH12 ' CG ' ' A' ' 86' ' ' ASP . 96.3 mtm-85 -65.83 140.81 58.42 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -92.11 122.03 34.22 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.245 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.9 t -135.47 122.52 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -136.49 142.76 43.56 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 77.3 mt -113.27 124.05 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.4 t -106.75 125.42 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -102.6 122.16 43.84 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.5 m -131.07 149.77 52.45 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -151.79 154.26 35.89 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.659 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.1 p -132.77 40.2 3.27 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.111 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.08 131.19 0.16 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 p30 47.35 17.33 0.07 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.087 0.555 . . . . 0.0 111.849 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.5 m -152.78 135.81 15.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.026 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.7 m -128.93 130.48 46.83 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -117.63 126.24 52.17 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.9 mt -101.18 123.82 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.01 128.52 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -142.99 140.58 31.09 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.0 m -137.01 142.65 42.52 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -153.94 155.63 35.98 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.362 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.547 0.838 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.739 -178.947 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.38 -54.49 46.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.881 0.372 . . . . 0.0 110.092 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.6 t -64.05 -42.07 97.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.917 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.05 -52.13 50.13 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.191 -0.528 . . . . 0.0 111.827 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -65.08 -41.61 94.9 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.645 0.259 . . . . 0.0 110.344 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -65.74 -37.82 87.44 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.413 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.69 68.79 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 31.3 pt -65.3 -35.47 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.905 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.3 mt -64.89 -37.11 86.54 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -62.97 -37.46 87.2 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.6 m -69.07 -33.64 73.87 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.792 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 53.3 t80 . . . . . 0 N--CA 1.469 0.507 0 CA-C-O 120.683 0.277 . . . . 0.0 111.358 -178.331 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.0 mttp . . . . . 0 N--CA 1.463 0.213 0 CA-C-O 121.115 0.483 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.59 137.36 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.2 m -122.87 133.27 54.42 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.8 m -138.74 160.05 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.21 165.9 30.47 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.231 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.02 144.25 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.2 p -92.12 125.42 36.79 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.59 130.7 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -97.25 92.82 6.19 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.06 152.53 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.966 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.33 138.06 58.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.202 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.7 tp -51.56 -37.79 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 121.067 0.461 . . . . 0.0 110.994 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -69.02 -36.74 78.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.15 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -68.64 -51.94 36.66 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 111.244 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -63.51 -36.51 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.364 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.498 ' NE1' ' ND2' ' A' ' 22' ' ' ASN . 27.5 t-105 -54.92 -49.55 71.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.828 0.347 . . . . 0.0 110.587 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.7 -45.15 83.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.374 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.451 ' CD2' ' ND1' ' A' ' 26' ' ' HIS . 50.1 t80 -63.95 -43.83 94.66 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 111.186 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -71.1 -19.08 62.5 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.463 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.498 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 86.1 m-20 -103.65 -23.92 13.42 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.999 0.519 . . . . 0.0 110.972 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.25 134.38 95.81 Favored Pre-proline 0 CA--C 1.553 1.064 0 CA-C-O 119.191 -0.433 . . . . 0.0 109.858 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.69 -41.49 0.55 Allowed 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.544 1.496 . . . . 0.0 111.622 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.67 -29.35 66.53 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.918 0.389 . . . . 0.0 110.695 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.451 ' ND1' ' CD2' ' A' ' 20' ' ' TYR . 33.3 m170 -79.93 -45.82 17.84 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.234 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 90.6 mt -63.52 -46.6 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 122.006 -0.434 . . . . 0.0 110.645 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -66.1 -3.37 5.4 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.71 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -90.58 -26.87 19.47 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.183 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -138.04 23.05 2.82 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.433 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.595 ' C ' ' H ' ' A' ' 33' ' ' ALA . 9.6 t -56.52 133.99 53.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.191 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 65.92 -23.99 0.1 Allowed 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.538 0.524 . . . . 0.0 110.668 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.595 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 53.3 28.19 7.0 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.507 0.194 . . . . 0.0 110.613 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.1 m -112.8 104.17 55.82 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 122.953 0.501 . . . . 0.0 110.058 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -50.09 -13.44 0.64 Allowed 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 122.266 1.977 . . . . 0.0 112.625 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -82.63 11.84 5.34 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.669 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -146.72 162.72 37.92 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -146.57 162.63 37.96 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.969 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.6 t -126.16 96.28 37.2 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.84 -10.99 23.63 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 121.76 1.64 . . . . 0.0 111.877 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.02 152.94 6.64 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.934 0.397 . . . . 0.0 110.473 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.68 150.09 9.98 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.458 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -143.65 156.25 44.5 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -157.98 104.18 1.9 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.699 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -91.99 87.62 6.26 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.2 tp -66.11 93.36 0.2 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.716 -0.394 . . . . 0.0 109.968 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -170.48 145.91 2.69 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.48 137.74 58.25 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.142 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.23 -1.58 25.2 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -77.26 163.49 51.98 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.8 m -124.14 155.41 38.5 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -135.04 158.05 45.35 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.467 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.7 m -146.17 122.37 10.84 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.6 m -119.12 119.63 34.76 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.6 m -88.86 113.4 24.37 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 93.2 mtp -119.14 124.66 47.38 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.35 140.74 33.82 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.17 150.37 47.57 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.08 -37.75 64.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.692 0.282 . . . . 0.0 110.523 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -81.17 -7.42 59.56 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.125 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.76 14.68 37.98 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.9 t -67.4 -19.14 65.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.733 0.301 . . . . 0.0 110.489 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 47.6 ttp -159.85 134.99 8.05 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.972 0.415 . . . . 0.0 110.383 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m -146.16 154.58 41.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.259 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -154.88 146.94 23.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.33 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -108.19 119.99 41.08 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.389 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -93.92 137.69 32.87 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.44 153.9 25.13 Favored Glycine 0 N--CA 1.46 0.27 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.3 178.21 43.15 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.33 134.15 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -75.68 121.05 21.92 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -75.22 -39.2 60.26 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -162.34 146.4 11.98 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.849 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.5 p -149.95 138.67 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.656 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -148.99 134.64 18.72 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.8 m -48.07 118.22 2.27 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.454 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 54.11 79.6 0.13 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.377 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -167.9 -83.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.472 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 tt -152.78 141.49 20.96 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.774 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 63.1 mt -130.16 130.52 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -152.94 160.55 43.05 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -160.57 155.2 23.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.644 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.4 p -91.84 134.3 34.88 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.666 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.411 HG22 ' H ' ' A' ' 86' ' ' ASP . 79.6 mt -104.71 147.37 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.05 -41.38 59.98 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.411 ' H ' HG22 ' A' ' 84' ' ' ILE . 82.5 m-20 -60.72 -17.76 50.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.777 0.323 . . . . 0.0 110.148 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.75 3.72 80.15 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -65.88 141.52 58.22 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -95.4 135.26 37.24 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.2 t -139.55 128.64 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -136.15 133.73 37.51 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.6 mt -116.59 116.18 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.5 t -101.13 116.02 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -90.89 132.52 35.87 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.5 p -132.25 156.93 45.63 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -143.85 148.69 35.85 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.2 m -150.82 87.05 1.4 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.94 -134.29 50.93 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -79.0 39.88 0.39 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.749 0.309 . . . . 0.0 110.498 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.8 m -150.09 147.62 28.0 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.2 m -134.0 146.38 50.35 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.406 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -132.68 131.08 40.91 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.5 mt -107.55 128.15 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.15 126.96 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -144.59 145.55 31.85 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 95.3 p -132.37 148.72 52.43 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -131.34 174.81 9.7 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 . . . . . 0 N--CA 1.467 0.389 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.827 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 120.605 0.241 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -53.74 -46.98 71.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.935 0.398 . . . . 0.0 110.385 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 81.5 p -64.67 -37.37 87.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.134 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.57 -52.45 46.04 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.531 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -66.41 -37.09 84.43 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.905 0.383 . . . . 0.0 110.541 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -70.55 -39.02 74.23 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.458 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.16 -52.0 67.38 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.726 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.4 tt -62.23 -37.97 79.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.7 mt -64.47 -41.99 96.17 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.28 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -67.39 -41.83 84.31 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.2 t -61.37 -32.83 72.75 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.467 0.48 . . . . 0.0 110.875 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 77.9 t80 . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 120.862 0.363 . . . . 0.0 111.031 -179.235 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.9 mt -50.17 143.01 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 t -129.91 133.96 47.18 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.4 m -139.69 158.34 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -148.65 162.88 38.83 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.335 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 p -145.3 140.59 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.3 p -93.36 119.33 32.36 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.2 t -127.48 128.7 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -98.98 88.22 3.92 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.29 154.43 4.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.041 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.25 118.84 7.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.2 tt -51.68 -34.96 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.167 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -60.31 -39.82 88.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -73.24 -45.43 55.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.238 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.88 -42.34 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.688 0.28 . . . . 0.0 110.499 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.462 ' HE1' HD11 ' A' ' 80' ' ' ILE . 21.0 t90 -48.92 -34.59 13.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.616 0.246 . . . . 0.0 111.123 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -61.55 -47.86 83.64 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.631 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -69.36 -42.37 75.31 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.699 0.285 . . . . 0.0 110.572 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -65.93 -15.63 63.14 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.307 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.442 ' ND2' ' CD1' ' A' ' 18' ' ' TRP . 2.1 m-80 -108.81 -26.88 10.06 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.377 0.671 . . . . 0.0 111.478 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -76.83 125.84 86.54 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.54 -31.36 13.72 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 121.427 1.418 . . . . 0.0 111.883 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.63 -37.29 78.25 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.437 0.461 . . . . 0.0 110.876 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -79.42 -41.45 27.66 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.988 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.48 -49.06 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.239 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.9 ptm -60.46 -16.35 35.59 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.495 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -72.28 -34.99 68.59 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -127.68 5.29 6.12 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.092 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.541 ' C ' ' H ' ' A' ' 33' ' ' ALA . 30.5 t -51.35 140.52 17.09 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 71.36 -36.64 0.37 Allowed 'General case' 0 CA--C 1.536 0.432 0 O-C-N 123.698 0.624 . . . . 0.0 109.573 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.541 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 56.21 34.81 24.65 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.533 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.1 m -121.93 136.03 25.84 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 122.816 0.446 . . . . 0.0 110.48 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.28 -20.34 16.42 Favored 'Trans proline' 0 N--CA 1.503 2.074 0 C-N-CA 121.832 1.688 . . . . 0.0 112.524 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -78.04 -24.06 47.94 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.543 0.211 . . . . 0.0 110.991 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -109.54 153.79 23.63 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.411 ' CD2' ' O ' ' A' ' 57' ' ' ALA . 6.1 p80 -144.77 162.87 35.68 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.3 t -120.74 95.25 48.99 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.12 -10.77 22.95 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 121.637 1.558 . . . . 0.0 111.688 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -167.49 151.99 6.81 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.893 0.378 . . . . 0.0 110.433 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -162.41 146.4 11.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.245 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -139.21 152.92 47.74 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -160.57 127.77 4.33 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.857 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -133.89 93.58 3.13 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.17 102.34 1.33 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.174 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -163.8 129.92 3.12 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.55 123.19 12.35 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.715 0.293 . . . . 0.0 110.67 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.68 4.92 90.23 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.28 173.01 52.95 Favored Glycine 0 N--CA 1.467 0.745 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.5 t -134.08 164.21 27.84 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 117.058 0.429 . . . . 0.0 110.045 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -148.8 169.13 21.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.067 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.1 m -148.99 125.32 10.87 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.8 m -120.5 118.31 29.91 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.3 m -94.89 117.93 30.94 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 46.4 ttp -137.06 130.25 31.05 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' A' ' 38' ' ' HIS . . . -153.54 158.04 40.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.208 0.528 . . . . 0.0 110.157 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.84 150.72 48.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.778 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -58.03 -38.12 75.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.587 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -71.23 -11.1 60.74 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.91 6.63 60.36 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.1 m -63.78 -39.96 95.52 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.598 0.237 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.2 mtm -117.44 142.2 47.42 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.133 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.8 p -144.23 149.24 36.04 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.872 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -154.49 154.21 32.77 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -138.18 120.15 15.47 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.589 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -93.7 121.83 35.54 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -132.46 134.92 7.83 Favored Glycine 0 N--CA 1.473 1.161 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.74 -175.11 44.67 Favored Glycine 0 CA--C 1.518 0.28 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.5 m -132.38 156.81 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.894 0.378 . . . . 0.0 110.207 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -88.34 124.51 33.99 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.517 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.32 -38.49 65.8 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -167.46 149.6 5.84 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.664 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.7 t -134.59 132.46 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -141.46 117.42 10.53 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 m -55.88 123.69 15.13 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.964 0.412 . . . . 0.0 111.349 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 52.14 66.22 1.27 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.011 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -167.08 -77.55 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.227 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tp -151.82 131.6 13.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.51 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.462 HD11 ' HE1' ' A' ' 18' ' ' TRP . 64.6 mt -132.94 131.69 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -153.09 165.56 35.22 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -157.28 164.79 37.28 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 54.3 m -115.36 132.57 56.58 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.8 mm -99.28 150.05 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.22 -40.49 67.62 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.424 ' CB ' ' NH1' ' A' ' 88' ' ' ARG . 63.1 m-20 -61.66 -19.41 62.28 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.59 0.233 . . . . 0.0 110.709 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.93 -3.08 48.32 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.424 ' NH1' ' CB ' ' A' ' 86' ' ' ASP . 84.5 mtt85 -64.72 144.2 57.4 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -120.97 146.42 46.7 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.567 0.542 . . . . 0.0 109.654 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.3 t -138.1 136.89 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -132.92 120.02 20.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 70.8 mt -108.72 117.6 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.0 t -108.17 114.9 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -89.87 128.43 36.19 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.4 p -132.75 152.43 51.76 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -153.93 158.65 41.01 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.3 p -135.94 36.59 2.83 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.023 0.44 . . . . 0.0 109.901 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 69.92 131.2 0.07 OUTLIER Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 57.34 8.71 0.62 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.838 0.352 . . . . 0.0 110.955 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.7 m -150.47 139.54 21.08 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.114 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.9 m -127.76 130.36 48.62 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -120.53 123.29 42.55 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.0 mt -103.27 128.43 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.61 131.66 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -130.31 132.7 45.99 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.3 t -118.29 149.11 41.7 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -144.0 160.69 40.41 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.622 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 120.466 0.174 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -53.27 -44.98 68.65 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.01 0.433 . . . . 0.0 110.008 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.1 t -64.45 -40.72 96.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.352 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.47 -51.72 55.95 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -62.74 -36.3 82.58 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.705 0.288 . . . . 0.0 110.279 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -74.05 -37.67 64.21 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.791 0.329 . . . . 0.0 110.194 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.15 -51.08 71.56 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.805 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.3 tt -63.6 -39.57 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.5 mt -63.62 -38.61 91.76 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -62.14 -40.03 94.57 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.072 0.463 . . . . 0.0 109.763 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.5 t -72.63 -31.04 64.84 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.689 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 62.3 t80 . . . . . 0 N--CA 1.469 0.496 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -178.079 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.9 pttt . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 120.901 0.381 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.9 mt -51.53 138.97 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 m -135.64 138.73 43.16 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 m -136.17 157.05 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -147.74 161.16 41.78 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.39 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.61 142.61 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.5 m -93.48 121.27 34.7 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.7 t -126.57 124.88 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -94.74 89.9 5.88 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.98 153.47 4.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.06 134.28 55.85 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.7 tp -52.83 -34.39 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.88 0.372 . . . . 0.0 110.884 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -60.46 -40.8 92.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.473 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -72.07 -46.66 56.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.845 0.355 . . . . 0.0 110.555 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.48 -41.57 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.401 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.781 ' CH2' HD11 ' A' ' 80' ' ' ILE . 26.4 t-105 -56.11 -45.31 79.54 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.84 0.353 . . . . 0.0 110.868 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -65.26 -45.01 86.25 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.339 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -65.51 -43.37 90.33 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.727 0.299 . . . . 0.0 110.973 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -69.23 -20.19 63.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.492 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.743 HD21 HD22 ' A' ' 46' ' ' LEU . 2.3 m-20 -104.93 -30.86 9.55 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.129 0.571 . . . . 0.0 111.752 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -50.76 106.52 0.66 Allowed Pre-proline 0 CA--C 1.557 1.214 0 CA-C-O 119.113 -0.47 . . . . 0.0 109.819 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -53.58 -43.07 60.82 Favored 'Trans proline' 0 N--CA 1.508 2.381 0 CA-C-N 120.646 1.266 . . . . 0.0 112.244 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.06 -33.79 73.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.909 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.433 ' O ' ' CD1' ' A' ' 30' ' ' TRP . 46.5 t-80 -73.74 -38.45 64.76 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.795 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.41 -44.46 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 122.038 -0.414 . . . . 0.0 110.752 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.7 ptp -67.21 -24.9 65.89 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.283 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -62.29 -45.8 91.61 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.529 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.488 ' CE3' ' O ' ' A' ' 31' ' ' CYS . 62.7 p-90 -109.13 -10.19 15.01 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.523 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.488 ' O ' ' CE3' ' A' ' 30' ' ' TRP . 29.4 p 30.71 -130.99 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.962 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 177.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.425 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 55.2 tp60 -74.55 -4.34 36.34 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 30' ' ' TRP . . . 64.32 32.52 12.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.225 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.8 m -132.3 141.17 40.33 Favored Pre-proline 0 N--CA 1.482 1.154 0 O-C-N 123.337 0.398 . . . . 0.0 110.534 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.5 -9.94 23.32 Favored 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 121.892 1.728 . . . . 0.0 112.27 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -79.14 -24.56 43.22 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.426 0.155 . . . . 0.0 110.724 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -122.24 148.86 44.47 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.829 0.452 . . . . 0.0 110.313 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -140.09 163.25 33.2 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.179 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.21 89.23 52.94 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.61 -10.12 20.14 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 121.537 1.491 . . . . 0.0 111.141 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -167.77 150.36 5.78 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.008 0.432 . . . . 0.0 110.273 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.86 150.47 11.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.092 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -138.99 144.91 39.13 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -163.6 135.67 5.03 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -125.05 97.45 5.26 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.743 HD22 HD21 ' A' ' 22' ' ' ASN . 48.1 tp -65.34 94.48 0.17 Allowed 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -168.34 140.83 2.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.26 137.71 57.88 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.262 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.45 -0.05 61.24 Favored Glycine 0 N--CA 1.466 0.691 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.06 169.1 41.72 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 t -129.87 168.41 16.66 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.704 0.402 . . . . 0.0 110.066 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -140.57 166.38 24.9 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.244 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 m -154.88 118.09 4.45 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.7 m -116.96 121.46 41.47 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.1 m -93.36 116.66 29.21 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.9 mtp -121.76 125.88 47.57 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.81 138.31 42.44 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.014 0.435 . . . . 0.0 110.116 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.77 148.83 51.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.393 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.02 -39.96 75.76 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.712 0.292 . . . . 0.0 110.451 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -76.2 -9.65 58.8 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.24 22.23 62.84 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 97.0 p -81.06 -10.75 59.64 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.736 0.303 . . . . 0.0 110.617 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.1 ttt -164.49 136.48 4.59 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.087 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.9 p -144.43 161.1 39.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.874 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.466 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 61.7 t80 -159.47 168.63 25.76 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.466 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 40.8 t0 -138.55 119.53 14.39 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -93.99 140.58 29.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.71 156.21 26.97 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.36 -171.55 40.99 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 p -127.36 141.63 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 122.672 0.389 . . . . 0.0 110.107 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -81.04 123.65 28.54 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -77.0 -47.87 19.52 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.076 0.465 . . . . 0.0 110.04 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -147.38 141.31 25.87 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.559 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.3 t -136.06 125.5 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -140.54 123.13 16.16 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.8 m -53.62 121.95 8.84 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.073 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 53.47 70.16 0.62 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.77 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -166.1 -82.39 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.536 0.208 . . . . 0.0 110.943 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.1 tp -147.02 139.55 24.85 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.781 HD11 ' CH2' ' A' ' 18' ' ' TRP . 58.9 mt -133.77 130.28 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -153.7 157.51 39.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -155.95 160.16 39.86 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.3 m -112.27 135.24 53.19 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.3 mm -89.19 155.89 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.8 -33.97 80.44 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -69.46 -10.26 57.27 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 122.477 -0.425 . . . . 0.0 110.352 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.7 -8.15 56.14 Favored Glycine 0 N--CA 1.475 1.29 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -71.18 161.32 31.3 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -145.4 160.79 41.03 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.428 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.4 t -144.43 113.03 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.325 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -93.92 127.41 39.67 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.7 mt -124.83 113.06 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.0 p -108.71 133.55 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.475 ' CE1' HD12 ' A' ' 80' ' ' ILE . 87.4 m-85 -103.93 132.64 49.99 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.0 p -134.3 153.3 51.95 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -153.84 158.22 40.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.541 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 63.6 p -134.86 27.38 3.6 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.049 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.0 129.32 1.39 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 55.7 11.77 0.72 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.885 0.374 . . . . 0.0 111.03 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.2 m -153.53 141.93 20.66 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.046 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.9 m -130.37 130.85 44.9 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -117.88 122.86 44.43 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.6 mt -104.37 126.27 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.5 t -128.18 133.83 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -142.63 145.9 33.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.036 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 78.4 p -132.24 141.97 49.23 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -154.15 155.55 35.56 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 CA--C 1.547 0.831 0 CA-C-O 119.136 -0.459 . . . . 0.0 110.656 -179.165 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.496 0.188 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.53 -48.09 69.37 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.774 0.321 . . . . 0.0 110.506 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.7 t -63.34 -42.57 98.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.337 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.68 -51.78 55.21 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -64.17 -36.06 82.81 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.967 0.384 . . . . 0.0 110.291 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -73.61 -38.19 65.16 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.17 -51.23 70.89 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.9 tt -61.7 -37.76 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.4 mt -63.26 -40.92 98.77 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.2 -41.29 97.14 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 110.049 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.5 m -61.05 -33.32 73.13 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.132 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 57.6 t80 . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.986 -178.683 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.7 mttt . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.4 mt -50.14 138.15 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.4 m -133.42 134.47 43.67 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.24 156.34 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.427 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 32.8 mp0 -140.75 158.36 44.08 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.917 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 p -143.88 140.46 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -93.44 113.95 26.23 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.7 t -119.01 125.9 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -98.23 87.84 4.02 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.09 152.78 4.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.087 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.63 135.88 57.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.485 HD13 ' CE1' ' A' ' 94' ' ' PHE . 9.7 tp -53.41 -32.2 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.622 0.248 . . . . 0.0 111.441 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -59.51 -39.74 84.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.774 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -75.17 -46.4 34.43 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 110.437 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.5 t -62.53 -43.44 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.24 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.7 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 25.2 t-105 -56.26 -46.05 79.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.934 0.397 . . . . 0.0 110.583 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -67.38 -45.43 76.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.606 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -65.31 -43.43 91.09 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.793 0.33 . . . . 0.0 111.136 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -70.43 -20.02 62.94 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.647 -178.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.519 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 83.1 m-20 -104.68 -22.25 13.26 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.139 0.576 . . . . 0.0 111.41 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -65.8 132.09 94.76 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.02 -40.55 1.28 Allowed 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 121.262 1.308 . . . . 0.0 111.57 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.76 -35.9 69.19 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.085 0.469 . . . . 0.0 110.833 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -73.86 -45.8 48.82 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.255 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 91.8 mt -61.85 -50.29 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.816 -0.553 . . . . 0.0 111.015 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 20.0 ptm -60.8 -17.38 49.14 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -74.2 -31.73 62.76 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -133.41 14.86 4.11 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.602 0.361 . . . . 0.0 110.837 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.531 ' C ' ' H ' ' A' ' 33' ' ' ALA . 20.4 t -53.95 136.4 41.12 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 122.138 -0.351 . . . . 0.0 110.279 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 70.81 -36.25 0.35 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.539 0.524 . . . . 0.0 110.011 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 56.86 36.16 27.34 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.763 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.0 m -131.63 141.51 41.92 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 122.682 0.393 . . . . 0.0 110.436 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -75.46 -8.9 19.9 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.04 1.827 . . . . 0.0 112.03 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -86.31 7.32 25.9 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.681 0.277 . . . . 0.0 110.457 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -153.45 155.66 36.72 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.243 0.544 . . . . 0.0 110.357 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -148.55 163.18 37.98 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.303 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.6 t -127.62 91.94 44.24 Favored Pre-proline 0 N--CA 1.476 0.833 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.81 -1.94 12.09 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.768 1.645 . . . . 0.0 111.709 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.25 152.42 8.96 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.884 0.373 . . . . 0.0 110.078 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -166.07 150.47 8.03 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.36 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -136.77 150.47 48.4 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.917 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -160.88 131.4 5.25 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.09 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -129.54 95.83 4.11 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.79 93.87 0.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.08 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -168.19 140.9 3.05 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.96 137.75 58.21 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.425 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.87 1.65 48.24 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.9 148.12 34.45 Favored Glycine 0 N--CA 1.465 0.6 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.1 p -111.7 157.43 20.5 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.899 0.48 . . . . 0.0 109.846 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 69' ' ' GLY . 45.5 p90 -156.72 169.18 25.32 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.026 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.7 m -156.39 141.58 17.39 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.1 m -122.09 120.74 35.17 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.8 m -86.39 111.14 20.22 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 44.3 ttp -127.74 114.07 16.81 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -132.08 141.48 49.2 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.59 0.356 . . . . 0.0 110.275 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.35 148.07 33.75 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -58.83 -37.9 77.47 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.712 0.291 . . . . 0.0 110.263 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.51 -10.6 59.72 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.89 17.66 67.73 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.9 t -62.48 -42.22 99.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.801 0.334 . . . . 0.0 111.012 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 62.4 ttp -145.19 147.0 31.97 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.175 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.5 t -144.7 154.7 43.04 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.135 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -154.13 143.25 21.24 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -95.47 108.85 21.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.467 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -96.04 130.66 42.99 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.95 176.44 41.95 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 52' ' ' PHE . . . -174.57 -172.42 39.64 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 36.7 t -126.94 132.48 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -72.68 113.79 10.1 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -74.29 -48.14 30.36 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -139.81 137.88 35.35 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.78 125.82 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -144.19 113.15 6.77 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.3 m -47.38 116.49 1.44 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 53.98 71.21 0.53 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.602 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -168.65 -68.86 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.634 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.0 tp -150.12 133.69 16.62 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.7 HD11 ' CZ3' ' A' ' 18' ' ' TRP . 84.5 mt -128.49 125.21 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -153.6 152.13 30.53 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 20.2 p90 -151.2 152.25 33.03 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.9 m -82.16 128.53 34.24 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.479 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.3 mm -82.27 144.1 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.251 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.32 -41.64 87.62 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -66.21 -5.28 9.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.758 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.17 0.89 84.82 Favored Glycine 0 N--CA 1.473 1.132 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -66.84 159.3 28.47 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -113.92 132.84 55.79 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.97 0.415 . . . . 0.0 109.944 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.2 t -136.48 134.35 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -135.43 127.34 29.48 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.82 117.46 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.56 128.58 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.485 ' CE1' HD13 ' A' ' 14' ' ' ILE . 4.0 t80 -92.46 126.32 37.49 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.9 m -146.21 141.25 27.23 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.433 ' N ' ' ND1' ' A' ' 96' ' ' HIS . 2.3 p-80 -153.69 148.84 26.87 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.2 p -98.05 -13.63 20.94 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.011 0.434 . . . . 0.0 109.957 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.43 -101.29 0.2 Allowed Glycine 0 N--CA 1.465 0.622 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 18.0 p-10 -78.0 -2.06 35.2 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.343 0.257 . . . . 0.0 110.892 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.0 p -118.54 128.18 54.32 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.03 0.532 . . . . 0.0 109.709 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.9 m -103.72 135.07 45.97 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.666 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -119.23 115.37 24.05 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.8 mt -101.51 125.79 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.3 t -121.35 127.57 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -142.43 144.47 33.1 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 94.7 p -130.51 148.9 52.37 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.117 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -137.22 150.57 47.96 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.153 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 CA--C 1.551 0.982 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.992 179.929 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 . . . . . 0 N--CA 1.468 0.448 0 CA-C-O 120.349 0.119 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.412 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -55.52 -38.81 69.71 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.188 0.518 . . . . 0.0 110.633 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.412 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 40.7 t -59.0 -40.83 86.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.954 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.4 -48.23 64.96 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.717 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -59.04 -39.71 82.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.802 0.334 . . . . 0.0 110.563 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -74.85 -34.65 62.32 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.75 -51.0 71.63 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.7 tt -63.19 -39.11 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.7 mt -63.56 -40.04 95.96 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -62.71 -39.66 94.73 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.5 t -60.02 -37.07 78.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.811 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 48.5 t80 . . . . . 0 CA--C 1.534 0.352 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.681 -179.049 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.9 mt -46.38 138.16 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.0 m -136.29 136.95 40.21 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.77 156.33 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.438 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 31.6 mp0 -141.06 158.91 43.28 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.851 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 p -151.26 142.59 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.186 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.5 p -97.32 124.11 41.35 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.7 t -128.46 129.48 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -93.83 88.2 5.68 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.48 151.73 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.19 133.74 54.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.143 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.6 tt -53.44 -36.48 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.701 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.407 ' OE2' ' N ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -63.31 -34.98 78.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.984 0.421 . . . . 0.0 110.011 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.407 ' N ' ' OE2' ' A' ' 15' ' ' GLU . 63.9 tttm -73.38 -50.21 23.11 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.9 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.35 -42.64 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.154 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.476 ' NE1' ' ND2' ' A' ' 22' ' ' ASN . 25.9 t-105 -54.13 -40.15 67.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.763 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -65.46 -54.31 30.23 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.538 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -69.53 -41.63 75.71 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.838 0.351 . . . . 0.0 111.396 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -61.82 -20.69 63.91 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.708 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.476 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 91.8 m-20 -106.22 -19.58 13.66 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.809 0.444 . . . . 0.0 110.282 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -68.27 122.92 86.1 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.7 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.93 -35.1 12.74 Favored 'Trans proline' 0 N--CA 1.504 2.125 0 C-N-CA 121.324 1.35 . . . . 0.0 112.217 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.73 -39.57 94.48 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.84 0.352 . . . . 0.0 110.48 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -65.36 -45.39 84.33 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.37 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 31' ' ' CYS . 96.7 mt -62.48 -43.84 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 36.3 ttp -54.85 -15.96 2.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.497 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -84.49 -25.98 28.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.641 0.258 . . . . 0.0 111.355 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -140.75 26.21 2.1 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.878 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.588 ' C ' ' H ' ' A' ' 33' ' ' ALA . 16.1 t -59.73 130.24 45.82 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.937 -0.477 . . . . 0.0 110.12 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 66.08 -27.46 0.11 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.754 0.658 . . . . 0.0 110.55 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 51.96 30.26 7.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.0 t -118.86 136.71 24.39 Favored Pre-proline 0 N--CA 1.48 1.068 0 O-C-N 123.476 0.485 . . . . 0.0 111.168 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.95 -13.02 24.01 Favored 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 121.931 1.754 . . . . 0.0 111.939 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -85.05 9.78 13.78 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.921 0.391 . . . . 0.0 110.911 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -149.31 162.17 40.59 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.232 0.539 . . . . 0.0 109.747 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -148.74 162.89 38.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.911 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.79 91.2 13.77 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.8 -3.07 13.36 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 122.312 2.008 . . . . 0.0 112.049 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.29 153.06 11.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.737 0.303 . . . . 0.0 110.228 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -165.03 148.21 8.4 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -150.72 152.99 34.73 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -163.16 103.65 0.98 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.095 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -85.68 90.99 8.16 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.6 tp -65.41 95.66 0.21 Allowed 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -169.51 140.69 2.28 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.08 138.05 57.96 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.192 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.87 -2.29 60.32 Favored Glycine 0 N--CA 1.467 0.732 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.18 174.22 43.54 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 t -135.21 168.06 19.86 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -135.89 167.19 21.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.975 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.9 m -160.66 125.93 3.83 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.7 m -123.99 125.63 44.91 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 m -86.73 112.17 21.41 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 72.4 mtp -119.72 118.62 31.39 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.49 139.72 40.74 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.53 147.59 52.48 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -55.18 -34.89 64.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 110.668 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -82.71 -9.21 59.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.345 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.83 15.34 64.46 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.6 t -62.5 -40.97 98.43 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.72 0.295 . . . . 0.0 110.664 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 44.6 ttp -143.58 143.32 31.45 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.09 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.6 p -145.83 157.56 43.91 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.878 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.448 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 63.5 t80 -159.81 166.69 29.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.517 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.448 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 24.1 p-10 -138.2 121.92 17.53 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.045 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -94.38 143.62 26.24 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.92 157.44 28.01 Favored Glycine 0 C--N 1.331 0.268 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.51 -173.06 40.92 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.4 t -128.31 135.85 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -76.06 120.0 20.77 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -74.05 -45.08 51.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.893 0.377 . . . . 0.0 110.23 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -148.77 139.42 22.73 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -137.34 127.67 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -144.16 129.01 18.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.0 m -60.55 135.01 57.62 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.793 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 54.81 57.8 5.37 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.915 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -154.37 -82.76 0.08 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.934 0.397 . . . . 0.0 110.273 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -163.07 160.56 24.58 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.26 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.2 mt -134.38 135.96 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.404 ' OE1' ' NH1' ' A' ' 91' ' ' ARG . 14.2 pt-20 -149.92 154.92 39.09 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -158.91 155.2 27.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.9 m -95.57 134.41 38.48 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.7 mt -101.32 152.74 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -51.88 -42.19 53.05 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -60.83 -17.46 49.97 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.984 0.421 . . . . 0.0 110.095 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.42 7.55 72.34 Favored Glycine 0 N--CA 1.471 0.99 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -70.58 139.35 51.45 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -93.7 136.47 33.94 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.0 t -137.83 132.12 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.404 ' NH1' ' OE1' ' A' ' 81' ' ' GLU . 70.2 mtp85 -135.61 135.53 40.31 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.9 mt -124.18 114.07 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.88 129.11 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -95.8 132.8 40.67 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.5 p -136.11 155.47 50.13 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -152.43 143.64 23.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.738 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.4 p -91.1 -41.46 11.04 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.003 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.45 -68.06 0.11 Allowed Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -107.28 17.4 22.92 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.157 0.583 . . . . 0.0 110.73 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.5 m -155.77 119.79 4.52 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.105 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 43.0 m -83.99 146.44 27.99 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -128.49 122.61 31.59 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.6 mt -100.27 126.67 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.37 126.73 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -144.71 146.49 32.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.523 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 96.5 p -134.52 147.5 50.33 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -122.27 170.95 9.41 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.411 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.642 0.258 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -54.02 -41.35 67.9 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.508 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.2 t -60.91 -41.85 96.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.396 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.51 -50.9 61.68 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -61.36 -36.33 79.93 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.015 0.436 . . . . 0.0 110.18 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -75.86 -36.45 59.56 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.138 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.35 -51.41 70.06 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.003 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.8 tt -61.1 -37.33 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.8 mt -63.74 -40.67 97.3 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.334 -0.393 . . . . 0.0 109.962 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -63.9 -39.23 93.7 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.2 m -57.6 -35.52 70.53 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 110.665 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 59.3 t80 . . . . . 0 CA--C 1.534 0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.465 179.819 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.1 mttp . . . . . 0 C--O 1.234 0.243 0 CA-C-O 121.04 0.448 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.9 mt -53.26 134.63 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.5 m -131.19 130.99 43.68 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.8 m -137.32 159.01 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -148.47 162.41 39.68 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.417 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 p -144.14 142.54 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 m -95.46 117.65 30.76 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -123.43 129.38 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -97.61 87.55 4.11 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.82 152.54 4.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.984 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.86 133.04 52.62 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.041 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.8 tt -53.36 -36.69 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.736 0.303 . . . . 0.0 111.629 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.35 -35.29 75.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.424 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -74.92 -47.17 31.16 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.165 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.3 -43.03 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.31 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.663 ' CH2' HD11 ' A' ' 80' ' ' ILE . 26.6 t-105 -53.98 -43.54 70.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.139 0.495 . . . . 0.0 110.864 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.69 -45.78 74.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.614 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -66.63 -42.72 86.32 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.886 0.374 . . . . 0.0 111.332 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -68.73 -18.09 64.17 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.571 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -109.66 -29.54 8.31 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.938 0.495 . . . . 0.0 111.981 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -51.42 106.21 0.62 Allowed Pre-proline 0 CA--C 1.561 1.383 0 CA-C-O 118.734 -0.651 . . . . 0.0 109.519 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.53 -43.33 55.61 Favored 'Trans proline' 0 N--CA 1.506 2.254 0 CA-C-N 121.006 1.395 . . . . 0.0 112.331 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.46 84.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.257 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -69.04 -36.93 78.27 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.371 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 98.7 mt -62.0 -52.41 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 121.856 -0.528 . . . . 0.0 111.218 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.8 ptp -61.59 -16.55 49.14 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -70.15 -26.92 64.16 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 32' ' ' GLN . 68.8 p-90 -134.17 6.79 3.63 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 119.525 -0.274 . . . . 0.0 111.096 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.4 t -67.93 72.52 0.17 Allowed 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 121.416 0.627 . . . . 0.0 109.706 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 30' ' ' TRP . 55.6 tt0 -161.74 63.17 0.25 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.615 ' HB2' HD12 ' A' ' 125' ' ' ILE . . . -69.77 -5.02 22.51 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.09 -1.413 . . . . 0.0 110.716 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 79.4 p -146.2 140.67 15.67 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.33 -13.92 22.95 Favored 'Trans proline' 0 N--CA 1.509 2.44 0 C-N-CA 122.071 1.847 . . . . 0.0 112.372 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -83.97 14.07 4.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.676 0.274 . . . . 0.0 110.598 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -147.71 143.99 27.99 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -130.95 163.01 28.46 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 t -127.93 87.35 55.92 Favored Pre-proline 0 N--CA 1.477 0.914 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.89 -7.83 14.42 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.816 1.678 . . . . 0.0 111.496 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.79 151.37 4.19 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.0 156.05 5.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.432 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -148.11 154.05 39.68 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.86 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -163.58 135.27 4.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.591 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -129.0 101.15 5.93 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tp -69.27 99.39 1.16 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -166.91 138.18 3.28 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.85 137.1 58.15 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.694 0.283 . . . . 0.0 110.436 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.96 2.14 60.99 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.2 169.57 38.21 Favored Glycine 0 N--CA 1.47 0.902 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 t -130.2 165.39 22.47 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.095 0.474 . . . . 0.0 110.203 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -140.5 162.15 36.03 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.53 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.3 m -150.45 134.91 17.25 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.8 p -131.39 119.17 21.28 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 m -88.98 118.19 28.53 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.4 mtp -134.4 125.91 28.49 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.87 146.74 33.24 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.279 0.561 . . . . 0.0 110.398 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.18 148.94 43.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.604 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -56.52 -39.67 73.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.817 0.341 . . . . 0.0 110.451 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -75.14 -10.49 59.52 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.876 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.29 10.82 70.41 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.2 t -62.72 -41.97 99.42 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.008 -0.113 . . . . 0.0 111.057 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.1 tpt -120.2 143.18 48.39 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.6 t -143.53 139.41 29.76 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.454 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 58.5 t80 -160.0 160.54 33.43 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.454 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 73.8 m-20 -138.03 128.34 26.14 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.5 134.08 38.76 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.38 156.13 26.75 Favored Glycine 0 N--CA 1.465 0.614 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.6 -172.14 40.98 Favored Glycine 0 CA--C 1.517 0.177 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.03 140.8 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 122.593 0.357 . . . . 0.0 110.301 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -79.24 121.69 25.38 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.06 -39.09 63.73 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.226 0.536 . . . . 0.0 109.757 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -166.16 147.75 6.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.218 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.7 t -137.39 135.26 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -140.74 119.63 12.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.7 m -50.99 118.61 3.29 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.89 72.17 0.44 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.915 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -168.15 -77.02 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.256 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.0 tp -150.99 140.6 21.65 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.349 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.663 HD11 ' CH2' ' A' ' 18' ' ' TRP . 61.7 mt -132.09 132.09 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.14 155.15 36.2 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -155.81 155.1 32.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.4 m -98.64 128.69 45.02 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.423 HG22 ' H ' ' A' ' 86' ' ' ASP . 88.3 mt -92.06 150.48 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.95 -41.44 68.05 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.423 ' H ' HG22 ' A' ' 84' ' ' ILE . 81.2 m-20 -60.71 -12.14 9.57 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.727 0.298 . . . . 0.0 110.477 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.49 -3.56 81.81 Favored Glycine 0 N--CA 1.468 0.822 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -65.88 138.42 57.85 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -98.37 142.69 29.69 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.2 t -143.46 136.66 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -136.24 138.77 42.16 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.1 mt -129.94 114.68 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.0 p -107.91 132.58 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -103.83 117.52 34.53 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.5 m -109.17 152.08 25.61 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -145.85 143.08 29.39 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 65.2 p -144.03 105.09 4.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.842 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.96 -93.92 0.2 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 21.3 p-10 -132.06 32.7 3.99 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.607 0.363 . . . . 0.0 110.984 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.3 m -134.72 126.64 29.43 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.6 m -108.26 124.97 51.12 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -117.18 121.24 40.68 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.8 mt -98.03 124.48 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.88 130.66 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -142.5 144.22 32.89 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 56.4 m -123.33 148.62 45.82 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -128.61 153.38 47.32 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 . . . . . 0 CA--C 1.539 0.552 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.429 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 . . . . . 0 CA--C 1.521 -0.169 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -55.04 -41.79 71.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.997 0.427 . . . . 0.0 110.358 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.1 t -61.24 -43.36 99.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.352 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.79 -51.7 57.03 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -65.23 -42.96 92.89 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.169 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.85 -38.9 92.79 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.56 -54.16 49.16 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.615 HD12 ' HB2' ' A' ' 33' ' ' ALA . 12.9 tt -67.39 -37.54 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.312 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.2 mt -61.52 -41.62 97.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.766 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 128' ' ' SER . 25.2 p30 -67.48 -31.68 71.99 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.16 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.415 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 96.2 p -76.79 -29.16 55.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.936 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 56.6 t80 . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.936 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.755 0.312 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.3 mm -51.77 136.18 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.5 m -135.73 128.9 31.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.988 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.96 149.83 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -148.91 158.29 44.06 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.664 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.43 158.9 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.503 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -122.45 124.71 44.25 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.3 p -128.42 141.8 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 122.542 0.337 . . . . 0.0 110.769 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -87.7 87.1 7.28 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.152 0.501 . . . . 0.0 110.078 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.41 147.05 4.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.403 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.16 137.67 58.07 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.242 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.6 tt -52.8 -32.24 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.248 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -59.43 -42.73 92.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.73 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -71.03 -44.47 65.75 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.076 0.465 . . . . 0.0 110.487 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.57 -43.11 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.409 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -58.72 -49.93 75.77 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.8 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -67.65 -45.82 74.22 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.575 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -63.18 -44.66 94.81 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.096 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -67.35 -21.32 65.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.649 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -101.44 -23.96 14.25 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.95 0.5 . . . . 0.0 111.797 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -62.5 117.98 36.41 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 118.743 -0.646 . . . . 0.0 109.284 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.5 -37.16 7.73 Favored 'Trans proline' 0 N--CA 1.504 2.141 0 CA-C-N 121.081 1.422 . . . . 0.0 112.214 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.13 -30.71 66.53 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.927 0.394 . . . . 0.0 111.111 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -79.96 -36.51 36.04 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.384 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 31' ' ' CYS . 96.8 mt -63.39 -42.98 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 122.087 -0.383 . . . . 0.0 110.598 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 17.2 ptp -60.09 -14.87 18.91 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.262 -0.274 . . . . 0.0 111.163 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -79.47 -30.57 42.17 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 122.133 -0.354 . . . . 0.0 110.779 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -133.89 20.57 3.82 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.514 ' C ' ' H ' ' A' ' 33' ' ' ALA . 42.9 t -57.35 134.22 55.82 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.64 -0.663 . . . . 0.0 111.219 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 70.59 -35.56 0.33 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.665 0.603 . . . . 0.0 110.283 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 55.64 33.42 21.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.189 0.518 . . . . 0.0 110.64 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.9 t -124.5 114.12 27.3 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.24 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.79 -22.1 28.23 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 121.573 1.515 . . . . 0.0 112.184 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -79.91 13.37 2.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.879 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -150.11 159.0 44.75 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.027 0.441 . . . . 0.0 110.254 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -140.0 163.3 33.05 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.387 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 39' ' ' VAL . 6.1 p -126.78 92.52 44.54 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 123.559 0.744 . . . . 0.0 109.464 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.2 -12.65 23.34 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 121.302 1.335 . . . . 0.0 111.976 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.57 154.72 5.7 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.983 0.42 . . . . 0.0 110.073 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.81 144.61 13.52 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.904 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -139.86 153.59 47.07 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -159.03 103.37 1.67 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.897 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -93.49 85.83 5.05 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 tp -65.53 92.74 0.14 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -170.21 147.3 3.1 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.916 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.52 136.55 58.06 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.34 -1.77 18.16 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -73.59 155.54 50.02 Favored Glycine 0 N--CA 1.467 0.716 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.9 m -115.69 152.8 32.51 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.92 0.488 . . . . 0.0 109.966 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -136.68 160.55 38.5 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.29 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.0 m -150.99 115.98 5.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 43.5 m -109.02 113.09 25.66 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 m -94.3 122.07 36.46 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 13.4 ptp -141.82 141.91 33.15 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.81 149.83 33.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.98 0.419 . . . . 0.0 110.369 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.8 148.45 51.23 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -54.88 -38.45 67.55 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.815 0.341 . . . . 0.0 110.972 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -79.45 -7.78 58.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.915 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.87 22.09 61.85 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.9 p -82.26 -10.47 59.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.459 0.171 . . . . 0.0 111.059 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 49.3 ttp -165.78 130.93 2.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.463 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.4 p -145.38 164.12 32.47 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.318 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -155.91 143.02 19.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -108.11 114.7 28.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.178 0.591 . . . . 0.0 110.26 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -94.54 137.56 33.51 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.26 157.9 28.73 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.05 -171.59 41.58 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.8 t -131.58 138.52 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -77.55 121.66 24.2 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -72.64 -38.65 67.64 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -163.58 147.71 10.54 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.772 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.5 p -149.22 137.53 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.155 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -145.17 137.44 25.87 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.2 m -56.45 127.66 32.19 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.849 0.357 . . . . 0.0 111.497 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.6 m120 56.36 63.74 1.9 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.211 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -155.22 -84.1 0.06 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.729 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -164.22 159.28 19.92 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.893 0.377 . . . . 0.0 110.771 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.72 130.77 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -145.42 155.11 42.94 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -158.86 156.11 29.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.986 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.7 m -97.98 133.02 43.02 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.8 mt -97.87 151.3 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.2 -40.45 67.41 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -60.98 -15.71 34.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.913 0.387 . . . . 0.0 110.118 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.27 -0.2 65.96 Favored Glycine 0 N--CA 1.469 0.874 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.65 136.52 45.68 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -99.64 152.37 20.14 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.9 t -140.59 137.11 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -132.79 129.01 38.02 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.5 mt -124.44 112.51 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.9 t -109.98 128.72 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -100.4 127.01 46.83 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.1 p -132.97 153.21 51.66 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -154.0 166.01 34.35 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.847 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 t -136.96 -11.2 1.74 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.883 0.373 . . . . 0.0 110.192 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.21 -127.51 1.29 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.2 p-10 -75.03 6.88 3.69 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 122.988 -0.124 . . . . 0.0 110.749 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 53.1 m -124.59 129.73 51.12 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.0 m -106.91 135.86 47.76 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -110.83 111.15 22.11 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.7 mt -92.35 122.65 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.28 126.84 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -143.01 143.49 31.92 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.236 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.2 m -129.15 146.21 51.14 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -117.51 166.09 12.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.127 0.571 . . . . 0.0 109.606 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 . . . . . 0 N--CA 1.471 0.619 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.796 179.551 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 111.452 0.168 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -54.68 -45.4 73.92 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.897 0.38 . . . . 0.0 110.36 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.5 t -68.17 -33.03 73.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.651 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.3 -51.19 60.32 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -62.44 -38.4 89.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.905 0.383 . . . . 0.0 110.508 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -70.51 -38.29 74.26 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.97 -52.46 65.42 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.096 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.0 tt -60.92 -37.85 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.02 -46.91 79.38 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.427 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -77.87 -32.08 51.74 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 122.193 -0.317 . . . . 0.0 111.095 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.9 m -60.12 -40.73 90.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.732 0.301 . . . . 0.0 110.455 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.1 t80 . . . . . 0 N--CA 1.467 0.394 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.511 -179.638 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.2 pttm . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 120.99 0.424 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.6 mt -50.37 140.23 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.8 m -134.12 135.26 43.06 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.5 m -132.49 160.72 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -138.44 158.72 43.72 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.957 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.501 ' CG2' HD22 ' A' ' 126' ' ' LEU . 3.7 t -133.48 126.43 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.9 p -88.76 109.05 19.84 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.0 t -126.36 127.02 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -97.47 89.13 4.59 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.09 154.75 5.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.032 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.62 132.23 50.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.18 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.4 tt -54.08 -34.74 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.611 0.244 . . . . 0.0 110.929 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.93 -40.31 92.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.083 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -70.18 -48.09 58.78 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.803 0.335 . . . . 0.0 110.786 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.0 -41.7 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.356 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.544 ' NE1' ' ND2' ' A' ' 22' ' ' ASN . 42.9 t-105 -50.66 -39.87 51.93 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.551 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -65.68 -48.35 72.36 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.311 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -68.59 -43.0 77.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.662 0.268 . . . . 0.0 110.971 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -65.57 -19.39 65.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.612 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.544 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 3.1 m-20 -102.57 -22.82 13.94 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.282 0.633 . . . . 0.0 110.583 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -63.19 120.63 63.36 Favored Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.94 -40.98 4.44 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 CA-C-N 120.997 1.392 . . . . 0.0 112.086 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.96 -30.31 63.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.697 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -78.07 -45.17 24.27 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.378 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 31' ' ' CYS . 95.7 mt -59.73 -50.86 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 121.946 -0.471 . . . . 0.0 111.064 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.6 ptm -57.64 -15.49 7.78 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -79.03 -33.27 44.98 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -133.69 20.8 3.89 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.661 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.567 ' C ' ' H ' ' A' ' 33' ' ' ALA . 44.1 t -55.12 129.32 37.64 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.764 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 68.63 -19.33 0.16 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.116 0.484 . . . . 0.0 110.496 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.567 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.64 35.55 23.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.482 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -111.25 97.78 36.89 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.064 0.546 . . . . 0.0 110.087 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.33 -23.21 22.97 Favored 'Trans proline' 0 N--CA 1.505 2.175 0 C-N-CA 122.378 2.052 . . . . 0.0 112.576 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -68.76 -24.67 64.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.536 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -104.76 163.96 12.12 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -141.22 162.33 35.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.21 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -129.81 89.86 44.9 Favored Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -73.95 -9.04 21.94 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 121.694 1.596 . . . . 0.0 111.873 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.1 152.58 6.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.003 0.43 . . . . 0.0 110.105 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.14 145.89 13.75 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.084 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -133.72 150.3 51.5 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -159.86 125.58 4.17 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.698 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -133.25 94.78 3.4 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.7 mt -66.83 97.37 0.47 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.139 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -162.56 135.96 6.05 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.69 133.92 56.54 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.673 0.273 . . . . 0.0 110.307 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.06 5.05 69.58 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.21 165.73 39.69 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.8 p -131.09 161.56 31.8 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.442 ' CD1' ' CE2' ' A' ' 71' ' ' TYR . 30.6 p90 -154.75 170.02 22.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.068 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.8 m -153.69 139.34 17.89 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.5 m -121.33 120.64 35.67 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.3 m -92.87 123.55 36.22 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.0 ptm -142.76 138.6 30.58 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.18 145.33 26.21 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.044 0.45 . . . . 0.0 110.326 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.48 149.8 28.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.765 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -51.46 -39.93 58.45 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.866 0.365 . . . . 0.0 110.775 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -80.21 -9.32 59.72 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.139 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.3 18.21 67.09 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.0 t -62.19 -40.51 96.29 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.659 0.266 . . . . 0.0 110.922 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 44.3 ttp -142.31 136.78 30.05 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.226 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.8 p -145.74 158.86 43.82 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -159.13 139.11 11.94 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -88.56 111.01 21.37 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -94.53 131.01 40.71 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.69 175.11 42.09 Favored Glycine 0 C--O 1.227 -0.335 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.45 -174.01 40.88 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.12 129.39 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.442 ' CE2' ' CD1' ' A' ' 52' ' ' PHE . 74.6 m-85 -72.45 113.48 9.53 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -73.4 -39.05 65.38 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.219 0.533 . . . . 0.0 109.767 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -166.89 146.21 5.4 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.524 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.6 131.03 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -140.03 128.32 22.57 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.5 p -61.51 134.88 57.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.249 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 55.98 55.36 6.99 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.673 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -155.1 -82.52 0.07 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.645 0.259 . . . . 0.0 110.35 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -163.63 160.12 22.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.355 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.7 mt -133.7 134.99 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.06 156.69 42.92 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' A' ' 84' ' ' ILE . 37.7 p90 -161.16 156.26 24.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.5 p -103.5 133.06 49.17 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.661 HD12 ' N ' ' A' ' 84' ' ' ILE . 2.6 mp -93.44 160.37 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.437 ' N ' HG22 ' A' ' 84' ' ' ILE . . . -53.25 -44.95 64.93 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -62.8 -12.8 26.84 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.831 0.315 . . . . 0.0 110.36 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.34 9.56 66.93 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -58.94 155.08 13.98 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -114.57 127.73 55.94 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.7 t -136.93 132.02 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -134.98 133.79 39.85 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 77.1 mt -123.72 114.17 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 43.2 t -111.78 129.54 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -98.92 119.58 37.94 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 39.7 m -120.44 148.77 43.37 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -154.07 158.23 40.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.0 p -135.86 23.33 3.34 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.249 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 100' ' ' THR . . . 88.34 128.31 2.97 Favored Glycine 0 N--CA 1.47 0.96 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 58.07 6.06 0.46 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.824 0.345 . . . . 0.0 111.061 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 98' ' ' GLY . 28.2 m -148.23 137.56 22.08 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.2 m -130.99 125.24 32.8 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -110.32 119.35 38.95 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.4 mt -95.58 120.55 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 36.6 t -105.15 132.07 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -134.0 114.37 13.15 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.7 t -94.52 149.63 21.05 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -144.36 140.9 29.36 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.758 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 . . . . . 0 CA--C 1.52 -0.21 0 CA-C-O 120.528 0.204 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.54 -50.64 59.63 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.871 0.367 . . . . 0.0 110.363 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.5 m -62.33 -38.55 89.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.601 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.44 -52.33 49.9 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.943 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -62.45 -39.44 93.37 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.772 0.286 . . . . 0.0 110.483 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.402 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -74.07 -35.08 64.23 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.625 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.14 -50.54 73.64 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.45 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.4 pt -63.64 -34.53 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.818 0.342 . . . . 0.0 110.798 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.501 HD22 ' CG2' ' A' ' 8' ' ' VAL . 36.0 mt -64.67 -37.07 86.34 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.029 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -61.24 -40.63 94.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.751 0.31 . . . . 0.0 110.461 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.7 t -62.69 -40.3 96.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.549 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 75.9 t80 . . . . . 0 N--CA 1.464 0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.443 -179.563 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.1 mttt . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 81.3 mt -142.28 133.01 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.8 m -137.77 133.43 34.05 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 m -138.7 153.35 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.11 163.94 36.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.049 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.9 m -145.83 157.52 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -102.73 126.73 49.95 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.19 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.06 129.5 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -98.59 89.2 4.31 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.14 155.25 6.43 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.8 135.91 57.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.209 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.6 tp -52.88 -36.49 23.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 121.1 0.476 . . . . 0.0 111.417 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -68.87 -33.62 74.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.167 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -71.42 -51.73 22.36 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.603 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 p -62.51 -36.3 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.676 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.473 ' CE2' ' ND2' ' A' ' 22' ' ' ASN . 68.4 t90 -54.47 -44.0 72.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.979 0.418 . . . . 0.0 110.906 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -69.39 -45.94 68.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.712 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -65.32 -40.56 93.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.982 0.42 . . . . 0.0 110.96 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -73.54 -17.22 61.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.707 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.473 ' ND2' ' CE2' ' A' ' 18' ' ' TRP . 90.4 m-20 -109.41 -20.39 12.93 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.182 0.593 . . . . 0.0 110.72 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -64.41 138.71 97.52 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.8 -43.48 0.43 Allowed 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 121.763 1.642 . . . . 0.0 112.43 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.25 -40.56 96.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 110.909 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -66.69 -46.26 76.17 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.641 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 31' ' ' CYS . 89.2 mt -62.8 -48.51 87.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.431 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 43.2 ttp -60.38 -23.27 64.18 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -65.58 -31.78 73.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.437 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -135.67 14.17 3.42 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.444 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 27' ' ' ILE . 12.0 t -55.73 141.05 39.68 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 122.1 -0.375 . . . . 0.0 110.0 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 72.07 -46.79 0.65 Allowed 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.233 0.958 . . . . 0.0 109.227 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.38 40.58 31.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.307 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.5 m -124.32 139.12 32.17 Favored Pre-proline 0 N--CA 1.481 1.121 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.973 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.42 -30.05 8.65 Favored 'Trans proline' 0 N--CA 1.506 2.253 0 C-N-CA 121.941 1.761 . . . . 0.0 112.51 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.94 6.47 7.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.725 0.298 . . . . 0.0 110.692 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -147.32 158.39 43.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.182 0.515 . . . . 0.0 109.717 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.4 ' CE1' ' O ' ' A' ' 57' ' ' ALA . 14.3 p-80 -146.59 155.21 42.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.229 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.85 89.63 34.25 Favored Pre-proline 0 N--CA 1.476 0.828 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.63 -1.78 11.89 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.167 1.912 . . . . 0.0 111.587 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.71 147.91 6.13 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.025 0.441 . . . . 0.0 110.031 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.68 141.82 18.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.755 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -134.95 137.96 43.6 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -163.17 136.43 5.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.62 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -130.46 99.33 4.96 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 tp -65.43 95.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.877 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -169.54 141.41 2.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.17 135.93 57.79 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.289 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.08 1.7 60.37 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.77 158.43 36.96 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 178.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 t -118.27 165.26 14.05 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.142 0.577 . . . . 0.0 109.851 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -144.8 159.77 42.33 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.157 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.2 m -149.36 123.96 9.77 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.8 p -120.89 123.33 42.25 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.7 m -90.36 117.4 29.05 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 60.7 mtt -129.87 104.55 7.44 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.4 ' O ' ' CE1' ' A' ' 38' ' ' HIS . . . -126.82 156.42 41.32 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.02 148.83 37.76 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -58.73 -39.54 81.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.77 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -70.7 -9.58 57.51 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.72 9.84 63.0 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.2 t -62.99 -39.36 94.5 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 110.887 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 69.5 mmm -122.63 148.97 44.63 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.882 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.3 p -146.81 128.13 14.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.168 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -159.9 155.37 25.47 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -139.71 142.88 36.84 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.274 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.43 143.2 28.4 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.45 152.02 23.7 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.91 -172.44 41.52 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.48 142.15 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 122.974 0.51 . . . . 0.0 110.175 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -79.01 120.53 23.72 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.51 -42.77 58.33 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -168.57 148.31 4.46 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.838 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.57 136.56 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -136.03 124.11 22.95 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.426 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 4.3 m -59.2 130.65 48.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.162 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.432 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 0.7 OUTLIER 40.98 57.67 2.7 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 178.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -157.77 -77.47 0.08 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 110.449 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.2 tp -149.68 133.88 17.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.738 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.437 HD11 ' HE1' ' A' ' 18' ' ' TRP . 61.5 mt -133.02 133.14 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -153.93 160.38 42.09 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -160.2 156.78 27.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.9 m -101.92 127.65 48.66 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.413 HG22 ' H ' ' A' ' 86' ' ' ASP . 86.7 mt -90.54 153.81 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.74 -41.96 67.23 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.413 ' H ' HG22 ' A' ' 84' ' ' ILE . 82.4 m-20 -60.26 -10.58 4.78 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.788 0.328 . . . . 0.0 110.17 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.0 8.81 86.12 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -68.82 150.71 47.51 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -101.89 129.29 48.1 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.8 t -139.77 131.03 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -138.94 141.75 38.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.2 mt -118.97 126.93 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.97 126.82 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -99.12 125.84 44.75 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.8 p -133.64 143.5 48.64 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -154.89 156.14 35.6 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.6 t -115.59 -24.11 8.45 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.973 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.1 -112.14 0.37 Allowed Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -76.77 10.78 2.01 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.613 0.244 . . . . 0.0 110.67 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.3 p -126.72 144.92 50.78 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.7 m -125.55 131.3 52.79 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.296 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -116.33 121.83 43.11 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.9 mt -102.51 128.98 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.9 t -119.26 133.56 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -137.94 146.08 42.8 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.0 p -133.33 148.84 51.9 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -143.31 143.14 31.57 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 . . . . . 0 CA--C 1.518 -0.254 0 CA-C-O 120.529 0.204 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -53.39 -44.42 68.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.876 0.37 . . . . 0.0 110.145 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.2 m -61.58 -40.94 96.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.255 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.97 -51.96 48.94 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -62.39 -37.72 86.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.015 0.436 . . . . 0.0 110.299 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -72.29 -35.77 68.78 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.256 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.91 -51.14 70.96 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.56 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.6 tt -63.06 -40.13 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 120.791 0.329 . . . . 0.0 110.136 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.2 mt -63.85 -38.86 92.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.4 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -61.99 -38.17 87.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.2 t -57.92 -32.79 68.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.762 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 52.7 t80 . . . . . 0 CA--C 1.534 0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.375 -179.88 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttp . . . . . 0 N--CA 1.466 0.354 0 CA-C-O 120.919 0.39 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.538 HD12 HE22 ' A' ' 118' ' ' GLN . 82.7 mt -58.94 131.19 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 t -137.0 149.73 47.67 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.9 m -136.85 158.39 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 161.7 40.31 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.587 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -148.96 143.04 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.886 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.7 m -94.26 119.41 33.01 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.5 t -124.87 128.03 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -95.65 92.47 6.62 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.91 154.52 5.26 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.23 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.89 135.76 57.49 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.339 -0.391 . . . . 0.0 109.956 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.8 tp -50.72 -40.79 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.141 0.496 . . . . 0.0 111.66 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -64.25 -35.27 80.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.551 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -70.54 -46.5 63.48 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.782 0.325 . . . . 0.0 110.424 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.26 -40.39 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.308 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.786 ' CH2' HD11 ' A' ' 80' ' ' ILE . 31.8 t-105 -54.53 -40.49 68.71 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.805 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -67.2 -52.8 36.74 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.278 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -64.84 -42.67 94.74 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.845 0.355 . . . . 0.0 110.885 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -64.13 -18.81 64.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.326 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.589 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 49.6 m-20 -110.2 -25.49 10.14 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 122.845 0.458 . . . . 0.0 112.177 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -53.09 110.21 1.88 Allowed Pre-proline 0 CA--C 1.556 1.196 0 CA-C-O 118.837 -0.602 . . . . 0.0 109.765 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.61 -43.05 58.13 Favored 'Trans proline' 0 N--CA 1.506 2.208 0 CA-C-N 120.869 1.346 . . . . 0.0 111.837 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.57 73.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.949 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -74.15 -42.74 59.46 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.417 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.18 -44.74 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.872 -0.517 . . . . 0.0 110.498 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.8 ptm -70.95 -6.42 38.48 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -84.95 -29.59 24.99 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -133.78 17.9 3.88 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.593 0.357 . . . . 0.0 110.954 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.59 ' C ' ' H ' ' A' ' 33' ' ' ALA . 32.1 p -45.85 128.95 9.26 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.063 0.392 . . . . 0.0 111.457 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 61.54 -11.02 0.06 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 120.982 0.42 . . . . 0.0 110.523 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.59 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 52.58 32.81 12.3 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.673 0.389 . . . . 0.0 111.24 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.5 t -122.8 135.74 26.07 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.011 0.524 . . . . 0.0 110.568 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.87 -9.96 16.86 Favored 'Trans proline' 0 N--CA 1.506 2.249 0 C-N-CA 122.097 1.865 . . . . 0.0 112.418 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -73.91 -24.74 59.73 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.728 0.299 . . . . 0.0 110.737 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -103.66 155.21 18.74 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.663 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -139.02 164.15 30.51 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.1 t -132.36 94.33 23.32 Favored Pre-proline 0 N--CA 1.477 0.925 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.29 -12.01 25.12 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.343 1.362 . . . . 0.0 111.211 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.8 150.8 4.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.418 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.59 141.74 20.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.227 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -138.0 142.07 40.42 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -163.13 135.55 5.35 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -129.86 104.0 7.13 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.64 93.71 1.27 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.914 0.388 . . . . 0.0 110.111 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -171.41 151.06 2.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.662 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.09 137.95 58.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.661 0.267 . . . . 0.0 110.453 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.31 0.74 47.65 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.85 149.44 44.68 Favored Glycine 0 N--CA 1.464 0.533 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.9 p -110.75 144.01 40.38 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -127.16 152.84 46.81 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.3 m -149.94 116.83 5.92 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.7 m -116.52 115.86 26.55 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.1 m -91.84 116.27 28.76 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 71.3 mtp -117.79 129.43 55.67 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.09 135.12 37.17 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.071 0.462 . . . . 0.0 110.57 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.7 149.92 49.38 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.309 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -55.93 -39.7 72.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.626 0.25 . . . . 0.0 110.463 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -76.38 -10.21 59.22 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.62 17.62 62.66 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.6 p -83.93 -9.97 58.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.617 0.246 . . . . 0.0 110.774 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.7 ttt -152.92 120.86 6.12 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.452 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.2 m -144.25 148.68 35.2 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -158.9 164.55 35.56 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 22.4 p-10 -137.08 123.33 20.56 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.804 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -94.11 145.92 24.34 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.05 153.68 25.12 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.27 -171.68 41.05 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -128.63 135.69 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -71.94 121.85 19.81 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -73.56 -38.44 65.2 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -163.05 145.42 10.29 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.508 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.1 t -137.97 130.5 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -146.88 123.8 11.33 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.6 p -51.71 121.92 7.31 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.211 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 54.28 62.02 2.77 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.28 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -156.04 -84.58 0.06 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.753 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 tp -148.42 136.24 20.81 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.771 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.786 HD11 ' CH2' ' A' ' 18' ' ' TRP . 75.2 mt -130.32 127.82 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -153.49 165.29 36.3 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -160.8 154.42 22.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.836 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.1 m -89.35 131.09 35.59 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 80.0 mt -102.27 148.82 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.88 -44.05 71.21 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.0 p30 -61.93 -18.69 61.18 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.367 0.584 . . . . 0.0 110.394 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.07 5.19 77.19 Favored Glycine 0 N--CA 1.47 0.954 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 65.6 mmt-85 -63.04 139.38 58.77 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -89.96 128.53 36.26 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.5 t -141.34 125.96 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -136.84 142.92 42.87 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 75.5 mt -119.86 118.94 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.8 t -104.2 124.29 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -96.15 122.43 38.99 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 36.4 m -140.36 146.62 38.65 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -150.74 164.63 35.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.2 t -137.85 23.51 2.85 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.292 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.12 129.65 2.82 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 55.49 12.02 0.7 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.816 0.341 . . . . 0.0 111.037 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.9 m -153.78 140.75 19.27 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.4 m -125.43 130.68 52.33 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.756 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -110.45 117.03 32.49 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.9 mt -106.85 122.21 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.04 139.56 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -144.98 142.76 30.08 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.048 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.4 p -94.23 152.7 18.5 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -151.49 139.74 20.31 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 N--CA 1.477 0.884 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.34 -179.156 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.538 HE22 HD12 ' A' ' 4' ' ' ILE . 1.5 pp0? . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 119.978 -0.058 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -57.42 -47.32 82.07 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.84 0.352 . . . . 0.0 110.06 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.0 m -64.04 -33.04 74.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.588 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.61 -50.46 67.53 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -62.45 -39.52 93.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.985 0.422 . . . . 0.0 110.429 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -71.91 -37.57 70.06 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.348 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.35 -50.69 72.75 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.836 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 42.0 pt -65.4 -32.75 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 110.734 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.2 -37.01 82.92 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -62.55 -41.56 98.98 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.08 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.9 p -62.52 -32.4 73.33 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.616 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.5 t80 . . . . . 0 N--CA 1.467 0.377 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.579 -179.547 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 pttm . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 121.194 0.521 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.3 mt -54.65 139.99 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 t -129.27 137.43 51.05 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.682 0.614 . . . . 0.0 109.718 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.61 158.08 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.41 158.0 43.8 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.558 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.9 p -146.14 144.78 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.673 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.9 m -97.58 120.79 38.6 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.94 127.5 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -91.7 93.96 9.15 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.8 151.52 3.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.09 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.43 140.44 58.87 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.664 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.7 tp -51.6 -37.22 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.169 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -68.94 -34.32 75.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.435 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -69.3 -50.58 45.44 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.903 0.382 . . . . 0.0 111.218 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -64.3 -36.19 76.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.62 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -58.29 -49.84 75.71 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.614 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -67.64 -45.83 74.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.641 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.45 ' CD2' ' ND1' ' A' ' 26' ' ' HIS . 56.2 t80 -63.88 -44.23 93.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.049 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.414 ' C ' HD22 ' A' ' 22' ' ' ASN . 64.0 t-105 -70.82 -19.65 62.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.626 HD22 ' N ' ' A' ' 22' ' ' ASN . 0.7 OUTLIER -103.05 -23.82 13.66 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.845 0.458 . . . . 0.0 111.437 -179.24 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -62.94 135.17 95.99 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.1 -40.67 0.81 Allowed 'Trans proline' 0 N--CA 1.504 2.142 0 C-N-CA 121.681 1.588 . . . . 0.0 111.745 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.83 -33.0 68.16 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.051 0.453 . . . . 0.0 110.78 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.45 ' ND1' ' CD2' ' A' ' 20' ' ' TYR . 35.5 m170 -76.4 -42.36 44.59 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.573 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.13 -44.93 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 122.161 -0.337 . . . . 0.0 110.804 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.512 ' O ' HG11 ' A' ' 39' ' ' VAL . 25.6 ptm -68.14 -10.64 55.66 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -79.7 -28.6 40.63 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.333 -0.23 . . . . 0.0 110.395 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -137.48 21.61 2.93 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.204 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.539 ' C ' ' H ' ' A' ' 33' ' ' ALA . 29.3 t -55.97 133.17 51.44 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.639 -0.663 . . . . 0.0 110.189 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 69.35 -32.08 0.22 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.108 0.563 . . . . 0.0 110.423 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.539 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 55.66 34.61 23.6 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.327 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.8 p -128.51 138.66 33.54 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.087 0.555 . . . . 0.0 110.033 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.48 -12.53 18.66 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.746 1.63 . . . . 0.0 112.239 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -76.25 -24.61 54.52 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -115.41 140.2 49.34 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.929 0.492 . . . . 0.0 110.545 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -117.33 163.79 15.81 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.251 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 39' ' ' VAL . 7.7 p -131.84 87.62 44.47 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.079 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.75 -8.2 14.59 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.053 1.835 . . . . 0.0 111.559 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.44 153.23 5.11 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.894 0.378 . . . . 0.0 110.055 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.99 152.88 5.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.961 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -141.28 155.52 45.98 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -159.25 103.05 1.61 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.019 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -95.59 86.98 4.58 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 tp -66.4 93.25 0.22 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.357 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -169.93 145.19 2.89 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.61 135.93 56.74 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.425 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.16 -1.05 35.76 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.96 162.28 52.69 Favored Glycine 0 N--CA 1.468 0.81 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.4 p -125.24 157.22 37.1 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.672 0.389 . . . . 0.0 110.262 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -138.16 157.03 47.11 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.318 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.0 m -146.93 116.01 6.92 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.9 m -106.99 112.62 25.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 m -92.88 120.08 32.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.7 ptm -143.14 142.12 31.39 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.79 152.73 40.78 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.028 0.442 . . . . 0.0 110.748 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.08 148.71 50.58 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.636 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -57.89 -39.32 77.58 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.591 0.234 . . . . 0.0 110.523 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -78.05 -6.06 53.41 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.78 17.51 54.57 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.1 p -66.37 -25.52 66.83 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.769 0.319 . . . . 0.0 110.389 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.2 ttt -149.09 145.34 27.18 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.916 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.7 t -142.7 144.85 32.89 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.737 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.408 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 71.1 t80 -159.35 162.53 35.91 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.408 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 30.3 p-10 -138.04 130.69 29.55 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.098 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -94.54 137.61 33.44 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.27 154.96 25.85 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.71 -176.03 40.41 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.4 t -126.24 133.26 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -75.44 115.49 15.15 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -73.85 -44.84 54.31 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.184 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -153.23 145.87 24.23 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 p -148.1 137.3 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -143.06 132.37 23.34 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.9 m -56.77 128.62 37.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.732 0.301 . . . . 0.0 111.453 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 54.88 69.38 0.74 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.767 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -165.84 -80.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -160.35 159.99 31.85 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.976 0.417 . . . . 0.0 110.795 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.9 mt -134.74 135.63 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.86 155.55 41.06 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -159.09 159.65 34.82 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 49.6 m -102.25 129.89 48.79 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.5 tt -94.57 167.1 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.91 -38.11 94.86 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -63.28 -16.77 61.34 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 117.184 0.492 . . . . 0.0 109.962 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.21 11.6 78.05 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -77.86 148.36 34.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -83.92 153.96 23.66 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.0 t -144.99 130.5 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -137.21 122.01 18.74 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.9 mt -122.46 113.93 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.4 p -118.82 131.75 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-O 121.279 0.561 . . . . 0.0 110.034 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -97.13 109.21 22.01 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 61.3 m -98.22 122.95 42.01 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -101.8 146.73 27.38 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.3 m -146.62 99.32 3.19 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.411 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.89 -95.43 0.04 OUTLIER Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -128.56 48.4 2.32 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.006 0.431 . . . . 0.0 110.587 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.6 m -161.35 119.22 2.33 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.0 m -95.27 141.09 29.26 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -127.45 129.48 47.57 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.2 mt -103.07 125.53 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.7 t -122.68 127.83 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -142.92 144.62 32.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.23 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.8 t -136.11 143.11 44.38 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.079 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -127.57 169.19 13.99 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.671 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.473 0.681 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.722 179.143 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 . . . . . 0 CA--C 1.52 -0.193 0 CA-C-O 120.648 0.261 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -54.13 -44.43 71.35 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.805 0.336 . . . . 0.0 110.299 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 78.8 p -68.28 -35.9 78.56 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.83 -51.99 51.6 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -64.22 -37.08 86.21 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.816 0.341 . . . . 0.0 110.421 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -72.4 -37.43 68.7 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.461 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.99 67.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.909 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.5 tt -60.89 -36.96 75.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.8 mt -66.19 -49.1 68.46 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.467 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -75.78 -33.71 60.19 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.664 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.0 m -60.54 -40.34 91.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.32 . . . . 0.0 110.399 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.2 t80 . . . . . 0 N--CA 1.467 0.391 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.512 -179.482 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.8 tttt . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 79.5 mt -46.14 121.28 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 m -112.89 130.7 56.01 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 m -134.48 156.59 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.406 ' CD ' ' N ' ' A' ' 7' ' ' GLU . 1.3 pm0 -148.3 161.29 41.82 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.14 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -145.05 143.84 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.1 m -91.17 117.29 29.5 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.8 t -124.65 128.36 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -100.16 88.57 3.75 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.74 153.59 5.01 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.048 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.12 133.28 52.67 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 20.1 tt -52.25 -37.53 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.776 0.322 . . . . 0.0 111.733 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -58.96 -35.58 73.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.356 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -74.92 -46.07 38.29 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.022 0.439 . . . . 0.0 110.442 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.09 -43.28 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.189 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.698 ' CH2' HD11 ' A' ' 80' ' ' ILE . 28.0 t-105 -54.86 -46.09 74.65 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.84 0.352 . . . . 0.0 110.943 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.78 -45.85 77.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.335 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -65.19 -43.75 90.61 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.894 0.378 . . . . 0.0 111.166 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -69.5 -15.96 63.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.561 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.543 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 86.7 m-20 -109.52 -24.64 10.89 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.274 0.63 . . . . 0.0 111.298 -178.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -65.09 117.23 37.43 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.499 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.97 -34.59 10.33 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 CA-C-N 121.033 1.405 . . . . 0.0 112.005 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -34.22 70.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.002 0.429 . . . . 0.0 110.575 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -81.17 -40.89 23.21 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.405 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.9 -45.4 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 122.069 -0.394 . . . . 0.0 111.088 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.7 ptm -59.32 -12.85 6.35 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.335 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -81.32 -39.71 24.72 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -120.22 20.76 11.95 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.654 0.381 . . . . 0.0 111.183 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.606 ' C ' ' H ' ' A' ' 33' ' ' ALA . 12.9 t -57.54 135.82 56.68 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.829 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.513 ' NE2' ' CG ' ' A' ' 37' ' ' TRP . 26.6 mt-30 67.83 -26.29 0.13 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.612 0.57 . . . . 0.0 110.327 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.606 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 55.5 27.33 10.09 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.565 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.1 t -124.06 139.92 33.64 Favored Pre-proline 0 N--CA 1.478 0.93 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.253 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.54 -8.9 19.8 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 121.95 1.767 . . . . 0.0 111.668 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -83.16 9.26 10.92 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.622 0.249 . . . . 0.0 110.668 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.513 ' CG ' ' NE2' ' A' ' 32' ' ' GLN . 95.7 m95 -151.72 157.72 42.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.242 0.544 . . . . 0.0 110.072 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -147.58 163.5 36.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.105 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.57 93.14 48.69 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 123.023 0.529 . . . . 0.0 109.853 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.46 -8.79 19.81 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.488 1.459 . . . . 0.0 111.597 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.72 151.99 9.56 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.844 0.354 . . . . 0.0 110.228 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.02 144.94 14.96 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.247 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -137.59 145.11 42.41 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -162.03 134.02 5.57 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.853 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -132.99 99.42 4.57 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.5 96.58 0.53 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -166.62 147.77 6.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.09 137.55 58.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.1 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.78 5.19 44.41 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.89 151.54 33.87 Favored Glycine 0 N--CA 1.466 0.655 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.1 p -113.42 161.46 17.28 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -143.51 166.03 25.93 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.215 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.3 m -160.49 128.61 4.6 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.1 m -122.78 123.4 40.96 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -92.35 115.65 28.28 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.3 mtt -120.68 132.43 55.09 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.43 136.15 23.21 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.794 0.331 . . . . 0.0 110.699 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.66 148.77 45.39 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -58.58 -39.54 80.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.723 0.297 . . . . 0.0 110.32 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -74.16 -11.38 60.28 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.25 17.12 67.85 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.4 m -61.89 -40.46 95.5 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.847 0.356 . . . . 0.0 110.725 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 44.4 ttp -147.1 149.55 33.25 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.187 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.1 t -145.04 152.35 39.98 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.329 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -156.5 155.5 32.09 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -138.24 131.11 29.71 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.872 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -95.81 145.36 25.4 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.97 153.31 24.91 Favored Glycine 0 N--CA 1.466 0.65 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -179.09 -171.14 41.93 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.46 145.89 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -82.87 126.12 32.11 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -81.74 -26.9 34.16 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 110.035 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -167.59 140.27 3.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.839 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.5 t -137.24 126.92 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -145.66 124.72 12.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.0 m -50.07 119.57 3.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 53.67 75.8 0.25 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.443 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -168.16 -81.31 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.365 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.435 HD11 ' HE ' ' A' ' 91' ' ' ARG . 7.1 tp -149.94 135.03 17.95 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.902 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.698 HD11 ' CH2' ' A' ' 18' ' ' TRP . 79.0 mt -128.69 130.02 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -153.09 165.35 35.89 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -158.77 164.54 35.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.511 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.6 m -116.26 129.77 56.45 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.7 mm -98.37 149.16 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.961 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.72 -40.39 71.04 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -60.96 -15.8 35.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.656 0.265 . . . . 0.0 110.503 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.4 -2.85 59.35 Favored Glycine 0 N--CA 1.473 1.138 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -64.96 143.77 57.73 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -123.66 139.88 53.55 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.6 t -133.57 134.67 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.435 ' HE ' HD11 ' A' ' 79' ' ' LEU . 77.0 ttt180 -127.51 122.72 34.11 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 68.7 mt -110.78 124.1 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.8 123.21 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -94.98 123.29 38.37 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.9 p -134.06 150.69 51.21 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -154.38 164.4 38.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.902 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 m -149.5 118.53 6.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.753 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.09 -94.47 0.07 OUTLIER Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -130.99 31.77 4.41 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.666 0.386 . . . . 0.0 111.015 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 46.4 m -132.16 124.85 29.89 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.8 m -100.86 133.46 45.3 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -122.37 117.53 26.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.9 mt -98.01 129.04 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.48 130.84 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -132.63 120.07 21.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.0 t -99.22 148.2 24.36 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -136.01 149.92 49.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.445 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 120.531 0.205 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -55.23 -43.48 74.56 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.084 0.469 . . . . 0.0 109.771 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.4 m -62.23 -40.73 97.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.165 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.15 -51.99 48.23 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -63.35 -37.25 86.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.78 0.324 . . . . 0.0 110.277 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -72.1 -36.24 69.41 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.683 0.278 . . . . 0.0 110.338 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.25 70.69 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.789 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.6 tt -62.62 -39.23 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 25.5 mt -63.87 -39.14 93.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -63.89 -40.95 97.7 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m -58.37 -30.65 66.95 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.344 0.403 . . . . 0.0 111.232 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 63.9 t80 . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 120.933 0.397 . . . . 0.0 110.898 -178.589 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -64.34 -25.98 68.28 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 121.012 0.434 . . . . 0.0 110.269 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -71.81 55.45 0.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.95 0.405 . . . . 0.0 110.082 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 82.0 mt -55.42 132.49 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -130.31 139.11 50.74 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.4 m -136.15 156.38 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -145.24 157.48 44.06 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.038 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 p -145.81 142.78 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.9 p -97.18 117.34 31.17 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.55 126.12 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -93.64 88.73 5.96 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.09 0.471 . . . . 0.0 109.863 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.88 153.12 4.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.055 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.74 139.3 58.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.221 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.5 tp -51.07 -36.79 16.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 120.893 0.378 . . . . 0.0 111.612 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -67.66 -33.1 74.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.44 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -71.17 -51.32 25.53 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 p -65.3 -36.59 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.318 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.758 ' CH2' HD11 ' A' ' 80' ' ' ILE . 29.1 t-105 -54.61 -43.41 72.18 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.932 0.396 . . . . 0.0 110.56 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -68.37 -45.33 73.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.622 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -65.71 -44.42 86.14 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.902 0.382 . . . . 0.0 111.497 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -66.75 -20.7 66.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.932 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -102.63 -22.56 13.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.982 0.513 . . . . 0.0 111.512 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -64.16 123.02 80.96 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.93 -39.74 3.07 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 CA-C-N 120.863 1.344 . . . . 0.0 111.889 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.11 -39.21 71.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.894 0.378 . . . . 0.0 110.759 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.9 m170 -66.33 -42.86 87.57 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.64 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 31' ' ' CYS . 97.2 mt -62.61 -43.75 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 93.5 mtp -59.31 -13.45 8.06 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.737 -0.21 . . . . 0.0 111.077 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -85.14 -38.56 18.91 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.978 -0.451 . . . . 0.0 110.759 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -122.4 23.74 9.58 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.729 0.412 . . . . 0.0 111.216 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.552 ' C ' ' H ' ' A' ' 33' ' ' ALA . 38.3 t -54.39 129.37 35.4 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.804 -0.56 . . . . 0.0 110.958 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 68.54 -30.67 0.18 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.341 0.401 . . . . 0.0 110.478 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.65 38.37 29.85 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.048 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.7 p -136.81 141.46 35.15 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.302 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.39 -16.41 21.87 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 122.008 1.805 . . . . 0.0 112.289 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -84.06 14.1 4.48 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -151.41 154.81 37.36 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.171 0.51 . . . . 0.0 110.232 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -142.5 163.01 33.99 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.234 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.589 HG13 ' O ' ' A' ' 39' ' ' VAL . 7.1 p -127.58 89.57 50.72 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.97 -12.22 23.74 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.263 1.309 . . . . 0.0 111.479 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -171.91 153.05 3.13 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.02 0.438 . . . . 0.0 110.577 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -157.84 150.72 22.92 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.214 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -137.08 145.33 43.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.591 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -161.46 132.32 5.22 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.96 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -128.98 96.01 4.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.0 tp -65.8 96.65 0.3 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -167.67 142.31 3.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.964 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.55 138.19 58.41 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.23 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.27 2.44 59.12 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.9 166.49 37.29 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.8 p -129.14 164.95 22.24 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.639 0.376 . . . . 0.0 110.047 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -140.71 164.52 29.98 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.6 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 36.1 m -150.61 122.56 8.19 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.421 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 37.5 m -116.39 116.57 27.94 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.2 m -95.11 119.68 34.04 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 14.8 ptm -145.67 144.83 30.64 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.75 156.15 40.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.061 0.458 . . . . 0.0 110.535 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.81 148.05 40.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.666 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -56.58 -39.87 74.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.763 0.315 . . . . 0.0 110.721 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -76.37 -7.46 55.05 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.18 11.32 67.13 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.5 t -62.93 -41.84 99.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.45 0.167 . . . . 0.0 111.097 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.9 ttt -120.85 146.32 46.7 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -144.11 141.25 29.9 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.81 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.438 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 56.4 t80 -159.98 161.26 34.1 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.438 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 67.4 t0 -138.54 126.56 22.59 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -94.76 135.54 36.13 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.66 155.74 26.5 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.05 -171.4 41.39 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 p -128.72 139.67 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.785 0.434 . . . . 0.0 110.008 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -78.36 124.96 28.69 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -75.85 -40.01 55.55 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.926 0.393 . . . . 0.0 110.09 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -159.83 146.03 15.93 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.844 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.2 t -135.69 130.69 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -145.4 123.61 12.21 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.4 m -55.12 122.28 10.65 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 54.79 60.54 3.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.608 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -156.12 -82.31 0.07 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.089 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.6 tp -147.76 136.8 22.15 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.554 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.758 HD11 ' CH2' ' A' ' 18' ' ' TRP . 69.7 mt -129.79 126.78 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -154.16 164.18 38.92 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -155.05 154.98 33.3 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.941 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.1 m -87.58 129.53 35.07 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.78 139.87 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.66 -43.21 59.43 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -60.72 -18.56 55.09 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.633 0.254 . . . . 0.0 110.73 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.31 0.67 65.13 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -60.71 168.64 2.17 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -125.19 118.38 25.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.789 0.436 . . . . 0.0 110.126 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -131.96 125.12 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -135.24 136.63 41.86 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.0 mt -112.48 111.52 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.9 t -97.36 128.33 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -98.61 122.15 41.45 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.268 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.1 m -144.75 149.67 35.93 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -142.14 129.16 20.78 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.7 m -63.89 -45.8 87.71 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-O 121.135 0.493 . . . . 0.0 109.968 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.09 -69.43 0.08 OUTLIER Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -102.07 10.04 39.83 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.753 0.421 . . . . 0.0 110.963 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 54.7 m -147.18 129.88 16.06 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.2 m -86.65 140.21 30.03 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -120.47 116.69 25.93 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.6 mt -96.19 124.79 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -120.34 128.35 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -142.0 125.43 16.65 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 120.858 0.361 . . . . 0.0 110.541 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.4 p -94.88 150.99 19.59 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -134.47 149.96 50.77 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -102.36 96.95 7.86 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.123 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.51 155.84 36.2 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.898 1.732 . . . . 0.0 112.293 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -82.06 157.03 24.29 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.951 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -79.17 -35.12 42.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.526 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 62.0 p -64.91 -44.72 88.64 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.9 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -87.44 142.87 33.45 Favored Pre-proline 0 N--CA 1.474 0.77 0 CA-C-O 119.457 -0.306 . . . . 0.0 110.551 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -69.93 137.87 35.96 Favored 'Trans proline' 0 N--CA 1.506 2.261 0 C-N-CA 121.573 1.515 . . . . 0.0 111.95 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -64.66 -39.92 94.53 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.689 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -50.96 -46.31 61.1 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.415 ' N ' ' CD2' ' A' ' 117' ' ' LEU . 3.6 mm? -62.97 -50.81 69.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 118' ' ' GLN . 6.4 pt20 -72.14 -33.2 67.6 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.111 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -59.26 -47.68 84.46 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.5 t -68.94 -25.2 64.44 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.278 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.59 -51.87 48.17 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -62.01 -38.14 87.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.902 0.382 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -70.76 -37.08 73.38 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.723 0.297 . . . . 0.0 110.38 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.11 -51.62 69.24 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.795 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.0 tt -63.66 -37.68 80.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.702 0.287 . . . . 0.0 110.381 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.9 mt -63.45 -37.13 86.1 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -60.92 -30.95 70.51 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.562 0.22 . . . . 0.0 110.877 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.7 m -56.15 -35.48 67.21 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.665 0.269 . . . . 0.0 110.968 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -61.67 -43.79 98.19 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -62.57 -44.72 95.62 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 48.7 m -61.05 -37.5 82.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.558 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -61.52 -47.68 84.52 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.444 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 70.4 p -63.48 -32.52 73.99 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.919 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.404 ' C ' ' H ' ' A' ' 136' ' ' ASN . 77.1 tt0 -58.15 -14.01 6.05 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.283 0.563 . . . . 0.0 110.246 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -59.4 -4.93 0.66 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.149 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 138' ' ' GLU . 12.7 m120 -62.58 -16.09 54.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.629 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 67.5 tp 57.6 -78.66 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.785 0.678 . . . . 0.0 110.34 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 136' ' ' ASN . 92.1 mt-10 -58.85 -40.85 85.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.168 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.413 ' O ' ' CG ' ' A' ' 139' ' ' HIS . 56.0 t-80 53.8 17.84 1.4 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.653 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -60.89 145.28 50.8 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.341 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -155.47 146.84 22.81 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.085 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -82.48 118.69 23.42 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 77.9 m80 53.06 -88.45 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.017 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 67.6 m80 . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.541 -179.865 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.494 2.532 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 56.23 -81.52 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 110.782 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 1' ' ' GLY . 67.6 mttm -73.92 53.77 0.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.1 mt -48.45 138.47 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 t -135.69 138.73 43.08 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.7 m -139.14 157.35 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -147.95 159.92 43.37 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.322 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 p -145.82 142.39 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.1 m -97.29 118.25 33.34 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.36 128.16 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -93.69 85.41 4.85 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.45 153.01 3.39 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.981 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.86 135.51 55.82 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.0 tt -54.52 -32.12 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.673 0.273 . . . . 0.0 111.29 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -60.35 -39.72 88.15 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.265 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -73.12 -47.61 42.66 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.38 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.64 -43.38 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.094 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.791 ' CH2' HD11 ' A' ' 80' ' ' ILE . 22.4 t-105 -54.76 -38.16 66.87 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.889 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.58 -53.33 56.19 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.799 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -69.67 -40.29 76.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.545 0.212 . . . . 0.0 111.398 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -59.94 -17.46 37.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.892 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -115.72 -28.18 6.83 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.165 0.586 . . . . 0.0 112.011 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -54.76 107.5 0.88 Allowed Pre-proline 0 N--CA 1.477 0.881 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.941 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.56 -42.49 64.81 Favored 'Trans proline' 0 N--CA 1.508 2.38 0 CA-C-N 121.097 1.427 . . . . 0.0 112.296 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.98 -28.45 66.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.479 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -79.8 -37.66 34.7 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.705 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.24 -44.91 99.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.641 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.5 ptp -54.46 -21.52 10.14 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 120.694 0.283 . . . . 0.0 111.66 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -73.15 -39.49 65.63 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.811 -0.555 . . . . 0.0 111.528 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -124.31 21.72 8.68 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.74 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.522 ' C ' ' H ' ' A' ' 33' ' ' ALA . 17.9 t -60.58 134.25 56.89 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.817 -0.552 . . . . 0.0 110.315 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 69.43 -33.9 0.26 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.998 0.811 . . . . 0.0 110.519 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 53.78 21.57 2.78 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 110.577 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.5 m -108.54 110.13 61.47 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.573 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -51.54 -27.97 26.96 Favored 'Trans proline' 0 N--CA 1.513 2.658 0 C-N-CA 122.112 1.875 . . . . 0.0 112.782 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -74.75 5.33 5.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.656 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -146.89 156.48 43.12 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.415 ' CE1' ' O ' ' A' ' 57' ' ' ALA . 45.8 p-80 -144.1 163.65 32.95 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 39' ' ' VAL . 7.3 p -121.55 94.8 48.44 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 122.886 0.474 . . . . 0.0 109.915 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.32 -8.46 17.38 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.265 1.31 . . . . 0.0 111.782 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.88 154.39 6.29 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.03 150.66 6.66 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -146.39 146.17 30.53 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -164.52 135.97 4.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.47 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -125.45 101.58 7.0 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 tp -65.73 95.79 0.25 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -169.26 141.91 2.62 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.75 137.92 58.15 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.346 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.32 0.86 48.45 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.02 153.94 36.68 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 p -105.22 158.25 16.73 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 120.871 0.367 . . . . 0.0 110.058 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -145.08 154.48 42.53 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.882 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.9 m -151.73 129.88 11.92 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.2 m -123.09 121.48 36.13 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.8 m -94.74 117.35 29.98 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 68.1 mtm -130.89 140.87 50.26 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.415 ' O ' ' CE1' ' A' ' 38' ' ' HIS . . . -147.6 147.4 30.01 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.132 0.491 . . . . 0.0 110.725 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.85 148.38 51.26 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.455 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.43 -40.19 71.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.639 0.257 . . . . 0.0 110.515 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.58 -11.24 59.98 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.12 21.21 63.63 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.7 m -80.95 -12.97 59.3 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.705 0.288 . . . . 0.0 110.674 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.1 ttt -160.59 135.31 7.53 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.8 p -145.07 162.39 37.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.995 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.485 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 52.8 t80 -159.28 163.68 35.55 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.485 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 73.9 m-20 -137.88 123.65 19.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -95.29 141.22 29.13 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.04 152.71 24.26 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.95 -171.73 42.48 Favored Glycine 0 CA--C 1.517 0.174 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.76 137.54 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -70.06 120.88 16.42 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.72 -40.9 63.23 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -164.89 148.08 8.57 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.0 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.8 p -145.86 138.56 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -143.6 130.62 20.59 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.5 m -55.11 121.15 8.14 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.581 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.0 m120 51.62 72.43 0.38 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -168.74 -79.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.378 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 tp -148.53 136.72 21.09 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.498 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.791 HD11 ' CH2' ' A' ' 18' ' ' TRP . 75.3 mt -129.82 129.47 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -154.21 165.07 37.44 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -154.5 155.18 34.39 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.7 m -87.52 129.35 35.11 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.5 139.51 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.63 -40.84 56.17 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -61.3 -17.8 55.41 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.49 3.52 71.7 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -64.11 165.44 9.16 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -121.95 121.98 38.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.955 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.92 129.11 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.56 138.7 43.26 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 73.4 mt -113.36 118.32 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.7 t -105.9 122.73 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.14 125.16 44.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.0 p -132.15 150.91 52.04 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -154.63 147.43 24.4 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.8 p -105.77 -19.47 13.74 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.87 -107.88 0.28 Allowed Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -81.44 7.41 11.89 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.397 0.279 . . . . 0.0 110.69 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.6 m -128.23 124.67 37.25 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.6 m -101.89 135.25 43.77 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -119.09 119.48 34.34 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.5 mt -99.75 127.32 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.87 130.32 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -142.36 144.83 33.36 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.5 t -111.69 149.31 31.78 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -143.12 141.4 31.21 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -97.53 120.41 60.75 Favored Pre-proline 0 N--CA 1.481 1.087 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.229 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.89 151.42 35.62 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 CA-C-N 121.216 1.47 . . . . 0.0 111.472 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -79.97 167.18 20.81 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -71.54 -50.01 35.31 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.606 0.241 . . . . 0.0 110.465 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.9 m -63.01 -45.95 89.97 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.504 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.454 HD22 HD23 ' A' ' 117' ' ' LEU . 23.1 t-20 -80.99 131.91 58.43 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.313 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.73 146.47 48.61 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 121.25 1.3 . . . . 0.0 111.701 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -61.89 -38.75 89.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.4 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -51.1 -46.68 61.92 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.448 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.454 HD23 HD22 ' A' ' 113' ' ' ASN . 60.2 tp -63.38 -43.66 96.94 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.755 0.312 . . . . 0.0 110.188 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -61.5 -53.86 50.81 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.651 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -54.66 -47.81 73.11 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.0 t -61.82 -42.34 98.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.109 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.38 -51.73 56.08 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.563 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.5 -39.37 93.29 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.863 0.331 . . . . 0.0 110.558 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -70.98 -37.06 72.74 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.67 -52.54 64.51 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.762 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.4 tt -66.87 -36.75 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.372 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.9 mt -60.06 -41.94 93.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.187 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 128' ' ' SER . 25.8 p30 -66.4 -30.61 71.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.537 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.406 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 21.9 p -61.03 -37.74 83.66 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.864 0.364 . . . . 0.0 110.654 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -59.52 -41.76 90.71 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.446 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -60.33 -43.49 96.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 97.7 p -61.33 -38.84 88.36 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.794 0.331 . . . . 0.0 110.324 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -62.21 -45.36 93.73 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.393 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 99.2 m -59.08 -49.42 77.96 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.715 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.54 -36.79 84.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.821 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -64.47 -36.83 85.45 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.266 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -62.34 -35.69 79.9 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.206 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 38.7 mt 57.56 -171.81 0.09 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.975 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 54.07 14.95 0.78 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.948 0.404 . . . . 0.0 110.517 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -67.91 139.59 56.46 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.445 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -67.75 142.69 56.19 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -164.25 138.2 5.42 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -162.49 154.33 18.48 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 52.29 84.33 0.05 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.141 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.72 179.929 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.608 ' H3 ' ' NH2' ' A' ' 115' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 109' ' ' PRO . 15.9 t-20 -63.24 -40.43 97.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.841 0.353 . . . . 0.0 110.324 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -72.53 52.89 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.1 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.2 mt -50.83 143.4 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 t -133.42 139.47 46.77 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.7 m -138.88 159.68 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.81 157.15 43.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.591 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.58 144.32 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 m -101.32 119.24 38.46 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.8 t -124.71 131.33 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -93.09 89.3 6.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.82 151.55 4.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.293 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.17 130.14 43.33 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.4 tt -52.58 -33.31 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.577 0.227 . . . . 0.0 111.28 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -60.16 -41.34 92.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.622 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -72.44 -46.55 54.49 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.864 0.364 . . . . 0.0 110.033 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.28 -43.02 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.613 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -55.91 -43.88 77.74 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.787 0.327 . . . . 0.0 110.744 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 23' ' ' GLU . 88.5 tttt -67.82 -47.52 68.81 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.588 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.36 -43.09 95.63 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.697 0.284 . . . . 0.0 111.382 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -61.7 -20.71 63.78 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -106.99 -23.03 12.47 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.134 0.574 . . . . 0.0 111.293 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 19' ' ' LYS . 28.5 tp10 -62.74 122.94 77.41 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 118.703 -0.665 . . . . 0.0 109.54 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.6 -38.61 5.76 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 CA-C-N 120.923 1.365 . . . . 0.0 111.607 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.67 -38.71 78.79 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.989 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -65.64 -44.01 87.73 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.56 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.69 -44.87 99.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 42' ' ' ALA . 1.2 mtm -62.99 -0.02 0.63 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -99.95 -50.25 4.07 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.441 ' O ' ' N ' ' A' ' 32' ' ' GLN . 68.6 p-90 -102.74 -3.67 26.13 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 31' ' ' CYS . 24.8 p -67.51 72.06 0.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.437 0.637 . . . . 0.0 110.009 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 30' ' ' TRP . 23.7 pt20 -153.18 48.74 0.7 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.05 -7.44 3.96 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.692 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 t -148.6 138.04 12.41 Favored Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.13 -11.9 23.32 Favored 'Trans proline' 0 N--CA 1.506 2.23 0 C-N-CA 121.71 1.607 . . . . 0.0 112.425 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -84.74 14.99 4.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.024 0.44 . . . . 0.0 110.17 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -146.57 146.69 30.55 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.975 0.417 . . . . 0.0 110.228 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -130.52 162.68 28.7 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 39' ' ' VAL . 8.2 p -114.03 95.17 37.27 Favored Pre-proline 0 N--CA 1.475 0.784 0 C-N-CA 122.69 0.396 . . . . 0.0 110.585 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.79 -19.48 14.22 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 CA-C-N 120.346 1.159 . . . . 0.0 111.29 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -178.56 160.03 1.2 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.4 0.438 . . . . 0.0 110.212 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.519 ' HB3' ' SD ' ' A' ' 28' ' ' MET . . . -156.41 148.81 23.48 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.135 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -136.05 146.13 46.76 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -156.02 104.23 2.27 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.691 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -98.28 86.42 3.65 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.97 93.22 0.11 Allowed 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.328 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -169.5 143.77 2.86 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.16 137.13 58.08 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.273 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.51 1.51 37.3 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.14 159.35 43.22 Favored Glycine 0 N--CA 1.468 0.808 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.7 m -119.3 155.89 31.01 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.007 0.432 . . . . 0.0 109.919 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -135.9 163.41 30.3 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.388 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.8 m -151.12 115.37 5.06 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.656 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.1 m -115.1 119.94 38.13 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 m -94.8 125.11 39.24 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.5 mtt -130.77 106.14 8.26 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.89 144.69 46.26 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.022 0.439 . . . . 0.0 110.769 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.83 148.28 50.49 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -57.99 -40.34 80.44 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.719 0.295 . . . . 0.0 110.386 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -76.18 -9.16 58.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.039 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.99 13.88 62.52 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.2 t -65.69 -19.89 66.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.988 0.423 . . . . 0.0 110.62 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.0 ttt -148.16 145.89 28.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.878 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.8 t -143.35 139.11 29.91 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.427 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 62.9 t80 -159.84 158.82 31.68 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.427 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 29.4 p-10 -138.9 134.16 32.87 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.39 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.02 139.63 31.1 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.38 152.36 24.07 Favored Glycine 0 N--CA 1.465 0.605 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.69 -174.12 41.13 Favored Glycine 0 CA--C 1.517 0.167 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.12 136.58 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -74.52 118.8 17.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.11 -37.01 69.6 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -165.09 149.2 8.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.732 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.02 131.91 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -143.64 122.14 12.44 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.5 m -59.45 123.9 18.3 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.91 0.386 . . . . 0.0 111.964 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 52.4 59.41 4.53 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.021 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -157.27 -76.6 0.09 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.467 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 tp -152.94 135.26 15.01 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.1 mt -131.33 130.6 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -152.2 164.88 36.44 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -157.95 157.25 32.71 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.6 m -107.96 130.73 55.02 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.8 mm -93.86 151.55 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.78 -39.6 68.28 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -63.28 -11.91 25.31 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.956 0.378 . . . . 0.0 110.648 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.86 -2.13 61.77 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -72.44 152.02 42.22 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.493 ' NZ ' ' NH2' ' A' ' 91' ' ' ARG . 88.4 tttt -136.43 152.05 50.17 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -136.41 120.58 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.289 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.493 ' NH2' ' NZ ' ' A' ' 89' ' ' LYS . 87.4 mtt-85 -101.66 130.68 48.07 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 66.9 mt -118.42 125.07 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.48 124.34 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -100.4 123.44 44.63 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.1 m -122.73 124.37 43.21 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -100.73 121.57 41.88 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.5 p -105.78 8.83 33.02 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.99 122.63 0.66 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 58.32 9.9 1.16 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.715 0.293 . . . . 0.0 110.905 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.7 m -160.17 119.63 2.8 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 67.9 m -98.01 136.8 37.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -119.26 121.55 39.9 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.7 mt -100.4 123.74 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.7 t -123.95 126.68 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -143.56 145.96 32.94 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.329 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 78.3 p -126.14 148.3 49.42 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -122.45 162.45 21.66 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -129.43 77.97 76.48 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.464 ' O ' ' ND2' ' A' ' 2' ' ' ASN . 91.8 Cg_endo -76.72 170.21 20.3 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.976 1.784 . . . . 0.0 111.512 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -62.15 151.28 36.27 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.19 0.519 . . . . 0.0 110.635 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -70.02 -42.76 72.54 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.604 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 t -63.86 -34.45 77.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.579 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -65.73 148.69 98.06 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.3 108.74 2.57 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 121.961 1.774 . . . . 0.0 111.443 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.608 ' NH2' ' H3 ' ' A' ' 1' ' ' GLY . 8.8 ptm180 -68.28 -25.22 65.05 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.065 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -58.95 -50.75 72.87 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.681 0.277 . . . . 0.0 111.147 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.1 mt -64.87 -38.58 91.43 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.844 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -60.9 -45.05 96.14 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.52 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -54.12 -46.21 72.11 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.973 0.416 . . . . 0.0 109.929 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.9 t -66.77 -38.83 87.35 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.248 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.03 -52.04 54.73 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.683 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -64.47 -35.96 82.62 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.776 0.322 . . . . 0.0 110.151 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -72.81 -37.1 67.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.691 0.281 . . . . 0.0 110.432 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.11 -50.55 73.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 9.0 tt -62.27 -37.99 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 53.5 mt -63.57 -42.58 98.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -65.33 -39.29 92.21 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.3 t -58.38 -33.39 69.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -53.03 -25.28 11.87 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.883 0.373 . . . . 0.0 110.904 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -64.12 -38.91 92.77 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.632 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.9 t -58.14 -45.44 87.38 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.708 0.289 . . . . 0.0 110.395 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -64.18 -45.11 89.81 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.971 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.4 m -62.53 -40.59 97.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.842 0.353 . . . . 0.0 110.703 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -69.54 6.68 1.02 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.02 0.438 . . . . 0.0 110.713 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -59.81 -9.68 3.11 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.695 0.283 . . . . 0.0 110.499 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -83.36 8.16 14.48 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.423 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.94 -44.34 96.96 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.984 0.421 . . . . 0.0 110.069 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -164.85 142.45 6.28 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.052 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -163.87 150.45 11.68 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.708 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -170.16 61.44 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 52.18 -169.22 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.724 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.438 ' O ' ' N ' ' A' ' 144' ' ' HIS . 37.1 p-80 -170.35 93.92 0.22 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 55.46 -83.66 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.922 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 142' ' ' HIS . 95.4 m-70 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -72.25 -7.4 49.13 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.143 0.497 . . . . 0.0 110.438 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -77.88 51.06 0.91 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.517 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mt -69.98 140.57 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 t -137.28 160.07 40.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.35 166.71 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.3 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -147.36 158.66 44.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.076 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -149.45 144.99 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.75 121.67 44.5 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -128.97 137.38 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -94.82 89.7 5.77 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.98 150.86 3.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.957 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 128.54 36.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.766 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.2 tt -53.36 -36.24 26.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.632 0.254 . . . . 0.0 110.998 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -57.86 -42.27 84.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.673 0.273 . . . . 0.0 110.592 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -69.93 -47.03 64.0 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.392 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.0 t -62.33 -40.38 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.515 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 66.5 t90 -54.07 -39.76 66.57 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.741 0.305 . . . . 0.0 111.345 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -63.26 -51.03 67.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.954 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -68.89 -37.25 78.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.965 0.412 . . . . 0.0 110.684 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -61.01 -18.56 58.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.853 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -115.56 -26.44 7.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.155 0.582 . . . . 0.0 110.908 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -50.64 108.73 1.09 Allowed Pre-proline 0 CA--C 1.555 1.145 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.172 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.19 -43.4 57.54 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 CA-C-N 120.512 1.218 . . . . 0.0 112.835 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.86 -30.75 69.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.556 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -79.28 -38.98 34.1 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.186 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' A' ' 31' ' ' CYS . 98.2 mt -61.93 -45.38 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 O-C-N 121.964 -0.46 . . . . 0.0 110.657 -177.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 20.5 ptp -61.73 -17.78 57.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.252 0.549 . . . . 0.0 111.251 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -74.96 -29.46 60.93 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.162 -0.336 . . . . 0.0 111.292 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -139.34 23.26 2.54 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.601 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.583 ' C ' ' H ' ' A' ' 33' ' ' ALA . 36.8 t -55.43 125.79 22.39 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.621 -0.674 . . . . 0.0 110.239 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 67.3 -22.88 0.11 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.868 0.73 . . . . 0.0 110.459 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.583 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 51.79 37.01 19.34 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 122.761 0.424 . . . . 0.0 110.977 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.2 m -111.65 96.45 32.56 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.954 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.5 -25.59 10.9 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 122.118 1.879 . . . . 0.0 112.562 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -69.04 -26.63 65.07 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.491 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -106.22 170.26 8.02 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -147.78 152.04 37.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.996 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 39' ' ' VAL . 6.0 p -116.73 96.92 49.57 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.76 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.17 -9.51 17.77 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 121.541 1.494 . . . . 0.0 111.662 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.91 155.32 6.76 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.903 0.383 . . . . 0.0 110.298 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.05 145.47 13.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.922 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -139.17 144.99 38.82 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -163.0 132.46 4.21 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.585 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -135.47 103.63 5.54 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mp -69.56 98.74 1.18 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -166.31 137.66 3.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.74 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.0 134.1 56.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.286 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.9 1.69 63.21 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.25 163.27 44.83 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.8 p -129.65 161.39 30.7 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -137.84 166.84 23.03 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.93 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.4 m -151.72 110.37 3.81 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.1 p -107.07 113.01 26.21 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.0 m -86.35 113.24 22.17 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.4 mtt -122.57 129.28 51.75 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.77 150.14 29.83 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.49 148.38 48.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.596 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.72 -31.97 66.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.958 0.409 . . . . 0.0 110.565 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -74.75 -9.53 58.65 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.125 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.24 4.67 44.8 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.7 m -62.74 -34.95 78.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.641 0.258 . . . . 0.0 110.656 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 71.4 mtp -126.26 136.44 52.79 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.149 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.8 p -145.96 129.65 17.09 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.642 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -155.13 162.42 41.0 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.8 127.04 24.54 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.673 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -94.23 144.76 25.24 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -148.59 151.58 23.75 Favored Glycine 0 N--CA 1.461 0.357 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.01 175.3 42.25 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 t -121.54 132.82 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -74.82 116.12 15.18 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -73.62 -39.56 64.46 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.225 0.536 . . . . 0.0 109.591 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -166.71 147.62 6.05 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.553 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.53 130.74 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -137.82 126.17 23.27 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.4 m -58.31 123.44 16.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.71 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 51.26 69.17 0.68 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.915 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -166.98 -81.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.806 0.336 . . . . 0.0 110.148 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 tp -150.51 131.78 14.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.422 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.0 mt -132.14 131.99 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -153.97 164.47 38.38 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -162.69 155.97 19.96 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.4 p -100.45 132.28 45.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 86' ' ' ASP . 88.9 mt -93.78 140.96 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.48 28.62 1.03 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 84' ' ' ILE . 29.0 t70 -120.41 -9.53 9.45 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.009 0.523 . . . . 0.0 109.897 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.79 -14.77 57.41 Favored Glycine 0 N--CA 1.479 1.533 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -75.13 174.97 8.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -146.24 151.28 37.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.715 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.6 t -140.55 136.81 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.994 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -136.51 133.69 36.77 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 75.0 mt -116.0 128.01 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.81 122.98 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -95.37 127.35 41.34 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.3 m -137.47 141.64 41.55 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -151.19 161.18 43.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 65.4 p -127.48 -13.68 5.4 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.095 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.06 -122.4 0.94 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -73.08 5.69 3.23 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.899 -0.177 . . . . 0.0 110.76 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.4 m -122.55 127.25 49.24 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.0 m -108.73 133.24 53.07 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -110.97 126.12 54.43 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.9 mt -106.3 128.38 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.9 t -129.19 133.89 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -142.19 135.24 28.73 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 86.2 p -95.13 153.33 17.7 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -145.17 145.92 31.55 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -117.33 87.22 23.7 Favored Pre-proline 0 N--CA 1.478 0.946 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -77.75 160.69 30.99 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.14 1.893 . . . . 0.0 111.468 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -58.01 155.02 11.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.034 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -65.15 -38.95 92.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.823 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 59.2 p -63.21 -43.0 99.35 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.712 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -60.96 118.99 41.01 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.253 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.54 134.27 39.29 Favored 'Trans proline' 0 N--CA 1.506 2.254 0 C-N-CA 121.242 1.295 . . . . 0.0 112.123 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -69.64 -39.33 77.2 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.129 0.49 . . . . 0.0 110.852 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 116' ' ' GLU . 27.3 mp0 -67.78 -46.48 71.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.026 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 117' ' ' LEU . 1.6 tt -70.17 -52.61 22.11 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.02 0.438 . . . . 0.0 111.123 -177.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -37.44 65.84 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.945 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -59.0 -39.17 81.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.043 0.449 . . . . 0.0 110.255 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.8 t -64.86 -36.27 83.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.56 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.12 -51.72 57.15 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -63.35 -37.54 87.66 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.008 0.432 . . . . 0.0 110.145 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -73.53 -35.07 65.51 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.429 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.46 -50.34 74.09 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.686 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 36.4 pt -63.62 -34.19 66.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.725 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.0 mt -66.87 -39.4 87.52 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.026 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -63.8 -41.19 97.96 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 22.4 m -62.24 -35.15 78.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.837 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -57.78 -28.43 63.97 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.037 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.45 -41.05 98.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.313 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 97.0 p -58.54 -34.87 71.48 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 110.909 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -61.59 -46.48 89.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.474 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.6 p -64.71 -35.02 79.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.709 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.52 -29.58 68.2 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.734 0.302 . . . . 0.0 110.408 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -65.14 -1.92 2.53 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.489 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -61.36 -41.36 96.94 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.543 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 76.1 mt -88.86 76.36 7.96 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.046 0.451 . . . . 0.0 110.039 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -166.79 -60.63 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.923 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.452 ' ND1' ' N ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -164.78 149.77 9.6 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.427 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -63.85 -52.06 61.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 0.0 110.339 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 47.65 75.9 0.12 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.766 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 70.1 m80 52.7 90.34 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.683 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -60.58 -45.4 94.1 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.797 0.332 . . . . 0.0 110.457 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 69.6 m80 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.618 179.869 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -63.07 -40.14 96.79 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.696 0.284 . . . . 0.0 110.509 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -71.42 55.43 0.23 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 84.3 mt -57.83 139.67 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 t -133.67 141.63 47.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.774 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.76 155.3 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -148.8 162.09 40.49 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.549 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 m -149.01 152.62 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.494 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.67 119.48 38.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.171 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.8 t -123.8 127.29 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -94.9 89.34 5.6 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.95 151.37 4.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.974 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.58 135.78 56.32 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.9 tt -52.45 -37.14 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -60.62 -36.06 77.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.461 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -72.7 -48.24 40.56 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.262 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.5 t -64.0 -41.13 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.127 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.79 ' CH2' HD11 ' A' ' 80' ' ' ILE . 31.0 t-105 -52.97 -39.42 62.96 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.081 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -62.31 -49.7 74.58 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.528 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -65.86 -41.38 91.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.609 0.242 . . . . 0.0 110.925 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -68.78 -16.82 63.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.409 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.535 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 2.4 m120 -112.24 -28.7 7.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.254 0.622 . . . . 0.0 112.333 -178.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.05 135.02 96.14 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.04 -42.29 0.31 Allowed 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 121.406 1.404 . . . . 0.0 111.537 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.67 69.93 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.844 0.355 . . . . 0.0 111.016 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.511 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.2 OUTLIER -76.32 -38.92 55.32 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.787 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 31' ' ' CYS . 95.1 mt -62.95 -44.02 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 O-C-N 122.031 -0.418 . . . . 0.0 111.042 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.4 ptp -63.2 -20.87 65.81 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.858 0.361 . . . . 0.0 111.066 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -67.57 -32.11 72.64 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.116 -0.365 . . . . 0.0 110.888 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -135.39 19.95 3.38 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.448 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.471 ' C ' ' H ' ' A' ' 33' ' ' ALA . 21.9 t -58.73 133.93 56.38 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.75 -0.594 . . . . 0.0 110.429 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.2 tp60 71.33 -39.87 0.46 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.213 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 56.44 29.84 15.99 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.878 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.2 m -115.12 106.68 50.99 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.269 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.73 -23.08 19.17 Favored 'Trans proline' 0 N--CA 1.506 2.212 0 C-N-CA 121.999 1.799 . . . . 0.0 112.413 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.33 2.65 12.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.683 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -142.15 169.7 17.1 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.094 0.473 . . . . 0.0 109.848 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -146.03 163.33 35.57 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.35 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 39' ' ' VAL . 6.7 p -123.73 91.21 49.93 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 123.364 0.666 . . . . 0.0 109.777 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.34 -11.78 20.88 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.296 1.33 . . . . 0.0 111.559 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.21 152.24 6.07 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.02 146.55 9.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.24 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -134.72 145.94 48.96 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -152.56 114.91 4.47 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -133.18 95.44 3.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.84 93.8 6.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.853 0.835 . . . . 0.0 109.457 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -149.08 137.28 20.81 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.436 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.8 123.45 12.43 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.776 0.322 . . . . 0.0 111.0 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.79 1.66 78.87 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.03 163.18 47.13 Favored Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.2 p -128.22 159.81 34.04 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.742 0.417 . . . . 0.0 110.098 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.458 ' CD1' ' CE2' ' A' ' 71' ' ' TYR . 42.5 p90 -152.94 169.83 21.9 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.344 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.1 m -161.31 141.97 11.11 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.9 m -121.87 123.01 40.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.8 m -93.22 118.06 30.8 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.1 mtm -127.91 132.94 49.26 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.72 147.68 29.15 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.065 0.459 . . . . 0.0 110.225 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.9 148.51 48.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.552 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -58.41 -34.17 70.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.739 0.304 . . . . 0.0 110.239 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -73.03 -10.22 59.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.979 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.94 15.8 58.64 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.2 m -83.7 -17.69 40.49 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 122.886 -0.185 . . . . 0.0 110.812 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 67.9 mtp -134.43 140.82 46.54 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.893 0.377 . . . . 0.0 110.247 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 96.5 p -144.38 149.6 36.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.184 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -155.29 161.49 41.09 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.786 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -136.07 99.73 4.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.711 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -94.46 134.1 37.34 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.47 172.85 41.84 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.28 -176.65 39.95 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.9 t -118.96 128.84 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.458 ' CE2' ' CD1' ' A' ' 52' ' ' PHE . 57.8 m-85 -71.9 112.23 7.82 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -73.64 -38.13 65.1 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.329 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -165.1 151.53 10.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.776 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.2 p -143.68 142.83 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -145.17 121.64 11.01 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.7 m -52.89 120.83 6.26 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.813 0.34 . . . . 0.0 111.91 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.4 m120 51.58 69.96 0.6 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.667 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -167.86 -77.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.332 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 tt -150.49 136.15 18.19 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.199 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.79 HD11 ' CH2' ' A' ' 18' ' ' TRP . 83.1 mt -129.55 131.41 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.44 162.21 41.51 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -157.31 155.52 30.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.829 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 84.9 m -98.32 131.79 44.33 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 86' ' ' ASP . 5.1 mp -94.58 139.44 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.66 26.93 0.61 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 84' ' ' ILE . 24.1 t0 -119.67 -12.79 9.21 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.76 -7.69 63.26 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.349 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.425 HH21 ' CD ' ' A' ' 110' ' ' GLU . 35.8 mmt180 -74.96 143.44 43.67 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.513 -0.404 . . . . 0.0 110.118 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -110.84 135.4 51.45 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.17 136.96 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -134.52 135.14 42.15 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.6 mt -119.61 128.34 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.2 t -118.4 129.99 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -97.23 123.15 40.93 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 67.1 p -128.58 140.56 51.72 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -154.08 148.03 25.58 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.1 p -99.56 -18.74 17.22 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.063 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.09 -102.81 0.21 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -75.72 -6.79 52.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.402 0.144 . . . . 0.0 110.805 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.9 p -107.44 165.18 11.59 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.3 m -143.14 135.48 27.26 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.14 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -124.93 124.2 41.52 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.7 mt -105.64 126.85 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.56 134.45 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -137.24 131.51 32.47 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 89.3 p -136.91 127.68 27.24 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -156.93 168.88 26.15 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.737 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.54 102.3 54.08 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.833 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.65 -169.8 0.78 Allowed 'Trans proline' 0 N--CA 1.501 1.971 0 C-N-CA 121.219 1.28 . . . . 0.0 111.22 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.425 ' CD ' HH21 ' A' ' 88' ' ' ARG . 81.0 mm-40 -56.47 137.15 53.62 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.619 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -83.49 -36.82 23.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.795 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.5 t -63.64 -34.22 77.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.974 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -73.89 150.28 88.19 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.242 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -64.66 102.54 0.42 Allowed 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 121.571 1.514 . . . . 0.0 110.7 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 78.9 mtm-85 -60.65 -25.6 66.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.055 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -59.59 -51.2 70.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.664 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.0 mt -65.46 -38.0 88.53 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.296 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -57.42 -39.63 76.62 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.635 0.255 . . . . 0.0 110.837 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -50.88 -48.48 60.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.6 t -71.4 -34.83 70.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.11 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.7 -52.38 51.14 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.21 -0.519 . . . . 0.0 111.826 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -63.21 -34.88 78.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 110.125 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -74.9 -34.16 62.13 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.075 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.08 -49.45 77.29 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 10.0 tt -61.26 -41.57 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.97 -40.55 96.66 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.046 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -63.46 -39.38 94.32 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.8 m -58.51 -41.29 85.07 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.713 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -59.19 -47.73 84.23 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.271 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -63.98 -43.09 96.77 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.007 0.432 . . . . 0.0 110.208 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 38.8 t -60.12 -39.36 85.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.797 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.471 ' CZ ' ' ND2' ' A' ' 136' ' ' ASN . 61.8 t80 -60.13 -48.26 82.47 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.47 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 76.0 p -62.88 -45.5 92.26 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.737 0.303 . . . . 0.0 110.631 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -66.48 -38.11 86.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.271 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.01 -40.9 99.14 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.395 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.471 ' ND2' ' CZ ' ' A' ' 132' ' ' TYR . 84.9 m-20 -91.62 -4.73 54.94 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.05 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.0 mt 53.03 -178.15 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.534 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -70.44 73.58 0.52 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.984 0.421 . . . . 0.0 109.946 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -168.89 147.39 3.99 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.53 127.99 34.49 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -72.55 101.98 3.13 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -66.01 145.89 55.34 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.139 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 52.24 89.34 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.002 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.608 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -69.08 -15.93 63.56 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.101 0.477 . . . . 0.0 110.565 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -73.13 55.73 0.43 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.701 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.6 mm -52.92 140.07 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 t -137.35 134.46 36.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.86 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.6 m -138.97 158.18 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -147.16 158.01 43.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.04 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 p -149.14 140.68 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.888 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.3 p -92.69 124.71 36.89 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.42 125.62 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -93.37 88.24 5.9 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.18 151.7 3.98 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.103 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.92 132.43 52.05 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.8 tt -54.06 -33.09 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.7 0.286 . . . . 0.0 111.103 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -59.01 -40.43 84.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.656 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -73.59 -46.9 44.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.928 0.394 . . . . 0.0 110.153 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -61.77 -43.06 96.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.719 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -55.92 -40.88 73.76 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.788 0.328 . . . . 0.0 110.883 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -68.41 -48.31 65.0 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.027 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.507 ' CD2' ' ND1' ' A' ' 26' ' ' HIS . 9.9 m-85 -66.74 -42.34 86.4 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.867 0.365 . . . . 0.0 110.902 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -62.88 -15.73 55.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.184 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -112.0 -23.27 10.6 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.032 0.533 . . . . 0.0 111.358 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -69.13 122.28 84.78 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 118.809 -0.615 . . . . 0.0 109.712 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.61 -32.16 24.89 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 CA-C-N 121.104 1.43 . . . . 0.0 111.895 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.62 75.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.966 0.412 . . . . 0.0 110.764 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.507 ' ND1' ' CD2' ' A' ' 20' ' ' TYR . 45.8 m170 -80.05 -42.52 23.57 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.993 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 31' ' ' CYS . 92.3 mt -63.04 -48.11 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 122.123 -0.36 . . . . 0.0 110.842 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -64.11 -12.2 37.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.783 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -78.46 -28.11 46.52 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.871 -0.15 . . . . 0.0 111.107 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -133.37 5.89 3.79 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.994 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.499 ' C ' ' H ' ' A' ' 33' ' ' ALA . 37.0 t -50.44 138.09 17.84 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.075 -0.391 . . . . 0.0 110.623 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 71.68 -39.94 0.46 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.69 39.15 31.12 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.148 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.9 m -134.29 140.81 37.03 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 122.749 0.42 . . . . 0.0 110.286 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -75.78 -10.32 19.94 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.873 1.715 . . . . 0.0 112.559 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -88.1 15.08 7.89 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.983 0.421 . . . . 0.0 110.262 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -150.16 155.26 39.46 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.137 0.494 . . . . 0.0 109.758 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -142.56 163.46 32.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.047 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.4 t -127.72 87.08 56.79 Favored Pre-proline 0 N--CA 1.475 0.825 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.83 -20.7 44.98 Favored 'Trans proline' 0 N--CA 1.505 2.167 0 C-N-CA 122.369 2.046 . . . . 0.0 111.825 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.92 161.54 8.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.68 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.74 146.08 16.1 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.449 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -140.93 152.08 44.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -161.29 132.95 5.6 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.04 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -122.58 86.93 2.66 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.9 tp -67.21 94.9 0.39 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.939 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -169.02 144.14 3.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.03 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.5 137.7 57.93 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.317 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.89 -1.47 54.25 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.64 172.83 41.3 Favored Glycine 0 N--CA 1.47 0.929 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 t -139.02 172.92 12.14 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.396 0.278 . . . . 0.0 110.556 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -138.76 167.54 21.76 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.203 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.5 m -157.74 121.61 4.13 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.6 m -123.77 124.93 43.79 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.2 m -90.29 114.4 26.45 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.7 mtt -119.11 129.73 55.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.44 143.58 32.68 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.136 0.494 . . . . 0.0 110.223 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.68 148.53 51.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.33 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -56.35 -39.96 73.7 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.556 0.217 . . . . 0.0 110.475 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -79.21 -7.17 58.02 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.897 0.38 . . . . 0.0 110.141 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.35 18.84 67.93 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.4 p -65.63 -34.88 79.25 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.838 -0.213 . . . . 0.0 110.683 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.3 ttt -137.33 145.88 43.93 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.9 t -143.76 145.45 32.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.885 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.422 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 66.8 t80 -159.09 166.63 31.19 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.422 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 74.3 m-20 -137.78 121.05 16.93 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -93.54 140.39 29.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.847 0.356 . . . . 0.0 110.168 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -157.22 157.77 28.35 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.74 -177.67 41.55 Favored Glycine 0 N--CA 1.458 0.112 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -123.61 131.66 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -72.5 115.25 11.54 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -73.66 -47.08 42.59 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -149.79 144.11 25.81 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 74' ' ' VAL . 9.6 p -133.04 128.15 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -138.13 111.21 7.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 t -56.35 131.16 47.46 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.257 0.551 . . . . 0.0 112.289 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 49.85 51.89 15.68 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.453 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -157.69 -80.81 0.06 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.688 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 tp -146.27 134.8 22.07 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.2 mt -130.33 131.27 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -152.15 162.71 40.72 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -158.16 154.67 27.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.665 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.3 m -94.78 129.8 41.59 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 88.6 mt -93.63 153.49 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.56 -41.98 65.51 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.816 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -61.49 -10.84 8.61 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.061 0.458 . . . . 0.0 110.632 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 91.53 1.79 70.98 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -77.32 142.94 39.15 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -106.42 162.38 13.75 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.142 0.496 . . . . 0.0 110.395 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.4 t -141.17 121.34 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.778 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -112.41 123.22 49.81 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 71.1 mt -117.06 119.89 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.6 t -107.91 118.22 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -93.41 122.75 36.15 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.8 m -131.72 143.65 50.42 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -152.93 147.36 25.87 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 80.7 p -102.47 -19.25 14.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.014 0.435 . . . . 0.0 109.842 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.43 -104.73 0.23 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 1.3 m-20 -77.12 -2.08 32.45 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 122.21 0.204 . . . . 0.0 111.113 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.8 m -119.91 124.24 45.53 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.2 m -105.51 133.89 49.52 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -115.48 124.57 51.44 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.0 mt -104.66 125.42 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.4 t -119.73 128.31 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -127.94 123.47 34.95 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.3 m -134.72 128.27 32.61 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.945 0.402 . . . . 0.0 110.096 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -157.13 166.8 32.24 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.567 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -97.33 116.02 65.84 Favored Pre-proline 0 N--CA 1.477 0.903 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.392 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.47 168.47 22.71 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 121.741 1.627 . . . . 0.0 110.989 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -58.13 145.68 36.02 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.747 0.308 . . . . 0.0 110.377 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -70.33 -39.72 74.58 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.18 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 46.9 p -63.77 -44.43 93.46 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.511 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -73.59 135.92 78.1 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.118 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.08 133.07 47.9 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 CA-C-N 120.444 1.194 . . . . 0.0 111.12 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -68.68 -37.39 79.54 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.225 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -58.58 -42.41 87.94 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.33 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.2 tp -63.44 -44.29 94.94 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.722 0.296 . . . . 0.0 110.718 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.65 -46.13 89.62 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.529 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -52.28 -46.64 65.95 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.5 m -66.9 -39.62 87.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.183 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.73 -52.01 51.65 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.77 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -63.83 -35.92 82.19 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.825 0.345 . . . . 0.0 110.449 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -72.01 -38.01 69.68 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.785 0.326 . . . . 0.0 110.161 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.79 72.36 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.124 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.3 tt -62.34 -37.86 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.3 mt -63.87 -40.24 96.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -63.38 -40.88 98.44 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.2 m -60.95 -38.37 85.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.619 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -59.36 -43.11 92.89 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.663 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -60.32 -48.07 83.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.818 0.342 . . . . 0.0 110.447 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 78.1 p -64.74 -44.32 90.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.386 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -62.06 -47.25 85.51 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.412 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.0 m -61.06 -46.06 92.22 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.705 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -67.88 -34.0 75.83 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.457 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -62.82 -4.39 2.09 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.613 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -58.77 -22.44 58.14 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.903 0.382 . . . . 0.0 110.636 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.2 pp -168.64 153.03 5.87 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.134 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -170.09 28.14 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.315 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 53.4 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.989 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -160.06 148.45 17.05 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.471 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -69.96 149.48 47.72 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.07 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -66.16 140.49 58.2 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -62.83 -45.74 91.17 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.897 0.379 . . . . 0.0 110.327 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.483 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.4 m120 55.47 34.11 22.37 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.614 0.245 . . . . 0.0 110.782 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -72.62 55.22 0.36 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.293 0.568 . . . . 0.0 110.117 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.6 mt -65.14 136.37 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 t -137.47 150.91 47.93 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.56 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.6 m -136.0 161.71 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.669 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -139.45 158.92 43.31 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.694 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.12 142.93 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 m -95.05 123.28 38.45 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.4 t -126.98 123.21 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -90.79 87.03 6.5 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.83 152.12 3.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.99 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.63 137.2 57.69 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.7 tt -52.69 -38.26 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.721 0.296 . . . . 0.0 111.35 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -60.81 -35.25 76.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.222 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -74.51 -48.06 29.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.01 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -62.71 -43.93 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.102 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.557 ' NE1' ' ND2' ' A' ' 22' ' ' ASN . 24.4 t-105 -54.27 -39.11 66.58 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.875 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -64.02 -55.76 20.0 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.506 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -69.39 -42.93 74.46 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.837 0.351 . . . . 0.0 111.492 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -59.74 -16.62 28.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.324 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.557 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 83.0 m-20 -112.71 -21.72 11.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.282 0.633 . . . . 0.0 109.895 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -67.55 120.6 74.28 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.736 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.63 -36.56 18.97 Favored 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 121.512 1.474 . . . . 0.0 111.941 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.73 -31.71 69.87 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.104 0.478 . . . . 0.0 110.562 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -80.93 -45.92 15.97 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.789 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.6 mt -61.68 -47.32 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.621 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -63.61 -3.57 2.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.12 0.486 . . . . 0.0 111.072 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -90.25 -29.59 18.07 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 122.098 -0.376 . . . . 0.0 110.341 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 60.6 p-90 -135.73 21.95 3.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.128 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.571 ' C ' ' H ' ' A' ' 33' ' ' ALA . 28.5 p -55.43 131.14 45.18 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.353 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.483 ' NE2' ' CD1' ' A' ' 37' ' ' TRP . 49.9 tt0 68.57 -29.1 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.527 0.517 . . . . 0.0 110.467 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.571 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 53.48 39.72 30.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.429 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 t -128.28 136.45 29.08 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.796 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -73.21 -17.54 24.36 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 122.035 1.823 . . . . 0.0 112.372 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -81.93 13.06 3.52 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.753 0.311 . . . . 0.0 110.687 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.483 ' CD1' ' NE2' ' A' ' 32' ' ' GLN . 87.3 m95 -149.87 159.95 43.97 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.331 0.586 . . . . 0.0 109.664 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.405 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 83.6 t60 -149.13 163.43 37.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.222 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 39' ' ' VAL . 7.2 p -128.6 96.86 29.06 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.869 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.1 -9.2 19.19 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 121.927 1.752 . . . . 0.0 111.747 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.15 153.89 7.05 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.834 0.35 . . . . 0.0 110.544 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.47 145.87 13.17 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.185 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -141.04 151.96 44.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -162.41 135.28 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.922 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -133.97 99.12 4.34 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.427 HD22 ' N ' ' A' ' 46' ' ' LEU . 4.4 mm? -67.75 95.22 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.074 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -168.15 145.25 4.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.673 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.83 137.11 58.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.056 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.97 3.57 36.86 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.13 146.14 33.03 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.6 m -107.45 154.25 21.62 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -141.52 156.81 45.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.426 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.7 m -148.25 128.0 13.4 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.1 m -123.81 121.14 34.63 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 m -92.25 124.86 36.63 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.1 mtp -135.63 135.95 40.62 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.16 147.22 30.3 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.956 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.4 148.88 50.95 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.425 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -57.51 -40.48 78.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.71 0.29 . . . . 0.0 110.397 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.24 -10.05 59.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.035 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.14 14.25 68.24 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 85.3 p -67.27 -33.49 75.42 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.668 0.271 . . . . 0.0 110.616 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.3 ttt -129.2 149.37 51.03 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.846 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.2 t -144.27 142.4 30.43 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.724 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.446 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 57.8 t80 -159.47 159.0 33.03 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.446 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 68.3 m-20 -139.12 129.85 26.09 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.867 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -94.95 134.58 37.46 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.39 149.17 20.79 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.79 -172.05 41.86 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -131.97 139.37 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -73.97 122.94 23.37 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.525 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -77.21 -32.56 56.02 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -165.41 144.91 6.6 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.722 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.6 t -135.7 130.28 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -143.09 116.86 9.28 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 65.8 p -57.33 134.2 55.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.696 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 53.76 56.02 7.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.554 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -155.01 -79.58 0.09 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -162.32 161.52 27.57 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.907 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.5 mt -136.06 141.04 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -153.43 160.27 42.56 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -159.46 165.66 32.62 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.3 m -120.94 133.76 55.29 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.7 mm -99.72 153.85 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -55.57 -41.49 81.8 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -60.59 -18.2 51.36 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.717 0.294 . . . . 0.0 110.488 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.28 -3.66 47.52 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -65.37 146.51 54.81 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -136.44 145.48 45.29 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.578 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.69 137.97 31.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -121.45 130.32 53.5 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 76.8 mt -116.97 120.19 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.72 128.37 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -95.9 123.67 39.59 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.7 m -121.14 145.0 48.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -153.44 161.8 41.91 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.3 p -132.69 -47.96 0.88 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.227 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.74 120.74 0.59 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 56.0 15.82 1.91 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 111.039 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.4 m -151.56 139.18 19.66 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 48.4 m -125.84 132.11 52.28 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -117.83 122.52 43.61 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.0 mt -96.68 128.06 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.0 t -121.73 132.49 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -136.8 134.79 37.38 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 83.9 p -138.92 130.45 27.29 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -155.93 170.12 22.86 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -112.29 93.37 22.04 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 123.736 0.648 . . . . 0.0 109.856 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.53 -166.98 0.43 Allowed 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 122.04 1.827 . . . . 0.0 111.382 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -54.44 116.5 2.68 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.283 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -69.09 -32.07 71.23 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.302 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 80.7 p -62.57 -43.43 98.83 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.303 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -68.66 148.4 98.05 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.721 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.01 138.98 88.76 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 121.387 1.391 . . . . 0.0 112.048 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -66.47 -40.3 89.26 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -63.3 -43.01 99.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.735 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.54 -51.37 65.76 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 120.896 0.379 . . . . 0.0 110.182 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -61.1 -50.84 71.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.582 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -58.0 -41.88 83.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.399 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 74.1 m -58.3 -32.83 68.82 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 123.412 0.445 . . . . 0.0 110.556 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.27 -44.72 12.7 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -60.45 -39.43 87.5 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.75 0.31 . . . . 0.0 111.587 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -76.09 -34.66 59.54 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.076 0.465 . . . . 0.0 110.546 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.96 -50.92 72.23 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.5 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.7 tt -61.14 -36.62 73.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.0 mt -66.42 -36.61 83.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 45.2 m-20 -62.26 -40.72 97.15 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.525 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 91.7 p -62.17 -33.89 75.38 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.983 0.421 . . . . 0.0 110.656 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -59.68 -41.15 90.02 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.541 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -59.24 -41.02 87.74 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.37 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.8 m -60.41 -40.79 92.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.496 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -61.31 -47.55 85.42 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.64 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 75.8 p -62.27 -33.8 75.33 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.489 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -66.83 -33.84 76.5 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.848 0.356 . . . . 0.0 110.085 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -76.43 -18.79 58.63 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.991 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -70.03 -18.04 63.29 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.937 0.399 . . . . 0.0 111.029 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.418 HD22 ' N ' ' A' ' 137' ' ' LEU . 4.3 mm? -62.56 -41.88 99.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.336 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -62.81 83.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.54 ' CD2' ' H ' ' A' ' 141' ' ' HIS . 80.7 t60 -169.25 -87.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.811 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 82.1 t60 55.98 7.88 0.33 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.048 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.54 ' H ' ' CD2' ' A' ' 139' ' ' HIS . 30.0 m170 -103.51 62.74 0.78 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.275 0.56 . . . . 0.0 110.213 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -64.16 -41.25 97.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.682 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 52.15 87.32 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.711 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 . . . . . 0 C--O 1.218 -0.572 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.132 -179.678 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 55.18 81.83 0.11 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.693 0.282 . . . . 0.0 110.573 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -71.87 -67.38 0.54 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.388 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.2 mt -131.04 134.91 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -135.26 139.16 44.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.49 153.82 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -148.81 162.12 40.44 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.924 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.7 p -148.34 140.8 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.703 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.5 p -89.59 119.74 30.28 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.83 124.34 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -93.21 88.54 6.08 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.31 153.33 4.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.743 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.08 134.0 55.38 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.8 tt -51.78 -36.22 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -60.03 -35.59 75.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.359 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -75.21 -44.93 43.67 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 109.958 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.6 t -63.39 -43.8 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.36 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.571 ' CE2' ' ND2' ' A' ' 22' ' ' ASN . 72.1 t90 -57.24 -46.31 83.12 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.473 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.01 -44.69 88.36 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.751 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -66.49 -44.28 83.06 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.879 0.371 . . . . 0.0 110.962 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -69.29 -18.33 63.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.483 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.571 ' ND2' ' CE2' ' A' ' 18' ' ' TRP . 8.6 m-20 -98.49 -26.24 14.51 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.062 0.545 . . . . 0.0 111.14 -178.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -64.95 119.96 62.75 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.81 -36.32 4.79 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 CA-C-N 120.863 1.344 . . . . 0.0 111.869 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.59 86.19 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.843 0.354 . . . . 0.0 111.142 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -66.84 -40.57 88.01 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.58 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.452 ' O ' ' N ' ' A' ' 31' ' ' CYS . 96.5 mt -63.31 -43.8 98.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.8 mtp -55.88 -12.27 1.31 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.599 0.238 . . . . 0.0 111.279 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -86.33 -28.73 23.5 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.154 -0.341 . . . . 0.0 110.978 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -136.36 21.66 3.18 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.481 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.586 ' C ' ' H ' ' A' ' 33' ' ' ALA . 10.4 t -57.12 131.34 49.62 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.66 -0.65 . . . . 0.0 110.479 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 66.14 -27.83 0.12 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.689 0.618 . . . . 0.0 110.864 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 47.3 29.62 1.3 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.539 0.335 . . . . 0.0 111.017 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.7 m -108.12 135.55 19.89 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.264 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.76 -17.3 20.31 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.517 1.478 . . . . 0.0 111.983 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -86.87 8.67 22.0 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.705 0.288 . . . . 0.0 110.578 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -148.4 156.31 42.33 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.314 0.578 . . . . 0.0 110.261 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -143.96 150.38 38.23 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.105 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 39' ' ' VAL . 8.4 p -111.5 89.57 10.87 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.889 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.78 -11.72 20.08 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 121.334 1.356 . . . . 0.0 111.422 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -170.15 152.47 4.23 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 120.982 0.42 . . . . 0.0 110.47 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.26 151.92 18.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.248 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -139.13 150.93 46.24 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.627 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -161.23 131.45 5.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.863 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -130.27 97.53 4.45 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -71.05 94.54 1.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.926 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -167.97 140.15 3.04 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.18 137.78 58.04 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.684 0.278 . . . . 0.0 110.28 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.42 -1.58 50.17 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.97 164.88 44.91 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.4 p -126.27 157.88 37.16 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.841 0.456 . . . . 0.0 110.323 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -132.93 156.58 46.99 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.431 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.2 m -146.92 119.54 8.54 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.9 p -114.73 113.69 24.63 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.2 m -89.78 114.78 26.55 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.2 mtt -128.5 133.79 48.54 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.78 145.62 26.72 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.947 0.403 . . . . 0.0 110.176 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.58 147.58 53.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.377 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -56.33 -32.94 65.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.858 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -83.08 -7.01 59.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.08 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.82 16.34 59.13 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.8 m -60.85 -38.7 86.43 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.718 0.294 . . . . 0.0 110.763 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.4 ttp -145.31 146.42 31.62 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.047 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.4 t -143.97 155.72 44.15 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.917 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.466 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 56.4 t80 -153.8 165.18 36.84 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.466 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 30.8 t0 -138.26 119.46 14.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.186 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -93.33 136.57 33.47 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.95 154.36 25.46 Favored Glycine 0 N--CA 1.465 0.622 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.16 -173.39 40.9 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 t -123.75 132.92 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -71.3 121.35 18.32 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.54 -42.19 62.01 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -159.85 146.14 15.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.778 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.5 t -134.56 129.44 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -145.41 121.75 10.93 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.1 m -58.38 129.18 40.81 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.43 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 54.32 56.37 7.01 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.578 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -155.95 -83.95 0.06 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.005 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 tp -149.17 134.87 18.73 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.682 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.9 mt -127.29 127.97 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.11 164.18 38.51 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -156.07 154.39 30.9 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.906 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.3 m -87.97 131.76 34.5 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.7 mt -104.78 144.41 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.55 -42.49 57.9 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.419 ' CG ' HH12 ' A' ' 88' ' ' ARG . 44.2 m-20 -62.02 -21.35 64.81 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.766 0.317 . . . . 0.0 110.351 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.62 2.94 72.04 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.419 HH12 ' CG ' ' A' ' 86' ' ' ASP . 96.3 mtm-85 -65.83 140.81 58.42 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -92.11 122.03 34.22 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.245 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.9 t -135.47 122.52 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -136.49 142.76 43.56 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 77.3 mt -113.27 124.05 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.4 t -106.75 125.42 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -102.6 122.16 43.84 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.5 m -131.07 149.77 52.45 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -151.79 154.26 35.89 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.659 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.1 p -132.77 40.2 3.27 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.111 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.08 131.19 0.16 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 p30 47.35 17.33 0.07 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.087 0.555 . . . . 0.0 111.849 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.5 m -152.78 135.81 15.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.026 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.7 m -128.93 130.48 46.83 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -117.63 126.24 52.17 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.9 mt -101.18 123.82 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.01 128.52 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -142.99 140.58 31.09 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.0 m -137.01 142.65 42.52 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -153.94 155.63 35.98 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.362 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.54 139.23 74.45 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.739 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.75 -170.3 0.88 Allowed 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 121.964 1.776 . . . . 0.0 111.158 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 78.91 27.85 0.42 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.145 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -85.32 -71.39 0.53 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.631 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.6 m -123.63 -29.88 3.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.793 0.437 . . . . 0.0 111.37 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.405 ' OD1' ' NE2' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -139.04 163.92 42.87 Favored Pre-proline 0 N--CA 1.484 1.268 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.881 -176.263 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.89 171.31 7.49 Favored 'Trans proline' 0 N--CA 1.508 2.358 0 C-N-CA 122.607 2.204 . . . . 0.0 112.303 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -59.98 -51.6 68.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.167 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -50.94 -50.92 56.88 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 tp -65.86 -40.14 91.39 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.075 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.405 ' NE2' ' OD1' ' A' ' 113' ' ' ASN . 26.5 mm-40 -64.76 -52.59 56.13 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.769 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.38 -54.49 46.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.881 0.372 . . . . 0.0 110.092 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.6 t -64.05 -42.07 97.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.917 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.05 -52.13 50.13 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.191 -0.528 . . . . 0.0 111.827 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -65.08 -41.61 94.9 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.645 0.259 . . . . 0.0 110.344 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -65.74 -37.82 87.44 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.413 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.69 68.79 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 31.3 pt -65.3 -35.47 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.905 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.3 mt -64.89 -37.11 86.54 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -62.97 -37.46 87.2 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.6 m -69.07 -33.64 73.87 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.792 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -58.32 -50.63 72.94 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.683 0.277 . . . . 0.0 111.358 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -66.21 -36.0 81.92 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.255 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 36.3 t -60.83 -34.88 75.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.718 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -60.35 -43.57 96.38 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.75 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.2 p -62.57 -34.58 77.24 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.651 0.262 . . . . 0.0 110.661 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -68.28 -40.43 81.84 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.018 0.437 . . . . 0.0 109.83 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -66.93 -28.37 68.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.935 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -66.95 -14.68 63.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.659 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.6 tp -62.12 150.04 39.63 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.121 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 54.7 33.76 20.12 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.562 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -161.5 -8.78 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.384 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -63.38 -41.45 98.79 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -168.16 57.33 0.06 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.242 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -65.04 -42.67 94.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.9 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -64.76 146.74 54.37 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.419 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.689 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.626 ' N ' ' HE ' ' A' ' 115' ' ' ARG . 26.3 p30 -64.55 -10.83 28.64 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.329 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -73.08 51.88 0.32 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.909 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.59 137.36 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.2 m -122.87 133.27 54.42 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.8 m -138.74 160.05 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.21 165.9 30.47 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.231 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.02 144.25 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.2 p -92.12 125.42 36.79 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.59 130.7 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -97.25 92.82 6.19 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.06 152.53 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.966 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.33 138.06 58.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.202 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.7 tp -51.56 -37.79 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 121.067 0.461 . . . . 0.0 110.994 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -69.02 -36.74 78.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.15 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -68.64 -51.94 36.66 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 111.244 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -63.51 -36.51 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.364 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.498 ' NE1' ' ND2' ' A' ' 22' ' ' ASN . 27.5 t-105 -54.92 -49.55 71.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.828 0.347 . . . . 0.0 110.587 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.7 -45.15 83.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.374 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.451 ' CD2' ' ND1' ' A' ' 26' ' ' HIS . 50.1 t80 -63.95 -43.83 94.66 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 111.186 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -71.1 -19.08 62.5 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.463 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.498 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 86.1 m-20 -103.65 -23.92 13.42 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.999 0.519 . . . . 0.0 110.972 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.25 134.38 95.81 Favored Pre-proline 0 CA--C 1.553 1.064 0 CA-C-O 119.191 -0.433 . . . . 0.0 109.858 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.69 -41.49 0.55 Allowed 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.544 1.496 . . . . 0.0 111.622 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.67 -29.35 66.53 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.918 0.389 . . . . 0.0 110.695 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.451 ' ND1' ' CD2' ' A' ' 20' ' ' TYR . 33.3 m170 -79.93 -45.82 17.84 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.234 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 90.6 mt -63.52 -46.6 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 122.006 -0.434 . . . . 0.0 110.645 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -66.1 -3.37 5.4 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.71 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -90.58 -26.87 19.47 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.183 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -138.04 23.05 2.82 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.433 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.595 ' C ' ' H ' ' A' ' 33' ' ' ALA . 9.6 t -56.52 133.99 53.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.191 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 65.92 -23.99 0.1 Allowed 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.538 0.524 . . . . 0.0 110.668 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.595 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 53.3 28.19 7.0 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.507 0.194 . . . . 0.0 110.613 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.1 m -112.8 104.17 55.82 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 122.953 0.501 . . . . 0.0 110.058 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -50.09 -13.44 0.64 Allowed 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 122.266 1.977 . . . . 0.0 112.625 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -82.63 11.84 5.34 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.669 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -146.72 162.72 37.92 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -146.57 162.63 37.96 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.969 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.6 t -126.16 96.28 37.2 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.84 -10.99 23.63 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 121.76 1.64 . . . . 0.0 111.877 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.02 152.94 6.64 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.934 0.397 . . . . 0.0 110.473 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.68 150.09 9.98 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.458 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -143.65 156.25 44.5 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -157.98 104.18 1.9 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.699 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -91.99 87.62 6.26 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.2 tp -66.11 93.36 0.2 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.716 -0.394 . . . . 0.0 109.968 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -170.48 145.91 2.69 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.48 137.74 58.25 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.142 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.23 -1.58 25.2 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -77.26 163.49 51.98 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.8 m -124.14 155.41 38.5 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -135.04 158.05 45.35 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.467 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.7 m -146.17 122.37 10.84 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.6 m -119.12 119.63 34.76 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.6 m -88.86 113.4 24.37 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 93.2 mtp -119.14 124.66 47.38 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.35 140.74 33.82 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.17 150.37 47.57 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.08 -37.75 64.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.692 0.282 . . . . 0.0 110.523 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -81.17 -7.42 59.56 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.125 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.76 14.68 37.98 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.9 t -67.4 -19.14 65.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.733 0.301 . . . . 0.0 110.489 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 47.6 ttp -159.85 134.99 8.05 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.972 0.415 . . . . 0.0 110.383 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m -146.16 154.58 41.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.259 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -154.88 146.94 23.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.33 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -108.19 119.99 41.08 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.389 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -93.92 137.69 32.87 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.44 153.9 25.13 Favored Glycine 0 N--CA 1.46 0.27 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.3 178.21 43.15 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.33 134.15 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -75.68 121.05 21.92 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -75.22 -39.2 60.26 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -162.34 146.4 11.98 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.849 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.5 p -149.95 138.67 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.656 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -148.99 134.64 18.72 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.8 m -48.07 118.22 2.27 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.454 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 54.11 79.6 0.13 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.377 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -167.9 -83.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.472 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 tt -152.78 141.49 20.96 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.774 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 63.1 mt -130.16 130.52 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -152.94 160.55 43.05 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -160.57 155.2 23.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.644 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.4 p -91.84 134.3 34.88 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.666 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.411 HG22 ' H ' ' A' ' 86' ' ' ASP . 79.6 mt -104.71 147.37 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.05 -41.38 59.98 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.411 ' H ' HG22 ' A' ' 84' ' ' ILE . 82.5 m-20 -60.72 -17.76 50.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.777 0.323 . . . . 0.0 110.148 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.75 3.72 80.15 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -65.88 141.52 58.22 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -95.4 135.26 37.24 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.2 t -139.55 128.64 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -136.15 133.73 37.51 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.6 mt -116.59 116.18 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.5 t -101.13 116.02 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -90.89 132.52 35.87 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.5 p -132.25 156.93 45.63 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -143.85 148.69 35.85 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.2 m -150.82 87.05 1.4 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.94 -134.29 50.93 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -79.0 39.88 0.39 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.749 0.309 . . . . 0.0 110.498 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.8 m -150.09 147.62 28.0 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.2 m -134.0 146.38 50.35 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.406 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -132.68 131.08 40.91 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.5 mt -107.55 128.15 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.15 126.96 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -144.59 145.55 31.85 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 95.3 p -132.37 148.72 52.43 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -131.34 174.81 9.7 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -135.73 78.14 49.76 Favored Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.07 167.84 5.27 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.999 1.799 . . . . 0.0 111.701 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -58.8 148.67 29.0 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.177 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -68.64 -33.16 73.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.332 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.2 m -62.64 -45.48 92.63 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.992 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -73.27 143.31 83.0 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.717 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -71.23 141.34 39.15 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 121.521 1.48 . . . . 0.0 111.6 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.626 ' HE ' ' N ' ' A' ' 2' ' ' ASN . 79.9 mtt85 -65.92 -36.67 84.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.173 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 116' ' ' GLU . 22.3 mp0 -53.37 -48.43 68.59 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.239 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.4 tp -63.08 -44.86 94.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.864 0.364 . . . . 0.0 110.312 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -63.97 -46.62 83.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.651 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -53.74 -46.98 71.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.935 0.398 . . . . 0.0 110.385 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 81.5 p -64.67 -37.37 87.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.134 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.57 -52.45 46.04 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.531 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -66.41 -37.09 84.43 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.905 0.383 . . . . 0.0 110.541 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -70.55 -39.02 74.23 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.458 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.16 -52.0 67.38 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.726 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.4 tt -62.23 -37.97 79.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.7 mt -64.47 -41.99 96.17 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.28 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -67.39 -41.83 84.31 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.2 t -61.37 -32.83 72.75 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.467 0.48 . . . . 0.0 110.875 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -52.58 -14.08 0.46 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.862 0.363 . . . . 0.0 111.031 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -60.68 -38.2 84.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.645 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.6 m -58.28 -45.67 87.47 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.775 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -66.0 -44.69 84.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.045 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 95.1 m -61.87 -47.47 84.88 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.887 0.375 . . . . 0.0 110.745 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -78.43 8.39 5.2 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.813 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -62.12 -6.65 3.17 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.939 0.4 . . . . 0.0 110.31 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -63.01 -39.71 95.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.137 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.14 175.7 13.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.934 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -82.83 165.69 19.61 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.61 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -64.71 133.17 51.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.275 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -155.0 162.46 41.08 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.867 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -168.67 82.94 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.744 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -71.03 130.17 40.88 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -61.14 -87.12 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.692 0.282 . . . . 0.0 110.449 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 144' ' ' HIS . 35.8 p-80 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.472 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.478 ' C ' ' HE ' ' A' ' 115' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -62.69 -40.72 98.01 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.695 0.283 . . . . 0.0 110.378 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -72.68 51.5 0.27 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.374 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.9 mt -50.17 143.01 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 t -129.91 133.96 47.18 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.4 m -139.69 158.34 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -148.65 162.88 38.83 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.335 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 p -145.3 140.59 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.3 p -93.36 119.33 32.36 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.2 t -127.48 128.7 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -98.98 88.22 3.92 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.29 154.43 4.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.041 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.25 118.84 7.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.2 tt -51.68 -34.96 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.167 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -60.31 -39.82 88.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -73.24 -45.43 55.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.238 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.88 -42.34 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.688 0.28 . . . . 0.0 110.499 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.462 ' HE1' HD11 ' A' ' 80' ' ' ILE . 21.0 t90 -48.92 -34.59 13.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.616 0.246 . . . . 0.0 111.123 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -61.55 -47.86 83.64 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.631 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -69.36 -42.37 75.31 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.699 0.285 . . . . 0.0 110.572 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -65.93 -15.63 63.14 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.307 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.442 ' ND2' ' CD1' ' A' ' 18' ' ' TRP . 2.1 m-80 -108.81 -26.88 10.06 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.377 0.671 . . . . 0.0 111.478 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -76.83 125.84 86.54 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.54 -31.36 13.72 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 121.427 1.418 . . . . 0.0 111.883 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.63 -37.29 78.25 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.437 0.461 . . . . 0.0 110.876 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -79.42 -41.45 27.66 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.988 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.48 -49.06 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.239 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.9 ptm -60.46 -16.35 35.59 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.495 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -72.28 -34.99 68.59 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -127.68 5.29 6.12 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.092 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.541 ' C ' ' H ' ' A' ' 33' ' ' ALA . 30.5 t -51.35 140.52 17.09 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 71.36 -36.64 0.37 Allowed 'General case' 0 CA--C 1.536 0.432 0 O-C-N 123.698 0.624 . . . . 0.0 109.573 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.541 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 56.21 34.81 24.65 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.533 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.1 m -121.93 136.03 25.84 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 122.816 0.446 . . . . 0.0 110.48 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.28 -20.34 16.42 Favored 'Trans proline' 0 N--CA 1.503 2.074 0 C-N-CA 121.832 1.688 . . . . 0.0 112.524 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -78.04 -24.06 47.94 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.543 0.211 . . . . 0.0 110.991 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -109.54 153.79 23.63 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.411 ' CD2' ' O ' ' A' ' 57' ' ' ALA . 6.1 p80 -144.77 162.87 35.68 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.3 t -120.74 95.25 48.99 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.12 -10.77 22.95 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 121.637 1.558 . . . . 0.0 111.688 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -167.49 151.99 6.81 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.893 0.378 . . . . 0.0 110.433 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -162.41 146.4 11.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.245 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -139.21 152.92 47.74 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -160.57 127.77 4.33 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.857 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -133.89 93.58 3.13 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.17 102.34 1.33 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.174 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -163.8 129.92 3.12 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.55 123.19 12.35 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.715 0.293 . . . . 0.0 110.67 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.68 4.92 90.23 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.28 173.01 52.95 Favored Glycine 0 N--CA 1.467 0.745 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.5 t -134.08 164.21 27.84 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 117.058 0.429 . . . . 0.0 110.045 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -148.8 169.13 21.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.067 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.1 m -148.99 125.32 10.87 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.8 m -120.5 118.31 29.91 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.3 m -94.89 117.93 30.94 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 46.4 ttp -137.06 130.25 31.05 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' A' ' 38' ' ' HIS . . . -153.54 158.04 40.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.208 0.528 . . . . 0.0 110.157 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.84 150.72 48.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.778 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -58.03 -38.12 75.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.587 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -71.23 -11.1 60.74 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.91 6.63 60.36 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.1 m -63.78 -39.96 95.52 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.598 0.237 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.2 mtm -117.44 142.2 47.42 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.133 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.8 p -144.23 149.24 36.04 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.872 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -154.49 154.21 32.77 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -138.18 120.15 15.47 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.589 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -93.7 121.83 35.54 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -132.46 134.92 7.83 Favored Glycine 0 N--CA 1.473 1.161 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.74 -175.11 44.67 Favored Glycine 0 CA--C 1.518 0.28 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.5 m -132.38 156.81 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.894 0.378 . . . . 0.0 110.207 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -88.34 124.51 33.99 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.517 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.32 -38.49 65.8 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -167.46 149.6 5.84 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.664 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.7 t -134.59 132.46 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -141.46 117.42 10.53 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 m -55.88 123.69 15.13 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.964 0.412 . . . . 0.0 111.349 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 52.14 66.22 1.27 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.011 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -167.08 -77.55 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.227 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tp -151.82 131.6 13.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.51 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.462 HD11 ' HE1' ' A' ' 18' ' ' TRP . 64.6 mt -132.94 131.69 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -153.09 165.56 35.22 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -157.28 164.79 37.28 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 54.3 m -115.36 132.57 56.58 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.8 mm -99.28 150.05 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.22 -40.49 67.62 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.424 ' CB ' ' NH1' ' A' ' 88' ' ' ARG . 63.1 m-20 -61.66 -19.41 62.28 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.59 0.233 . . . . 0.0 110.709 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.93 -3.08 48.32 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.424 ' NH1' ' CB ' ' A' ' 86' ' ' ASP . 84.5 mtt85 -64.72 144.2 57.4 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -120.97 146.42 46.7 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.567 0.542 . . . . 0.0 109.654 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.3 t -138.1 136.89 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -132.92 120.02 20.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 70.8 mt -108.72 117.6 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.0 t -108.17 114.9 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -89.87 128.43 36.19 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.4 p -132.75 152.43 51.76 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -153.93 158.65 41.01 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.3 p -135.94 36.59 2.83 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.023 0.44 . . . . 0.0 109.901 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 69.92 131.2 0.07 OUTLIER Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 57.34 8.71 0.62 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.838 0.352 . . . . 0.0 110.955 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.7 m -150.47 139.54 21.08 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.114 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.9 m -127.76 130.36 48.62 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -120.53 123.29 42.55 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.0 mt -103.27 128.43 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.61 131.66 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -130.31 132.7 45.99 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.3 t -118.29 149.11 41.7 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -144.0 160.69 40.41 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -134.16 78.24 59.16 Favored Pre-proline 0 N--CA 1.474 0.751 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.96 164.46 6.2 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.949 1.766 . . . . 0.0 111.718 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -63.35 151.46 40.79 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.43 -43.49 90.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.412 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.0 p -64.0 -42.94 97.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.945 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -63.11 146.79 95.53 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.639 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.17 110.64 3.1 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 121.944 1.763 . . . . 0.0 111.407 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.478 ' HE ' ' C ' ' A' ' 1' ' ' GLY . 9.0 ptm180 -66.37 -26.31 67.21 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.018 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 116' ' ' GLU . 30.1 mp0 -56.97 -50.98 71.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.257 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.6 mt -66.71 -37.26 84.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.59 0.233 . . . . 0.0 110.717 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -60.3 -47.21 86.97 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.61 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -53.27 -44.98 68.65 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.01 0.433 . . . . 0.0 110.008 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.1 t -64.45 -40.72 96.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.352 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.47 -51.72 55.95 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -62.74 -36.3 82.58 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.705 0.288 . . . . 0.0 110.279 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -74.05 -37.67 64.21 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.791 0.329 . . . . 0.0 110.194 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.15 -51.08 71.56 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.805 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.3 tt -63.6 -39.57 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.5 mt -63.62 -38.61 91.76 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -62.14 -40.03 94.57 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.072 0.463 . . . . 0.0 109.763 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.5 t -72.63 -31.04 64.84 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.689 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -55.35 -52.24 64.15 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -70.51 -36.09 73.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.972 0.415 . . . . 0.0 110.768 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 52.6 p -54.66 -36.23 64.37 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -62.51 -48.17 80.72 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.046 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.1 p -64.27 -43.84 93.59 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.612 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.83 -36.46 83.54 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.034 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -62.03 -43.88 97.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.679 0.276 . . . . 0.0 110.465 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -66.71 -42.82 85.79 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.777 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.0 tp -63.77 -44.16 94.22 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.923 0.392 . . . . 0.0 110.357 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -168.56 -167.87 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.431 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 54.1 73.51 0.38 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.923 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -68.36 -163.61 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.704 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -153.67 -51.34 0.1 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 53.12 83.49 0.06 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.652 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.484 ' ND1' ' ND1' ' A' ' 144' ' ' HIS . 62.4 t-80 -62.53 -42.69 99.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.545 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.484 ' ND1' ' ND1' ' A' ' 143' ' ' HIS . 43.8 p-80 . . . . . 0 C--O 1.218 -0.561 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.203 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -65.58 169.58 6.03 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -106.47 52.61 0.72 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.279 0.632 . . . . 0.0 110.265 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.9 mt -51.53 138.97 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 m -135.64 138.73 43.16 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 m -136.17 157.05 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -147.74 161.16 41.78 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.39 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.61 142.61 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.5 m -93.48 121.27 34.7 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.7 t -126.57 124.88 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -94.74 89.9 5.88 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.98 153.47 4.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.06 134.28 55.85 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.7 tp -52.83 -34.39 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.88 0.372 . . . . 0.0 110.884 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -60.46 -40.8 92.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.473 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -72.07 -46.66 56.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.845 0.355 . . . . 0.0 110.555 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.48 -41.57 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.401 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.781 ' CH2' HD11 ' A' ' 80' ' ' ILE . 26.4 t-105 -56.11 -45.31 79.54 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.84 0.353 . . . . 0.0 110.868 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -65.26 -45.01 86.25 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.339 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -65.51 -43.37 90.33 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.727 0.299 . . . . 0.0 110.973 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 67.2 t-105 -69.23 -20.19 63.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.492 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.743 HD21 HD22 ' A' ' 46' ' ' LEU . 2.3 m-20 -104.93 -30.86 9.55 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.129 0.571 . . . . 0.0 111.752 -178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -50.76 106.52 0.66 Allowed Pre-proline 0 CA--C 1.557 1.214 0 CA-C-O 119.113 -0.47 . . . . 0.0 109.819 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -53.58 -43.07 60.82 Favored 'Trans proline' 0 N--CA 1.508 2.381 0 CA-C-N 120.646 1.266 . . . . 0.0 112.244 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.06 -33.79 73.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.909 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.433 ' O ' ' CD1' ' A' ' 30' ' ' TRP . 46.5 t-80 -73.74 -38.45 64.76 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.795 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.41 -44.46 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 122.038 -0.414 . . . . 0.0 110.752 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.7 ptp -67.21 -24.9 65.89 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.283 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -62.29 -45.8 91.61 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.529 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.488 ' CE3' ' O ' ' A' ' 31' ' ' CYS . 62.7 p-90 -109.13 -10.19 15.01 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.523 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.488 ' O ' ' CE3' ' A' ' 30' ' ' TRP . 29.4 p 30.71 -130.99 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.962 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 177.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.425 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 55.2 tp60 -74.55 -4.34 36.34 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 30' ' ' TRP . . . 64.32 32.52 12.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.225 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.8 m -132.3 141.17 40.33 Favored Pre-proline 0 N--CA 1.482 1.154 0 O-C-N 123.337 0.398 . . . . 0.0 110.534 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.5 -9.94 23.32 Favored 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 121.892 1.728 . . . . 0.0 112.27 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -79.14 -24.56 43.22 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.426 0.155 . . . . 0.0 110.724 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -122.24 148.86 44.47 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.829 0.452 . . . . 0.0 110.313 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -140.09 163.25 33.2 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.179 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.21 89.23 52.94 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.61 -10.12 20.14 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 121.537 1.491 . . . . 0.0 111.141 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -167.77 150.36 5.78 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.008 0.432 . . . . 0.0 110.273 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.86 150.47 11.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.092 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -138.99 144.91 39.13 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -163.6 135.67 5.03 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -125.05 97.45 5.26 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.743 HD22 HD21 ' A' ' 22' ' ' ASN . 48.1 tp -65.34 94.48 0.17 Allowed 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -168.34 140.83 2.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.26 137.71 57.88 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.262 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.45 -0.05 61.24 Favored Glycine 0 N--CA 1.466 0.691 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.06 169.1 41.72 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 t -129.87 168.41 16.66 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.704 0.402 . . . . 0.0 110.066 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -140.57 166.38 24.9 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.244 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 m -154.88 118.09 4.45 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.7 m -116.96 121.46 41.47 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.1 m -93.36 116.66 29.21 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.9 mtp -121.76 125.88 47.57 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.81 138.31 42.44 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.014 0.435 . . . . 0.0 110.116 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.77 148.83 51.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.393 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.02 -39.96 75.76 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.712 0.292 . . . . 0.0 110.451 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -76.2 -9.65 58.8 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.24 22.23 62.84 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 97.0 p -81.06 -10.75 59.64 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.736 0.303 . . . . 0.0 110.617 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.1 ttt -164.49 136.48 4.59 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.087 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.9 p -144.43 161.1 39.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.874 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.466 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 61.7 t80 -159.47 168.63 25.76 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.466 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 40.8 t0 -138.55 119.53 14.39 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -93.99 140.58 29.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.71 156.21 26.97 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.36 -171.55 40.99 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 p -127.36 141.63 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 122.672 0.389 . . . . 0.0 110.107 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -81.04 123.65 28.54 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -77.0 -47.87 19.52 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.076 0.465 . . . . 0.0 110.04 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -147.38 141.31 25.87 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.559 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.3 t -136.06 125.5 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -140.54 123.13 16.16 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.8 m -53.62 121.95 8.84 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.073 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 53.47 70.16 0.62 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.77 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -166.1 -82.39 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.536 0.208 . . . . 0.0 110.943 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.1 tp -147.02 139.55 24.85 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.781 HD11 ' CH2' ' A' ' 18' ' ' TRP . 58.9 mt -133.77 130.28 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -153.7 157.51 39.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -155.95 160.16 39.86 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.3 m -112.27 135.24 53.19 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.3 mm -89.19 155.89 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.8 -33.97 80.44 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -69.46 -10.26 57.27 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 122.477 -0.425 . . . . 0.0 110.352 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.7 -8.15 56.14 Favored Glycine 0 N--CA 1.475 1.29 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -71.18 161.32 31.3 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -145.4 160.79 41.03 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.428 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.4 t -144.43 113.03 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.325 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -93.92 127.41 39.67 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.7 mt -124.83 113.06 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.0 p -108.71 133.55 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.475 ' CE1' HD12 ' A' ' 80' ' ' ILE . 87.4 m-85 -103.93 132.64 49.99 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.0 p -134.3 153.3 51.95 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -153.84 158.22 40.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.541 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 63.6 p -134.86 27.38 3.6 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.049 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.0 129.32 1.39 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 55.7 11.77 0.72 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.885 0.374 . . . . 0.0 111.03 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.2 m -153.53 141.93 20.66 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.046 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.9 m -130.37 130.85 44.9 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -117.88 122.86 44.43 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.6 mt -104.37 126.27 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.5 t -128.18 133.83 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -142.63 145.9 33.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.036 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 78.4 p -132.24 141.97 49.23 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -154.15 155.55 35.56 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.64 137.07 34.15 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-O 119.136 -0.459 . . . . 0.0 110.656 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.447 ' HA ' HE22 ' A' ' 118' ' ' GLN . 87.3 Cg_endo -75.87 158.63 38.7 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 121.423 1.415 . . . . 0.0 111.519 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -74.06 154.04 39.38 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -84.38 -42.23 15.9 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.75 0.31 . . . . 0.0 110.782 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 71.1 p -63.09 -44.93 94.36 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.536 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -93.43 147.95 34.63 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-O 119.592 -0.242 . . . . 0.0 110.76 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -62.32 137.22 64.21 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 121.424 1.416 . . . . 0.0 111.864 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -69.11 -37.55 78.43 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.988 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -56.67 -41.33 77.09 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.936 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.6 tp -63.86 -42.98 97.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.715 0.293 . . . . 0.0 110.427 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.447 HE22 ' HA ' ' A' ' 109' ' ' PRO . 33.1 mt-30 -60.97 -46.91 88.85 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.549 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.53 -48.09 69.37 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.774 0.321 . . . . 0.0 110.506 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.7 t -63.34 -42.57 98.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.337 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.68 -51.78 55.21 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -64.17 -36.06 82.81 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.967 0.384 . . . . 0.0 110.291 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -73.61 -38.19 65.16 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.17 -51.23 70.89 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.9 tt -61.7 -37.76 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.4 mt -63.26 -40.92 98.77 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.2 -41.29 97.14 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 110.049 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.5 m -61.05 -33.32 73.13 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.132 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -55.76 -46.29 77.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.986 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -63.39 -44.71 93.93 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.174 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.2 m -61.41 -43.77 98.29 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.498 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -62.22 -44.3 96.88 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.208 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.3 m -58.48 -47.92 82.48 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.832 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.9 -43.96 82.05 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.974 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -64.47 -35.46 81.0 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.304 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -60.99 -42.89 99.28 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 50.7 tp -152.44 122.39 7.03 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -79.15 35.28 0.26 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.128 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 54.19 79.55 0.13 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.79 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -67.53 141.07 57.0 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.903 0.382 . . . . 0.0 110.094 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -67.4 139.06 57.12 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.939 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -162.48 155.58 20.01 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.054 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -169.0 89.63 0.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 64.8 m80 . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.415 179.614 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -79.31 8.85 5.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.768 0.318 . . . . 0.0 110.442 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -125.15 52.86 1.56 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.991 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.4 mt -50.14 138.15 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.4 m -133.42 134.47 43.67 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.24 156.34 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.427 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 32.8 mp0 -140.75 158.36 44.08 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.917 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 p -143.88 140.46 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -93.44 113.95 26.23 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.7 t -119.01 125.9 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -98.23 87.84 4.02 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.09 152.78 4.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.087 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.63 135.88 57.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.485 HD13 ' CE1' ' A' ' 94' ' ' PHE . 9.7 tp -53.41 -32.2 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.622 0.248 . . . . 0.0 111.441 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -59.51 -39.74 84.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.774 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -75.17 -46.4 34.43 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 110.437 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.5 t -62.53 -43.44 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.24 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.7 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 25.2 t-105 -56.26 -46.05 79.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.934 0.397 . . . . 0.0 110.583 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -67.38 -45.43 76.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.606 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -65.31 -43.43 91.09 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.793 0.33 . . . . 0.0 111.136 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -70.43 -20.02 62.94 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.647 -178.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.519 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 83.1 m-20 -104.68 -22.25 13.26 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.139 0.576 . . . . 0.0 111.41 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -65.8 132.09 94.76 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.02 -40.55 1.28 Allowed 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 121.262 1.308 . . . . 0.0 111.57 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.76 -35.9 69.19 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.085 0.469 . . . . 0.0 110.833 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -73.86 -45.8 48.82 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.255 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 91.8 mt -61.85 -50.29 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.816 -0.553 . . . . 0.0 111.015 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 20.0 ptm -60.8 -17.38 49.14 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -74.2 -31.73 62.76 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -133.41 14.86 4.11 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.602 0.361 . . . . 0.0 110.837 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.531 ' C ' ' H ' ' A' ' 33' ' ' ALA . 20.4 t -53.95 136.4 41.12 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 122.138 -0.351 . . . . 0.0 110.279 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 70.81 -36.25 0.35 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.539 0.524 . . . . 0.0 110.011 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 56.86 36.16 27.34 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.763 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.0 m -131.63 141.51 41.92 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 122.682 0.393 . . . . 0.0 110.436 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -75.46 -8.9 19.9 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.04 1.827 . . . . 0.0 112.03 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -86.31 7.32 25.9 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.681 0.277 . . . . 0.0 110.457 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -153.45 155.66 36.72 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.243 0.544 . . . . 0.0 110.357 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -148.55 163.18 37.98 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.303 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.6 t -127.62 91.94 44.24 Favored Pre-proline 0 N--CA 1.476 0.833 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.81 -1.94 12.09 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.768 1.645 . . . . 0.0 111.709 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.25 152.42 8.96 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.884 0.373 . . . . 0.0 110.078 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -166.07 150.47 8.03 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.36 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -136.77 150.47 48.4 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.917 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -160.88 131.4 5.25 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.09 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -129.54 95.83 4.11 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.79 93.87 0.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.08 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -168.19 140.9 3.05 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.96 137.75 58.21 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.425 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.87 1.65 48.24 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.9 148.12 34.45 Favored Glycine 0 N--CA 1.465 0.6 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.1 p -111.7 157.43 20.5 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.899 0.48 . . . . 0.0 109.846 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 69' ' ' GLY . 45.5 p90 -156.72 169.18 25.32 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.026 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.7 m -156.39 141.58 17.39 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.1 m -122.09 120.74 35.17 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.8 m -86.39 111.14 20.22 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 44.3 ttp -127.74 114.07 16.81 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -132.08 141.48 49.2 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.59 0.356 . . . . 0.0 110.275 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.35 148.07 33.75 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -58.83 -37.9 77.47 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.712 0.291 . . . . 0.0 110.263 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.51 -10.6 59.72 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.89 17.66 67.73 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.9 t -62.48 -42.22 99.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.801 0.334 . . . . 0.0 111.012 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 62.4 ttp -145.19 147.0 31.97 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.175 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.5 t -144.7 154.7 43.04 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.135 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -154.13 143.25 21.24 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -95.47 108.85 21.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.467 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -96.04 130.66 42.99 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.95 176.44 41.95 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 52' ' ' PHE . . . -174.57 -172.42 39.64 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 36.7 t -126.94 132.48 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -72.68 113.79 10.1 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -74.29 -48.14 30.36 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -139.81 137.88 35.35 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.78 125.82 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -144.19 113.15 6.77 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.3 m -47.38 116.49 1.44 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 53.98 71.21 0.53 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.602 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -168.65 -68.86 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.634 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.0 tp -150.12 133.69 16.62 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.7 HD11 ' CZ3' ' A' ' 18' ' ' TRP . 84.5 mt -128.49 125.21 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -153.6 152.13 30.53 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 20.2 p90 -151.2 152.25 33.03 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.9 m -82.16 128.53 34.24 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.479 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.3 mm -82.27 144.1 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.251 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.32 -41.64 87.62 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -66.21 -5.28 9.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.758 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.17 0.89 84.82 Favored Glycine 0 N--CA 1.473 1.132 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -66.84 159.3 28.47 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -113.92 132.84 55.79 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.97 0.415 . . . . 0.0 109.944 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.2 t -136.48 134.35 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -135.43 127.34 29.48 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.82 117.46 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.56 128.58 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.485 ' CE1' HD13 ' A' ' 14' ' ' ILE . 4.0 t80 -92.46 126.32 37.49 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.9 m -146.21 141.25 27.23 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.433 ' N ' ' ND1' ' A' ' 96' ' ' HIS . 2.3 p-80 -153.69 148.84 26.87 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.2 p -98.05 -13.63 20.94 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.011 0.434 . . . . 0.0 109.957 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.43 -101.29 0.2 Allowed Glycine 0 N--CA 1.465 0.622 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 18.0 p-10 -78.0 -2.06 35.2 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.343 0.257 . . . . 0.0 110.892 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.0 p -118.54 128.18 54.32 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.03 0.532 . . . . 0.0 109.709 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.9 m -103.72 135.07 45.97 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.666 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -119.23 115.37 24.05 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.8 mt -101.51 125.79 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.3 t -121.35 127.57 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -142.43 144.47 33.1 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 94.7 p -130.51 148.9 52.37 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.117 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -137.22 150.57 47.96 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.153 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -89.81 110.95 43.33 Favored Pre-proline 0 CA--C 1.551 0.982 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.992 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.82 159.28 27.81 Favored 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 122.002 1.801 . . . . 0.0 112.145 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.8 151.94 31.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.839 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -78.23 -39.97 38.73 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.66 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 76.1 p -63.46 -44.61 93.98 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.472 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -87.53 144.65 35.84 Favored Pre-proline 0 N--CA 1.474 0.744 0 CA-C-O 119.553 -0.26 . . . . 0.0 110.53 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -70.02 134.22 26.93 Favored 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 121.652 1.568 . . . . 0.0 111.819 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -65.25 -34.24 77.88 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.891 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -49.91 -39.36 39.63 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.942 0.401 . . . . 0.0 111.526 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.427 HD22 ' N ' ' A' ' 117' ' ' LEU . 3.8 mm? -75.83 -39.53 56.55 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -65.27 -54.61 26.61 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.069 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.412 ' OE1' ' N ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -55.52 -38.81 69.71 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.188 0.518 . . . . 0.0 110.633 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.412 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 40.7 t -59.0 -40.83 86.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.954 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.4 -48.23 64.96 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.717 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -59.04 -39.71 82.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.802 0.334 . . . . 0.0 110.563 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -74.85 -34.65 62.32 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.75 -51.0 71.63 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.7 tt -63.19 -39.11 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.7 mt -63.56 -40.04 95.96 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -62.71 -39.66 94.73 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.5 t -60.02 -37.07 78.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.811 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -57.23 -47.47 81.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.681 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -64.36 -41.99 96.45 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 41.9 t -60.5 -43.91 96.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.576 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -61.99 -47.3 85.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.243 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.0 m -61.44 -46.19 91.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.587 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -65.77 -35.53 80.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.025 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -62.96 -34.82 78.32 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.361 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -61.57 -36.4 80.54 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.423 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.6 mt 56.14 -111.36 0.61 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.515 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -62.5 175.41 0.78 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -167.25 133.77 2.25 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -169.91 23.02 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.968 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -60.37 -43.72 96.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.267 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 83.4 t60 50.94 86.81 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.743 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 53.1 80.48 0.1 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.909 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.925 -1.036 . . . . 0.0 111.205 -179.8 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -158.21 115.98 2.97 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -126.39 55.6 1.5 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.132 0.573 . . . . 0.0 110.291 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.9 mt -46.38 138.16 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.0 m -136.29 136.95 40.21 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.77 156.33 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.438 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 31.6 mp0 -141.06 158.91 43.28 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.851 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 p -151.26 142.59 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.186 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.5 p -97.32 124.11 41.35 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.7 t -128.46 129.48 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -93.83 88.2 5.68 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.48 151.73 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.19 133.74 54.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.143 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.6 tt -53.44 -36.48 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.701 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.407 ' OE2' ' N ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -63.31 -34.98 78.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.984 0.421 . . . . 0.0 110.011 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.407 ' N ' ' OE2' ' A' ' 15' ' ' GLU . 63.9 tttm -73.38 -50.21 23.11 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.9 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.35 -42.64 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.154 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.476 ' NE1' ' ND2' ' A' ' 22' ' ' ASN . 25.9 t-105 -54.13 -40.15 67.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.763 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -65.46 -54.31 30.23 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.538 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -69.53 -41.63 75.71 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.838 0.351 . . . . 0.0 111.396 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -61.82 -20.69 63.91 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.708 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.476 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 91.8 m-20 -106.22 -19.58 13.66 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.809 0.444 . . . . 0.0 110.282 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -68.27 122.92 86.1 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.7 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.93 -35.1 12.74 Favored 'Trans proline' 0 N--CA 1.504 2.125 0 C-N-CA 121.324 1.35 . . . . 0.0 112.217 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.73 -39.57 94.48 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.84 0.352 . . . . 0.0 110.48 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -65.36 -45.39 84.33 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.37 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 31' ' ' CYS . 96.7 mt -62.48 -43.84 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 36.3 ttp -54.85 -15.96 2.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.497 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -84.49 -25.98 28.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.641 0.258 . . . . 0.0 111.355 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -140.75 26.21 2.1 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.878 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.588 ' C ' ' H ' ' A' ' 33' ' ' ALA . 16.1 t -59.73 130.24 45.82 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.937 -0.477 . . . . 0.0 110.12 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 66.08 -27.46 0.11 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.754 0.658 . . . . 0.0 110.55 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 51.96 30.26 7.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.0 t -118.86 136.71 24.39 Favored Pre-proline 0 N--CA 1.48 1.068 0 O-C-N 123.476 0.485 . . . . 0.0 111.168 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.95 -13.02 24.01 Favored 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 121.931 1.754 . . . . 0.0 111.939 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -85.05 9.78 13.78 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.921 0.391 . . . . 0.0 110.911 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -149.31 162.17 40.59 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.232 0.539 . . . . 0.0 109.747 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -148.74 162.89 38.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.911 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.79 91.2 13.77 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.8 -3.07 13.36 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 122.312 2.008 . . . . 0.0 112.049 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.29 153.06 11.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.737 0.303 . . . . 0.0 110.228 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -165.03 148.21 8.4 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -150.72 152.99 34.73 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -163.16 103.65 0.98 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.095 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -85.68 90.99 8.16 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.6 tp -65.41 95.66 0.21 Allowed 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -169.51 140.69 2.28 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.08 138.05 57.96 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.192 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.87 -2.29 60.32 Favored Glycine 0 N--CA 1.467 0.732 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.18 174.22 43.54 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 t -135.21 168.06 19.86 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -135.89 167.19 21.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.975 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.9 m -160.66 125.93 3.83 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.7 m -123.99 125.63 44.91 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 m -86.73 112.17 21.41 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 72.4 mtp -119.72 118.62 31.39 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.49 139.72 40.74 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.53 147.59 52.48 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -55.18 -34.89 64.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 110.668 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -82.71 -9.21 59.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.345 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.83 15.34 64.46 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.6 t -62.5 -40.97 98.43 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.72 0.295 . . . . 0.0 110.664 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 44.6 ttp -143.58 143.32 31.45 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.09 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.6 p -145.83 157.56 43.91 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.878 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.448 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 63.5 t80 -159.81 166.69 29.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.517 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.448 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 24.1 p-10 -138.2 121.92 17.53 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.045 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -94.38 143.62 26.24 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.92 157.44 28.01 Favored Glycine 0 C--N 1.331 0.268 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.51 -173.06 40.92 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.4 t -128.31 135.85 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -76.06 120.0 20.77 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -74.05 -45.08 51.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.893 0.377 . . . . 0.0 110.23 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -148.77 139.42 22.73 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -137.34 127.67 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -144.16 129.01 18.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.0 m -60.55 135.01 57.62 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.793 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 54.81 57.8 5.37 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.915 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -154.37 -82.76 0.08 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.934 0.397 . . . . 0.0 110.273 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -163.07 160.56 24.58 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.26 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.2 mt -134.38 135.96 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.404 ' OE1' ' NH1' ' A' ' 91' ' ' ARG . 14.2 pt-20 -149.92 154.92 39.09 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -158.91 155.2 27.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.9 m -95.57 134.41 38.48 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.7 mt -101.32 152.74 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -51.88 -42.19 53.05 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -60.83 -17.46 49.97 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.984 0.421 . . . . 0.0 110.095 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.42 7.55 72.34 Favored Glycine 0 N--CA 1.471 0.99 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -70.58 139.35 51.45 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -93.7 136.47 33.94 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.0 t -137.83 132.12 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.404 ' NH1' ' OE1' ' A' ' 81' ' ' GLU . 70.2 mtp85 -135.61 135.53 40.31 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.9 mt -124.18 114.07 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.88 129.11 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -95.8 132.8 40.67 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.5 p -136.11 155.47 50.13 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -152.43 143.64 23.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.738 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.4 p -91.1 -41.46 11.04 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.003 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.45 -68.06 0.11 Allowed Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -107.28 17.4 22.92 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.157 0.583 . . . . 0.0 110.73 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.5 m -155.77 119.79 4.52 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.105 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 43.0 m -83.99 146.44 27.99 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -128.49 122.61 31.59 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.6 mt -100.27 126.67 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.37 126.73 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -144.71 146.49 32.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.523 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 96.5 p -134.52 147.5 50.33 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -122.27 170.95 9.41 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -137.17 78.29 40.27 Favored Pre-proline 0 N--CA 1.469 0.491 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.58 -172.5 1.55 Allowed 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.161 1.907 . . . . 0.0 111.494 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -61.28 138.12 58.24 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.136 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -67.83 -40.03 83.8 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.527 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.8 p -62.59 -40.77 97.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.976 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -61.25 147.37 87.15 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.703 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.87 112.75 3.35 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.712 1.608 . . . . 0.0 111.586 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -62.82 -31.94 73.04 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.25 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -59.52 -45.68 91.03 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.613 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 117' ' ' LEU . 1.4 tt -64.62 -47.0 80.19 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.104 0.478 . . . . 0.0 109.768 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -62.35 -41.29 98.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.474 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -54.02 -41.35 67.9 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.508 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.2 t -60.91 -41.85 96.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.396 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.51 -50.9 61.68 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -61.36 -36.33 79.93 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.015 0.436 . . . . 0.0 110.18 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -75.86 -36.45 59.56 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.138 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.35 -51.41 70.06 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.003 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.8 tt -61.1 -37.33 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.8 mt -63.74 -40.67 97.3 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.334 -0.393 . . . . 0.0 109.962 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -63.9 -39.23 93.7 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.2 m -57.6 -35.52 70.53 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 110.665 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -58.34 -43.58 88.37 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.465 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -61.49 -45.05 95.88 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.682 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 89.7 p -63.0 -40.49 97.95 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.24 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -60.57 -45.02 95.5 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.379 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 28.5 m -59.07 -46.82 87.3 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.563 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -67.58 -44.29 78.52 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.213 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -63.85 -38.36 90.81 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.427 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -63.03 -14.84 53.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.16 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.2 tp 55.51 84.86 0.07 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.194 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -73.44 86.8 1.54 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 139' ' ' HIS . 81.1 t60 52.45 19.0 1.04 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.896 0.379 . . . . 0.0 111.061 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.531 ' CG ' ' H ' ' A' ' 141' ' ' HIS . 79.7 t60 57.52 175.72 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.158 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.531 ' H ' ' CG ' ' A' ' 140' ' ' HIS . 61.1 t-80 -160.32 142.64 13.03 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -164.7 -28.82 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.169 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.434 ' CE1' ' NE2' ' A' ' 141' ' ' HIS . 29.6 p80 -62.01 138.75 58.41 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.349 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.19 -179.866 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.429 ' H ' HD21 ' A' ' 2' ' ' ASN . 5.4 m-80 -61.98 -40.54 95.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.933 0.397 . . . . 0.0 110.443 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -73.09 52.65 0.34 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.04 0.448 . . . . 0.0 110.024 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.9 mt -53.26 134.63 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.5 m -131.19 130.99 43.68 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.8 m -137.32 159.01 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -148.47 162.41 39.68 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.417 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 p -144.14 142.54 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 m -95.46 117.65 30.76 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -123.43 129.38 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -97.61 87.55 4.11 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.82 152.54 4.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.984 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.86 133.04 52.62 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.041 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.8 tt -53.36 -36.69 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.736 0.303 . . . . 0.0 111.629 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.35 -35.29 75.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.424 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -74.92 -47.17 31.16 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.165 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.3 -43.03 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.31 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.663 ' CH2' HD11 ' A' ' 80' ' ' ILE . 26.6 t-105 -53.98 -43.54 70.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.139 0.495 . . . . 0.0 110.864 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.69 -45.78 74.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.614 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -66.63 -42.72 86.32 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.886 0.374 . . . . 0.0 111.332 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -68.73 -18.09 64.17 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.571 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -109.66 -29.54 8.31 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.938 0.495 . . . . 0.0 111.981 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -51.42 106.21 0.62 Allowed Pre-proline 0 CA--C 1.561 1.383 0 CA-C-O 118.734 -0.651 . . . . 0.0 109.519 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.53 -43.33 55.61 Favored 'Trans proline' 0 N--CA 1.506 2.254 0 CA-C-N 121.006 1.395 . . . . 0.0 112.331 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.46 84.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.257 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -69.04 -36.93 78.27 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.371 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 98.7 mt -62.0 -52.41 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 121.856 -0.528 . . . . 0.0 111.218 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.8 ptp -61.59 -16.55 49.14 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -70.15 -26.92 64.16 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 32' ' ' GLN . 68.8 p-90 -134.17 6.79 3.63 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 119.525 -0.274 . . . . 0.0 111.096 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.4 t -67.93 72.52 0.17 Allowed 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 121.416 0.627 . . . . 0.0 109.706 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 30' ' ' TRP . 55.6 tt0 -161.74 63.17 0.25 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.615 ' HB2' HD12 ' A' ' 125' ' ' ILE . . . -69.77 -5.02 22.51 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.09 -1.413 . . . . 0.0 110.716 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 79.4 p -146.2 140.67 15.67 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.33 -13.92 22.95 Favored 'Trans proline' 0 N--CA 1.509 2.44 0 C-N-CA 122.071 1.847 . . . . 0.0 112.372 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -83.97 14.07 4.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.676 0.274 . . . . 0.0 110.598 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -147.71 143.99 27.99 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -130.95 163.01 28.46 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 t -127.93 87.35 55.92 Favored Pre-proline 0 N--CA 1.477 0.914 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.89 -7.83 14.42 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.816 1.678 . . . . 0.0 111.496 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.79 151.37 4.19 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.0 156.05 5.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.432 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -148.11 154.05 39.68 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.86 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -163.58 135.27 4.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.591 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -129.0 101.15 5.93 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tp -69.27 99.39 1.16 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -166.91 138.18 3.28 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.85 137.1 58.15 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.694 0.283 . . . . 0.0 110.436 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.96 2.14 60.99 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.2 169.57 38.21 Favored Glycine 0 N--CA 1.47 0.902 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 t -130.2 165.39 22.47 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.095 0.474 . . . . 0.0 110.203 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -140.5 162.15 36.03 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.53 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.3 m -150.45 134.91 17.25 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.8 p -131.39 119.17 21.28 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 m -88.98 118.19 28.53 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.4 mtp -134.4 125.91 28.49 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.87 146.74 33.24 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.279 0.561 . . . . 0.0 110.398 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.18 148.94 43.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.604 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -56.52 -39.67 73.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.817 0.341 . . . . 0.0 110.451 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -75.14 -10.49 59.52 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.876 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.29 10.82 70.41 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.2 t -62.72 -41.97 99.42 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.008 -0.113 . . . . 0.0 111.057 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.1 tpt -120.2 143.18 48.39 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.6 t -143.53 139.41 29.76 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.454 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 58.5 t80 -160.0 160.54 33.43 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.454 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 73.8 m-20 -138.03 128.34 26.14 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.5 134.08 38.76 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.38 156.13 26.75 Favored Glycine 0 N--CA 1.465 0.614 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.6 -172.14 40.98 Favored Glycine 0 CA--C 1.517 0.177 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.03 140.8 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 122.593 0.357 . . . . 0.0 110.301 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -79.24 121.69 25.38 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.06 -39.09 63.73 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.226 0.536 . . . . 0.0 109.757 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -166.16 147.75 6.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.218 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.7 t -137.39 135.26 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -140.74 119.63 12.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.7 m -50.99 118.61 3.29 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 52.89 72.17 0.44 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.915 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -168.15 -77.02 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.256 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.0 tp -150.99 140.6 21.65 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.349 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.663 HD11 ' CH2' ' A' ' 18' ' ' TRP . 61.7 mt -132.09 132.09 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.14 155.15 36.2 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -155.81 155.1 32.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.4 m -98.64 128.69 45.02 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.423 HG22 ' H ' ' A' ' 86' ' ' ASP . 88.3 mt -92.06 150.48 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.95 -41.44 68.05 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.423 ' H ' HG22 ' A' ' 84' ' ' ILE . 81.2 m-20 -60.71 -12.14 9.57 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.727 0.298 . . . . 0.0 110.477 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.49 -3.56 81.81 Favored Glycine 0 N--CA 1.468 0.822 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -65.88 138.42 57.85 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -98.37 142.69 29.69 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.2 t -143.46 136.66 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -136.24 138.77 42.16 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.1 mt -129.94 114.68 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.0 p -107.91 132.58 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -103.83 117.52 34.53 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.5 m -109.17 152.08 25.61 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -145.85 143.08 29.39 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 65.2 p -144.03 105.09 4.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.842 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.96 -93.92 0.2 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 21.3 p-10 -132.06 32.7 3.99 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.607 0.363 . . . . 0.0 110.984 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.3 m -134.72 126.64 29.43 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.6 m -108.26 124.97 51.12 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -117.18 121.24 40.68 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.8 mt -98.03 124.48 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.88 130.66 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -142.5 144.22 32.89 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 56.4 m -123.33 148.62 45.82 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -128.61 153.38 47.32 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -124.3 78.4 60.81 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.66 177.02 9.22 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 121.977 1.784 . . . . 0.0 111.775 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -72.07 152.73 42.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.46 0.647 . . . . 0.0 110.465 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -66.83 -42.73 85.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.339 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 58.3 p -64.43 -40.59 96.04 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.565 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -61.32 144.91 91.25 Favored Pre-proline 0 CA--C 1.551 0.996 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.795 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.57 114.44 4.01 Favored 'Trans proline' 0 N--CA 1.505 2.198 0 C-N-CA 122.098 1.866 . . . . 0.0 111.786 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 79.0 mtt85 -64.37 -42.16 96.34 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.493 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -53.05 -44.56 67.52 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.47 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.4 tp -63.29 -45.44 91.43 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.955 0.407 . . . . 0.0 110.72 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -63.9 -53.25 53.33 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.227 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -55.04 -41.79 71.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.997 0.427 . . . . 0.0 110.358 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.1 t -61.24 -43.36 99.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.352 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.79 -51.7 57.03 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -65.23 -42.96 92.89 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.169 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.85 -38.9 92.79 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.56 -54.16 49.16 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.615 HD12 ' HB2' ' A' ' 33' ' ' ALA . 12.9 tt -67.39 -37.54 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.312 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.2 mt -61.52 -41.62 97.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.766 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 128' ' ' SER . 25.2 p30 -67.48 -31.68 71.99 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.16 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.415 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 96.2 p -76.79 -29.16 55.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.936 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -54.43 -50.72 66.97 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -66.98 -36.07 81.38 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.841 0.353 . . . . 0.0 110.594 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.3 t -60.17 -41.25 92.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.766 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -60.56 -49.19 78.55 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.039 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.9 p -65.84 -37.7 86.9 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.373 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -66.64 -32.68 74.16 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.425 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -60.46 -35.09 75.03 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.474 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -62.41 -41.68 98.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.672 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 137' ' ' LEU . 9.9 mp -76.75 142.65 40.34 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -64.52 142.78 58.3 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.33 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -64.5 -38.39 90.84 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.426 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -64.22 141.43 58.77 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.346 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.499 ' ND1' ' ND1' ' A' ' 144' ' ' HIS . 17.1 p80 -60.99 100.63 0.12 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.46 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -73.26 -3.76 28.88 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.401 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -59.16 -47.68 84.39 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.652 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.499 ' ND1' ' ND1' ' A' ' 141' ' ' HIS . 76.0 m80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.007 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.527 ' N ' HH12 ' A' ' 115' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -82.42 25.92 0.59 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -125.83 52.89 1.63 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.111 0.564 . . . . 0.0 110.269 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.3 mm -51.77 136.18 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.5 m -135.73 128.9 31.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.988 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.96 149.83 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -148.91 158.29 44.06 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.664 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.43 158.9 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.503 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -122.45 124.71 44.25 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.3 p -128.42 141.8 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 122.542 0.337 . . . . 0.0 110.769 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -87.7 87.1 7.28 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.152 0.501 . . . . 0.0 110.078 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.41 147.05 4.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.403 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.16 137.67 58.07 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.242 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.6 tt -52.8 -32.24 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.248 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -59.43 -42.73 92.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.73 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -71.03 -44.47 65.75 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.076 0.465 . . . . 0.0 110.487 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.57 -43.11 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.409 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -58.72 -49.93 75.77 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.8 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -67.65 -45.82 74.22 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.575 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -63.18 -44.66 94.81 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.096 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -67.35 -21.32 65.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.649 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -101.44 -23.96 14.25 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.95 0.5 . . . . 0.0 111.797 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -62.5 117.98 36.41 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 118.743 -0.646 . . . . 0.0 109.284 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.5 -37.16 7.73 Favored 'Trans proline' 0 N--CA 1.504 2.141 0 CA-C-N 121.081 1.422 . . . . 0.0 112.214 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.13 -30.71 66.53 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.927 0.394 . . . . 0.0 111.111 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -79.96 -36.51 36.04 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.384 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 31' ' ' CYS . 96.8 mt -63.39 -42.98 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 122.087 -0.383 . . . . 0.0 110.598 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 17.2 ptp -60.09 -14.87 18.91 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.262 -0.274 . . . . 0.0 111.163 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -79.47 -30.57 42.17 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 122.133 -0.354 . . . . 0.0 110.779 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -133.89 20.57 3.82 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.514 ' C ' ' H ' ' A' ' 33' ' ' ALA . 42.9 t -57.35 134.22 55.82 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.64 -0.663 . . . . 0.0 111.219 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 70.59 -35.56 0.33 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.665 0.603 . . . . 0.0 110.283 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 55.64 33.42 21.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.189 0.518 . . . . 0.0 110.64 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.9 t -124.5 114.12 27.3 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.24 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.79 -22.1 28.23 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 121.573 1.515 . . . . 0.0 112.184 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -79.91 13.37 2.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.879 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -150.11 159.0 44.75 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.027 0.441 . . . . 0.0 110.254 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -140.0 163.3 33.05 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.387 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 39' ' ' VAL . 6.1 p -126.78 92.52 44.54 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 123.559 0.744 . . . . 0.0 109.464 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.2 -12.65 23.34 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 121.302 1.335 . . . . 0.0 111.976 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.57 154.72 5.7 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.983 0.42 . . . . 0.0 110.073 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.81 144.61 13.52 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.904 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -139.86 153.59 47.07 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -159.03 103.37 1.67 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.897 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -93.49 85.83 5.05 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 tp -65.53 92.74 0.14 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -170.21 147.3 3.1 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.916 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.52 136.55 58.06 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.34 -1.77 18.16 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -73.59 155.54 50.02 Favored Glycine 0 N--CA 1.467 0.716 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.9 m -115.69 152.8 32.51 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.92 0.488 . . . . 0.0 109.966 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -136.68 160.55 38.5 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.29 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.0 m -150.99 115.98 5.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 43.5 m -109.02 113.09 25.66 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 m -94.3 122.07 36.46 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 13.4 ptp -141.82 141.91 33.15 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.81 149.83 33.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.98 0.419 . . . . 0.0 110.369 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.8 148.45 51.23 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -54.88 -38.45 67.55 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.815 0.341 . . . . 0.0 110.972 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -79.45 -7.78 58.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.915 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.87 22.09 61.85 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.9 p -82.26 -10.47 59.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.459 0.171 . . . . 0.0 111.059 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 49.3 ttp -165.78 130.93 2.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.463 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.4 p -145.38 164.12 32.47 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.318 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -155.91 143.02 19.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -108.11 114.7 28.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.178 0.591 . . . . 0.0 110.26 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -94.54 137.56 33.51 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.26 157.9 28.73 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.05 -171.59 41.58 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.8 t -131.58 138.52 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -77.55 121.66 24.2 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -72.64 -38.65 67.64 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -163.58 147.71 10.54 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.772 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.5 p -149.22 137.53 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.155 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -145.17 137.44 25.87 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.2 m -56.45 127.66 32.19 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.849 0.357 . . . . 0.0 111.497 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.6 m120 56.36 63.74 1.9 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.211 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -155.22 -84.1 0.06 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.729 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -164.22 159.28 19.92 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.893 0.377 . . . . 0.0 110.771 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.72 130.77 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -145.42 155.11 42.94 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -158.86 156.11 29.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.986 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.7 m -97.98 133.02 43.02 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.8 mt -97.87 151.3 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.2 -40.45 67.41 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -60.98 -15.71 34.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.913 0.387 . . . . 0.0 110.118 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.27 -0.2 65.96 Favored Glycine 0 N--CA 1.469 0.874 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.65 136.52 45.68 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -99.64 152.37 20.14 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.9 t -140.59 137.11 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -132.79 129.01 38.02 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.5 mt -124.44 112.51 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.9 t -109.98 128.72 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -100.4 127.01 46.83 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.1 p -132.97 153.21 51.66 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -154.0 166.01 34.35 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.847 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 t -136.96 -11.2 1.74 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.883 0.373 . . . . 0.0 110.192 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.21 -127.51 1.29 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.2 p-10 -75.03 6.88 3.69 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 122.988 -0.124 . . . . 0.0 110.749 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 53.1 m -124.59 129.73 51.12 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.0 m -106.91 135.86 47.76 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -110.83 111.15 22.11 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.7 mt -92.35 122.65 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.28 126.84 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -143.01 143.49 31.92 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.236 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.2 m -129.15 146.21 51.14 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -117.51 166.09 12.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.127 0.571 . . . . 0.0 109.606 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -128.28 78.57 75.38 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.796 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.42 163.97 33.44 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 121.708 1.605 . . . . 0.0 112.121 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -69.17 174.13 4.95 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.847 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -84.37 -50.79 7.49 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.65 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.3 p -63.28 -41.85 99.04 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.724 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -59.2 146.72 77.41 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 119.552 -0.261 . . . . 0.0 110.371 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.05 105.39 1.82 Allowed 'Trans proline' 0 N--CA 1.504 2.104 0 C-N-CA 121.799 1.666 . . . . 0.0 111.299 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.527 HH12 ' N ' ' A' ' 1' ' ' GLY . 88.4 mtm180 -65.03 -41.97 94.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.177 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.9 -38.06 84.39 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.274 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.87 -50.93 71.44 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.649 0.262 . . . . 0.0 110.916 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -72.74 -27.97 62.35 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.452 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -54.68 -45.4 73.92 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.897 0.38 . . . . 0.0 110.36 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.5 t -68.17 -33.03 73.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.651 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.3 -51.19 60.32 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -62.44 -38.4 89.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.905 0.383 . . . . 0.0 110.508 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -70.51 -38.29 74.26 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.97 -52.46 65.42 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.096 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.0 tt -60.92 -37.85 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.02 -46.91 79.38 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.427 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -77.87 -32.08 51.74 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 122.193 -0.317 . . . . 0.0 111.095 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.9 m -60.12 -40.73 90.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.732 0.301 . . . . 0.0 110.455 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -58.28 -44.38 88.43 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.511 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.5 -44.7 96.6 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.284 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 48.8 m -61.0 -49.67 76.48 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.516 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -62.87 -47.72 82.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.818 0.342 . . . . 0.0 110.477 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 27.4 m -61.62 -45.05 95.75 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.068 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -70.67 -37.57 73.67 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -85.5 8.9 17.42 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.707 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -58.97 -36.5 74.95 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.276 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.8 tp -61.3 -47.93 83.71 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.78 0.324 . . . . 0.0 110.131 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -85.32 162.17 19.2 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.898 0.38 . . . . 0.0 110.04 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -159.12 153.8 24.51 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.766 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -152.88 160.7 43.08 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -64.5 -42.48 95.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.485 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -169.8 -7.5 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.38 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -64.11 -38.58 91.58 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.061 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.905 179.849 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.465 ' H3 ' ' NH1' ' A' ' 115' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -63.03 -42.76 99.84 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.949 0.404 . . . . 0.0 110.183 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -72.61 51.68 0.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.294 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.6 mt -50.37 140.23 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.8 m -134.12 135.26 43.06 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.5 m -132.49 160.72 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -138.44 158.72 43.72 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.957 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.501 ' CG2' HD22 ' A' ' 126' ' ' LEU . 3.7 t -133.48 126.43 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.9 p -88.76 109.05 19.84 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.0 t -126.36 127.02 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -97.47 89.13 4.59 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.09 154.75 5.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.032 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.62 132.23 50.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.18 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.4 tt -54.08 -34.74 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.611 0.244 . . . . 0.0 110.929 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.93 -40.31 92.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.083 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -70.18 -48.09 58.78 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.803 0.335 . . . . 0.0 110.786 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.0 -41.7 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.356 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.544 ' NE1' ' ND2' ' A' ' 22' ' ' ASN . 42.9 t-105 -50.66 -39.87 51.93 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.551 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -65.68 -48.35 72.36 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.311 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -68.59 -43.0 77.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.662 0.268 . . . . 0.0 110.971 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -65.57 -19.39 65.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.612 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.544 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 3.1 m-20 -102.57 -22.82 13.94 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.282 0.633 . . . . 0.0 110.583 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -63.19 120.63 63.36 Favored Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.94 -40.98 4.44 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 CA-C-N 120.997 1.392 . . . . 0.0 112.086 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.96 -30.31 63.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.697 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -78.07 -45.17 24.27 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.378 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 31' ' ' CYS . 95.7 mt -59.73 -50.86 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 121.946 -0.471 . . . . 0.0 111.064 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.6 ptm -57.64 -15.49 7.78 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -79.03 -33.27 44.98 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 58.1 p-90 -133.69 20.8 3.89 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.661 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.567 ' C ' ' H ' ' A' ' 33' ' ' ALA . 44.1 t -55.12 129.32 37.64 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.764 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 68.63 -19.33 0.16 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.116 0.484 . . . . 0.0 110.496 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.567 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.64 35.55 23.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.482 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -111.25 97.78 36.89 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.064 0.546 . . . . 0.0 110.087 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.33 -23.21 22.97 Favored 'Trans proline' 0 N--CA 1.505 2.175 0 C-N-CA 122.378 2.052 . . . . 0.0 112.576 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -68.76 -24.67 64.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.536 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -104.76 163.96 12.12 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -141.22 162.33 35.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.21 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -129.81 89.86 44.9 Favored Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -73.95 -9.04 21.94 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 121.694 1.596 . . . . 0.0 111.873 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.1 152.58 6.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.003 0.43 . . . . 0.0 110.105 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.14 145.89 13.75 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.084 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -133.72 150.3 51.5 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -159.86 125.58 4.17 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.698 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -133.25 94.78 3.4 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.7 mt -66.83 97.37 0.47 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.139 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -162.56 135.96 6.05 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.69 133.92 56.54 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.673 0.273 . . . . 0.0 110.307 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.06 5.05 69.58 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.21 165.73 39.69 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.8 p -131.09 161.56 31.8 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.442 ' CD1' ' CE2' ' A' ' 71' ' ' TYR . 30.6 p90 -154.75 170.02 22.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.068 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.8 m -153.69 139.34 17.89 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.5 m -121.33 120.64 35.67 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.3 m -92.87 123.55 36.22 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.0 ptm -142.76 138.6 30.58 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.18 145.33 26.21 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.044 0.45 . . . . 0.0 110.326 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.48 149.8 28.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.765 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -51.46 -39.93 58.45 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.866 0.365 . . . . 0.0 110.775 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -80.21 -9.32 59.72 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.139 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.3 18.21 67.09 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.0 t -62.19 -40.51 96.29 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.659 0.266 . . . . 0.0 110.922 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 44.3 ttp -142.31 136.78 30.05 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.226 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.8 p -145.74 158.86 43.82 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -159.13 139.11 11.94 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -88.56 111.01 21.37 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -94.53 131.01 40.71 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.69 175.11 42.09 Favored Glycine 0 C--O 1.227 -0.335 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.45 -174.01 40.88 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.12 129.39 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.442 ' CE2' ' CD1' ' A' ' 52' ' ' PHE . 74.6 m-85 -72.45 113.48 9.53 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -73.4 -39.05 65.38 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.219 0.533 . . . . 0.0 109.767 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -166.89 146.21 5.4 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.524 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.6 131.03 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -140.03 128.32 22.57 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.5 p -61.51 134.88 57.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.249 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 55.98 55.36 6.99 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.673 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -155.1 -82.52 0.07 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.645 0.259 . . . . 0.0 110.35 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -163.63 160.12 22.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.355 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.7 mt -133.7 134.99 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.06 156.69 42.92 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' A' ' 84' ' ' ILE . 37.7 p90 -161.16 156.26 24.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.5 p -103.5 133.06 49.17 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.661 HD12 ' N ' ' A' ' 84' ' ' ILE . 2.6 mp -93.44 160.37 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.437 ' N ' HG22 ' A' ' 84' ' ' ILE . . . -53.25 -44.95 64.93 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -62.8 -12.8 26.84 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.831 0.315 . . . . 0.0 110.36 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.34 9.56 66.93 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -58.94 155.08 13.98 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -114.57 127.73 55.94 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.7 t -136.93 132.02 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -134.98 133.79 39.85 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 77.1 mt -123.72 114.17 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 43.2 t -111.78 129.54 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -98.92 119.58 37.94 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 39.7 m -120.44 148.77 43.37 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -154.07 158.23 40.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.0 p -135.86 23.33 3.34 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.249 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 100' ' ' THR . . . 88.34 128.31 2.97 Favored Glycine 0 N--CA 1.47 0.96 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 58.07 6.06 0.46 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.824 0.345 . . . . 0.0 111.061 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 98' ' ' GLY . 28.2 m -148.23 137.56 22.08 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.2 m -130.99 125.24 32.8 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -110.32 119.35 38.95 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.4 mt -95.58 120.55 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 36.6 t -105.15 132.07 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -134.0 114.37 13.15 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.7 t -94.52 149.63 21.05 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -144.36 140.9 29.36 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -114.72 90.37 21.85 Favored Pre-proline 0 N--CA 1.478 0.968 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.76 163.85 32.98 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 121.56 1.507 . . . . 0.0 111.638 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -71.27 165.67 23.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.167 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -83.05 -28.54 29.51 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.966 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.9 p -62.74 -44.67 95.6 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.063 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -86.48 145.22 39.18 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -70.22 138.73 37.02 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.534 1.489 . . . . 0.0 111.813 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.465 ' NH1' ' H3 ' ' A' ' 1' ' ' GLY . 87.6 mtm180 -66.19 -38.94 89.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.128 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -50.07 -45.38 52.4 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.389 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.34 -45.94 85.62 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.899 0.38 . . . . 0.0 110.536 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -64.34 -50.38 67.98 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.725 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.54 -50.64 59.63 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.871 0.367 . . . . 0.0 110.363 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.5 m -62.33 -38.55 89.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.601 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.44 -52.33 49.9 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.943 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -62.45 -39.44 93.37 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.772 0.286 . . . . 0.0 110.483 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.402 ' O ' ' NE2' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -74.07 -35.08 64.23 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.625 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.14 -50.54 73.64 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.45 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.4 pt -63.64 -34.53 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.818 0.342 . . . . 0.0 110.798 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.501 HD22 ' CG2' ' A' ' 8' ' ' VAL . 36.0 mt -64.67 -37.07 86.34 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.029 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -61.24 -40.63 94.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.751 0.31 . . . . 0.0 110.461 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.7 t -62.69 -40.3 96.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.549 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -58.17 -44.63 88.08 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.443 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -62.11 -40.69 96.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.084 0.468 . . . . 0.0 110.392 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 42.1 m -69.04 -34.93 75.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.529 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -60.06 -52.28 66.06 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.019 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.2 t -64.57 -33.72 76.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.445 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -69.85 -46.73 64.92 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.772 0.32 . . . . 0.0 110.387 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -65.84 -26.45 67.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.935 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -62.84 -43.08 99.76 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.442 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.6 mt -75.83 139.22 41.62 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.983 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -71.5 153.39 42.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.053 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -60.58 -87.35 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.617 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 73.4 m80 48.17 -106.35 0.17 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.524 0.202 . . . . 0.0 110.765 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 49.74 -97.29 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.534 0.206 . . . . 0.0 110.983 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -70.34 136.97 50.21 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -70.04 137.98 51.75 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.585 -179.795 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.504 ' ND2' ' OG1' ' A' ' 5' ' ' THR . 8.5 p30 42.19 -160.1 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.791 0.436 . . . . 0.0 111.199 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -75.47 -69.68 0.47 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 109.973 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 81.3 mt -142.28 133.01 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.504 ' OG1' ' ND2' ' A' ' 2' ' ' ASN . 40.8 m -137.77 133.43 34.05 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 m -138.7 153.35 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.11 163.94 36.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.049 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.9 m -145.83 157.52 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -102.73 126.73 49.95 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.19 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.06 129.5 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -98.59 89.2 4.31 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.14 155.25 6.43 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.8 135.91 57.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.209 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.6 tp -52.88 -36.49 23.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 121.1 0.476 . . . . 0.0 111.417 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -68.87 -33.62 74.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.167 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -71.42 -51.73 22.36 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.603 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 p -62.51 -36.3 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.676 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.473 ' CE2' ' ND2' ' A' ' 22' ' ' ASN . 68.4 t90 -54.47 -44.0 72.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.979 0.418 . . . . 0.0 110.906 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -69.39 -45.94 68.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.712 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -65.32 -40.56 93.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.982 0.42 . . . . 0.0 110.96 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -73.54 -17.22 61.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.707 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.473 ' ND2' ' CE2' ' A' ' 18' ' ' TRP . 90.4 m-20 -109.41 -20.39 12.93 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.182 0.593 . . . . 0.0 110.72 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -64.41 138.71 97.52 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.8 -43.48 0.43 Allowed 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 121.763 1.642 . . . . 0.0 112.43 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.25 -40.56 96.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 110.909 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -66.69 -46.26 76.17 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.641 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 31' ' ' CYS . 89.2 mt -62.8 -48.51 87.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.431 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 43.2 ttp -60.38 -23.27 64.18 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -65.58 -31.78 73.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.437 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -135.67 14.17 3.42 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.444 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 27' ' ' ILE . 12.0 t -55.73 141.05 39.68 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 122.1 -0.375 . . . . 0.0 110.0 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 72.07 -46.79 0.65 Allowed 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.233 0.958 . . . . 0.0 109.227 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.38 40.58 31.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.307 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.5 m -124.32 139.12 32.17 Favored Pre-proline 0 N--CA 1.481 1.121 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.973 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.42 -30.05 8.65 Favored 'Trans proline' 0 N--CA 1.506 2.253 0 C-N-CA 121.941 1.761 . . . . 0.0 112.51 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.94 6.47 7.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.725 0.298 . . . . 0.0 110.692 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -147.32 158.39 43.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.182 0.515 . . . . 0.0 109.717 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.4 ' CE1' ' O ' ' A' ' 57' ' ' ALA . 14.3 p-80 -146.59 155.21 42.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.229 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.85 89.63 34.25 Favored Pre-proline 0 N--CA 1.476 0.828 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.63 -1.78 11.89 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.167 1.912 . . . . 0.0 111.587 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.71 147.91 6.13 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.025 0.441 . . . . 0.0 110.031 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.68 141.82 18.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.755 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -134.95 137.96 43.6 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -163.17 136.43 5.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.62 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -130.46 99.33 4.96 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 tp -65.43 95.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.877 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -169.54 141.41 2.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.17 135.93 57.79 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.289 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.08 1.7 60.37 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.77 158.43 36.96 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 178.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 t -118.27 165.26 14.05 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.142 0.577 . . . . 0.0 109.851 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -144.8 159.77 42.33 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.157 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.2 m -149.36 123.96 9.77 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.8 p -120.89 123.33 42.25 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.7 m -90.36 117.4 29.05 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 60.7 mtt -129.87 104.55 7.44 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.4 ' O ' ' CE1' ' A' ' 38' ' ' HIS . . . -126.82 156.42 41.32 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.02 148.83 37.76 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -58.73 -39.54 81.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.77 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -70.7 -9.58 57.51 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.72 9.84 63.0 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.2 t -62.99 -39.36 94.5 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 110.887 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 69.5 mmm -122.63 148.97 44.63 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.882 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.3 p -146.81 128.13 14.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.168 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -159.9 155.37 25.47 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -139.71 142.88 36.84 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.274 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.43 143.2 28.4 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.45 152.02 23.7 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.91 -172.44 41.52 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.48 142.15 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 122.974 0.51 . . . . 0.0 110.175 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -79.01 120.53 23.72 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.51 -42.77 58.33 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -168.57 148.31 4.46 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.838 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.57 136.56 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -136.03 124.11 22.95 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.426 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 4.3 m -59.2 130.65 48.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.162 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.432 ' O ' ' ND2' ' A' ' 77' ' ' ASN . 0.7 OUTLIER 40.98 57.67 2.7 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 178.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -157.77 -77.47 0.08 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 110.449 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.2 tp -149.68 133.88 17.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.738 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.437 HD11 ' HE1' ' A' ' 18' ' ' TRP . 61.5 mt -133.02 133.14 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -153.93 160.38 42.09 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -160.2 156.78 27.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.9 m -101.92 127.65 48.66 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.413 HG22 ' H ' ' A' ' 86' ' ' ASP . 86.7 mt -90.54 153.81 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.74 -41.96 67.23 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.413 ' H ' HG22 ' A' ' 84' ' ' ILE . 82.4 m-20 -60.26 -10.58 4.78 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.788 0.328 . . . . 0.0 110.17 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.0 8.81 86.12 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.409 ' NH2' ' OE2' ' A' ' 110' ' ' GLU . 89.6 mtt-85 -68.82 150.71 47.51 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -101.89 129.29 48.1 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.8 t -139.77 131.03 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -138.94 141.75 38.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.2 mt -118.97 126.93 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.97 126.82 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -99.12 125.84 44.75 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.8 p -133.64 143.5 48.64 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -154.89 156.14 35.6 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.6 t -115.59 -24.11 8.45 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.973 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.1 -112.14 0.37 Allowed Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -76.77 10.78 2.01 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.613 0.244 . . . . 0.0 110.67 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.3 p -126.72 144.92 50.78 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.7 m -125.55 131.3 52.79 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.296 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -116.33 121.83 43.11 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.9 mt -102.51 128.98 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.9 t -119.26 133.56 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -137.94 146.08 42.8 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.0 p -133.33 148.84 51.9 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -143.31 143.14 31.57 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.2 115.83 64.71 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.19 157.42 33.71 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 121.693 1.596 . . . . 0.0 111.399 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.409 ' OE2' ' NH2' ' A' ' 88' ' ' ARG . 70.7 mt-10 -77.6 156.71 30.66 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -80.77 -41.24 23.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.309 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 72.9 p -63.06 -44.75 94.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -85.18 147.7 48.28 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 119.664 -0.208 . . . . 0.0 110.972 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.72 136.73 64.05 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 121.523 1.482 . . . . 0.0 111.859 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -68.35 -42.0 79.9 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.596 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -52.27 -37.11 54.51 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.76 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.3 tp -66.6 -43.29 85.23 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.883 0.373 . . . . 0.0 110.489 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -60.32 -51.76 68.15 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.832 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -53.39 -44.42 68.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.876 0.37 . . . . 0.0 110.145 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.2 m -61.58 -40.94 96.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.255 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.97 -51.96 48.94 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -62.39 -37.72 86.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.015 0.436 . . . . 0.0 110.299 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -72.29 -35.77 68.78 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.256 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.91 -51.14 70.96 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.56 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.6 tt -63.06 -40.13 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 120.791 0.329 . . . . 0.0 110.136 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.2 mt -63.85 -38.86 92.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.4 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -61.99 -38.17 87.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.2 t -57.92 -32.79 68.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.762 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -57.61 -42.36 83.13 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.375 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -61.11 -42.68 98.97 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.369 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 36.5 m -60.98 -39.7 90.6 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.504 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -60.27 -49.08 79.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.61 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.2 p -60.81 -39.53 89.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.818 0.342 . . . . 0.0 110.31 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -66.49 -43.73 84.56 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -63.89 -36.65 84.62 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.494 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -62.97 -38.12 89.85 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.196 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.9 tp -61.06 -42.91 99.37 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.156 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -60.92 -45.04 96.26 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.38 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -74.37 132.43 42.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.815 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -69.02 109.78 4.14 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.021 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.479 ' NE2' ' CE1' ' A' ' 142' ' ' HIS . 22.1 p-80 -72.46 -17.78 61.74 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.822 0.344 . . . . 0.0 110.187 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.479 ' CE1' ' NE2' ' A' ' 141' ' ' HIS . 69.2 m80 -63.69 120.18 11.33 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.132 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -74.91 137.66 41.86 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.08 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.4 p80 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.383 179.863 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -63.68 -38.23 90.35 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.047 0.451 . . . . 0.0 110.702 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -72.12 55.36 0.31 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.919 0.39 . . . . 0.0 110.423 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 82.7 mt -58.94 131.19 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 t -137.0 149.73 47.67 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.9 m -136.85 158.39 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 161.7 40.31 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.587 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -148.96 143.04 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.886 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.7 m -94.26 119.41 33.01 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.5 t -124.87 128.03 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -95.65 92.47 6.62 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.91 154.52 5.26 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.23 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.89 135.76 57.49 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.339 -0.391 . . . . 0.0 109.956 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.8 tp -50.72 -40.79 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.141 0.496 . . . . 0.0 111.66 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -64.25 -35.27 80.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.551 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -70.54 -46.5 63.48 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.782 0.325 . . . . 0.0 110.424 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.26 -40.39 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.308 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.786 ' CH2' HD11 ' A' ' 80' ' ' ILE . 31.8 t-105 -54.53 -40.49 68.71 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.805 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -67.2 -52.8 36.74 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.278 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -64.84 -42.67 94.74 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.845 0.355 . . . . 0.0 110.885 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -64.13 -18.81 64.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.326 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.589 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 49.6 m-20 -110.2 -25.49 10.14 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 122.845 0.458 . . . . 0.0 112.177 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -53.09 110.21 1.88 Allowed Pre-proline 0 CA--C 1.556 1.196 0 CA-C-O 118.837 -0.602 . . . . 0.0 109.765 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.61 -43.05 58.13 Favored 'Trans proline' 0 N--CA 1.506 2.208 0 CA-C-N 120.869 1.346 . . . . 0.0 111.837 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.57 73.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.949 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -74.15 -42.74 59.46 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.417 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.18 -44.74 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.872 -0.517 . . . . 0.0 110.498 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.8 ptm -70.95 -6.42 38.48 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -84.95 -29.59 24.99 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -133.78 17.9 3.88 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.593 0.357 . . . . 0.0 110.954 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.59 ' C ' ' H ' ' A' ' 33' ' ' ALA . 32.1 p -45.85 128.95 9.26 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.063 0.392 . . . . 0.0 111.457 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 61.54 -11.02 0.06 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 120.982 0.42 . . . . 0.0 110.523 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.59 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 52.58 32.81 12.3 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.673 0.389 . . . . 0.0 111.24 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.5 t -122.8 135.74 26.07 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.011 0.524 . . . . 0.0 110.568 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.87 -9.96 16.86 Favored 'Trans proline' 0 N--CA 1.506 2.249 0 C-N-CA 122.097 1.865 . . . . 0.0 112.418 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -73.91 -24.74 59.73 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.728 0.299 . . . . 0.0 110.737 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -103.66 155.21 18.74 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.663 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -139.02 164.15 30.51 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.1 t -132.36 94.33 23.32 Favored Pre-proline 0 N--CA 1.477 0.925 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.29 -12.01 25.12 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.343 1.362 . . . . 0.0 111.211 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.8 150.8 4.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.418 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.59 141.74 20.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.227 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -138.0 142.07 40.42 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -163.13 135.55 5.35 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -129.86 104.0 7.13 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.64 93.71 1.27 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.914 0.388 . . . . 0.0 110.111 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -171.41 151.06 2.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.662 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.09 137.95 58.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.661 0.267 . . . . 0.0 110.453 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.31 0.74 47.65 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.85 149.44 44.68 Favored Glycine 0 N--CA 1.464 0.533 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.9 p -110.75 144.01 40.38 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -127.16 152.84 46.81 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.3 m -149.94 116.83 5.92 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.7 m -116.52 115.86 26.55 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.1 m -91.84 116.27 28.76 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 71.3 mtp -117.79 129.43 55.67 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.09 135.12 37.17 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.071 0.462 . . . . 0.0 110.57 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.7 149.92 49.38 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.309 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -55.93 -39.7 72.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.626 0.25 . . . . 0.0 110.463 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -76.38 -10.21 59.22 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.62 17.62 62.66 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.6 p -83.93 -9.97 58.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.617 0.246 . . . . 0.0 110.774 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.7 ttt -152.92 120.86 6.12 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.452 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.2 m -144.25 148.68 35.2 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -158.9 164.55 35.56 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 22.4 p-10 -137.08 123.33 20.56 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.804 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -94.11 145.92 24.34 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.05 153.68 25.12 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.27 -171.68 41.05 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -128.63 135.69 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -71.94 121.85 19.81 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -73.56 -38.44 65.2 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -163.05 145.42 10.29 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.508 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.1 t -137.97 130.5 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -146.88 123.8 11.33 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.6 p -51.71 121.92 7.31 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.211 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 54.28 62.02 2.77 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.28 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -156.04 -84.58 0.06 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.753 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 tp -148.42 136.24 20.81 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.771 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.786 HD11 ' CH2' ' A' ' 18' ' ' TRP . 75.2 mt -130.32 127.82 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -153.49 165.29 36.3 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -160.8 154.42 22.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.836 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.1 m -89.35 131.09 35.59 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 80.0 mt -102.27 148.82 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.88 -44.05 71.21 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.0 p30 -61.93 -18.69 61.18 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.367 0.584 . . . . 0.0 110.394 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.07 5.19 77.19 Favored Glycine 0 N--CA 1.47 0.954 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 65.6 mmt-85 -63.04 139.38 58.77 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -89.96 128.53 36.26 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.5 t -141.34 125.96 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -136.84 142.92 42.87 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 75.5 mt -119.86 118.94 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.8 t -104.2 124.29 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -96.15 122.43 38.99 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 36.4 m -140.36 146.62 38.65 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -150.74 164.63 35.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.2 t -137.85 23.51 2.85 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.292 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.12 129.65 2.82 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 55.49 12.02 0.7 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.816 0.341 . . . . 0.0 111.037 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.9 m -153.78 140.75 19.27 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.4 m -125.43 130.68 52.33 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.756 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -110.45 117.03 32.49 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.9 mt -106.85 122.21 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.04 139.56 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -144.98 142.76 30.08 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.048 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.4 p -94.23 152.7 18.5 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -151.49 139.74 20.31 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -92.15 138.92 24.21 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.34 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.49 146.3 34.73 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.637 1.558 . . . . 0.0 111.93 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -87.0 153.76 21.3 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -74.01 -39.29 63.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.474 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.0 m -68.51 -46.32 69.91 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -92.29 133.39 30.06 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-O 118.673 -0.679 . . . . 0.0 110.329 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.85 147.45 41.54 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 CA-C-N 120.862 1.344 . . . . 0.0 111.755 178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -68.62 -35.18 76.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.144 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -66.45 -47.21 73.86 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.947 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.23 -52.4 41.47 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -177.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.51 HE21 ' C ' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -58.56 -35.32 72.17 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.888 -179.508 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -57.42 -47.32 82.07 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.84 0.352 . . . . 0.0 110.06 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.0 m -64.04 -33.04 74.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.588 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.61 -50.46 67.53 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -62.45 -39.52 93.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.985 0.422 . . . . 0.0 110.429 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -71.91 -37.57 70.06 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.348 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.35 -50.69 72.75 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.836 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 42.0 pt -65.4 -32.75 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 110.734 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.2 -37.01 82.92 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -62.55 -41.56 98.98 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.08 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.9 p -62.52 -32.4 73.33 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.616 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -59.24 -38.62 80.47 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.579 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.69 -45.54 91.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.436 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 78.6 p -65.12 -39.52 93.18 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 109.961 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -61.57 -44.9 96.18 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.154 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 27.3 m -58.9 -47.03 86.42 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.928 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -66.55 -42.84 86.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -64.58 -34.93 79.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.468 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -62.93 -47.96 80.99 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.733 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.85 142.88 33.2 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 139' ' ' HIS . 93.0 mt-10 53.79 -126.91 2.38 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.726 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.405 ' CG ' ' O ' ' A' ' 138' ' ' GLU . 73.0 m80 -155.4 162.55 40.76 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -60.5 -43.13 97.38 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.359 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -65.39 136.29 56.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.237 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -70.42 143.06 51.94 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.259 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -63.46 142.32 58.44 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.336 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 70.5 m80 . . . . . 0 C--O 1.222 -0.345 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.48 -179.945 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -62.45 -38.63 90.5 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.009 0.433 . . . . 0.0 110.372 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -72.49 51.13 0.25 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.057 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.3 mt -54.65 139.99 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 t -129.27 137.43 51.05 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.682 0.614 . . . . 0.0 109.718 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.61 158.08 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.41 158.0 43.8 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.558 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.9 p -146.14 144.78 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.673 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.9 m -97.58 120.79 38.6 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.94 127.5 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -91.7 93.96 9.15 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.8 151.52 3.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.09 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.43 140.44 58.87 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.664 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.7 tp -51.6 -37.22 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.169 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -68.94 -34.32 75.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.435 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -69.3 -50.58 45.44 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.903 0.382 . . . . 0.0 111.218 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -64.3 -36.19 76.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.62 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -58.29 -49.84 75.71 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.614 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -67.64 -45.83 74.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.641 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.45 ' CD2' ' ND1' ' A' ' 26' ' ' HIS . 56.2 t80 -63.88 -44.23 93.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.049 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.414 ' C ' HD22 ' A' ' 22' ' ' ASN . 64.0 t-105 -70.82 -19.65 62.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.626 HD22 ' N ' ' A' ' 22' ' ' ASN . 0.7 OUTLIER -103.05 -23.82 13.66 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.845 0.458 . . . . 0.0 111.437 -179.24 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -62.94 135.17 95.99 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.1 -40.67 0.81 Allowed 'Trans proline' 0 N--CA 1.504 2.142 0 C-N-CA 121.681 1.588 . . . . 0.0 111.745 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.83 -33.0 68.16 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.051 0.453 . . . . 0.0 110.78 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.45 ' ND1' ' CD2' ' A' ' 20' ' ' TYR . 35.5 m170 -76.4 -42.36 44.59 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.573 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.13 -44.93 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 122.161 -0.337 . . . . 0.0 110.804 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.512 ' O ' HG11 ' A' ' 39' ' ' VAL . 25.6 ptm -68.14 -10.64 55.66 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -79.7 -28.6 40.63 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.333 -0.23 . . . . 0.0 110.395 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -137.48 21.61 2.93 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.204 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.539 ' C ' ' H ' ' A' ' 33' ' ' ALA . 29.3 t -55.97 133.17 51.44 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.639 -0.663 . . . . 0.0 110.189 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 69.35 -32.08 0.22 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.108 0.563 . . . . 0.0 110.423 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.539 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 55.66 34.61 23.6 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.327 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.8 p -128.51 138.66 33.54 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.087 0.555 . . . . 0.0 110.033 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.48 -12.53 18.66 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.746 1.63 . . . . 0.0 112.239 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -76.25 -24.61 54.52 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -115.41 140.2 49.34 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.929 0.492 . . . . 0.0 110.545 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -117.33 163.79 15.81 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.251 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 39' ' ' VAL . 7.7 p -131.84 87.62 44.47 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.079 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.75 -8.2 14.59 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.053 1.835 . . . . 0.0 111.559 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.44 153.23 5.11 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.894 0.378 . . . . 0.0 110.055 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.99 152.88 5.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.961 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -141.28 155.52 45.98 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -159.25 103.05 1.61 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.019 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -95.59 86.98 4.58 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 tp -66.4 93.25 0.22 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.357 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -169.93 145.19 2.89 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.61 135.93 56.74 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.425 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.16 -1.05 35.76 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.96 162.28 52.69 Favored Glycine 0 N--CA 1.468 0.81 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.4 p -125.24 157.22 37.1 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.672 0.389 . . . . 0.0 110.262 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -138.16 157.03 47.11 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.318 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.0 m -146.93 116.01 6.92 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.9 m -106.99 112.62 25.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 m -92.88 120.08 32.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.7 ptm -143.14 142.12 31.39 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.79 152.73 40.78 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.028 0.442 . . . . 0.0 110.748 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.08 148.71 50.58 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.636 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -57.89 -39.32 77.58 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.591 0.234 . . . . 0.0 110.523 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -78.05 -6.06 53.41 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.78 17.51 54.57 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.1 p -66.37 -25.52 66.83 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.769 0.319 . . . . 0.0 110.389 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.2 ttt -149.09 145.34 27.18 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.916 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.7 t -142.7 144.85 32.89 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.737 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.408 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 71.1 t80 -159.35 162.53 35.91 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.408 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 30.3 p-10 -138.04 130.69 29.55 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.098 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -94.54 137.61 33.44 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.27 154.96 25.85 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.71 -176.03 40.41 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.4 t -126.24 133.26 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -75.44 115.49 15.15 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -73.85 -44.84 54.31 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.184 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -153.23 145.87 24.23 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 p -148.1 137.3 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -143.06 132.37 23.34 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.9 m -56.77 128.62 37.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.732 0.301 . . . . 0.0 111.453 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 54.88 69.38 0.74 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.767 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -165.84 -80.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -160.35 159.99 31.85 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.976 0.417 . . . . 0.0 110.795 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.9 mt -134.74 135.63 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.86 155.55 41.06 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -159.09 159.65 34.82 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 49.6 m -102.25 129.89 48.79 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.5 tt -94.57 167.1 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.91 -38.11 94.86 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -63.28 -16.77 61.34 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 117.184 0.492 . . . . 0.0 109.962 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.21 11.6 78.05 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -77.86 148.36 34.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -83.92 153.96 23.66 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.0 t -144.99 130.5 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -137.21 122.01 18.74 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.9 mt -122.46 113.93 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.4 p -118.82 131.75 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-O 121.279 0.561 . . . . 0.0 110.034 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -97.13 109.21 22.01 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 61.3 m -98.22 122.95 42.01 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -101.8 146.73 27.38 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.3 m -146.62 99.32 3.19 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.411 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.89 -95.43 0.04 OUTLIER Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -128.56 48.4 2.32 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.006 0.431 . . . . 0.0 110.587 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.6 m -161.35 119.22 2.33 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.0 m -95.27 141.09 29.26 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -127.45 129.48 47.57 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.2 mt -103.07 125.53 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.7 t -122.68 127.83 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -142.92 144.62 32.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.23 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.8 t -136.11 143.11 44.38 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.079 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -127.57 169.19 13.99 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.671 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -132.07 79.39 67.0 Favored Pre-proline 0 N--CA 1.473 0.681 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.722 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -59.03 168.23 4.77 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.141 1.894 . . . . 0.0 111.697 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.95 168.9 2.17 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.113 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -81.78 -44.7 16.63 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.781 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.7 t -65.32 -36.15 83.18 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.251 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -67.31 146.01 98.71 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 119.573 -0.251 . . . . 0.0 110.604 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.23 120.81 7.02 Favored 'Trans proline' 0 N--CA 1.504 2.092 0 C-N-CA 121.758 1.639 . . . . 0.0 111.767 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 81.7 mtm-85 -65.4 -39.67 92.48 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.763 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.84 -44.24 73.73 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.607 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.5 tp -60.74 -43.52 97.83 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.147 0.499 . . . . 0.0 110.655 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -64.37 -43.05 95.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.425 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -54.13 -44.43 71.35 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.805 0.336 . . . . 0.0 110.299 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 78.8 p -68.28 -35.9 78.56 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.83 -51.99 51.6 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -64.22 -37.08 86.21 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.816 0.341 . . . . 0.0 110.421 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -72.4 -37.43 68.7 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.461 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.99 67.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.909 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.5 tt -60.89 -36.96 75.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.8 mt -66.19 -49.1 68.46 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.467 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -75.78 -33.71 60.19 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.664 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.0 m -60.54 -40.34 91.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.32 . . . . 0.0 110.399 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -56.84 -42.65 80.03 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.512 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -60.68 -39.0 86.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.671 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 29.0 m -58.34 -46.65 85.81 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.988 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -65.45 -37.88 88.18 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.374 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 97.8 m -60.46 -48.19 82.83 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.8 0.333 . . . . 0.0 110.852 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -70.56 -41.68 72.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.385 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -66.41 -24.99 66.55 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.995 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -61.04 -41.14 96.03 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.422 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.2 mt 52.06 101.4 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.773 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -160.58 129.28 4.74 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -69.62 144.28 53.02 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -64.87 142.45 58.43 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.289 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -166.82 104.0 0.57 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.048 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -157.71 165.7 34.73 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' HIS . . . . . 0.404 ' O ' ' CG ' ' A' ' 144' ' ' HIS . 96.5 m-70 -152.58 -36.01 0.12 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.185 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.404 ' CG ' ' O ' ' A' ' 143' ' ' HIS . 33.5 p80 . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.386 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.609 ' H ' ' NH1' ' A' ' 115' ' ' ARG . 72.6 m-20 54.74 35.2 23.43 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.368 0.128 . . . . 0.0 110.918 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -126.28 55.92 1.47 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.811 0.445 . . . . 0.0 110.173 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 79.5 mt -46.14 121.28 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 m -112.89 130.7 56.01 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 m -134.48 156.59 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.406 ' CD ' ' N ' ' A' ' 7' ' ' GLU . 1.3 pm0 -148.3 161.29 41.82 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.14 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -145.05 143.84 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.1 m -91.17 117.29 29.5 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.8 t -124.65 128.36 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -100.16 88.57 3.75 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.74 153.59 5.01 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.048 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.12 133.28 52.67 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 20.1 tt -52.25 -37.53 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.776 0.322 . . . . 0.0 111.733 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -58.96 -35.58 73.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.356 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -74.92 -46.07 38.29 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.022 0.439 . . . . 0.0 110.442 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.09 -43.28 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.189 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.698 ' CH2' HD11 ' A' ' 80' ' ' ILE . 28.0 t-105 -54.86 -46.09 74.65 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.84 0.352 . . . . 0.0 110.943 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.78 -45.85 77.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.335 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -65.19 -43.75 90.61 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.894 0.378 . . . . 0.0 111.166 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -69.5 -15.96 63.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.561 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.543 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 86.7 m-20 -109.52 -24.64 10.89 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.274 0.63 . . . . 0.0 111.298 -178.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -65.09 117.23 37.43 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.499 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.97 -34.59 10.33 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 CA-C-N 121.033 1.405 . . . . 0.0 112.005 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -34.22 70.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.002 0.429 . . . . 0.0 110.575 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -81.17 -40.89 23.21 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.405 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.9 -45.4 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 122.069 -0.394 . . . . 0.0 111.088 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.7 ptm -59.32 -12.85 6.35 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.335 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -81.32 -39.71 24.72 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -120.22 20.76 11.95 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.654 0.381 . . . . 0.0 111.183 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.606 ' C ' ' H ' ' A' ' 33' ' ' ALA . 12.9 t -57.54 135.82 56.68 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.829 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.513 ' NE2' ' CG ' ' A' ' 37' ' ' TRP . 26.6 mt-30 67.83 -26.29 0.13 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.612 0.57 . . . . 0.0 110.327 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.606 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 55.5 27.33 10.09 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.565 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.1 t -124.06 139.92 33.64 Favored Pre-proline 0 N--CA 1.478 0.93 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.253 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.54 -8.9 19.8 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 121.95 1.767 . . . . 0.0 111.668 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -83.16 9.26 10.92 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.622 0.249 . . . . 0.0 110.668 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.513 ' CG ' ' NE2' ' A' ' 32' ' ' GLN . 95.7 m95 -151.72 157.72 42.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.242 0.544 . . . . 0.0 110.072 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -147.58 163.5 36.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.105 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.57 93.14 48.69 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 123.023 0.529 . . . . 0.0 109.853 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.46 -8.79 19.81 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.488 1.459 . . . . 0.0 111.597 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.72 151.99 9.56 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.844 0.354 . . . . 0.0 110.228 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.02 144.94 14.96 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.247 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -137.59 145.11 42.41 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -162.03 134.02 5.57 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.853 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -132.99 99.42 4.57 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.5 96.58 0.53 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -166.62 147.77 6.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.09 137.55 58.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.1 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.78 5.19 44.41 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.89 151.54 33.87 Favored Glycine 0 N--CA 1.466 0.655 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.1 p -113.42 161.46 17.28 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -143.51 166.03 25.93 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.215 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.3 m -160.49 128.61 4.6 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.1 m -122.78 123.4 40.96 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -92.35 115.65 28.28 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.3 mtt -120.68 132.43 55.09 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.43 136.15 23.21 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.794 0.331 . . . . 0.0 110.699 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.66 148.77 45.39 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -58.58 -39.54 80.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.723 0.297 . . . . 0.0 110.32 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -74.16 -11.38 60.28 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.25 17.12 67.85 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.4 m -61.89 -40.46 95.5 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.847 0.356 . . . . 0.0 110.725 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 44.4 ttp -147.1 149.55 33.25 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.187 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.1 t -145.04 152.35 39.98 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.329 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -156.5 155.5 32.09 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -138.24 131.11 29.71 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.872 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -95.81 145.36 25.4 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.97 153.31 24.91 Favored Glycine 0 N--CA 1.466 0.65 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -179.09 -171.14 41.93 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.46 145.89 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -82.87 126.12 32.11 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -81.74 -26.9 34.16 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 110.035 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -167.59 140.27 3.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.839 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.5 t -137.24 126.92 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -145.66 124.72 12.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.0 m -50.07 119.57 3.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 53.67 75.8 0.25 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.443 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -168.16 -81.31 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.365 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.435 HD11 ' HE ' ' A' ' 91' ' ' ARG . 7.1 tp -149.94 135.03 17.95 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.902 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.698 HD11 ' CH2' ' A' ' 18' ' ' TRP . 79.0 mt -128.69 130.02 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -153.09 165.35 35.89 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -158.77 164.54 35.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.511 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.6 m -116.26 129.77 56.45 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.7 mm -98.37 149.16 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.961 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.72 -40.39 71.04 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -60.96 -15.8 35.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.656 0.265 . . . . 0.0 110.503 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.4 -2.85 59.35 Favored Glycine 0 N--CA 1.473 1.138 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -64.96 143.77 57.73 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -123.66 139.88 53.55 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.6 t -133.57 134.67 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.435 ' HE ' HD11 ' A' ' 79' ' ' LEU . 77.0 ttt180 -127.51 122.72 34.11 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 68.7 mt -110.78 124.1 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.8 123.21 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -94.98 123.29 38.37 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.9 p -134.06 150.69 51.21 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -154.38 164.4 38.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.902 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 m -149.5 118.53 6.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.753 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.09 -94.47 0.07 OUTLIER Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -130.99 31.77 4.41 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.666 0.386 . . . . 0.0 111.015 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 46.4 m -132.16 124.85 29.89 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.8 m -100.86 133.46 45.3 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -122.37 117.53 26.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.9 mt -98.01 129.04 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.48 130.84 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -132.63 120.07 21.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.0 t -99.22 148.2 24.36 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -136.01 149.92 49.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -131.68 78.21 71.19 Favored Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -84.17 -169.85 0.74 Allowed 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.106 1.871 . . . . 0.0 111.141 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 110' ' ' GLU . 28.1 mp0 -65.43 129.28 39.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.074 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -64.05 -34.55 78.28 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.216 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 78.9 p -65.22 -38.64 91.04 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.95 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -64.7 149.16 96.26 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.36 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.33 106.53 1.95 Allowed 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 121.866 1.711 . . . . 0.0 111.398 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.609 ' NH1' ' H ' ' A' ' 2' ' ' ASN . 89.8 mtm180 -62.49 -32.8 73.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.332 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -48.92 -49.82 38.24 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.622 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.6 mt -68.34 -39.51 81.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.717 0.294 . . . . 0.0 110.928 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -61.43 -45.85 92.58 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.644 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -55.23 -43.48 74.56 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.084 0.469 . . . . 0.0 109.771 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.4 m -62.23 -40.73 97.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.165 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.15 -51.99 48.23 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -63.35 -37.25 86.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.78 0.324 . . . . 0.0 110.277 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -72.1 -36.24 69.41 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.683 0.278 . . . . 0.0 110.338 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.25 70.69 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.789 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.6 tt -62.62 -39.23 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 25.5 mt -63.87 -39.14 93.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -63.89 -40.95 97.7 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m -58.37 -30.65 66.95 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.344 0.403 . . . . 0.0 111.232 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -51.14 -20.2 1.42 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.933 0.397 . . . . 0.0 110.898 -178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -70.12 -38.99 75.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.715 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.0 m -58.25 -44.14 88.17 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.196 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -61.68 -50.5 72.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.522 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 74.5 p -65.29 -39.97 93.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.787 0.327 . . . . 0.0 110.372 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -67.74 -35.55 78.95 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -61.97 -41.69 98.29 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.377 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -63.41 -43.32 97.84 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.385 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.0 tp -97.13 108.55 21.3 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -169.7 95.9 0.29 Allowed 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -66.3 82.13 0.09 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 80.5 t60 58.0 160.45 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.593 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -167.11 159.39 12.98 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.182 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -65.64 133.97 52.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.938 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -68.16 133.94 49.71 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 86.1 t60 . . . . . 0 C--O 1.219 -0.535 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.181 179.835 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 120.95 0.405 . . . . 0.0 110.082 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 82.0 mt -55.42 132.49 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -130.31 139.11 50.74 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.4 m -136.15 156.38 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -145.24 157.48 44.06 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.038 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 p -145.81 142.78 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.9 p -97.18 117.34 31.17 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.55 126.12 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -93.64 88.73 5.96 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.09 0.471 . . . . 0.0 109.863 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.88 153.12 4.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.055 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.74 139.3 58.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.221 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.5 tp -51.07 -36.79 16.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 120.893 0.378 . . . . 0.0 111.612 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -67.66 -33.1 74.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.44 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -71.17 -51.32 25.53 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 p -65.3 -36.59 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.318 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.758 ' CH2' HD11 ' A' ' 80' ' ' ILE . 29.1 t-105 -54.61 -43.41 72.18 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.932 0.396 . . . . 0.0 110.56 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -68.37 -45.33 73.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.622 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -65.71 -44.42 86.14 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.902 0.382 . . . . 0.0 111.497 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -66.75 -20.7 66.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.932 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -102.63 -22.56 13.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.982 0.513 . . . . 0.0 111.512 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -64.16 123.02 80.96 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.93 -39.74 3.07 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 CA-C-N 120.863 1.344 . . . . 0.0 111.889 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.11 -39.21 71.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.894 0.378 . . . . 0.0 110.759 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.9 m170 -66.33 -42.86 87.57 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.64 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 31' ' ' CYS . 97.2 mt -62.61 -43.75 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 93.5 mtp -59.31 -13.45 8.06 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.737 -0.21 . . . . 0.0 111.077 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -85.14 -38.56 18.91 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.978 -0.451 . . . . 0.0 110.759 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -122.4 23.74 9.58 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.729 0.412 . . . . 0.0 111.216 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.552 ' C ' ' H ' ' A' ' 33' ' ' ALA . 38.3 t -54.39 129.37 35.4 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.804 -0.56 . . . . 0.0 110.958 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 68.54 -30.67 0.18 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.341 0.401 . . . . 0.0 110.478 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.65 38.37 29.85 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.048 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.7 p -136.81 141.46 35.15 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.302 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.39 -16.41 21.87 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 122.008 1.805 . . . . 0.0 112.289 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -84.06 14.1 4.48 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -151.41 154.81 37.36 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.171 0.51 . . . . 0.0 110.232 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -142.5 163.01 33.99 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.234 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 39' ' ' VAL . 7.1 p -127.58 89.57 50.72 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.97 -12.22 23.74 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.263 1.309 . . . . 0.0 111.479 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -171.91 153.05 3.13 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.02 0.438 . . . . 0.0 110.577 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -157.84 150.72 22.92 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.214 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -137.08 145.33 43.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.591 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -161.46 132.32 5.22 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.96 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -128.98 96.01 4.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.0 tp -65.8 96.65 0.3 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -167.67 142.31 3.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.964 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.55 138.19 58.41 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.23 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.27 2.44 59.12 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.9 166.49 37.29 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.8 p -129.14 164.95 22.24 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.639 0.376 . . . . 0.0 110.047 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -140.71 164.52 29.98 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.6 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 36.1 m -150.61 122.56 8.19 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.421 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 37.5 m -116.39 116.57 27.94 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.2 m -95.11 119.68 34.04 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 14.8 ptm -145.67 144.83 30.64 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.75 156.15 40.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.061 0.458 . . . . 0.0 110.535 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.81 148.05 40.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.666 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -56.58 -39.87 74.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.763 0.315 . . . . 0.0 110.721 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -76.37 -7.46 55.05 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.18 11.32 67.13 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.5 t -62.93 -41.84 99.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.45 0.167 . . . . 0.0 111.097 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.9 ttt -120.85 146.32 46.7 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -144.11 141.25 29.9 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.81 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.438 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 56.4 t80 -159.98 161.26 34.1 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.438 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 67.4 t0 -138.54 126.56 22.59 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -94.76 135.54 36.13 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.66 155.74 26.5 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.05 -171.4 41.39 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 p -128.72 139.67 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.785 0.434 . . . . 0.0 110.008 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -78.36 124.96 28.69 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -75.85 -40.01 55.55 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.926 0.393 . . . . 0.0 110.09 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -159.83 146.03 15.93 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.844 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.2 t -135.69 130.69 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -145.4 123.61 12.21 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.4 m -55.12 122.28 10.65 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.9 m120 54.79 60.54 3.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.608 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -156.12 -82.31 0.07 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.089 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.6 tp -147.76 136.8 22.15 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.554 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.758 HD11 ' CH2' ' A' ' 18' ' ' TRP . 69.7 mt -129.79 126.78 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -154.16 164.18 38.92 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -155.05 154.98 33.3 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.941 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.1 m -87.58 129.53 35.07 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.78 139.87 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.66 -43.21 59.43 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -60.72 -18.56 55.09 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.633 0.254 . . . . 0.0 110.73 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.31 0.67 65.13 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -60.71 168.64 2.17 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -125.19 118.38 25.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.789 0.436 . . . . 0.0 110.126 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -131.96 125.12 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -135.24 136.63 41.86 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.0 mt -112.48 111.52 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.9 t -97.36 128.33 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -98.61 122.15 41.45 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.268 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.1 m -144.75 149.67 35.93 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -142.14 129.16 20.78 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.7 m -63.89 -45.8 87.71 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-O 121.135 0.493 . . . . 0.0 109.968 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.09 -69.43 0.08 OUTLIER Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -102.07 10.04 39.83 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.753 0.421 . . . . 0.0 110.963 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 54.7 m -147.18 129.88 16.06 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.2 m -86.65 140.21 30.03 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -120.47 116.69 25.93 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.6 mt -96.19 124.79 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -120.34 128.35 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -142.0 125.43 16.65 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 120.858 0.361 . . . . 0.0 110.541 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.4 p -94.88 150.99 19.59 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -134.47 149.96 50.77 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 CA--C 1.549 0.907 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.123 -179.662 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 111.111 0.041 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -59.26 -47.68 84.46 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.5 t -68.94 -25.2 64.44 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.278 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.59 -51.87 48.17 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -62.01 -38.14 87.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.902 0.382 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -70.76 -37.08 73.38 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.723 0.297 . . . . 0.0 110.38 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.11 -51.62 69.24 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.795 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.0 tt -63.66 -37.68 80.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.702 0.287 . . . . 0.0 110.381 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.9 mt -63.45 -37.13 86.1 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -60.92 -30.95 70.51 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.562 0.22 . . . . 0.0 110.877 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.7 m -56.15 -35.48 67.21 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.665 0.269 . . . . 0.0 110.968 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.276 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.6 mttm . . . . . 0 C--O 1.233 0.203 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.1 mt -48.45 138.47 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 t -135.69 138.73 43.08 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.7 m -139.14 157.35 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -147.95 159.92 43.37 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.322 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 p -145.82 142.39 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.1 m -97.29 118.25 33.34 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.36 128.16 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -93.69 85.41 4.85 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.45 153.01 3.39 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.981 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.86 135.51 55.82 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.0 tt -54.52 -32.12 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.673 0.273 . . . . 0.0 111.29 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -60.35 -39.72 88.15 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.265 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -73.12 -47.61 42.66 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.38 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.64 -43.38 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.094 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.791 ' CH2' HD11 ' A' ' 80' ' ' ILE . 22.4 t-105 -54.76 -38.16 66.87 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.889 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.58 -53.33 56.19 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.799 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -69.67 -40.29 76.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.545 0.212 . . . . 0.0 111.398 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -59.94 -17.46 37.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.892 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.579 HD22 ' N ' ' A' ' 22' ' ' ASN . 0.8 OUTLIER -115.72 -28.18 6.83 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.165 0.586 . . . . 0.0 112.011 -179.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -54.76 107.5 0.88 Allowed Pre-proline 0 N--CA 1.477 0.881 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.941 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.56 -42.49 64.81 Favored 'Trans proline' 0 N--CA 1.508 2.38 0 CA-C-N 121.097 1.427 . . . . 0.0 112.296 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.98 -28.45 66.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.479 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -79.8 -37.66 34.7 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.705 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.24 -44.91 99.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.641 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.5 ptp -54.46 -21.52 10.14 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 120.694 0.283 . . . . 0.0 111.66 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -73.15 -39.49 65.63 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.811 -0.555 . . . . 0.0 111.528 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -124.31 21.72 8.68 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.74 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.522 ' C ' ' H ' ' A' ' 33' ' ' ALA . 17.9 t -60.58 134.25 56.89 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.817 -0.552 . . . . 0.0 110.315 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 69.43 -33.9 0.26 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.998 0.811 . . . . 0.0 110.519 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 53.78 21.57 2.78 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 110.577 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.5 m -108.54 110.13 61.47 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.573 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -51.54 -27.97 26.96 Favored 'Trans proline' 0 N--CA 1.513 2.658 0 C-N-CA 122.112 1.875 . . . . 0.0 112.782 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -74.75 5.33 5.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.656 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -146.89 156.48 43.12 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.415 ' CE1' ' O ' ' A' ' 57' ' ' ALA . 45.8 p-80 -144.1 163.65 32.95 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 39' ' ' VAL . 7.3 p -121.55 94.8 48.44 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 122.886 0.474 . . . . 0.0 109.915 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.32 -8.46 17.38 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.265 1.31 . . . . 0.0 111.782 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.88 154.39 6.29 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.03 150.66 6.66 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -146.39 146.17 30.53 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -164.52 135.97 4.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.47 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -125.45 101.58 7.0 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 tp -65.73 95.79 0.25 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -169.26 141.91 2.62 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.75 137.92 58.15 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.346 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.32 0.86 48.45 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.02 153.94 36.68 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 p -105.22 158.25 16.73 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 120.871 0.367 . . . . 0.0 110.058 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -145.08 154.48 42.53 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.882 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.9 m -151.73 129.88 11.92 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.2 m -123.09 121.48 36.13 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.8 m -94.74 117.35 29.98 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 68.1 mtm -130.89 140.87 50.26 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.415 ' O ' ' CE1' ' A' ' 38' ' ' HIS . . . -147.6 147.4 30.01 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.132 0.491 . . . . 0.0 110.725 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.85 148.38 51.26 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.455 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.43 -40.19 71.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.639 0.257 . . . . 0.0 110.515 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.58 -11.24 59.98 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.12 21.21 63.63 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.7 m -80.95 -12.97 59.3 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.705 0.288 . . . . 0.0 110.674 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.1 ttt -160.59 135.31 7.53 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.8 p -145.07 162.39 37.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.995 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.485 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 52.8 t80 -159.28 163.68 35.55 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.485 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 73.9 m-20 -137.88 123.65 19.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -95.29 141.22 29.13 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.04 152.71 24.26 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.95 -171.73 42.48 Favored Glycine 0 CA--C 1.517 0.174 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.76 137.54 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -70.06 120.88 16.42 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.72 -40.9 63.23 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -164.89 148.08 8.57 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.0 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.8 p -145.86 138.56 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -143.6 130.62 20.59 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.5 m -55.11 121.15 8.14 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.581 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.0 m120 51.62 72.43 0.38 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -168.74 -79.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.378 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 tp -148.53 136.72 21.09 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.498 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.791 HD11 ' CH2' ' A' ' 18' ' ' TRP . 75.3 mt -129.82 129.47 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -154.21 165.07 37.44 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -154.5 155.18 34.39 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.7 m -87.52 129.35 35.11 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.5 139.51 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.63 -40.84 56.17 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -61.3 -17.8 55.41 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.49 3.52 71.7 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -64.11 165.44 9.16 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -121.95 121.98 38.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.955 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.92 129.11 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.56 138.7 43.26 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 73.4 mt -113.36 118.32 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.7 t -105.9 122.73 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.14 125.16 44.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.0 p -132.15 150.91 52.04 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -154.63 147.43 24.4 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.8 p -105.77 -19.47 13.74 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.87 -107.88 0.28 Allowed Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -81.44 7.41 11.89 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.397 0.279 . . . . 0.0 110.69 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.6 m -128.23 124.67 37.25 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.6 m -101.89 135.25 43.77 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -119.09 119.48 34.34 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.5 mt -99.75 127.32 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.87 130.32 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -142.36 144.83 33.36 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.5 t -111.69 149.31 31.78 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -143.12 141.4 31.21 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t70 . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.229 -179.356 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 . . . . . 0 N--CA 1.463 0.178 0 N-CA-C 110.651 -0.129 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -54.66 -47.81 73.11 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.0 t -61.82 -42.34 98.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.109 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.38 -51.73 56.08 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.563 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.5 -39.37 93.29 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.863 0.331 . . . . 0.0 110.558 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -70.98 -37.06 72.74 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.67 -52.54 64.51 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.762 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.4 tt -66.87 -36.75 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.372 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.9 mt -60.06 -41.94 93.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.187 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 128' ' ' SER . 25.8 p30 -66.4 -30.61 71.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.537 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.406 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 21.9 p -61.03 -37.74 83.66 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.864 0.364 . . . . 0.0 110.654 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 53.8 t80 . . . . . 0 CA--C 1.536 0.423 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.446 -179.73 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.7 mttp . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.971 0.415 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.2 mt -50.83 143.4 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 t -133.42 139.47 46.77 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.7 m -138.88 159.68 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.81 157.15 43.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.591 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.58 144.32 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 m -101.32 119.24 38.46 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.8 t -124.71 131.33 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -93.09 89.3 6.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.82 151.55 4.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.293 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.17 130.14 43.33 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.4 tt -52.58 -33.31 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.577 0.227 . . . . 0.0 111.28 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -60.16 -41.34 92.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.622 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -72.44 -46.55 54.49 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.864 0.364 . . . . 0.0 110.033 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.28 -43.02 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.613 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -55.91 -43.88 77.74 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.787 0.327 . . . . 0.0 110.744 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 23' ' ' GLU . 88.5 tttt -67.82 -47.52 68.81 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.588 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.36 -43.09 95.63 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.697 0.284 . . . . 0.0 111.382 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -61.7 -20.71 63.78 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -106.99 -23.03 12.47 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.134 0.574 . . . . 0.0 111.293 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 19' ' ' LYS . 28.5 tp10 -62.74 122.94 77.41 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 118.703 -0.665 . . . . 0.0 109.54 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.6 -38.61 5.76 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 CA-C-N 120.923 1.365 . . . . 0.0 111.607 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.67 -38.71 78.79 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.989 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.538 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 66.9 t60 -65.64 -44.01 87.73 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.56 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.69 -44.87 99.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 42' ' ' ALA . 1.2 mtm -62.99 -0.02 0.63 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -99.95 -50.25 4.07 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.538 ' HE1' ' CD2' ' A' ' 26' ' ' HIS . 68.6 p-90 -102.74 -3.67 26.13 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 31' ' ' CYS . 24.8 p -67.51 72.06 0.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.437 0.637 . . . . 0.0 110.009 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 30' ' ' TRP . 23.7 pt20 -153.18 48.74 0.7 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.05 -7.44 3.96 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.692 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 t -148.6 138.04 12.41 Favored Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.13 -11.9 23.32 Favored 'Trans proline' 0 N--CA 1.506 2.23 0 C-N-CA 121.71 1.607 . . . . 0.0 112.425 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -84.74 14.99 4.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.024 0.44 . . . . 0.0 110.17 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -146.57 146.69 30.55 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.975 0.417 . . . . 0.0 110.228 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -130.52 162.68 28.7 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 39' ' ' VAL . 8.2 p -114.03 95.17 37.27 Favored Pre-proline 0 N--CA 1.475 0.784 0 C-N-CA 122.69 0.396 . . . . 0.0 110.585 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.79 -19.48 14.22 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 CA-C-N 120.346 1.159 . . . . 0.0 111.29 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -178.56 160.03 1.2 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.4 0.438 . . . . 0.0 110.212 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.519 ' HB3' ' SD ' ' A' ' 28' ' ' MET . . . -156.41 148.81 23.48 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.135 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -136.05 146.13 46.76 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -156.02 104.23 2.27 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.691 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -98.28 86.42 3.65 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.97 93.22 0.11 Allowed 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.328 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -169.5 143.77 2.86 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.16 137.13 58.08 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.273 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.51 1.51 37.3 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.14 159.35 43.22 Favored Glycine 0 N--CA 1.468 0.808 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.7 m -119.3 155.89 31.01 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.007 0.432 . . . . 0.0 109.919 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -135.9 163.41 30.3 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.388 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.8 m -151.12 115.37 5.06 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.656 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.1 m -115.1 119.94 38.13 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 m -94.8 125.11 39.24 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.5 mtt -130.77 106.14 8.26 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.89 144.69 46.26 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.022 0.439 . . . . 0.0 110.769 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.83 148.28 50.49 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -57.99 -40.34 80.44 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.719 0.295 . . . . 0.0 110.386 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -76.18 -9.16 58.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.039 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.99 13.88 62.52 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.2 t -65.69 -19.89 66.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.988 0.423 . . . . 0.0 110.62 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.0 ttt -148.16 145.89 28.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.878 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.8 t -143.35 139.11 29.91 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.427 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 62.9 t80 -159.84 158.82 31.68 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.427 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 29.4 p-10 -138.9 134.16 32.87 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.39 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.02 139.63 31.1 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.38 152.36 24.07 Favored Glycine 0 N--CA 1.465 0.605 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.69 -174.12 41.13 Favored Glycine 0 CA--C 1.517 0.167 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.12 136.58 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -74.52 118.8 17.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.11 -37.01 69.6 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -165.09 149.2 8.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.732 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.02 131.91 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -143.64 122.14 12.44 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.5 m -59.45 123.9 18.3 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.91 0.386 . . . . 0.0 111.964 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.9 m120 52.4 59.41 4.53 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.021 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -157.27 -76.6 0.09 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.467 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 tp -152.94 135.26 15.01 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.1 mt -131.33 130.6 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -152.2 164.88 36.44 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -157.95 157.25 32.71 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.6 m -107.96 130.73 55.02 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.8 mm -93.86 151.55 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.78 -39.6 68.28 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -63.28 -11.91 25.31 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.956 0.378 . . . . 0.0 110.648 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.86 -2.13 61.77 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -72.44 152.02 42.22 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.493 ' NZ ' ' NH2' ' A' ' 91' ' ' ARG . 88.4 tttt -136.43 152.05 50.17 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -136.41 120.58 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.289 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.493 ' NH2' ' NZ ' ' A' ' 89' ' ' LYS . 87.4 mtt-85 -101.66 130.68 48.07 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 66.9 mt -118.42 125.07 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.48 124.34 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -100.4 123.44 44.63 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.1 m -122.73 124.37 43.21 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -100.73 121.57 41.88 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.5 p -105.78 8.83 33.02 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.99 122.63 0.66 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 58.32 9.9 1.16 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.715 0.293 . . . . 0.0 110.905 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.7 m -160.17 119.63 2.8 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 67.9 m -98.01 136.8 37.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -119.26 121.55 39.9 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.7 mt -100.4 123.74 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.7 t -123.95 126.68 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -143.56 145.96 32.94 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.329 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 78.3 p -126.14 148.3 49.42 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -122.45 162.45 21.66 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.585 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 . . . . . 0 N--CA 1.467 0.378 0 N-CA-C 110.52 -0.178 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -54.12 -46.21 72.11 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.973 0.416 . . . . 0.0 109.929 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.9 t -66.77 -38.83 87.35 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.248 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.03 -52.04 54.73 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.683 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -64.47 -35.96 82.62 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.776 0.322 . . . . 0.0 110.151 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -72.81 -37.1 67.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.691 0.281 . . . . 0.0 110.432 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.11 -50.55 73.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 9.0 tt -62.27 -37.99 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 53.5 mt -63.57 -42.58 98.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -65.33 -39.29 92.21 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.3 t -58.38 -33.39 69.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 46.8 t80 . . . . . 0 CA--C 1.539 0.522 0 CA-C-O 120.883 0.373 . . . . 0.0 110.904 -179.38 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 121.014 0.435 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mt -69.98 140.57 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 t -137.28 160.07 40.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.35 166.71 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.3 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -147.36 158.66 44.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.076 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -149.45 144.99 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.75 121.67 44.5 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -128.97 137.38 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -94.82 89.7 5.77 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.98 150.86 3.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.957 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 128.54 36.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.766 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.2 tt -53.36 -36.24 26.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.632 0.254 . . . . 0.0 110.998 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -57.86 -42.27 84.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.673 0.273 . . . . 0.0 110.592 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -69.93 -47.03 64.0 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.392 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.0 t -62.33 -40.38 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.515 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.429 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 66.5 t90 -54.07 -39.76 66.57 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.741 0.305 . . . . 0.0 111.345 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -63.26 -51.03 67.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.954 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -68.89 -37.25 78.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.965 0.412 . . . . 0.0 110.684 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -61.01 -18.56 58.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.853 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 18' ' ' TRP . 81.4 m-20 -115.56 -26.44 7.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.155 0.582 . . . . 0.0 110.908 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -50.64 108.73 1.09 Allowed Pre-proline 0 CA--C 1.555 1.145 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.172 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.19 -43.4 57.54 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 CA-C-N 120.512 1.218 . . . . 0.0 112.835 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.86 -30.75 69.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.556 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -79.28 -38.98 34.1 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.186 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' A' ' 31' ' ' CYS . 98.2 mt -61.93 -45.38 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 O-C-N 121.964 -0.46 . . . . 0.0 110.657 -177.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 20.5 ptp -61.73 -17.78 57.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.252 0.549 . . . . 0.0 111.251 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -74.96 -29.46 60.93 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.162 -0.336 . . . . 0.0 111.292 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -139.34 23.26 2.54 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.601 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.583 ' C ' ' H ' ' A' ' 33' ' ' ALA . 36.8 t -55.43 125.79 22.39 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.621 -0.674 . . . . 0.0 110.239 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 67.3 -22.88 0.11 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.868 0.73 . . . . 0.0 110.459 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.583 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 51.79 37.01 19.34 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 122.761 0.424 . . . . 0.0 110.977 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.2 m -111.65 96.45 32.56 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.954 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.5 -25.59 10.9 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 122.118 1.879 . . . . 0.0 112.562 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -69.04 -26.63 65.07 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.491 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -106.22 170.26 8.02 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -147.78 152.04 37.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.996 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 39' ' ' VAL . 6.0 p -116.73 96.92 49.57 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.76 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.17 -9.51 17.77 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 121.541 1.494 . . . . 0.0 111.662 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.91 155.32 6.76 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.903 0.383 . . . . 0.0 110.298 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.05 145.47 13.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.922 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -139.17 144.99 38.82 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -163.0 132.46 4.21 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.585 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -135.47 103.63 5.54 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mp -69.56 98.74 1.18 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -166.31 137.66 3.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.74 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.0 134.1 56.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.286 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.9 1.69 63.21 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.25 163.27 44.83 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.8 p -129.65 161.39 30.7 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -137.84 166.84 23.03 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.93 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.4 m -151.72 110.37 3.81 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.1 p -107.07 113.01 26.21 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.0 m -86.35 113.24 22.17 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.4 mtt -122.57 129.28 51.75 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.77 150.14 29.83 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.49 148.38 48.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.596 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.72 -31.97 66.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.958 0.409 . . . . 0.0 110.565 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -74.75 -9.53 58.65 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.125 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.24 4.67 44.8 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.7 m -62.74 -34.95 78.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.641 0.258 . . . . 0.0 110.656 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 71.4 mtp -126.26 136.44 52.79 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.149 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.8 p -145.96 129.65 17.09 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.642 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -155.13 162.42 41.0 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.8 127.04 24.54 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.673 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -94.23 144.76 25.24 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -148.59 151.58 23.75 Favored Glycine 0 N--CA 1.461 0.357 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.01 175.3 42.25 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 t -121.54 132.82 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -74.82 116.12 15.18 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -73.62 -39.56 64.46 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.225 0.536 . . . . 0.0 109.591 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -166.71 147.62 6.05 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.553 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.53 130.74 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -137.82 126.17 23.27 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.4 m -58.31 123.44 16.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.71 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 51.26 69.17 0.68 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.915 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -166.98 -81.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.806 0.336 . . . . 0.0 110.148 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 tp -150.51 131.78 14.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.422 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.0 mt -132.14 131.99 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -153.97 164.47 38.38 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -162.69 155.97 19.96 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.4 p -100.45 132.28 45.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 86' ' ' ASP . 88.9 mt -93.78 140.96 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.48 28.62 1.03 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 84' ' ' ILE . 29.0 t70 -120.41 -9.53 9.45 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.009 0.523 . . . . 0.0 109.897 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.79 -14.77 57.41 Favored Glycine 0 N--CA 1.479 1.533 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -75.13 174.97 8.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -146.24 151.28 37.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.715 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.6 t -140.55 136.81 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.994 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -136.51 133.69 36.77 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 75.0 mt -116.0 128.01 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.81 122.98 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -95.37 127.35 41.34 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.3 m -137.47 141.64 41.55 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -151.19 161.18 43.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 65.4 p -127.48 -13.68 5.4 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.095 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.06 -122.4 0.94 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -73.08 5.69 3.23 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.899 -0.177 . . . . 0.0 110.76 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.4 m -122.55 127.25 49.24 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.0 m -108.73 133.24 53.07 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -110.97 126.12 54.43 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.9 mt -106.3 128.38 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.9 t -129.19 133.89 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -142.19 135.24 28.73 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 86.2 p -95.13 153.33 17.7 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -145.17 145.92 31.55 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 179.918 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.584 0.231 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -59.0 -39.17 81.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.043 0.449 . . . . 0.0 110.255 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.8 t -64.86 -36.27 83.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.56 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.12 -51.72 57.15 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -63.35 -37.54 87.66 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.008 0.432 . . . . 0.0 110.145 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -73.53 -35.07 65.51 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.429 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.46 -50.34 74.09 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.686 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 36.4 pt -63.62 -34.19 66.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.725 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.0 mt -66.87 -39.4 87.52 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.026 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -63.8 -41.19 97.96 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 22.4 m -62.24 -35.15 78.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.837 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 55.7 t80 . . . . . 0 CA--C 1.531 0.23 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.037 -179.102 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.921 0.391 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 84.3 mt -57.83 139.67 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 t -133.67 141.63 47.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.774 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.76 155.3 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -148.8 162.09 40.49 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.549 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 m -149.01 152.62 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.494 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.67 119.48 38.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.171 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.8 t -123.8 127.29 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -94.9 89.34 5.6 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.95 151.37 4.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.974 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.58 135.78 56.32 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.9 tt -52.45 -37.14 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -60.62 -36.06 77.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.461 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -72.7 -48.24 40.56 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.262 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.5 t -64.0 -41.13 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.127 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.79 ' CH2' HD11 ' A' ' 80' ' ' ILE . 31.0 t-105 -52.97 -39.42 62.96 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.081 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -62.31 -49.7 74.58 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.528 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -65.86 -41.38 91.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.609 0.242 . . . . 0.0 110.925 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -68.78 -16.82 63.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.409 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.565 HD22 ' N ' ' A' ' 22' ' ' ASN . 0.8 OUTLIER -112.24 -28.7 7.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.254 0.622 . . . . 0.0 112.333 -178.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.05 135.02 96.14 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.04 -42.29 0.31 Allowed 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 121.406 1.404 . . . . 0.0 111.537 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.67 69.93 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.844 0.355 . . . . 0.0 111.016 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.511 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.2 OUTLIER -76.32 -38.92 55.32 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.787 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 31' ' ' CYS . 95.1 mt -62.95 -44.02 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 O-C-N 122.031 -0.418 . . . . 0.0 111.042 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.4 ptp -63.2 -20.87 65.81 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.858 0.361 . . . . 0.0 111.066 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -67.57 -32.11 72.64 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.116 -0.365 . . . . 0.0 110.888 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -135.39 19.95 3.38 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.448 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.471 ' C ' ' H ' ' A' ' 33' ' ' ALA . 21.9 t -58.73 133.93 56.38 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.75 -0.594 . . . . 0.0 110.429 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.2 tp60 71.33 -39.87 0.46 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.213 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 56.44 29.84 15.99 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.878 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.2 m -115.12 106.68 50.99 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.269 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.73 -23.08 19.17 Favored 'Trans proline' 0 N--CA 1.506 2.212 0 C-N-CA 121.999 1.799 . . . . 0.0 112.413 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.33 2.65 12.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.683 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -142.15 169.7 17.1 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.094 0.473 . . . . 0.0 109.848 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -146.03 163.33 35.57 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.35 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 39' ' ' VAL . 6.7 p -123.73 91.21 49.93 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 123.364 0.666 . . . . 0.0 109.777 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.34 -11.78 20.88 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.296 1.33 . . . . 0.0 111.559 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.21 152.24 6.07 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.02 146.55 9.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.24 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -134.72 145.94 48.96 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -152.56 114.91 4.47 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -133.18 95.44 3.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.84 93.8 6.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.853 0.835 . . . . 0.0 109.457 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -149.08 137.28 20.81 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.436 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.8 123.45 12.43 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.776 0.322 . . . . 0.0 111.0 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.79 1.66 78.87 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.03 163.18 47.13 Favored Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.2 p -128.22 159.81 34.04 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.742 0.417 . . . . 0.0 110.098 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.458 ' CD1' ' CE2' ' A' ' 71' ' ' TYR . 42.5 p90 -152.94 169.83 21.9 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.344 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.1 m -161.31 141.97 11.11 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.9 m -121.87 123.01 40.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.8 m -93.22 118.06 30.8 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.1 mtm -127.91 132.94 49.26 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.72 147.68 29.15 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.065 0.459 . . . . 0.0 110.225 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.9 148.51 48.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.552 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -58.41 -34.17 70.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.739 0.304 . . . . 0.0 110.239 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -73.03 -10.22 59.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.979 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.94 15.8 58.64 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.2 m -83.7 -17.69 40.49 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 122.886 -0.185 . . . . 0.0 110.812 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 67.9 mtp -134.43 140.82 46.54 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.893 0.377 . . . . 0.0 110.247 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 96.5 p -144.38 149.6 36.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.184 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -155.29 161.49 41.09 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.786 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -136.07 99.73 4.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.711 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -94.46 134.1 37.34 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.47 172.85 41.84 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.28 -176.65 39.95 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.9 t -118.96 128.84 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.458 ' CE2' ' CD1' ' A' ' 52' ' ' PHE . 57.8 m-85 -71.9 112.23 7.82 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -73.64 -38.13 65.1 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.329 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -165.1 151.53 10.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.776 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.2 p -143.68 142.83 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -145.17 121.64 11.01 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.7 m -52.89 120.83 6.26 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.813 0.34 . . . . 0.0 111.91 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.4 m120 51.58 69.96 0.6 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.667 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -167.86 -77.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.332 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 tt -150.49 136.15 18.19 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.199 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.79 HD11 ' CH2' ' A' ' 18' ' ' TRP . 83.1 mt -129.55 131.41 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.44 162.21 41.51 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -157.31 155.52 30.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.829 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 84.9 m -98.32 131.79 44.33 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 86' ' ' ASP . 5.1 mp -94.58 139.44 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.66 26.93 0.61 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 84' ' ' ILE . 24.1 t0 -119.67 -12.79 9.21 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.76 -7.69 63.26 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.349 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -74.96 143.44 43.67 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.513 -0.404 . . . . 0.0 110.118 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -110.84 135.4 51.45 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.17 136.96 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -134.52 135.14 42.15 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.6 mt -119.61 128.34 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.2 t -118.4 129.99 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -97.23 123.15 40.93 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 67.1 p -128.58 140.56 51.72 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -154.08 148.03 25.58 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.1 p -99.56 -18.74 17.22 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.063 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.09 -102.81 0.21 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -75.72 -6.79 52.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.402 0.144 . . . . 0.0 110.805 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.9 p -107.44 165.18 11.59 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.3 m -143.14 135.48 27.26 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.14 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -124.93 124.2 41.52 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.7 mt -105.64 126.85 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.56 134.45 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -137.24 131.51 32.47 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 89.3 p -136.91 127.68 27.24 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -156.93 168.88 26.15 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.737 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.475 0.785 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.833 -179.368 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 120.635 0.255 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -50.88 -48.48 60.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.6 t -71.4 -34.83 70.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.11 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.7 -52.38 51.14 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.21 -0.519 . . . . 0.0 111.826 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -63.21 -34.88 78.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 110.125 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -74.9 -34.16 62.13 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.075 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.08 -49.45 77.29 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 10.0 tt -61.26 -41.57 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.97 -40.55 96.66 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.046 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -63.46 -39.38 94.32 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.8 m -58.51 -41.29 85.07 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.713 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 81.3 t80 . . . . . 0 N--CA 1.464 0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.271 -179.975 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 N--CA 1.466 0.326 0 CA-C-O 120.756 0.312 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.6 mm -52.92 140.07 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 t -137.35 134.46 36.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.86 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.6 m -138.97 158.18 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -147.16 158.01 43.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.04 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 p -149.14 140.68 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.888 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.3 p -92.69 124.71 36.89 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.42 125.62 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -93.37 88.24 5.9 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.18 151.7 3.98 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.103 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.92 132.43 52.05 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.8 tt -54.06 -33.09 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.7 0.286 . . . . 0.0 111.103 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -59.01 -40.43 84.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.656 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -73.59 -46.9 44.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.928 0.394 . . . . 0.0 110.153 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -61.77 -43.06 96.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.719 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -55.92 -40.88 73.76 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.788 0.328 . . . . 0.0 110.883 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -68.41 -48.31 65.0 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.027 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.507 ' CD2' ' ND1' ' A' ' 26' ' ' HIS . 9.9 m-85 -66.74 -42.34 86.4 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.867 0.365 . . . . 0.0 110.902 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -62.88 -15.73 55.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.184 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -112.0 -23.27 10.6 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.032 0.533 . . . . 0.0 111.358 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -69.13 122.28 84.78 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 118.809 -0.615 . . . . 0.0 109.712 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.61 -32.16 24.89 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 CA-C-N 121.104 1.43 . . . . 0.0 111.895 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.62 75.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.966 0.412 . . . . 0.0 110.764 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.507 ' ND1' ' CD2' ' A' ' 20' ' ' TYR . 45.8 m170 -80.05 -42.52 23.57 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.993 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 31' ' ' CYS . 92.3 mt -63.04 -48.11 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 122.123 -0.36 . . . . 0.0 110.842 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -64.11 -12.2 37.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.783 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -78.46 -28.11 46.52 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.871 -0.15 . . . . 0.0 111.107 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -133.37 5.89 3.79 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.994 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.499 ' C ' ' H ' ' A' ' 33' ' ' ALA . 37.0 t -50.44 138.09 17.84 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.075 -0.391 . . . . 0.0 110.623 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 71.68 -39.94 0.46 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.69 39.15 31.12 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.148 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.9 m -134.29 140.81 37.03 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 122.749 0.42 . . . . 0.0 110.286 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -75.78 -10.32 19.94 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.873 1.715 . . . . 0.0 112.559 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -88.1 15.08 7.89 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.983 0.421 . . . . 0.0 110.262 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -150.16 155.26 39.46 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.137 0.494 . . . . 0.0 109.758 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -142.56 163.46 32.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.047 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.4 t -127.72 87.08 56.79 Favored Pre-proline 0 N--CA 1.475 0.825 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.83 -20.7 44.98 Favored 'Trans proline' 0 N--CA 1.505 2.167 0 C-N-CA 122.369 2.046 . . . . 0.0 111.825 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.92 161.54 8.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.68 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.74 146.08 16.1 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.449 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -140.93 152.08 44.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -161.29 132.95 5.6 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.04 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -122.58 86.93 2.66 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.9 tp -67.21 94.9 0.39 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.939 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -169.02 144.14 3.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.03 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.5 137.7 57.93 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.317 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.89 -1.47 54.25 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.64 172.83 41.3 Favored Glycine 0 N--CA 1.47 0.929 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 t -139.02 172.92 12.14 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.396 0.278 . . . . 0.0 110.556 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -138.76 167.54 21.76 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.203 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.5 m -157.74 121.61 4.13 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.6 m -123.77 124.93 43.79 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.2 m -90.29 114.4 26.45 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.7 mtt -119.11 129.73 55.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.44 143.58 32.68 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.136 0.494 . . . . 0.0 110.223 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.68 148.53 51.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.33 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -56.35 -39.96 73.7 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.556 0.217 . . . . 0.0 110.475 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -79.21 -7.17 58.02 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.897 0.38 . . . . 0.0 110.141 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.35 18.84 67.93 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.4 p -65.63 -34.88 79.25 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.838 -0.213 . . . . 0.0 110.683 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.3 ttt -137.33 145.88 43.93 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.9 t -143.76 145.45 32.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.885 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.422 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 66.8 t80 -159.09 166.63 31.19 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.422 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 74.3 m-20 -137.78 121.05 16.93 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -93.54 140.39 29.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.847 0.356 . . . . 0.0 110.168 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -157.22 157.77 28.35 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.74 -177.67 41.55 Favored Glycine 0 N--CA 1.458 0.112 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -123.61 131.66 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -72.5 115.25 11.54 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -73.66 -47.08 42.59 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -149.79 144.11 25.81 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 74' ' ' VAL . 9.6 p -133.04 128.15 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -138.13 111.21 7.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 t -56.35 131.16 47.46 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.257 0.551 . . . . 0.0 112.289 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 49.85 51.89 15.68 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.453 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -157.69 -80.81 0.06 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.688 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 tp -146.27 134.8 22.07 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.2 mt -130.33 131.27 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -152.15 162.71 40.72 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -158.16 154.67 27.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.665 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.3 m -94.78 129.8 41.59 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 88.6 mt -93.63 153.49 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.56 -41.98 65.51 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.816 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -61.49 -10.84 8.61 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.061 0.458 . . . . 0.0 110.632 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 91.53 1.79 70.98 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -77.32 142.94 39.15 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -106.42 162.38 13.75 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.142 0.496 . . . . 0.0 110.395 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.4 t -141.17 121.34 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.778 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -112.41 123.22 49.81 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 71.1 mt -117.06 119.89 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.6 t -107.91 118.22 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -93.41 122.75 36.15 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.8 m -131.72 143.65 50.42 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -152.93 147.36 25.87 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 80.7 p -102.47 -19.25 14.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.014 0.435 . . . . 0.0 109.842 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.43 -104.73 0.23 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 1.3 m-20 -77.12 -2.08 32.45 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 122.21 0.204 . . . . 0.0 111.113 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.8 m -119.91 124.24 45.53 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.2 m -105.51 133.89 49.52 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -115.48 124.57 51.44 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.0 mt -104.66 125.42 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.4 t -119.73 128.31 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -127.94 123.47 34.95 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.3 m -134.72 128.27 32.61 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.945 0.402 . . . . 0.0 110.096 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -157.13 166.8 32.24 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.567 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.4 t70 . . . . . 0 N--CA 1.477 0.903 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.392 -179.184 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 . . . . . 0 N--CA 1.466 0.355 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -52.28 -46.64 65.95 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.5 m -66.9 -39.62 87.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.183 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.73 -52.01 51.65 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.77 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -63.83 -35.92 82.19 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.825 0.345 . . . . 0.0 110.449 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -72.01 -38.01 69.68 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.785 0.326 . . . . 0.0 110.161 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.79 72.36 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.124 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.3 tt -62.34 -37.86 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.3 mt -63.87 -40.24 96.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -63.38 -40.88 98.44 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.2 m -60.95 -38.37 85.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.619 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 CA--C 1.531 0.212 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.663 -179.794 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.8 tttp . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 121.293 0.568 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.6 mt -65.14 136.37 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 t -137.47 150.91 47.93 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.56 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.6 m -136.0 161.71 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.669 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -139.45 158.92 43.31 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.694 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.12 142.93 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 m -95.05 123.28 38.45 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.4 t -126.98 123.21 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -90.79 87.03 6.5 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.83 152.12 3.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.99 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.63 137.2 57.69 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.7 tt -52.69 -38.26 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.721 0.296 . . . . 0.0 111.35 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -60.81 -35.25 76.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.222 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -74.51 -48.06 29.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.01 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -62.71 -43.93 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.102 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.407 ' CD1' ' OD1' ' A' ' 22' ' ' ASN . 24.4 t-105 -54.27 -39.11 66.58 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.875 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -64.02 -55.76 20.0 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.506 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -69.39 -42.93 74.46 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.837 0.351 . . . . 0.0 111.492 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -59.74 -16.62 28.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.324 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.407 ' OD1' ' CD1' ' A' ' 18' ' ' TRP . 12.7 m120 -112.71 -21.72 11.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.282 0.633 . . . . 0.0 109.895 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -67.55 120.6 74.28 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.736 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.63 -36.56 18.97 Favored 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 121.512 1.474 . . . . 0.0 111.941 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.73 -31.71 69.87 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.104 0.478 . . . . 0.0 110.562 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -80.93 -45.92 15.97 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.789 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.6 mt -61.68 -47.32 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.621 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -63.61 -3.57 2.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.12 0.486 . . . . 0.0 111.072 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -90.25 -29.59 18.07 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 122.098 -0.376 . . . . 0.0 110.341 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 60.6 p-90 -135.73 21.95 3.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.128 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.571 ' C ' ' H ' ' A' ' 33' ' ' ALA . 28.5 p -55.43 131.14 45.18 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.353 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.483 ' NE2' ' CD1' ' A' ' 37' ' ' TRP . 49.9 tt0 68.57 -29.1 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.527 0.517 . . . . 0.0 110.467 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.571 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 53.48 39.72 30.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.429 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 t -128.28 136.45 29.08 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.796 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -73.21 -17.54 24.36 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 122.035 1.823 . . . . 0.0 112.372 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -81.93 13.06 3.52 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.753 0.311 . . . . 0.0 110.687 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.483 ' CD1' ' NE2' ' A' ' 32' ' ' GLN . 87.3 m95 -149.87 159.95 43.97 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.331 0.586 . . . . 0.0 109.664 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.405 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 83.6 t60 -149.13 163.43 37.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.222 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 39' ' ' VAL . 7.2 p -128.6 96.86 29.06 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.869 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.1 -9.2 19.19 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 121.927 1.752 . . . . 0.0 111.747 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.15 153.89 7.05 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.834 0.35 . . . . 0.0 110.544 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.47 145.87 13.17 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.185 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -141.04 151.96 44.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -162.41 135.28 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.922 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -133.97 99.12 4.34 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.427 HD22 ' N ' ' A' ' 46' ' ' LEU . 4.4 mm? -67.75 95.22 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.074 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -168.15 145.25 4.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.673 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.83 137.11 58.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.056 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.97 3.57 36.86 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.13 146.14 33.03 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.6 m -107.45 154.25 21.62 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -141.52 156.81 45.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.426 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.7 m -148.25 128.0 13.4 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.1 m -123.81 121.14 34.63 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 m -92.25 124.86 36.63 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.1 mtp -135.63 135.95 40.62 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.16 147.22 30.3 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.956 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.4 148.88 50.95 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.425 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -57.51 -40.48 78.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.71 0.29 . . . . 0.0 110.397 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.24 -10.05 59.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.035 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.14 14.25 68.24 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 85.3 p -67.27 -33.49 75.42 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.668 0.271 . . . . 0.0 110.616 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.3 ttt -129.2 149.37 51.03 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.846 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.2 t -144.27 142.4 30.43 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.724 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.446 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 57.8 t80 -159.47 159.0 33.03 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.446 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 68.3 m-20 -139.12 129.85 26.09 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.867 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -94.95 134.58 37.46 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.39 149.17 20.79 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.79 -172.05 41.86 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -131.97 139.37 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -73.97 122.94 23.37 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.525 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -77.21 -32.56 56.02 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -165.41 144.91 6.6 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.722 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.6 t -135.7 130.28 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -143.09 116.86 9.28 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 65.8 p -57.33 134.2 55.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.696 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 53.76 56.02 7.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.554 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -155.01 -79.58 0.09 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -162.32 161.52 27.57 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.907 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.5 mt -136.06 141.04 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -153.43 160.27 42.56 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -159.46 165.66 32.62 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.3 m -120.94 133.76 55.29 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.7 mm -99.72 153.85 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -55.57 -41.49 81.8 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -60.59 -18.2 51.36 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.717 0.294 . . . . 0.0 110.488 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.28 -3.66 47.52 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -65.37 146.51 54.81 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -136.44 145.48 45.29 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.578 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.69 137.97 31.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -121.45 130.32 53.5 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 76.8 mt -116.97 120.19 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.72 128.37 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -95.9 123.67 39.59 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.7 m -121.14 145.0 48.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -153.44 161.8 41.91 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.3 p -132.69 -47.96 0.88 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.227 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.74 120.74 0.59 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 56.0 15.82 1.91 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 111.039 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.4 m -151.56 139.18 19.66 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 48.4 m -125.84 132.11 52.28 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -117.83 122.52 43.61 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.0 mt -96.68 128.06 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.0 t -121.73 132.49 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -136.8 134.79 37.38 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 83.9 p -138.92 130.45 27.29 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -155.93 170.12 22.86 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 . . . . . 0 N--CA 1.473 0.713 0 O-C-N 123.736 0.648 . . . . 0.0 109.856 -179.79 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.578 0.227 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -58.0 -41.88 83.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.399 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 74.1 m -58.3 -32.83 68.82 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 123.412 0.445 . . . . 0.0 110.556 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.27 -44.72 12.7 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -60.45 -39.43 87.5 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.75 0.31 . . . . 0.0 111.587 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -76.09 -34.66 59.54 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.076 0.465 . . . . 0.0 110.546 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.96 -50.92 72.23 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.5 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.7 tt -61.14 -36.62 73.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.0 mt -66.42 -36.61 83.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -62.26 -40.72 97.15 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.525 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 91.7 p -62.17 -33.89 75.38 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.983 0.421 . . . . 0.0 110.656 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 59.6 t80 . . . . . 0 N--CA 1.463 0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.541 -179.673 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.2 mt -131.04 134.91 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -135.26 139.16 44.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.49 153.82 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -148.81 162.12 40.44 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.924 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.7 p -148.34 140.8 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.703 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.5 p -89.59 119.74 30.28 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.83 124.34 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -93.21 88.54 6.08 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.31 153.33 4.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.743 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.08 134.0 55.38 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.8 tt -51.78 -36.22 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -60.03 -35.59 75.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.359 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -75.21 -44.93 43.67 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 109.958 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.6 t -63.39 -43.8 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.36 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.422 ' CE2' ' OD1' ' A' ' 22' ' ' ASN . 72.1 t90 -57.24 -46.31 83.12 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.473 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.01 -44.69 88.36 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.751 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -66.49 -44.28 83.06 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.879 0.371 . . . . 0.0 110.962 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -69.29 -18.33 63.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.483 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.447 HD22 ' N ' ' A' ' 22' ' ' ASN . 1.0 OUTLIER -98.49 -26.24 14.51 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.062 0.545 . . . . 0.0 111.14 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -64.95 119.96 62.75 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.81 -36.32 4.79 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 CA-C-N 120.863 1.344 . . . . 0.0 111.869 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.59 86.19 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.843 0.354 . . . . 0.0 111.142 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -66.84 -40.57 88.01 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.58 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.452 ' O ' ' N ' ' A' ' 31' ' ' CYS . 96.5 mt -63.31 -43.8 98.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.8 mtp -55.88 -12.27 1.31 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.599 0.238 . . . . 0.0 111.279 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -86.33 -28.73 23.5 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.154 -0.341 . . . . 0.0 110.978 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -136.36 21.66 3.18 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.481 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.586 ' C ' ' H ' ' A' ' 33' ' ' ALA . 10.4 t -57.12 131.34 49.62 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.66 -0.65 . . . . 0.0 110.479 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 66.14 -27.83 0.12 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.689 0.618 . . . . 0.0 110.864 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 47.3 29.62 1.3 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.539 0.335 . . . . 0.0 111.017 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.7 m -108.12 135.55 19.89 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.264 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.76 -17.3 20.31 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.517 1.478 . . . . 0.0 111.983 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -86.87 8.67 22.0 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.705 0.288 . . . . 0.0 110.578 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -148.4 156.31 42.33 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.314 0.578 . . . . 0.0 110.261 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -143.96 150.38 38.23 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.105 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 39' ' ' VAL . 8.4 p -111.5 89.57 10.87 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.889 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.78 -11.72 20.08 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 121.334 1.356 . . . . 0.0 111.422 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -170.15 152.47 4.23 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 120.982 0.42 . . . . 0.0 110.47 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.26 151.92 18.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.248 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -139.13 150.93 46.24 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.627 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -161.23 131.45 5.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.863 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -130.27 97.53 4.45 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -71.05 94.54 1.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.926 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -167.97 140.15 3.04 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.18 137.78 58.04 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.684 0.278 . . . . 0.0 110.28 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.42 -1.58 50.17 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.97 164.88 44.91 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.4 p -126.27 157.88 37.16 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.841 0.456 . . . . 0.0 110.323 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -132.93 156.58 46.99 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.431 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.2 m -146.92 119.54 8.54 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.9 p -114.73 113.69 24.63 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.2 m -89.78 114.78 26.55 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.2 mtt -128.5 133.79 48.54 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.78 145.62 26.72 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.947 0.403 . . . . 0.0 110.176 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.58 147.58 53.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.377 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -56.33 -32.94 65.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.858 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -83.08 -7.01 59.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.08 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.82 16.34 59.13 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.8 m -60.85 -38.7 86.43 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.718 0.294 . . . . 0.0 110.763 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.4 ttp -145.31 146.42 31.62 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.047 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.4 t -143.97 155.72 44.15 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.917 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.466 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 56.4 t80 -153.8 165.18 36.84 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.466 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 30.8 t0 -138.26 119.46 14.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.186 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -93.33 136.57 33.47 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.95 154.36 25.46 Favored Glycine 0 N--CA 1.465 0.622 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.16 -173.39 40.9 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 t -123.75 132.92 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -71.3 121.35 18.32 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.54 -42.19 62.01 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -159.85 146.14 15.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.778 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.5 t -134.56 129.44 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -145.41 121.75 10.93 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.1 m -58.38 129.18 40.81 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.43 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 54.32 56.37 7.01 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.578 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -155.95 -83.95 0.06 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.005 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 tp -149.17 134.87 18.73 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.682 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.9 mt -127.29 127.97 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.11 164.18 38.51 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -156.07 154.39 30.9 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.906 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.3 m -87.97 131.76 34.5 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.7 mt -104.78 144.41 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.55 -42.49 57.9 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.419 ' CG ' HH12 ' A' ' 88' ' ' ARG . 44.2 m-20 -62.02 -21.35 64.81 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.766 0.317 . . . . 0.0 110.351 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.62 2.94 72.04 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.419 HH12 ' CG ' ' A' ' 86' ' ' ASP . 96.3 mtm-85 -65.83 140.81 58.42 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -92.11 122.03 34.22 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.245 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.9 t -135.47 122.52 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -136.49 142.76 43.56 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 77.3 mt -113.27 124.05 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.4 t -106.75 125.42 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -102.6 122.16 43.84 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.5 m -131.07 149.77 52.45 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -151.79 154.26 35.89 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.659 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.1 p -132.77 40.2 3.27 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.111 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.08 131.19 0.16 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 p30 47.35 17.33 0.07 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.087 0.555 . . . . 0.0 111.849 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.5 m -152.78 135.81 15.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.026 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.7 m -128.93 130.48 46.83 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -117.63 126.24 52.17 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.9 mt -101.18 123.82 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.01 128.52 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -142.99 140.58 31.09 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.0 m -137.01 142.65 42.52 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -153.94 155.63 35.98 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.362 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.547 0.838 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.739 -178.947 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 120.818 0.342 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.38 -54.49 46.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.881 0.372 . . . . 0.0 110.092 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.6 t -64.05 -42.07 97.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.917 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.05 -52.13 50.13 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.191 -0.528 . . . . 0.0 111.827 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -65.08 -41.61 94.9 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.645 0.259 . . . . 0.0 110.344 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -65.74 -37.82 87.44 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.413 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.69 68.79 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 31.3 pt -65.3 -35.47 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.905 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.3 mt -64.89 -37.11 86.54 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -62.97 -37.46 87.2 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.6 m -69.07 -33.64 73.87 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.792 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 53.3 t80 . . . . . 0 N--CA 1.469 0.507 0 CA-C-O 120.683 0.277 . . . . 0.0 111.358 -178.331 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.0 mttp . . . . . 0 N--CA 1.463 0.213 0 CA-C-O 121.115 0.483 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.59 137.36 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.2 m -122.87 133.27 54.42 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.8 m -138.74 160.05 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.21 165.9 30.47 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.231 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.02 144.25 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.2 p -92.12 125.42 36.79 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.59 130.7 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -97.25 92.82 6.19 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.06 152.53 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.966 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.33 138.06 58.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.202 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.7 tp -51.56 -37.79 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 121.067 0.461 . . . . 0.0 110.994 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -69.02 -36.74 78.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.15 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -68.64 -51.94 36.66 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 111.244 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -63.51 -36.51 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.364 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -54.92 -49.55 71.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.828 0.347 . . . . 0.0 110.587 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.7 -45.15 83.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.374 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.451 ' CD2' ' ND1' ' A' ' 26' ' ' HIS . 50.1 t80 -63.95 -43.83 94.66 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 111.186 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -71.1 -19.08 62.5 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.463 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.409 HD21 ' CD1' ' A' ' 80' ' ' ILE . 14.5 m120 -103.65 -23.92 13.42 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.999 0.519 . . . . 0.0 110.972 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.25 134.38 95.81 Favored Pre-proline 0 CA--C 1.553 1.064 0 CA-C-O 119.191 -0.433 . . . . 0.0 109.858 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.69 -41.49 0.55 Allowed 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.544 1.496 . . . . 0.0 111.622 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.67 -29.35 66.53 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.918 0.389 . . . . 0.0 110.695 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.451 ' ND1' ' CD2' ' A' ' 20' ' ' TYR . 33.3 m170 -79.93 -45.82 17.84 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.234 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 90.6 mt -63.52 -46.6 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 122.006 -0.434 . . . . 0.0 110.645 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -66.1 -3.37 5.4 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.71 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -90.58 -26.87 19.47 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.183 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -138.04 23.05 2.82 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.433 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.595 ' C ' ' H ' ' A' ' 33' ' ' ALA . 9.6 t -56.52 133.99 53.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.191 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 65.92 -23.99 0.1 Allowed 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.538 0.524 . . . . 0.0 110.668 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.595 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 53.3 28.19 7.0 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.507 0.194 . . . . 0.0 110.613 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.1 m -112.8 104.17 55.82 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 122.953 0.501 . . . . 0.0 110.058 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -50.09 -13.44 0.64 Allowed 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 122.266 1.977 . . . . 0.0 112.625 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -82.63 11.84 5.34 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.669 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -146.72 162.72 37.92 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -146.57 162.63 37.96 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.969 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.6 t -126.16 96.28 37.2 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.84 -10.99 23.63 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 121.76 1.64 . . . . 0.0 111.877 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.02 152.94 6.64 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.934 0.397 . . . . 0.0 110.473 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.68 150.09 9.98 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.458 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -143.65 156.25 44.5 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -157.98 104.18 1.9 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.699 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -91.99 87.62 6.26 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.2 tp -66.11 93.36 0.2 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.716 -0.394 . . . . 0.0 109.968 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -170.48 145.91 2.69 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.48 137.74 58.25 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.142 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.23 -1.58 25.2 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -77.26 163.49 51.98 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.8 m -124.14 155.41 38.5 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -135.04 158.05 45.35 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.467 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.7 m -146.17 122.37 10.84 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.6 m -119.12 119.63 34.76 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.6 m -88.86 113.4 24.37 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 93.2 mtp -119.14 124.66 47.38 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.35 140.74 33.82 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.17 150.37 47.57 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.08 -37.75 64.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.692 0.282 . . . . 0.0 110.523 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -81.17 -7.42 59.56 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.125 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.76 14.68 37.98 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.9 t -67.4 -19.14 65.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.733 0.301 . . . . 0.0 110.489 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 47.6 ttp -159.85 134.99 8.05 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.972 0.415 . . . . 0.0 110.383 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m -146.16 154.58 41.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.259 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -154.88 146.94 23.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.33 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -108.19 119.99 41.08 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.389 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -93.92 137.69 32.87 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.44 153.9 25.13 Favored Glycine 0 N--CA 1.46 0.27 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.3 178.21 43.15 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.33 134.15 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -75.68 121.05 21.92 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -75.22 -39.2 60.26 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -162.34 146.4 11.98 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.849 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.5 p -149.95 138.67 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.656 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -148.99 134.64 18.72 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.8 m -48.07 118.22 2.27 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.454 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.6 m120 54.11 79.6 0.13 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.377 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -167.9 -83.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.472 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 tt -152.78 141.49 20.96 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.774 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.409 ' CD1' HD21 ' A' ' 22' ' ' ASN . 63.1 mt -130.16 130.52 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -152.94 160.55 43.05 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -160.57 155.2 23.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.644 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.4 p -91.84 134.3 34.88 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.666 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.411 HG22 ' H ' ' A' ' 86' ' ' ASP . 79.6 mt -104.71 147.37 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.05 -41.38 59.98 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.411 ' H ' HG22 ' A' ' 84' ' ' ILE . 82.5 m-20 -60.72 -17.76 50.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.777 0.323 . . . . 0.0 110.148 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.75 3.72 80.15 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -65.88 141.52 58.22 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -95.4 135.26 37.24 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.2 t -139.55 128.64 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -136.15 133.73 37.51 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.6 mt -116.59 116.18 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.5 t -101.13 116.02 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -90.89 132.52 35.87 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.5 p -132.25 156.93 45.63 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -143.85 148.69 35.85 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.2 m -150.82 87.05 1.4 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.94 -134.29 50.93 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -79.0 39.88 0.39 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.749 0.309 . . . . 0.0 110.498 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.8 m -150.09 147.62 28.0 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.2 m -134.0 146.38 50.35 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.406 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -132.68 131.08 40.91 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.5 mt -107.55 128.15 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.15 126.96 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -144.59 145.55 31.85 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 95.3 p -132.37 148.72 52.43 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -131.34 174.81 9.7 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 . . . . . 0 N--CA 1.467 0.389 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.827 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 120.605 0.241 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -53.74 -46.98 71.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.935 0.398 . . . . 0.0 110.385 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 81.5 p -64.67 -37.37 87.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.134 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.57 -52.45 46.04 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.531 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -66.41 -37.09 84.43 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.905 0.383 . . . . 0.0 110.541 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -70.55 -39.02 74.23 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.458 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.16 -52.0 67.38 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.726 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.4 tt -62.23 -37.97 79.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.7 mt -64.47 -41.99 96.17 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.28 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -67.39 -41.83 84.31 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.2 t -61.37 -32.83 72.75 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.467 0.48 . . . . 0.0 110.875 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 77.9 t80 . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 120.862 0.363 . . . . 0.0 111.031 -179.235 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.9 mt -50.17 143.01 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 t -129.91 133.96 47.18 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.4 m -139.69 158.34 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -148.65 162.88 38.83 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.335 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 p -145.3 140.59 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.3 p -93.36 119.33 32.36 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.2 t -127.48 128.7 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -98.98 88.22 3.92 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.29 154.43 4.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.041 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.25 118.84 7.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.2 tt -51.68 -34.96 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.167 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -60.31 -39.82 88.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -73.24 -45.43 55.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.238 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.88 -42.34 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.688 0.28 . . . . 0.0 110.499 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.462 ' HE1' HD11 ' A' ' 80' ' ' ILE . 21.0 t90 -48.92 -34.59 13.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.616 0.246 . . . . 0.0 111.123 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -61.55 -47.86 83.64 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.631 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -69.36 -42.37 75.31 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.699 0.285 . . . . 0.0 110.572 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -65.93 -15.63 63.14 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.307 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.442 ' ND2' ' CD1' ' A' ' 18' ' ' TRP . 2.1 m-80 -108.81 -26.88 10.06 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.377 0.671 . . . . 0.0 111.478 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -76.83 125.84 86.54 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.54 -31.36 13.72 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 121.427 1.418 . . . . 0.0 111.883 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.63 -37.29 78.25 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.437 0.461 . . . . 0.0 110.876 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -79.42 -41.45 27.66 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.988 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.48 -49.06 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.239 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.9 ptm -60.46 -16.35 35.59 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.495 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -72.28 -34.99 68.59 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -127.68 5.29 6.12 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.092 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.541 ' C ' ' H ' ' A' ' 33' ' ' ALA . 30.5 t -51.35 140.52 17.09 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 71.36 -36.64 0.37 Allowed 'General case' 0 CA--C 1.536 0.432 0 O-C-N 123.698 0.624 . . . . 0.0 109.573 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.541 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 56.21 34.81 24.65 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.533 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.1 m -121.93 136.03 25.84 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 122.816 0.446 . . . . 0.0 110.48 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.28 -20.34 16.42 Favored 'Trans proline' 0 N--CA 1.503 2.074 0 C-N-CA 121.832 1.688 . . . . 0.0 112.524 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -78.04 -24.06 47.94 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.543 0.211 . . . . 0.0 110.991 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -109.54 153.79 23.63 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.411 ' CD2' ' O ' ' A' ' 57' ' ' ALA . 6.1 p80 -144.77 162.87 35.68 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.3 t -120.74 95.25 48.99 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.12 -10.77 22.95 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 121.637 1.558 . . . . 0.0 111.688 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -167.49 151.99 6.81 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.893 0.378 . . . . 0.0 110.433 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -162.41 146.4 11.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.245 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -139.21 152.92 47.74 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -160.57 127.77 4.33 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.857 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -133.89 93.58 3.13 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.17 102.34 1.33 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.174 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -163.8 129.92 3.12 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.55 123.19 12.35 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.715 0.293 . . . . 0.0 110.67 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.68 4.92 90.23 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.28 173.01 52.95 Favored Glycine 0 N--CA 1.467 0.745 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.5 t -134.08 164.21 27.84 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 117.058 0.429 . . . . 0.0 110.045 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -148.8 169.13 21.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.067 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.1 m -148.99 125.32 10.87 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.8 m -120.5 118.31 29.91 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.3 m -94.89 117.93 30.94 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 46.4 ttp -137.06 130.25 31.05 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' A' ' 38' ' ' HIS . . . -153.54 158.04 40.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.208 0.528 . . . . 0.0 110.157 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.84 150.72 48.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.778 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -58.03 -38.12 75.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.587 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -71.23 -11.1 60.74 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.91 6.63 60.36 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.1 m -63.78 -39.96 95.52 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.598 0.237 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.2 mtm -117.44 142.2 47.42 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.133 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.8 p -144.23 149.24 36.04 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.872 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -154.49 154.21 32.77 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -138.18 120.15 15.47 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.589 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -93.7 121.83 35.54 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -132.46 134.92 7.83 Favored Glycine 0 N--CA 1.473 1.161 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.74 -175.11 44.67 Favored Glycine 0 CA--C 1.518 0.28 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.5 m -132.38 156.81 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.894 0.378 . . . . 0.0 110.207 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -88.34 124.51 33.99 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.517 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.32 -38.49 65.8 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.46 149.6 5.84 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.664 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.7 t -134.59 132.46 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -141.46 117.42 10.53 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 m -55.88 123.69 15.13 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.964 0.412 . . . . 0.0 111.349 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.2 m120 52.14 66.22 1.27 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.011 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -167.08 -77.55 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.227 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tp -151.82 131.6 13.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.51 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.462 HD11 ' HE1' ' A' ' 18' ' ' TRP . 64.6 mt -132.94 131.69 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -153.09 165.56 35.22 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -157.28 164.79 37.28 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 54.3 m -115.36 132.57 56.58 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.8 mm -99.28 150.05 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.22 -40.49 67.62 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.424 ' CB ' ' NH1' ' A' ' 88' ' ' ARG . 63.1 m-20 -61.66 -19.41 62.28 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.59 0.233 . . . . 0.0 110.709 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.93 -3.08 48.32 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.424 ' NH1' ' CB ' ' A' ' 86' ' ' ASP . 84.5 mtt85 -64.72 144.2 57.4 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -120.97 146.42 46.7 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.567 0.542 . . . . 0.0 109.654 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.3 t -138.1 136.89 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -132.92 120.02 20.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 70.8 mt -108.72 117.6 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.0 t -108.17 114.9 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -89.87 128.43 36.19 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.4 p -132.75 152.43 51.76 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -153.93 158.65 41.01 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.3 p -135.94 36.59 2.83 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.023 0.44 . . . . 0.0 109.901 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 69.92 131.2 0.07 OUTLIER Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 57.34 8.71 0.62 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.838 0.352 . . . . 0.0 110.955 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.7 m -150.47 139.54 21.08 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.114 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.9 m -127.76 130.36 48.62 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -120.53 123.29 42.55 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.0 mt -103.27 128.43 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.61 131.66 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -130.31 132.7 45.99 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.3 t -118.29 149.11 41.7 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -144.0 160.69 40.41 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.622 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 120.466 0.174 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -53.27 -44.98 68.65 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.01 0.433 . . . . 0.0 110.008 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.1 t -64.45 -40.72 96.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.352 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.47 -51.72 55.95 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -62.74 -36.3 82.58 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.705 0.288 . . . . 0.0 110.279 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -74.05 -37.67 64.21 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.791 0.329 . . . . 0.0 110.194 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.15 -51.08 71.56 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.805 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.3 tt -63.6 -39.57 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.5 mt -63.62 -38.61 91.76 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -62.14 -40.03 94.57 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.072 0.463 . . . . 0.0 109.763 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.5 t -72.63 -31.04 64.84 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.689 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 62.3 t80 . . . . . 0 N--CA 1.469 0.496 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -178.079 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.9 pttt . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 120.901 0.381 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.9 mt -51.53 138.97 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 m -135.64 138.73 43.16 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 m -136.17 157.05 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -147.74 161.16 41.78 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.39 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.61 142.61 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.5 m -93.48 121.27 34.7 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.7 t -126.57 124.88 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -94.74 89.9 5.88 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.98 153.47 4.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.06 134.28 55.85 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.7 tp -52.83 -34.39 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.88 0.372 . . . . 0.0 110.884 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -60.46 -40.8 92.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.473 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -72.07 -46.66 56.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.845 0.355 . . . . 0.0 110.555 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.48 -41.57 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.401 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.781 ' CH2' HD11 ' A' ' 80' ' ' ILE . 26.4 t-105 -56.11 -45.31 79.54 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.84 0.353 . . . . 0.0 110.868 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -65.26 -45.01 86.25 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.339 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -65.51 -43.37 90.33 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.727 0.299 . . . . 0.0 110.973 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.424 ' C ' HD22 ' A' ' 22' ' ' ASN . 67.2 t-105 -69.23 -20.19 63.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.492 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.653 HD22 ' N ' ' A' ' 22' ' ' ASN . 0.7 OUTLIER -104.93 -30.86 9.55 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.129 0.571 . . . . 0.0 111.752 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -50.76 106.52 0.66 Allowed Pre-proline 0 CA--C 1.557 1.214 0 CA-C-O 119.113 -0.47 . . . . 0.0 109.819 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -53.58 -43.07 60.82 Favored 'Trans proline' 0 N--CA 1.508 2.381 0 CA-C-N 120.646 1.266 . . . . 0.0 112.244 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.06 -33.79 73.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.909 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.506 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 81.4 t60 -73.74 -38.45 64.76 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.795 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.41 -44.46 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 122.038 -0.414 . . . . 0.0 110.752 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.7 ptp -67.21 -24.9 65.89 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.283 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -62.29 -45.8 91.61 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.529 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.506 ' HE1' ' CD2' ' A' ' 26' ' ' HIS . 62.7 p-90 -109.13 -10.19 15.01 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.523 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.488 ' O ' ' CE3' ' A' ' 30' ' ' TRP . 29.4 p 30.71 -130.99 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.962 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 177.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.425 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 55.2 tp60 -74.55 -4.34 36.34 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 30' ' ' TRP . . . 64.32 32.52 12.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.225 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.8 m -132.3 141.17 40.33 Favored Pre-proline 0 N--CA 1.482 1.154 0 O-C-N 123.337 0.398 . . . . 0.0 110.534 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.5 -9.94 23.32 Favored 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 121.892 1.728 . . . . 0.0 112.27 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -79.14 -24.56 43.22 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.426 0.155 . . . . 0.0 110.724 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -122.24 148.86 44.47 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.829 0.452 . . . . 0.0 110.313 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -140.09 163.25 33.2 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.179 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.21 89.23 52.94 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.61 -10.12 20.14 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 121.537 1.491 . . . . 0.0 111.141 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -167.77 150.36 5.78 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.008 0.432 . . . . 0.0 110.273 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.86 150.47 11.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.092 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -138.99 144.91 39.13 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -163.6 135.67 5.03 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -125.05 97.45 5.26 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.1 tp -65.34 94.48 0.17 Allowed 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -168.34 140.83 2.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.26 137.71 57.88 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.262 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.45 -0.05 61.24 Favored Glycine 0 N--CA 1.466 0.691 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.06 169.1 41.72 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 t -129.87 168.41 16.66 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.704 0.402 . . . . 0.0 110.066 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -140.57 166.38 24.9 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.244 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 m -154.88 118.09 4.45 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.7 m -116.96 121.46 41.47 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.1 m -93.36 116.66 29.21 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.9 mtp -121.76 125.88 47.57 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.81 138.31 42.44 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.014 0.435 . . . . 0.0 110.116 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.77 148.83 51.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.393 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.02 -39.96 75.76 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.712 0.292 . . . . 0.0 110.451 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -76.2 -9.65 58.8 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.24 22.23 62.84 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 97.0 p -81.06 -10.75 59.64 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.736 0.303 . . . . 0.0 110.617 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.1 ttt -164.49 136.48 4.59 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.087 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.9 p -144.43 161.1 39.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.874 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.466 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 61.7 t80 -159.47 168.63 25.76 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.466 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 40.8 t0 -138.55 119.53 14.39 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -93.99 140.58 29.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.71 156.21 26.97 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.36 -171.55 40.99 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 p -127.36 141.63 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 122.672 0.389 . . . . 0.0 110.107 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -81.04 123.65 28.54 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -77.0 -47.87 19.52 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.076 0.465 . . . . 0.0 110.04 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -147.38 141.31 25.87 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.559 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.3 t -136.06 125.5 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -140.54 123.13 16.16 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.8 m -53.62 121.95 8.84 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.073 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.5 m120 53.47 70.16 0.62 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.77 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -166.1 -82.39 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.536 0.208 . . . . 0.0 110.943 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.1 tp -147.02 139.55 24.85 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.781 HD11 ' CH2' ' A' ' 18' ' ' TRP . 58.9 mt -133.77 130.28 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -153.7 157.51 39.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -155.95 160.16 39.86 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.3 m -112.27 135.24 53.19 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.3 mm -89.19 155.89 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.8 -33.97 80.44 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -69.46 -10.26 57.27 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 122.477 -0.425 . . . . 0.0 110.352 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.7 -8.15 56.14 Favored Glycine 0 N--CA 1.475 1.29 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -71.18 161.32 31.3 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -145.4 160.79 41.03 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.428 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.4 t -144.43 113.03 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.325 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -93.92 127.41 39.67 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.7 mt -124.83 113.06 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.0 p -108.71 133.55 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.475 ' CE1' HD12 ' A' ' 80' ' ' ILE . 87.4 m-85 -103.93 132.64 49.99 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.0 p -134.3 153.3 51.95 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -153.84 158.22 40.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.541 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 63.6 p -134.86 27.38 3.6 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.049 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.0 129.32 1.39 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 55.7 11.77 0.72 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.885 0.374 . . . . 0.0 111.03 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.2 m -153.53 141.93 20.66 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.046 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.9 m -130.37 130.85 44.9 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -117.88 122.86 44.43 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.6 mt -104.37 126.27 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.5 t -128.18 133.83 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -142.63 145.9 33.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.036 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 78.4 p -132.24 141.97 49.23 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -154.15 155.55 35.56 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 CA--C 1.547 0.831 0 CA-C-O 119.136 -0.459 . . . . 0.0 110.656 -179.165 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.496 0.188 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.53 -48.09 69.37 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.774 0.321 . . . . 0.0 110.506 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.7 t -63.34 -42.57 98.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.337 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.68 -51.78 55.21 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -64.17 -36.06 82.81 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.967 0.384 . . . . 0.0 110.291 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -73.61 -38.19 65.16 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.17 -51.23 70.89 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.9 tt -61.7 -37.76 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.4 mt -63.26 -40.92 98.77 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.2 -41.29 97.14 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 110.049 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.5 m -61.05 -33.32 73.13 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.132 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 57.6 t80 . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.986 -178.683 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.7 mttt . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.4 mt -50.14 138.15 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.4 m -133.42 134.47 43.67 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.24 156.34 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.427 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 32.8 mp0 -140.75 158.36 44.08 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.917 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 p -143.88 140.46 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -93.44 113.95 26.23 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.7 t -119.01 125.9 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -98.23 87.84 4.02 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.09 152.78 4.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.087 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.63 135.88 57.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.485 HD13 ' CE1' ' A' ' 94' ' ' PHE . 9.7 tp -53.41 -32.2 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.622 0.248 . . . . 0.0 111.441 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -59.51 -39.74 84.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.774 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -75.17 -46.4 34.43 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 110.437 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.5 t -62.53 -43.44 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.24 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.7 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 25.2 t-105 -56.26 -46.05 79.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.934 0.397 . . . . 0.0 110.583 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -67.38 -45.43 76.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.606 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -65.31 -43.43 91.09 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.793 0.33 . . . . 0.0 111.136 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -70.43 -20.02 62.94 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.647 -178.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -104.68 -22.25 13.26 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.139 0.576 . . . . 0.0 111.41 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -65.8 132.09 94.76 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.02 -40.55 1.28 Allowed 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 121.262 1.308 . . . . 0.0 111.57 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.76 -35.9 69.19 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.085 0.469 . . . . 0.0 110.833 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -73.86 -45.8 48.82 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.255 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 91.8 mt -61.85 -50.29 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.816 -0.553 . . . . 0.0 111.015 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 20.0 ptm -60.8 -17.38 49.14 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -74.2 -31.73 62.76 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -133.41 14.86 4.11 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.602 0.361 . . . . 0.0 110.837 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.531 ' C ' ' H ' ' A' ' 33' ' ' ALA . 20.4 t -53.95 136.4 41.12 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 122.138 -0.351 . . . . 0.0 110.279 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 70.81 -36.25 0.35 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.539 0.524 . . . . 0.0 110.011 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 56.86 36.16 27.34 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.763 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.0 m -131.63 141.51 41.92 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 122.682 0.393 . . . . 0.0 110.436 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -75.46 -8.9 19.9 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.04 1.827 . . . . 0.0 112.03 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -86.31 7.32 25.9 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.681 0.277 . . . . 0.0 110.457 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -153.45 155.66 36.72 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.243 0.544 . . . . 0.0 110.357 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -148.55 163.18 37.98 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.303 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.6 t -127.62 91.94 44.24 Favored Pre-proline 0 N--CA 1.476 0.833 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.81 -1.94 12.09 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.768 1.645 . . . . 0.0 111.709 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.25 152.42 8.96 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.884 0.373 . . . . 0.0 110.078 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -166.07 150.47 8.03 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.36 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -136.77 150.47 48.4 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.917 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -160.88 131.4 5.25 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.09 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -129.54 95.83 4.11 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.79 93.87 0.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.08 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -168.19 140.9 3.05 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.96 137.75 58.21 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.425 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.87 1.65 48.24 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.9 148.12 34.45 Favored Glycine 0 N--CA 1.465 0.6 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.1 p -111.7 157.43 20.5 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.899 0.48 . . . . 0.0 109.846 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 69' ' ' GLY . 45.5 p90 -156.72 169.18 25.32 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.026 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.7 m -156.39 141.58 17.39 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.1 m -122.09 120.74 35.17 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.8 m -86.39 111.14 20.22 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 44.3 ttp -127.74 114.07 16.81 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -132.08 141.48 49.2 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.59 0.356 . . . . 0.0 110.275 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.35 148.07 33.75 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -58.83 -37.9 77.47 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.712 0.291 . . . . 0.0 110.263 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.51 -10.6 59.72 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.89 17.66 67.73 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.9 t -62.48 -42.22 99.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.801 0.334 . . . . 0.0 111.012 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 62.4 ttp -145.19 147.0 31.97 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.175 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.5 t -144.7 154.7 43.04 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.135 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -154.13 143.25 21.24 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -95.47 108.85 21.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.467 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -96.04 130.66 42.99 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.95 176.44 41.95 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 52' ' ' PHE . . . -174.57 -172.42 39.64 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 36.7 t -126.94 132.48 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -72.68 113.79 10.1 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.42 ' O ' ' NE2' ' A' ' 73' ' ' GLN . 23.9 t0 -74.29 -48.14 30.36 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.42 ' NE2' ' O ' ' A' ' 72' ' ' ASP . 99.2 mm-40 -139.81 137.88 35.35 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.78 125.82 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -144.19 113.15 6.77 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.3 m -47.38 116.49 1.44 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.4 m120 53.98 71.21 0.53 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.602 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -168.65 -68.86 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.634 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.0 tp -150.12 133.69 16.62 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.7 HD11 ' CZ3' ' A' ' 18' ' ' TRP . 84.5 mt -128.49 125.21 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -153.6 152.13 30.53 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 20.2 p90 -151.2 152.25 33.03 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.9 m -82.16 128.53 34.24 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.479 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.3 mm -82.27 144.1 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.251 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.32 -41.64 87.62 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -66.21 -5.28 9.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.758 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.17 0.89 84.82 Favored Glycine 0 N--CA 1.473 1.132 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -66.84 159.3 28.47 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -113.92 132.84 55.79 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.97 0.415 . . . . 0.0 109.944 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.2 t -136.48 134.35 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -135.43 127.34 29.48 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.82 117.46 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.56 128.58 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.485 ' CE1' HD13 ' A' ' 14' ' ' ILE . 4.0 t80 -92.46 126.32 37.49 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.9 m -146.21 141.25 27.23 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.433 ' ND1' ' N ' ' A' ' 96' ' ' HIS . 2.3 p-80 -153.69 148.84 26.87 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.2 p -98.05 -13.63 20.94 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.011 0.434 . . . . 0.0 109.957 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.43 -101.29 0.2 Allowed Glycine 0 N--CA 1.465 0.622 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 18.0 p-10 -78.0 -2.06 35.2 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.343 0.257 . . . . 0.0 110.892 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.0 p -118.54 128.18 54.32 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.03 0.532 . . . . 0.0 109.709 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.9 m -103.72 135.07 45.97 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.666 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -119.23 115.37 24.05 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.8 mt -101.51 125.79 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.3 t -121.35 127.57 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -142.43 144.47 33.1 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 94.7 p -130.51 148.9 52.37 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.117 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -137.22 150.57 47.96 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.153 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 CA--C 1.551 0.982 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.992 179.929 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 . . . . . 0 N--CA 1.468 0.448 0 CA-C-O 120.349 0.119 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.503 ' NE2' ' NE2' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -55.52 -38.81 69.71 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.188 0.518 . . . . 0.0 110.633 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.412 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 40.7 t -59.0 -40.83 86.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.954 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.4 -48.23 64.96 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.717 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -59.04 -39.71 82.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.802 0.334 . . . . 0.0 110.563 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.503 ' NE2' ' NE2' ' A' ' 119' ' ' GLN . 78.3 mt-30 -74.85 -34.65 62.32 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.75 -51.0 71.63 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.7 tt -63.19 -39.11 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.7 mt -63.56 -40.04 95.96 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -62.71 -39.66 94.73 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.5 t -60.02 -37.07 78.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.811 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 48.5 t80 . . . . . 0 CA--C 1.534 0.352 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.681 -179.049 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 110.291 -0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.9 mt -46.38 138.16 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.0 m -136.29 136.95 40.21 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.77 156.33 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 31.6 mp0 -141.06 158.91 43.28 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.851 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 p -151.26 142.59 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.186 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.5 p -97.32 124.11 41.35 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.7 t -128.46 129.48 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -93.83 88.2 5.68 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.48 151.73 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.19 133.74 54.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.143 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.6 tt -53.44 -36.48 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.701 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.407 ' OE2' ' N ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -63.31 -34.98 78.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.984 0.421 . . . . 0.0 110.011 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.407 ' N ' ' OE2' ' A' ' 15' ' ' GLU . 63.9 tttm -73.38 -50.21 23.11 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.9 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.35 -42.64 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.154 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.476 ' NE1' ' ND2' ' A' ' 22' ' ' ASN . 25.9 t-105 -54.13 -40.15 67.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.763 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -65.46 -54.31 30.23 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.538 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -69.53 -41.63 75.71 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.838 0.351 . . . . 0.0 111.396 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -61.82 -20.69 63.91 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.708 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.476 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 91.8 m-20 -106.22 -19.58 13.66 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.809 0.444 . . . . 0.0 110.282 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -68.27 122.92 86.1 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.7 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.93 -35.1 12.74 Favored 'Trans proline' 0 N--CA 1.504 2.125 0 C-N-CA 121.324 1.35 . . . . 0.0 112.217 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.73 -39.57 94.48 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.84 0.352 . . . . 0.0 110.48 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.539 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 84.4 t60 -65.36 -45.39 84.33 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.37 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 31' ' ' CYS . 96.7 mt -62.48 -43.84 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 36.3 ttp -54.85 -15.96 2.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.497 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -84.49 -25.98 28.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.641 0.258 . . . . 0.0 111.355 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.539 ' HE1' ' CD2' ' A' ' 26' ' ' HIS . 56.7 p-90 -140.75 26.21 2.1 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.878 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.588 ' C ' ' H ' ' A' ' 33' ' ' ALA . 16.1 t -59.73 130.24 45.82 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.937 -0.477 . . . . 0.0 110.12 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 66.08 -27.46 0.11 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.754 0.658 . . . . 0.0 110.55 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 51.96 30.26 7.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.0 t -118.86 136.71 24.39 Favored Pre-proline 0 N--CA 1.48 1.068 0 O-C-N 123.476 0.485 . . . . 0.0 111.168 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.95 -13.02 24.01 Favored 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 121.931 1.754 . . . . 0.0 111.939 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -85.05 9.78 13.78 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.921 0.391 . . . . 0.0 110.911 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -149.31 162.17 40.59 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.232 0.539 . . . . 0.0 109.747 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -148.74 162.89 38.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.911 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.79 91.2 13.77 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.8 -3.07 13.36 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 122.312 2.008 . . . . 0.0 112.049 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.29 153.06 11.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.737 0.303 . . . . 0.0 110.228 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -165.03 148.21 8.4 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -150.72 152.99 34.73 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -163.16 103.65 0.98 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.095 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -85.68 90.99 8.16 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.6 tp -65.41 95.66 0.21 Allowed 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -169.51 140.69 2.28 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.08 138.05 57.96 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.192 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.87 -2.29 60.32 Favored Glycine 0 N--CA 1.467 0.732 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.18 174.22 43.54 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 t -135.21 168.06 19.86 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -135.89 167.19 21.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.975 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.9 m -160.66 125.93 3.83 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.7 m -123.99 125.63 44.91 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 m -86.73 112.17 21.41 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 72.4 mtp -119.72 118.62 31.39 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.49 139.72 40.74 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.53 147.59 52.48 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -55.18 -34.89 64.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 110.668 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -82.71 -9.21 59.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.345 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.83 15.34 64.46 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.6 t -62.5 -40.97 98.43 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.72 0.295 . . . . 0.0 110.664 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 44.6 ttp -143.58 143.32 31.45 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.09 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.6 p -145.83 157.56 43.91 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.878 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.448 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 63.5 t80 -159.81 166.69 29.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.517 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.448 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 24.1 p-10 -138.2 121.92 17.53 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.045 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -94.38 143.62 26.24 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.92 157.44 28.01 Favored Glycine 0 C--N 1.331 0.268 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.51 -173.06 40.92 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.4 t -128.31 135.85 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -76.06 120.0 20.77 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -74.05 -45.08 51.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.893 0.377 . . . . 0.0 110.23 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -148.77 139.42 22.73 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -137.34 127.67 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -144.16 129.01 18.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.0 m -60.55 135.01 57.62 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.793 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 54.81 57.8 5.37 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.915 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -154.37 -82.76 0.08 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.934 0.397 . . . . 0.0 110.273 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -163.07 160.56 24.58 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.26 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.2 mt -134.38 135.96 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.404 ' OE1' ' NH1' ' A' ' 91' ' ' ARG . 14.2 pt-20 -149.92 154.92 39.09 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -158.91 155.2 27.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.9 m -95.57 134.41 38.48 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.7 mt -101.32 152.74 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -51.88 -42.19 53.05 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -60.83 -17.46 49.97 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.984 0.421 . . . . 0.0 110.095 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.42 7.55 72.34 Favored Glycine 0 N--CA 1.471 0.99 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -70.58 139.35 51.45 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -93.7 136.47 33.94 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.0 t -137.83 132.12 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.404 ' NH1' ' OE1' ' A' ' 81' ' ' GLU . 70.2 mtp85 -135.61 135.53 40.31 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.9 mt -124.18 114.07 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.88 129.11 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -95.8 132.8 40.67 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.5 p -136.11 155.47 50.13 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -152.43 143.64 23.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.738 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.4 p -91.1 -41.46 11.04 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.003 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.45 -68.06 0.11 Allowed Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -107.28 17.4 22.92 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.157 0.583 . . . . 0.0 110.73 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.5 m -155.77 119.79 4.52 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.105 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 43.0 m -83.99 146.44 27.99 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -128.49 122.61 31.59 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.6 mt -100.27 126.67 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.37 126.73 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -144.71 146.49 32.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.523 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 96.5 p -134.52 147.5 50.33 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -122.27 170.95 9.41 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.411 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.642 0.258 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -54.02 -41.35 67.9 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.508 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.2 t -60.91 -41.85 96.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.396 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.51 -50.9 61.68 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -61.36 -36.33 79.93 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.015 0.436 . . . . 0.0 110.18 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -75.86 -36.45 59.56 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.138 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.35 -51.41 70.06 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.003 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.8 tt -61.1 -37.33 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.8 mt -63.74 -40.67 97.3 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.334 -0.393 . . . . 0.0 109.962 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -63.9 -39.23 93.7 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.2 m -57.6 -35.52 70.53 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 110.665 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 59.3 t80 . . . . . 0 CA--C 1.534 0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.465 179.819 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.1 mttp . . . . . 0 C--O 1.234 0.243 0 CA-C-O 121.04 0.448 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.9 mt -53.26 134.63 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.5 m -131.19 130.99 43.68 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.8 m -137.32 159.01 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -148.47 162.41 39.68 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.417 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 p -144.14 142.54 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 m -95.46 117.65 30.76 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -123.43 129.38 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -97.61 87.55 4.11 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.82 152.54 4.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.984 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.86 133.04 52.62 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.041 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.8 tt -53.36 -36.69 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.736 0.303 . . . . 0.0 111.629 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.35 -35.29 75.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.424 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -74.92 -47.17 31.16 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.165 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.3 -43.03 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.31 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.663 ' CH2' HD11 ' A' ' 80' ' ' ILE . 26.6 t-105 -53.98 -43.54 70.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.139 0.495 . . . . 0.0 110.864 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.69 -45.78 74.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.614 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -66.63 -42.72 86.32 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.886 0.374 . . . . 0.0 111.332 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -68.73 -18.09 64.17 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.571 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -109.66 -29.54 8.31 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.938 0.495 . . . . 0.0 111.981 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -51.42 106.21 0.62 Allowed Pre-proline 0 CA--C 1.561 1.383 0 CA-C-O 118.734 -0.651 . . . . 0.0 109.519 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.53 -43.33 55.61 Favored 'Trans proline' 0 N--CA 1.506 2.254 0 CA-C-N 121.006 1.395 . . . . 0.0 112.331 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.46 84.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.257 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -69.04 -36.93 78.27 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.371 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 98.7 mt -62.0 -52.41 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 121.856 -0.528 . . . . 0.0 111.218 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.8 ptp -61.59 -16.55 49.14 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -70.15 -26.92 64.16 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 32' ' ' GLN . 68.8 p-90 -134.17 6.79 3.63 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 119.525 -0.274 . . . . 0.0 111.096 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.4 t -67.93 72.52 0.17 Allowed 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 121.416 0.627 . . . . 0.0 109.706 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 30' ' ' TRP . 55.6 tt0 -161.74 63.17 0.25 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.615 ' HB2' HD12 ' A' ' 125' ' ' ILE . . . -69.77 -5.02 22.51 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.09 -1.413 . . . . 0.0 110.716 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 79.4 p -146.2 140.67 15.67 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.33 -13.92 22.95 Favored 'Trans proline' 0 N--CA 1.509 2.44 0 C-N-CA 122.071 1.847 . . . . 0.0 112.372 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -83.97 14.07 4.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.676 0.274 . . . . 0.0 110.598 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -147.71 143.99 27.99 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -130.95 163.01 28.46 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 t -127.93 87.35 55.92 Favored Pre-proline 0 N--CA 1.477 0.914 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.89 -7.83 14.42 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.816 1.678 . . . . 0.0 111.496 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.79 151.37 4.19 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.0 156.05 5.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.432 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -148.11 154.05 39.68 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.86 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -163.58 135.27 4.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.591 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -129.0 101.15 5.93 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tp -69.27 99.39 1.16 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -166.91 138.18 3.28 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.85 137.1 58.15 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.694 0.283 . . . . 0.0 110.436 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.96 2.14 60.99 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.2 169.57 38.21 Favored Glycine 0 N--CA 1.47 0.902 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 t -130.2 165.39 22.47 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.095 0.474 . . . . 0.0 110.203 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -140.5 162.15 36.03 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.53 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.3 m -150.45 134.91 17.25 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.8 p -131.39 119.17 21.28 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 m -88.98 118.19 28.53 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.4 mtp -134.4 125.91 28.49 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.87 146.74 33.24 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.279 0.561 . . . . 0.0 110.398 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.18 148.94 43.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.604 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -56.52 -39.67 73.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.817 0.341 . . . . 0.0 110.451 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -75.14 -10.49 59.52 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.876 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.29 10.82 70.41 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.2 t -62.72 -41.97 99.42 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.008 -0.113 . . . . 0.0 111.057 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.1 tpt -120.2 143.18 48.39 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.6 t -143.53 139.41 29.76 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.454 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 58.5 t80 -160.0 160.54 33.43 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.454 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 73.8 m-20 -138.03 128.34 26.14 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.5 134.08 38.76 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.38 156.13 26.75 Favored Glycine 0 N--CA 1.465 0.614 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.6 -172.14 40.98 Favored Glycine 0 CA--C 1.517 0.177 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.03 140.8 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 122.593 0.357 . . . . 0.0 110.301 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -79.24 121.69 25.38 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.06 -39.09 63.73 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.226 0.536 . . . . 0.0 109.757 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -166.16 147.75 6.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.218 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.7 t -137.39 135.26 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -140.74 119.63 12.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.7 m -50.99 118.61 3.29 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.7 m120 52.89 72.17 0.44 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.915 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -168.15 -77.02 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.256 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.0 tp -150.99 140.6 21.65 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.349 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.663 HD11 ' CH2' ' A' ' 18' ' ' TRP . 61.7 mt -132.09 132.09 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.14 155.15 36.2 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -155.81 155.1 32.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.4 m -98.64 128.69 45.02 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.423 HG22 ' H ' ' A' ' 86' ' ' ASP . 88.3 mt -92.06 150.48 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.95 -41.44 68.05 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.423 ' H ' HG22 ' A' ' 84' ' ' ILE . 81.2 m-20 -60.71 -12.14 9.57 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.727 0.298 . . . . 0.0 110.477 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.49 -3.56 81.81 Favored Glycine 0 N--CA 1.468 0.822 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -65.88 138.42 57.85 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -98.37 142.69 29.69 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.2 t -143.46 136.66 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -136.24 138.77 42.16 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.1 mt -129.94 114.68 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.0 p -107.91 132.58 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -103.83 117.52 34.53 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.5 m -109.17 152.08 25.61 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -145.85 143.08 29.39 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 65.2 p -144.03 105.09 4.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.842 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.96 -93.92 0.2 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 21.3 p-10 -132.06 32.7 3.99 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.607 0.363 . . . . 0.0 110.984 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.3 m -134.72 126.64 29.43 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.6 m -108.26 124.97 51.12 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -117.18 121.24 40.68 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.8 mt -98.03 124.48 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.88 130.66 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -142.5 144.22 32.89 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 56.4 m -123.33 148.62 45.82 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -128.61 153.38 47.32 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 . . . . . 0 CA--C 1.539 0.552 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.429 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 . . . . . 0 CA--C 1.521 -0.169 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -55.04 -41.79 71.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.997 0.427 . . . . 0.0 110.358 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.1 t -61.24 -43.36 99.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.352 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.79 -51.7 57.03 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -65.23 -42.96 92.89 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.169 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.85 -38.9 92.79 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.56 -54.16 49.16 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.615 HD12 ' HB2' ' A' ' 33' ' ' ALA . 12.9 tt -67.39 -37.54 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.312 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.2 mt -61.52 -41.62 97.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.766 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 128' ' ' SER . 25.2 p30 -67.48 -31.68 71.99 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.16 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.415 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 96.2 p -76.79 -29.16 55.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.936 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 56.6 t80 . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.936 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt . . . . . 0 N--CA 1.479 1.018 0 CA-C-O 120.755 0.312 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.3 mm -51.77 136.18 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.5 m -135.73 128.9 31.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.988 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.96 149.83 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -148.91 158.29 44.06 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.664 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.43 158.9 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.503 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -122.45 124.71 44.25 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.3 p -128.42 141.8 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 122.542 0.337 . . . . 0.0 110.769 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -87.7 87.1 7.28 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.152 0.501 . . . . 0.0 110.078 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.41 147.05 4.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.403 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.16 137.67 58.07 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.242 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.6 tt -52.8 -32.24 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.248 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -59.43 -42.73 92.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.73 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -71.03 -44.47 65.75 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.076 0.465 . . . . 0.0 110.487 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.57 -43.11 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.409 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -58.72 -49.93 75.77 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.8 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -67.65 -45.82 74.22 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.575 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -63.18 -44.66 94.81 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.096 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -67.35 -21.32 65.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.649 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -101.44 -23.96 14.25 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.95 0.5 . . . . 0.0 111.797 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -62.5 117.98 36.41 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 118.743 -0.646 . . . . 0.0 109.284 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.5 -37.16 7.73 Favored 'Trans proline' 0 N--CA 1.504 2.141 0 CA-C-N 121.081 1.422 . . . . 0.0 112.214 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.13 -30.71 66.53 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.927 0.394 . . . . 0.0 111.111 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -79.96 -36.51 36.04 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.384 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 31' ' ' CYS . 96.8 mt -63.39 -42.98 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 122.087 -0.383 . . . . 0.0 110.598 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 17.2 ptp -60.09 -14.87 18.91 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.262 -0.274 . . . . 0.0 111.163 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -79.47 -30.57 42.17 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 122.133 -0.354 . . . . 0.0 110.779 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -133.89 20.57 3.82 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.514 ' C ' ' H ' ' A' ' 33' ' ' ALA . 42.9 t -57.35 134.22 55.82 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.64 -0.663 . . . . 0.0 111.219 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 70.59 -35.56 0.33 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.665 0.603 . . . . 0.0 110.283 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 55.64 33.42 21.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.189 0.518 . . . . 0.0 110.64 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.9 t -124.5 114.12 27.3 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.24 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.79 -22.1 28.23 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 121.573 1.515 . . . . 0.0 112.184 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -79.91 13.37 2.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.879 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -150.11 159.0 44.75 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.027 0.441 . . . . 0.0 110.254 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -140.0 163.3 33.05 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.387 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 39' ' ' VAL . 6.1 p -126.78 92.52 44.54 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 123.559 0.744 . . . . 0.0 109.464 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.2 -12.65 23.34 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 121.302 1.335 . . . . 0.0 111.976 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.57 154.72 5.7 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.983 0.42 . . . . 0.0 110.073 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.81 144.61 13.52 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.904 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -139.86 153.59 47.07 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -159.03 103.37 1.67 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.897 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -93.49 85.83 5.05 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 tp -65.53 92.74 0.14 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -170.21 147.3 3.1 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.916 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.52 136.55 58.06 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.34 -1.77 18.16 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -73.59 155.54 50.02 Favored Glycine 0 N--CA 1.467 0.716 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.9 m -115.69 152.8 32.51 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.92 0.488 . . . . 0.0 109.966 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -136.68 160.55 38.5 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.29 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.0 m -150.99 115.98 5.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 43.5 m -109.02 113.09 25.66 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 m -94.3 122.07 36.46 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 13.4 ptp -141.82 141.91 33.15 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.81 149.83 33.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.98 0.419 . . . . 0.0 110.369 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.8 148.45 51.23 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -54.88 -38.45 67.55 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.815 0.341 . . . . 0.0 110.972 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -79.45 -7.78 58.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.915 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.87 22.09 61.85 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.9 p -82.26 -10.47 59.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.459 0.171 . . . . 0.0 111.059 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 49.3 ttp -165.78 130.93 2.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.463 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.4 p -145.38 164.12 32.47 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.318 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -155.91 143.02 19.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -108.11 114.7 28.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.178 0.591 . . . . 0.0 110.26 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -94.54 137.56 33.51 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.26 157.9 28.73 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.05 -171.59 41.58 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.8 t -131.58 138.52 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -77.55 121.66 24.2 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -72.64 -38.65 67.64 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -163.58 147.71 10.54 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.772 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.5 p -149.22 137.53 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.155 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -145.17 137.44 25.87 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.2 m -56.45 127.66 32.19 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.849 0.357 . . . . 0.0 111.497 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.6 m120 56.36 63.74 1.9 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.211 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -155.22 -84.1 0.06 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.729 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -164.22 159.28 19.92 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.893 0.377 . . . . 0.0 110.771 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.72 130.77 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -145.42 155.11 42.94 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -158.86 156.11 29.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.986 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.7 m -97.98 133.02 43.02 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.8 mt -97.87 151.3 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.2 -40.45 67.41 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -60.98 -15.71 34.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.913 0.387 . . . . 0.0 110.118 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.27 -0.2 65.96 Favored Glycine 0 N--CA 1.469 0.874 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.65 136.52 45.68 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -99.64 152.37 20.14 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.9 t -140.59 137.11 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -132.79 129.01 38.02 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.5 mt -124.44 112.51 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.9 t -109.98 128.72 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -100.4 127.01 46.83 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.1 p -132.97 153.21 51.66 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -154.0 166.01 34.35 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.847 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 t -136.96 -11.2 1.74 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.883 0.373 . . . . 0.0 110.192 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.21 -127.51 1.29 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.2 p-10 -75.03 6.88 3.69 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 122.988 -0.124 . . . . 0.0 110.749 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 53.1 m -124.59 129.73 51.12 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.0 m -106.91 135.86 47.76 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -110.83 111.15 22.11 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.7 mt -92.35 122.65 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.28 126.84 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -143.01 143.49 31.92 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.236 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.2 m -129.15 146.21 51.14 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -117.51 166.09 12.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.127 0.571 . . . . 0.0 109.606 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 . . . . . 0 N--CA 1.471 0.619 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.796 179.551 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 111.452 0.168 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -54.68 -45.4 73.92 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.897 0.38 . . . . 0.0 110.36 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.5 t -68.17 -33.03 73.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.651 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.3 -51.19 60.32 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -62.44 -38.4 89.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.905 0.383 . . . . 0.0 110.508 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -70.51 -38.29 74.26 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.97 -52.46 65.42 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.096 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.0 tt -60.92 -37.85 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.02 -46.91 79.38 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.427 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -77.87 -32.08 51.74 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 122.193 -0.317 . . . . 0.0 111.095 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.9 m -60.12 -40.73 90.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.732 0.301 . . . . 0.0 110.455 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.1 t80 . . . . . 0 N--CA 1.467 0.394 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.511 -179.638 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.2 pttm . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 120.99 0.424 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.6 mt -50.37 140.23 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.8 m -134.12 135.26 43.06 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.5 m -132.49 160.72 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -138.44 158.72 43.72 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.957 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.501 ' CG2' HD22 ' A' ' 126' ' ' LEU . 3.7 t -133.48 126.43 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.9 p -88.76 109.05 19.84 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.0 t -126.36 127.02 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -97.47 89.13 4.59 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.09 154.75 5.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.032 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.62 132.23 50.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.18 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.4 tt -54.08 -34.74 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.611 0.244 . . . . 0.0 110.929 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.93 -40.31 92.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.083 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -70.18 -48.09 58.78 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.803 0.335 . . . . 0.0 110.786 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.0 -41.7 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.356 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 42.9 t-105 -50.66 -39.87 51.93 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.551 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -65.68 -48.35 72.36 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.311 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -68.59 -43.0 77.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.662 0.268 . . . . 0.0 110.971 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -65.57 -19.39 65.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.612 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.59 HD22 ' N ' ' A' ' 22' ' ' ASN . 0.8 OUTLIER -102.57 -22.82 13.94 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.282 0.633 . . . . 0.0 110.583 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -63.19 120.63 63.36 Favored Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.94 -40.98 4.44 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 CA-C-N 120.997 1.392 . . . . 0.0 112.086 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.96 -30.31 63.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.697 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.556 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 81.1 t60 -78.07 -45.17 24.27 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.378 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 31' ' ' CYS . 95.7 mt -59.73 -50.86 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 121.946 -0.471 . . . . 0.0 111.064 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.6 ptm -57.64 -15.49 7.78 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -79.03 -33.27 44.98 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.556 ' HE1' ' CD2' ' A' ' 26' ' ' HIS . 58.1 p-90 -133.69 20.8 3.89 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.661 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.567 ' C ' ' H ' ' A' ' 33' ' ' ALA . 44.1 t -55.12 129.32 37.64 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.764 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 68.63 -19.33 0.16 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.116 0.484 . . . . 0.0 110.496 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.567 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.64 35.55 23.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.482 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -111.25 97.78 36.89 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.064 0.546 . . . . 0.0 110.087 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.33 -23.21 22.97 Favored 'Trans proline' 0 N--CA 1.505 2.175 0 C-N-CA 122.378 2.052 . . . . 0.0 112.576 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -68.76 -24.67 64.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.536 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -104.76 163.96 12.12 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -141.22 162.33 35.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.21 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -129.81 89.86 44.9 Favored Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -73.95 -9.04 21.94 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 121.694 1.596 . . . . 0.0 111.873 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.1 152.58 6.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.003 0.43 . . . . 0.0 110.105 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.14 145.89 13.75 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.084 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -133.72 150.3 51.5 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -159.86 125.58 4.17 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.698 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -133.25 94.78 3.4 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.7 mt -66.83 97.37 0.47 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.139 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -162.56 135.96 6.05 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.69 133.92 56.54 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.673 0.273 . . . . 0.0 110.307 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.06 5.05 69.58 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.21 165.73 39.69 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.8 p -131.09 161.56 31.8 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.442 ' CD1' ' CE2' ' A' ' 71' ' ' TYR . 30.6 p90 -154.75 170.02 22.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.068 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.8 m -153.69 139.34 17.89 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.5 m -121.33 120.64 35.67 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.3 m -92.87 123.55 36.22 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.0 ptm -142.76 138.6 30.58 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.18 145.33 26.21 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.044 0.45 . . . . 0.0 110.326 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.48 149.8 28.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.765 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -51.46 -39.93 58.45 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.866 0.365 . . . . 0.0 110.775 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -80.21 -9.32 59.72 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.139 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.3 18.21 67.09 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.0 t -62.19 -40.51 96.29 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.659 0.266 . . . . 0.0 110.922 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 44.3 ttp -142.31 136.78 30.05 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.226 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.8 p -145.74 158.86 43.82 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -159.13 139.11 11.94 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -88.56 111.01 21.37 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -94.53 131.01 40.71 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.69 175.11 42.09 Favored Glycine 0 C--O 1.227 -0.335 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.45 -174.01 40.88 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.12 129.39 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.442 ' CE2' ' CD1' ' A' ' 52' ' ' PHE . 74.6 m-85 -72.45 113.48 9.53 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -73.4 -39.05 65.38 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.219 0.533 . . . . 0.0 109.767 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -166.89 146.21 5.4 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.524 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.6 131.03 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -140.03 128.32 22.57 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.5 p -61.51 134.88 57.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.249 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.2 m120 55.98 55.36 6.99 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.673 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -155.1 -82.52 0.07 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.645 0.259 . . . . 0.0 110.35 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -163.63 160.12 22.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.355 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.7 mt -133.7 134.99 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.06 156.69 42.92 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' A' ' 84' ' ' ILE . 37.7 p90 -161.16 156.26 24.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.5 p -103.5 133.06 49.17 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.661 ' N ' HD12 ' A' ' 84' ' ' ILE . 2.6 mp -93.44 160.37 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.437 ' N ' HG22 ' A' ' 84' ' ' ILE . . . -53.25 -44.95 64.93 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -62.8 -12.8 26.84 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.831 0.315 . . . . 0.0 110.36 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.34 9.56 66.93 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -58.94 155.08 13.98 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -114.57 127.73 55.94 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.7 t -136.93 132.02 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -134.98 133.79 39.85 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 77.1 mt -123.72 114.17 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 43.2 t -111.78 129.54 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -98.92 119.58 37.94 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 39.7 m -120.44 148.77 43.37 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -154.07 158.23 40.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.0 p -135.86 23.33 3.34 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.249 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 100' ' ' THR . . . 88.34 128.31 2.97 Favored Glycine 0 N--CA 1.47 0.96 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 58.07 6.06 0.46 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.824 0.345 . . . . 0.0 111.061 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 98' ' ' GLY . 28.2 m -148.23 137.56 22.08 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.2 m -130.99 125.24 32.8 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -110.32 119.35 38.95 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.4 mt -95.58 120.55 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 36.6 t -105.15 132.07 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -134.0 114.37 13.15 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.7 t -94.52 149.63 21.05 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -144.36 140.9 29.36 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.758 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 . . . . . 0 CA--C 1.52 -0.21 0 CA-C-O 120.528 0.204 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.54 -50.64 59.63 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.871 0.367 . . . . 0.0 110.363 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.5 m -62.33 -38.55 89.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.601 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.44 -52.33 49.9 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.943 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -62.45 -39.44 93.37 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.772 0.286 . . . . 0.0 110.483 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.635 ' NE2' HD21 ' A' ' 127' ' ' ASN . 0.0 OUTLIER -74.07 -35.08 64.23 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.625 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.14 -50.54 73.64 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.45 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.4 pt -63.64 -34.53 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.818 0.342 . . . . 0.0 110.798 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.501 HD22 ' CG2' ' A' ' 8' ' ' VAL . 36.0 mt -64.67 -37.07 86.34 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.029 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.635 HD21 ' NE2' ' A' ' 123' ' ' GLN . 80.0 m-20 -61.24 -40.63 94.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.751 0.31 . . . . 0.0 110.461 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.7 t -62.69 -40.3 96.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.549 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 75.9 t80 . . . . . 0 N--CA 1.464 0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.443 -179.563 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.1 mttt . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 81.3 mt -142.28 133.01 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.8 m -137.77 133.43 34.05 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 m -138.7 153.35 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.11 163.94 36.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.049 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.9 m -145.83 157.52 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -102.73 126.73 49.95 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.19 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.06 129.5 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -98.59 89.2 4.31 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.14 155.25 6.43 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.8 135.91 57.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.209 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.6 tp -52.88 -36.49 23.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 121.1 0.476 . . . . 0.0 111.417 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -68.87 -33.62 74.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.167 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -71.42 -51.73 22.36 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.603 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 p -62.51 -36.3 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.676 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.473 ' CE2' ' ND2' ' A' ' 22' ' ' ASN . 68.4 t90 -54.47 -44.0 72.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.979 0.418 . . . . 0.0 110.906 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -69.39 -45.94 68.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.712 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -65.32 -40.56 93.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.982 0.42 . . . . 0.0 110.96 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -73.54 -17.22 61.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.707 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.473 ' ND2' ' CE2' ' A' ' 18' ' ' TRP . 90.4 m-20 -109.41 -20.39 12.93 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.182 0.593 . . . . 0.0 110.72 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -64.41 138.71 97.52 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.8 -43.48 0.43 Allowed 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 121.763 1.642 . . . . 0.0 112.43 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.25 -40.56 96.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 110.909 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -66.69 -46.26 76.17 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.641 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 31' ' ' CYS . 89.2 mt -62.8 -48.51 87.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.431 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 43.2 ttp -60.38 -23.27 64.18 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -65.58 -31.78 73.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.437 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -135.67 14.17 3.42 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.444 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 27' ' ' ILE . 12.0 t -55.73 141.05 39.68 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 122.1 -0.375 . . . . 0.0 110.0 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 72.07 -46.79 0.65 Allowed 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.233 0.958 . . . . 0.0 109.227 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.38 40.58 31.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.307 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.5 m -124.32 139.12 32.17 Favored Pre-proline 0 N--CA 1.481 1.121 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.973 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.42 -30.05 8.65 Favored 'Trans proline' 0 N--CA 1.506 2.253 0 C-N-CA 121.941 1.761 . . . . 0.0 112.51 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.94 6.47 7.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.725 0.298 . . . . 0.0 110.692 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -147.32 158.39 43.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.182 0.515 . . . . 0.0 109.717 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.4 ' CE1' ' O ' ' A' ' 57' ' ' ALA . 14.3 p-80 -146.59 155.21 42.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.229 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.85 89.63 34.25 Favored Pre-proline 0 N--CA 1.476 0.828 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.63 -1.78 11.89 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.167 1.912 . . . . 0.0 111.587 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.71 147.91 6.13 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.025 0.441 . . . . 0.0 110.031 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.68 141.82 18.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.755 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -134.95 137.96 43.6 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -163.17 136.43 5.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.62 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -130.46 99.33 4.96 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 tp -65.43 95.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.877 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -169.54 141.41 2.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.17 135.93 57.79 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.289 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.08 1.7 60.37 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.77 158.43 36.96 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 178.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 t -118.27 165.26 14.05 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.142 0.577 . . . . 0.0 109.851 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -144.8 159.77 42.33 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.157 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.2 m -149.36 123.96 9.77 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.8 p -120.89 123.33 42.25 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.7 m -90.36 117.4 29.05 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 60.7 mtt -129.87 104.55 7.44 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.4 ' O ' ' CE1' ' A' ' 38' ' ' HIS . . . -126.82 156.42 41.32 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.02 148.83 37.76 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -58.73 -39.54 81.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.77 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -70.7 -9.58 57.51 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.72 9.84 63.0 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.2 t -62.99 -39.36 94.5 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 110.887 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 69.5 mmm -122.63 148.97 44.63 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.882 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.3 p -146.81 128.13 14.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.168 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -159.9 155.37 25.47 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -139.71 142.88 36.84 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.274 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.43 143.2 28.4 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.45 152.02 23.7 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.91 -172.44 41.52 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.48 142.15 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 122.974 0.51 . . . . 0.0 110.175 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -79.01 120.53 23.72 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.51 -42.77 58.33 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -168.57 148.31 4.46 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.838 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.57 136.56 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -136.03 124.11 22.95 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 m -59.2 130.65 48.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.162 -178.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.2 p30 40.98 57.67 2.7 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -157.77 -77.47 0.08 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 110.449 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.2 tp -149.68 133.88 17.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.738 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.437 HD11 ' HE1' ' A' ' 18' ' ' TRP . 61.5 mt -133.02 133.14 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -153.93 160.38 42.09 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -160.2 156.78 27.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.9 m -101.92 127.65 48.66 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.413 HG22 ' H ' ' A' ' 86' ' ' ASP . 86.7 mt -90.54 153.81 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.74 -41.96 67.23 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.413 ' H ' HG22 ' A' ' 84' ' ' ILE . 82.4 m-20 -60.26 -10.58 4.78 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.788 0.328 . . . . 0.0 110.17 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.0 8.81 86.12 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -68.82 150.71 47.51 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -101.89 129.29 48.1 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.8 t -139.77 131.03 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -138.94 141.75 38.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.2 mt -118.97 126.93 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.97 126.82 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -99.12 125.84 44.75 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.8 p -133.64 143.5 48.64 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -154.89 156.14 35.6 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.6 t -115.59 -24.11 8.45 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.973 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.1 -112.14 0.37 Allowed Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -76.77 10.78 2.01 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.613 0.244 . . . . 0.0 110.67 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.3 p -126.72 144.92 50.78 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.7 m -125.55 131.3 52.79 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.296 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -116.33 121.83 43.11 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.9 mt -102.51 128.98 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.9 t -119.26 133.56 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -137.94 146.08 42.8 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.0 p -133.33 148.84 51.9 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -143.31 143.14 31.57 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.547 0.863 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 . . . . . 0 CA--C 1.518 -0.254 0 CA-C-O 120.529 0.204 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -53.39 -44.42 68.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.876 0.37 . . . . 0.0 110.145 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.2 m -61.58 -40.94 96.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.255 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.97 -51.96 48.94 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -62.39 -37.72 86.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.015 0.436 . . . . 0.0 110.299 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -72.29 -35.77 68.78 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.256 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.91 -51.14 70.96 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.56 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.6 tt -63.06 -40.13 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 120.791 0.329 . . . . 0.0 110.136 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.2 mt -63.85 -38.86 92.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.4 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -61.99 -38.17 87.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.2 t -57.92 -32.79 68.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.762 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 52.7 t80 . . . . . 0 CA--C 1.534 0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.375 -179.88 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttp . . . . . 0 N--CA 1.466 0.354 0 CA-C-O 120.919 0.39 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 82.7 mt -58.94 131.19 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 t -137.0 149.73 47.67 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.9 m -136.85 158.39 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 161.7 40.31 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.587 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -148.96 143.04 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.886 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.7 m -94.26 119.41 33.01 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.5 t -124.87 128.03 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -95.65 92.47 6.62 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.91 154.52 5.26 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.23 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.89 135.76 57.49 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.339 -0.391 . . . . 0.0 109.956 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.8 tp -50.72 -40.79 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.141 0.496 . . . . 0.0 111.66 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -64.25 -35.27 80.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.551 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -70.54 -46.5 63.48 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.782 0.325 . . . . 0.0 110.424 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.26 -40.39 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.308 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.786 ' CH2' HD11 ' A' ' 80' ' ' ILE . 31.8 t-105 -54.53 -40.49 68.71 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.805 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -67.2 -52.8 36.74 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.278 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -64.84 -42.67 94.74 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.845 0.355 . . . . 0.0 110.885 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -64.13 -18.81 64.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.326 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.439 ' OD1' ' NE1' ' A' ' 18' ' ' TRP . 4.1 m120 -110.2 -25.49 10.14 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 122.845 0.458 . . . . 0.0 112.177 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -53.09 110.21 1.88 Allowed Pre-proline 0 CA--C 1.556 1.196 0 CA-C-O 118.837 -0.602 . . . . 0.0 109.765 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.61 -43.05 58.13 Favored 'Trans proline' 0 N--CA 1.506 2.208 0 CA-C-N 120.869 1.346 . . . . 0.0 111.837 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.57 73.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.949 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.537 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 80.6 t60 -74.15 -42.74 59.46 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.417 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.18 -44.74 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.872 -0.517 . . . . 0.0 110.498 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.8 ptm -70.95 -6.42 38.48 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -84.95 -29.59 24.99 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.537 ' HE1' ' CD2' ' A' ' 26' ' ' HIS . 63.3 p-90 -133.78 17.9 3.88 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.593 0.357 . . . . 0.0 110.954 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.59 ' C ' ' H ' ' A' ' 33' ' ' ALA . 32.1 p -45.85 128.95 9.26 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.063 0.392 . . . . 0.0 111.457 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 61.54 -11.02 0.06 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 120.982 0.42 . . . . 0.0 110.523 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.59 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 52.58 32.81 12.3 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.673 0.389 . . . . 0.0 111.24 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.5 t -122.8 135.74 26.07 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.011 0.524 . . . . 0.0 110.568 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.87 -9.96 16.86 Favored 'Trans proline' 0 N--CA 1.506 2.249 0 C-N-CA 122.097 1.865 . . . . 0.0 112.418 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -73.91 -24.74 59.73 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.728 0.299 . . . . 0.0 110.737 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -103.66 155.21 18.74 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.663 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -139.02 164.15 30.51 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.1 t -132.36 94.33 23.32 Favored Pre-proline 0 N--CA 1.477 0.925 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.29 -12.01 25.12 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.343 1.362 . . . . 0.0 111.211 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.8 150.8 4.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.418 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.59 141.74 20.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.227 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -138.0 142.07 40.42 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -163.13 135.55 5.35 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -129.86 104.0 7.13 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.64 93.71 1.27 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.914 0.388 . . . . 0.0 110.111 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -171.41 151.06 2.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.662 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.09 137.95 58.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.661 0.267 . . . . 0.0 110.453 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.31 0.74 47.65 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.85 149.44 44.68 Favored Glycine 0 N--CA 1.464 0.533 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.9 p -110.75 144.01 40.38 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -127.16 152.84 46.81 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.3 m -149.94 116.83 5.92 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.7 m -116.52 115.86 26.55 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.1 m -91.84 116.27 28.76 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 71.3 mtp -117.79 129.43 55.67 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.09 135.12 37.17 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.071 0.462 . . . . 0.0 110.57 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.7 149.92 49.38 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.309 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -55.93 -39.7 72.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.626 0.25 . . . . 0.0 110.463 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -76.38 -10.21 59.22 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.62 17.62 62.66 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.6 p -83.93 -9.97 58.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.617 0.246 . . . . 0.0 110.774 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.7 ttt -152.92 120.86 6.12 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.452 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.2 m -144.25 148.68 35.2 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -158.9 164.55 35.56 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 22.4 p-10 -137.08 123.33 20.56 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.804 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -94.11 145.92 24.34 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.05 153.68 25.12 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.27 -171.68 41.05 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -128.63 135.69 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -71.94 121.85 19.81 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -73.56 -38.44 65.2 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -163.05 145.42 10.29 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.508 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.1 t -137.97 130.5 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -146.88 123.8 11.33 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.6 p -51.71 121.92 7.31 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.211 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 54.28 62.02 2.77 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.28 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -156.04 -84.58 0.06 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.753 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 tp -148.42 136.24 20.81 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.771 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.786 HD11 ' CH2' ' A' ' 18' ' ' TRP . 75.2 mt -130.32 127.82 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -153.49 165.29 36.3 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -160.8 154.42 22.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.836 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.1 m -89.35 131.09 35.59 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 80.0 mt -102.27 148.82 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.88 -44.05 71.21 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.0 p30 -61.93 -18.69 61.18 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.367 0.584 . . . . 0.0 110.394 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.07 5.19 77.19 Favored Glycine 0 N--CA 1.47 0.954 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 65.6 mmt-85 -63.04 139.38 58.77 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -89.96 128.53 36.26 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.5 t -141.34 125.96 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -136.84 142.92 42.87 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 75.5 mt -119.86 118.94 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.8 t -104.2 124.29 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -96.15 122.43 38.99 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 36.4 m -140.36 146.62 38.65 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -150.74 164.63 35.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.2 t -137.85 23.51 2.85 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.292 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.12 129.65 2.82 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 55.49 12.02 0.7 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.816 0.341 . . . . 0.0 111.037 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.9 m -153.78 140.75 19.27 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.4 m -125.43 130.68 52.33 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.756 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -110.45 117.03 32.49 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.9 mt -106.85 122.21 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.04 139.56 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -144.98 142.76 30.08 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.048 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.4 p -94.23 152.7 18.5 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -151.49 139.74 20.31 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 N--CA 1.477 0.884 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.34 -179.156 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.51 HE21 ' C ' ' A' ' 118' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 119.978 -0.058 . . . . 0.0 110.888 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -57.42 -47.32 82.07 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.84 0.352 . . . . 0.0 110.06 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.0 m -64.04 -33.04 74.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.588 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.61 -50.46 67.53 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -62.45 -39.52 93.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.985 0.422 . . . . 0.0 110.429 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -71.91 -37.57 70.06 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.348 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.35 -50.69 72.75 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.836 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 42.0 pt -65.4 -32.75 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 110.734 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.2 -37.01 82.92 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -62.55 -41.56 98.98 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.08 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.9 p -62.52 -32.4 73.33 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.616 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.5 t80 . . . . . 0 N--CA 1.467 0.377 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.579 -179.547 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 pttm . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 121.194 0.521 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.3 mt -54.65 139.99 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 t -129.27 137.43 51.05 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.682 0.614 . . . . 0.0 109.718 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.61 158.08 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.41 158.0 43.8 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.558 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.9 p -146.14 144.78 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.673 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.9 m -97.58 120.79 38.6 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.94 127.5 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -91.7 93.96 9.15 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.8 151.52 3.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.09 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.43 140.44 58.87 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.664 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.7 tp -51.6 -37.22 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.169 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -68.94 -34.32 75.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.435 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -69.3 -50.58 45.44 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.903 0.382 . . . . 0.0 111.218 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -64.3 -36.19 76.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.62 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -58.29 -49.84 75.71 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.614 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -67.64 -45.83 74.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.641 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.45 ' CD2' ' ND1' ' A' ' 26' ' ' HIS . 56.2 t80 -63.88 -44.23 93.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.049 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.414 ' C ' HD22 ' A' ' 22' ' ' ASN . 64.0 t-105 -70.82 -19.65 62.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.626 HD22 ' N ' ' A' ' 22' ' ' ASN . 0.7 OUTLIER -103.05 -23.82 13.66 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.845 0.458 . . . . 0.0 111.437 -179.24 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -62.94 135.17 95.99 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.1 -40.67 0.81 Allowed 'Trans proline' 0 N--CA 1.504 2.142 0 C-N-CA 121.681 1.588 . . . . 0.0 111.745 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.83 -33.0 68.16 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.051 0.453 . . . . 0.0 110.78 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.45 ' ND1' ' CD2' ' A' ' 20' ' ' TYR . 35.5 m170 -76.4 -42.36 44.59 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.573 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.13 -44.93 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 122.161 -0.337 . . . . 0.0 110.804 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.512 ' O ' HG11 ' A' ' 39' ' ' VAL . 25.6 ptm -68.14 -10.64 55.66 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -79.7 -28.6 40.63 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.333 -0.23 . . . . 0.0 110.395 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -137.48 21.61 2.93 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.204 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.539 ' C ' ' H ' ' A' ' 33' ' ' ALA . 29.3 t -55.97 133.17 51.44 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.639 -0.663 . . . . 0.0 110.189 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 69.35 -32.08 0.22 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.108 0.563 . . . . 0.0 110.423 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.539 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 55.66 34.61 23.6 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.327 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.8 p -128.51 138.66 33.54 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.087 0.555 . . . . 0.0 110.033 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.48 -12.53 18.66 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.746 1.63 . . . . 0.0 112.239 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -76.25 -24.61 54.52 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -115.41 140.2 49.34 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.929 0.492 . . . . 0.0 110.545 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -117.33 163.79 15.81 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.251 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 39' ' ' VAL . 7.7 p -131.84 87.62 44.47 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.079 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.75 -8.2 14.59 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.053 1.835 . . . . 0.0 111.559 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.44 153.23 5.11 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.894 0.378 . . . . 0.0 110.055 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.99 152.88 5.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.961 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -141.28 155.52 45.98 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -159.25 103.05 1.61 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.019 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -95.59 86.98 4.58 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 tp -66.4 93.25 0.22 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.357 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -169.93 145.19 2.89 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.61 135.93 56.74 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.425 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.16 -1.05 35.76 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.96 162.28 52.69 Favored Glycine 0 N--CA 1.468 0.81 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.4 p -125.24 157.22 37.1 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.672 0.389 . . . . 0.0 110.262 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -138.16 157.03 47.11 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.318 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.0 m -146.93 116.01 6.92 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.9 m -106.99 112.62 25.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 m -92.88 120.08 32.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.7 ptm -143.14 142.12 31.39 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.79 152.73 40.78 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.028 0.442 . . . . 0.0 110.748 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.08 148.71 50.58 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.636 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -57.89 -39.32 77.58 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.591 0.234 . . . . 0.0 110.523 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -78.05 -6.06 53.41 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.78 17.51 54.57 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.1 p -66.37 -25.52 66.83 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.769 0.319 . . . . 0.0 110.389 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.2 ttt -149.09 145.34 27.18 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.916 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.7 t -142.7 144.85 32.89 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.737 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.408 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 71.1 t80 -159.35 162.53 35.91 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.408 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 30.3 p-10 -138.04 130.69 29.55 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.098 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -94.54 137.61 33.44 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.27 154.96 25.85 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.71 -176.03 40.41 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.4 t -126.24 133.26 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -75.44 115.49 15.15 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -73.85 -44.84 54.31 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.184 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -153.23 145.87 24.23 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 p -148.1 137.3 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -143.06 132.37 23.34 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.9 m -56.77 128.62 37.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.732 0.301 . . . . 0.0 111.453 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 54.88 69.38 0.74 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.767 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -165.84 -80.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -160.35 159.99 31.85 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.976 0.417 . . . . 0.0 110.795 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.9 mt -134.74 135.63 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.86 155.55 41.06 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -159.09 159.65 34.82 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 49.6 m -102.25 129.89 48.79 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.5 tt -94.57 167.1 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.91 -38.11 94.86 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -63.28 -16.77 61.34 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 117.184 0.492 . . . . 0.0 109.962 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.21 11.6 78.05 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -77.86 148.36 34.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -83.92 153.96 23.66 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.0 t -144.99 130.5 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -137.21 122.01 18.74 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.9 mt -122.46 113.93 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.4 p -118.82 131.75 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-O 121.279 0.561 . . . . 0.0 110.034 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -97.13 109.21 22.01 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 61.3 m -98.22 122.95 42.01 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -101.8 146.73 27.38 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.3 m -146.62 99.32 3.19 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.411 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.89 -95.43 0.04 OUTLIER Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -128.56 48.4 2.32 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.006 0.431 . . . . 0.0 110.587 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.6 m -161.35 119.22 2.33 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.0 m -95.27 141.09 29.26 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -127.45 129.48 47.57 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.2 mt -103.07 125.53 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.7 t -122.68 127.83 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -142.92 144.62 32.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.23 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.8 t -136.11 143.11 44.38 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.079 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -127.57 169.19 13.99 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.671 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.473 0.681 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.722 179.143 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 . . . . . 0 CA--C 1.52 -0.193 0 CA-C-O 120.648 0.261 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -54.13 -44.43 71.35 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.805 0.336 . . . . 0.0 110.299 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 78.8 p -68.28 -35.9 78.56 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.83 -51.99 51.6 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -64.22 -37.08 86.21 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.816 0.341 . . . . 0.0 110.421 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -72.4 -37.43 68.7 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.461 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.99 67.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.909 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.5 tt -60.89 -36.96 75.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.8 mt -66.19 -49.1 68.46 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.467 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -75.78 -33.71 60.19 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.664 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.0 m -60.54 -40.34 91.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.32 . . . . 0.0 110.399 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.2 t80 . . . . . 0 N--CA 1.467 0.391 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.512 -179.482 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.8 tttt . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 79.5 mt -46.14 121.28 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 m -112.89 130.7 56.01 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 m -134.48 156.59 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.406 ' CD ' ' N ' ' A' ' 7' ' ' GLU . 1.3 pm0 -148.3 161.29 41.82 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.14 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -145.05 143.84 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.1 m -91.17 117.29 29.5 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.8 t -124.65 128.36 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -100.16 88.57 3.75 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.74 153.59 5.01 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.048 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.12 133.28 52.67 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 20.1 tt -52.25 -37.53 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.776 0.322 . . . . 0.0 111.733 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -58.96 -35.58 73.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.356 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -74.92 -46.07 38.29 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.022 0.439 . . . . 0.0 110.442 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.09 -43.28 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.189 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.698 ' CH2' HD11 ' A' ' 80' ' ' ILE . 28.0 t-105 -54.86 -46.09 74.65 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.84 0.352 . . . . 0.0 110.943 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.78 -45.85 77.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.335 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -65.19 -43.75 90.61 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.894 0.378 . . . . 0.0 111.166 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -69.5 -15.96 63.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.561 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -109.52 -24.64 10.89 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.274 0.63 . . . . 0.0 111.298 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -65.09 117.23 37.43 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.499 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.97 -34.59 10.33 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 CA-C-N 121.033 1.405 . . . . 0.0 112.005 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -34.22 70.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.002 0.429 . . . . 0.0 110.575 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -81.17 -40.89 23.21 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.405 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.9 -45.4 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 122.069 -0.394 . . . . 0.0 111.088 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.7 ptm -59.32 -12.85 6.35 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.335 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -81.32 -39.71 24.72 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -120.22 20.76 11.95 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.654 0.381 . . . . 0.0 111.183 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.606 ' C ' ' H ' ' A' ' 33' ' ' ALA . 12.9 t -57.54 135.82 56.68 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.829 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 67.83 -26.29 0.13 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.612 0.57 . . . . 0.0 110.327 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.606 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 55.5 27.33 10.09 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.565 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.1 t -124.06 139.92 33.64 Favored Pre-proline 0 N--CA 1.478 0.93 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.253 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.54 -8.9 19.8 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 121.95 1.767 . . . . 0.0 111.668 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -83.16 9.26 10.92 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.622 0.249 . . . . 0.0 110.668 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -151.72 157.72 42.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.242 0.544 . . . . 0.0 110.072 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -147.58 163.5 36.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.105 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.57 93.14 48.69 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 123.023 0.529 . . . . 0.0 109.853 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.46 -8.79 19.81 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.488 1.459 . . . . 0.0 111.597 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.72 151.99 9.56 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.844 0.354 . . . . 0.0 110.228 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.02 144.94 14.96 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.247 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -137.59 145.11 42.41 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -162.03 134.02 5.57 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.853 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -132.99 99.42 4.57 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.5 96.58 0.53 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -166.62 147.77 6.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.09 137.55 58.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.1 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.78 5.19 44.41 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.89 151.54 33.87 Favored Glycine 0 N--CA 1.466 0.655 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.1 p -113.42 161.46 17.28 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -143.51 166.03 25.93 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.215 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.3 m -160.49 128.61 4.6 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.1 m -122.78 123.4 40.96 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -92.35 115.65 28.28 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.3 mtt -120.68 132.43 55.09 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.43 136.15 23.21 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.794 0.331 . . . . 0.0 110.699 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.66 148.77 45.39 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -58.58 -39.54 80.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.723 0.297 . . . . 0.0 110.32 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -74.16 -11.38 60.28 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.25 17.12 67.85 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.4 m -61.89 -40.46 95.5 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.847 0.356 . . . . 0.0 110.725 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 44.4 ttp -147.1 149.55 33.25 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.187 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.1 t -145.04 152.35 39.98 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.329 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -156.5 155.5 32.09 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -138.24 131.11 29.71 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.872 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -95.81 145.36 25.4 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.97 153.31 24.91 Favored Glycine 0 N--CA 1.466 0.65 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -179.09 -171.14 41.93 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.46 145.89 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -82.87 126.12 32.11 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -81.74 -26.9 34.16 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 110.035 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -167.59 140.27 3.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.839 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.5 t -137.24 126.92 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -145.66 124.72 12.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.0 m -50.07 119.57 3.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 53.67 75.8 0.25 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.443 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -168.16 -81.31 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.365 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.435 HD11 ' HE ' ' A' ' 91' ' ' ARG . 7.1 tp -149.94 135.03 17.95 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.902 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.698 HD11 ' CH2' ' A' ' 18' ' ' TRP . 79.0 mt -128.69 130.02 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -153.09 165.35 35.89 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -158.77 164.54 35.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.511 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.6 m -116.26 129.77 56.45 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.7 mm -98.37 149.16 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.961 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.72 -40.39 71.04 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -60.96 -15.8 35.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.656 0.265 . . . . 0.0 110.503 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.4 -2.85 59.35 Favored Glycine 0 N--CA 1.473 1.138 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -64.96 143.77 57.73 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -123.66 139.88 53.55 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.6 t -133.57 134.67 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.435 ' HE ' HD11 ' A' ' 79' ' ' LEU . 77.0 ttt180 -127.51 122.72 34.11 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 68.7 mt -110.78 124.1 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.8 123.21 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -94.98 123.29 38.37 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.9 p -134.06 150.69 51.21 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -154.38 164.4 38.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.902 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 m -149.5 118.53 6.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.753 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.09 -94.47 0.07 OUTLIER Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -130.99 31.77 4.41 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.666 0.386 . . . . 0.0 111.015 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 46.4 m -132.16 124.85 29.89 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.8 m -100.86 133.46 45.3 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -122.37 117.53 26.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.9 mt -98.01 129.04 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.48 130.84 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -132.63 120.07 21.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.0 t -99.22 148.2 24.36 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -136.01 149.92 49.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.0 t70 . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.445 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 120.531 0.205 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -55.23 -43.48 74.56 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.084 0.469 . . . . 0.0 109.771 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.4 m -62.23 -40.73 97.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.165 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.15 -51.99 48.23 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -63.35 -37.25 86.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.78 0.324 . . . . 0.0 110.277 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -72.1 -36.24 69.41 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.683 0.278 . . . . 0.0 110.338 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.25 70.69 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.789 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.6 tt -62.62 -39.23 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 25.5 mt -63.87 -39.14 93.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -63.89 -40.95 97.7 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m -58.37 -30.65 66.95 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.344 0.403 . . . . 0.0 111.232 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 63.9 t80 . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 120.933 0.397 . . . . 0.0 110.898 -178.589 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -64.34 -25.98 68.28 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 121.012 0.434 . . . . 0.0 110.269 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -71.81 55.45 0.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.95 0.405 . . . . 0.0 110.082 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 82.0 mt -55.42 132.49 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -130.31 139.11 50.74 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.4 m -136.15 156.38 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -145.24 157.48 44.06 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.038 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 p -145.81 142.78 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.9 p -97.18 117.34 31.17 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.55 126.12 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -93.64 88.73 5.96 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.09 0.471 . . . . 0.0 109.863 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.88 153.12 4.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.055 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.74 139.3 58.67 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.221 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.5 tp -51.07 -36.79 16.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 120.893 0.378 . . . . 0.0 111.612 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -67.66 -33.1 74.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.44 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -71.17 -51.32 25.53 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.3 p -65.3 -36.59 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.318 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.758 ' CH2' HD11 ' A' ' 80' ' ' ILE . 29.1 t-105 -54.61 -43.41 72.18 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.932 0.396 . . . . 0.0 110.56 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -68.37 -45.33 73.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.622 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -65.71 -44.42 86.14 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.902 0.382 . . . . 0.0 111.497 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -66.75 -20.7 66.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.932 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -102.63 -22.56 13.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.982 0.513 . . . . 0.0 111.512 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -64.16 123.02 80.96 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.93 -39.74 3.07 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 CA-C-N 120.863 1.344 . . . . 0.0 111.889 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.11 -39.21 71.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.894 0.378 . . . . 0.0 110.759 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.9 m170 -66.33 -42.86 87.57 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.64 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 31' ' ' CYS . 97.2 mt -62.61 -43.75 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 93.5 mtp -59.31 -13.45 8.06 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.737 -0.21 . . . . 0.0 111.077 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -85.14 -38.56 18.91 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 121.978 -0.451 . . . . 0.0 110.759 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 62.8 p-90 -122.4 23.74 9.58 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.729 0.412 . . . . 0.0 111.216 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.552 ' C ' ' H ' ' A' ' 33' ' ' ALA . 38.3 t -54.39 129.37 35.4 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.804 -0.56 . . . . 0.0 110.958 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tp60 68.54 -30.67 0.18 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.341 0.401 . . . . 0.0 110.478 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.65 38.37 29.85 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.048 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 86.7 p -136.81 141.46 35.15 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.302 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.39 -16.41 21.87 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 122.008 1.805 . . . . 0.0 112.289 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -84.06 14.1 4.48 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -151.41 154.81 37.36 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.171 0.51 . . . . 0.0 110.232 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -142.5 163.01 33.99 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.234 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 39' ' ' VAL . 7.1 p -127.58 89.57 50.72 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.97 -12.22 23.74 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.263 1.309 . . . . 0.0 111.479 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -171.91 153.05 3.13 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 121.02 0.438 . . . . 0.0 110.577 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -157.84 150.72 22.92 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.214 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -137.08 145.33 43.82 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.591 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -161.46 132.32 5.22 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.96 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -128.98 96.01 4.23 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 62.0 tp -65.8 96.65 0.3 Allowed 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -167.67 142.31 3.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.964 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.55 138.19 58.41 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.23 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.27 2.44 59.12 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.9 166.49 37.29 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.8 p -129.14 164.95 22.24 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.639 0.376 . . . . 0.0 110.047 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -140.71 164.52 29.98 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.6 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 36.1 m -150.61 122.56 8.19 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.421 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 37.5 m -116.39 116.57 27.94 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.2 m -95.11 119.68 34.04 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 14.8 ptm -145.67 144.83 30.64 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.75 156.15 40.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.061 0.458 . . . . 0.0 110.535 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.81 148.05 40.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.666 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -56.58 -39.87 74.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.763 0.315 . . . . 0.0 110.721 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -76.37 -7.46 55.05 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.18 11.32 67.13 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.5 t -62.93 -41.84 99.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.45 0.167 . . . . 0.0 111.097 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.9 ttt -120.85 146.32 46.7 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -144.11 141.25 29.9 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.81 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.438 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 56.4 t80 -159.98 161.26 34.1 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.438 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 67.4 t0 -138.54 126.56 22.59 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -94.76 135.54 36.13 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.66 155.74 26.5 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.05 -171.4 41.39 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 p -128.72 139.67 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.785 0.434 . . . . 0.0 110.008 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -78.36 124.96 28.69 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -75.85 -40.01 55.55 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.926 0.393 . . . . 0.0 110.09 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -159.83 146.03 15.93 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.844 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.2 t -135.69 130.69 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -145.4 123.61 12.21 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.4 m -55.12 122.28 10.65 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.9 m120 54.79 60.54 3.44 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.608 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -156.12 -82.31 0.07 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.089 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.6 tp -147.76 136.8 22.15 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.554 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.758 HD11 ' CH2' ' A' ' 18' ' ' TRP . 69.7 mt -129.79 126.78 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -154.16 164.18 38.92 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -155.05 154.98 33.3 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.941 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.1 m -87.58 129.53 35.07 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.78 139.87 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.66 -43.21 59.43 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -60.72 -18.56 55.09 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.633 0.254 . . . . 0.0 110.73 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.31 0.67 65.13 Favored Glycine 0 N--CA 1.472 1.091 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -60.71 168.64 2.17 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -125.19 118.38 25.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.789 0.436 . . . . 0.0 110.126 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.3 t -131.96 125.12 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -135.24 136.63 41.86 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.0 mt -112.48 111.52 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.9 t -97.36 128.33 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -98.61 122.15 41.45 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.268 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.1 m -144.75 149.67 35.93 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -142.14 129.16 20.78 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 19.7 m -63.89 -45.8 87.71 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-O 121.135 0.493 . . . . 0.0 109.968 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.09 -69.43 0.08 OUTLIER Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -102.07 10.04 39.83 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.753 0.421 . . . . 0.0 110.963 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 54.7 m -147.18 129.88 16.06 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.2 m -86.65 140.21 30.03 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -120.47 116.69 25.93 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.6 mt -96.19 124.79 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -120.34 128.35 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -142.0 125.43 16.65 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 120.858 0.361 . . . . 0.0 110.541 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 92.4 p -94.88 150.99 19.59 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -134.47 149.96 50.77 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -102.36 96.95 7.86 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.123 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -76.51 155.84 36.2 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.898 1.732 . . . . 0.0 112.293 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -82.06 157.03 24.29 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.951 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -79.17 -35.12 42.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.526 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 62.0 p -64.91 -44.72 88.64 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.9 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -87.44 142.87 33.45 Favored Pre-proline 0 N--CA 1.474 0.77 0 CA-C-O 119.457 -0.306 . . . . 0.0 110.551 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -69.93 137.87 35.96 Favored 'Trans proline' 0 N--CA 1.506 2.261 0 C-N-CA 121.573 1.515 . . . . 0.0 111.95 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -64.66 -39.92 94.53 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.689 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -50.96 -46.31 61.1 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.415 ' N ' ' CD2' ' A' ' 117' ' ' LEU . 3.6 mm? -62.97 -50.81 69.3 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 118' ' ' GLN . 6.4 pt20 -72.14 -33.2 67.6 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.111 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -59.26 -47.68 84.46 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.5 t -68.94 -25.2 64.44 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.278 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.59 -51.87 48.17 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -62.01 -38.14 87.54 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.902 0.382 . . . . 0.0 110.396 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -70.76 -37.08 73.38 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.723 0.297 . . . . 0.0 110.38 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.11 -51.62 69.24 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.795 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.0 tt -63.66 -37.68 80.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.702 0.287 . . . . 0.0 110.381 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.9 mt -63.45 -37.13 86.1 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -60.92 -30.95 70.51 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.562 0.22 . . . . 0.0 110.877 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.7 m -56.15 -35.48 67.21 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.665 0.269 . . . . 0.0 110.968 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -61.67 -43.79 98.19 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -62.57 -44.72 95.62 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 48.7 m -61.05 -37.5 82.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.558 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.405 ' O ' ' ND2' ' A' ' 135' ' ' ASN . 68.3 t80 -61.52 -47.68 84.52 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.444 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 70.4 p -63.48 -32.52 73.99 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.919 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.404 ' C ' ' H ' ' A' ' 136' ' ' ASN . 77.1 tt0 -58.15 -14.01 6.05 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.283 0.563 . . . . 0.0 110.246 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.553 ' N ' HD22 ' A' ' 135' ' ' ASN . 0.1 OUTLIER -59.4 -4.93 0.66 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.149 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 138' ' ' GLU . 12.7 m120 -62.58 -16.09 54.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.629 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 67.5 tp 57.6 -78.66 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.785 0.678 . . . . 0.0 110.34 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 136' ' ' ASN . 92.1 mt-10 -58.85 -40.85 85.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.168 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.413 ' O ' ' CG ' ' A' ' 139' ' ' HIS . 56.0 t-80 53.8 17.84 1.4 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.653 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -60.89 145.28 50.8 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.341 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -155.47 146.84 22.81 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.085 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -82.48 118.69 23.42 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 77.9 m80 53.06 -88.45 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.017 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 67.6 m80 . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.541 -179.865 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.494 2.532 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 56.23 -81.52 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 110.782 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 1' ' ' GLY . 67.6 mttm -73.92 53.77 0.48 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.1 mt -48.45 138.47 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 t -135.69 138.73 43.08 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.7 m -139.14 157.35 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -147.95 159.92 43.37 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.322 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 p -145.82 142.39 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.1 m -97.29 118.25 33.34 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.36 128.16 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -93.69 85.41 4.85 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.45 153.01 3.39 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.981 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.86 135.51 55.82 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.0 tt -54.52 -32.12 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.673 0.273 . . . . 0.0 111.29 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -60.35 -39.72 88.15 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.265 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 66.5 tttm -73.12 -47.61 42.66 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.38 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.64 -43.38 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.094 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.791 ' CH2' HD11 ' A' ' 80' ' ' ILE . 22.4 t-105 -54.76 -38.16 66.87 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.889 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.58 -53.33 56.19 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.799 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -69.67 -40.29 76.49 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.545 0.212 . . . . 0.0 111.398 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -59.94 -17.46 37.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.892 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.579 HD22 ' N ' ' A' ' 22' ' ' ASN . 0.8 OUTLIER -115.72 -28.18 6.83 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.165 0.586 . . . . 0.0 112.011 -179.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -54.76 107.5 0.88 Allowed Pre-proline 0 N--CA 1.477 0.881 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.941 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.56 -42.49 64.81 Favored 'Trans proline' 0 N--CA 1.508 2.38 0 CA-C-N 121.097 1.427 . . . . 0.0 112.296 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.98 -28.45 66.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.479 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -79.8 -37.66 34.7 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.705 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.24 -44.91 99.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.641 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.5 ptp -54.46 -21.52 10.14 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 120.694 0.283 . . . . 0.0 111.66 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -73.15 -39.49 65.63 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.811 -0.555 . . . . 0.0 111.528 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -124.31 21.72 8.68 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.74 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.522 ' C ' ' H ' ' A' ' 33' ' ' ALA . 17.9 t -60.58 134.25 56.89 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.817 -0.552 . . . . 0.0 110.315 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 69.43 -33.9 0.26 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.998 0.811 . . . . 0.0 110.519 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 53.78 21.57 2.78 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.927 0.394 . . . . 0.0 110.577 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.5 m -108.54 110.13 61.47 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.573 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -51.54 -27.97 26.96 Favored 'Trans proline' 0 N--CA 1.513 2.658 0 C-N-CA 122.112 1.875 . . . . 0.0 112.782 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -74.75 5.33 5.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.656 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -146.89 156.48 43.12 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.415 ' CE1' ' O ' ' A' ' 57' ' ' ALA . 45.8 p-80 -144.1 163.65 32.95 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 39' ' ' VAL . 7.3 p -121.55 94.8 48.44 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 122.886 0.474 . . . . 0.0 109.915 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.32 -8.46 17.38 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 121.265 1.31 . . . . 0.0 111.782 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.88 154.39 6.29 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -167.03 150.66 6.66 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -146.39 146.17 30.53 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -164.52 135.97 4.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.47 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -125.45 101.58 7.0 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 tp -65.73 95.79 0.25 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -169.26 141.91 2.62 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.75 137.92 58.15 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.346 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.32 0.86 48.45 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.02 153.94 36.68 Favored Glycine 0 N--CA 1.467 0.751 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 p -105.22 158.25 16.73 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 120.871 0.367 . . . . 0.0 110.058 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -145.08 154.48 42.53 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.882 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.9 m -151.73 129.88 11.92 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.2 m -123.09 121.48 36.13 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.8 m -94.74 117.35 29.98 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 68.1 mtm -130.89 140.87 50.26 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.415 ' O ' ' CE1' ' A' ' 38' ' ' HIS . . . -147.6 147.4 30.01 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.132 0.491 . . . . 0.0 110.725 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.85 148.38 51.26 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.455 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -55.43 -40.19 71.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.639 0.257 . . . . 0.0 110.515 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.58 -11.24 59.98 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.12 21.21 63.63 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.7 m -80.95 -12.97 59.3 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.705 0.288 . . . . 0.0 110.674 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.1 ttt -160.59 135.31 7.53 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.8 p -145.07 162.39 37.09 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.995 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.485 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 52.8 t80 -159.28 163.68 35.55 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.485 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 73.9 m-20 -137.88 123.65 19.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -95.29 141.22 29.13 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.04 152.71 24.26 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.95 -171.73 42.48 Favored Glycine 0 CA--C 1.517 0.174 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.76 137.54 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -70.06 120.88 16.42 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.72 -40.9 63.23 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -164.89 148.08 8.57 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.0 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.8 p -145.86 138.56 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -143.6 130.62 20.59 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.5 m -55.11 121.15 8.14 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.581 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.0 m120 51.62 72.43 0.38 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -168.74 -79.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.378 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.1 tp -148.53 136.72 21.09 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.498 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.791 HD11 ' CH2' ' A' ' 18' ' ' TRP . 75.3 mt -129.82 129.47 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -154.21 165.07 37.44 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -154.5 155.18 34.39 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.7 m -87.52 129.35 35.11 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.5 139.51 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 110.035 -0.358 . . . . 0.0 110.035 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.63 -40.84 56.17 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -61.3 -17.8 55.41 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.49 3.52 71.7 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -64.11 165.44 9.16 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -121.95 121.98 38.31 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.955 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.92 129.11 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.56 138.7 43.26 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 73.4 mt -113.36 118.32 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.7 t -105.9 122.73 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.14 125.16 44.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 74.0 p -132.15 150.91 52.04 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -154.63 147.43 24.4 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.8 p -105.77 -19.47 13.74 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 169.87 -107.88 0.28 Allowed Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -81.44 7.41 11.89 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.397 0.279 . . . . 0.0 110.69 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.6 m -128.23 124.67 37.25 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.6 m -101.89 135.25 43.77 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -119.09 119.48 34.34 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.5 mt -99.75 127.32 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.87 130.32 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -142.36 144.83 33.36 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.5 t -111.69 149.31 31.78 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -143.12 141.4 31.21 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -97.53 120.41 60.75 Favored Pre-proline 0 N--CA 1.481 1.087 0 CA-C-O 118.637 -0.697 . . . . 0.0 110.229 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.89 151.42 35.62 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 CA-C-N 121.216 1.47 . . . . 0.0 111.472 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.6 mp0 -79.97 167.18 20.81 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -71.54 -50.01 35.31 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.606 0.241 . . . . 0.0 110.465 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.9 m -63.01 -45.95 89.97 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.504 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.426 ' ND2' HE21 ' A' ' 118' ' ' GLN . 0.4 OUTLIER -80.99 131.91 58.43 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.313 -178.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.73 146.47 48.61 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 121.25 1.3 . . . . 0.0 111.701 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -61.89 -38.75 89.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.4 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -51.1 -46.68 61.92 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.448 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.38 -43.66 96.94 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.755 0.312 . . . . 0.0 110.188 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.426 HE21 ' ND2' ' A' ' 113' ' ' ASN . 97.2 mm-40 -61.5 -53.86 50.81 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.651 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.9 tm0? -54.66 -47.81 73.11 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.0 t -61.82 -42.34 98.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.109 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.38 -51.73 56.08 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.563 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -62.5 -39.37 93.29 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.863 0.331 . . . . 0.0 110.558 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -70.98 -37.06 72.74 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.67 -52.54 64.51 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.762 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.4 tt -66.87 -36.75 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.372 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.9 mt -60.06 -41.94 93.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.187 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.406 ' OD1' ' N ' ' A' ' 128' ' ' SER . 25.8 p30 -66.4 -30.61 71.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.537 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.406 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 21.9 p -61.03 -37.74 83.66 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.864 0.364 . . . . 0.0 110.654 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -59.52 -41.76 90.71 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.446 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -60.33 -43.49 96.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 97.7 p -61.33 -38.84 88.36 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.794 0.331 . . . . 0.0 110.324 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -62.21 -45.36 93.73 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.393 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 99.2 m -59.08 -49.42 77.96 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.715 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.54 -36.79 84.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.821 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -64.47 -36.83 85.45 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.266 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -62.34 -35.69 79.9 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.206 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 38.7 mt 57.56 -171.81 0.09 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.975 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 54.07 14.95 0.78 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.948 0.404 . . . . 0.0 110.517 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -67.91 139.59 56.46 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.445 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -67.75 142.69 56.19 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -164.25 138.2 5.42 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -162.49 154.33 18.48 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 52.29 84.33 0.05 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.141 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 118.134 -0.936 . . . . 0.0 110.72 179.929 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.608 ' H3 ' ' NH2' ' A' ' 115' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -63.24 -40.43 97.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.841 0.353 . . . . 0.0 110.324 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -72.53 52.89 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.1 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.2 mt -50.83 143.4 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 t -133.42 139.47 46.77 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.7 m -138.88 159.68 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -147.81 157.15 43.4 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.591 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.58 144.32 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 m -101.32 119.24 38.46 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.8 t -124.71 131.33 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -93.09 89.3 6.42 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.82 151.55 4.22 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.293 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.17 130.14 43.33 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.4 tt -52.58 -33.31 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.577 0.227 . . . . 0.0 111.28 -179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.1 tp10 -60.16 -41.34 92.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.622 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -72.44 -46.55 54.49 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.864 0.364 . . . . 0.0 110.033 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.28 -43.02 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.613 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -55.91 -43.88 77.74 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.787 0.327 . . . . 0.0 110.744 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 23' ' ' GLU . 88.5 tttt -67.82 -47.52 68.81 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.588 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.36 -43.09 95.63 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.697 0.284 . . . . 0.0 111.382 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -61.7 -20.71 63.78 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -106.99 -23.03 12.47 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.134 0.574 . . . . 0.0 111.293 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 19' ' ' LYS . 28.5 tp10 -62.74 122.94 77.41 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 118.703 -0.665 . . . . 0.0 109.54 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.6 -38.61 5.76 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 CA-C-N 120.923 1.365 . . . . 0.0 111.607 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.67 -38.71 78.79 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.989 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.538 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 66.9 t60 -65.64 -44.01 87.73 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.56 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.69 -44.87 99.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 42' ' ' ALA . 1.2 mtm -62.99 -0.02 0.63 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -99.95 -50.25 4.07 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.538 ' HE1' ' CD2' ' A' ' 26' ' ' HIS . 68.6 p-90 -102.74 -3.67 26.13 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 31' ' ' CYS . 24.8 p -67.51 72.06 0.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.437 0.637 . . . . 0.0 110.009 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 30' ' ' TRP . 23.7 pt20 -153.18 48.74 0.7 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.05 -7.44 3.96 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.692 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.3 t -148.6 138.04 12.41 Favored Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.13 -11.9 23.32 Favored 'Trans proline' 0 N--CA 1.506 2.23 0 C-N-CA 121.71 1.607 . . . . 0.0 112.425 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -84.74 14.99 4.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.024 0.44 . . . . 0.0 110.17 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -146.57 146.69 30.55 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 120.975 0.417 . . . . 0.0 110.228 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -130.52 162.68 28.7 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.617 ' O ' HG13 ' A' ' 39' ' ' VAL . 8.2 p -114.03 95.17 37.27 Favored Pre-proline 0 N--CA 1.475 0.784 0 C-N-CA 122.69 0.396 . . . . 0.0 110.585 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.79 -19.48 14.22 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 CA-C-N 120.346 1.159 . . . . 0.0 111.29 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -178.56 160.03 1.2 Allowed 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.4 0.438 . . . . 0.0 110.212 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.519 ' HB3' ' SD ' ' A' ' 28' ' ' MET . . . -156.41 148.81 23.48 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.135 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -136.05 146.13 46.76 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -156.02 104.23 2.27 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.691 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -98.28 86.42 3.65 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.97 93.22 0.11 Allowed 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.328 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -169.5 143.77 2.86 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.16 137.13 58.08 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.273 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.51 1.51 37.3 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.14 159.35 43.22 Favored Glycine 0 N--CA 1.468 0.808 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.7 m -119.3 155.89 31.01 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.007 0.432 . . . . 0.0 109.919 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -135.9 163.41 30.3 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.388 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.8 m -151.12 115.37 5.06 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.656 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.1 m -115.1 119.94 38.13 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 m -94.8 125.11 39.24 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.5 mtt -130.77 106.14 8.26 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -118.89 144.69 46.26 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.022 0.439 . . . . 0.0 110.769 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.83 148.28 50.49 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -57.99 -40.34 80.44 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.719 0.295 . . . . 0.0 110.386 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -76.18 -9.16 58.42 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.039 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.99 13.88 62.52 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.2 t -65.69 -19.89 66.08 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.988 0.423 . . . . 0.0 110.62 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.0 ttt -148.16 145.89 28.51 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.878 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.8 t -143.35 139.11 29.91 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.427 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 62.9 t80 -159.84 158.82 31.68 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.427 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 29.4 p-10 -138.9 134.16 32.87 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.39 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.02 139.63 31.1 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.38 152.36 24.07 Favored Glycine 0 N--CA 1.465 0.605 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.69 -174.12 41.13 Favored Glycine 0 CA--C 1.517 0.167 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -128.12 136.58 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -74.52 118.8 17.88 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.11 -37.01 69.6 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -165.09 149.2 8.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.732 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.02 131.91 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -143.64 122.14 12.44 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.5 m -59.45 123.9 18.3 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.91 0.386 . . . . 0.0 111.964 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.9 m120 52.4 59.41 4.53 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.021 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -157.27 -76.6 0.09 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.467 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 tp -152.94 135.26 15.01 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.1 mt -131.33 130.6 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -152.2 164.88 36.44 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -157.95 157.25 32.71 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.6 m -107.96 130.73 55.02 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.8 mm -93.86 151.55 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.78 -39.6 68.28 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -63.28 -11.91 25.31 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.956 0.378 . . . . 0.0 110.648 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.86 -2.13 61.77 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -72.44 152.02 42.22 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.493 ' NZ ' ' NH2' ' A' ' 91' ' ' ARG . 88.4 tttt -136.43 152.05 50.17 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -136.41 120.58 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.289 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.493 ' NH2' ' NZ ' ' A' ' 89' ' ' LYS . 87.4 mtt-85 -101.66 130.68 48.07 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 66.9 mt -118.42 125.07 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.4 t -115.48 124.34 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -100.4 123.44 44.63 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.1 m -122.73 124.37 43.21 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -100.73 121.57 41.88 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.5 p -105.78 8.83 33.02 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.99 122.63 0.66 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 58.32 9.9 1.16 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.715 0.293 . . . . 0.0 110.905 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.7 m -160.17 119.63 2.8 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 67.9 m -98.01 136.8 37.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -119.26 121.55 39.9 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.7 mt -100.4 123.74 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.7 t -123.95 126.68 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -143.56 145.96 32.94 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.329 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 78.3 p -126.14 148.3 49.42 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -122.45 162.45 21.66 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -129.43 77.97 76.48 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.72 170.21 20.3 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.976 1.784 . . . . 0.0 111.512 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -62.15 151.28 36.27 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.19 0.519 . . . . 0.0 110.635 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -70.02 -42.76 72.54 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.604 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.2 t -63.86 -34.45 77.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.579 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -65.73 148.69 98.06 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.3 108.74 2.57 Favored 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 121.961 1.774 . . . . 0.0 111.443 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.608 ' NH2' ' H3 ' ' A' ' 1' ' ' GLY . 8.8 ptm180 -68.28 -25.22 65.05 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.065 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -58.95 -50.75 72.87 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.681 0.277 . . . . 0.0 111.147 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.1 mt -64.87 -38.58 91.43 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.844 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -60.9 -45.05 96.14 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.52 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -54.12 -46.21 72.11 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.973 0.416 . . . . 0.0 109.929 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.9 t -66.77 -38.83 87.35 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.248 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.03 -52.04 54.73 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.683 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -64.47 -35.96 82.62 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.776 0.322 . . . . 0.0 110.151 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -72.81 -37.1 67.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.691 0.281 . . . . 0.0 110.432 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.11 -50.55 73.09 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 9.0 tt -62.27 -37.99 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 53.5 mt -63.57 -42.58 98.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -65.33 -39.29 92.21 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.3 t -58.38 -33.39 69.55 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -53.03 -25.28 11.87 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.883 0.373 . . . . 0.0 110.904 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -64.12 -38.91 92.77 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.632 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.9 t -58.14 -45.44 87.38 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.708 0.289 . . . . 0.0 110.395 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -64.18 -45.11 89.81 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.328 -0.396 . . . . 0.0 109.971 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.4 m -62.53 -40.59 97.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.842 0.353 . . . . 0.0 110.703 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -69.54 6.68 1.02 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.02 0.438 . . . . 0.0 110.713 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -59.81 -9.68 3.11 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.695 0.283 . . . . 0.0 110.499 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -83.36 8.16 14.48 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.423 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.94 -44.34 96.96 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.984 0.421 . . . . 0.0 110.069 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -164.85 142.45 6.28 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.052 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 43.1 p-80 -163.87 150.45 11.68 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.708 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -170.16 61.44 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 52.18 -169.22 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.724 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.438 ' O ' ' N ' ' A' ' 144' ' ' HIS . 37.1 p-80 -170.35 93.92 0.22 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 55.46 -83.66 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.922 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 142' ' ' HIS . 95.4 m-70 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.937 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -72.25 -7.4 49.13 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.143 0.497 . . . . 0.0 110.438 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -77.88 51.06 0.91 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.517 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.8 mt -69.98 140.57 18.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 t -137.28 160.07 40.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.35 166.71 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.3 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -147.36 158.66 44.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.076 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.0 p -149.45 144.99 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.75 121.67 44.5 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 m -128.97 137.38 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -94.82 89.7 5.77 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.98 150.86 3.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.957 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 128.54 36.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.766 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.2 tt -53.36 -36.24 26.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.632 0.254 . . . . 0.0 110.998 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -57.86 -42.27 84.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.673 0.273 . . . . 0.0 110.592 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -69.93 -47.03 64.0 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.392 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.0 t -62.33 -40.38 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.515 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.429 ' O ' ' ND2' ' A' ' 22' ' ' ASN . 66.5 t90 -54.07 -39.76 66.57 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.741 0.305 . . . . 0.0 111.345 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -63.26 -51.03 67.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.954 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -68.89 -37.25 78.87 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.965 0.412 . . . . 0.0 110.684 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 70.3 t-105 -61.01 -18.56 58.36 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.853 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 18' ' ' TRP . 81.4 m-20 -115.56 -26.44 7.49 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.155 0.582 . . . . 0.0 110.908 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -50.64 108.73 1.09 Allowed Pre-proline 0 CA--C 1.555 1.145 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.172 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.19 -43.4 57.54 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 CA-C-N 120.512 1.218 . . . . 0.0 112.835 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.86 -30.75 69.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.556 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -79.28 -38.98 34.1 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.186 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' A' ' 31' ' ' CYS . 98.2 mt -61.93 -45.38 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 O-C-N 121.964 -0.46 . . . . 0.0 110.657 -177.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 20.5 ptp -61.73 -17.78 57.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.252 0.549 . . . . 0.0 111.251 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -74.96 -29.46 60.93 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.162 -0.336 . . . . 0.0 111.292 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -139.34 23.26 2.54 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.601 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.583 ' C ' ' H ' ' A' ' 33' ' ' ALA . 36.8 t -55.43 125.79 22.39 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.621 -0.674 . . . . 0.0 110.239 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 67.3 -22.88 0.11 Allowed 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.868 0.73 . . . . 0.0 110.459 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.583 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 51.79 37.01 19.34 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 122.761 0.424 . . . . 0.0 110.977 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.2 m -111.65 96.45 32.56 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.954 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.5 -25.59 10.9 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 122.118 1.879 . . . . 0.0 112.562 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -69.04 -26.63 65.07 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.491 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -106.22 170.26 8.02 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -147.78 152.04 37.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.996 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 39' ' ' VAL . 6.0 p -116.73 96.92 49.57 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.76 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.17 -9.51 17.77 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 121.541 1.494 . . . . 0.0 111.662 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.91 155.32 6.76 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.903 0.383 . . . . 0.0 110.298 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.05 145.47 13.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.922 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -139.17 144.99 38.82 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -163.0 132.46 4.21 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.585 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -135.47 103.63 5.54 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mp -69.56 98.74 1.18 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -166.31 137.66 3.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.74 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.0 134.1 56.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.286 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.9 1.69 63.21 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.25 163.27 44.83 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.8 p -129.65 161.39 30.7 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -137.84 166.84 23.03 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.93 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.4 m -151.72 110.37 3.81 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.1 p -107.07 113.01 26.21 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.0 m -86.35 113.24 22.17 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.4 mtt -122.57 129.28 51.75 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.77 150.14 29.83 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.49 148.38 48.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.596 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -57.72 -31.97 66.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.958 0.409 . . . . 0.0 110.565 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -74.75 -9.53 58.65 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.125 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.24 4.67 44.8 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 48.7 m -62.74 -34.95 78.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.641 0.258 . . . . 0.0 110.656 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 71.4 mtp -126.26 136.44 52.79 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.149 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 93.8 p -145.96 129.65 17.09 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.642 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -155.13 162.42 41.0 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.8 127.04 24.54 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.673 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -94.23 144.76 25.24 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -148.59 151.58 23.75 Favored Glycine 0 N--CA 1.461 0.357 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.01 175.3 42.25 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 t -121.54 132.82 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -74.82 116.12 15.18 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -73.62 -39.56 64.46 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.225 0.536 . . . . 0.0 109.591 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -166.71 147.62 6.05 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.553 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.53 130.74 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.7 mmtp -137.82 126.17 23.27 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.4 m -58.31 123.44 16.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.71 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 51.26 69.17 0.68 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.915 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -166.98 -81.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.806 0.336 . . . . 0.0 110.148 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 tp -150.51 131.78 14.55 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.422 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.0 mt -132.14 131.99 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -153.97 164.47 38.38 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -162.69 155.97 19.96 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.4 p -100.45 132.28 45.92 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 86' ' ' ASP . 88.9 mt -93.78 140.96 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.48 28.62 1.03 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 84' ' ' ILE . 29.0 t70 -120.41 -9.53 9.45 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.009 0.523 . . . . 0.0 109.897 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.79 -14.77 57.41 Favored Glycine 0 N--CA 1.479 1.533 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -75.13 174.97 8.7 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -146.24 151.28 37.32 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.715 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.6 t -140.55 136.81 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.994 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -136.51 133.69 36.77 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 75.0 mt -116.0 128.01 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 43.2 t -118.81 122.98 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -95.37 127.35 41.34 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.3 m -137.47 141.64 41.55 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -151.19 161.18 43.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 65.4 p -127.48 -13.68 5.4 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.095 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.06 -122.4 0.94 Allowed Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -73.08 5.69 3.23 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 122.899 -0.177 . . . . 0.0 110.76 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.4 m -122.55 127.25 49.24 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 63.0 m -108.73 133.24 53.07 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -110.97 126.12 54.43 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.9 mt -106.3 128.38 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.9 t -129.19 133.89 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -142.19 135.24 28.73 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 86.2 p -95.13 153.33 17.7 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -145.17 145.92 31.55 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -117.33 87.22 23.7 Favored Pre-proline 0 N--CA 1.478 0.946 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -77.75 160.69 30.99 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.14 1.893 . . . . 0.0 111.468 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -58.01 155.02 11.51 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.034 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -65.15 -38.95 92.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.823 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 59.2 p -63.21 -43.0 99.35 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.712 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -60.96 118.99 41.01 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.253 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.54 134.27 39.29 Favored 'Trans proline' 0 N--CA 1.506 2.254 0 C-N-CA 121.242 1.295 . . . . 0.0 112.123 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -69.64 -39.33 77.2 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.129 0.49 . . . . 0.0 110.852 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 116' ' ' GLU . 27.3 mp0 -67.78 -46.48 71.87 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.026 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.428 ' O ' HD23 ' A' ' 117' ' ' LEU . 1.6 tt -70.17 -52.61 22.11 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.02 0.438 . . . . 0.0 111.123 -177.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -54.71 -37.44 65.84 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.945 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -59.0 -39.17 81.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.043 0.449 . . . . 0.0 110.255 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.8 t -64.86 -36.27 83.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.56 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.12 -51.72 57.15 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -63.35 -37.54 87.66 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.008 0.432 . . . . 0.0 110.145 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -73.53 -35.07 65.51 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.429 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.46 -50.34 74.09 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.686 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 36.4 pt -63.62 -34.19 66.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.725 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.0 mt -66.87 -39.4 87.52 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.026 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -63.8 -41.19 97.96 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 22.4 m -62.24 -35.15 78.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.837 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -57.78 -28.43 63.97 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.037 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.45 -41.05 98.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.313 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 97.0 p -58.54 -34.87 71.48 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 110.909 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -61.59 -46.48 89.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.474 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.6 p -64.71 -35.02 79.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.709 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.52 -29.58 68.2 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.734 0.302 . . . . 0.0 110.408 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -65.14 -1.92 2.53 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.489 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -61.36 -41.36 96.94 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.543 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 76.1 mt -88.86 76.36 7.96 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.046 0.451 . . . . 0.0 110.039 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -166.79 -60.63 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.923 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.452 ' N ' ' ND1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -164.78 149.77 9.6 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.427 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -63.85 -52.06 61.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 0.0 110.339 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 47.65 75.9 0.12 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.766 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 70.1 m80 52.7 90.34 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.683 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -60.58 -45.4 94.1 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.797 0.332 . . . . 0.0 110.457 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 69.6 m80 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.618 179.869 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -63.07 -40.14 96.79 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.696 0.284 . . . . 0.0 110.509 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -71.42 55.43 0.23 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.092 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 84.3 mt -57.83 139.67 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 t -133.67 141.63 47.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.774 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.76 155.3 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -148.8 162.09 40.49 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.549 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 m -149.01 152.62 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.494 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.67 119.48 38.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.171 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.8 t -123.8 127.29 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -94.9 89.34 5.6 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.95 151.37 4.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.974 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.58 135.78 56.32 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.9 tt -52.45 -37.14 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -60.62 -36.06 77.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.461 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -72.7 -48.24 40.56 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.262 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.5 t -64.0 -41.13 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.127 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.79 ' CH2' HD11 ' A' ' 80' ' ' ILE . 31.0 t-105 -52.97 -39.42 62.96 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.081 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -62.31 -49.7 74.58 Favored 'General case' 0 C--O 1.221 -0.416 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.528 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -65.86 -41.38 91.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.609 0.242 . . . . 0.0 110.925 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -68.78 -16.82 63.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.409 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.565 HD22 ' N ' ' A' ' 22' ' ' ASN . 0.8 OUTLIER -112.24 -28.7 7.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.254 0.622 . . . . 0.0 112.333 -178.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.05 135.02 96.14 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.04 -42.29 0.31 Allowed 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 121.406 1.404 . . . . 0.0 111.537 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.67 69.93 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.844 0.355 . . . . 0.0 111.016 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.511 ' ND1' ' N ' ' A' ' 26' ' ' HIS . 0.2 OUTLIER -76.32 -38.92 55.32 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.787 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' A' ' 31' ' ' CYS . 95.1 mt -62.95 -44.02 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 O-C-N 122.031 -0.418 . . . . 0.0 111.042 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.4 ptp -63.2 -20.87 65.81 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.858 0.361 . . . . 0.0 111.066 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -67.57 -32.11 72.64 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 122.116 -0.365 . . . . 0.0 110.888 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -135.39 19.95 3.38 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.448 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.471 ' C ' ' H ' ' A' ' 33' ' ' ALA . 21.9 t -58.73 133.93 56.38 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 121.75 -0.594 . . . . 0.0 110.429 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.2 tp60 71.33 -39.87 0.46 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.213 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 56.44 29.84 15.99 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.878 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.2 m -115.12 106.68 50.99 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.269 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -52.73 -23.08 19.17 Favored 'Trans proline' 0 N--CA 1.506 2.212 0 C-N-CA 121.999 1.799 . . . . 0.0 112.413 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.33 2.65 12.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.683 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -142.15 169.7 17.1 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.094 0.473 . . . . 0.0 109.848 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -146.03 163.33 35.57 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.35 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 39' ' ' VAL . 6.7 p -123.73 91.21 49.93 Favored Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 123.364 0.666 . . . . 0.0 109.777 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.34 -11.78 20.88 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.296 1.33 . . . . 0.0 111.559 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.21 152.24 6.07 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.02 146.55 9.31 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.24 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -134.72 145.94 48.96 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -152.56 114.91 4.47 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -133.18 95.44 3.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.84 93.8 6.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.853 0.835 . . . . 0.0 109.457 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -149.08 137.28 20.81 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.436 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.8 123.45 12.43 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.776 0.322 . . . . 0.0 111.0 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.79 1.66 78.87 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.03 163.18 47.13 Favored Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.2 p -128.22 159.81 34.04 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.742 0.417 . . . . 0.0 110.098 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.458 ' CD1' ' CE2' ' A' ' 71' ' ' TYR . 42.5 p90 -152.94 169.83 21.9 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.344 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.1 m -161.31 141.97 11.11 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.9 m -121.87 123.01 40.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.8 m -93.22 118.06 30.8 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.1 mtm -127.91 132.94 49.26 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.72 147.68 29.15 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.065 0.459 . . . . 0.0 110.225 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.9 148.51 48.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.552 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -58.41 -34.17 70.46 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.739 0.304 . . . . 0.0 110.239 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -73.03 -10.22 59.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.979 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.94 15.8 58.64 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.2 m -83.7 -17.69 40.49 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 122.886 -0.185 . . . . 0.0 110.812 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 67.9 mtp -134.43 140.82 46.54 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.893 0.377 . . . . 0.0 110.247 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 96.5 p -144.38 149.6 36.39 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.184 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -155.29 161.49 41.09 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.786 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -136.07 99.73 4.22 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.711 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -94.46 134.1 37.34 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.47 172.85 41.84 Favored Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.28 -176.65 39.95 Favored Glycine 0 CA--C 1.519 0.324 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.9 t -118.96 128.84 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.458 ' CE2' ' CD1' ' A' ' 52' ' ' PHE . 57.8 m-85 -71.9 112.23 7.82 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -73.64 -38.13 65.1 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.329 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -165.1 151.53 10.26 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.776 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.2 p -143.68 142.83 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -145.17 121.64 11.01 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.7 m -52.89 120.83 6.26 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.813 0.34 . . . . 0.0 111.91 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.4 m120 51.58 69.96 0.6 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.667 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -167.86 -77.91 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.332 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.3 tt -150.49 136.15 18.19 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.199 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.79 HD11 ' CH2' ' A' ' 18' ' ' TRP . 83.1 mt -129.55 131.41 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -152.44 162.21 41.51 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -157.31 155.52 30.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.829 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 84.9 m -98.32 131.79 44.33 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 86' ' ' ASP . 5.1 mp -94.58 139.44 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.66 26.93 0.61 Allowed Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 84' ' ' ILE . 24.1 t0 -119.67 -12.79 9.21 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 97.76 -7.69 63.26 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.349 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.425 HH21 ' CD ' ' A' ' 110' ' ' GLU . 35.8 mmt180 -74.96 143.44 43.67 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.513 -0.404 . . . . 0.0 110.118 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -110.84 135.4 51.45 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 51.4 t -136.17 136.96 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -134.52 135.14 42.15 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.6 mt -119.61 128.34 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.2 t -118.4 129.99 73.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -97.23 123.15 40.93 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 67.1 p -128.58 140.56 51.72 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -154.08 148.03 25.58 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 70.1 p -99.56 -18.74 17.22 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.063 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.09 -102.81 0.21 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -75.72 -6.79 52.28 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.402 0.144 . . . . 0.0 110.805 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.9 p -107.44 165.18 11.59 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.3 m -143.14 135.48 27.26 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.14 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -124.93 124.2 41.52 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.7 mt -105.64 126.85 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.56 134.45 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -137.24 131.51 32.47 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 89.3 p -136.91 127.68 27.24 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -156.93 168.88 26.15 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.737 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.54 102.3 54.08 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.833 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.65 -169.8 0.78 Allowed 'Trans proline' 0 N--CA 1.501 1.971 0 C-N-CA 121.219 1.28 . . . . 0.0 111.22 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.425 ' CD ' HH21 ' A' ' 88' ' ' ARG . 81.0 mm-40 -56.47 137.15 53.62 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.619 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -83.49 -36.82 23.82 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.795 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.5 t -63.64 -34.22 77.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.974 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -73.89 150.28 88.19 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.242 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -64.66 102.54 0.42 Allowed 'Trans proline' 0 N--CA 1.502 2.015 0 C-N-CA 121.571 1.514 . . . . 0.0 110.7 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 78.9 mtm-85 -60.65 -25.6 66.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.055 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -59.59 -51.2 70.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.664 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.0 mt -65.46 -38.0 88.53 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.296 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -57.42 -39.63 76.62 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.635 0.255 . . . . 0.0 110.837 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 -50.88 -48.48 60.3 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.6 t -71.4 -34.83 70.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.11 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.7 -52.38 51.14 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 121.21 -0.519 . . . . 0.0 111.826 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -63.21 -34.88 78.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 110.125 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -74.9 -34.16 62.13 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.075 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.08 -49.45 77.29 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 10.0 tt -61.26 -41.57 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.97 -40.55 96.66 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.046 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -63.46 -39.38 94.32 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.8 m -58.51 -41.29 85.07 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.713 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -59.19 -47.73 84.23 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.271 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -63.98 -43.09 96.77 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.007 0.432 . . . . 0.0 110.208 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 38.8 t -60.12 -39.36 85.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.797 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.471 ' CZ ' ' ND2' ' A' ' 136' ' ' ASN . 61.8 t80 -60.13 -48.26 82.47 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.47 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 76.0 p -62.88 -45.5 92.26 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.737 0.303 . . . . 0.0 110.631 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -66.48 -38.11 86.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.271 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.01 -40.9 99.14 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.395 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.471 ' ND2' ' CZ ' ' A' ' 132' ' ' TYR . 84.9 m-20 -91.62 -4.73 54.94 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.05 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.0 mt 53.03 -178.15 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.534 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -70.44 73.58 0.52 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.984 0.421 . . . . 0.0 109.946 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -168.89 147.39 3.99 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -66.53 127.99 34.49 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -72.55 101.98 3.13 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -66.01 145.89 55.34 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.139 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 52.24 89.34 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.002 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.608 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -69.08 -15.93 63.56 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.101 0.477 . . . . 0.0 110.565 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -73.13 55.73 0.43 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.701 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 38.6 mm -52.92 140.07 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 t -137.35 134.46 36.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.86 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.6 m -138.97 158.18 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -147.16 158.01 43.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.04 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 p -149.14 140.68 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.888 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.3 p -92.69 124.71 36.89 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.42 125.62 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -93.37 88.24 5.9 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.18 151.7 3.98 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.103 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.92 132.43 52.05 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.8 tt -54.06 -33.09 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.7 0.286 . . . . 0.0 111.103 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -59.01 -40.43 84.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.656 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -73.59 -46.9 44.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.928 0.394 . . . . 0.0 110.153 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -61.77 -43.06 96.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.719 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -55.92 -40.88 73.76 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.788 0.328 . . . . 0.0 110.883 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -68.41 -48.31 65.0 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.027 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.507 ' CD2' ' ND1' ' A' ' 26' ' ' HIS . 9.9 m-85 -66.74 -42.34 86.4 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.867 0.365 . . . . 0.0 110.902 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.0 t-105 -62.88 -15.73 55.98 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.184 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -112.0 -23.27 10.6 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.032 0.533 . . . . 0.0 111.358 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -69.13 122.28 84.78 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 118.809 -0.615 . . . . 0.0 109.712 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.61 -32.16 24.89 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 CA-C-N 121.104 1.43 . . . . 0.0 111.895 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.62 75.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.966 0.412 . . . . 0.0 110.764 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.507 ' ND1' ' CD2' ' A' ' 20' ' ' TYR . 45.8 m170 -80.05 -42.52 23.57 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.993 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 31' ' ' CYS . 92.3 mt -63.04 -48.11 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 O-C-N 122.123 -0.36 . . . . 0.0 110.842 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -64.11 -12.2 37.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.783 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -78.46 -28.11 46.52 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.871 -0.15 . . . . 0.0 111.107 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 69.0 p-90 -133.37 5.89 3.79 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.994 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.499 ' C ' ' H ' ' A' ' 33' ' ' ALA . 37.0 t -50.44 138.09 17.84 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.075 -0.391 . . . . 0.0 110.623 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 71.68 -39.94 0.46 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.499 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.69 39.15 31.12 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.148 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.9 m -134.29 140.81 37.03 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 122.749 0.42 . . . . 0.0 110.286 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -75.78 -10.32 19.94 Favored 'Trans proline' 0 N--CA 1.507 2.284 0 C-N-CA 121.873 1.715 . . . . 0.0 112.559 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 -88.1 15.08 7.89 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.983 0.421 . . . . 0.0 110.262 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -150.16 155.26 39.46 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.137 0.494 . . . . 0.0 109.758 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -142.56 163.46 32.76 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.047 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.4 t -127.72 87.08 56.79 Favored Pre-proline 0 N--CA 1.475 0.825 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.83 -20.7 44.98 Favored 'Trans proline' 0 N--CA 1.505 2.167 0 C-N-CA 122.369 2.046 . . . . 0.0 111.825 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.92 161.54 8.94 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.68 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -159.74 146.08 16.1 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.449 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -140.93 152.08 44.73 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -161.29 132.95 5.6 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.04 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -122.58 86.93 2.66 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.9 tp -67.21 94.9 0.39 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.939 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -169.02 144.14 3.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.03 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.5 137.7 57.93 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.317 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.89 -1.47 54.25 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.64 172.83 41.3 Favored Glycine 0 N--CA 1.47 0.929 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 t -139.02 172.92 12.14 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.396 0.278 . . . . 0.0 110.556 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -138.76 167.54 21.76 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.203 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.5 m -157.74 121.61 4.13 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.6 m -123.77 124.93 43.79 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.2 m -90.29 114.4 26.45 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.7 mtt -119.11 129.73 55.2 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.44 143.58 32.68 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.136 0.494 . . . . 0.0 110.223 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.68 148.53 51.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.33 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -56.35 -39.96 73.7 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.556 0.217 . . . . 0.0 110.475 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -79.21 -7.17 58.02 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.897 0.38 . . . . 0.0 110.141 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.35 18.84 67.93 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 78.4 p -65.63 -34.88 79.25 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 122.838 -0.213 . . . . 0.0 110.683 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 27.3 ttt -137.33 145.88 43.93 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.9 t -143.76 145.45 32.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.885 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.422 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 66.8 t80 -159.09 166.63 31.19 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.422 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 74.3 m-20 -137.78 121.05 16.93 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -93.54 140.39 29.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.847 0.356 . . . . 0.0 110.168 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -157.22 157.77 28.35 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.74 -177.67 41.55 Favored Glycine 0 N--CA 1.458 0.112 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.4 t -123.61 131.66 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -72.5 115.25 11.54 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -73.66 -47.08 42.59 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -149.79 144.11 25.81 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 74' ' ' VAL . 9.6 p -133.04 128.15 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -138.13 111.21 7.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 t -56.35 131.16 47.46 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.257 0.551 . . . . 0.0 112.289 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 49.85 51.89 15.68 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.453 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -157.69 -80.81 0.06 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.688 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 tp -146.27 134.8 22.07 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.2 mt -130.33 131.27 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -152.15 162.71 40.72 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -158.16 154.67 27.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.665 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.3 m -94.78 129.8 41.59 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 88.6 mt -93.63 153.49 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.56 -41.98 65.51 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.816 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -61.49 -10.84 8.61 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.061 0.458 . . . . 0.0 110.632 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 91.53 1.79 70.98 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -77.32 142.94 39.15 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -106.42 162.38 13.75 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.142 0.496 . . . . 0.0 110.395 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.4 t -141.17 121.34 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.778 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.5 mtt-85 -112.41 123.22 49.81 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 71.1 mt -117.06 119.89 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.6 t -107.91 118.22 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -93.41 122.75 36.15 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 41.8 m -131.72 143.65 50.42 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -152.93 147.36 25.87 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 80.7 p -102.47 -19.25 14.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.014 0.435 . . . . 0.0 109.842 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 165.43 -104.73 0.23 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.404 ' N ' ' OD1' ' A' ' 99' ' ' ASP . 1.3 m-20 -77.12 -2.08 32.45 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 122.21 0.204 . . . . 0.0 111.113 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.8 m -119.91 124.24 45.53 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 89.2 m -105.51 133.89 49.52 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -115.48 124.57 51.44 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.0 mt -104.66 125.42 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.4 t -119.73 128.31 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -127.94 123.47 34.95 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.3 m -134.72 128.27 32.61 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.945 0.402 . . . . 0.0 110.096 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -157.13 166.8 32.24 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.567 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -97.33 116.02 65.84 Favored Pre-proline 0 N--CA 1.477 0.903 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.392 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.47 168.47 22.71 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 121.741 1.627 . . . . 0.0 110.989 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -58.13 145.68 36.02 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.747 0.308 . . . . 0.0 110.377 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -70.33 -39.72 74.58 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.18 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 46.9 p -63.77 -44.43 93.46 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.511 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -73.59 135.92 78.1 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.118 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.08 133.07 47.9 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 CA-C-N 120.444 1.194 . . . . 0.0 111.12 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -68.68 -37.39 79.54 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.225 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -58.58 -42.41 87.94 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.33 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.2 tp -63.44 -44.29 94.94 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.722 0.296 . . . . 0.0 110.718 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.65 -46.13 89.62 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.529 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -52.28 -46.64 65.95 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.5 m -66.9 -39.62 87.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.183 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.73 -52.01 51.65 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.77 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -63.83 -35.92 82.19 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.825 0.345 . . . . 0.0 110.449 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -72.01 -38.01 69.68 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.785 0.326 . . . . 0.0 110.161 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.79 72.36 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.124 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.3 tt -62.34 -37.86 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.3 mt -63.87 -40.24 96.09 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -63.38 -40.88 98.44 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 44.2 m -60.95 -38.37 85.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.619 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -59.36 -43.11 92.89 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.663 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -60.32 -48.07 83.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.818 0.342 . . . . 0.0 110.447 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 78.1 p -64.74 -44.32 90.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.386 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -62.06 -47.25 85.51 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.412 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 31.0 m -61.06 -46.06 92.22 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.705 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -67.88 -34.0 75.83 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.457 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -62.82 -4.39 2.09 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.613 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -58.77 -22.44 58.14 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.903 0.382 . . . . 0.0 110.636 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.2 pp -168.64 153.03 5.87 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.134 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -170.09 28.14 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.315 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 53.4 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.989 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -160.06 148.45 17.05 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.471 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 -69.96 149.48 47.72 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.07 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -66.16 140.49 58.2 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -62.83 -45.74 91.17 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.897 0.379 . . . . 0.0 110.327 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.483 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.4 m120 55.47 34.11 22.37 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.614 0.245 . . . . 0.0 110.782 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -72.62 55.22 0.36 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.293 0.568 . . . . 0.0 110.117 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.6 mt -65.14 136.37 26.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 t -137.47 150.91 47.93 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.56 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.6 m -136.0 161.71 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.669 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -139.45 158.92 43.31 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.694 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.12 142.93 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 m -95.05 123.28 38.45 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.4 t -126.98 123.21 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -90.79 87.03 6.5 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.83 152.12 3.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.99 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.63 137.2 57.69 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.7 tt -52.69 -38.26 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.721 0.296 . . . . 0.0 111.35 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -60.81 -35.25 76.04 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.222 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -74.51 -48.06 29.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.01 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.4 t -62.71 -43.93 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.102 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.407 ' CD1' ' OD1' ' A' ' 22' ' ' ASN . 24.4 t-105 -54.27 -39.11 66.58 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.875 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -64.02 -55.76 20.0 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.506 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -69.39 -42.93 74.46 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.837 0.351 . . . . 0.0 111.492 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -59.74 -16.62 28.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.324 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.407 ' OD1' ' CD1' ' A' ' 18' ' ' TRP . 12.7 m120 -112.71 -21.72 11.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.282 0.633 . . . . 0.0 109.895 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -67.55 120.6 74.28 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.736 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.63 -36.56 18.97 Favored 'Trans proline' 0 N--CA 1.507 2.319 0 C-N-CA 121.512 1.474 . . . . 0.0 111.941 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.73 -31.71 69.87 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.104 0.478 . . . . 0.0 110.562 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -80.93 -45.92 15.97 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.789 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.6 mt -61.68 -47.32 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.621 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -63.61 -3.57 2.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.12 0.486 . . . . 0.0 111.072 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -90.25 -29.59 18.07 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 122.098 -0.376 . . . . 0.0 110.341 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 60.6 p-90 -135.73 21.95 3.34 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.128 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.571 ' C ' ' H ' ' A' ' 33' ' ' ALA . 28.5 p -55.43 131.14 45.18 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.353 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.483 ' NE2' ' CD1' ' A' ' 37' ' ' TRP . 49.9 tt0 68.57 -29.1 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 O-C-N 123.527 0.517 . . . . 0.0 110.467 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.571 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 53.48 39.72 30.38 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.429 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 t -128.28 136.45 29.08 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.796 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -73.21 -17.54 24.36 Favored 'Trans proline' 0 N--CA 1.502 1.971 0 C-N-CA 122.035 1.823 . . . . 0.0 112.372 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -81.93 13.06 3.52 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.753 0.311 . . . . 0.0 110.687 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.483 ' CD1' ' NE2' ' A' ' 32' ' ' GLN . 87.3 m95 -149.87 159.95 43.97 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.331 0.586 . . . . 0.0 109.664 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.405 ' CG ' ' N ' ' A' ' 39' ' ' VAL . 83.6 t60 -149.13 163.43 37.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.222 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 39' ' ' VAL . 7.2 p -128.6 96.86 29.06 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.869 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.1 -9.2 19.19 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 121.927 1.752 . . . . 0.0 111.747 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.15 153.89 7.05 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.834 0.35 . . . . 0.0 110.544 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.47 145.87 13.17 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.185 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -141.04 151.96 44.47 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 55.8 t-20 -162.41 135.28 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.922 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -133.97 99.12 4.34 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.427 HD22 ' N ' ' A' ' 46' ' ' LEU . 4.4 mm? -67.75 95.22 0.49 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.074 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -168.15 145.25 4.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.673 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.83 137.11 58.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.056 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.97 3.57 36.86 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.13 146.14 33.03 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.6 m -107.45 154.25 21.62 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -141.52 156.81 45.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.426 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.7 m -148.25 128.0 13.4 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.1 m -123.81 121.14 34.63 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.6 m -92.25 124.86 36.63 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.1 mtp -135.63 135.95 40.62 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.16 147.22 30.3 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.956 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.4 148.88 50.95 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.425 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -57.51 -40.48 78.79 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.71 0.29 . . . . 0.0 110.397 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.24 -10.05 59.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.035 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.14 14.25 68.24 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 85.3 p -67.27 -33.49 75.42 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.668 0.271 . . . . 0.0 110.616 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.3 ttt -129.2 149.37 51.03 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.846 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.2 t -144.27 142.4 30.43 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.724 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.446 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 57.8 t80 -159.47 159.0 33.03 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.446 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 68.3 m-20 -139.12 129.85 26.09 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.867 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -94.95 134.58 37.46 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.39 149.17 20.79 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.79 -172.05 41.86 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -131.97 139.37 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -73.97 122.94 23.37 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.525 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -77.21 -32.56 56.02 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -165.41 144.91 6.6 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.722 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.6 t -135.7 130.28 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -143.09 116.86 9.28 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 65.8 p -57.33 134.2 55.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.696 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 53.76 56.02 7.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.554 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -155.01 -79.58 0.09 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -162.32 161.52 27.57 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.907 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.5 mt -136.06 141.04 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -153.43 160.27 42.56 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -159.46 165.66 32.62 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.3 m -120.94 133.76 55.29 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.7 mm -99.72 153.85 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -55.57 -41.49 81.8 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -60.59 -18.2 51.36 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.717 0.294 . . . . 0.0 110.488 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 103.28 -3.66 47.52 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -65.37 146.51 54.81 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -136.44 145.48 45.29 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.578 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.69 137.97 31.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -121.45 130.32 53.5 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 76.8 mt -116.97 120.19 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.6 t -116.72 128.37 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -95.9 123.67 39.59 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.7 m -121.14 145.0 48.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -153.44 161.8 41.91 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 60.3 p -132.69 -47.96 0.88 Allowed 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.227 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.74 120.74 0.59 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 56.0 15.82 1.91 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 111.039 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.4 m -151.56 139.18 19.66 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 48.4 m -125.84 132.11 52.28 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -117.83 122.52 43.61 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.0 mt -96.68 128.06 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 35.0 t -121.73 132.49 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -136.8 134.79 37.38 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 83.9 p -138.92 130.45 27.29 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -155.93 170.12 22.86 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -112.29 93.37 22.04 Favored Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 123.736 0.648 . . . . 0.0 109.856 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.53 -166.98 0.43 Allowed 'Trans proline' 0 N--CA 1.501 1.922 0 C-N-CA 122.04 1.827 . . . . 0.0 111.382 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -54.44 116.5 2.68 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.283 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -69.09 -32.07 71.23 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.302 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 80.7 p -62.57 -43.43 98.83 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.303 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.592 ' N ' HD22 ' A' ' 113' ' ' ASN . 1.0 OUTLIER -68.66 148.4 98.05 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.721 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -58.01 138.98 88.76 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 121.387 1.391 . . . . 0.0 112.048 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -66.47 -40.3 89.26 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -63.3 -43.01 99.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.735 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.54 -51.37 65.76 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 120.896 0.379 . . . . 0.0 110.182 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -61.1 -50.84 71.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.582 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -58.0 -41.88 83.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.399 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 74.1 m -58.3 -32.83 68.82 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 123.412 0.445 . . . . 0.0 110.556 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.27 -44.72 12.7 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -60.45 -39.43 87.5 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.75 0.31 . . . . 0.0 111.587 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -76.09 -34.66 59.54 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.076 0.465 . . . . 0.0 110.546 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.96 -50.92 72.23 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.5 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.7 tt -61.14 -36.62 73.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.0 mt -66.42 -36.61 83.24 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -62.26 -40.72 97.15 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.525 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 91.7 p -62.17 -33.89 75.38 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.983 0.421 . . . . 0.0 110.656 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -59.68 -41.15 90.02 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.541 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -59.24 -41.02 87.74 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.37 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.8 m -60.41 -40.79 92.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.496 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -61.31 -47.55 85.42 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.64 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 75.8 p -62.27 -33.8 75.33 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.489 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -66.83 -33.84 76.5 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.848 0.356 . . . . 0.0 110.085 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -76.43 -18.79 58.63 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.991 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -70.03 -18.04 63.29 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.937 0.399 . . . . 0.0 111.029 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.418 ' N ' HD22 ' A' ' 137' ' ' LEU . 4.3 mm? -62.56 -41.88 99.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.336 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -62.81 83.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.54 ' CD2' ' H ' ' A' ' 141' ' ' HIS . 80.7 t60 -169.25 -87.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.811 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 82.1 t60 55.98 7.88 0.33 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.048 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.54 ' H ' ' CD2' ' A' ' 139' ' ' HIS . 44.8 m-70 -103.51 62.74 0.78 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.275 0.56 . . . . 0.0 110.213 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -64.16 -41.25 97.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.682 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 52.15 87.32 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.711 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 . . . . . 0 C--O 1.218 -0.572 0 CA-C-O 118.087 -0.958 . . . . 0.0 110.132 -179.678 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 55.18 81.83 0.11 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.693 0.282 . . . . 0.0 110.573 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -71.87 -67.38 0.54 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.388 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.2 mt -131.04 134.91 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.5 m -135.26 139.16 44.2 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.49 153.82 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -148.81 162.12 40.44 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.924 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.7 p -148.34 140.8 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.703 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.5 p -89.59 119.74 30.28 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.0 t -121.83 124.34 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -93.21 88.54 6.08 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.31 153.33 4.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.743 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.08 134.0 55.38 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.8 tt -51.78 -36.22 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -60.03 -35.59 75.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.359 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -75.21 -44.93 43.67 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 109.958 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.6 t -63.39 -43.8 98.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.36 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.422 ' CE2' ' OD1' ' A' ' 22' ' ' ASN . 72.1 t90 -57.24 -46.31 83.12 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.473 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.01 -44.69 88.36 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.751 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -66.49 -44.28 83.06 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.879 0.371 . . . . 0.0 110.962 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -69.29 -18.33 63.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.483 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.447 HD22 ' N ' ' A' ' 22' ' ' ASN . 1.0 OUTLIER -98.49 -26.24 14.51 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.062 0.545 . . . . 0.0 111.14 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -64.95 119.96 62.75 Favored Pre-proline 0 CA--C 1.549 0.906 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.81 -36.32 4.79 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 CA-C-N 120.863 1.344 . . . . 0.0 111.869 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.59 86.19 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.843 0.354 . . . . 0.0 111.142 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -66.84 -40.57 88.01 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.58 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.452 ' O ' ' N ' ' A' ' 31' ' ' CYS . 96.5 mt -63.31 -43.8 98.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.8 mtp -55.88 -12.27 1.31 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.599 0.238 . . . . 0.0 111.279 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -86.33 -28.73 23.5 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 122.154 -0.341 . . . . 0.0 110.978 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -136.36 21.66 3.18 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.481 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.586 ' C ' ' H ' ' A' ' 33' ' ' ALA . 10.4 t -57.12 131.34 49.62 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.66 -0.65 . . . . 0.0 110.479 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 66.14 -27.83 0.12 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.689 0.618 . . . . 0.0 110.864 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.586 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 47.3 29.62 1.3 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.539 0.335 . . . . 0.0 111.017 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.7 m -108.12 135.55 19.89 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.264 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.76 -17.3 20.31 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.517 1.478 . . . . 0.0 111.983 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -86.87 8.67 22.0 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.705 0.288 . . . . 0.0 110.578 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -148.4 156.31 42.33 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.314 0.578 . . . . 0.0 110.261 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -143.96 150.38 38.23 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.105 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 39' ' ' VAL . 8.4 p -111.5 89.57 10.87 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.889 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.78 -11.72 20.08 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 121.334 1.356 . . . . 0.0 111.422 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -170.15 152.47 4.23 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 120.982 0.42 . . . . 0.0 110.47 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.26 151.92 18.04 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.248 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -139.13 150.93 46.24 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.627 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -161.23 131.45 5.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.863 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -130.27 97.53 4.45 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -71.05 94.54 1.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.926 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -167.97 140.15 3.04 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.18 137.78 58.04 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.684 0.278 . . . . 0.0 110.28 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.42 -1.58 50.17 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.97 164.88 44.91 Favored Glycine 0 N--CA 1.468 0.813 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.4 p -126.27 157.88 37.16 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.841 0.456 . . . . 0.0 110.323 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -132.93 156.58 46.99 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.431 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.2 m -146.92 119.54 8.54 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.9 p -114.73 113.69 24.63 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.2 m -89.78 114.78 26.55 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.2 mtt -128.5 133.79 48.54 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.78 145.62 26.72 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.947 0.403 . . . . 0.0 110.176 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.58 147.58 53.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.377 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -56.33 -32.94 65.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.858 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -83.08 -7.01 59.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.08 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.82 16.34 59.13 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.8 m -60.85 -38.7 86.43 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.718 0.294 . . . . 0.0 110.763 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.4 ttp -145.31 146.42 31.62 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.047 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.4 t -143.97 155.72 44.15 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.917 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.466 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 56.4 t80 -153.8 165.18 36.84 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.466 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 30.8 t0 -138.26 119.46 14.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.186 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -93.33 136.57 33.47 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.95 154.36 25.46 Favored Glycine 0 N--CA 1.465 0.622 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.16 -173.39 40.9 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 t -123.75 132.92 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -71.3 121.35 18.32 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.54 -42.19 62.01 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -159.85 146.14 15.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.778 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.5 t -134.56 129.44 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -145.41 121.75 10.93 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 27.1 m -58.38 129.18 40.81 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.43 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 54.32 56.37 7.01 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.578 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -155.95 -83.95 0.06 Allowed 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.005 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.5 tp -149.17 134.87 18.73 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.682 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.9 mt -127.29 127.97 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.11 164.18 38.51 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -156.07 154.39 30.9 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.906 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.3 m -87.97 131.76 34.5 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 73.7 mt -104.78 144.41 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -52.55 -42.49 57.9 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.419 ' CG ' HH12 ' A' ' 88' ' ' ARG . 44.2 m-20 -62.02 -21.35 64.81 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.766 0.317 . . . . 0.0 110.351 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.62 2.94 72.04 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.419 HH12 ' CG ' ' A' ' 86' ' ' ASP . 96.3 mtm-85 -65.83 140.81 58.42 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -92.11 122.03 34.22 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.245 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.9 t -135.47 122.52 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -136.49 142.76 43.56 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 77.3 mt -113.27 124.05 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.4 t -106.75 125.42 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -102.6 122.16 43.84 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.5 m -131.07 149.77 52.45 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -151.79 154.26 35.89 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.659 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.1 p -132.77 40.2 3.27 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.111 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.08 131.19 0.16 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 p30 47.35 17.33 0.07 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.087 0.555 . . . . 0.0 111.849 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.5 m -152.78 135.81 15.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.026 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.7 m -128.93 130.48 46.83 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -117.63 126.24 52.17 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.9 mt -101.18 123.82 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.1 t -125.01 128.52 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -142.99 140.58 31.09 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.0 m -137.01 142.65 42.52 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -153.94 155.63 35.98 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.362 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.54 139.23 74.45 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.739 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.75 -170.3 0.88 Allowed 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 121.964 1.776 . . . . 0.0 111.158 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 78.91 27.85 0.42 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.145 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -85.32 -71.39 0.53 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.631 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.6 m -123.63 -29.88 3.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.793 0.437 . . . . 0.0 111.37 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.405 ' OD1' ' NE2' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -139.04 163.92 42.87 Favored Pre-proline 0 N--CA 1.484 1.268 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.881 -176.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -63.89 171.31 7.49 Favored 'Trans proline' 0 N--CA 1.508 2.358 0 C-N-CA 122.607 2.204 . . . . 0.0 112.303 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -59.98 -51.6 68.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.167 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -50.94 -50.92 56.88 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 tp -65.86 -40.14 91.39 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.075 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.405 ' NE2' ' OD1' ' A' ' 113' ' ' ASN . 26.5 mm-40 -64.76 -52.59 56.13 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.769 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.38 -54.49 46.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.881 0.372 . . . . 0.0 110.092 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.6 t -64.05 -42.07 97.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.917 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.05 -52.13 50.13 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.191 -0.528 . . . . 0.0 111.827 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 13.9 m95 -65.08 -41.61 94.9 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.645 0.259 . . . . 0.0 110.344 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -65.74 -37.82 87.44 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.413 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.69 68.79 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 31.3 pt -65.3 -35.47 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 121.171 -0.212 . . . . 0.0 110.905 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.3 mt -64.89 -37.11 86.54 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -62.97 -37.46 87.2 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.6 m -69.07 -33.64 73.87 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.792 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -58.32 -50.63 72.94 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.683 0.277 . . . . 0.0 111.358 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -66.21 -36.0 81.92 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.255 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 36.3 t -60.83 -34.88 75.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.718 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -60.35 -43.57 96.38 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.75 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.2 p -62.57 -34.58 77.24 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.651 0.262 . . . . 0.0 110.661 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -68.28 -40.43 81.84 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.018 0.437 . . . . 0.0 109.83 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -66.93 -28.37 68.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.935 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -66.95 -14.68 63.08 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.659 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.6 tp -62.12 150.04 39.63 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.121 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 54.7 33.76 20.12 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.562 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -161.5 -8.78 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.384 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -63.38 -41.45 98.79 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -168.16 57.33 0.06 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.242 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -65.04 -42.67 94.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.9 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -64.76 146.74 54.37 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.419 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 11.2 p80 . . . . . 0 C--O 1.221 -0.402 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.689 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.626 ' N ' ' HE ' ' A' ' 115' ' ' ARG . 26.3 p30 -64.55 -10.83 28.64 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.329 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -73.08 51.88 0.32 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.909 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.59 137.36 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.2 m -122.87 133.27 54.42 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.8 m -138.74 160.05 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.21 165.9 30.47 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.231 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -152.02 144.25 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 79.2 p -92.12 125.42 36.79 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.59 130.7 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -97.25 92.82 6.19 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.06 152.53 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.275 -0.42 . . . . 0.0 109.966 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.33 138.06 58.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.202 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.7 tp -51.56 -37.79 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 121.067 0.461 . . . . 0.0 110.994 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -69.02 -36.74 78.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.15 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -68.64 -51.94 36.66 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 111.244 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 p -63.51 -36.51 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.364 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -54.92 -49.55 71.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.828 0.347 . . . . 0.0 110.587 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.7 -45.15 83.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.374 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.451 ' CD2' ' ND1' ' A' ' 26' ' ' HIS . 50.1 t80 -63.95 -43.83 94.66 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 111.186 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 66.0 t-105 -71.1 -19.08 62.5 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.463 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.409 HD21 ' CD1' ' A' ' 80' ' ' ILE . 14.5 m120 -103.65 -23.92 13.42 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.999 0.519 . . . . 0.0 110.972 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.25 134.38 95.81 Favored Pre-proline 0 CA--C 1.553 1.064 0 CA-C-O 119.191 -0.433 . . . . 0.0 109.858 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.69 -41.49 0.55 Allowed 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 121.544 1.496 . . . . 0.0 111.622 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.67 -29.35 66.53 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.918 0.389 . . . . 0.0 110.695 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.451 ' ND1' ' CD2' ' A' ' 20' ' ' TYR . 33.3 m170 -79.93 -45.82 17.84 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.234 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 90.6 mt -63.52 -46.6 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 122.006 -0.434 . . . . 0.0 110.645 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -66.1 -3.37 5.4 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.71 -178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -90.58 -26.87 19.47 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.183 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -138.04 23.05 2.82 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.433 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.595 ' C ' ' H ' ' A' ' 33' ' ' ALA . 9.6 t -56.52 133.99 53.82 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.191 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 65.92 -23.99 0.1 Allowed 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.538 0.524 . . . . 0.0 110.668 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.595 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 53.3 28.19 7.0 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.507 0.194 . . . . 0.0 110.613 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.1 m -112.8 104.17 55.82 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 122.953 0.501 . . . . 0.0 110.058 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -50.09 -13.44 0.64 Allowed 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 122.266 1.977 . . . . 0.0 112.625 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -82.63 11.84 5.34 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.669 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -146.72 162.72 37.92 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -146.57 162.63 37.96 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.372 -0.831 . . . . 0.0 108.969 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.6 t -126.16 96.28 37.2 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.84 -10.99 23.63 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 121.76 1.64 . . . . 0.0 111.877 -178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.02 152.94 6.64 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.934 0.397 . . . . 0.0 110.473 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -164.68 150.09 9.98 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.458 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -143.65 156.25 44.5 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -157.98 104.18 1.9 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.699 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -91.99 87.62 6.26 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 37.2 tp -66.11 93.36 0.2 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.716 -0.394 . . . . 0.0 109.968 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -170.48 145.91 2.69 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.48 137.74 58.25 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.142 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.23 -1.58 25.2 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -77.26 163.49 51.98 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.8 m -124.14 155.41 38.5 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -135.04 158.05 45.35 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.467 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.7 m -146.17 122.37 10.84 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.6 m -119.12 119.63 34.76 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.6 m -88.86 113.4 24.37 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 93.2 mtp -119.14 124.66 47.38 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.35 140.74 33.82 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.17 150.37 47.57 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -54.08 -37.75 64.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.692 0.282 . . . . 0.0 110.523 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -81.17 -7.42 59.56 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.125 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.76 14.68 37.98 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.9 t -67.4 -19.14 65.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.733 0.301 . . . . 0.0 110.489 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 47.6 ttp -159.85 134.99 8.05 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.972 0.415 . . . . 0.0 110.383 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m -146.16 154.58 41.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.259 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -154.88 146.94 23.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.33 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -108.19 119.99 41.08 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.389 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -93.92 137.69 32.87 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -154.44 153.9 25.13 Favored Glycine 0 N--CA 1.46 0.27 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -170.3 178.21 43.15 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.33 134.15 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -75.68 121.05 21.92 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -75.22 -39.2 60.26 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -162.34 146.4 11.98 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.849 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.5 p -149.95 138.67 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.656 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -148.99 134.64 18.72 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.8 m -48.07 118.22 2.27 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.454 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.6 m120 54.11 79.6 0.13 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.377 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -167.9 -83.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.472 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 tt -152.78 141.49 20.96 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.774 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.409 ' CD1' HD21 ' A' ' 22' ' ' ASN . 63.1 mt -130.16 130.52 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -152.94 160.55 43.05 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -160.57 155.2 23.82 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.644 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.4 p -91.84 134.3 34.88 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.666 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.411 HG22 ' H ' ' A' ' 86' ' ' ASP . 79.6 mt -104.71 147.37 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.05 -41.38 59.98 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.411 ' H ' HG22 ' A' ' 84' ' ' ILE . 82.5 m-20 -60.72 -17.76 50.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.777 0.323 . . . . 0.0 110.148 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.75 3.72 80.15 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -65.88 141.52 58.22 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -95.4 135.26 37.24 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.2 t -139.55 128.64 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -136.15 133.73 37.51 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 62.6 mt -116.59 116.18 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 24.5 t -101.13 116.02 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -90.89 132.52 35.87 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.5 p -132.25 156.93 45.63 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -143.85 148.69 35.85 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.2 m -150.82 87.05 1.4 Allowed 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 59.94 -134.29 50.93 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -79.0 39.88 0.39 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.749 0.309 . . . . 0.0 110.498 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.8 m -150.09 147.62 28.0 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.2 m -134.0 146.38 50.35 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.406 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -132.68 131.08 40.91 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.5 mt -107.55 128.15 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.15 126.96 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -144.59 145.55 31.85 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 95.3 p -132.37 148.72 52.43 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -131.34 174.81 9.7 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -135.73 78.14 49.76 Favored Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.07 167.84 5.27 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.999 1.799 . . . . 0.0 111.701 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -58.8 148.67 29.0 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.177 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -68.64 -33.16 73.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.332 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.2 m -62.64 -45.48 92.63 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.992 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -73.27 143.31 83.0 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.717 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -71.23 141.34 39.15 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 121.521 1.48 . . . . 0.0 111.6 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.626 ' HE ' ' N ' ' A' ' 2' ' ' ASN . 79.9 mtt85 -65.92 -36.67 84.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.173 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.513 ' H ' ' CD ' ' A' ' 116' ' ' GLU . 22.3 mp0 -53.37 -48.43 68.59 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.239 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.4 tp -63.08 -44.86 94.56 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.864 0.364 . . . . 0.0 110.312 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -63.97 -46.62 83.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.651 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -53.74 -46.98 71.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.935 0.398 . . . . 0.0 110.385 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 81.5 p -64.67 -37.37 87.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.134 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.57 -52.45 46.04 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.531 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -66.41 -37.09 84.43 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.905 0.383 . . . . 0.0 110.541 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -70.55 -39.02 74.23 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.458 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.16 -52.0 67.38 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.726 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.4 tt -62.23 -37.97 79.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 28.7 mt -64.47 -41.99 96.17 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.28 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -67.39 -41.83 84.31 Favored 'General case' 0 C--O 1.218 -0.597 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.2 t -61.37 -32.83 72.75 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.467 0.48 . . . . 0.0 110.875 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -52.58 -14.08 0.46 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.862 0.363 . . . . 0.0 111.031 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -60.68 -38.2 84.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.645 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.6 m -58.28 -45.67 87.47 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.775 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -66.0 -44.69 84.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.045 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 95.1 m -61.87 -47.47 84.88 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.887 0.375 . . . . 0.0 110.745 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -78.43 8.39 5.2 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.813 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -62.12 -6.65 3.17 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.939 0.4 . . . . 0.0 110.31 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -63.01 -39.71 95.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.137 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.14 175.7 13.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.934 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -82.83 165.69 19.61 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.61 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -64.71 133.17 51.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.275 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -155.0 162.46 41.08 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.867 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -168.67 82.94 0.15 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.744 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -71.03 130.17 40.88 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -61.14 -87.12 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.692 0.282 . . . . 0.0 110.449 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 144' ' ' HIS . 35.8 p-80 . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.472 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.478 ' C ' ' HE ' ' A' ' 115' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -62.69 -40.72 98.01 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.695 0.283 . . . . 0.0 110.378 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -72.68 51.5 0.27 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.374 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 73.9 mt -50.17 143.01 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 t -129.91 133.96 47.18 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.4 m -139.69 158.34 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -148.65 162.88 38.83 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.335 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 p -145.3 140.59 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.3 p -93.36 119.33 32.36 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.2 t -127.48 128.7 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -98.98 88.22 3.92 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.29 154.43 4.84 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.041 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.25 118.84 7.96 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.2 tt -51.68 -34.96 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.167 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -60.31 -39.82 88.35 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -73.24 -45.43 55.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.238 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.2 t -62.88 -42.34 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.688 0.28 . . . . 0.0 110.499 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.462 ' HE1' HD11 ' A' ' 80' ' ' ILE . 21.0 t90 -48.92 -34.59 13.09 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.616 0.246 . . . . 0.0 111.123 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -61.55 -47.86 83.64 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.631 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -69.36 -42.37 75.31 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.699 0.285 . . . . 0.0 110.572 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -65.93 -15.63 63.14 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.307 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.442 ' ND2' ' CD1' ' A' ' 18' ' ' TRP . 2.1 m-80 -108.81 -26.88 10.06 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.377 0.671 . . . . 0.0 111.478 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -76.83 125.84 86.54 Favored Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.54 -31.36 13.72 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 121.427 1.418 . . . . 0.0 111.883 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.63 -37.29 78.25 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.437 0.461 . . . . 0.0 110.876 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -79.42 -41.45 27.66 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.988 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.4 mt -61.48 -49.06 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.239 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.9 ptm -60.46 -16.35 35.59 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.495 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -72.28 -34.99 68.59 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -127.68 5.29 6.12 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.092 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.541 ' C ' ' H ' ' A' ' 33' ' ' ALA . 30.5 t -51.35 140.52 17.09 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 71.36 -36.64 0.37 Allowed 'General case' 0 CA--C 1.536 0.432 0 O-C-N 123.698 0.624 . . . . 0.0 109.573 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.541 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 56.21 34.81 24.65 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.533 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.1 m -121.93 136.03 25.84 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 122.816 0.446 . . . . 0.0 110.48 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.28 -20.34 16.42 Favored 'Trans proline' 0 N--CA 1.503 2.074 0 C-N-CA 121.832 1.688 . . . . 0.0 112.524 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -78.04 -24.06 47.94 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.543 0.211 . . . . 0.0 110.991 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -109.54 153.79 23.63 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.411 ' CD2' ' O ' ' A' ' 57' ' ' ALA . 6.1 p80 -144.77 162.87 35.68 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.3 t -120.74 95.25 48.99 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.12 -10.77 22.95 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 121.637 1.558 . . . . 0.0 111.688 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -167.49 151.99 6.81 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.893 0.378 . . . . 0.0 110.433 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -162.41 146.4 11.87 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.245 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -139.21 152.92 47.74 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -160.57 127.77 4.33 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.857 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -133.89 93.58 3.13 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.17 102.34 1.33 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.174 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -163.8 129.92 3.12 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.55 123.19 12.35 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.715 0.293 . . . . 0.0 110.67 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.68 4.92 90.23 Favored Glycine 0 N--CA 1.469 0.851 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.28 173.01 52.95 Favored Glycine 0 N--CA 1.467 0.745 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.5 t -134.08 164.21 27.84 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 117.058 0.429 . . . . 0.0 110.045 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -148.8 169.13 21.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.067 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.1 m -148.99 125.32 10.87 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.8 m -120.5 118.31 29.91 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.3 m -94.89 117.93 30.94 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 46.4 ttp -137.06 130.25 31.05 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' ' CD2' ' A' ' 38' ' ' HIS . . . -153.54 158.04 40.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.208 0.528 . . . . 0.0 110.157 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.84 150.72 48.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.778 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -58.03 -38.12 75.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.587 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -71.23 -11.1 60.74 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.91 6.63 60.36 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.1 m -63.78 -39.96 95.52 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.598 0.237 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.2 mtm -117.44 142.2 47.42 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.133 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 92.8 p -144.23 149.24 36.04 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.872 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -154.49 154.21 32.77 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -138.18 120.15 15.47 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.589 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -93.7 121.83 35.54 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -132.46 134.92 7.83 Favored Glycine 0 N--CA 1.473 1.161 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.74 -175.11 44.67 Favored Glycine 0 CA--C 1.518 0.28 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.5 m -132.38 156.81 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.894 0.378 . . . . 0.0 110.207 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -88.34 124.51 33.99 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.517 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -73.32 -38.49 65.8 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.46 149.6 5.84 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.664 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.7 t -134.59 132.46 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -141.46 117.42 10.53 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.9 m -55.88 123.69 15.13 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.964 0.412 . . . . 0.0 111.349 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.2 m120 52.14 66.22 1.27 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.011 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -167.08 -77.55 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.227 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 tp -151.82 131.6 13.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.51 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.462 HD11 ' HE1' ' A' ' 18' ' ' TRP . 64.6 mt -132.94 131.69 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -153.09 165.56 35.22 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -157.28 164.79 37.28 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 54.3 m -115.36 132.57 56.58 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.8 mm -99.28 150.05 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.22 -40.49 67.62 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.424 ' CB ' ' NH1' ' A' ' 88' ' ' ARG . 63.1 m-20 -61.66 -19.41 62.28 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.59 0.233 . . . . 0.0 110.709 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.93 -3.08 48.32 Favored Glycine 0 N--CA 1.473 1.147 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.424 ' NH1' ' CB ' ' A' ' 86' ' ' ASP . 84.5 mtt85 -64.72 144.2 57.4 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -120.97 146.42 46.7 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.567 0.542 . . . . 0.0 109.654 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.3 t -138.1 136.89 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -132.92 120.02 20.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 70.8 mt -108.72 117.6 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.0 t -108.17 114.9 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -89.87 128.43 36.19 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 57.4 p -132.75 152.43 51.76 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.2 p-80 -153.93 158.65 41.01 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.3 p -135.94 36.59 2.83 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.023 0.44 . . . . 0.0 109.901 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 69.92 131.2 0.07 OUTLIER Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 57.34 8.71 0.62 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.838 0.352 . . . . 0.0 110.955 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.7 m -150.47 139.54 21.08 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.114 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.9 m -127.76 130.36 48.62 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -120.53 123.29 42.55 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.0 mt -103.27 128.43 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.7 t -117.61 131.66 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -130.31 132.7 45.99 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 48.3 t -118.29 149.11 41.7 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -144.0 160.69 40.41 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -134.16 78.24 59.16 Favored Pre-proline 0 N--CA 1.474 0.751 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.96 164.46 6.2 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.949 1.766 . . . . 0.0 111.718 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -63.35 151.46 40.79 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.43 -43.49 90.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.412 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.0 p -64.0 -42.94 97.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.945 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.594 ' N ' HD22 ' A' ' 113' ' ' ASN . 0.8 OUTLIER -63.11 146.79 95.53 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.639 -178.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.17 110.64 3.1 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 121.944 1.763 . . . . 0.0 111.407 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.478 ' HE ' ' C ' ' A' ' 1' ' ' GLY . 9.0 ptm180 -66.37 -26.31 67.21 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.018 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.531 ' H ' ' CD ' ' A' ' 116' ' ' GLU . 30.1 mp0 -56.97 -50.98 71.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.257 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.6 mt -66.71 -37.26 84.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.59 0.233 . . . . 0.0 110.717 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -60.3 -47.21 86.97 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.61 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -53.27 -44.98 68.65 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.01 0.433 . . . . 0.0 110.008 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.1 t -64.45 -40.72 96.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.352 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.47 -51.72 55.95 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.611 -0.596 . . . . 0.0 111.611 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -62.74 -36.3 82.58 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.705 0.288 . . . . 0.0 110.279 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -74.05 -37.67 64.21 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.791 0.329 . . . . 0.0 110.194 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.15 -51.08 71.56 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.805 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 14.3 tt -63.6 -39.57 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.5 mt -63.62 -38.61 91.76 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -62.14 -40.03 94.57 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.072 0.463 . . . . 0.0 109.763 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.5 t -72.63 -31.04 64.84 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.689 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -55.35 -52.24 64.15 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -70.51 -36.09 73.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.972 0.415 . . . . 0.0 110.768 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 52.6 p -54.66 -36.23 64.37 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -62.51 -48.17 80.72 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.046 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.1 p -64.27 -43.84 93.59 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.612 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.83 -36.46 83.54 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.034 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -62.03 -43.88 97.9 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.679 0.276 . . . . 0.0 110.465 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -66.71 -42.82 85.79 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.777 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.0 tp -63.77 -44.16 94.22 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.923 0.392 . . . . 0.0 110.357 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -168.56 -167.87 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.431 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 54.1 73.51 0.38 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.923 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -68.36 -163.61 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.704 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -153.67 -51.34 0.1 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 53.12 83.49 0.06 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.652 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.484 ' ND1' ' ND1' ' A' ' 144' ' ' HIS . 62.4 t-80 -62.53 -42.69 99.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.545 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.484 ' ND1' ' ND1' ' A' ' 143' ' ' HIS . 43.8 p-80 . . . . . 0 C--O 1.218 -0.561 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.203 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.482 ' ND2' ' NH2' ' A' ' 115' ' ' ARG . 54.3 t30 -65.58 169.58 6.03 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -106.47 52.61 0.72 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.279 0.632 . . . . 0.0 110.265 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.9 mt -51.53 138.97 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 m -135.64 138.73 43.16 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 m -136.17 157.05 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -147.74 161.16 41.78 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.39 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.61 142.61 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.5 m -93.48 121.27 34.7 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.7 t -126.57 124.88 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -94.74 89.9 5.88 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.98 153.47 4.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.06 134.28 55.85 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.7 tp -52.83 -34.39 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.88 0.372 . . . . 0.0 110.884 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -60.46 -40.8 92.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.473 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -72.07 -46.66 56.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.845 0.355 . . . . 0.0 110.555 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.48 -41.57 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.401 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.781 ' CH2' HD11 ' A' ' 80' ' ' ILE . 26.4 t-105 -56.11 -45.31 79.54 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.84 0.353 . . . . 0.0 110.868 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -65.26 -45.01 86.25 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.339 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -65.51 -43.37 90.33 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.727 0.299 . . . . 0.0 110.973 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.424 ' C ' HD22 ' A' ' 22' ' ' ASN . 67.2 t-105 -69.23 -20.19 63.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.492 -178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.653 HD22 ' N ' ' A' ' 22' ' ' ASN . 0.7 OUTLIER -104.93 -30.86 9.55 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.129 0.571 . . . . 0.0 111.752 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -50.76 106.52 0.66 Allowed Pre-proline 0 CA--C 1.557 1.214 0 CA-C-O 119.113 -0.47 . . . . 0.0 109.819 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -53.58 -43.07 60.82 Favored 'Trans proline' 0 N--CA 1.508 2.381 0 CA-C-N 120.646 1.266 . . . . 0.0 112.244 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.06 -33.79 73.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.909 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.506 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 81.4 t60 -73.74 -38.45 64.76 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.795 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.41 -44.46 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 122.038 -0.414 . . . . 0.0 110.752 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.7 ptp -67.21 -24.9 65.89 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.283 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -62.29 -45.8 91.61 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.529 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.506 ' HE1' ' CD2' ' A' ' 26' ' ' HIS . 62.7 p-90 -109.13 -10.19 15.01 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.523 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.488 ' O ' ' CE3' ' A' ' 30' ' ' TRP . 29.4 p 30.71 -130.99 0.03 OUTLIER 'General case' 0 C--O 1.211 -0.962 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 177.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.425 ' N ' ' SG ' ' A' ' 31' ' ' CYS . 55.2 tp60 -74.55 -4.34 36.34 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 30' ' ' TRP . . . 64.32 32.52 12.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.225 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.8 m -132.3 141.17 40.33 Favored Pre-proline 0 N--CA 1.482 1.154 0 O-C-N 123.337 0.398 . . . . 0.0 110.534 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.5 -9.94 23.32 Favored 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 121.892 1.728 . . . . 0.0 112.27 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -79.14 -24.56 43.22 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.426 0.155 . . . . 0.0 110.724 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -122.24 148.86 44.47 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.829 0.452 . . . . 0.0 110.313 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -140.09 163.25 33.2 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.179 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.21 89.23 52.94 Favored Pre-proline 0 N--CA 1.48 1.04 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.61 -10.12 20.14 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 121.537 1.491 . . . . 0.0 111.141 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -167.77 150.36 5.78 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.008 0.432 . . . . 0.0 110.273 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.86 150.47 11.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.092 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -138.99 144.91 39.13 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -163.6 135.67 5.03 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -125.05 97.45 5.26 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.1 tp -65.34 94.48 0.17 Allowed 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -168.34 140.83 2.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.26 137.71 57.88 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.262 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.45 -0.05 61.24 Favored Glycine 0 N--CA 1.466 0.691 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.06 169.1 41.72 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 t -129.87 168.41 16.66 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.704 0.402 . . . . 0.0 110.066 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -140.57 166.38 24.9 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.244 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.0 m -154.88 118.09 4.45 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.7 m -116.96 121.46 41.47 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.1 m -93.36 116.66 29.21 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.9 mtp -121.76 125.88 47.57 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -135.81 138.31 42.44 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.014 0.435 . . . . 0.0 110.116 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.77 148.83 51.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.393 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.02 -39.96 75.76 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.712 0.292 . . . . 0.0 110.451 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -76.2 -9.65 58.8 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 62.24 22.23 62.84 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 97.0 p -81.06 -10.75 59.64 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.736 0.303 . . . . 0.0 110.617 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.1 ttt -164.49 136.48 4.59 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.087 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.9 p -144.43 161.1 39.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.253 -0.431 . . . . 0.0 109.874 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.466 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 61.7 t80 -159.47 168.63 25.76 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.466 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 40.8 t0 -138.55 119.53 14.39 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -93.99 140.58 29.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.71 156.21 26.97 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.36 -171.55 40.99 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 p -127.36 141.63 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 122.672 0.389 . . . . 0.0 110.107 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -81.04 123.65 28.54 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -77.0 -47.87 19.52 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.076 0.465 . . . . 0.0 110.04 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -147.38 141.31 25.87 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.559 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.3 t -136.06 125.5 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -140.54 123.13 16.16 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.8 m -53.62 121.95 8.84 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.073 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.5 m120 53.47 70.16 0.62 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.77 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -166.1 -82.39 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.536 0.208 . . . . 0.0 110.943 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.1 tp -147.02 139.55 24.85 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.781 HD11 ' CH2' ' A' ' 18' ' ' TRP . 58.9 mt -133.77 130.28 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -153.7 157.51 39.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -155.95 160.16 39.86 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.3 m -112.27 135.24 53.19 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.3 mm -89.19 155.89 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -59.8 -33.97 80.44 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -69.46 -10.26 57.27 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 122.477 -0.425 . . . . 0.0 110.352 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 101.7 -8.15 56.14 Favored Glycine 0 N--CA 1.475 1.29 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -71.18 161.32 31.3 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -145.4 160.79 41.03 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.428 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.4 t -144.43 113.03 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.325 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -93.92 127.41 39.67 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 65.7 mt -124.83 113.06 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.0 p -108.71 133.55 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.475 ' CE1' HD12 ' A' ' 80' ' ' ILE . 87.4 m-85 -103.93 132.64 49.99 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.0 p -134.3 153.3 51.95 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -153.84 158.22 40.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.541 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 63.6 p -134.86 27.38 3.6 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.049 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.0 129.32 1.39 Allowed Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 55.7 11.77 0.72 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.885 0.374 . . . . 0.0 111.03 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.2 m -153.53 141.93 20.66 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.046 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.9 m -130.37 130.85 44.9 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -117.88 122.86 44.43 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.6 mt -104.37 126.27 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.5 t -128.18 133.83 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -142.63 145.9 33.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.036 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 78.4 p -132.24 141.97 49.23 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -154.15 155.55 35.56 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.64 137.07 34.15 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-O 119.136 -0.459 . . . . 0.0 110.656 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.87 158.63 38.7 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 121.423 1.415 . . . . 0.0 111.519 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.773 ' H ' HE22 ' A' ' 118' ' ' GLN . 93.3 mt-10 -74.06 154.04 39.38 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -84.38 -42.23 15.9 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.75 0.31 . . . . 0.0 110.782 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 71.1 p -63.09 -44.93 94.36 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.536 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -93.43 147.95 34.63 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-O 119.592 -0.242 . . . . 0.0 110.76 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -62.32 137.22 64.21 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 121.424 1.416 . . . . 0.0 111.864 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.482 ' NH2' ' ND2' ' A' ' 2' ' ' ASN . 17.2 ptm180 -69.11 -37.55 78.43 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.988 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -56.67 -41.33 77.09 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.936 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.6 tp -63.86 -42.98 97.41 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.715 0.293 . . . . 0.0 110.427 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.773 HE22 ' H ' ' A' ' 110' ' ' GLU . 76.8 mt-30 -60.97 -46.91 88.85 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.549 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.53 -48.09 69.37 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.774 0.321 . . . . 0.0 110.506 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.7 t -63.34 -42.57 98.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.337 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.68 -51.78 55.21 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -64.17 -36.06 82.81 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.967 0.384 . . . . 0.0 110.291 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -73.61 -38.19 65.16 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.17 -51.23 70.89 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.9 tt -61.7 -37.76 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.4 mt -63.26 -40.92 98.77 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -64.2 -41.29 97.14 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 110.049 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.5 m -61.05 -33.32 73.13 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.132 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -55.76 -46.29 77.9 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.986 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -63.39 -44.71 93.93 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.174 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 47.2 m -61.41 -43.77 98.29 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.498 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -62.22 -44.3 96.88 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.208 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.3 m -58.48 -47.92 82.48 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.832 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -66.9 -43.96 82.05 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.357 -0.383 . . . . 0.0 109.974 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -64.47 -35.46 81.0 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.304 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -60.99 -42.89 99.28 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 50.7 tp -152.44 122.39 7.03 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -79.15 35.28 0.26 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.128 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 54.19 79.55 0.13 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.79 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -67.53 141.07 57.0 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.903 0.382 . . . . 0.0 110.094 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -67.4 139.06 57.12 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.939 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -162.48 155.58 20.01 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.054 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -169.0 89.63 0.21 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 64.8 m80 . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.415 179.614 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -79.31 8.85 5.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.768 0.318 . . . . 0.0 110.442 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -125.15 52.86 1.56 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.991 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.4 mt -50.14 138.15 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.4 m -133.42 134.47 43.67 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.24 156.34 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.427 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 32.8 mp0 -140.75 158.36 44.08 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.917 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.9 p -143.88 140.46 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.5 p -93.44 113.95 26.23 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.7 t -119.01 125.9 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -98.23 87.84 4.02 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.09 152.78 4.38 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.087 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.63 135.88 57.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.485 HD13 ' CE1' ' A' ' 94' ' ' PHE . 9.7 tp -53.41 -32.2 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.622 0.248 . . . . 0.0 111.441 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -59.51 -39.74 84.8 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.774 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -75.17 -46.4 34.43 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 110.437 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.5 t -62.53 -43.44 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.24 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.7 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 25.2 t-105 -56.26 -46.05 79.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.934 0.397 . . . . 0.0 110.583 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -67.38 -45.43 76.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.606 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -65.31 -43.43 91.09 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.793 0.33 . . . . 0.0 111.136 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -70.43 -20.02 62.94 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.647 -178.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -104.68 -22.25 13.26 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.139 0.576 . . . . 0.0 111.41 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -65.8 132.09 94.76 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.02 -40.55 1.28 Allowed 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 121.262 1.308 . . . . 0.0 111.57 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.76 -35.9 69.19 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.085 0.469 . . . . 0.0 110.833 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -73.86 -45.8 48.82 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.255 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 91.8 mt -61.85 -50.29 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 121.816 -0.553 . . . . 0.0 111.015 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 20.0 ptm -60.8 -17.38 49.14 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -74.2 -31.73 62.76 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -133.41 14.86 4.11 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.602 0.361 . . . . 0.0 110.837 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.531 ' C ' ' H ' ' A' ' 33' ' ' ALA . 20.4 t -53.95 136.4 41.12 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 122.138 -0.351 . . . . 0.0 110.279 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 70.81 -36.25 0.35 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.539 0.524 . . . . 0.0 110.011 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 56.86 36.16 27.34 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.763 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.0 m -131.63 141.51 41.92 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 122.682 0.393 . . . . 0.0 110.436 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -75.46 -8.9 19.9 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.04 1.827 . . . . 0.0 112.03 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -86.31 7.32 25.9 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.681 0.277 . . . . 0.0 110.457 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -153.45 155.66 36.72 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.243 0.544 . . . . 0.0 110.357 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -148.55 163.18 37.98 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.303 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.6 t -127.62 91.94 44.24 Favored Pre-proline 0 N--CA 1.476 0.833 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.81 -1.94 12.09 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.768 1.645 . . . . 0.0 111.709 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.25 152.42 8.96 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.884 0.373 . . . . 0.0 110.078 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -166.07 150.47 8.03 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.36 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -136.77 150.47 48.4 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.917 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -160.88 131.4 5.25 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.09 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -129.54 95.83 4.11 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.4 tp -63.79 93.87 0.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.08 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -168.19 140.9 3.05 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.96 137.75 58.21 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.425 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.87 1.65 48.24 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.9 148.12 34.45 Favored Glycine 0 N--CA 1.465 0.6 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.1 p -111.7 157.43 20.5 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.899 0.48 . . . . 0.0 109.846 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 69' ' ' GLY . 45.5 p90 -156.72 169.18 25.32 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.026 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 29.7 m -156.39 141.58 17.39 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.1 m -122.09 120.74 35.17 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.8 m -86.39 111.14 20.22 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 44.3 ttp -127.74 114.07 16.81 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -132.08 141.48 49.2 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.59 0.356 . . . . 0.0 110.275 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.35 148.07 33.75 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -58.83 -37.9 77.47 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.712 0.291 . . . . 0.0 110.263 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -74.51 -10.6 59.72 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.89 17.66 67.73 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 38.9 t -62.48 -42.22 99.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.801 0.334 . . . . 0.0 111.012 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 62.4 ttp -145.19 147.0 31.97 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.175 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.5 t -144.7 154.7 43.04 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.135 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -154.13 143.25 21.24 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -95.47 108.85 21.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.467 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -96.04 130.66 42.99 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.95 176.44 41.95 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.404 ' O ' ' CE1' ' A' ' 52' ' ' PHE . . . -174.57 -172.42 39.64 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 36.7 t -126.94 132.48 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -72.68 113.79 10.1 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.42 ' O ' ' NE2' ' A' ' 73' ' ' GLN . 23.9 t0 -74.29 -48.14 30.36 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.42 ' NE2' ' O ' ' A' ' 72' ' ' ASP . 99.2 mm-40 -139.81 137.88 35.35 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -132.78 125.82 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -144.19 113.15 6.77 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.3 m -47.38 116.49 1.44 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.4 m120 53.98 71.21 0.53 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.602 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -168.65 -68.86 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.634 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.0 tp -150.12 133.69 16.62 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.7 HD11 ' CZ3' ' A' ' 18' ' ' TRP . 84.5 mt -128.49 125.21 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -153.6 152.13 30.53 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 20.2 p90 -151.2 152.25 33.03 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.9 m -82.16 128.53 34.24 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.479 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.3 mm -82.27 144.1 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.251 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -56.32 -41.64 87.62 Favored Glycine 0 CA--C 1.532 1.13 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -66.21 -5.28 9.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.758 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.17 0.89 84.82 Favored Glycine 0 N--CA 1.473 1.132 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -66.84 159.3 28.47 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -113.92 132.84 55.79 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.97 0.415 . . . . 0.0 109.944 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.2 t -136.48 134.35 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -135.43 127.34 29.48 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.82 117.46 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.56 128.58 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.485 ' CE1' HD13 ' A' ' 14' ' ' ILE . 4.0 t80 -92.46 126.32 37.49 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 35.9 m -146.21 141.25 27.23 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.433 ' ND1' ' N ' ' A' ' 96' ' ' HIS . 2.3 p-80 -153.69 148.84 26.87 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.2 p -98.05 -13.63 20.94 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.011 0.434 . . . . 0.0 109.957 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.43 -101.29 0.2 Allowed Glycine 0 N--CA 1.465 0.622 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 18.0 p-10 -78.0 -2.06 35.2 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.343 0.257 . . . . 0.0 110.892 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.0 p -118.54 128.18 54.32 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.03 0.532 . . . . 0.0 109.709 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 85.9 m -103.72 135.07 45.97 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.666 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -119.23 115.37 24.05 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.8 mt -101.51 125.79 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.3 t -121.35 127.57 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -142.43 144.47 33.1 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 94.7 p -130.51 148.9 52.37 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.117 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -137.22 150.57 47.96 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.153 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -89.81 110.95 43.33 Favored Pre-proline 0 CA--C 1.551 0.982 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.992 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.82 159.28 27.81 Favored 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 122.002 1.801 . . . . 0.0 112.145 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.8 151.94 31.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.839 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -78.23 -39.97 38.73 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.66 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 76.1 p -63.46 -44.61 93.98 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.472 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -87.53 144.65 35.84 Favored Pre-proline 0 N--CA 1.474 0.744 0 CA-C-O 119.553 -0.26 . . . . 0.0 110.53 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -70.02 134.22 26.93 Favored 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 121.652 1.568 . . . . 0.0 111.819 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -65.25 -34.24 77.88 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.891 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -49.91 -39.36 39.63 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.942 0.401 . . . . 0.0 111.526 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.427 ' N ' HD22 ' A' ' 117' ' ' LEU . 3.8 mm? -75.83 -39.53 56.55 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -65.27 -54.61 26.61 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 121.052 -0.259 . . . . 0.0 111.069 -178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.503 ' NE2' ' NE2' ' A' ' 123' ' ' GLN . 0.0 OUTLIER -55.52 -38.81 69.71 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.188 0.518 . . . . 0.0 110.633 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.412 ' N ' ' OE1' ' A' ' 119' ' ' GLN . 40.7 t -59.0 -40.83 86.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.954 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.4 -48.23 64.96 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.717 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -59.04 -39.71 82.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.802 0.334 . . . . 0.0 110.563 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.503 ' NE2' ' NE2' ' A' ' 119' ' ' GLN . 78.3 mt-30 -74.85 -34.65 62.32 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.75 -51.0 71.63 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.7 tt -63.19 -39.11 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.7 mt -63.56 -40.04 95.96 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -62.71 -39.66 94.73 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.5 t -60.02 -37.07 78.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.811 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -57.23 -47.47 81.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.681 -179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -64.36 -41.99 96.45 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 41.9 t -60.5 -43.91 96.53 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.576 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -61.99 -47.3 85.42 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.243 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.0 m -61.44 -46.19 91.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.587 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -65.77 -35.53 80.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.025 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -62.96 -34.82 78.32 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.361 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -61.57 -36.4 80.54 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.423 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.6 mt 56.14 -111.36 0.61 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.515 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -62.5 175.41 0.78 Allowed 'General case' 0 C--O 1.232 0.158 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -167.25 133.77 2.25 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -169.91 23.02 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.968 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -60.37 -43.72 96.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.267 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 83.4 t60 50.94 86.81 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.743 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 53.1 80.48 0.1 Allowed 'General case' 0 CA--C 1.535 0.365 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.909 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 117.925 -1.036 . . . . 0.0 111.205 -179.8 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -158.21 115.98 2.97 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -126.39 55.6 1.5 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.132 0.573 . . . . 0.0 110.291 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 76.9 mt -46.38 138.16 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.0 m -136.29 136.95 40.21 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.5 m -136.77 156.33 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 7' ' ' GLU . 31.6 mp0 -141.06 158.91 43.28 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.851 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 p -151.26 142.59 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.186 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.5 p -97.32 124.11 41.35 Favored 'General case' 0 C--N 1.334 -0.083 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.7 t -128.46 129.48 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -93.83 88.2 5.68 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.48 151.73 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.19 133.74 54.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.143 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.6 tt -53.44 -36.48 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.701 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.407 ' OE2' ' N ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -63.31 -34.98 78.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.984 0.421 . . . . 0.0 110.011 -179.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.407 ' N ' ' OE2' ' A' ' 15' ' ' GLU . 63.9 tttm -73.38 -50.21 23.11 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.9 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.35 -42.64 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.154 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.476 ' NE1' ' ND2' ' A' ' 22' ' ' ASN . 25.9 t-105 -54.13 -40.15 67.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.763 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -65.46 -54.31 30.23 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.538 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -69.53 -41.63 75.71 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.838 0.351 . . . . 0.0 111.396 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -61.82 -20.69 63.91 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.708 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.476 ' ND2' ' NE1' ' A' ' 18' ' ' TRP . 91.8 m-20 -106.22 -19.58 13.66 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.809 0.444 . . . . 0.0 110.282 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -68.27 122.92 86.1 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.7 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.93 -35.1 12.74 Favored 'Trans proline' 0 N--CA 1.504 2.125 0 C-N-CA 121.324 1.35 . . . . 0.0 112.217 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.73 -39.57 94.48 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.84 0.352 . . . . 0.0 110.48 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.539 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 84.4 t60 -65.36 -45.39 84.33 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.37 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 31' ' ' CYS . 96.7 mt -62.48 -43.84 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 36.3 ttp -54.85 -15.96 2.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.497 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -84.49 -25.98 28.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.641 0.258 . . . . 0.0 111.355 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.539 ' HE1' ' CD2' ' A' ' 26' ' ' HIS . 56.7 p-90 -140.75 26.21 2.1 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.878 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.588 ' C ' ' H ' ' A' ' 33' ' ' ALA . 16.1 t -59.73 130.24 45.82 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 121.937 -0.477 . . . . 0.0 110.12 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 66.08 -27.46 0.11 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.754 0.658 . . . . 0.0 110.55 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.588 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 51.96 30.26 7.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.0 t -118.86 136.71 24.39 Favored Pre-proline 0 N--CA 1.48 1.068 0 O-C-N 123.476 0.485 . . . . 0.0 111.168 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -73.95 -13.02 24.01 Favored 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 121.931 1.754 . . . . 0.0 111.939 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -85.05 9.78 13.78 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.921 0.391 . . . . 0.0 110.911 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -149.31 162.17 40.59 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.232 0.539 . . . . 0.0 109.747 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -148.74 162.89 38.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.911 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -137.79 91.2 13.77 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.8 -3.07 13.36 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 122.312 2.008 . . . . 0.0 112.049 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.29 153.06 11.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.737 0.303 . . . . 0.0 110.228 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -165.03 148.21 8.4 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -150.72 152.99 34.73 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -163.16 103.65 0.98 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.095 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -85.68 90.99 8.16 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.6 tp -65.41 95.66 0.21 Allowed 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -169.51 140.69 2.28 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.08 138.05 57.96 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.192 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.87 -2.29 60.32 Favored Glycine 0 N--CA 1.467 0.732 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.18 174.22 43.54 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 t -135.21 168.06 19.86 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -135.89 167.19 21.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.975 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.9 m -160.66 125.93 3.83 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.7 m -123.99 125.63 44.91 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 m -86.73 112.17 21.41 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 72.4 mtp -119.72 118.62 31.39 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.49 139.72 40.74 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.53 147.59 52.48 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -55.18 -34.89 64.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 110.668 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -82.71 -9.21 59.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.345 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.83 15.34 64.46 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.6 t -62.5 -40.97 98.43 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.72 0.295 . . . . 0.0 110.664 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 44.6 ttp -143.58 143.32 31.45 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.09 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.6 p -145.83 157.56 43.91 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.878 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.448 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 63.5 t80 -159.81 166.69 29.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.517 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.448 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 24.1 p-10 -138.2 121.92 17.53 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.045 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -94.38 143.62 26.24 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.92 157.44 28.01 Favored Glycine 0 C--N 1.331 0.268 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -175.51 -173.06 40.92 Favored Glycine 0 CA--C 1.52 0.353 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.4 t -128.31 135.85 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -76.06 120.0 20.77 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -74.05 -45.08 51.7 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.893 0.377 . . . . 0.0 110.23 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -148.77 139.42 22.73 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -137.34 127.67 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -144.16 129.01 18.39 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.0 m -60.55 135.01 57.62 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.793 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 54.81 57.8 5.37 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.915 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -154.37 -82.76 0.08 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.934 0.397 . . . . 0.0 110.273 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -163.07 160.56 24.58 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.26 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 72.2 mt -134.38 135.96 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.404 ' OE1' ' NH1' ' A' ' 91' ' ' ARG . 14.2 pt-20 -149.92 154.92 39.09 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -158.91 155.2 27.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.9 m -95.57 134.41 38.48 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.7 mt -101.32 152.74 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -51.88 -42.19 53.05 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -60.83 -17.46 49.97 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.984 0.421 . . . . 0.0 110.095 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.42 7.55 72.34 Favored Glycine 0 N--CA 1.471 0.99 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -70.58 139.35 51.45 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.3 tptp -93.7 136.47 33.94 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.0 t -137.83 132.12 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.404 ' NH1' ' OE1' ' A' ' 81' ' ' GLU . 70.2 mtp85 -135.61 135.53 40.31 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.9 mt -124.18 114.07 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.88 129.11 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -95.8 132.8 40.67 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 75.5 p -136.11 155.47 50.13 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -152.43 143.64 23.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.738 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 59.4 p -91.1 -41.46 11.04 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.003 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 173.45 -68.06 0.11 Allowed Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -107.28 17.4 22.92 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.157 0.583 . . . . 0.0 110.73 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.5 m -155.77 119.79 4.52 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.105 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 43.0 m -83.99 146.44 27.99 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -128.49 122.61 31.59 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.6 mt -100.27 126.67 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.37 126.73 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -144.71 146.49 32.23 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.523 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 96.5 p -134.52 147.5 50.33 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -122.27 170.95 9.41 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -137.17 78.29 40.27 Favored Pre-proline 0 N--CA 1.469 0.491 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.58 -172.5 1.55 Allowed 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.161 1.907 . . . . 0.0 111.494 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -61.28 138.12 58.24 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.136 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -67.83 -40.03 83.8 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.527 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.8 p -62.59 -40.77 97.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.976 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -61.25 147.37 87.15 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.703 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.87 112.75 3.35 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.712 1.608 . . . . 0.0 111.586 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -62.82 -31.94 73.04 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.25 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -59.52 -45.68 91.03 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.613 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.429 ' O ' HD23 ' A' ' 117' ' ' LEU . 1.4 tt -64.62 -47.0 80.19 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.104 0.478 . . . . 0.0 109.768 -178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -62.35 -41.29 98.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.474 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -54.02 -41.35 67.9 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.508 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.2 t -60.91 -41.85 96.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.396 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -61.51 -50.9 61.68 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -61.36 -36.33 79.93 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.015 0.436 . . . . 0.0 110.18 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -75.86 -36.45 59.56 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.138 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.35 -51.41 70.06 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.003 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.8 tt -61.1 -37.33 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.8 mt -63.74 -40.67 97.3 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.334 -0.393 . . . . 0.0 109.962 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -63.9 -39.23 93.7 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.2 m -57.6 -35.52 70.53 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 110.665 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -58.34 -43.58 88.37 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.465 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -61.49 -45.05 95.88 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.682 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 89.7 p -63.0 -40.49 97.95 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.24 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -60.57 -45.02 95.5 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.379 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 28.5 m -59.07 -46.82 87.3 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.563 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -67.58 -44.29 78.52 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.213 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -63.85 -38.36 90.81 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.427 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -63.03 -14.84 53.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.16 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.2 tp 55.51 84.86 0.07 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.194 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -73.44 86.8 1.54 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 139' ' ' HIS . 81.1 t60 52.45 19.0 1.04 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.896 0.379 . . . . 0.0 111.061 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.531 ' CG ' ' H ' ' A' ' 141' ' ' HIS . 79.7 t60 57.52 175.72 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.158 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.531 ' H ' ' CG ' ' A' ' 140' ' ' HIS . 61.1 t-80 -160.32 142.64 13.03 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -164.7 -28.82 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.169 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.434 ' CE1' ' NE2' ' A' ' 141' ' ' HIS . 29.6 p80 -62.01 138.75 58.41 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.349 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.19 -179.866 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.695 HD21 HH21 ' A' ' 115' ' ' ARG . 9.6 m120 -61.98 -40.54 95.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.933 0.397 . . . . 0.0 110.443 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -73.09 52.65 0.34 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.04 0.448 . . . . 0.0 110.024 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.9 mt -53.26 134.63 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.5 m -131.19 130.99 43.68 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.8 m -137.32 159.01 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -148.47 162.41 39.68 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.417 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 p -144.14 142.54 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 m -95.46 117.65 30.76 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.9 t -123.43 129.38 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -97.61 87.55 4.11 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.82 152.54 4.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.984 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.86 133.04 52.62 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.041 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.8 tt -53.36 -36.69 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.736 0.303 . . . . 0.0 111.629 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -60.35 -35.29 75.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.424 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -74.92 -47.17 31.16 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.165 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.3 -43.03 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.31 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.663 ' CH2' HD11 ' A' ' 80' ' ' ILE . 26.6 t-105 -53.98 -43.54 70.06 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.139 0.495 . . . . 0.0 110.864 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -67.69 -45.78 74.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.614 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -66.63 -42.72 86.32 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.886 0.374 . . . . 0.0 111.332 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -68.73 -18.09 64.17 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.571 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -109.66 -29.54 8.31 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.938 0.495 . . . . 0.0 111.981 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -51.42 106.21 0.62 Allowed Pre-proline 0 CA--C 1.561 1.383 0 CA-C-O 118.734 -0.651 . . . . 0.0 109.519 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.53 -43.33 55.61 Favored 'Trans proline' 0 N--CA 1.506 2.254 0 CA-C-N 121.006 1.395 . . . . 0.0 112.331 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.46 84.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.257 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -69.04 -36.93 78.27 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.371 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 98.7 mt -62.0 -52.41 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 O-C-N 121.856 -0.528 . . . . 0.0 111.218 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.8 ptp -61.59 -16.55 49.14 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -70.15 -26.92 64.16 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 32' ' ' GLN . 68.8 p-90 -134.17 6.79 3.63 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 119.525 -0.274 . . . . 0.0 111.096 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 43.4 t -67.93 72.52 0.17 Allowed 'General case' 0 C--O 1.226 -0.175 0 CA-C-O 121.416 0.627 . . . . 0.0 109.706 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 30' ' ' TRP . 55.6 tt0 -161.74 63.17 0.25 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.615 ' HB2' HD12 ' A' ' 125' ' ' ILE . . . -69.77 -5.02 22.51 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.09 -1.413 . . . . 0.0 110.716 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 79.4 p -146.2 140.67 15.67 Favored Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.33 -13.92 22.95 Favored 'Trans proline' 0 N--CA 1.509 2.44 0 C-N-CA 122.071 1.847 . . . . 0.0 112.372 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -83.97 14.07 4.42 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.676 0.274 . . . . 0.0 110.598 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -147.71 143.99 27.99 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -130.95 163.01 28.46 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 t -127.93 87.35 55.92 Favored Pre-proline 0 N--CA 1.477 0.914 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -79.89 -7.83 14.42 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.816 1.678 . . . . 0.0 111.496 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.79 151.37 4.19 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -170.0 156.05 5.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.432 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -148.11 154.05 39.68 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.86 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -163.58 135.27 4.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.591 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -129.0 101.15 5.93 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tp -69.27 99.39 1.16 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.5 tptt -166.91 138.18 3.28 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.85 137.1 58.15 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.694 0.283 . . . . 0.0 110.436 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.96 2.14 60.99 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.2 169.57 38.21 Favored Glycine 0 N--CA 1.47 0.902 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 t -130.2 165.39 22.47 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.095 0.474 . . . . 0.0 110.203 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -140.5 162.15 36.03 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.53 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.3 m -150.45 134.91 17.25 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.8 p -131.39 119.17 21.28 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.6 m -88.98 118.19 28.53 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.4 mtp -134.4 125.91 28.49 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -143.87 146.74 33.24 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.279 0.561 . . . . 0.0 110.398 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.18 148.94 43.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.604 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -56.52 -39.67 73.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.817 0.341 . . . . 0.0 110.451 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -75.14 -10.49 59.52 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.876 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.29 10.82 70.41 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.2 t -62.72 -41.97 99.42 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 123.008 -0.113 . . . . 0.0 111.057 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.1 tpt -120.2 143.18 48.39 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.6 t -143.53 139.41 29.76 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.454 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 58.5 t80 -160.0 160.54 33.43 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.454 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 73.8 m-20 -138.03 128.34 26.14 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.5 134.08 38.76 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.38 156.13 26.75 Favored Glycine 0 N--CA 1.465 0.614 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.6 -172.14 40.98 Favored Glycine 0 CA--C 1.517 0.177 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.03 140.8 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 122.593 0.357 . . . . 0.0 110.301 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -79.24 121.69 25.38 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.06 -39.09 63.73 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.226 0.536 . . . . 0.0 109.757 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -166.16 147.75 6.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.218 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.7 t -137.39 135.26 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -140.74 119.63 12.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.7 m -50.99 118.61 3.29 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.7 m120 52.89 72.17 0.44 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.915 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -168.15 -77.02 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.256 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 51.0 tp -150.99 140.6 21.65 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.349 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.663 HD11 ' CH2' ' A' ' 18' ' ' TRP . 61.7 mt -132.09 132.09 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -153.14 155.15 36.2 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -155.81 155.1 32.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.4 m -98.64 128.69 45.02 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.423 HG22 ' H ' ' A' ' 86' ' ' ASP . 88.3 mt -92.06 150.48 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.95 -41.44 68.05 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.554 -0.619 . . . . 0.0 111.554 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.423 ' H ' HG22 ' A' ' 84' ' ' ILE . 81.2 m-20 -60.71 -12.14 9.57 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.727 0.298 . . . . 0.0 110.477 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.49 -3.56 81.81 Favored Glycine 0 N--CA 1.468 0.822 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -65.88 138.42 57.85 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -98.37 142.69 29.69 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 43.2 t -143.46 136.66 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -136.24 138.77 42.16 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 63.1 mt -129.94 114.68 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.0 p -107.91 132.58 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -103.83 117.52 34.53 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.5 m -109.17 152.08 25.61 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -145.85 143.08 29.39 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 65.2 p -144.03 105.09 4.22 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.842 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 65.96 -93.92 0.2 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 21.3 p-10 -132.06 32.7 3.99 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.607 0.363 . . . . 0.0 110.984 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 33.3 m -134.72 126.64 29.43 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 86.6 m -108.26 124.97 51.12 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -117.18 121.24 40.68 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.8 mt -98.03 124.48 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.88 130.66 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -142.5 144.22 32.89 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 56.4 m -123.33 148.62 45.82 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -128.61 153.38 47.32 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -124.3 78.4 60.81 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.66 177.02 9.22 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 121.977 1.784 . . . . 0.0 111.775 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -72.07 152.73 42.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.46 0.647 . . . . 0.0 110.465 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -66.83 -42.73 85.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.339 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 58.3 p -64.43 -40.59 96.04 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.565 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -61.32 144.91 91.25 Favored Pre-proline 0 CA--C 1.551 0.996 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.795 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.57 114.44 4.01 Favored 'Trans proline' 0 N--CA 1.505 2.198 0 C-N-CA 122.098 1.866 . . . . 0.0 111.786 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.695 HH21 HD21 ' A' ' 2' ' ' ASN . 79.0 mtt85 -64.37 -42.16 96.34 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.493 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -53.05 -44.56 67.52 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.47 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.4 tp -63.29 -45.44 91.43 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.955 0.407 . . . . 0.0 110.72 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -63.9 -53.25 53.33 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.227 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -55.04 -41.79 71.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.997 0.427 . . . . 0.0 110.358 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.1 t -61.24 -43.36 99.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.352 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.79 -51.7 57.03 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -65.23 -42.96 92.89 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.84 0.352 . . . . 0.0 110.169 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.85 -38.9 92.79 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.56 -54.16 49.16 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.615 HD12 ' HB2' ' A' ' 33' ' ' ALA . 12.9 tt -67.39 -37.54 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.312 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 27.2 mt -61.52 -41.62 97.59 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.766 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 128' ' ' SER . 25.2 p30 -67.48 -31.68 71.99 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.16 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.415 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 96.2 p -76.79 -29.16 55.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.936 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -54.43 -50.72 66.97 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -66.98 -36.07 81.38 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.841 0.353 . . . . 0.0 110.594 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.3 t -60.17 -41.25 92.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.766 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -60.56 -49.19 78.55 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.039 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.9 p -65.84 -37.7 86.9 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.373 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -66.64 -32.68 74.16 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.425 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -60.46 -35.09 75.03 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.474 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -62.41 -41.68 98.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.672 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.436 ' N ' HD12 ' A' ' 137' ' ' LEU . 9.9 mp -76.75 142.65 40.34 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -64.52 142.78 58.3 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.33 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -64.5 -38.39 90.84 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.426 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -64.22 141.43 58.77 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.346 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.499 ' ND1' ' ND1' ' A' ' 144' ' ' HIS . 17.1 p80 -60.99 100.63 0.12 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.46 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -73.26 -3.76 28.88 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.401 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -59.16 -47.68 84.39 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.652 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.499 ' ND1' ' ND1' ' A' ' 141' ' ' HIS . 76.0 m80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.007 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.527 ' N ' HH12 ' A' ' 115' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -82.42 25.92 0.59 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -125.83 52.89 1.63 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.111 0.564 . . . . 0.0 110.269 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.3 mm -51.77 136.18 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.5 m -135.73 128.9 31.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.988 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.96 149.83 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -148.91 158.29 44.06 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.664 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.43 158.9 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.503 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -122.45 124.71 44.25 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.3 p -128.42 141.8 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 122.542 0.337 . . . . 0.0 110.769 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -87.7 87.1 7.28 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.152 0.501 . . . . 0.0 110.078 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.41 147.05 4.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.403 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.16 137.67 58.07 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.242 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 17.6 tt -52.8 -32.24 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.248 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -59.43 -42.73 92.54 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.73 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 tptm -71.03 -44.47 65.75 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.076 0.465 . . . . 0.0 110.487 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.57 -43.11 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.409 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -58.72 -49.93 75.77 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.8 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -67.65 -45.82 74.22 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.575 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -63.18 -44.66 94.81 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 111.096 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -67.35 -21.32 65.65 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.649 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -101.44 -23.96 14.25 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.95 0.5 . . . . 0.0 111.797 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -62.5 117.98 36.41 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 118.743 -0.646 . . . . 0.0 109.284 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.5 -37.16 7.73 Favored 'Trans proline' 0 N--CA 1.504 2.141 0 CA-C-N 121.081 1.422 . . . . 0.0 112.214 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.13 -30.71 66.53 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.927 0.394 . . . . 0.0 111.111 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -79.96 -36.51 36.04 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.384 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 31' ' ' CYS . 96.8 mt -63.39 -42.98 98.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 122.087 -0.383 . . . . 0.0 110.598 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 17.2 ptp -60.09 -14.87 18.91 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.262 -0.274 . . . . 0.0 111.163 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -79.47 -30.57 42.17 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 122.133 -0.354 . . . . 0.0 110.779 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -133.89 20.57 3.82 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.514 ' C ' ' H ' ' A' ' 33' ' ' ALA . 42.9 t -57.35 134.22 55.82 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 121.64 -0.663 . . . . 0.0 111.219 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 70.59 -35.56 0.33 Allowed 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.665 0.603 . . . . 0.0 110.283 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 55.64 33.42 21.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.189 0.518 . . . . 0.0 110.64 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.9 t -124.5 114.12 27.3 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.24 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.79 -22.1 28.23 Favored 'Trans proline' 0 N--CA 1.506 2.22 0 C-N-CA 121.573 1.515 . . . . 0.0 112.184 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -79.91 13.37 2.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.879 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -150.11 159.0 44.75 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.027 0.441 . . . . 0.0 110.254 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -140.0 163.3 33.05 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.387 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 39' ' ' VAL . 6.1 p -126.78 92.52 44.54 Favored Pre-proline 0 N--CA 1.477 0.916 0 C-N-CA 123.559 0.744 . . . . 0.0 109.464 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.2 -12.65 23.34 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 121.302 1.335 . . . . 0.0 111.976 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.57 154.72 5.7 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.983 0.42 . . . . 0.0 110.073 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.81 144.61 13.52 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.904 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -139.86 153.59 47.07 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -159.03 103.37 1.67 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.897 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -93.49 85.83 5.05 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 tp -65.53 92.74 0.14 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -170.21 147.3 3.1 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.916 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.52 136.55 58.06 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.34 -1.77 18.16 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -73.59 155.54 50.02 Favored Glycine 0 N--CA 1.467 0.716 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.9 m -115.69 152.8 32.51 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.92 0.488 . . . . 0.0 109.966 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -136.68 160.55 38.5 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.29 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.0 m -150.99 115.98 5.27 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 43.5 m -109.02 113.09 25.66 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.8 m -94.3 122.07 36.46 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 13.4 ptp -141.82 141.91 33.15 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.81 149.83 33.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.98 0.419 . . . . 0.0 110.369 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.8 148.45 51.23 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -54.88 -38.45 67.55 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 120.815 0.341 . . . . 0.0 110.972 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -79.45 -7.78 58.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.915 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.87 22.09 61.85 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 99.9 p -82.26 -10.47 59.11 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.459 0.171 . . . . 0.0 111.059 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 49.3 ttp -165.78 130.93 2.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.463 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 86.4 p -145.38 164.12 32.47 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.318 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -155.91 143.02 19.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -108.11 114.7 28.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.178 0.591 . . . . 0.0 110.26 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -94.54 137.56 33.51 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.26 157.9 28.73 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.05 -171.59 41.58 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.8 t -131.58 138.52 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -77.55 121.66 24.2 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -72.64 -38.65 67.64 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -163.58 147.71 10.54 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.772 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.5 p -149.22 137.53 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.155 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -145.17 137.44 25.87 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.2 m -56.45 127.66 32.19 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.849 0.357 . . . . 0.0 111.497 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.6 m120 56.36 63.74 1.9 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.211 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -155.22 -84.1 0.06 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.729 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -164.22 159.28 19.92 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.893 0.377 . . . . 0.0 110.771 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.72 130.77 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -145.42 155.11 42.94 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -158.86 156.11 29.02 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.986 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.7 m -97.98 133.02 43.02 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.8 mt -97.87 151.3 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.2 -40.45 67.41 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -60.98 -15.71 34.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.913 0.387 . . . . 0.0 110.118 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 94.27 -0.2 65.96 Favored Glycine 0 N--CA 1.469 0.874 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.65 136.52 45.68 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -99.64 152.37 20.14 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.9 t -140.59 137.11 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -132.79 129.01 38.02 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.5 mt -124.44 112.51 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.9 t -109.98 128.72 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -100.4 127.01 46.83 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.1 p -132.97 153.21 51.66 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -154.0 166.01 34.35 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.847 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 t -136.96 -11.2 1.74 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.883 0.373 . . . . 0.0 110.192 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.21 -127.51 1.29 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 46.2 p-10 -75.03 6.88 3.69 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 122.988 -0.124 . . . . 0.0 110.749 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 53.1 m -124.59 129.73 51.12 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.0 m -106.91 135.86 47.76 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -110.83 111.15 22.11 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.7 mt -92.35 122.65 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.28 126.84 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -143.01 143.49 31.92 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.236 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.2 m -129.15 146.21 51.14 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -117.51 166.09 12.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.127 0.571 . . . . 0.0 109.606 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -128.28 78.57 75.38 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.796 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.42 163.97 33.44 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 121.708 1.605 . . . . 0.0 112.121 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -69.17 174.13 4.95 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.847 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -84.37 -50.79 7.49 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.65 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.3 p -63.28 -41.85 99.04 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.724 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.673 HD22 ' H ' ' A' ' 113' ' ' ASN . 0.7 OUTLIER -59.2 146.72 77.41 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 119.552 -0.261 . . . . 0.0 110.371 -179.069 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.05 105.39 1.82 Allowed 'Trans proline' 0 N--CA 1.504 2.104 0 C-N-CA 121.799 1.666 . . . . 0.0 111.299 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.527 HH12 ' N ' ' A' ' 1' ' ' GLY . 88.4 mtm180 -65.03 -41.97 94.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.177 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.9 -38.06 84.39 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.274 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.87 -50.93 71.44 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.649 0.262 . . . . 0.0 110.916 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -72.74 -27.97 62.35 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.452 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -54.68 -45.4 73.92 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.897 0.38 . . . . 0.0 110.36 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.5 t -68.17 -33.03 73.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.651 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -60.3 -51.19 60.32 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -62.44 -38.4 89.59 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.905 0.383 . . . . 0.0 110.508 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -70.51 -38.29 74.26 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.97 -52.46 65.42 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.096 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.0 tt -60.92 -37.85 77.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.02 -46.91 79.38 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.427 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -77.87 -32.08 51.74 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 122.193 -0.317 . . . . 0.0 111.095 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.9 m -60.12 -40.73 90.72 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.732 0.301 . . . . 0.0 110.455 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -58.28 -44.38 88.43 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.511 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.5 -44.7 96.6 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.284 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 48.8 m -61.0 -49.67 76.48 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.516 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -62.87 -47.72 82.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.818 0.342 . . . . 0.0 110.477 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.408 ' O ' ' ND2' ' A' ' 136' ' ' ASN . 27.4 m -61.62 -45.05 95.75 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.068 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -70.67 -37.57 73.67 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -85.5 8.9 17.42 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.707 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.617 HD22 ' N ' ' A' ' 136' ' ' ASN . 0.1 OUTLIER -58.97 -36.5 74.95 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.276 -179.005 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.483 ' H ' ' ND2' ' A' ' 136' ' ' ASN . 59.8 tp -61.3 -47.93 83.71 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.78 0.324 . . . . 0.0 110.131 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -85.32 162.17 19.2 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.898 0.38 . . . . 0.0 110.04 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -159.12 153.8 24.51 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.766 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -152.88 160.7 43.08 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -64.5 -42.48 95.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.485 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -169.8 -7.5 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.38 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -64.11 -38.58 91.58 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.061 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.905 179.849 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.465 ' H3 ' ' NH1' ' A' ' 115' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -63.03 -42.76 99.84 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.949 0.404 . . . . 0.0 110.183 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -72.61 51.68 0.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.294 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.6 mt -50.37 140.23 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.8 m -134.12 135.26 43.06 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.5 m -132.49 160.72 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -138.44 158.72 43.72 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.957 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.501 ' CG2' HD22 ' A' ' 126' ' ' LEU . 3.7 t -133.48 126.43 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 62.9 p -88.76 109.05 19.84 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.0 t -126.36 127.02 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -97.47 89.13 4.59 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.09 154.75 5.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.032 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.62 132.23 50.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.18 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 16.4 tt -54.08 -34.74 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 120.611 0.244 . . . . 0.0 110.929 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.93 -40.31 92.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.083 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -70.18 -48.09 58.78 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.803 0.335 . . . . 0.0 110.786 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.0 -41.7 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.356 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 42.9 t-105 -50.66 -39.87 51.93 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.551 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -65.68 -48.35 72.36 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.311 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -68.59 -43.0 77.42 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.662 0.268 . . . . 0.0 110.971 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 53.9 t-105 -65.57 -19.39 65.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.612 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.59 HD22 ' N ' ' A' ' 22' ' ' ASN . 0.8 OUTLIER -102.57 -22.82 13.94 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.282 0.633 . . . . 0.0 110.583 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -63.19 120.63 63.36 Favored Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.94 -40.98 4.44 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 CA-C-N 120.997 1.392 . . . . 0.0 112.086 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.96 -30.31 63.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.697 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.556 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 81.1 t60 -78.07 -45.17 24.27 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.378 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 31' ' ' CYS . 95.7 mt -59.73 -50.86 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 121.946 -0.471 . . . . 0.0 111.064 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.6 ptm -57.64 -15.49 7.78 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -79.03 -33.27 44.98 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.556 ' HE1' ' CD2' ' A' ' 26' ' ' HIS . 58.1 p-90 -133.69 20.8 3.89 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.661 -179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.567 ' C ' ' H ' ' A' ' 33' ' ' ALA . 44.1 t -55.12 129.32 37.64 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.764 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 68.63 -19.33 0.16 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.116 0.484 . . . . 0.0 110.496 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.567 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.64 35.55 23.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.482 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -111.25 97.78 36.89 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.064 0.546 . . . . 0.0 110.087 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -53.33 -23.21 22.97 Favored 'Trans proline' 0 N--CA 1.505 2.175 0 C-N-CA 122.378 2.052 . . . . 0.0 112.576 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -68.76 -24.67 64.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.536 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -104.76 163.96 12.12 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -141.22 162.33 35.73 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.21 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.8 t -129.81 89.86 44.9 Favored Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -73.95 -9.04 21.94 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 121.694 1.596 . . . . 0.0 111.873 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.1 152.58 6.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.003 0.43 . . . . 0.0 110.105 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -161.14 145.89 13.75 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.084 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -133.72 150.3 51.5 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -159.86 125.58 4.17 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.698 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -133.25 94.78 3.4 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 92.7 mt -66.83 97.37 0.47 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.139 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -162.56 135.96 6.05 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.69 133.92 56.54 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.673 0.273 . . . . 0.0 110.307 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.06 5.05 69.58 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.21 165.73 39.69 Favored Glycine 0 N--CA 1.467 0.752 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.8 p -131.09 161.56 31.8 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.442 ' CD1' ' CE2' ' A' ' 71' ' ' TYR . 30.6 p90 -154.75 170.02 22.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.068 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.8 m -153.69 139.34 17.89 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.5 m -121.33 120.64 35.67 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.3 m -92.87 123.55 36.22 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.0 ptm -142.76 138.6 30.58 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.18 145.33 26.21 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.044 0.45 . . . . 0.0 110.326 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.48 149.8 28.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.765 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -51.46 -39.93 58.45 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.866 0.365 . . . . 0.0 110.775 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -80.21 -9.32 59.72 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.139 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.3 18.21 67.09 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.0 t -62.19 -40.51 96.29 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.659 0.266 . . . . 0.0 110.922 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 44.3 ttp -142.31 136.78 30.05 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.226 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 88.8 p -145.74 158.86 43.82 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -159.13 139.11 11.94 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -88.56 111.01 21.37 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -94.53 131.01 40.71 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.69 175.11 42.09 Favored Glycine 0 C--O 1.227 -0.335 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.45 -174.01 40.88 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.1 t -117.12 129.39 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.442 ' CE2' ' CD1' ' A' ' 52' ' ' PHE . 74.6 m-85 -72.45 113.48 9.53 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -73.4 -39.05 65.38 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.219 0.533 . . . . 0.0 109.767 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -166.89 146.21 5.4 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.524 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.6 131.03 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -140.03 128.32 22.57 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.5 p -61.51 134.88 57.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.249 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.2 m120 55.98 55.36 6.99 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.673 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -155.1 -82.52 0.07 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.645 0.259 . . . . 0.0 110.35 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -163.63 160.12 22.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.355 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.7 mt -133.7 134.99 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.06 156.69 42.92 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' A' ' 84' ' ' ILE . 37.7 p90 -161.16 156.26 24.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.5 p -103.5 133.06 49.17 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.661 ' N ' HD12 ' A' ' 84' ' ' ILE . 2.6 mp -93.44 160.37 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.437 ' N ' HG22 ' A' ' 84' ' ' ILE . . . -53.25 -44.95 64.93 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 111.306 -0.717 . . . . 0.0 111.306 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -62.8 -12.8 26.84 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.831 0.315 . . . . 0.0 110.36 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.34 9.56 66.93 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -58.94 155.08 13.98 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -114.57 127.73 55.94 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.7 t -136.93 132.02 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -134.98 133.79 39.85 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 77.1 mt -123.72 114.17 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 43.2 t -111.78 129.54 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -98.92 119.58 37.94 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 39.7 m -120.44 148.77 43.37 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 p-80 -154.07 158.23 40.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.0 p -135.86 23.33 3.34 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.249 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 100' ' ' THR . . . 88.34 128.31 2.97 Favored Glycine 0 N--CA 1.47 0.96 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 58.07 6.06 0.46 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.824 0.345 . . . . 0.0 111.061 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 98' ' ' GLY . 28.2 m -148.23 137.56 22.08 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 58.2 m -130.99 125.24 32.8 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -110.32 119.35 38.95 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.4 mt -95.58 120.55 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 36.6 t -105.15 132.07 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -134.0 114.37 13.15 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.7 t -94.52 149.63 21.05 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -144.36 140.9 29.36 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -114.72 90.37 21.85 Favored Pre-proline 0 N--CA 1.478 0.968 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.76 163.85 32.98 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 121.56 1.507 . . . . 0.0 111.638 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -71.27 165.67 23.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.167 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -83.05 -28.54 29.51 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.966 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.9 p -62.74 -44.67 95.6 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.063 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -86.48 145.22 39.18 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -70.22 138.73 37.02 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.534 1.489 . . . . 0.0 111.813 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.465 ' NH1' ' H3 ' ' A' ' 1' ' ' GLY . 87.6 mtm180 -66.19 -38.94 89.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.128 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -50.07 -45.38 52.4 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.389 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.34 -45.94 85.62 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.899 0.38 . . . . 0.0 110.536 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -64.34 -50.38 67.98 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.725 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -51.54 -50.64 59.63 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.871 0.367 . . . . 0.0 110.363 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.5 m -62.33 -38.55 89.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.601 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.44 -52.33 49.9 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.943 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -62.45 -39.44 93.37 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.772 0.286 . . . . 0.0 110.483 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.635 ' NE2' HD21 ' A' ' 127' ' ' ASN . 0.0 OUTLIER -74.07 -35.08 64.23 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.625 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.14 -50.54 73.64 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.45 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.4 pt -63.64 -34.53 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.818 0.342 . . . . 0.0 110.798 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.501 HD22 ' CG2' ' A' ' 8' ' ' VAL . 36.0 mt -64.67 -37.07 86.34 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.029 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.635 HD21 ' NE2' ' A' ' 123' ' ' GLN . 80.0 m-20 -61.24 -40.63 94.76 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.751 0.31 . . . . 0.0 110.461 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.7 t -62.69 -40.3 96.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.549 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -58.17 -44.63 88.08 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.443 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -62.11 -40.69 96.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.084 0.468 . . . . 0.0 110.392 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 42.1 m -69.04 -34.93 75.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.529 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -60.06 -52.28 66.06 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.019 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 3.2 t -64.57 -33.72 76.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.445 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -69.85 -46.73 64.92 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.772 0.32 . . . . 0.0 110.387 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -65.84 -26.45 67.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.935 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -62.84 -43.08 99.76 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.442 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.6 mt -75.83 139.22 41.62 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.983 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -71.5 153.39 42.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.053 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -60.58 -87.35 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.617 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 73.4 m80 48.17 -106.35 0.17 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.524 0.202 . . . . 0.0 110.765 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 48.3 m170 49.74 -97.29 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.534 0.206 . . . . 0.0 110.983 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -70.34 136.97 50.21 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -70.04 137.98 51.75 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.585 -179.795 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 42.19 -160.1 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.791 0.436 . . . . 0.0 111.199 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -75.47 -69.68 0.47 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 109.973 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 81.3 mt -142.28 133.01 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.8 m -137.77 133.43 34.05 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 m -138.7 153.35 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.11 163.94 36.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.049 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.9 m -145.83 157.52 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -102.73 126.73 49.95 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.19 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.4 t -131.06 129.5 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -98.59 89.2 4.31 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.14 155.25 6.43 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.8 135.91 57.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.209 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.6 tp -52.88 -36.49 23.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 CA-C-O 121.1 0.476 . . . . 0.0 111.417 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -68.87 -33.62 74.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.167 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -71.42 -51.73 22.36 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.603 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.5 p -62.51 -36.3 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.676 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.473 ' CE2' ' ND2' ' A' ' 22' ' ' ASN . 68.4 t90 -54.47 -44.0 72.21 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.979 0.418 . . . . 0.0 110.906 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -69.39 -45.94 68.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.712 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -65.32 -40.56 93.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.982 0.42 . . . . 0.0 110.96 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -73.54 -17.22 61.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.707 -178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.473 ' ND2' ' CE2' ' A' ' 18' ' ' TRP . 90.4 m-20 -109.41 -20.39 12.93 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.182 0.593 . . . . 0.0 110.72 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -64.41 138.71 97.52 Favored Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.8 -43.48 0.43 Allowed 'Trans proline' 0 N--CA 1.509 2.383 0 C-N-CA 121.763 1.642 . . . . 0.0 112.43 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.25 -40.56 96.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 110.909 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -66.69 -46.26 76.17 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.641 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 31' ' ' CYS . 89.2 mt -62.8 -48.51 87.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.431 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 43.2 ttp -60.38 -23.27 64.18 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -65.58 -31.78 73.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.437 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -135.67 14.17 3.42 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.444 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 27' ' ' ILE . 12.0 t -55.73 141.05 39.68 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 122.1 -0.375 . . . . 0.0 110.0 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 72.07 -46.79 0.65 Allowed 'General case' 0 C--N 1.331 -0.234 0 O-C-N 124.233 0.958 . . . . 0.0 109.227 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 54.38 40.58 31.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.307 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.5 m -124.32 139.12 32.17 Favored Pre-proline 0 N--CA 1.481 1.121 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.973 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.42 -30.05 8.65 Favored 'Trans proline' 0 N--CA 1.506 2.253 0 C-N-CA 121.941 1.761 . . . . 0.0 112.51 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -77.94 6.47 7.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.725 0.298 . . . . 0.0 110.692 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -147.32 158.39 43.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.182 0.515 . . . . 0.0 109.717 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.4 ' CE1' ' O ' ' A' ' 57' ' ' ALA . 14.3 p-80 -146.59 155.21 42.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.229 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.85 89.63 34.25 Favored Pre-proline 0 N--CA 1.476 0.828 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.63 -1.78 11.89 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.167 1.912 . . . . 0.0 111.587 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.71 147.91 6.13 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.025 0.441 . . . . 0.0 110.031 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.68 141.82 18.34 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.755 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -134.95 137.96 43.6 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -163.17 136.43 5.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.62 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -130.46 99.33 4.96 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 tp -65.43 95.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.877 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -169.54 141.41 2.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.17 135.93 57.79 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.289 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.08 1.7 60.37 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -82.77 158.43 36.96 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 178.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 t -118.27 165.26 14.05 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.142 0.577 . . . . 0.0 109.851 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -144.8 159.77 42.33 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.157 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.2 m -149.36 123.96 9.77 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 67.8 p -120.89 123.33 42.25 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.7 m -90.36 117.4 29.05 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 60.7 mtt -129.87 104.55 7.44 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.4 ' O ' ' CE1' ' A' ' 38' ' ' HIS . . . -126.82 156.42 41.32 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.02 148.83 37.76 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -58.73 -39.54 81.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.77 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -70.7 -9.58 57.51 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.72 9.84 63.0 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.2 t -62.99 -39.36 94.5 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 110.887 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 69.5 mmm -122.63 148.97 44.63 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.882 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 95.3 p -146.81 128.13 14.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.168 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -159.9 155.37 25.47 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -139.71 142.88 36.84 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.274 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.43 143.2 28.4 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.45 152.02 23.7 Favored Glycine 0 N--CA 1.463 0.457 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -176.91 -172.44 41.52 Favored Glycine 0 CA--C 1.518 0.281 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 p -128.48 142.15 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 122.974 0.51 . . . . 0.0 110.175 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -79.01 120.53 23.72 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -74.51 -42.77 58.33 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -168.57 148.31 4.46 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.838 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.57 136.56 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -136.03 124.11 22.95 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.3 m -59.2 130.65 48.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.162 -178.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.2 p30 40.98 57.67 2.7 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -157.77 -77.47 0.08 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 110.449 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.2 tp -149.68 133.88 17.25 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.738 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.437 HD11 ' HE1' ' A' ' 18' ' ' TRP . 61.5 mt -133.02 133.14 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -153.93 160.38 42.09 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -160.2 156.78 27.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.9 m -101.92 127.65 48.66 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.413 HG22 ' H ' ' A' ' 86' ' ' ASP . 86.7 mt -90.54 153.81 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.74 -41.96 67.23 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.413 ' H ' HG22 ' A' ' 84' ' ' ILE . 82.4 m-20 -60.26 -10.58 4.78 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.788 0.328 . . . . 0.0 110.17 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.0 8.81 86.12 Favored Glycine 0 N--CA 1.471 1.023 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.409 ' NH2' ' OE2' ' A' ' 110' ' ' GLU . 89.6 mtt-85 -68.82 150.71 47.51 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -101.89 129.29 48.1 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.8 t -139.77 131.03 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -138.94 141.75 38.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 74.2 mt -118.97 126.93 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.97 126.82 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -99.12 125.84 44.75 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 56.8 p -133.64 143.5 48.64 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -154.89 156.14 35.6 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.6 t -115.59 -24.11 8.45 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.973 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.1 -112.14 0.37 Allowed Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -76.77 10.78 2.01 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.613 0.244 . . . . 0.0 110.67 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.3 p -126.72 144.92 50.78 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.7 m -125.55 131.3 52.79 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.296 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -116.33 121.83 43.11 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.9 mt -102.51 128.98 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.9 t -119.26 133.56 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -137.94 146.08 42.8 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.0 p -133.33 148.84 51.9 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -143.31 143.14 31.57 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.2 115.83 64.71 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.19 157.42 33.71 Favored 'Trans proline' 0 N--CA 1.502 2.022 0 C-N-CA 121.693 1.596 . . . . 0.0 111.399 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.409 ' OE2' ' NH2' ' A' ' 88' ' ' ARG . 70.7 mt-10 -77.6 156.71 30.66 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -80.77 -41.24 23.76 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.309 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 72.9 p -63.06 -44.75 94.98 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -85.18 147.7 48.28 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 119.664 -0.208 . . . . 0.0 110.972 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.72 136.73 64.05 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 121.523 1.482 . . . . 0.0 111.859 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -68.35 -42.0 79.9 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.596 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -52.27 -37.11 54.51 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.76 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 58.3 tp -66.6 -43.29 85.23 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.883 0.373 . . . . 0.0 110.489 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -60.32 -51.76 68.15 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.832 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -53.39 -44.42 68.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.876 0.37 . . . . 0.0 110.145 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.2 m -61.58 -40.94 96.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.255 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -63.97 -51.96 48.94 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -62.39 -37.72 86.83 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.015 0.436 . . . . 0.0 110.299 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -72.29 -35.77 68.78 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.256 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.91 -51.14 70.96 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.56 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 12.6 tt -63.06 -40.13 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 120.791 0.329 . . . . 0.0 110.136 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.2 mt -63.85 -38.86 92.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.4 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -61.99 -38.17 87.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.2 t -57.92 -32.79 68.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.762 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -57.61 -42.36 83.13 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.375 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -61.11 -42.68 98.97 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.369 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 36.5 m -60.98 -39.7 90.6 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.504 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -60.27 -49.08 79.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.61 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.2 p -60.81 -39.53 89.28 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.818 0.342 . . . . 0.0 110.31 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -66.49 -43.73 84.56 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -63.89 -36.65 84.62 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.494 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -62.97 -38.12 89.85 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.196 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.9 tp -61.06 -42.91 99.37 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.156 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -60.92 -45.04 96.26 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.38 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -74.37 132.43 42.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.815 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -69.02 109.78 4.14 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.021 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.479 ' NE2' ' CE1' ' A' ' 142' ' ' HIS . 22.1 p-80 -72.46 -17.78 61.74 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.822 0.344 . . . . 0.0 110.187 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.479 ' CE1' ' NE2' ' A' ' 141' ' ' HIS . 69.2 m80 -63.69 120.18 11.33 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.132 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -74.91 137.66 41.86 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.08 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 28.4 p80 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.383 179.863 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -63.68 -38.23 90.35 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.047 0.451 . . . . 0.0 110.702 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -72.12 55.36 0.31 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.919 0.39 . . . . 0.0 110.423 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 82.7 mt -58.94 131.19 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 t -137.0 149.73 47.67 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.9 m -136.85 158.39 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 161.7 40.31 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.587 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -148.96 143.04 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.886 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.7 m -94.26 119.41 33.01 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.5 t -124.87 128.03 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -95.65 92.47 6.62 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.91 154.52 5.26 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.23 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.89 135.76 57.49 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.339 -0.391 . . . . 0.0 109.956 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.8 tp -50.72 -40.79 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.141 0.496 . . . . 0.0 111.66 -178.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -64.25 -35.27 80.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.551 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -70.54 -46.5 63.48 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.782 0.325 . . . . 0.0 110.424 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.26 -40.39 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.308 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.786 ' CH2' HD11 ' A' ' 80' ' ' ILE . 31.8 t-105 -54.53 -40.49 68.71 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.805 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -67.2 -52.8 36.74 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.278 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -64.84 -42.67 94.74 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.845 0.355 . . . . 0.0 110.885 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -64.13 -18.81 64.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.326 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.439 ' OD1' ' NE1' ' A' ' 18' ' ' TRP . 4.1 m120 -110.2 -25.49 10.14 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 122.845 0.458 . . . . 0.0 112.177 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -53.09 110.21 1.88 Allowed Pre-proline 0 CA--C 1.556 1.196 0 CA-C-O 118.837 -0.602 . . . . 0.0 109.765 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.61 -43.05 58.13 Favored 'Trans proline' 0 N--CA 1.506 2.208 0 CA-C-N 120.869 1.346 . . . . 0.0 111.837 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.8 -34.57 73.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.949 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.537 ' CD2' ' HE1' ' A' ' 30' ' ' TRP . 80.6 t60 -74.15 -42.74 59.46 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.417 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.18 -44.74 99.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.872 -0.517 . . . . 0.0 110.498 -177.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.8 ptm -70.95 -6.42 38.48 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -84.95 -29.59 24.99 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.537 ' HE1' ' CD2' ' A' ' 26' ' ' HIS . 63.3 p-90 -133.78 17.9 3.88 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.593 0.357 . . . . 0.0 110.954 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.59 ' C ' ' H ' ' A' ' 33' ' ' ALA . 32.1 p -45.85 128.95 9.26 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.063 0.392 . . . . 0.0 111.457 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 61.54 -11.02 0.06 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 120.982 0.42 . . . . 0.0 110.523 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.59 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 52.58 32.81 12.3 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.673 0.389 . . . . 0.0 111.24 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.5 t -122.8 135.74 26.07 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 123.011 0.524 . . . . 0.0 110.568 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.87 -9.96 16.86 Favored 'Trans proline' 0 N--CA 1.506 2.249 0 C-N-CA 122.097 1.865 . . . . 0.0 112.418 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -73.91 -24.74 59.73 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.728 0.299 . . . . 0.0 110.737 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -103.66 155.21 18.74 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.663 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -139.02 164.15 30.51 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.1 t -132.36 94.33 23.32 Favored Pre-proline 0 N--CA 1.477 0.925 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.29 -12.01 25.12 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.343 1.362 . . . . 0.0 111.211 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.8 150.8 4.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.418 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.59 141.74 20.42 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.227 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -138.0 142.07 40.42 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -163.13 135.55 5.35 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -129.86 104.0 7.13 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -71.64 93.71 1.27 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.914 0.388 . . . . 0.0 110.111 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -171.41 151.06 2.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.662 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.09 137.95 58.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.661 0.267 . . . . 0.0 110.453 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.31 0.74 47.65 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.85 149.44 44.68 Favored Glycine 0 N--CA 1.464 0.533 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.9 p -110.75 144.01 40.38 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -127.16 152.84 46.81 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.3 m -149.94 116.83 5.92 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.7 m -116.52 115.86 26.55 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.1 m -91.84 116.27 28.76 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 71.3 mtp -117.79 129.43 55.67 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -137.09 135.12 37.17 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.071 0.462 . . . . 0.0 110.57 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.7 149.92 49.38 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.309 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -55.93 -39.7 72.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.626 0.25 . . . . 0.0 110.463 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -76.38 -10.21 59.22 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.62 17.62 62.66 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.6 p -83.93 -9.97 58.31 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.617 0.246 . . . . 0.0 110.774 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 26.7 ttt -152.92 120.86 6.12 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.452 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.2 m -144.25 148.68 35.2 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -158.9 164.55 35.56 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 22.4 p-10 -137.08 123.33 20.56 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.804 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -94.11 145.92 24.34 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.05 153.68 25.12 Favored Glycine 0 N--CA 1.466 0.684 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -177.27 -171.68 41.05 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.8 t -128.63 135.69 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -71.94 121.85 19.81 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -73.56 -38.44 65.2 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -163.05 145.42 10.29 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.508 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.1 t -137.97 130.5 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -146.88 123.8 11.33 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.6 p -51.71 121.92 7.31 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.211 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 54.28 62.02 2.77 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.28 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -156.04 -84.58 0.06 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.753 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.7 tp -148.42 136.24 20.81 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.771 -178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.786 HD11 ' CH2' ' A' ' 18' ' ' TRP . 75.2 mt -130.32 127.82 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -153.49 165.29 36.3 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -160.8 154.42 22.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.836 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.1 m -89.35 131.09 35.59 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 80.0 mt -102.27 148.82 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -53.88 -44.05 71.21 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.0 p30 -61.93 -18.69 61.18 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.367 0.584 . . . . 0.0 110.394 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.07 5.19 77.19 Favored Glycine 0 N--CA 1.47 0.954 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 65.6 mmt-85 -63.04 139.38 58.77 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -89.96 128.53 36.26 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 39.5 t -141.34 125.96 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -136.84 142.92 42.87 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 75.5 mt -119.86 118.94 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.8 t -104.2 124.29 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -96.15 122.43 38.99 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 36.4 m -140.36 146.62 38.65 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -150.74 164.63 35.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.2 t -137.85 23.51 2.85 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.292 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.12 129.65 2.82 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 55.49 12.02 0.7 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.816 0.341 . . . . 0.0 111.037 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.9 m -153.78 140.75 19.27 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.4 m -125.43 130.68 52.33 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.756 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -110.45 117.03 32.49 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.9 mt -106.85 122.21 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.04 139.56 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -144.98 142.76 30.08 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.048 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 87.4 p -94.23 152.7 18.5 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -151.49 139.74 20.31 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -92.15 138.92 24.21 Favored Pre-proline 0 N--CA 1.477 0.884 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.34 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.49 146.3 34.73 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.637 1.558 . . . . 0.0 111.93 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -87.0 153.76 21.3 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -74.01 -39.29 63.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.474 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.0 m -68.51 -46.32 69.91 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.423 HD22 ' C ' ' A' ' 113' ' ' ASN . 0.4 OUTLIER -92.29 133.39 30.06 Favored Pre-proline 0 CA--C 1.55 0.964 0 CA-C-O 118.673 -0.679 . . . . 0.0 110.329 -179.312 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.85 147.45 41.54 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 CA-C-N 120.862 1.344 . . . . 0.0 111.755 178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -68.62 -35.18 76.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.144 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -66.45 -47.21 73.86 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.947 -178.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.23 -52.4 41.47 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -177.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.51 HE21 ' C ' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -58.56 -35.32 72.17 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.888 -179.508 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -57.42 -47.32 82.07 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.84 0.352 . . . . 0.0 110.06 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.0 m -64.04 -33.04 74.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.588 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -59.61 -50.46 67.53 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -62.45 -39.52 93.65 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.985 0.422 . . . . 0.0 110.429 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -71.91 -37.57 70.06 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.348 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.35 -50.69 72.75 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.836 -178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 42.0 pt -65.4 -32.75 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 110.734 -178.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.2 -37.01 82.92 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -62.55 -41.56 98.98 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.08 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 98.9 p -62.52 -32.4 73.33 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.616 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -59.24 -38.62 80.47 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.579 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -59.69 -45.54 91.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.436 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 78.6 p -65.12 -39.52 93.18 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 109.961 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -61.57 -44.9 96.18 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.154 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 27.3 m -58.9 -47.03 86.42 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.928 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -66.55 -42.84 86.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -64.58 -34.93 79.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.468 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -62.93 -47.96 80.99 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.733 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.85 142.88 33.2 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.405 ' O ' ' CG ' ' A' ' 139' ' ' HIS . 93.0 mt-10 53.79 -126.91 2.38 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.726 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.405 ' CG ' ' O ' ' A' ' 138' ' ' GLU . 73.0 m80 -155.4 162.55 40.76 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -60.5 -43.13 97.38 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.359 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -65.39 136.29 56.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.237 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -70.42 143.06 51.94 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.259 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -63.46 142.32 58.44 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.336 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 70.5 m80 . . . . . 0 C--O 1.222 -0.345 0 CA-C-O 118.126 -0.94 . . . . 0.0 110.48 -179.945 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -62.45 -38.63 90.5 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.009 0.433 . . . . 0.0 110.372 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -72.49 51.13 0.25 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.057 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.3 mt -54.65 139.99 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 t -129.27 137.43 51.05 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.682 0.614 . . . . 0.0 109.718 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.61 158.08 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.41 158.0 43.8 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.558 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.9 p -146.14 144.78 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.673 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.9 m -97.58 120.79 38.6 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -125.94 127.5 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -91.7 93.96 9.15 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.8 151.52 3.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.09 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.43 140.44 58.87 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.664 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.7 tp -51.6 -37.22 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.169 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -68.94 -34.32 75.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.435 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -69.3 -50.58 45.44 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.903 0.382 . . . . 0.0 111.218 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -64.3 -36.19 76.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.62 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -58.29 -49.84 75.71 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.614 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -67.64 -45.83 74.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.641 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.45 ' CD2' ' ND1' ' A' ' 26' ' ' HIS . 56.2 t80 -63.88 -44.23 93.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.049 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.414 ' C ' HD22 ' A' ' 22' ' ' ASN . 64.0 t-105 -70.82 -19.65 62.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.626 HD22 ' N ' ' A' ' 22' ' ' ASN . 0.7 OUTLIER -103.05 -23.82 13.66 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.845 0.458 . . . . 0.0 111.437 -179.24 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -62.94 135.17 95.99 Favored Pre-proline 0 CA--C 1.555 1.143 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -75.1 -40.67 0.81 Allowed 'Trans proline' 0 N--CA 1.504 2.142 0 C-N-CA 121.681 1.588 . . . . 0.0 111.745 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.83 -33.0 68.16 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.051 0.453 . . . . 0.0 110.78 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.45 ' ND1' ' CD2' ' A' ' 20' ' ' TYR . 35.5 m170 -76.4 -42.36 44.59 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.573 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.13 -44.93 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 122.161 -0.337 . . . . 0.0 110.804 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.512 ' O ' HG11 ' A' ' 39' ' ' VAL . 25.6 ptm -68.14 -10.64 55.66 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -79.7 -28.6 40.63 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 122.333 -0.23 . . . . 0.0 110.395 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -137.48 21.61 2.93 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.204 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.539 ' C ' ' H ' ' A' ' 33' ' ' ALA . 29.3 t -55.97 133.17 51.44 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.639 -0.663 . . . . 0.0 110.189 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 69.35 -32.08 0.22 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.108 0.563 . . . . 0.0 110.423 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.539 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 55.66 34.61 23.6 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.327 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.8 p -128.51 138.66 33.54 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.087 0.555 . . . . 0.0 110.033 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -76.48 -12.53 18.66 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.746 1.63 . . . . 0.0 112.239 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -76.25 -24.61 54.52 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -115.41 140.2 49.34 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.929 0.492 . . . . 0.0 110.545 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -117.33 163.79 15.81 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.251 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.564 ' O ' HG13 ' A' ' 39' ' ' VAL . 7.7 p -131.84 87.62 44.47 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.079 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.75 -8.2 14.59 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 122.053 1.835 . . . . 0.0 111.559 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.44 153.23 5.11 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.894 0.378 . . . . 0.0 110.055 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -168.99 152.88 5.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.961 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -141.28 155.52 45.98 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -159.25 103.05 1.61 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.019 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -95.59 86.98 4.58 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 tp -66.4 93.25 0.22 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.357 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -169.93 145.19 2.89 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.61 135.93 56.74 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.425 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.16 -1.05 35.76 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -75.96 162.28 52.69 Favored Glycine 0 N--CA 1.468 0.81 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.4 p -125.24 157.22 37.1 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.672 0.389 . . . . 0.0 110.262 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -138.16 157.03 47.11 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.318 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.0 m -146.93 116.01 6.92 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.9 m -106.99 112.62 25.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 m -92.88 120.08 32.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 16.7 ptm -143.14 142.12 31.39 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.79 152.73 40.78 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.028 0.442 . . . . 0.0 110.748 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.08 148.71 50.58 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.636 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -57.89 -39.32 77.58 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.591 0.234 . . . . 0.0 110.523 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 39.6 p30 -78.05 -6.06 53.41 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.78 17.51 54.57 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 80.1 p -66.37 -25.52 66.83 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.769 0.319 . . . . 0.0 110.389 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 28.2 ttt -149.09 145.34 27.18 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.916 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.7 t -142.7 144.85 32.89 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.737 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.408 ' CD2' ' N ' ' A' ' 66' ' ' ASP . 71.1 t80 -159.35 162.53 35.91 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.408 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 30.3 p-10 -138.04 130.69 29.55 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.098 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -94.54 137.61 33.44 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -153.27 154.96 25.85 Favored Glycine 0 N--CA 1.464 0.553 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.71 -176.03 40.41 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.4 t -126.24 133.26 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -75.44 115.49 15.15 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -73.85 -44.84 54.31 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.184 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -153.23 145.87 24.23 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 11.1 p -148.1 137.3 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -143.06 132.37 23.34 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 28.9 m -56.77 128.62 37.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.732 0.301 . . . . 0.0 111.453 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 54.88 69.38 0.74 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.767 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -165.84 -80.58 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -160.35 159.99 31.85 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.976 0.417 . . . . 0.0 110.795 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.9 mt -134.74 135.63 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.86 155.55 41.06 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -159.09 159.65 34.82 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 49.6 m -102.25 129.89 48.79 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.5 tt -94.57 167.1 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.91 -38.11 94.86 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -63.28 -16.77 61.34 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 117.184 0.492 . . . . 0.0 109.962 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.21 11.6 78.05 Favored Glycine 0 N--CA 1.47 0.937 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -77.86 148.36 34.69 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -83.92 153.96 23.66 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 40.0 t -144.99 130.5 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -137.21 122.01 18.74 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.9 mt -122.46 113.93 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.4 p -118.82 131.75 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-O 121.279 0.561 . . . . 0.0 110.034 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -97.13 109.21 22.01 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 61.3 m -98.22 122.95 42.01 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -101.8 146.73 27.38 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 34.3 m -146.62 99.32 3.19 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.411 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 56.89 -95.43 0.04 OUTLIER Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -128.56 48.4 2.32 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.006 0.431 . . . . 0.0 110.587 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.6 m -161.35 119.22 2.33 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.0 m -95.27 141.09 29.26 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -127.45 129.48 47.57 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.2 mt -103.07 125.53 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.7 t -122.68 127.83 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -142.92 144.62 32.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.23 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.8 t -136.11 143.11 44.38 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.079 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -127.57 169.19 13.99 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.671 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -132.07 79.39 67.0 Favored Pre-proline 0 N--CA 1.473 0.681 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.722 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -59.03 168.23 4.77 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.141 1.894 . . . . 0.0 111.697 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.95 168.9 2.17 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.113 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -81.78 -44.7 16.63 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.781 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.7 t -65.32 -36.15 83.18 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.251 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -67.31 146.01 98.71 Favored Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 119.573 -0.251 . . . . 0.0 110.604 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.23 120.81 7.02 Favored 'Trans proline' 0 N--CA 1.504 2.092 0 C-N-CA 121.758 1.639 . . . . 0.0 111.767 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 81.7 mtm-85 -65.4 -39.67 92.48 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.763 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -54.84 -44.24 73.73 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.607 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.5 tp -60.74 -43.52 97.83 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.147 0.499 . . . . 0.0 110.655 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -64.37 -43.05 95.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.425 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -54.13 -44.43 71.35 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.805 0.336 . . . . 0.0 110.299 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 78.8 p -68.28 -35.9 78.56 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.83 -51.99 51.6 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -64.22 -37.08 86.21 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.816 0.341 . . . . 0.0 110.421 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -72.4 -37.43 68.7 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.461 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.99 67.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.909 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.5 tt -60.89 -36.96 75.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 47.8 mt -66.19 -49.1 68.46 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.467 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -75.78 -33.71 60.19 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.664 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.0 m -60.54 -40.34 91.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.32 . . . . 0.0 110.399 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -56.84 -42.65 80.03 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.512 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -60.68 -39.0 86.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.671 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 29.0 m -58.34 -46.65 85.81 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.988 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -65.45 -37.88 88.18 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.374 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 97.8 m -60.46 -48.19 82.83 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.8 0.333 . . . . 0.0 110.852 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -70.56 -41.68 72.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.385 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -66.41 -24.99 66.55 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.995 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -61.04 -41.14 96.03 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.422 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.2 mt 52.06 101.4 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.773 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -160.58 129.28 4.74 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -69.62 144.28 53.02 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -64.87 142.45 58.43 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.289 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -166.82 104.0 0.57 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.048 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -157.71 165.7 34.73 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . 0.404 ' O ' ' CG ' ' A' ' 144' ' ' HIS . 96.5 m-70 -152.58 -36.01 0.12 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.185 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.404 ' CG ' ' O ' ' A' ' 143' ' ' HIS . 33.5 p80 . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.386 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.609 ' H ' ' NH1' ' A' ' 115' ' ' ARG . 72.6 m-20 54.74 35.2 23.43 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.368 0.128 . . . . 0.0 110.918 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -126.28 55.92 1.47 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.811 0.445 . . . . 0.0 110.173 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 79.5 mt -46.14 121.28 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 m -112.89 130.7 56.01 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 m -134.48 156.59 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.406 ' CD ' ' N ' ' A' ' 7' ' ' GLU . 1.3 pm0 -148.3 161.29 41.82 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.14 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 p -145.05 143.84 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.1 m -91.17 117.29 29.5 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.8 t -124.65 128.36 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -100.16 88.57 3.75 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.74 153.59 5.01 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.048 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.12 133.28 52.67 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 20.1 tt -52.25 -37.53 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.776 0.322 . . . . 0.0 111.733 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -58.96 -35.58 73.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.356 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -74.92 -46.07 38.29 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.022 0.439 . . . . 0.0 110.442 178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.09 -43.28 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.189 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.698 ' CH2' HD11 ' A' ' 80' ' ' ILE . 28.0 t-105 -54.86 -46.09 74.65 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.84 0.352 . . . . 0.0 110.943 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.78 -45.85 77.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.335 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -65.19 -43.75 90.61 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.894 0.378 . . . . 0.0 111.166 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -69.5 -15.96 63.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.561 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -109.52 -24.64 10.89 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.274 0.63 . . . . 0.0 111.298 -178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -65.09 117.23 37.43 Favored Pre-proline 0 CA--C 1.553 1.063 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.499 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.97 -34.59 10.33 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 CA-C-N 121.033 1.405 . . . . 0.0 112.005 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -34.22 70.56 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.002 0.429 . . . . 0.0 110.575 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -81.17 -40.89 23.21 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.405 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.9 -45.4 98.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 122.069 -0.394 . . . . 0.0 111.088 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.7 ptm -59.32 -12.85 6.35 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.335 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -81.32 -39.71 24.72 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -120.22 20.76 11.95 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.654 0.381 . . . . 0.0 111.183 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.606 ' C ' ' H ' ' A' ' 33' ' ' ALA . 12.9 t -57.54 135.82 56.68 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.829 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 67.83 -26.29 0.13 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.612 0.57 . . . . 0.0 110.327 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.606 ' H ' ' C ' ' A' ' 31' ' ' CYS . . . 55.5 27.33 10.09 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.565 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.1 t -124.06 139.92 33.64 Favored Pre-proline 0 N--CA 1.478 0.93 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.253 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.54 -8.9 19.8 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 121.95 1.767 . . . . 0.0 111.668 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -83.16 9.26 10.92 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.622 0.249 . . . . 0.0 110.668 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -151.72 157.72 42.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.242 0.544 . . . . 0.0 110.072 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -147.58 163.5 36.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.105 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.57 93.14 48.69 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 123.023 0.529 . . . . 0.0 109.853 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.46 -8.79 19.81 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.488 1.459 . . . . 0.0 111.597 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.72 151.99 9.56 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.844 0.354 . . . . 0.0 110.228 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.02 144.94 14.96 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.247 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -137.59 145.11 42.41 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -162.03 134.02 5.57 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.853 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -132.99 99.42 4.57 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.5 96.58 0.53 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -166.62 147.77 6.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.09 137.55 58.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.1 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.78 5.19 44.41 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.89 151.54 33.87 Favored Glycine 0 N--CA 1.466 0.655 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.1 p -113.42 161.46 17.28 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -143.51 166.03 25.93 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.215 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.3 m -160.49 128.61 4.6 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.1 m -122.78 123.4 40.96 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -92.35 115.65 28.28 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.3 mtt -120.68 132.43 55.09 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.43 136.15 23.21 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.794 0.331 . . . . 0.0 110.699 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.66 148.77 45.39 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -58.58 -39.54 80.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.723 0.297 . . . . 0.0 110.32 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -74.16 -11.38 60.28 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.25 17.12 67.85 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.4 m -61.89 -40.46 95.5 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.847 0.356 . . . . 0.0 110.725 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 44.4 ttp -147.1 149.55 33.25 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.187 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.1 t -145.04 152.35 39.98 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.329 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -156.5 155.5 32.09 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 p-10 -138.24 131.11 29.71 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.872 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -95.81 145.36 25.4 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.97 153.31 24.91 Favored Glycine 0 N--CA 1.466 0.65 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -179.09 -171.14 41.93 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.9 p -132.46 145.89 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -82.87 126.12 32.11 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -81.74 -26.9 34.16 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 110.035 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -167.59 140.27 3.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.839 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.5 t -137.24 126.92 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -145.66 124.72 12.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.0 m -50.07 119.57 3.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 53.67 75.8 0.25 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.443 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -168.16 -81.31 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.365 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.435 HD11 ' HE ' ' A' ' 91' ' ' ARG . 7.1 tp -149.94 135.03 17.95 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.902 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.698 HD11 ' CH2' ' A' ' 18' ' ' TRP . 79.0 mt -128.69 130.02 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -153.09 165.35 35.89 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -158.77 164.54 35.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.511 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.6 m -116.26 129.77 56.45 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.7 mm -98.37 149.16 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.961 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -54.72 -40.39 71.04 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -60.96 -15.8 35.5 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.656 0.265 . . . . 0.0 110.503 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 98.4 -2.85 59.35 Favored Glycine 0 N--CA 1.473 1.138 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.6 mtp85 -64.96 143.77 57.73 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -123.66 139.88 53.55 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.6 t -133.57 134.67 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.435 ' HE ' HD11 ' A' ' 79' ' ' LEU . 77.0 ttt180 -127.51 122.72 34.11 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 68.7 mt -110.78 124.1 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.8 123.21 70.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -94.98 123.29 38.37 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 73.9 p -134.06 150.69 51.21 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -154.38 164.4 38.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.902 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 m -149.5 118.53 6.72 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.753 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 60.09 -94.47 0.07 OUTLIER Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -130.99 31.77 4.41 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.666 0.386 . . . . 0.0 111.015 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 46.4 m -132.16 124.85 29.89 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.8 m -100.86 133.46 45.3 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -122.37 117.53 26.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.9 mt -98.01 129.04 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 45.1 t -119.48 130.84 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -132.63 120.07 21.28 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 15.0 t -99.22 148.2 24.36 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -136.01 149.92 49.01 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -131.68 78.21 71.19 Favored Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -84.17 -169.85 0.74 Allowed 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.106 1.871 . . . . 0.0 111.141 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 110' ' ' GLU . 28.1 mp0 -65.43 129.28 39.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.074 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -64.05 -34.55 78.28 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.216 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 78.9 p -65.22 -38.64 91.04 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.95 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -64.7 149.16 96.26 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.36 -179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.33 106.53 1.95 Allowed 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 121.866 1.711 . . . . 0.0 111.398 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.609 ' NH1' ' H ' ' A' ' 2' ' ' ASN . 89.8 mtm180 -62.49 -32.8 73.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.332 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -48.92 -49.82 38.24 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.622 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 49.6 mt -68.34 -39.51 81.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.717 0.294 . . . . 0.0 110.928 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -61.43 -45.85 92.58 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.644 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -55.23 -43.48 74.56 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.084 0.469 . . . . 0.0 109.771 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.4 m -62.23 -40.73 97.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.165 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.15 -51.99 48.23 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -63.35 -37.25 86.56 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.78 0.324 . . . . 0.0 110.277 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -72.1 -36.24 69.41 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.683 0.278 . . . . 0.0 110.338 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.55 -51.25 70.69 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.789 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.6 tt -62.62 -39.23 83.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 25.5 mt -63.87 -39.14 93.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -63.89 -40.95 97.7 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.6 m -58.37 -30.65 66.95 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.344 0.403 . . . . 0.0 111.232 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -51.14 -20.2 1.42 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.933 0.397 . . . . 0.0 110.898 -178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -70.12 -38.99 75.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.715 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 49.0 m -58.25 -44.14 88.17 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.196 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -61.68 -50.5 72.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.522 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 74.5 p -65.29 -39.97 93.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.787 0.327 . . . . 0.0 110.372 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -67.74 -35.55 78.95 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -61.97 -41.69 98.29 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.377 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -63.41 -43.32 97.84 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.385 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.0 tp -97.13 108.55 21.3 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -169.7 95.9 0.29 Allowed 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -66.3 82.13 0.09 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 80.5 t60 58.0 160.45 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.593 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -167.11 159.39 12.98 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.182 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -65.64 133.97 52.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.938 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -68.16 133.94 49.71 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 86.1 t60 . . . . . 0 C--O 1.219 -0.535 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.181 179.835 . . . . . . . . 0 0 . 1 stop_ save_